{
  "file_name": "(가이드라인-005)_정맥주사용+B형간염+사람면역글로불린제제의+안전성유효성+평가+가이드라인.pdf",
  "total_pages": 28,
  "pdf_type": "normal",
  "font_analysis": {
    "font_sizes_frequency": {
      "27.937164306640625": 7,
      "17.985300064086914": 1,
      "20.02363395690918": 1,
      "11.99020004272461": 14,
      "11.030982971191406": 71,
      "14.987749099731445": 2,
      "17.02608299255371": 1,
      "9.951866149902344": 2,
      "14.028532981872559": 7,
      "12.94941520690918": 9,
      "24.0": 9,
      "20.040000915527344": 11,
      "15.960000038146973": 3,
      "12.0": 783,
      "11.384199142456055": 1,
      "15.0": 18,
      "20.855199813842773": 2,
      "12.960000038146973": 107,
      "9.960000038146973": 1179,
      "18.0": 5,
      "8.039999961853027": 40
    },
    "heading_sizes": [
      27.937164306640625,
      24.0,
      20.855199813842773,
      20.040000915527344,
      18.0,
      15.960000038146973,
      15.0,
      14.987749099731445,
      14.028532981872559,
      12.960000038146973,
      12.94941520690918,
      12.0,
      11.99020004272461,
      11.030982971191406
    ]
  },
  "table_analysis": {
    "total_tables": 2,
    "tables_info": [
      {
        "bbox": [
          70.76165008544922,
          196.56948852539062,
          506.365234375,
          520.97900390625
        ],
        "num_rows": 8,
        "num_cols": 2
      },
      {
        "bbox": [
          71.99789428710938,
          318.8090515136719,
          527.0040893554688,
          605.3700561523438
        ],
        "num_rows": 4,
        "num_cols": 2
      }
    ]
  },
  "text_blocks": [
    {
      "text": "Biopharmaceuticals",
      "font_size": 27.937164306640625,
      "font_name": "Arial-Black",
      "bbox": [
        128.98289489746094,
        401.50750732421875,
        435.81024169921875,
        440.8929443359375
      ],
      "page_num": 1,
      "block_type": "heading",
      "level": 1,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Biopharmaceuticals",
      "font_size": 27.937164306640625,
      "font_name": "Arial-Black",
      "bbox": [
        128.98289489746094,
        401.50750732421875,
        435.81024169921875,
        440.8929443359375
      ],
      "page_num": 1,
      "block_type": "heading",
      "level": 1,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "정맥주사용 B형 간염 사람면역글로불린",
      "font_size": 27.937164306640625,
      "font_name": "HYgtrE",
      "bbox": [
        52.823997497558594,
        171.39183044433594,
        542.513427734375,
        199.32131958007812
      ],
      "page_num": 1,
      "block_type": "heading",
      "level": 1,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "제제의 안전성·유효성 평가 가이드라인",
      "font_size": 27.937164306640625,
      "font_name": "HYgtrE",
      "bbox": [
        49.945556640625,
        215.0240936279297,
        545.2744140625,
        242.95358276367188
      ],
      "page_num": 1,
      "block_type": "heading",
      "level": 1,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "[민원인 안내서]",
      "font_size": 27.937164306640625,
      "font_name": "HYgtrE",
      "bbox": [
        197.58554077148438,
        258.6563720703125,
        397.24322509765625,
        286.5858459472656
      ],
      "page_num": 1,
      "block_type": "heading",
      "level": 1,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Biopharmaceuticals",
      "font_size": 27.937164306640625,
      "font_name": "Arial-Black",
      "bbox": [
        128.98289489746094,
        401.50799560546875,
        435.8101806640625,
        440.8929443359375
      ],
      "page_num": 1,
      "block_type": "heading",
      "level": 1,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Biopharmaceuticals",
      "font_size": 27.937164306640625,
      "font_name": "Arial-Black",
      "bbox": [
        128.98289489746094,
        401.50799560546875,
        435.8101806640625,
        440.8929443359375
      ],
      "page_num": 1,
      "block_type": "heading",
      "level": 1,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2008.12.",
      "font_size": 17.985300064086914,
      "font_name": "Gulim",
      "bbox": [
        280.0693054199219,
        465.5794982910156,
        353.0014953613281,
        483.5598449707031
      ],
      "page_num": 1,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "제·개정 이력서",
      "font_size": 20.02363395690918,
      "font_name": "MalgunGothicBold",
      "bbox": [
        230.2751922607422,
        94.36575317382812,
        364.6021728515625,
        120.99142456054688
      ],
      "page_num": 2,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "연번",
      "font_size": 11.99020004272461,
      "font_name": "MalgunGothicBold",
      "bbox": [
        68.4828872680664,
        258.2172546386719,
        451.1954650878906,
        274.1607666015625
      ],
      "page_num": 2,
      "block_type": "heading",
      "level": 13,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "제·개정번호",
      "font_size": 11.99020004272461,
      "font_name": "MalgunGothicBold",
      "bbox": [
        68.4828872680664,
        258.2172546386719,
        451.1954650878906,
        274.1607666015625
      ],
      "page_num": 2,
      "block_type": "heading",
      "level": 13,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "승인일자",
      "font_size": 11.99020004272461,
      "font_name": "MalgunGothicBold",
      "bbox": [
        68.4828872680664,
        258.2172546386719,
        451.1954650878906,
        274.1607666015625
      ],
      "page_num": 2,
      "block_type": "heading",
      "level": 13,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "주요내용",
      "font_size": 11.99020004272461,
      "font_name": "MalgunGothicBold",
      "bbox": [
        68.4828872680664,
        258.2172546386719,
        451.1954650878906,
        274.1607666015625
      ],
      "page_num": 2,
      "block_type": "heading",
      "level": 13,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1",
      "font_size": 11.99020004272461,
      "font_name": "MalgunGothicRegular",
      "bbox": [
        77.2381362915039,
        288.06463623046875,
        438.24249267578125,
        304.0081481933594
      ],
      "page_num": 2,
      "block_type": "heading",
      "level": 13,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "B1-2008-3-020",
      "font_size": 11.99020004272461,
      "font_name": "MalgunGothicRegular",
      "bbox": [
        77.2381362915039,
        288.06463623046875,
        438.24249267578125,
        304.0081481933594
      ],
      "page_num": 2,
      "block_type": "heading",
      "level": 13,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2008.12",
      "font_size": 11.99020004272461,
      "font_name": "MalgunGothicRegular",
      "bbox": [
        77.2381362915039,
        288.06463623046875,
        438.24249267578125,
        304.0081481933594
      ],
      "page_num": 2,
      "block_type": "heading",
      "level": 13,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "제정",
      "font_size": 11.030982971191406,
      "font_name": "MalgunGothicRegular",
      "bbox": [
        77.2381362915039,
        288.06463623046875,
        438.24249267578125,
        304.0081481933594
      ],
      "page_num": 2,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2",
      "font_size": 11.99020004272461,
      "font_name": "MalgunGothicRegular",
      "bbox": [
        77.2381362915039,
        313.2019958496094,
        535.7906494140625,
        338.7781066894531
      ],
      "page_num": 2,
      "block_type": "heading",
      "level": 13,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "안내서-0256-01",
      "font_size": 11.99020004272461,
      "font_name": "MalgunGothicRegular",
      "bbox": [
        77.2381362915039,
        313.2019958496094,
        535.7906494140625,
        338.7781066894531
      ],
      "page_num": 2,
      "block_type": "heading",
      "level": 13,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2017.06.01",
      "font_size": 11.99020004272461,
      "font_name": "MalgunGothicRegular",
      "bbox": [
        77.2381362915039,
        313.2019958496094,
        535.7906494140625,
        338.7781066894531
      ],
      "page_num": 2,
      "block_type": "heading",
      "level": 13,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "「식품의약품안전처 지침서등의 관리에 관한",
      "font_size": 11.030982971191406,
      "font_name": "MalgunGothicRegular",
      "bbox": [
        77.2381362915039,
        313.2019958496094,
        535.7906494140625,
        338.7781066894531
      ],
      "page_num": 2,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "규정」 개정에 따른 등록번호 일괄 정비",
      "font_size": 11.030982971191406,
      "font_name": "MalgunGothicRegular",
      "bbox": [
        77.2381362915039,
        313.2019958496094,
        535.7906494140625,
        338.7781066894531
      ],
      "page_num": 2,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "정맥주사용 B형 간염 사람면역글로불린제제의",
      "font_size": 14.987749099731445,
      "font_name": "MalgunGothicBold",
      "bbox": [
        161.19264221191406,
        169.3692169189453,
        437.2516784667969,
        208.83726501464844
      ],
      "page_num": 2,
      "block_type": "heading",
      "level": 8,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "안전성·유효성 평가 가이드라인(민원인 안내서)",
      "font_size": 14.987749099731445,
      "font_name": "MalgunGothicBold",
      "bbox": [
        161.19264221191406,
        169.3692169189453,
        437.2516784667969,
        208.83726501464844
      ],
      "page_num": 2,
      "block_type": "heading",
      "level": 8,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "지침‧가이드라인‧해설서 (지침 등) 재분류 점검표",
      "font_size": 17.02608299255371,
      "font_name": "H2hdrM",
      "bbox": [
        113.09870147705078,
        110.29235076904297,
        477.5811462402344,
        127.31375122070312
      ],
      "page_num": 3,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "지침 등 명칭",
      "font_size": 11.030982971191406,
      "font_name": "MalgunGothicBold",
      "bbox": [
        63.68548583984375,
        150.65963745117188,
        526.5059204101562,
        165.3276824951172
      ],
      "page_num": 3,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "정맥주사용 B형 간염 사람면역글로불린제제의 안전성·유효성 평가 가이드라인(민원인 안내서)",
      "font_size": 11.030982971191406,
      "font_name": "MalgunGothicBold",
      "bbox": [
        63.68548583984375,
        150.65963745117188,
        526.5059204101562,
        165.3276824951172
      ],
      "page_num": 3,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "아래에 해당하는 사항에 체크하여 주시기 바랍니다.",
      "font_size": 11.030982971191406,
      "font_name": "MalgunGothicBold",
      "bbox": [
        164.91062927246094,
        179.068603515625,
        426.138427734375,
        193.73663330078125
      ],
      "page_num": 3,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "폐지대상",
      "font_size": 11.030982971191406,
      "font_name": "MalgunGothicBold",
      "bbox": [
        70.76165008544922,
        266.8127136230469,
        114.77745819091797,
        281.4807434082031
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "여부",
      "font_size": 11.030982971191406,
      "font_name": "MalgunGothicBold",
      "bbox": [
        81.79566955566406,
        281.1969909667969,
        103.86370849609375,
        295.8650207519531
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "□ 법령(법‧시행령‧시행규칙) 또는 행정규칙(고시‧훈령‧예규) 등을",
      "font_size": 11.030982971191406,
      "font_name": "MalgunGothicRegular",
      "bbox": [
        132.64810180664062,
        196.56948852539062,
        450.51654052734375,
        211.23751831054688
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "나열하는 것입니까?",
      "font_size": 11.030982971191406,
      "font_name": "MalgunGothicRegular",
      "bbox": [
        149.79881286621094,
        210.83389282226562,
        248.42637634277344,
        225.50192260742188
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "□ 예",
      "font_size": 11.030982971191406,
      "font_name": "MalgunGothicRegular",
      "bbox": [
        456.95233154296875,
        196.56948852539062,
        506.365234375,
        225.50192260742188
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "■ 아니오",
      "font_size": 11.030982971191406,
      "font_name": "MalgunGothicRegular",
      "bbox": [
        456.95233154296875,
        196.56948852539062,
        506.365234375,
        225.50192260742188
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "□ 단순한 사실을 대외적으로 알리는 공고의 내용입니까?",
      "font_size": 11.030982971191406,
      "font_name": "MalgunGothicRegular",
      "bbox": [
        132.64810180664062,
        224.61883544921875,
        506.365234375,
        253.671142578125
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "□ 예",
      "font_size": 11.030982971191406,
      "font_name": "MalgunGothicRegular",
      "bbox": [
        132.64810180664062,
        224.61883544921875,
        506.365234375,
        253.671142578125
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "■ 아니오",
      "font_size": 11.030982971191406,
      "font_name": "MalgunGothicRegular",
      "bbox": [
        132.64810180664062,
        224.61883544921875,
        506.365234375,
        253.671142578125
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "□ 일회성 지시 또는 일일 명령에 해당하는 내용입니까?",
      "font_size": 11.030982971191406,
      "font_name": "MalgunGothicRegular",
      "bbox": [
        132.64810180664062,
        252.78802490234375,
        506.365234375,
        281.720458984375
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "□ 예",
      "font_size": 11.030982971191406,
      "font_name": "MalgunGothicRegular",
      "bbox": [
        132.64810180664062,
        252.78802490234375,
        506.365234375,
        281.720458984375
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "■ 아니오",
      "font_size": 11.030982971191406,
      "font_name": "MalgunGothicRegular",
      "bbox": [
        132.64810180664062,
        252.78802490234375,
        506.365234375,
        281.720458984375
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "□ 외국 규정을 번역하거나 설명하는 내용입니까?",
      "font_size": 11.030982971191406,
      "font_name": "MalgunGothicRegular",
      "bbox": [
        132.64810180664062,
        280.8373718261719,
        506.365234375,
        309.8896789550781
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "□ 예",
      "font_size": 11.030982971191406,
      "font_name": "MalgunGothicRegular",
      "bbox": [
        132.64810180664062,
        280.8373718261719,
        506.365234375,
        309.8896789550781
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "■ 아니오",
      "font_size": 11.030982971191406,
      "font_name": "MalgunGothicRegular",
      "bbox": [
        132.64810180664062,
        280.8373718261719,
        506.365234375,
        309.8896789550781
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "□ 정보제공 등 직원 교육용 자료입니까?",
      "font_size": 11.030982971191406,
      "font_name": "MalgunGothicRegular",
      "bbox": [
        132.64810180664062,
        309.006591796875,
        506.365234375,
        337.93902587890625
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "□ 예",
      "font_size": 11.030982971191406,
      "font_name": "MalgunGothicRegular",
      "bbox": [
        132.64810180664062,
        309.006591796875,
        506.365234375,
        337.93902587890625
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "■ 아니오",
      "font_size": 11.030982971191406,
      "font_name": "MalgunGothicRegular",
      "bbox": [
        132.64810180664062,
        309.006591796875,
        506.365234375,
        337.93902587890625
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "상기 사항 중 어느 하나라도 ‘예’에 해당되는 경우에 폐지 대상입니다.",
      "font_size": 11.030982971191406,
      "font_name": "MalgunGothicRegular",
      "bbox": [
        132.64810180664062,
        337.0559387207031,
        444.2542419433594,
        366.1082458496094
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "폐지 대상에 해당합니까?",
      "font_size": 11.030982971191406,
      "font_name": "MalgunGothicRegular",
      "bbox": [
        132.64810180664062,
        337.0559387207031,
        444.2542419433594,
        366.1082458496094
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "□ 예",
      "font_size": 11.030982971191406,
      "font_name": "MalgunGothicRegular",
      "bbox": [
        456.95233154296875,
        337.0559387207031,
        506.365234375,
        366.1082458496094
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "■ 아니오",
      "font_size": 11.030982971191406,
      "font_name": "MalgunGothicRegular",
      "bbox": [
        456.95233154296875,
        337.0559387207031,
        506.365234375,
        366.1082458496094
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "등록대상",
      "font_size": 11.030982971191406,
      "font_name": "MalgunGothicBold",
      "bbox": [
        70.76165008544922,
        428.6358642578125,
        118.65660858154297,
        457.56829833984375
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "세부정보",
      "font_size": 11.030982971191406,
      "font_name": "MalgunGothicBold",
      "bbox": [
        70.76165008544922,
        428.6358642578125,
        118.65660858154297,
        457.56829833984375
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "□ 내부적으로 행정사무의 통일을 기하기 위하여 반복적으로 행정",
      "font_size": 11.030982971191406,
      "font_name": "MalgunGothicRegular",
      "bbox": [
        132.64810180664062,
        365.22515869140625,
        446.6377868652344,
        379.8931884765625
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "사무의 세부기준이나 절차를 제시하는 것입니까? (지침)",
      "font_size": 11.030982971191406,
      "font_name": "MalgunGothicRegular",
      "bbox": [
        149.1991424560547,
        379.48956298828125,
        416.45501708984375,
        394.1575927734375
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "□ 예",
      "font_size": 11.030982971191406,
      "font_name": "MalgunGothicRegular",
      "bbox": [
        456.95233154296875,
        365.22515869140625,
        506.365234375,
        394.1575927734375
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "■ 아니오",
      "font_size": 11.030982971191406,
      "font_name": "MalgunGothicRegular",
      "bbox": [
        456.95233154296875,
        365.22515869140625,
        506.365234375,
        394.1575927734375
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "□ 대내외적으로 특정한 사안 등에 대하여 식약처의 입장을 기술",
      "font_size": 11.030982971191406,
      "font_name": "MalgunGothicRegular",
      "bbox": [
        132.64810180664062,
        393.2745056152344,
        446.6377868652344,
        407.9425354003906
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "하는 것입니까? (가이드라인)",
      "font_size": 11.030982971191406,
      "font_name": "MalgunGothicRegular",
      "bbox": [
        149.1991424560547,
        407.6587829589844,
        291.0030212402344,
        422.3268127441406
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "■ 예",
      "font_size": 11.030982971191406,
      "font_name": "MalgunGothicRegular",
      "bbox": [
        456.95233154296875,
        393.2745056152344,
        506.365234375,
        422.3268127441406
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "□ 아니오",
      "font_size": 11.030982971191406,
      "font_name": "MalgunGothicRegular",
      "bbox": [
        456.95233154296875,
        393.2745056152344,
        506.365234375,
        422.3268127441406
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "□ 법령, 고시‧훈령‧예규와 같은 규정 또는 식약처장이 정한 특정한",
      "font_size": 11.030982971191406,
      "font_name": "MalgunGothicRegular",
      "bbox": [
        132.64810180664062,
        421.4437255859375,
        450.5161437988281,
        436.11175537109375
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "사안에 대하여 그 절차 등의 내용을 알기 쉽게 풀어 설명하거나",
      "font_size": 11.030982971191406,
      "font_name": "MalgunGothicRegular",
      "bbox": [
        149.1991424560547,
        435.7081298828125,
        450.5172424316406,
        464.76043701171875
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "질의‧응답하는 형태입니까? (해설서)",
      "font_size": 11.030982971191406,
      "font_name": "MalgunGothicRegular",
      "bbox": [
        149.1991424560547,
        435.7081298828125,
        450.5172424316406,
        464.76043701171875
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "□ 예",
      "font_size": 11.030982971191406,
      "font_name": "MalgunGothicRegular",
      "bbox": [
        456.95233154296875,
        428.6358642578125,
        506.365234375,
        457.56829833984375
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "■ 아니오",
      "font_size": 11.030982971191406,
      "font_name": "MalgunGothicRegular",
      "bbox": [
        456.95233154296875,
        428.6358642578125,
        506.365234375,
        457.56829833984375
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "□ 내부 직원용(위임‧위탁기관 직원 포함)에 해당합니까?",
      "font_size": 11.030982971191406,
      "font_name": "MalgunGothicRegular",
      "bbox": [
        132.64810180664062,
        463.8773498535156,
        416.81207275390625,
        492.8097839355469
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(“예”인 경우, 지침에 해당)",
      "font_size": 11.030982971191406,
      "font_name": "MalgunGothicRegular",
      "bbox": [
        132.64810180664062,
        463.8773498535156,
        416.81207275390625,
        492.8097839355469
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "□ 예",
      "font_size": 11.030982971191406,
      "font_name": "MalgunGothicRegular",
      "bbox": [
        456.95233154296875,
        463.8773498535156,
        506.365234375,
        492.8097839355469
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "■ 아니오",
      "font_size": 11.030982971191406,
      "font_name": "MalgunGothicRegular",
      "bbox": [
        456.95233154296875,
        463.8773498535156,
        506.365234375,
        492.8097839355469
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "□ 외부(관련 협회, 민원인 등) 참고용에 해당합니까?",
      "font_size": 11.030982971191406,
      "font_name": "MalgunGothicRegular",
      "bbox": [
        132.64810180664062,
        491.92669677734375,
        399.54144287109375,
        520.97900390625
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(“예”인 경우, 가이드라인 또는 해설서에 해당)",
      "font_size": 11.030982971191406,
      "font_name": "MalgunGothicRegular",
      "bbox": [
        132.64810180664062,
        491.92669677734375,
        399.54144287109375,
        520.97900390625
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "■ 예",
      "font_size": 11.030982971191406,
      "font_name": "MalgunGothicRegular",
      "bbox": [
        456.95233154296875,
        491.92669677734375,
        506.365234375,
        520.97900390625
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "□ 아니오",
      "font_size": 11.030982971191406,
      "font_name": "MalgunGothicRegular",
      "bbox": [
        456.95233154296875,
        491.92669677734375,
        506.365234375,
        520.97900390625
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "등록번호",
      "font_size": 11.030982971191406,
      "font_name": "MalgunGothicBold",
      "bbox": [
        70.76165008544922,
        533.880859375,
        349.1304626464844,
        548.5488891601562
      ],
      "page_num": 3,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "B1-2008-3-020",
      "font_size": 11.030982971191406,
      "font_name": "MalgunGothicBold",
      "bbox": [
        70.76165008544922,
        533.880859375,
        349.1304626464844,
        548.5488891601562
      ],
      "page_num": 3,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "현행분류",
      "font_size": 11.030982971191406,
      "font_name": "MalgunGothicBold",
      "bbox": [
        70.76165008544922,
        533.880859375,
        349.1304626464844,
        548.5488891601562
      ],
      "page_num": 3,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "□ 지침",
      "font_size": 11.030982971191406,
      "font_name": "MalgunGothicBold",
      "bbox": [
        359.68505859375,
        520.095947265625,
        436.562744140625,
        562.3338623046875
      ],
      "page_num": 3,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "■ 가이드라인",
      "font_size": 11.030982971191406,
      "font_name": "MalgunGothicBold",
      "bbox": [
        359.68505859375,
        520.095947265625,
        436.562744140625,
        562.3338623046875
      ],
      "page_num": 3,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "□ 해설서",
      "font_size": 11.030982971191406,
      "font_name": "MalgunGothicBold",
      "bbox": [
        359.68505859375,
        520.095947265625,
        436.562744140625,
        562.3338623046875
      ],
      "page_num": 3,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "분류",
      "font_size": 11.030982971191406,
      "font_name": "MalgunGothicBold",
      "bbox": [
        76.7583999633789,
        595.6134033203125,
        108.90049743652344,
        624.5458374023438
      ],
      "page_num": 3,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "적정성",
      "font_size": 11.030982971191406,
      "font_name": "MalgunGothicBold",
      "bbox": [
        76.7583999633789,
        595.6134033203125,
        108.90049743652344,
        624.5458374023438
      ],
      "page_num": 3,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "□ 해당 지침 등의 분류가 적정합니까?",
      "font_size": 11.030982971191406,
      "font_name": "MalgunGothicRegular",
      "bbox": [
        132.64810180664062,
        561.4507446289062,
        506.365234375,
        590.5030517578125
      ],
      "page_num": 3,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "■ 예",
      "font_size": 11.030982971191406,
      "font_name": "MalgunGothicRegular",
      "bbox": [
        132.64810180664062,
        561.4507446289062,
        506.365234375,
        590.5030517578125
      ],
      "page_num": 3,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "□ 아니오",
      "font_size": 11.030982971191406,
      "font_name": "MalgunGothicRegular",
      "bbox": [
        132.64810180664062,
        561.4507446289062,
        506.365234375,
        590.5030517578125
      ],
      "page_num": 3,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "□ “아니오”인 경우 변경분류 사항에 체크하여 주십시오",
      "font_size": 11.030982971191406,
      "font_name": "MalgunGothicRegular",
      "bbox": [
        132.64810180664062,
        589.6199340820312,
        415.69439697265625,
        632.3373413085938
      ],
      "page_num": 3,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "□ 지침         □ 가이드라인      □ 해설서",
      "font_size": 11.030982971191406,
      "font_name": "MalgunGothicBold",
      "bbox": [
        132.64810180664062,
        589.6199340820312,
        415.69439697265625,
        632.3373413085938
      ],
      "page_num": 3,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "□ 지침에 해당하는 경우, 예규로 전환이 필요합니까?",
      "font_size": 11.030982971191406,
      "font_name": "MalgunGothicRegular",
      "bbox": [
        132.64810180664062,
        589.6199340820312,
        415.69439697265625,
        632.3373413085938
      ],
      "page_num": 3,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "*“예규“란 행정사무의 통일을 기하기 위한 것으로 반복적 행정사무의 처리",
      "font_size": 9.951866149902344,
      "font_name": "T6",
      "bbox": [
        137.6853790283203,
        633.2679443359375,
        446.63824462890625,
        658.1527099609375
      ],
      "page_num": 3,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "기준을 제시하는 행정규칙의 형태로, 식약처 전 부서에 해당하는 사항임",
      "font_size": 9.951866149902344,
      "font_name": "T6",
      "bbox": [
        137.6853790283203,
        633.2679443359375,
        446.63824462890625,
        658.1527099609375
      ],
      "page_num": 3,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "□ 예",
      "font_size": 11.030982971191406,
      "font_name": "MalgunGothicRegular",
      "bbox": [
        456.95233154296875,
        623.6627197265625,
        506.365234375,
        652.715087890625
      ],
      "page_num": 3,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "□ 아니오",
      "font_size": 11.030982971191406,
      "font_name": "MalgunGothicRegular",
      "bbox": [
        456.95233154296875,
        623.6627197265625,
        506.365234375,
        652.715087890625
      ],
      "page_num": 3,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "상기 사항에 대하여 확인하였음.",
      "font_size": 11.030982971191406,
      "font_name": "MalgunGothicBold",
      "bbox": [
        213.12449645996094,
        657.825439453125,
        378.884033203125,
        672.4934692382812
      ],
      "page_num": 3,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2017년   06월   01일",
      "font_size": 11.030982971191406,
      "font_name": "MalgunGothicBold",
      "bbox": [
        219.48104858398438,
        688.0324096679688,
        361.1242980957031,
        702.700439453125
      ],
      "page_num": 3,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "확  인(부서장)",
      "font_size": 11.030982971191406,
      "font_name": "MalgunGothicBold",
      "bbox": [
        276.0903625488281,
        716.6810913085938,
        519.68212890625,
        731.34912109375
      ],
      "page_num": 3,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "정 혜 주 (서   명)",
      "font_size": 11.030982971191406,
      "font_name": "MalgunGothicRegular",
      "bbox": [
        276.0903625488281,
        716.6810913085938,
        519.68212890625,
        731.34912109375
      ],
      "page_num": 3,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "이 안내서는 바이오, 생약, 화장품의 허가 관련 질의에 대하여 알기 쉽게",
      "font_size": 14.028532981872559,
      "font_name": "MalgunGothicRegular",
      "bbox": [
        71.00151824951172,
        115.99240112304688,
        524.6110229492188,
        134.6463165283203
      ],
      "page_num": 4,
      "block_type": "heading",
      "level": 9,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "설명하거나 식품의약품안전처의 입장을 기술한 것입니다.",
      "font_size": 14.028532981872559,
      "font_name": "MalgunGothicRegular",
      "bbox": [
        71.00151824951172,
        145.3603057861328,
        402.3975524902344,
        164.01422119140625
      ],
      "page_num": 4,
      "block_type": "heading",
      "level": 9,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "본 안내서는 대외적으로 법적 효력을 가지는 것이 아니므로 본문의 기술",
      "font_size": 14.028532981872559,
      "font_name": "MalgunGothicRegular",
      "bbox": [
        71.00151824951172,
        184.67733764648438,
        519.7985229492188,
        203.3312530517578
      ],
      "page_num": 4,
      "block_type": "heading",
      "level": 9,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "방식(‘∼하여야 한다’ 등)에도 불구하고 민원인 여러분께서 반드시 준수하셔야",
      "font_size": 14.028532981872559,
      "font_name": "MalgunGothicRegular",
      "bbox": [
        71.00151824951172,
        214.0452423095703,
        524.6116333007812,
        232.69915771484375
      ],
      "page_num": 4,
      "block_type": "heading",
      "level": 9,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "하는 사항이 아님을 알려드립니다. 또한, 본 안내서는 2015년 12월 31일 현재의",
      "font_size": 14.028532981872559,
      "font_name": "MalgunGothicRegular",
      "bbox": [
        71.00151824951172,
        243.41314697265625,
        524.6116333007812,
        262.0670471191406
      ],
      "page_num": 4,
      "block_type": "heading",
      "level": 9,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "과학적ㆍ기술적 사실 및 유효한 법규를 토대로 작성되었으므로 이후 최신",
      "font_size": 14.028532981872559,
      "font_name": "MalgunGothicRegular",
      "bbox": [
        71.00151824951172,
        272.7810363769531,
        538.64404296875,
        291.4349365234375
      ],
      "page_num": 4,
      "block_type": "heading",
      "level": 9,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "개정 법규 내용 및 구체적인 사실관계 등에 따라 달리 적용될 수 있음을 알려드립니다.",
      "font_size": 14.028532981872559,
      "font_name": "MalgunGothicRegular",
      "bbox": [
        71.00151824951172,
        302.1489562988281,
        521.4933471679688,
        320.8028564453125
      ],
      "page_num": 4,
      "block_type": "heading",
      "level": 9,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "※ “민원인 안내서”란 대내외적으로 법령 또는 고시ㆍ훈령ㆍ예규 등을 알기",
      "font_size": 12.94941520690918,
      "font_name": "MalgunGothicRegular",
      "bbox": [
        71.00151824951172,
        354.2674560546875,
        524.2320556640625,
        371.4864501953125
      ],
      "page_num": 4,
      "block_type": "heading",
      "level": 11,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "쉽게 풀어서 설명하거나 특정한 사안에 대하여 식품의약품안전처의 입장을",
      "font_size": 12.94941520690918,
      "font_name": "MalgunGothicRegular",
      "bbox": [
        95.10845184326172,
        371.1689758300781,
        530.7086181640625,
        406.1285705566406
      ],
      "page_num": 4,
      "block_type": "heading",
      "level": 11,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "기술하는 것(식품의약품안전처 지침서등의 관리에 관한 규정 제2조)",
      "font_size": 12.94941520690918,
      "font_name": "MalgunGothicRegular",
      "bbox": [
        95.10845184326172,
        371.1689758300781,
        530.7086181640625,
        406.1285705566406
      ],
      "page_num": 4,
      "block_type": "heading",
      "level": 11,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "※ 본 안내서에 대한 의견이나 문의사항이 있을 경우 식품의약품안전평가원",
      "font_size": 11.99020004272461,
      "font_name": "MalgunGothicRegular",
      "bbox": [
        62.48613357543945,
        435.0240173339844,
        497.8689270019531,
        450.967529296875
      ],
      "page_num": 4,
      "block_type": "heading",
      "level": 13,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "바이오생약심사부 생물제제과에 문의하시기 바랍니다.",
      "font_size": 11.99020004272461,
      "font_name": "MalgunGothicRegular",
      "bbox": [
        56.609317779541016,
        454.20306396484375,
        383.41717529296875,
        470.1465759277344
      ],
      "page_num": 4,
      "block_type": "heading",
      "level": 13,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "전화번호 : 043-719-3451",
      "font_size": 11.99020004272461,
      "font_name": "MalgunGothicRegular",
      "bbox": [
        56.609317779541016,
        473.3821105957031,
        219.0106658935547,
        489.32562255859375
      ],
      "page_num": 4,
      "block_type": "heading",
      "level": 13,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "팩스번호 : 043-719-3450",
      "font_size": 11.99020004272461,
      "font_name": "MalgunGothicRegular",
      "bbox": [
        56.609317779541016,
        492.5611572265625,
        219.0106658935547,
        508.5046691894531
      ],
      "page_num": 4,
      "block_type": "heading",
      "level": 13,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "정맥주사용",
      "font_size": 24.0,
      "font_name": "TTBB48454EtCID",
      "bbox": [
        72.48049926757812,
        255.87841796875,
        522.7350463867188,
        279.87841796875
      ],
      "page_num": 5,
      "block_type": "heading",
      "level": 2,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "형 간염 사람면역글로불린제제의",
      "font_size": 24.0,
      "font_name": "TTBB48454EtCID",
      "bbox": [
        72.48049926757812,
        255.87841796875,
        522.7350463867188,
        279.87841796875
      ],
      "page_num": 5,
      "block_type": "heading",
      "level": 2,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "B",
      "font_size": 24.0,
      "font_name": "TTBB48454EtCID",
      "bbox": [
        72.48049926757812,
        255.87841796875,
        522.7350463867188,
        279.87841796875
      ],
      "page_num": 5,
      "block_type": "heading",
      "level": 2,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "안전성유효성 평가 가이드라인",
      "font_size": 24.0,
      "font_name": "TTBB48454EtCID",
      "bbox": [
        143.28109741210938,
        294.27679443359375,
        451.9334411621094,
        318.27679443359375
      ],
      "page_num": 5,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "․",
      "font_size": 24.0,
      "font_name": "TTA184C656tCID32K",
      "bbox": [
        143.28109741210938,
        294.27679443359375,
        451.9334411621094,
        318.27679443359375
      ],
      "page_num": 5,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Guideline on the Safety and Efficacy Evaluation",
      "font_size": 20.040000915527344,
      "font_name": "TTBB48454EtCID",
      "bbox": [
        67.19900512695312,
        332.59796142578125,
        528.1263427734375,
        352.6379699707031
      ],
      "page_num": 5,
      "block_type": "heading",
      "level": 4,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "of Human Hepatitis B Immunoglobulin",
      "font_size": 20.040000915527344,
      "font_name": "TTBB48454EtCID",
      "bbox": [
        113.03880310058594,
        364.6370544433594,
        482.26190185546875,
        384.67706298828125
      ],
      "page_num": 5,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "for Intravenous Administration",
      "font_size": 20.040000915527344,
      "font_name": "TTBB48454EtCID",
      "bbox": [
        155.281005859375,
        396.6761474609375,
        440.0013732910156,
        416.7161560058594
      ],
      "page_num": 5,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2008",
      "font_size": 20.040000915527344,
      "font_name": "TTBB48454EtCID",
      "bbox": [
        274.1990051269531,
        524.5980834960938,
        320.92498779296875,
        544.6381225585938
      ],
      "page_num": 5,
      "block_type": "heading",
      "level": 4,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "생 물 의 약 품 국",
      "font_size": 15.960000038146973,
      "font_name": "TTBB8A43E4tCID",
      "bbox": [
        255.0,
        692.6043701171875,
        412.5600280761719,
        710.4035034179688
      ],
      "page_num": 5,
      "block_type": "heading",
      "level": 6,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "행정간행물 등록번호",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.23800659179688,
        121.69921875,
        186.23800659179688,
        133.69921875
      ],
      "page_num": 5,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "11-1470000-001752-14",
      "font_size": 11.384199142456055,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        66.48049926757812,
        142.93719482421875,
        192.02703857421875,
        154.93719482421875
      ],
      "page_num": 5,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "정맥주사용",
      "font_size": 24.0,
      "font_name": "TTBB48454EtCID",
      "bbox": [
        62.76169967651367,
        161.43743896484375,
        532.2969970703125,
        216.63665771484375
      ],
      "page_num": 6,
      "block_type": "heading",
      "level": 2,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "B형 간염 사람면역글로불린제제의",
      "font_size": 24.0,
      "font_name": "TTBB48454EtCID",
      "bbox": [
        62.76169967651367,
        161.43743896484375,
        532.2969970703125,
        216.63665771484375
      ],
      "page_num": 6,
      "block_type": "heading",
      "level": 2,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "안전성유효성 평가 가이드라인",
      "font_size": 24.0,
      "font_name": "TTBB48454EtCID",
      "bbox": [
        62.76169967651367,
        161.43743896484375,
        532.2969970703125,
        216.63665771484375
      ],
      "page_num": 6,
      "block_type": "heading",
      "level": 2,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "․",
      "font_size": 24.0,
      "font_name": "TTA184C656tCID32K",
      "bbox": [
        62.76169967651367,
        161.43743896484375,
        532.2969970703125,
        216.63665771484375
      ],
      "page_num": 6,
      "block_type": "heading",
      "level": 2,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Guideline on the Safety and Efficacy Evaluation",
      "font_size": 20.040000915527344,
      "font_name": "TTBB48454EtCID",
      "bbox": [
        67.19920349121094,
        231.79763793945312,
        528.1265258789062,
        303.9158935546875
      ],
      "page_num": 6,
      "block_type": "heading",
      "level": 4,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "of Human Hepatitis B Immunoglobulin",
      "font_size": 20.040000915527344,
      "font_name": "TTBB48454EtCID",
      "bbox": [
        67.19920349121094,
        231.79763793945312,
        528.1265258789062,
        303.9158935546875
      ],
      "page_num": 6,
      "block_type": "heading",
      "level": 4,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "for Intravenous Administration",
      "font_size": 20.040000915527344,
      "font_name": "TTBB48454EtCID",
      "bbox": [
        67.19920349121094,
        231.79763793945312,
        528.1265258789062,
        303.9158935546875
      ],
      "page_num": 6,
      "block_type": "heading",
      "level": 4,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2008",
      "font_size": 20.040000915527344,
      "font_name": "TTBB48454EtCID",
      "bbox": [
        274.19921875,
        367.3992919921875,
        320.9252014160156,
        387.4393005371094
      ],
      "page_num": 6,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "본 지침서에 대한 의견 및 제안이 있으시면",
      "font_size": 15.0,
      "font_name": "TT6B7C195EtCID",
      "bbox": [
        147.60122680664062,
        458.3623046875,
        447.4840393066406,
        492.8037109375
      ],
      "page_num": 6,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "연락주시기 바랍니다.",
      "font_size": 15.0,
      "font_name": "TT6B7C195EtCID",
      "bbox": [
        147.60122680664062,
        458.3623046875,
        447.4840393066406,
        492.8037109375
      ],
      "page_num": 6,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "담당부서",
      "font_size": 12.0,
      "font_name": "TT6B7C195EtCID",
      "bbox": [
        196.55783081054688,
        516.6171875,
        394.5578308105469,
        528.6171875
      ],
      "page_num": 6,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "생물의약품국 혈액제제과",
      "font_size": 12.0,
      "font_name": "TT6B7C195EtCID",
      "bbox": [
        196.55783081054688,
        516.6171875,
        394.5578308105469,
        528.6171875
      ],
      "page_num": 6,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "：",
      "font_size": 12.0,
      "font_name": "TT6B7C195EtCID",
      "bbox": [
        196.55783081054688,
        516.6171875,
        394.5578308105469,
        528.6171875
      ],
      "page_num": 6,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "담 당 자",
      "font_size": 12.0,
      "font_name": "TT6B7C195EtCID",
      "bbox": [
        196.55783081054688,
        535.8203125,
        292.5578308105469,
        547.8203125
      ],
      "page_num": 6,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "조민주",
      "font_size": 12.0,
      "font_name": "TT6B7C195EtCID",
      "bbox": [
        196.55783081054688,
        535.8203125,
        292.5578308105469,
        547.8203125
      ],
      "page_num": 6,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "：",
      "font_size": 12.0,
      "font_name": "TT6B7C195EtCID",
      "bbox": [
        196.55783081054688,
        535.8203125,
        292.5578308105469,
        547.8203125
      ],
      "page_num": 6,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "연 락 처",
      "font_size": 12.0,
      "font_name": "TT6B7C195EtCID",
      "bbox": [
        196.55783081054688,
        555.01953125,
        403.9907531738281,
        567.01953125
      ],
      "page_num": 6,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "서울시 은평구 통일로 194",
      "font_size": 12.0,
      "font_name": "TT6B7C195EtCID",
      "bbox": [
        196.55783081054688,
        555.01953125,
        403.9907531738281,
        567.01953125
      ],
      "page_num": 6,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "：",
      "font_size": 12.0,
      "font_name": "TT6B7C195EtCID",
      "bbox": [
        196.55783081054688,
        555.01953125,
        403.9907531738281,
        567.01953125
      ],
      "page_num": 6,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(전화",
      "font_size": 12.0,
      "font_name": "TT6B7C195EtCID",
      "bbox": [
        256.5578308105469,
        574.2186889648438,
        398.84857177734375,
        586.2186889648438
      ],
      "page_num": 6,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ") 02-380-1715, 65",
      "font_size": 12.0,
      "font_name": "TT6B7C195EtCID",
      "bbox": [
        256.5578308105469,
        574.2186889648438,
        398.84857177734375,
        586.2186889648438
      ],
      "page_num": 6,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(FAX) 02-386-6584",
      "font_size": 12.0,
      "font_name": "TT6B7C195EtCID",
      "bbox": [
        256.5578308105469,
        593.4179077148438,
        375.8178405761719,
        605.4179077148438
      ],
      "page_num": 6,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(E-mail) luck00@kfda.go.kr",
      "font_size": 12.0,
      "font_name": "TT6B7C195EtCID",
      "bbox": [
        256.5578308105469,
        612.6170654296875,
        418.7961120605469,
        624.6170654296875
      ],
      "page_num": 6,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "생 물 의 약 품 국",
      "font_size": 15.960000038146973,
      "font_name": "TTBB8A43E4tCID",
      "bbox": [
        255.0,
        716.8433837890625,
        412.5600280761719,
        734.6425170898438
      ],
      "page_num": 6,
      "block_type": "heading",
      "level": 6,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "본 가이드라인은 현재까지의 경험과 과학적 사실에 근거하여 식품의약",
      "font_size": 12.94941520690918,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        85.15384674072266,
        314.2294006347656,
        522.91552734375,
        331.0589904785156
      ],
      "page_num": 7,
      "block_type": "heading",
      "level": 11,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "품안전처의 입장을 기술하고 있습니다. 이 가이드라인에 기술된 사항은 법",
      "font_size": 12.94941520690918,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        80.1165771484375,
        337.6934509277344,
        522.9166259765625,
        351.39501953125
      ],
      "page_num": 7,
      "block_type": "heading",
      "level": 11,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "적 효력이 있는 것은 아니며, 법령이나 행정규칙 등에서 정하고 있는 사항",
      "font_size": 12.94941520690918,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        80.1165771484375,
        358.4307861328125,
        529.39306640625,
        372.1323547363281
      ],
      "page_num": 7,
      "block_type": "heading",
      "level": 11,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "외에는 식품의약품안전처의 권고사항입니다. 이는 새로운 과학적 근거가",
      "font_size": 12.94941520690918,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        80.1165771484375,
        379.2879943847656,
        529.39404296875,
        392.98956298828125
      ],
      "page_num": 7,
      "block_type": "heading",
      "level": 11,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "있을 경우 개정될 수 있으므로 이러한 사항이 있을 경우 식품의약품안전처",
      "font_size": 12.94941520690918,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        80.1165771484375,
        400.02532958984375,
        522.9198608398438,
        413.67913818359375
      ],
      "page_num": 7,
      "block_type": "heading",
      "level": 11,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "에 의견을 제시하여 주시기 바랍니다.",
      "font_size": 12.94941520690918,
      "font_name": "T3",
      "bbox": [
        80.1165771484375,
        420.7626647949219,
        295.3739929199219,
        434.4642333984375
      ],
      "page_num": 7,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "목",
      "font_size": 20.855199813842773,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        262.8009948730469,
        117.45693969726562,
        331.7772521972656,
        138.3121337890625
      ],
      "page_num": 8,
      "block_type": "heading",
      "level": 3,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "차",
      "font_size": 20.855199813842773,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        262.8009948730469,
        117.45693969726562,
        331.7772521972656,
        138.3121337890625
      ],
      "page_num": 8,
      "block_type": "heading",
      "level": 3,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Ⅰ. 서론",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        63.12110137939453,
        203.07394409179688,
        536.6415405273438,
        216.03395080566406
      ],
      "page_num": 8,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "······························································································································1",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        63.12110137939453,
        203.07394409179688,
        536.6415405273438,
        216.03395080566406
      ],
      "page_num": 8,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "구조 물리화학적 성질",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        63.121315002441406,
        249.87472534179688,
        536.6416015625,
        262.834716796875
      ],
      "page_num": 8,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "제조 및 품질관리",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        63.121315002441406,
        249.87472534179688,
        536.6416015625,
        262.834716796875
      ],
      "page_num": 8,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        63.121315002441406,
        249.87472534179688,
        536.6416015625,
        262.834716796875
      ],
      "page_num": 8,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        63.121315002441406,
        249.87472534179688,
        536.6416015625,
        262.834716796875
      ],
      "page_num": 8,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Ⅱ",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        63.121315002441406,
        249.87472534179688,
        536.6416015625,
        262.834716796875
      ],
      "page_num": 8,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "․",
      "font_size": 12.960000038146973,
      "font_name": "TTA184C656tCID32K",
      "bbox": [
        63.121315002441406,
        249.87472534179688,
        536.6416015625,
        262.834716796875
      ],
      "page_num": 8,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "····························································2",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        63.121315002441406,
        249.87472534179688,
        536.6416015625,
        262.834716796875
      ],
      "page_num": 8,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "구조결정",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        82.55882263183594,
        273.2731018066406,
        536.6409301757812,
        286.23309326171875
      ],
      "page_num": 8,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "물리화학적 성질",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        82.55882263183594,
        273.2731018066406,
        536.6409301757812,
        286.23309326171875
      ],
      "page_num": 8,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1.",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        82.55882263183594,
        273.2731018066406,
        536.6409301757812,
        286.23309326171875
      ],
      "page_num": 8,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        82.55882263183594,
        273.2731018066406,
        536.6409301757812,
        286.23309326171875
      ],
      "page_num": 8,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "················································································2",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        82.55882263183594,
        273.2731018066406,
        536.6409301757812,
        286.23309326171875
      ],
      "page_num": 8,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2. 원료물질의 수집 및 관리",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        82.55851745605469,
        296.6753845214844,
        536.6406860351562,
        309.6353759765625
      ],
      "page_num": 8,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "···················································································2",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        82.55851745605469,
        296.6753845214844,
        536.6406860351562,
        309.6353759765625
      ],
      "page_num": 8,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "3. 제조공정",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        82.55824279785156,
        320.07379150390625,
        536.6416015625,
        333.0337829589844
      ],
      "page_num": 8,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "·················································································································3",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        82.55824279785156,
        320.07379150390625,
        536.6416015625,
        333.0337829589844
      ],
      "page_num": 8,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "4. 품질관리",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        82.55894470214844,
        343.4761047363281,
        536.642333984375,
        356.43609619140625
      ],
      "page_num": 8,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "·················································································································4",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        82.55894470214844,
        343.4761047363281,
        536.642333984375,
        356.43609619140625
      ],
      "page_num": 8,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "III. 안정성시험",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        63.12256622314453,
        390.27301025390625,
        536.6432495117188,
        403.2330017089844
      ],
      "page_num": 8,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "··················································································································5",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        63.12256622314453,
        390.27301025390625,
        536.6432495117188,
        403.2330017089844
      ],
      "page_num": 8,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Ⅳ. 비임상시험",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        63.123268127441406,
        437.0738220214844,
        536.6436767578125,
        450.0338134765625
      ],
      "page_num": 8,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "··················································································································5",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        63.123268127441406,
        437.0738220214844,
        536.6436767578125,
        450.0338134765625
      ],
      "page_num": 8,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1. 일반적 고려사항",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        82.56105041503906,
        460.47613525390625,
        536.6434326171875,
        473.4361267089844
      ],
      "page_num": 8,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "···································································································5",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        82.56105041503906,
        460.47613525390625,
        536.6434326171875,
        473.4361267089844
      ],
      "page_num": 8,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2. 독성시험",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        82.56077575683594,
        483.8745422363281,
        536.6441650390625,
        496.83453369140625
      ],
      "page_num": 8,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "·················································································································6",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        82.56077575683594,
        483.8745422363281,
        536.6441650390625,
        496.83453369140625
      ],
      "page_num": 8,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "3. 약리시험",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        82.56150817871094,
        507.2729797363281,
        536.6448974609375,
        520.2329711914062
      ],
      "page_num": 8,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "·················································································································6",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        82.56150817871094,
        507.2729797363281,
        536.6448974609375,
        520.2329711914062
      ],
      "page_num": 8,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Ⅴ. 임상시험",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        63.12464141845703,
        554.0737915039062,
        536.64501953125,
        567.0337524414062
      ],
      "page_num": 8,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "······················································································································7",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        63.12464141845703,
        554.0737915039062,
        536.64501953125,
        567.0337524414062
      ],
      "page_num": 8,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1. 일반적 고려사항",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        82.56245422363281,
        577.47607421875,
        536.6448364257812,
        590.43603515625
      ],
      "page_num": 8,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "···································································································7",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        82.56245422363281,
        577.47607421875,
        536.6448364257812,
        590.43603515625
      ],
      "page_num": 8,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2. 임상약리시험",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        82.56217956542969,
        600.8744506835938,
        536.6453857421875,
        613.8344116210938
      ],
      "page_num": 8,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "·········································································································7",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        82.56217956542969,
        600.8744506835938,
        536.6453857421875,
        613.8344116210938
      ],
      "page_num": 8,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "3. 치료적 탐색 임상시험",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        82.56288146972656,
        624.2728881835938,
        536.6456298828125,
        637.2328491210938
      ],
      "page_num": 8,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "·························································································8",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        82.56288146972656,
        624.2728881835938,
        536.6456298828125,
        637.2328491210938
      ],
      "page_num": 8,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "4. 치료적 확증 임상시험",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        82.56260681152344,
        647.6751708984375,
        536.6453247070312,
        660.6351318359375
      ],
      "page_num": 8,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "·························································································8",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        82.56260681152344,
        647.6751708984375,
        536.6453247070312,
        660.6351318359375
      ],
      "page_num": 8,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Ⅵ. 참고문헌",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.6056900024414,
        694.4760131835938,
        536.6431274414062,
        707.4359741210938
      ],
      "page_num": 8,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "·················································································································11",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.6056900024414,
        694.4760131835938,
        536.6431274414062,
        707.4359741210938
      ],
      "page_num": 8,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 1 -",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        283.4410095214844,
        789.4503784179688,
        311.7458801269531,
        799.4103393554688
      ],
      "page_num": 9,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "정맥주사용",
      "font_size": 18.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        107.03900146484375,
        99.15081787109375,
        488.16455078125,
        117.15081787109375
      ],
      "page_num": 9,
      "block_type": "heading",
      "level": 5,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "B형 간염 사람면",
      "font_size": 18.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        107.03900146484375,
        99.15081787109375,
        488.16455078125,
        117.15081787109375
      ],
      "page_num": 9,
      "block_type": "heading",
      "level": 5,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "역글로불린제제의",
      "font_size": 18.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        107.03900146484375,
        99.15081787109375,
        488.16455078125,
        117.15081787109375
      ],
      "page_num": 9,
      "block_type": "heading",
      "level": 5,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "안전성 유효성 평가 가이드라인",
      "font_size": 18.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        170.03900146484375,
        127.94769287109375,
        425.16009521484375,
        145.94769287109375
      ],
      "page_num": 9,
      "block_type": "heading",
      "level": 5,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "․",
      "font_size": 18.0,
      "font_name": "TTA184C656tCID32K",
      "bbox": [
        170.03900146484375,
        127.94769287109375,
        425.16009521484375,
        145.94769287109375
      ],
      "page_num": 9,
      "block_type": "heading",
      "level": 5,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ". 서론",
      "font_size": 15.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.6405029296875,
        183.68310546875,
        114.12100219726562,
        198.68310546875
      ],
      "page_num": 9,
      "block_type": "heading",
      "level": 7,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Ⅰ",
      "font_size": 15.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.6405029296875,
        183.68310546875,
        114.12100219726562,
        198.68310546875
      ],
      "page_num": 9,
      "block_type": "heading",
      "level": 7,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "최근 국내에서 높은",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.6405029296875,
        237.73876953125,
        538.43798828125,
        249.73876953125
      ],
      "page_num": 9,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "형 간염 유병율과 함께 말기 간질환 환자에 대한 간 이식 수",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.6405029296875,
        237.73876953125,
        538.43798828125,
        249.73876953125
      ],
      "page_num": 9,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "B",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.6405029296875,
        237.73876953125,
        538.43798828125,
        249.73876953125
      ],
      "page_num": 9,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "술이 급격히 증가하고 있으나",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.6405029296875,
        259.34039306640625,
        538.4257202148438,
        271.34039306640625
      ],
      "page_num": 9,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "수술 이후",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.6405029296875,
        259.34039306640625,
        538.4257202148438,
        271.34039306640625
      ],
      "page_num": 9,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "형 간염의 재발이 보고됨에 따라 간 이식",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.6405029296875,
        259.34039306640625,
        538.4257202148438,
        271.34039306640625
      ],
      "page_num": 9,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.6405029296875,
        259.34039306640625,
        538.4257202148438,
        271.34039306640625
      ],
      "page_num": 9,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "B",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.6405029296875,
        259.34039306640625,
        538.4257202148438,
        271.34039306640625
      ],
      "page_num": 9,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "후",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.6405029296875,
        280.9381103515625,
        538.4461669921875,
        292.9381103515625
      ],
      "page_num": 9,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "형 간염 재발 방지가 중요한 문제로 대두되었다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.6405029296875,
        280.9381103515625,
        538.4461669921875,
        292.9381103515625
      ],
      "page_num": 9,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "형 간염 환자에서 간 이식 후",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.6405029296875,
        280.9381103515625,
        538.4461669921875,
        292.9381103515625
      ],
      "page_num": 9,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "B",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.6405029296875,
        280.9381103515625,
        538.4461669921875,
        292.9381103515625
      ],
      "page_num": 9,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ". B",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.6405029296875,
        280.9381103515625,
        538.4461669921875,
        292.9381103515625
      ],
      "page_num": 9,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "간염 재발방지 요법을 시행하지 않은 경우",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.64129638671875,
        302.53973388671875,
        538.43701171875,
        314.53973388671875
      ],
      "page_num": 9,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "년 후 재발율은",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.64129638671875,
        302.53973388671875,
        538.43701171875,
        314.53973388671875
      ],
      "page_num": 9,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "이상에 이른다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.64129638671875,
        302.53973388671875,
        538.43701171875,
        314.53973388671875
      ],
      "page_num": 9,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "간",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.64129638671875,
        302.53973388671875,
        538.43701171875,
        314.53973388671875
      ],
      "page_num": 9,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.64129638671875,
        302.53973388671875,
        538.43701171875,
        314.53973388671875
      ],
      "page_num": 9,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "70%",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.64129638671875,
        302.53973388671875,
        538.43701171875,
        314.53973388671875
      ],
      "page_num": 9,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.64129638671875,
        302.53973388671875,
        538.43701171875,
        314.53973388671875
      ],
      "page_num": 9,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "이식 후",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.64129638671875,
        324.1413269042969,
        538.5552368164062,
        336.1413269042969
      ],
      "page_num": 9,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "형 간염 바이러스",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.64129638671875,
        324.1413269042969,
        538.5552368164062,
        336.1413269042969
      ],
      "page_num": 9,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "의 재감염을 막기 위해서는 주로",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.64129638671875,
        324.1413269042969,
        538.5552368164062,
        336.1413269042969
      ],
      "page_num": 9,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "B",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.64129638671875,
        324.1413269042969,
        538.5552368164062,
        336.1413269042969
      ],
      "page_num": 9,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(hepatitis B virus, HBV)",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.64129638671875,
        324.1413269042969,
        538.5552368164062,
        336.1413269042969
      ],
      "page_num": 9,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "형 간염 사람면역글로불린제제",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.640411376953125,
        345.739013671875,
        538.44140625,
        357.739013671875
      ],
      "page_num": 9,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "를 단독",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.640411376953125,
        345.739013671875,
        538.44140625,
        357.739013671875
      ],
      "page_num": 9,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "B",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.640411376953125,
        345.739013671875,
        538.44140625,
        357.739013671875
      ],
      "page_num": 9,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(human hepatitis B immunoglobulin, HBIG)",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.640411376953125,
        345.739013671875,
        538.44140625,
        357.739013671875
      ],
      "page_num": 9,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "투여하거나 항바이러스제와",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.640411376953125,
        367.3406066894531,
        538.4435424804688,
        379.3406066894531
      ],
      "page_num": 9,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "의 병용요법이 이용되고 있으며 이 경우 재발율은",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.640411376953125,
        367.3406066894531,
        538.4435424804688,
        379.3406066894531
      ],
      "page_num": 9,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "HBIG",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.640411376953125,
        367.3406066894531,
        538.4435424804688,
        379.3406066894531
      ],
      "page_num": 9,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "20% 이하로 낮아진다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.64011764526367,
        388.93829345703125,
        180.88507080078125,
        400.93829345703125
      ],
      "page_num": 9,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.64011764526367,
        388.93829345703125,
        180.88507080078125,
        400.93829345703125
      ],
      "page_num": 9,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "이미 외국에서는 고용량의 정맥주사용",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64012145996094,
        432.1413879394531,
        538.4330444335938,
        444.1413879394531
      ],
      "page_num": 9,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "를 이용한 예방요법이 보편화되어 있으",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64012145996094,
        432.1413879394531,
        538.4330444335938,
        444.1413879394531
      ],
      "page_num": 9,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "HBIG",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64012145996094,
        432.1413879394531,
        538.4330444335938,
        444.1413879394531
      ],
      "page_num": 9,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "나",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.640106201171875,
        453.73907470703125,
        538.4404907226562,
        465.73907470703125
      ],
      "page_num": 9,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "우리나라에서는",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.640106201171875,
        453.73907470703125,
        538.4404907226562,
        465.73907470703125
      ],
      "page_num": 9,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "형 간염 표면항원",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.640106201171875,
        453.73907470703125,
        538.4404907226562,
        465.73907470703125
      ],
      "page_num": 9,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "양성 혈",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.640106201171875,
        453.73907470703125,
        538.4404907226562,
        465.73907470703125
      ],
      "page_num": 9,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.640106201171875,
        453.73907470703125,
        538.4404907226562,
        465.73907470703125
      ],
      "page_num": 9,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "B",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.640106201171875,
        453.73907470703125,
        538.4404907226562,
        465.73907470703125
      ],
      "page_num": 9,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(hepatitis B surface antigen, HBsAg)",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.640106201171875,
        453.73907470703125,
        538.4404907226562,
        465.73907470703125
      ],
      "page_num": 9,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "액 오염사고 후의",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.640106201171875,
        475.3406677246094,
        538.5424194335938,
        487.3406677246094
      ],
      "page_num": 9,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "형 간염 발증의 예방 및 신생아의",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.640106201171875,
        475.3406677246094,
        538.5424194335938,
        487.3406677246094
      ],
      "page_num": 9,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "형 간염 예방 목적으로 근육주",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.640106201171875,
        475.3406677246094,
        538.5424194335938,
        487.3406677246094
      ],
      "page_num": 9,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "B",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.640106201171875,
        475.3406677246094,
        538.5424194335938,
        487.3406677246094
      ],
      "page_num": 9,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "B",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.640106201171875,
        475.3406677246094,
        538.5424194335938,
        487.3406677246094
      ],
      "page_num": 9,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "사용",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.640106201171875,
        496.9383544921875,
        538.4281005859375,
        508.9383544921875
      ],
      "page_num": 9,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "만이 허가되어",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.640106201171875,
        496.9383544921875,
        538.4281005859375,
        508.9383544921875
      ],
      "page_num": 9,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "근육주사용",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.640106201171875,
        496.9383544921875,
        538.4281005859375,
        508.9383544921875
      ],
      "page_num": 9,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "를 간 이식 시 고용량으로 정맥주사 해왔",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.640106201171875,
        496.9383544921875,
        538.4281005859375,
        508.9383544921875
      ],
      "page_num": 9,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "HBIG",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.640106201171875,
        496.9383544921875,
        538.4281005859375,
        508.9383544921875
      ],
      "page_num": 9,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.640106201171875,
        496.9383544921875,
        538.4281005859375,
        508.9383544921875
      ],
      "page_num": 9,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "HBIG",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.640106201171875,
        496.9383544921875,
        538.4281005859375,
        508.9383544921875
      ],
      "page_num": 9,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "다.",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.640106201171875,
        518.5399169921875,
        72.64791870117188,
        530.5399169921875
      ],
      "page_num": 9,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "현재 간 이식 뿐만 아니라 수동면역에도 정맥주사용",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64010620117188,
        561.7391357421875,
        538.5467529296875,
        573.7391357421875
      ],
      "page_num": 9,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "가 세계적인 추세이고 국",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64010620117188,
        561.7391357421875,
        538.5467529296875,
        573.7391357421875
      ],
      "page_num": 9,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "HBIG",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64010620117188,
        561.7391357421875,
        538.5467529296875,
        573.7391357421875
      ],
      "page_num": 9,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "내 간 이식 수술 건수의 증가 및 수술 후",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.640106201171875,
        583.3406982421875,
        538.4439697265625,
        595.3406982421875
      ],
      "page_num": 9,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "형 간염 재발 방지를 위하여",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.640106201171875,
        583.3406982421875,
        538.4439697265625,
        595.3406982421875
      ],
      "page_num": 9,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "기존의 근육",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.640106201171875,
        583.3406982421875,
        538.4439697265625,
        595.3406982421875
      ],
      "page_num": 9,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "B",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.640106201171875,
        583.3406982421875,
        538.4439697265625,
        595.3406982421875
      ],
      "page_num": 9,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.640106201171875,
        583.3406982421875,
        538.4439697265625,
        595.3406982421875
      ],
      "page_num": 9,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "주사용 제제보다 품질이 우수하고 바이러스 안전성이 확보된 정맥주사용 제제 개발이",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.64009094238281,
        604.9384155273438,
        538.4419555664062,
        616.9384155273438
      ],
      "page_num": 9,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "필요하게 되었다.",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.64009094238281,
        626.5400390625,
        150.6479034423828,
        638.5400390625
      ],
      "page_num": 9,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "본 가이드라인은 혈장 유래 정맥주사용",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64009094238281,
        667.9384765625,
        538.44091796875,
        679.9384765625
      ],
      "page_num": 9,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "HBIG의 품질과 안전성 유효성 심사 시 비임",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64009094238281,
        667.9384765625,
        538.44091796875,
        679.9384765625
      ],
      "page_num": 9,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "․",
      "font_size": 12.0,
      "font_name": "TTA184C656tCID32K",
      "bbox": [
        74.64009094238281,
        667.9384765625,
        538.44091796875,
        679.9384765625
      ],
      "page_num": 9,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "상 및 임상시험자료 평가를 위한 지침으로서",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.639129638671875,
        689.5400390625,
        538.44384765625,
        701.5400390625
      ],
      "page_num": 9,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "심사자 및 제조자에게 정보를 제공함과",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.639129638671875,
        689.5400390625,
        538.44384765625,
        701.5400390625
      ],
      "page_num": 9,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.639129638671875,
        689.5400390625,
        538.44384765625,
        701.5400390625
      ],
      "page_num": 9,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "동시에 자료 요건의 투명성을 제고하는데 그 목적이 있다.",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.639129638671875,
        711.1416625976562,
        378.6469421386719,
        723.1416625976562
      ],
      "page_num": 9,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 2 -",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        283.4410095214844,
        789.4503784179688,
        311.7458801269531,
        799.4103393554688
      ],
      "page_num": 10,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "구조 물리화학적 성질",
      "font_size": 15.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.640602111816406,
        99.08502197265625,
        361.6831359863281,
        114.08502197265625
      ],
      "page_num": 10,
      "block_type": "heading",
      "level": 7,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "제조 및 품질관리",
      "font_size": 15.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.640602111816406,
        99.08502197265625,
        361.6831359863281,
        114.08502197265625
      ],
      "page_num": 10,
      "block_type": "heading",
      "level": 7,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 15.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.640602111816406,
        99.08502197265625,
        361.6831359863281,
        114.08502197265625
      ],
      "page_num": 10,
      "block_type": "heading",
      "level": 7,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 15.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.640602111816406,
        99.08502197265625,
        361.6831359863281,
        114.08502197265625
      ],
      "page_num": 10,
      "block_type": "heading",
      "level": 7,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Ⅱ",
      "font_size": 15.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.640602111816406,
        99.08502197265625,
        361.6831359863281,
        114.08502197265625
      ],
      "page_num": 10,
      "block_type": "heading",
      "level": 7,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "․",
      "font_size": 15.0,
      "font_name": "TTA184C656tCID32K",
      "bbox": [
        56.640602111816406,
        99.08502197265625,
        361.6831359863281,
        114.08502197265625
      ],
      "page_num": 10,
      "block_type": "heading",
      "level": 7,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "면역글로불린제제의 제조에 있어서 제조사는 원료물질의 특성",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.6406021118164,
        153.1407470703125,
        538.4850463867188,
        165.1407470703125
      ],
      "page_num": 10,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ", 제조 및 정제공정",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.6406021118164,
        153.1407470703125,
        538.4850463867188,
        165.1407470703125
      ],
      "page_num": 10,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.6406021118164,
        153.1407470703125,
        538.4850463867188,
        165.1407470703125
      ],
      "page_num": 10,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "그리고 안전성과 관련된 중요한 인자들을 고려해야 한다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.640594482421875,
        174.73846435546875,
        538.559326171875,
        186.73846435546875
      ],
      "page_num": 10,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "면역글로불린제제는 많은 사",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.640594482421875,
        174.73846435546875,
        538.559326171875,
        186.73846435546875
      ],
      "page_num": 10,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.640594482421875,
        174.73846435546875,
        538.559326171875,
        186.73846435546875
      ],
      "page_num": 10,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "람의 헌혈 혈장을 풀링하여 생산하기 때문에 한 사람의 헌혈 혈장의 바이러스 오염은",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.640594482421875,
        196.340087890625,
        538.4296875,
        208.340087890625
      ],
      "page_num": 10,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "면역글로불린제제를 사용하는 다수의 환자에게 바이러스성 질병을 전염시킬 수 있다.",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.640594482421875,
        217.93780517578125,
        538.4884033203125,
        229.93780517578125
      ],
      "page_num": 10,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "따라서 원료혈장의 오염을 최소화하면서 제조공정 중 혈액매개 바이러스의 불활화 제",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.640594482421875,
        239.5394287109375,
        538.546875,
        251.5394287109375
      ],
      "page_num": 10,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "/",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.640594482421875,
        239.5394287109375,
        538.546875,
        251.5394287109375
      ],
      "page_num": 10,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "거 효율을 극대화하기 위한 조치를 취하여 면역글로불린제제의 바이러스 안전성을 반",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.640594482421875,
        261.14105224609375,
        538.4424438476562,
        273.14105224609375
      ],
      "page_num": 10,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "드시 확보하여야 한다.",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.640594482421875,
        282.73876953125,
        180.64840698242188,
        294.73876953125
      ],
      "page_num": 10,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "면역글로불린제제 품질평가 전반에 관해서는",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64059448242188,
        325.9379577636719,
        538.5507202148438,
        337.9379577636719
      ],
      "page_num": 10,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "“혈장분획제제 품질평가 가이드 생물",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64059448242188,
        325.9379577636719,
        538.5507202148438,
        337.9379577636719
      ],
      "page_num": 10,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64059448242188,
        325.9379577636719,
        538.5507202148438,
        337.9379577636719
      ],
      "page_num": 10,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "의약품평가가이드",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.640594482421875,
        347.53955078125,
        538.4393310546875,
        359.53955078125
      ],
      "page_num": 10,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "와",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.640594482421875,
        347.53955078125,
        538.4393310546875,
        359.53955078125
      ],
      "page_num": 10,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "의",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.640594482421875,
        347.53955078125,
        538.4393310546875,
        359.53955078125
      ],
      "page_num": 10,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "4, 2002)”",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.640594482421875,
        347.53955078125,
        538.4393310546875,
        359.53955078125
      ],
      "page_num": 10,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "EMEA",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.640594482421875,
        347.53955078125,
        538.4393310546875,
        359.53955078125
      ],
      "page_num": 10,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "“Note for Guidance on Plasma-Derived",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.640594482421875,
        347.53955078125,
        538.4393310546875,
        359.53955078125
      ],
      "page_num": 10,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Medicinal Products(CPMP/BWP/269/95 rev. 3, 2001)” 등을 참고할 수 있다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.63958740234375,
        369.1411437988281,
        491.2765197753906,
        381.1411437988281
      ],
      "page_num": 10,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.63958740234375,
        369.1411437988281,
        491.2765197753906,
        381.1411437988281
      ],
      "page_num": 10,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "구조결정",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.6004867553711,
        417.75457763671875,
        248.16207885742188,
        430.7145690917969
      ],
      "page_num": 10,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "물리화학적 성질",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.6004867553711,
        417.75457763671875,
        248.16207885742188,
        430.7145690917969
      ],
      "page_num": 10,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1.",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.6004867553711,
        417.75457763671875,
        248.16207885742188,
        430.7145690917969
      ],
      "page_num": 10,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.6004867553711,
        417.75457763671875,
        248.16207885742188,
        430.7145690917969
      ],
      "page_num": 10,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "주성분의 구성 성분 및 그 특성에 관한 자료",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.63958740234375,
        441.1411437988281,
        538.5614624023438,
        453.1411437988281
      ],
      "page_num": 10,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "물리화학적 성질에 관한 자료",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.63958740234375,
        441.1411437988281,
        538.5614624023438,
        453.1411437988281
      ],
      "page_num": 10,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "면",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.63958740234375,
        441.1411437988281,
        538.5614624023438,
        453.1411437988281
      ],
      "page_num": 10,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.63958740234375,
        441.1411437988281,
        538.5614624023438,
        453.1411437988281
      ],
      "page_num": 10,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.63958740234375,
        441.1411437988281,
        538.5614624023438,
        453.1411437988281
      ],
      "page_num": 10,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "역학적 성질에 관한 자료 및 생물학적 성질에 관한 자료를 제출하여야 한다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.6005859375,
        462.73883056640625,
        538.5418090820312,
        474.73883056640625
      ],
      "page_num": 10,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "또한",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.6005859375,
        462.73883056640625,
        538.5418090820312,
        474.73883056640625
      ],
      "page_num": 10,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.6005859375,
        462.73883056640625,
        538.5418090820312,
        474.73883056640625
      ],
      "page_num": 10,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "기타 첨가제 또는 첨부용제의 성분 및 그 특성에 관한 자료를 제출하여야 한다.",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.6005859375,
        484.3404235839844,
        514.6083984375,
        496.3404235839844
      ],
      "page_num": 10,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "원료물질의 수집 및 관리",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.6001968383789,
        532.9539184570312,
        237.3610076904297,
        545.9138793945312
      ],
      "page_num": 10,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2.",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.6001968383789,
        532.9539184570312,
        237.3610076904297,
        545.9138793945312
      ],
      "page_num": 10,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "원료물질의 수집 및 관리는 혈장분획제제의 제조 및 품질보증에서 매우 중요한",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.63929748535156,
        556.3404541015625,
        538.5494384765625,
        568.3404541015625
      ],
      "page_num": 10,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "요소이다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.6001968383789,
        577.9381103515625,
        538.5587158203125,
        589.9381103515625
      ],
      "page_num": 10,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "바이러스 위해성을 줄이기 위한 방법으로 원료물질에 대한 세심한 관리",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.6001968383789,
        577.9381103515625,
        538.5587158203125,
        589.9381103515625
      ],
      "page_num": 10,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.6001968383789,
        577.9381103515625,
        538.5587158203125,
        589.9381103515625
      ],
      "page_num": 10,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "가 필요하다.",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.6001968383789,
        599.5397338867188,
        142.60800170898438,
        611.5397338867188
      ],
      "page_num": 10,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "원료물질의 수집 및 관리에 관한 상세 정보를 기록하여 제공하여야 한다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.63928985595703,
        642.7389526367188,
        538.445556640625,
        654.7389526367188
      ],
      "page_num": 10,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "즉",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.63928985595703,
        642.7389526367188,
        538.445556640625,
        654.7389526367188
      ],
      "page_num": 10,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "원",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.63928985595703,
        642.7389526367188,
        538.445556640625,
        654.7389526367188
      ],
      "page_num": 10,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.63928985595703,
        642.7389526367188,
        538.445556640625,
        654.7389526367188
      ],
      "page_num": 10,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.63928985595703,
        642.7389526367188,
        538.445556640625,
        654.7389526367188
      ],
      "page_num": 10,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "료혈장의 종류",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.60028076171875,
        664.340576171875,
        538.4359130859375,
        676.340576171875
      ],
      "page_num": 10,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "개별혈장 및 수집혈장의 풀링 사이즈",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.60028076171875,
        664.340576171875,
        538.4359130859375,
        676.340576171875
      ],
      "page_num": 10,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "풀링 방법",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.60028076171875,
        664.340576171875,
        538.4359130859375,
        676.340576171875
      ],
      "page_num": 10,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "품질관리 항목 및",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.60028076171875,
        664.340576171875,
        538.4359130859375,
        676.340576171875
      ],
      "page_num": 10,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.60028076171875,
        664.340576171875,
        538.4359130859375,
        676.340576171875
      ],
      "page_num": 10,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.60028076171875,
        664.340576171875,
        538.4359130859375,
        676.340576171875
      ],
      "page_num": 10,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.60028076171875,
        664.340576171875,
        538.4359130859375,
        676.340576171875
      ],
      "page_num": 10,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "기준",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.60067749023438,
        685.938232421875,
        538.4564208984375,
        697.938232421875
      ],
      "page_num": 10,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "보관 및 운송 등에 관한 정보를 제공하여야 한다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.60067749023438,
        685.938232421875,
        538.4564208984375,
        697.938232421875
      ],
      "page_num": 10,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "이 때 분획용 혈장 마스터",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.60067749023438,
        685.938232421875,
        538.4564208984375,
        697.938232421875
      ],
      "page_num": 10,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.60067749023438,
        685.938232421875,
        538.4564208984375,
        697.938232421875
      ],
      "page_num": 10,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.60067749023438,
        685.938232421875,
        538.4564208984375,
        697.938232421875
      ],
      "page_num": 10,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "파일",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.60067749023438,
        707.5398559570312,
        538.4428100585938,
        719.5398559570312
      ],
      "page_num": 10,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "의 형태로 정보를 제공할 수 있다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.60067749023438,
        707.5398559570312,
        538.4428100585938,
        719.5398559570312
      ],
      "page_num": 10,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "주성분과 첨가제",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.60067749023438,
        707.5398559570312,
        538.4428100585938,
        719.5398559570312
      ],
      "page_num": 10,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(plasma master file, PMF)",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.60067749023438,
        707.5398559570312,
        538.4428100585938,
        719.5398559570312
      ],
      "page_num": 10,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.60067749023438,
        707.5398559570312,
        538.4428100585938,
        719.5398559570312
      ],
      "page_num": 10,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "의 분량",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.60067749023438,
        729.1414794921875,
        538.4329833984375,
        741.1414794921875
      ],
      "page_num": 10,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "규격 등에 관한 모든 관련 정보가 필요하다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.60067749023438,
        729.1414794921875,
        538.4329833984375,
        741.1414794921875
      ],
      "page_num": 10,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "원료물질을 혈장으로 공급받",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.60067749023438,
        729.1414794921875,
        538.4329833984375,
        741.1414794921875
      ],
      "page_num": 10,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.60067749023438,
        729.1414794921875,
        538.4329833984375,
        741.1414794921875
      ],
      "page_num": 10,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.60067749023438,
        729.1414794921875,
        538.4329833984375,
        741.1414794921875
      ],
      "page_num": 10,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 3 -",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        283.4410095214844,
        789.4503784179688,
        311.7458801269531,
        799.4103393554688
      ],
      "page_num": 11,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "는지 또는 부분적으로 분획한 중간산물의 형태로 공급받는지에 대한 정보를 제공하",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.60101318359375,
        99.14019775390625,
        538.5592041015625,
        111.14019775390625
      ],
      "page_num": 11,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "여야 한다.",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.60101318359375,
        120.7379150390625,
        130.60882568359375,
        132.7379150390625
      ],
      "page_num": 11,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "는",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.6401138305664,
        163.9371337890625,
        538.5657958984375,
        175.9371337890625
      ],
      "page_num": 11,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "형 간염 항체 양성인 건강한 사람의 혈장을 원료로 사용하므로 면역방",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.6401138305664,
        163.9371337890625,
        538.5657958984375,
        175.9371337890625
      ],
      "page_num": 11,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "HBIG",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.6401138305664,
        163.9371337890625,
        538.5657958984375,
        175.9371337890625
      ],
      "page_num": 11,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "B",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.6401138305664,
        163.9371337890625,
        538.5657958984375,
        175.9371337890625
      ],
      "page_num": 11,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "법 등 원료혈장의 생산 경로를 기술하여야 한다.",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.60101318359375,
        185.53875732421875,
        340.60882568359375,
        197.53875732421875
      ],
      "page_num": 11,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "에 관해서는",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.64030456542969,
        228.73797607421875,
        538.4388427734375,
        240.73797607421875
      ],
      "page_num": 11,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "분획용 혈장 마스터 파일 가이드라인 생물의약품평가가이드",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.64030456542969,
        228.73797607421875,
        538.4388427734375,
        240.73797607421875
      ],
      "page_num": 11,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "PMF",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.64030456542969,
        228.73797607421875,
        538.4388427734375,
        240.73797607421875
      ],
      "page_num": 11,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "“",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.64030456542969,
        228.73797607421875,
        538.4388427734375,
        240.73797607421875
      ],
      "page_num": 11,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.64030456542969,
        228.73797607421875,
        538.4388427734375,
        240.73797607421875
      ],
      "page_num": 11,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "25, 2007)”을 참고할 수 있다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.60043334960938,
        250.339599609375,
        240.39785766601562,
        262.339599609375
      ],
      "page_num": 11,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.60043334960938,
        250.339599609375,
        240.39785766601562,
        262.339599609375
      ],
      "page_num": 11,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "제조공정",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.60150146484375,
        298.9531555175781,
        139.9208984375,
        311.91314697265625
      ],
      "page_num": 11,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "3.",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.60150146484375,
        298.9531555175781,
        139.9208984375,
        311.91314697265625
      ],
      "page_num": 11,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "면역글로불린제제의 제조방법은 제품의 품질과 안전성을 확보하는데 중요한 부분",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.6406021118164,
        322.3397216796875,
        538.4296264648438,
        334.3397216796875
      ],
      "page_num": 11,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "이다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.60150146484375,
        343.9374084472656,
        538.433837890625,
        355.9374084472656
      ],
      "page_num": 11,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ". 제조공정은 제조사에 따라 다양하지만 보통 몇 단계의 분획 정제공정과 바이",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.60150146484375,
        343.9374084472656,
        538.433837890625,
        355.9374084472656
      ],
      "page_num": 11,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "/",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.60150146484375,
        343.9374084472656,
        538.433837890625,
        355.9374084472656
      ],
      "page_num": 11,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "러스 불활화 제거를 위한 특별 공정이 필요하다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.60150146484375,
        365.53900146484375,
        538.4383544921875,
        377.53900146484375
      ],
      "page_num": 11,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "제조공정은 상세히 기술하고 제조",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.60150146484375,
        365.53900146484375,
        538.4383544921875,
        377.53900146484375
      ],
      "page_num": 11,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "/",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.60150146484375,
        365.53900146484375,
        538.4383544921875,
        377.53900146484375
      ],
      "page_num": 11,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.60150146484375,
        365.53900146484375,
        538.4383544921875,
        377.53900146484375
      ],
      "page_num": 11,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "공정 흐름도를 제출하여야 한다.",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.60150146484375,
        387.1405944824219,
        250.60931396484375,
        399.1405944824219
      ],
      "page_num": 11,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "면역글로불린제제 제조는",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.6405029296875,
        430.33978271484375,
        538.4423828125,
        442.33978271484375
      ],
      "page_num": 11,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "의 에탄올 분획법이 가장 널리 사용되고 있다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.6405029296875,
        430.33978271484375,
        538.4423828125,
        442.33978271484375
      ],
      "page_num": 11,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "에",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.6405029296875,
        430.33978271484375,
        538.4423828125,
        442.33978271484375
      ],
      "page_num": 11,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Cohn",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.6405029296875,
        430.33978271484375,
        538.4423828125,
        442.33978271484375
      ],
      "page_num": 11,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.6405029296875,
        430.33978271484375,
        538.4423828125,
        442.33978271484375
      ],
      "page_num": 11,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "탄올 분획법은 특정 요구조건에 맞는 몇 개의 개별 단계로 되어 있으며",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.60150146484375,
        451.9374694824219,
        538.5585327148438,
        463.9374694824219
      ],
      "page_num": 11,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "각 개별",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.60150146484375,
        451.9374694824219,
        538.5585327148438,
        463.9374694824219
      ],
      "page_num": 11,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.60150146484375,
        451.9374694824219,
        538.5585327148438,
        463.9374694824219
      ],
      "page_num": 11,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "단계는 제품의 품질에 매우 중요하고 그 중 일부 개별 단계는 잠재적인 바이러스",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.60150146484375,
        473.5390625,
        538.4569702148438,
        485.5390625
      ],
      "page_num": 11,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "오염을 효과적으로 감소시킬 수 있다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.60150146484375,
        495.1406555175781,
        538.477783203125,
        507.1406555175781
      ],
      "page_num": 11,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "따라서 에탄올 농도",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.60150146484375,
        495.1406555175781,
        538.477783203125,
        507.1406555175781
      ],
      "page_num": 11,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "단백질 농도",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.60150146484375,
        495.1406555175781,
        538.477783203125,
        507.1406555175781
      ],
      "page_num": 11,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "온도",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.60150146484375,
        495.1406555175781,
        538.477783203125,
        507.1406555175781
      ],
      "page_num": 11,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.60150146484375,
        495.1406555175781,
        538.477783203125,
        507.1406555175781
      ],
      "page_num": 11,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.60150146484375,
        495.1406555175781,
        538.477783203125,
        507.1406555175781
      ],
      "page_num": 11,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.60150146484375,
        495.1406555175781,
        538.477783203125,
        507.1406555175781
      ],
      "page_num": 11,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ", pH,",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.60150146484375,
        495.1406555175781,
        538.477783203125,
        507.1406555175781
      ],
      "page_num": 11,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "이온 강도 및 처리 시간 등에 대한 명확한 기준",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.60148620605469,
        516.7383422851562,
        538.5592041015625,
        528.7383422851562
      ],
      "page_num": 11,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "허용 오차범위 및 관리 방법을 제",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.60148620605469,
        516.7383422851562,
        538.5592041015625,
        528.7383422851562
      ],
      "page_num": 11,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.60148620605469,
        516.7383422851562,
        538.5592041015625,
        528.7383422851562
      ],
      "page_num": 11,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "시하여야 한다.",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.60150146484375,
        538.3399658203125,
        154.60931396484375,
        550.3399658203125
      ],
      "page_num": 11,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "크로마토그래피 등을 이용한 단백질의 분리 및 수율은 칼럼의 능력",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.6406021118164,
        581.5391235351562,
        538.43701171875,
        593.5391235351562
      ],
      "page_num": 11,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "단백질의 특",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.6406021118164,
        581.5391235351562,
        538.43701171875,
        593.5391235351562
      ],
      "page_num": 11,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.6406021118164,
        581.5391235351562,
        538.43701171875,
        593.5391235351562
      ],
      "page_num": 11,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "성 및 농도",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.60159301757812,
        603.1407470703125,
        538.4300537109375,
        615.1407470703125
      ],
      "page_num": 11,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "완충액의 이온 강도 및",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.60159301757812,
        603.1407470703125,
        538.4300537109375,
        615.1407470703125
      ],
      "page_num": 11,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "유속 및 온도와 같은 여러 인자들에 따라",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.60159301757812,
        603.1407470703125,
        538.4300537109375,
        615.1407470703125
      ],
      "page_num": 11,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.60159301757812,
        603.1407470703125,
        538.4300537109375,
        615.1407470703125
      ],
      "page_num": 11,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "pH,",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.60159301757812,
        603.1407470703125,
        538.4300537109375,
        615.1407470703125
      ],
      "page_num": 11,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "크게 좌우된다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.60159301757812,
        624.7384643554688,
        538.4453125,
        636.7384643554688
      ],
      "page_num": 11,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "따라서 적절한 규격과 기준을 명시하여야 한다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.60159301757812,
        624.7384643554688,
        538.4453125,
        636.7384643554688
      ],
      "page_num": 11,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "칼럼의 보관",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.60159301757812,
        624.7384643554688,
        538.4453125,
        636.7384643554688
      ],
      "page_num": 11,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "칼럼",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.60159301757812,
        624.7384643554688,
        538.4453125,
        636.7384643554688
      ],
      "page_num": 11,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.60159301757812,
        624.7384643554688,
        538.4453125,
        636.7384643554688
      ],
      "page_num": 11,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.60159301757812,
        624.7384643554688,
        538.4453125,
        636.7384643554688
      ],
      "page_num": 11,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.60159301757812,
        624.7384643554688,
        538.4453125,
        636.7384643554688
      ],
      "page_num": 11,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "보존제의 사용 및 재생방법 등을 기술하여야 하고",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.6016845703125,
        646.340087890625,
        538.4776000976562,
        658.340087890625
      ],
      "page_num": 11,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "무균여과",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.6016845703125,
        646.340087890625,
        538.4776000976562,
        658.340087890625
      ],
      "page_num": 11,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "투석여과",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.6016845703125,
        646.340087890625,
        538.4776000976562,
        658.340087890625
      ],
      "page_num": 11,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.6016845703125,
        646.340087890625,
        538.4776000976562,
        658.340087890625
      ],
      "page_num": 11,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.6016845703125,
        646.340087890625,
        538.4776000976562,
        658.340087890625
      ],
      "page_num": 11,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(diafiltration)",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.6016845703125,
        646.340087890625,
        538.4776000976562,
        658.340087890625
      ],
      "page_num": 11,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "또는 한외여과",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.6016845703125,
        667.937744140625,
        430.96148681640625,
        679.937744140625
      ],
      "page_num": 11,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(ultrafiltration) 등에 관한 상세한 설명도 필요하다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.6016845703125,
        667.937744140625,
        430.96148681640625,
        679.937744140625
      ],
      "page_num": 11,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.6016845703125,
        667.937744140625,
        430.96148681640625,
        679.937744140625
      ],
      "page_num": 11,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "근육주사용",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.64068603515625,
        711.140869140625,
        538.5606689453125,
        723.140869140625
      ],
      "page_num": 11,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "는 정맥 내 투여 시 부작용을 야기할 수 있다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.64068603515625,
        711.140869140625,
        538.5606689453125,
        723.140869140625
      ],
      "page_num": 11,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "만약 근육주사용",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.64068603515625,
        711.140869140625,
        538.5606689453125,
        723.140869140625
      ],
      "page_num": 11,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "HBIG",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.64068603515625,
        711.140869140625,
        538.5606689453125,
        723.140869140625
      ],
      "page_num": 11,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.64068603515625,
        711.140869140625,
        538.5606689453125,
        723.140869140625
      ],
      "page_num": 11,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "의 제조방법을 변경하여 정맥주사용",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.60169219970703,
        732.738525390625,
        538.5562133789062,
        744.738525390625
      ],
      "page_num": 11,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "를 제조하는 경우에는 주성분에는",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.60169219970703,
        732.738525390625,
        538.5562133789062,
        744.738525390625
      ],
      "page_num": 11,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "HBIG",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.60169219970703,
        732.738525390625,
        538.5562133789062,
        744.738525390625
      ],
      "page_num": 11,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "HBIG",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.60169219970703,
        732.738525390625,
        538.5562133789062,
        744.738525390625
      ],
      "page_num": 11,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 4 -",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        283.4410095214844,
        789.4503784179688,
        311.7458801269531,
        799.4103393554688
      ],
      "page_num": 12,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "영향을 미치지 않으면서 순도를 높여 부작용을 감소시킬 수 있는 다양한 공정을 거",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.60101318359375,
        99.14019775390625,
        538.4330444335938,
        111.14019775390625
      ],
      "page_num": 12,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "쳐야 한다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.60101318359375,
        120.7379150390625,
        538.449462890625,
        132.7379150390625
      ],
      "page_num": 12,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "따라서 이 때 사용한 물질 및 공정과 이들의 적합성에 대한 근거를 제",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.60101318359375,
        120.7379150390625,
        538.449462890625,
        132.7379150390625
      ],
      "page_num": 12,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.60101318359375,
        120.7379150390625,
        538.449462890625,
        132.7379150390625
      ],
      "page_num": 12,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "시하고 기술하여야 한다.",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.60101318359375,
        142.33953857421875,
        208.60882568359375,
        154.33953857421875
      ],
      "page_num": 12,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "바이러스 불활화 제거 공정은 각각 최소",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.6400146484375,
        185.53875732421875,
        538.4872436523438,
        197.53875732421875
      ],
      "page_num": 12,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "단계 이상의 공정을 포함하도록 하며",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.6400146484375,
        185.53875732421875,
        538.4872436523438,
        197.53875732421875
      ],
      "page_num": 12,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "/",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.6400146484375,
        185.53875732421875,
        538.4872436523438,
        197.53875732421875
      ],
      "page_num": 12,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.6400146484375,
        185.53875732421875,
        538.4872436523438,
        197.53875732421875
      ],
      "page_num": 12,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.6400146484375,
        185.53875732421875,
        538.4872436523438,
        197.53875732421875
      ],
      "page_num": 12,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "온도",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.60043334960938,
        207.140380859375,
        538.4404296875,
        219.140380859375
      ],
      "page_num": 12,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ", pH, 시간 등 바이러스 불활화 제거 조건을 상세히 기술하고 제조공정 흐름도",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.60043334960938,
        207.140380859375,
        538.4404296875,
        219.140380859375
      ],
      "page_num": 12,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "/",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.60043334960938,
        207.140380859375,
        538.4404296875,
        219.140380859375
      ],
      "page_num": 12,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "에 표시하여야 한다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.60043334960938,
        228.73809814453125,
        538.4328002929688,
        240.73809814453125
      ],
      "page_num": 12,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ". 바이러스 불활화 제거 공정의 유효성을 입증하기 위하여 바이",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.60043334960938,
        228.73809814453125,
        538.4328002929688,
        240.73809814453125
      ],
      "page_num": 12,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "/",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.60043334960938,
        228.73809814453125,
        538.4328002929688,
        240.73809814453125
      ],
      "page_num": 12,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "러스 검증 자료를 제출하여야 한다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.60042572021484,
        250.3397216796875,
        538.4442138671875,
        262.3397216796875
      ],
      "page_num": 12,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ". 개별 바이러스 불활화 제거 공정의 효과를 평가",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.60042572021484,
        250.3397216796875,
        538.4442138671875,
        262.3397216796875
      ],
      "page_num": 12,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "/",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.60042572021484,
        250.3397216796875,
        538.4442138671875,
        262.3397216796875
      ],
      "page_num": 12,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "한 후",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.60041809082031,
        271.93743896484375,
        535.6082153320312,
        283.93743896484375
      ],
      "page_num": 12,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ", 전 제조공정에서의 바이러스 불활화 제거 능력의 추정치를 제공하여야 한다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.60041809082031,
        271.93743896484375,
        535.6082153320312,
        283.93743896484375
      ],
      "page_num": 12,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "/",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.60041809082031,
        271.93743896484375,
        535.6082153320312,
        283.93743896484375
      ],
      "page_num": 12,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.60041809082031,
        271.93743896484375,
        535.6082153320312,
        283.93743896484375
      ],
      "page_num": 12,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "바이러스 검증 평가와 관련하여서는",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.639404296875,
        315.14056396484375,
        538.428466796875,
        327.14056396484375
      ],
      "page_num": 12,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "혈장분획제제 등 바이러스 검증 평가가이드",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.639404296875,
        315.14056396484375,
        538.428466796875,
        327.14056396484375
      ],
      "page_num": 12,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "“",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.639404296875,
        315.14056396484375,
        538.428466796875,
        327.14056396484375
      ],
      "page_num": 12,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "생물의약품평가가이드",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.60081481933594,
        336.7382507324219,
        538.4653930664062,
        348.7382507324219
      ],
      "page_num": 12,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "와",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.60081481933594,
        336.7382507324219,
        538.4653930664062,
        348.7382507324219
      ],
      "page_num": 12,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "의",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.60081481933594,
        336.7382507324219,
        538.4653930664062,
        348.7382507324219
      ],
      "page_num": 12,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.60081481933594,
        336.7382507324219,
        538.4653930664062,
        348.7382507324219
      ],
      "page_num": 12,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "20,",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.60081481933594,
        336.7382507324219,
        538.4653930664062,
        348.7382507324219
      ],
      "page_num": 12,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2006)”",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.60081481933594,
        336.7382507324219,
        538.4653930664062,
        348.7382507324219
      ],
      "page_num": 12,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "EMEA",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.60081481933594,
        336.7382507324219,
        538.4653930664062,
        348.7382507324219
      ],
      "page_num": 12,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "“Note",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.60081481933594,
        336.7382507324219,
        538.4653930664062,
        348.7382507324219
      ],
      "page_num": 12,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "for",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.60081481933594,
        336.7382507324219,
        538.4653930664062,
        348.7382507324219
      ],
      "page_num": 12,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Guidance",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.60081481933594,
        336.7382507324219,
        538.4653930664062,
        348.7382507324219
      ],
      "page_num": 12,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "on",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.60081481933594,
        336.7382507324219,
        538.4653930664062,
        348.7382507324219
      ],
      "page_num": 12,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Virus",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.60081481933594,
        336.7382507324219,
        538.4653930664062,
        348.7382507324219
      ],
      "page_num": 12,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Validation",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.60081481933594,
        358.33984375,
        538.4579467773438,
        370.33984375
      ],
      "page_num": 12,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Studies:",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.60081481933594,
        358.33984375,
        538.4579467773438,
        370.33984375
      ],
      "page_num": 12,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "The",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.60081481933594,
        358.33984375,
        538.4579467773438,
        370.33984375
      ],
      "page_num": 12,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Design,",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.60081481933594,
        358.33984375,
        538.4579467773438,
        370.33984375
      ],
      "page_num": 12,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Contribution",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.60081481933594,
        358.33984375,
        538.4579467773438,
        370.33984375
      ],
      "page_num": 12,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "and",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.60081481933594,
        358.33984375,
        538.4579467773438,
        370.33984375
      ],
      "page_num": 12,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Interpretation",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.60081481933594,
        358.33984375,
        538.4579467773438,
        370.33984375
      ],
      "page_num": 12,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "of",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.60081481933594,
        358.33984375,
        538.4579467773438,
        370.33984375
      ],
      "page_num": 12,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Studies",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.60081481933594,
        358.33984375,
        538.4579467773438,
        370.33984375
      ],
      "page_num": 12,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Validating the Inactivation and Removal of Viruses(CPMP/BWP/268/95, 1996)”",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.60079956054688,
        379.9375305175781,
        538.5286254882812,
        391.9375305175781
      ],
      "page_num": 12,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "등을 참고할 수 있다.",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.60079956054688,
        401.53912353515625,
        190.60861206054688,
        413.53912353515625
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "품질관리",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.60150146484375,
        450.1561584472656,
        139.9208984375,
        463.11614990234375
      ],
      "page_num": 12,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "4.",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.60150146484375,
        450.1561584472656,
        139.9208984375,
        463.11614990234375
      ],
      "page_num": 12,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "최소한 연속적인",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.6406021118164,
        473.538818359375,
        538.5703735351562,
        485.538818359375
      ],
      "page_num": 12,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "개 로트에 대해 검증된 시험법으로 시험한 원료의약품 및 완제",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.6406021118164,
        473.538818359375,
        538.5703735351562,
        485.538818359375
      ],
      "page_num": 12,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "3",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.6406021118164,
        473.538818359375,
        538.5703735351562,
        485.538818359375
      ],
      "page_num": 12,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "의약품의 시험성적서를 제출하고",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.6019058227539,
        495.1404113769531,
        482.6877136230469,
        507.1404113769531
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ", 제품 규격의 일관성을 입증하여야 한다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.6019058227539,
        495.1404113769531,
        482.6877136230469,
        507.1404113769531
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.6019058227539,
        495.1404113769531,
        482.6877136230469,
        507.1404113769531
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "또한 공정 중 관리",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.64089965820312,
        538.339599609375,
        538.5667724609375,
        550.339599609375
      ],
      "page_num": 12,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "시험항목과 기준을 제시하고",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.64089965820312,
        538.339599609375,
        538.5667724609375,
        550.339599609375
      ],
      "page_num": 12,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "제형",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.64089965820312,
        538.339599609375,
        538.5667724609375,
        550.339599609375
      ],
      "page_num": 12,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(in-process control, IPC)",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.64089965820312,
        538.339599609375,
        538.5667724609375,
        550.339599609375
      ],
      "page_num": 12,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.64089965820312,
        538.339599609375,
        538.5667724609375,
        550.339599609375
      ],
      "page_num": 12,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "화 과정 중 또는 생산 중 사용한 물질을 측정하고 예",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.60189819335938,
        559.937255859375,
        538.4896850585938,
        571.937255859375
      ],
      "page_num": 12,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "잔류용매",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.60189819335938,
        559.937255859375,
        538.4896850585938,
        571.937255859375
      ],
      "page_num": 12,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "계면활성제 등",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.60189819335938,
        559.937255859375,
        538.4896850585938,
        571.937255859375
      ],
      "page_num": 12,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.60189819335938,
        559.937255859375,
        538.4896850585938,
        571.937255859375
      ],
      "page_num": 12,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ":",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.60189819335938,
        559.937255859375,
        538.4896850585938,
        571.937255859375
      ],
      "page_num": 12,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.60189819335938,
        559.937255859375,
        538.4896850585938,
        571.937255859375
      ],
      "page_num": 12,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "),",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.60189819335938,
        559.937255859375,
        538.4896850585938,
        571.937255859375
      ],
      "page_num": 12,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "최소한 연속적인",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.60189819335938,
        581.5388793945312,
        527.5706787109375,
        593.5388793945312
      ],
      "page_num": 12,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "3개 로트에 대해 분석한 후 파라미터의 기준을 설정하여야 한다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.60189819335938,
        581.5388793945312,
        527.5706787109375,
        593.5388793945312
      ],
      "page_num": 12,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.60189819335938,
        581.5388793945312,
        527.5706787109375,
        593.5388793945312
      ],
      "page_num": 12,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "제조공정 중 또는 완제의약품에 잠재적 감염 위험이 있는 동물유래 물질을 사용",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.640869140625,
        624.7380981445312,
        538.4346313476562,
        636.7380981445312
      ],
      "page_num": 12,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "하는 경우에는 기원 동물 및 사용 부위를 기재하여야 하며",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.60176849365234,
        646.3397216796875,
        538.5430297851562,
        658.3397216796875
      ],
      "page_num": 12,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "반추동물 유래 성분의",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.60176849365234,
        646.3397216796875,
        538.5430297851562,
        658.3397216796875
      ],
      "page_num": 12,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.60176849365234,
        646.3397216796875,
        538.5430297851562,
        658.3397216796875
      ],
      "page_num": 12,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "경우에는 전염성 해면상 뇌증",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.60177612304688,
        667.9373779296875,
        538.44580078125,
        679.9373779296875
      ],
      "page_num": 12,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "감",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.60177612304688,
        667.9373779296875,
        538.44580078125,
        679.9373779296875
      ],
      "page_num": 12,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(transmissible spongiform encephalopathy, TSE)",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.60177612304688,
        667.9373779296875,
        538.44580078125,
        679.9373779296875
      ],
      "page_num": 12,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "염을 방지하기 위한 원료 선택 반추동물의 원산국",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.601806640625,
        689.5390014648438,
        538.4461669921875,
        701.5390014648438
      ],
      "page_num": 12,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "반추동물의 연령 등",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.601806640625,
        689.5390014648438,
        538.4461669921875,
        701.5390014648438
      ],
      "page_num": 12,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "또는 처리",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.601806640625,
        689.5390014648438,
        538.4461669921875,
        701.5390014648438
      ],
      "page_num": 12,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.601806640625,
        689.5390014648438,
        538.4461669921875,
        701.5390014648438
      ],
      "page_num": 12,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.601806640625,
        689.5390014648438,
        538.4461669921875,
        701.5390014648438
      ],
      "page_num": 12,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ")",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.601806640625,
        689.5390014648438,
        538.4461669921875,
        701.5390014648438
      ],
      "page_num": 12,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "방법 등을 기술하고",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.601806640625,
        711.140625,
        488.6876220703125,
        723.140625
      ],
      "page_num": 12,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ", 제품이 외래성 물질로부터 안전함을 입증하여야 한다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.601806640625,
        711.140625,
        488.6876220703125,
        723.140625
      ],
      "page_num": 12,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.601806640625,
        711.140625,
        488.6876220703125,
        723.140625
      ],
      "page_num": 12,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 5 -",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        283.4410095214844,
        789.4503784179688,
        311.7458801269531,
        799.4103393554688
      ],
      "page_num": 13,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ". 안정성시험",
      "font_size": 15.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.640602111816406,
        99.08502197265625,
        159.12109375,
        114.08502197265625
      ],
      "page_num": 13,
      "block_type": "heading",
      "level": 7,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Ⅲ",
      "font_size": 15.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.640602111816406,
        99.08502197265625,
        159.12109375,
        114.08502197265625
      ],
      "page_num": 13,
      "block_type": "heading",
      "level": 7,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "안정성시험은 제제의 물리화학적 상태 예",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.6406021118164,
        153.1407470703125,
        538.4389038085938,
        165.1407470703125
      ],
      "page_num": 13,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "분해물",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.6406021118164,
        153.1407470703125,
        538.4389038085938,
        165.1407470703125
      ],
      "page_num": 13,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "또는 중합물",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.6406021118164,
        153.1407470703125,
        538.4389038085938,
        165.1407470703125
      ],
      "page_num": 13,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "[",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.6406021118164,
        153.1407470703125,
        538.4389038085938,
        165.1407470703125
      ],
      "page_num": 13,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ":",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.6406021118164,
        153.1407470703125,
        538.4389038085938,
        165.1407470703125
      ],
      "page_num": 13,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(fragment)",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.6406021118164,
        153.1407470703125,
        538.4389038085938,
        165.1407470703125
      ],
      "page_num": 13,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(trimer",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.6406021118164,
        153.1407470703125,
        538.4389038085938,
        165.1407470703125
      ],
      "page_num": 13,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "이상의",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.640594482421875,
        174.73846435546875,
        538.5661010742188,
        186.73846435546875
      ],
      "page_num": 13,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "역가",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.640594482421875,
        174.73846435546875,
        538.5661010742188,
        186.73846435546875
      ],
      "page_num": 13,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "등 안정성에 대하여 설정기간 동안 일정한 간격으로 시험",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.640594482421875,
        174.73846435546875,
        538.5661010742188,
        186.73846435546875
      ],
      "page_num": 13,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "polymer)],",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.640594482421875,
        174.73846435546875,
        538.5661010742188,
        186.73846435546875
      ],
      "page_num": 13,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ", pH",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.640594482421875,
        174.73846435546875,
        538.5661010742188,
        186.73846435546875
      ],
      "page_num": 13,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "하도록 적절히 고안되어야 한다.",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.640594482421875,
        196.340087890625,
        234.64840698242188,
        208.340087890625
      ],
      "page_num": 13,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "품목허가를 위해서는 유통에 사용할 용기와 밀봉 형태로 충진된 완제의약품에 대하",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64059448242188,
        239.539306640625,
        538.4335327148438,
        251.539306640625
      ],
      "page_num": 13,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "여 유효기간을 입증할 수 있는 안정성시험을 수행하여야 한다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.640594482421875,
        261.14093017578125,
        538.4453125,
        273.14093017578125
      ],
      "page_num": 13,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "원료의약품 및 중간산",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.640594482421875,
        261.14093017578125,
        538.4453125,
        273.14093017578125
      ],
      "page_num": 13,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.640594482421875,
        261.14093017578125,
        538.4453125,
        273.14093017578125
      ],
      "page_num": 13,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "물을 보관할 경우 이에 대한 저장 및 유효기간도 안정성시험에 의해 입증하여야 한다.",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.640594482421875,
        282.7386474609375,
        534.6484375,
        294.7386474609375
      ],
      "page_num": 13,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "가속시험은 어떠한 시험항목이 안정성의 지표가 되는지를 확인하고 확립하는데 도",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.640625,
        325.9378356933594,
        538.4453125,
        337.9378356933594
      ],
      "page_num": 13,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "움을 줄 수 있으며",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.640625,
        347.5394287109375,
        508.60943603515625,
        359.5394287109375
      ],
      "page_num": 13,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ", 장기보존시험 자료를 보완할 수는 있지만 대체하지는 못한다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.640625,
        347.5394287109375,
        508.60943603515625,
        359.5394287109375
      ],
      "page_num": 13,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.640625,
        347.5394287109375,
        508.60943603515625,
        359.5394287109375
      ],
      "page_num": 13,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ". 비임상시험",
      "font_size": 15.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.64111328125,
        396.0853271484375,
        159.12161254882812,
        411.0853271484375
      ],
      "page_num": 13,
      "block_type": "heading",
      "level": 7,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Ⅳ",
      "font_size": 15.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.64111328125,
        396.0853271484375,
        159.12161254882812,
        411.0853271484375
      ],
      "page_num": 13,
      "block_type": "heading",
      "level": 7,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "일반적 고려사항",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.60201263427734,
        450.1567687988281,
        185.40188598632812,
        463.11676025390625
      ],
      "page_num": 13,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1.",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.60201263427734,
        450.1567687988281,
        185.40188598632812,
        463.11676025390625
      ],
      "page_num": 13,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "비임상시험의 목적은 사람에 있어서의 잠재적 부작용 및 독성을 확인하고 가능하",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.64111328125,
        473.5394287109375,
        538.43408203125,
        485.5394287109375
      ],
      "page_num": 13,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "다면 임상시험에서의 안전한 초회 투여 용량 등을 결정하기 위함이다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.60201263427734,
        495.1410217285156,
        538.453125,
        507.1410217285156
      ],
      "page_num": 13,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "임상시험 실",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.60201263427734,
        495.1410217285156,
        538.453125,
        507.1410217285156
      ],
      "page_num": 13,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.60201263427734,
        495.1410217285156,
        538.453125,
        507.1410217285156
      ],
      "page_num": 13,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "시 이전뿐만 아니라 임상시험 전 단계를 통해서 약리 및 독성학적 특성을 파악할",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.60202026367188,
        516.7387084960938,
        538.45751953125,
        528.7387084960938
      ],
      "page_num": 13,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "수 있다.",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.60202026367188,
        538.34033203125,
        118.60983276367188,
        550.34033203125
      ],
      "page_num": 13,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "면역글로불린제제는 사람의 혈장을 원료로 하여 혈장 내 면역글로불린이 변질되",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.64112091064453,
        581.5394897460938,
        538.44580078125,
        593.5394897460938
      ],
      "page_num": 13,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "지 않도록 에탄올로 분획",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.60202026367188,
        603.14111328125,
        538.43798828125,
        615.14111328125
      ],
      "page_num": 13,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "정제하여 제조한 사람 유래 단백질제제이다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.60202026367188,
        603.14111328125,
        538.43798828125,
        615.14111328125
      ],
      "page_num": 13,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "따라서 독성",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.60202026367188,
        603.14111328125,
        538.43798828125,
        615.14111328125
      ],
      "page_num": 13,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.60202026367188,
        603.14111328125,
        538.43798828125,
        615.14111328125
      ],
      "page_num": 13,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.60202026367188,
        603.14111328125,
        538.43798828125,
        615.14111328125
      ],
      "page_num": 13,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "시험이 간소화 될 수 있으며",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.60202026367188,
        624.7388305664062,
        538.5432739257812,
        636.7388305664062
      ],
      "page_num": 13,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "동물에 투여했을 때 면역원성을 일으킬 수 있으므로",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.60202026367188,
        624.7388305664062,
        538.5432739257812,
        636.7388305664062
      ],
      "page_num": 13,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.60202026367188,
        624.7388305664062,
        538.5432739257812,
        636.7388305664062
      ],
      "page_num": 13,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "이를 고려하여야 한다.",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.60202026367188,
        646.3404541015625,
        196.60983276367188,
        658.3404541015625
      ],
      "page_num": 13,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "독성시험 및 안전성약리시험은",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.64102172851562,
        689.5396118164062,
        538.448974609375,
        701.5396118164062
      ],
      "page_num": 13,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "“비임상시험관리기준",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.64102172851562,
        689.5396118164062,
        538.448974609375,
        701.5396118164062
      ],
      "page_num": 13,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(Good Laboratory Practice,",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.64102172851562,
        689.5396118164062,
        538.448974609375,
        701.5396118164062
      ],
      "page_num": 13,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "식품의약품안전청 고시",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.60153198242188,
        711.1412353515625,
        538.4337158203125,
        723.1412353515625
      ],
      "page_num": 13,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "에 적합하게 실시되어야 한다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.60153198242188,
        711.1412353515625,
        538.4337158203125,
        723.1412353515625
      ],
      "page_num": 13,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "그러나",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.60153198242188,
        711.1412353515625,
        538.4337158203125,
        723.1412353515625
      ],
      "page_num": 13,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "에 준하여",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.60153198242188,
        711.1412353515625,
        538.4337158203125,
        723.1412353515625
      ],
      "page_num": 13,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "GLP)(",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.60153198242188,
        711.1412353515625,
        538.4337158203125,
        723.1412353515625
      ],
      "page_num": 13,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ")”",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.60153198242188,
        711.1412353515625,
        538.4337158203125,
        723.1412353515625
      ],
      "page_num": 13,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.60153198242188,
        711.1412353515625,
        538.4337158203125,
        723.1412353515625
      ],
      "page_num": 13,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "GLP",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.60153198242188,
        711.1412353515625,
        538.4337158203125,
        723.1412353515625
      ],
      "page_num": 13,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "수행하지 않은 시험인 경우에는 시험방법 및 평가 기준 등이 과학적 합리적으로 타",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.60153198242188,
        732.7389526367188,
        538.5556030273438,
        744.7389526367188
      ],
      "page_num": 13,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "․",
      "font_size": 12.0,
      "font_name": "TTA184C656tCID32K",
      "bbox": [
        72.60153198242188,
        732.7389526367188,
        538.5556030273438,
        744.7389526367188
      ],
      "page_num": 13,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 6 -",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        283.4410095214844,
        789.4503784179688,
        311.7458801269531,
        799.4103393554688
      ],
      "page_num": 14,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "당성이 인정되어야 하며",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.60101318359375,
        99.14019775390625,
        538.4447021484375,
        111.14019775390625
      ],
      "page_num": 14,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "에 적합하지 않은 부분을 명확히 하고 안전성평가 전",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.60101318359375,
        99.14019775390625,
        538.4447021484375,
        111.14019775390625
      ],
      "page_num": 14,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ", GLP",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.60101318359375,
        99.14019775390625,
        538.4447021484375,
        111.14019775390625
      ],
      "page_num": 14,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "체에 대한 중요성에 대하여 평가해야 한다.",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.60101318359375,
        120.7379150390625,
        310.60882568359375,
        132.7379150390625
      ],
      "page_num": 14,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "독성시험",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.60150146484375,
        169.35513305664062,
        139.9208984375,
        182.3151397705078
      ],
      "page_num": 14,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2.",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.60150146484375,
        169.35513305664062,
        139.9208984375,
        182.3151397705078
      ],
      "page_num": 14,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "근육주사용",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.6406021118164,
        192.73779296875,
        538.5614013671875,
        204.73779296875
      ],
      "page_num": 14,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "는 이미 사용 경험이 풍부한 제제이다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.6406021118164,
        192.73779296875,
        538.5614013671875,
        204.73779296875
      ],
      "page_num": 14,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "정맥주사용",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.6406021118164,
        192.73779296875,
        538.5614013671875,
        204.73779296875
      ],
      "page_num": 14,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "는 근",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.6406021118164,
        192.73779296875,
        538.5614013671875,
        204.73779296875
      ],
      "page_num": 14,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "HBIG",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.6406021118164,
        192.73779296875,
        538.5614013671875,
        204.73779296875
      ],
      "page_num": 14,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.6406021118164,
        192.73779296875,
        538.5614013671875,
        204.73779296875
      ],
      "page_num": 14,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "HBIG",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.6406021118164,
        192.73779296875,
        538.5614013671875,
        204.73779296875
      ],
      "page_num": 14,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "육주사용",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.60183715820312,
        214.33941650390625,
        538.4481201171875,
        226.33941650390625
      ],
      "page_num": 14,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "와 주성분은 동일하나 정맥주사용으로 사용하기 위하여 주성분의 물",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.60183715820312,
        214.33941650390625,
        538.4481201171875,
        226.33941650390625
      ],
      "page_num": 14,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "HBIG",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.60183715820312,
        214.33941650390625,
        538.4481201171875,
        226.33941650390625
      ],
      "page_num": 14,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "리화학적 성질에는 거의 영향을 미치지 않으면서 순도를 향상시키기 위하여 정제공",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.60183715820312,
        235.9371337890625,
        538.5599975585938,
        247.9371337890625
      ],
      "page_num": 14,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "정 및 바이러스 불활화 제거 공정을 추가하게 된다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.60183715820312,
        257.53875732421875,
        357.6484680175781,
        269.53875732421875
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "/",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.60183715820312,
        257.53875732421875,
        357.6484680175781,
        269.53875732421875
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.60183715820312,
        257.53875732421875,
        357.6484680175781,
        269.53875732421875
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "이에 따라 새로운 투여 경로 및 용법 용량에 대한 추가적인 독성시험이 요구된다.",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.64083862304688,
        300.73797607421875,
        538.4886474609375,
        312.73797607421875
      ],
      "page_num": 14,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "․",
      "font_size": 12.0,
      "font_name": "TTA184C656tCID32K",
      "bbox": [
        86.64083862304688,
        300.73797607421875,
        538.4886474609375,
        312.73797607421875
      ],
      "page_num": 14,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "또한 제조공정 중에 새로이 사용한 물질 예",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.60183715820312,
        322.3395690917969,
        538.445556640625,
        334.3395690917969
      ],
      "page_num": 14,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "유기용매",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.60183715820312,
        322.3395690917969,
        538.445556640625,
        334.3395690917969
      ],
      "page_num": 14,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "계면활성제 등 이 있는 경",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.60183715820312,
        322.3395690917969,
        538.445556640625,
        334.3395690917969
      ],
      "page_num": 14,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.60183715820312,
        322.3395690917969,
        538.445556640625,
        334.3395690917969
      ],
      "page_num": 14,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ":",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.60183715820312,
        322.3395690917969,
        538.445556640625,
        334.3395690917969
      ],
      "page_num": 14,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.60183715820312,
        322.3395690917969,
        538.445556640625,
        334.3395690917969
      ],
      "page_num": 14,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ")",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.60183715820312,
        322.3395690917969,
        538.445556640625,
        334.3395690917969
      ],
      "page_num": 14,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "우에는 그 물질에 대해 최대 잔류량에서 나타날 수 있는 독성시험 자료가 추가로",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.60183715820312,
        343.937255859375,
        538.457275390625,
        355.937255859375
      ],
      "page_num": 14,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "요구된다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.60183715820312,
        365.5388488769531,
        538.4527587890625,
        377.5388488769531
      ],
      "page_num": 14,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "만약 사용한 물질이나 첨가제가 제품 사용량에서 독성이 없는 것으로 알",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.60183715820312,
        365.5388488769531,
        538.4527587890625,
        377.5388488769531
      ],
      "page_num": 14,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.60183715820312,
        365.5388488769531,
        538.4527587890625,
        377.5388488769531
      ],
      "page_num": 14,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "려진 경우에는 독성시험을 수행하지 않아도 된다.",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.60183715820312,
        387.14044189453125,
        346.6096496582031,
        399.14044189453125
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "만약 정맥주사용",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.64083862304688,
        427.9373474121094,
        538.5470581054688,
        439.9373474121094
      ],
      "page_num": 14,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "를 처음 개발하는 경우에는 그에 따른 독성시험 자료를 제",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.64083862304688,
        427.9373474121094,
        538.5470581054688,
        439.9373474121094
      ],
      "page_num": 14,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "HBIG",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.64083862304688,
        427.9373474121094,
        538.5470581054688,
        439.9373474121094
      ],
      "page_num": 14,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "출하여야 한다.",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.6013412475586,
        449.5389404296875,
        154.60916137695312,
        461.5389404296875
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "약리시험",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.60135650634766,
        498.1562805175781,
        139.92076110839844,
        511.11627197265625
      ],
      "page_num": 14,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "3.",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.60135650634766,
        498.1562805175781,
        139.92076110839844,
        511.11627197265625
      ],
      "page_num": 14,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "정맥주사용",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.64045715332031,
        521.5389404296875,
        538.4361572265625,
        533.5389404296875
      ],
      "page_num": 14,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "는 사람의 혈장을 에탄올로 분획",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.64045715332031,
        521.5389404296875,
        538.4361572265625,
        533.5389404296875
      ],
      "page_num": 14,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "정제하여 제조한 사람면역글",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.64045715332031,
        521.5389404296875,
        538.4361572265625,
        533.5389404296875
      ],
      "page_num": 14,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "HBIG",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.64045715332031,
        521.5389404296875,
        538.4361572265625,
        533.5389404296875
      ],
      "page_num": 14,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.64045715332031,
        521.5389404296875,
        538.4361572265625,
        533.5389404296875
      ],
      "page_num": 14,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "로불린으로 이러한 제조공정이 면역글로불린 분자의 물리화학적 성질에는 거의 영",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.60135650634766,
        543.1405029296875,
        538.4366455078125,
        555.1405029296875
      ],
      "page_num": 14,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "향을 미치지 않아 천연의 면역글로불린과 유사한 대사적 반감기를 나타낼 것으로",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.60135650634766,
        564.7382202148438,
        538.446044921875,
        576.7382202148438
      ],
      "page_num": 14,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "판단된다.",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.60135650634766,
        586.33984375,
        124.60916900634766,
        598.33984375
      ],
      "page_num": 14,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "이미 허가되어 사용 경험이 풍부한 근육주사용",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.64045715332031,
        629.5390014648438,
        538.4454956054688,
        641.5390014648438
      ],
      "page_num": 14,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "의 제조방법을 변경하여 정",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.64045715332031,
        629.5390014648438,
        538.4454956054688,
        641.5390014648438
      ],
      "page_num": 14,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "HBIG",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.64045715332031,
        629.5390014648438,
        538.4454956054688,
        641.5390014648438
      ],
      "page_num": 14,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "맥주사용",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.6014404296875,
        651.140625,
        538.4476928710938,
        663.140625
      ],
      "page_num": 14,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "를 제조하는 경우에는 주성분이 동일하여 추가적인 효력이나 약리시",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.6014404296875,
        651.140625,
        538.4476928710938,
        663.140625
      ],
      "page_num": 14,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "HBIG",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.6014404296875,
        651.140625,
        538.4476928710938,
        663.140625
      ],
      "page_num": 14,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "험은 필요하지 않을 수 있으며 제품의 역가는 임상시험이나 역가시험으로 확인할",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.6014404296875,
        672.7383422851562,
        538.4461059570312,
        684.7383422851562
      ],
      "page_num": 14,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "수 있으나",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.6014404296875,
        694.3399658203125,
        478.7302551269531,
        706.3399658203125
      ],
      "page_num": 14,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ", 새로운 효능 효과에 대해서는 효력시험자료가 요구될 수 있다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.6014404296875,
        694.3399658203125,
        478.7302551269531,
        706.3399658203125
      ],
      "page_num": 14,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.6014404296875,
        694.3399658203125,
        478.7302551269531,
        706.3399658203125
      ],
      "page_num": 14,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "․",
      "font_size": 12.0,
      "font_name": "TTA184C656tCID32K",
      "bbox": [
        72.6014404296875,
        694.3399658203125,
        478.7302551269531,
        706.3399658203125
      ],
      "page_num": 14,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 7 -",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        283.4410095214844,
        789.4503784179688,
        311.7458801269531,
        799.4103393554688
      ],
      "page_num": 15,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ". 임상시험",
      "font_size": 15.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.640602111816406,
        99.08502197265625,
        144.12109375,
        114.08502197265625
      ],
      "page_num": 15,
      "block_type": "heading",
      "level": 7,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Ⅴ",
      "font_size": 15.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.640602111816406,
        99.08502197265625,
        144.12109375,
        114.08502197265625
      ],
      "page_num": 15,
      "block_type": "heading",
      "level": 7,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "일반적 고려사항",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.60150146484375,
        153.15646362304688,
        185.40138244628906,
        166.11647033691406
      ],
      "page_num": 15,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1.",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.60150146484375,
        153.15646362304688,
        185.40138244628906,
        166.11647033691406
      ],
      "page_num": 15,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "간 이식 후",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.6406021118164,
        176.53912353515625,
        538.44140625,
        188.53912353515625
      ],
      "page_num": 15,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "형 간염의 재발을 막기 위해서는",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.6406021118164,
        176.53912353515625,
        538.44140625,
        188.53912353515625
      ],
      "page_num": 15,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "를 단독 투여하거나 항바이러",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.6406021118164,
        176.53912353515625,
        538.44140625,
        188.53912353515625
      ],
      "page_num": 15,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "B",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.6406021118164,
        176.53912353515625,
        538.44140625,
        188.53912353515625
      ],
      "page_num": 15,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "HBIG",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.6406021118164,
        176.53912353515625,
        538.44140625,
        188.53912353515625
      ],
      "page_num": 15,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "스제와",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.60150146484375,
        198.1407470703125,
        310.0158386230469,
        210.1407470703125
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "HBIG의 병용요법이 이용되고 있다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.60150146484375,
        198.1407470703125,
        310.0158386230469,
        210.1407470703125
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.60150146484375,
        198.1407470703125,
        310.0158386230469,
        210.1407470703125
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "본 가이드라인에서는 간 이식 환자의",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.6406021118164,
        241.3399658203125,
        538.4296875,
        253.3399658203125
      ],
      "page_num": 15,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "형 간염 재발의 예방 목적으로 사용되는",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.6406021118164,
        241.3399658203125,
        538.4296875,
        253.3399658203125
      ],
      "page_num": 15,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "B",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.6406021118164,
        241.3399658203125,
        538.4296875,
        253.3399658203125
      ],
      "page_num": 15,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "정맥주사용",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.60159301757812,
        262.93768310546875,
        538.4315185546875,
        274.93768310546875
      ],
      "page_num": 15,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "단독 투여에 의한 임상시험을 위주로 언급하고자 한다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.60159301757812,
        262.93768310546875,
        538.4315185546875,
        274.93768310546875
      ],
      "page_num": 15,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "만약",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.60159301757812,
        262.93768310546875,
        538.4315185546875,
        274.93768310546875
      ],
      "page_num": 15,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "HBIG",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.60159301757812,
        262.93768310546875,
        538.4315185546875,
        274.93768310546875
      ],
      "page_num": 15,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.60159301757812,
        262.93768310546875,
        538.4315185546875,
        274.93768310546875
      ],
      "page_num": 15,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "HBV",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.60159301757812,
        262.93768310546875,
        538.4315185546875,
        274.93768310546875
      ],
      "page_num": 15,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "에 노출된 후",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.601806640625,
        284.539306640625,
        538.449462890625,
        296.539306640625
      ],
      "page_num": 15,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "형 간염 발증의 예방 목적으로 사용하고자 하는 경우에는 해당 적응",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.601806640625,
        284.539306640625,
        538.449462890625,
        296.539306640625
      ],
      "page_num": 15,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "B",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.601806640625,
        284.539306640625,
        538.449462890625,
        296.539306640625
      ],
      "page_num": 15,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "증에 맞는 임상시험을 수행하여야 한다.",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.60179901123047,
        306.14093017578125,
        292.609619140625,
        318.14093017578125
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "임상약리시험",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.60140228271484,
        354.7543640136719,
        165.84268188476562,
        367.71435546875
      ],
      "page_num": 15,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2.",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.60140228271484,
        354.7543640136719,
        165.84268188476562,
        367.71435546875
      ],
      "page_num": 15,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "사람에서 실시되는 첫 임상시험으로서 주된 목적은 안전성을 평가하는 것이다.",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.6405029296875,
        378.14093017578125,
        538.48828125,
        390.14093017578125
      ],
      "page_num": 15,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "일반적으로 치료를 목적으로 하지 않으며 건강한 지원자를 대상으로 실시한다 본",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.60147094726562,
        399.7386169433594,
        538.5613403320312,
        411.7386169433594
      ],
      "page_num": 15,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.60147094726562,
        399.7386169433594,
        538.5613403320312,
        411.7386169433594
      ],
      "page_num": 15,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "제제는 항암제 등과 같이 세포독성 등의 심각한 잠재적 독성을 갖고 있지 않으므로",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.60150146484375,
        421.3402099609375,
        538.4335327148438,
        433.3402099609375
      ],
      "page_num": 15,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "환자를 대상으로 하지 아니한다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.60150146484375,
        442.9378967285156,
        538.4331665039062,
        454.9378967285156
      ],
      "page_num": 15,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "단기간의 안전성 및 내약성 평가",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.60150146484375,
        442.9378967285156,
        538.4331665039062,
        454.9378967285156
      ],
      "page_num": 15,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "약동학 및 약력",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.60150146484375,
        442.9378967285156,
        538.4331665039062,
        454.9378967285156
      ],
      "page_num": 15,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ").",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.60150146484375,
        442.9378967285156,
        538.4331665039062,
        454.9378967285156
      ],
      "page_num": 15,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.60150146484375,
        442.9378967285156,
        538.4331665039062,
        454.9378967285156
      ],
      "page_num": 15,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "학적 정보를 제공하여 치료적 탐색 임상시험의 적절한 용량 범위와 투여 일정을 정",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.60150146484375,
        464.53948974609375,
        538.4335327148438,
        476.53948974609375
      ],
      "page_num": 15,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "하는데 필요한 정보를 제공하여야 한다.",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.60150146484375,
        486.1410827636719,
        292.60931396484375,
        498.1410827636719
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "약물의 흡수",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.6405029296875,
        529.3402709960938,
        538.4415283203125,
        541.3402709960938
      ],
      "page_num": 15,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "분포",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.6405029296875,
        529.3402709960938,
        538.4415283203125,
        541.3402709960938
      ],
      "page_num": 15,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "대사 및 배설에 대한 특성 규명을 위한 독립된 연구 또는 안",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.6405029296875,
        529.3402709960938,
        538.4415283203125,
        541.3402709960938
      ],
      "page_num": 15,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.6405029296875,
        529.3402709960938,
        538.4415283203125,
        541.3402709960938
      ],
      "page_num": 15,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.6405029296875,
        529.3402709960938,
        538.4415283203125,
        541.3402709960938
      ],
      "page_num": 15,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "전성 유효성 및 내약성 연구의 한 부분으로 약동학적 임상시험을 수행하여야 한다.",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.60150146484375,
        550.93798828125,
        538.48828125,
        562.93798828125
      ],
      "page_num": 15,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "․",
      "font_size": 12.0,
      "font_name": "TTA184C656tCID32K",
      "bbox": [
        72.60150146484375,
        550.93798828125,
        538.48828125,
        562.93798828125
      ],
      "page_num": 15,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "일반적인 약동학적 평가에서 고려되어야 하는 고령자",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.60147094726562,
        572.53955078125,
        538.4525756835938,
        584.53955078125
      ],
      "page_num": 15,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "여성 등과 같은 특수 집단에",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.60147094726562,
        572.53955078125,
        538.4525756835938,
        584.53955078125
      ],
      "page_num": 15,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.60147094726562,
        572.53955078125,
        538.4525756835938,
        584.53955078125
      ],
      "page_num": 15,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "서의 약동학적 정보를 제공하여야 한다.",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.60147094726562,
        594.14111328125,
        292.6092834472656,
        606.14111328125
      ],
      "page_num": 15,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "정맥주사용",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.64047241210938,
        637.34033203125,
        538.4334106445312,
        649.34033203125
      ],
      "page_num": 15,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "는 분자량이 큰 면역글로불린제제이므로 간이나 신장 등에서 여",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.64047241210938,
        637.34033203125,
        538.4334106445312,
        649.34033203125
      ],
      "page_num": 15,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "HBIG",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.64047241210938,
        637.34033203125,
        538.4334106445312,
        649.34033203125
      ],
      "page_num": 15,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "과되거나 해독되지 않고 혈중을 다니다가 세망내피계(reticuloendothelial system,",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.60147857666016,
        658.9380493164062,
        538.3876342773438,
        670.9380493164062
      ],
      "page_num": 15,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "에서 탐식 당해 비장",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.60166931152344,
        680.5396728515625,
        538.4368896484375,
        692.5396728515625
      ],
      "page_num": 15,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "림프절",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.60166931152344,
        680.5396728515625,
        538.4368896484375,
        692.5396728515625
      ],
      "page_num": 15,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "골수 등에서 제거되므로 신장애 환자에 대한 약",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.60166931152344,
        680.5396728515625,
        538.4368896484375,
        692.5396728515625
      ],
      "page_num": 15,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "RES)",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.60166931152344,
        680.5396728515625,
        538.4368896484375,
        692.5396728515625
      ],
      "page_num": 15,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.60166931152344,
        680.5396728515625,
        538.4368896484375,
        692.5396728515625
      ],
      "page_num": 15,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.60166931152344,
        680.5396728515625,
        538.4368896484375,
        692.5396728515625
      ],
      "page_num": 15,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "동학 정보의 확보는 필수사항은 아니다.",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.60166931152344,
        702.1412353515625,
        292.6094970703125,
        714.1412353515625
      ],
      "page_num": 15,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 8 -",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        283.4410095214844,
        789.4503784179688,
        311.7458801269531,
        799.4103393554688
      ],
      "page_num": 16,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "치료적 탐색 임상시험",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.60150146484375,
        99.15615844726562,
        217.80372619628906,
        112.11616516113281
      ],
      "page_num": 16,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "3.",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.60150146484375,
        99.15615844726562,
        217.80372619628906,
        112.11616516113281
      ],
      "page_num": 16,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "치료적 유효성을 탐색하여 가능한 용량과 투여 기간 설정 등 다양한 정보 수집을",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.6406021118164,
        122.538818359375,
        538.55859375,
        134.538818359375
      ],
      "page_num": 16,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "목적으로 하며",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.60150146484375,
        144.14044189453125,
        538.5599975585938,
        156.14044189453125
      ],
      "page_num": 16,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "비교적 철저한 선정기준에 의해 모집된 환자군을 대상으로 수행하",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.60150146484375,
        144.14044189453125,
        538.5599975585938,
        156.14044189453125
      ],
      "page_num": 16,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.60150146484375,
        144.14044189453125,
        538.5599975585938,
        156.14044189453125
      ],
      "page_num": 16,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "여야 한다.",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.60150146484375,
        165.7381591796875,
        130.60931396484375,
        177.7381591796875
      ],
      "page_num": 16,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "치료적 확증 임상시험의 용량 및 용법을 결정하기 위하여 용량의 단계적 증량 디",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.6406021118164,
        208.9373779296875,
        538.55859375,
        220.9373779296875
      ],
      "page_num": 16,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "자인 등을 이용하여 적응증에 대한 용량 반응 관계를 확정하여야 한다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.60150146484375,
        230.53900146484375,
        468.16815185546875,
        242.53900146484375
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "-",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.60150146484375,
        230.53900146484375,
        468.16815185546875,
        242.53900146484375
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.60150146484375,
        230.53900146484375,
        468.16815185546875,
        242.53900146484375
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "치료적 확증 임상시험",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.6010971069336,
        279.1563415527344,
        217.80331420898438,
        292.1163330078125
      ],
      "page_num": 16,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "4.",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.6010971069336,
        279.1563415527344,
        217.80331420898438,
        292.1163330078125
      ],
      "page_num": 16,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "피험자의 선정",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.64010620117188,
        329.53900146484375,
        186.35890197753906,
        341.53900146484375
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "4.1.",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.64010620117188,
        329.53900146484375,
        186.35890197753906,
        341.53900146484375
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "감염에 의한 간경변증",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        110.64010620117188,
        351.1405944824219,
        538.4425048828125,
        363.1405944824219
      ],
      "page_num": 16,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "간암",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        110.64010620117188,
        351.1405944824219,
        538.4425048828125,
        363.1405944824219
      ],
      "page_num": 16,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "전격성 간부전 등 말기 간질환으로 간 이",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        110.64010620117188,
        351.1405944824219,
        538.4425048828125,
        363.1405944824219
      ],
      "page_num": 16,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "HBV",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        110.64010620117188,
        351.1405944824219,
        538.4425048828125,
        363.1405944824219
      ],
      "page_num": 16,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        110.64010620117188,
        351.1405944824219,
        538.4425048828125,
        363.1405944824219
      ],
      "page_num": 16,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        110.64010620117188,
        351.1405944824219,
        538.4425048828125,
        363.1405944824219
      ],
      "page_num": 16,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "식 수술 예정인 자로서",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.64010620117188,
        372.73828125,
        504.88262939453125,
        384.73828125
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "간 이식 수술 전에",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.64010620117188,
        372.73828125,
        504.88262939453125,
        384.73828125
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "양성인 환자이어야 한다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.64010620117188,
        372.73828125,
        504.88262939453125,
        384.73828125
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ",",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.64010620117188,
        372.73828125,
        504.88262939453125,
        384.73828125
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "HBsAg",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.64010620117188,
        372.73828125,
        504.88262939453125,
        384.73828125
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.64010620117188,
        372.73828125,
        504.88262939453125,
        384.73828125
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "면역글로불린제제는 단백질의",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        110.64010620117188,
        415.9374694824219,
        538.50634765625,
        427.9374694824219
      ],
      "page_num": 16,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "90% 이상이 면역글로불린",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        110.64010620117188,
        415.9374694824219,
        538.50634765625,
        427.9374694824219
      ],
      "page_num": 16,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "G(immunoglobulin",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        110.64010620117188,
        415.9374694824219,
        538.50634765625,
        427.9374694824219
      ],
      "page_num": 16,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "이며 소량의",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.64000701904297,
        437.5390625,
        538.4415283203125,
        449.5390625
      ],
      "page_num": 16,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "및",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.64000701904297,
        437.5390625,
        538.4415283203125,
        449.5390625
      ],
      "page_num": 16,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "이 함유되어 있다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.64000701904297,
        437.5390625,
        538.4415283203125,
        449.5390625
      ],
      "page_num": 16,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "최근 정제공정의 변경 또는 추",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.64000701904297,
        437.5390625,
        538.4415283203125,
        449.5390625
      ],
      "page_num": 16,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "G, IgG)",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.64000701904297,
        437.5390625,
        538.4415283203125,
        449.5390625
      ],
      "page_num": 16,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "IgA",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.64000701904297,
        437.5390625,
        538.4415283203125,
        449.5390625
      ],
      "page_num": 16,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "IgM",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.64000701904297,
        437.5390625,
        538.4415283203125,
        449.5390625
      ],
      "page_num": 16,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.64000701904297,
        437.5390625,
        538.4415283203125,
        449.5390625
      ],
      "page_num": 16,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "가로",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.64000701904297,
        459.1406555175781,
        538.4357299804688,
        471.1406555175781
      ],
      "page_num": 16,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "함량이 총 단백질의",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.64000701904297,
        459.1406555175781,
        538.4357299804688,
        471.1406555175781
      ],
      "page_num": 16,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "이상으로 순도가 개선되어",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.64000701904297,
        459.1406555175781,
        538.4357299804688,
        471.1406555175781
      ],
      "page_num": 16,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "정맥주사용",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.64000701904297,
        459.1406555175781,
        538.4357299804688,
        471.1406555175781
      ],
      "page_num": 16,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "IgG",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.64000701904297,
        459.1406555175781,
        538.4357299804688,
        471.1406555175781
      ],
      "page_num": 16,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "98%",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.64000701904297,
        459.1406555175781,
        538.4357299804688,
        471.1406555175781
      ],
      "page_num": 16,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.64000701904297,
        459.1406555175781,
        538.4357299804688,
        471.1406555175781
      ],
      "page_num": 16,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "HBIG",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.64000701904297,
        459.1406555175781,
        538.4357299804688,
        471.1406555175781
      ],
      "page_num": 16,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "의",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.64000701904297,
        480.73834228515625,
        538.4371337890625,
        492.73834228515625
      ],
      "page_num": 16,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "함량은",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.64000701904297,
        480.73834228515625,
        538.4371337890625,
        492.73834228515625
      ],
      "page_num": 16,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "함량 대비",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.64000701904297,
        480.73834228515625,
        538.4371337890625,
        492.73834228515625
      ],
      "page_num": 16,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "미만이고 이는 근육주사용",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.64000701904297,
        480.73834228515625,
        538.4371337890625,
        492.73834228515625
      ],
      "page_num": 16,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "에 비해서 매",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.64000701904297,
        480.73834228515625,
        538.4371337890625,
        492.73834228515625
      ],
      "page_num": 16,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "IgA",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.64000701904297,
        480.73834228515625,
        538.4371337890625,
        492.73834228515625
      ],
      "page_num": 16,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "IgG",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.64000701904297,
        480.73834228515625,
        538.4371337890625,
        492.73834228515625
      ],
      "page_num": 16,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "0.1%",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.64000701904297,
        480.73834228515625,
        538.4371337890625,
        492.73834228515625
      ],
      "page_num": 16,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "HBIG",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.64000701904297,
        480.73834228515625,
        538.4371337890625,
        492.73834228515625
      ],
      "page_num": 16,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "우 낮은 수준이다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.6400146484375,
        502.3399658203125,
        538.4376220703125,
        514.3399658203125
      ],
      "page_num": 16,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "그러나",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.6400146484375,
        502.3399658203125,
        538.4376220703125,
        514.3399658203125
      ],
      "page_num": 16,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "에 대한 항체를 갖고 있는",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.6400146484375,
        502.3399658203125,
        538.4376220703125,
        514.3399658203125
      ],
      "page_num": 16,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "결핍증 환자는 면역",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.6400146484375,
        502.3399658203125,
        538.4376220703125,
        514.3399658203125
      ],
      "page_num": 16,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.6400146484375,
        502.3399658203125,
        538.4376220703125,
        514.3399658203125
      ],
      "page_num": 16,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "IgA",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.6400146484375,
        502.3399658203125,
        538.4376220703125,
        514.3399658203125
      ],
      "page_num": 16,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "IgA",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.6400146484375,
        502.3399658203125,
        538.4376220703125,
        514.3399658203125
      ],
      "page_num": 16,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "글로불린제제 투여로 제품에 함유되어 있는",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.64000701904297,
        523.9376220703125,
        538.4368896484375,
        535.9376220703125
      ],
      "page_num": 16,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "IgA로 인한 항원 항체 반응 때문에 과",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.64000701904297,
        523.9376220703125,
        538.4368896484375,
        535.9376220703125
      ],
      "page_num": 16,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "-",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.64000701904297,
        523.9376220703125,
        538.4368896484375,
        535.9376220703125
      ],
      "page_num": 16,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "민반응이 생길 수 있으므로 투여해서는 안 된다.",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.6400146484375,
        545.5391845703125,
        348.6478271484375,
        557.5391845703125
      ],
      "page_num": 16,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "투여 용량",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.64021301269531,
        594.1408081054688,
        162.3590087890625,
        606.1408081054688
      ],
      "page_num": 16,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "4.2.",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.64021301269531,
        594.1408081054688,
        162.3590087890625,
        606.1408081054688
      ],
      "page_num": 16,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "일반적으로 간 이식 후",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        110.64021301269531,
        615.738525390625,
        538.437744140625,
        627.738525390625
      ],
      "page_num": 16,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "형 간염 재발 예방을 위한 투여 용량은 간 이식 전",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        110.64021301269531,
        615.738525390625,
        538.437744140625,
        627.738525390625
      ],
      "page_num": 16,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "B",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        110.64021301269531,
        615.738525390625,
        538.437744140625,
        627.738525390625
      ],
      "page_num": 16,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "바이러스의 상태에 영향을 받는다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.64021301269531,
        637.340087890625,
        538.4293212890625,
        649.340087890625
      ],
      "page_num": 16,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "대개의 경우 간 이식 전에",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.64021301269531,
        637.340087890625,
        538.4293212890625,
        649.340087890625
      ],
      "page_num": 16,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "가 양성인",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.64021301269531,
        637.340087890625,
        538.4293212890625,
        649.340087890625
      ],
      "page_num": 16,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.64021301269531,
        637.340087890625,
        538.4293212890625,
        649.340087890625
      ],
      "page_num": 16,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "HBV DNA",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.64021301269531,
        637.340087890625,
        538.4293212890625,
        649.340087890625
      ],
      "page_num": 16,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "경우에는",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.64022827148438,
        658.9378051757812,
        538.2755737304688,
        670.9378051757812
      ],
      "page_num": 16,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "B형 간염 표면항체",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.64022827148438,
        658.9378051757812,
        538.2755737304688,
        670.9378051757812
      ],
      "page_num": 16,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(antibody to hepatitis B surface antigen, anti-HBs)",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.64022827148438,
        658.9378051757812,
        538.2755737304688,
        670.9378051757812
      ],
      "page_num": 16,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "농도를",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.64022827148438,
        680.5394287109375,
        538.4362182617188,
        692.5394287109375
      ],
      "page_num": 16,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "이상으로 유지하고",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.64022827148438,
        680.5394287109375,
        538.4362182617188,
        692.5394287109375
      ],
      "page_num": 16,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "가 음성인 경우에는 이보다 적은",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.64022827148438,
        680.5394287109375,
        538.4362182617188,
        692.5394287109375
      ],
      "page_num": 16,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "500 IU/L",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.64022827148438,
        680.5394287109375,
        538.4362182617188,
        692.5394287109375
      ],
      "page_num": 16,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ", HBV DNA",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.64022827148438,
        680.5394287109375,
        538.4362182617188,
        692.5394287109375
      ],
      "page_num": 16,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "농도로 유지할 수 있다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.64022827148438,
        702.1409912109375,
        538.3253784179688,
        714.1409912109375
      ],
      "page_num": 16,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "외에",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.64022827148438,
        702.1409912109375,
        538.3253784179688,
        714.1409912109375
      ],
      "page_num": 16,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "형 간염",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.64022827148438,
        702.1409912109375,
        538.3253784179688,
        714.1409912109375
      ],
      "page_num": 16,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "항원",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.64022827148438,
        702.1409912109375,
        538.3253784179688,
        714.1409912109375
      ],
      "page_num": 16,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ". HBV DNA",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.64022827148438,
        702.1409912109375,
        538.3253784179688,
        714.1409912109375
      ],
      "page_num": 16,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "B",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.64022827148438,
        702.1409912109375,
        538.3253784179688,
        714.1409912109375
      ],
      "page_num": 16,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "e",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.64022827148438,
        702.1409912109375,
        538.3253784179688,
        714.1409912109375
      ],
      "page_num": 16,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(hepatitis B e antigen,",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.64022827148438,
        702.1409912109375,
        538.3253784179688,
        714.1409912109375
      ],
      "page_num": 16,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "HBeAg)의 유 무도 고려하여 투여 용량을 결정하여야 한다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.64042663574219,
        723.7387084960938,
        406.01123046875,
        735.7387084960938
      ],
      "page_num": 16,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.64042663574219,
        723.7387084960938,
        406.01123046875,
        735.7387084960938
      ],
      "page_num": 16,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "․",
      "font_size": 12.0,
      "font_name": "TTA184C656tCID32K",
      "bbox": [
        80.64042663574219,
        723.7387084960938,
        406.01123046875,
        735.7387084960938
      ],
      "page_num": 16,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 9 -",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        283.4410095214844,
        789.4503784179688,
        311.7458801269531,
        799.4103393554688
      ],
      "page_num": 17,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "환자마다 다양한 반감기를 보일 수 있으므로 간 이식 전 바이러스의 상태를",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        110.6400146484375,
        99.14019775390625,
        538.4337158203125,
        111.14019775390625
      ],
      "page_num": 17,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "고려하여 순환하는",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.6400146484375,
        120.7379150390625,
        538.5618286132812,
        132.7379150390625
      ],
      "page_num": 17,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "를 중화할 수 있는 안전한 농도를 투여하여야 하며",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.6400146484375,
        120.7379150390625,
        538.5618286132812,
        132.7379150390625
      ],
      "page_num": 17,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "정기",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.6400146484375,
        120.7379150390625,
        538.5618286132812,
        132.7379150390625
      ],
      "page_num": 17,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "HBV",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.6400146484375,
        120.7379150390625,
        538.5618286132812,
        132.7379150390625
      ],
      "page_num": 17,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.6400146484375,
        120.7379150390625,
        538.5618286132812,
        132.7379150390625
      ],
      "page_num": 17,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "적으로 혈중",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.6400146484375,
        142.33953857421875,
        375.7588195800781,
        154.33953857421875
      ],
      "page_num": 17,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "anti-HBs 농도를 모니터링 하여야 한다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.6400146484375,
        142.33953857421875,
        375.7588195800781,
        154.33953857421875
      ],
      "page_num": 17,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.6400146484375,
        142.33953857421875,
        375.7588195800781,
        154.33953857421875
      ],
      "page_num": 17,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "상기 사항들을 고려하여 수술 중 무간기",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        110.6400146484375,
        185.53875732421875,
        538.554443359375,
        197.53875732421875
      ],
      "page_num": 17,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "의 초회 투여 용량",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        110.6400146484375,
        185.53875732421875,
        538.554443359375,
        197.53875732421875
      ],
      "page_num": 17,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(anheptic phase)",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        110.6400146484375,
        185.53875732421875,
        538.554443359375,
        197.53875732421875
      ],
      "page_num": 17,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "및 수술 후의 투여 용량을 신중하게 결정하여야 한다.",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.6400146484375,
        207.140380859375,
        378.6478271484375,
        219.140380859375
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "투여 기간",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.64019775390625,
        255.73822021484375,
        162.3590087890625,
        267.73822021484375
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "4.3.",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.64019775390625,
        255.73822021484375,
        162.3590087890625,
        267.73822021484375
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "간 이식 환자의",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        110.64019775390625,
        277.33984375,
        538.5659790039062,
        289.33984375
      ],
      "page_num": 17,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "형 간염 재발을 예방하기 위한 본 제제의 투여 기간은 현",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        110.64019775390625,
        277.33984375,
        538.5659790039062,
        289.33984375
      ],
      "page_num": 17,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "B",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        110.64019775390625,
        277.33984375,
        538.5659790039062,
        289.33984375
      ],
      "page_num": 17,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "재까지 정해진 바 없으나",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.64019775390625,
        298.93756103515625,
        538.425048828125,
        310.93756103515625
      ],
      "page_num": 17,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "의사의 판단과 환자의 여건에 따라 간 이식 수술 후 짧",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.64019775390625,
        298.93756103515625,
        538.425048828125,
        310.93756103515625
      ],
      "page_num": 17,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.64019775390625,
        298.93756103515625,
        538.425048828125,
        310.93756103515625
      ],
      "page_num": 17,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "게는",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.64019775390625,
        320.5391540527344,
        538.4391479492188,
        332.5391540527344
      ],
      "page_num": 17,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "년에서 길게는 평생 투여되고 있다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.64019775390625,
        320.5391540527344,
        538.4391479492188,
        332.5391540527344
      ],
      "page_num": 17,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "따라서 치료적 확증 임상시험 시",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.64019775390625,
        320.5391540527344,
        538.4391479492188,
        332.5391540527344
      ],
      "page_num": 17,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "년",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.64019775390625,
        320.5391540527344,
        538.4391479492188,
        332.5391540527344
      ],
      "page_num": 17,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.64019775390625,
        320.5391540527344,
        538.4391479492188,
        332.5391540527344
      ],
      "page_num": 17,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.64019775390625,
        320.5391540527344,
        538.4391479492188,
        332.5391540527344
      ],
      "page_num": 17,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.64019775390625,
        320.5391540527344,
        538.4391479492188,
        332.5391540527344
      ],
      "page_num": 17,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "이상 장기간 투여가 요구되며",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.6405029296875,
        342.1407470703125,
        538.4451904296875,
        354.1407470703125
      ],
      "page_num": 17,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "이에 따라 전 연령층에 대하여 의약품의 품목허가",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.6405029296875,
        342.1407470703125,
        538.4451904296875,
        354.1407470703125
      ],
      "page_num": 17,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.6405029296875,
        342.1407470703125,
        538.4451904296875,
        354.1407470703125
      ],
      "page_num": 17,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "에 필요한 정보 예",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.6405029296875,
        363.7384338378906,
        538.4434204101562,
        375.7384338378906
      ],
      "page_num": 17,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "병용약물 요법",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.6405029296875,
        363.7384338378906,
        538.4434204101562,
        375.7384338378906
      ],
      "page_num": 17,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "약물 상호작용 등 가 충분히 확보되어야 한",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.6405029296875,
        363.7384338378906,
        538.4434204101562,
        375.7384338378906
      ],
      "page_num": 17,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.6405029296875,
        363.7384338378906,
        538.4434204101562,
        375.7384338378906
      ],
      "page_num": 17,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ":",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.6405029296875,
        363.7384338378906,
        538.4434204101562,
        375.7384338378906
      ],
      "page_num": 17,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.6405029296875,
        363.7384338378906,
        538.4434204101562,
        375.7384338378906
      ],
      "page_num": 17,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ")",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.6405029296875,
        363.7384338378906,
        538.4434204101562,
        375.7384338378906
      ],
      "page_num": 17,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.64049530029297,
        385.34002685546875,
        538.4332275390625,
        397.34002685546875
      ],
      "page_num": 17,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "간 이식 수술 후",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.64049530029297,
        385.34002685546875,
        538.4332275390625,
        397.34002685546875
      ],
      "page_num": 17,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "년 내에",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.64049530029297,
        385.34002685546875,
        538.4332275390625,
        397.34002685546875
      ],
      "page_num": 17,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "형 간염의 재발이 빈번히 나타나므로",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.64049530029297,
        385.34002685546875,
        538.4332275390625,
        397.34002685546875
      ],
      "page_num": 17,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "최근 외",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.64049530029297,
        385.34002685546875,
        538.4332275390625,
        397.34002685546875
      ],
      "page_num": 17,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.64049530029297,
        385.34002685546875,
        538.4332275390625,
        397.34002685546875
      ],
      "page_num": 17,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2~3",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.64049530029297,
        385.34002685546875,
        538.4332275390625,
        397.34002685546875
      ],
      "page_num": 17,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "B",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.64049530029297,
        385.34002685546875,
        538.4332275390625,
        397.34002685546875
      ],
      "page_num": 17,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.64049530029297,
        385.34002685546875,
        538.4332275390625,
        397.34002685546875
      ],
      "page_num": 17,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "국에서 수행되는 임상시험들은",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.6405029296875,
        406.9377136230469,
        456.73883056640625,
        418.9377136230469
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "년 이상",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.6405029296875,
        406.9377136230469,
        456.73883056640625,
        418.9377136230469
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "을 하고 있다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.6405029296875,
        406.9377136230469,
        456.73883056640625,
        418.9377136230469
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2~3",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.6405029296875,
        406.9377136230469,
        456.73883056640625,
        418.9377136230469
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "follow-up",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.6405029296875,
        406.9377136230469,
        456.73883056640625,
        418.9377136230469
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.6405029296875,
        406.9377136230469,
        456.73883056640625,
        418.9377136230469
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "간 이식 수술 중 및 수술 후 관리를 위한 목적의 투여 기간에 대한 정확한",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        110.6405029296875,
        450.14080810546875,
        538.4217529296875,
        462.14080810546875
      ],
      "page_num": 17,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "가이드가 확립되어 있지 않으므로",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.6405029296875,
        471.7384948730469,
        538.4451904296875,
        483.7384948730469
      ],
      "page_num": 17,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "간 이식 전후로 투여되는 다른 약물과의 상호",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.6405029296875,
        471.7384948730469,
        538.4451904296875,
        483.7384948730469
      ],
      "page_num": 17,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.6405029296875,
        471.7384948730469,
        538.4451904296875,
        483.7384948730469
      ],
      "page_num": 17,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "작용뿐만 아니라 간 이식 후에도 지속적인 모니터링을 통해 약물의 단독 및 잠재",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.6405029296875,
        493.340087890625,
        538.4295654296875,
        505.340087890625
      ],
      "page_num": 17,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "적 약물 약물 상호작용을 확인하여야 한다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.6405029296875,
        514.937744140625,
        320.2071533203125,
        526.937744140625
      ],
      "page_num": 17,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "-",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.6405029296875,
        514.937744140625,
        320.2071533203125,
        526.937744140625
      ],
      "page_num": 17,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.6405029296875,
        514.937744140625,
        320.2071533203125,
        526.937744140625
      ],
      "page_num": 17,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "효과 평가기준",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.64041137695312,
        563.5393676757812,
        186.3592071533203,
        575.5393676757812
      ],
      "page_num": 17,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "4.4.",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.64041137695312,
        563.5393676757812,
        186.3592071533203,
        575.5393676757812
      ],
      "page_num": 17,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "정맥주사용",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        110.64041137695312,
        585.1409912109375,
        538.48095703125,
        597.1409912109375
      ],
      "page_num": 17,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "의 유효성 평가는 간 이식 수술 후 혈청",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        110.64041137695312,
        585.1409912109375,
        538.48095703125,
        597.1409912109375
      ],
      "page_num": 17,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "의 재발율",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        110.64041137695312,
        585.1409912109375,
        538.48095703125,
        597.1409912109375
      ],
      "page_num": 17,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "HBIG",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        110.64041137695312,
        585.1409912109375,
        538.48095703125,
        597.1409912109375
      ],
      "page_num": 17,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "HBsAg",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        110.64041137695312,
        585.1409912109375,
        538.48095703125,
        597.1409912109375
      ],
      "page_num": 17,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        110.64041137695312,
        585.1409912109375,
        538.48095703125,
        597.1409912109375
      ],
      "page_num": 17,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "즉",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.64019775390625,
        606.7386474609375,
        538.4334716796875,
        618.7386474609375
      ],
      "page_num": 17,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "간 이식 후",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.64019775390625,
        606.7386474609375,
        538.4334716796875,
        618.7386474609375
      ],
      "page_num": 17,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "가 음성에서 양성으로 재발한 피험자의 백분율로 설정하고",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.64019775390625,
        606.7386474609375,
        538.4334716796875,
        618.7386474609375
      ],
      "page_num": 17,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.64019775390625,
        606.7386474609375,
        538.4334716796875,
        618.7386474609375
      ],
      "page_num": 17,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "HBsAg",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.64019775390625,
        606.7386474609375,
        538.4334716796875,
        618.7386474609375
      ],
      "page_num": 17,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "95% 신뢰구간을 제시하여야 한다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.64019775390625,
        628.3402709960938,
        270.8848876953125,
        640.3402709960938
      ],
      "page_num": 17,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.64019775390625,
        628.3402709960938,
        270.8848876953125,
        640.3402709960938
      ],
      "page_num": 17,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "그러나",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        110.64019775390625,
        671.5394897460938,
        538.4368896484375,
        683.5394897460938
      ],
      "page_num": 17,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "투여로 인해",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        110.64019775390625,
        671.5394897460938,
        538.4368896484375,
        683.5394897460938
      ],
      "page_num": 17,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "존재가 마스킹 될 우려가 있고",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        110.64019775390625,
        671.5394897460938,
        538.4368896484375,
        683.5394897460938
      ],
      "page_num": 17,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "가",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        110.64019775390625,
        671.5394897460938,
        538.4368896484375,
        683.5394897460938
      ],
      "page_num": 17,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "HBIG",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        110.64019775390625,
        671.5394897460938,
        538.4368896484375,
        683.5394897460938
      ],
      "page_num": 17,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "HBsAg",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        110.64019775390625,
        671.5394897460938,
        538.4368896484375,
        683.5394897460938
      ],
      "page_num": 17,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "HBsAg",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        110.64019775390625,
        671.5394897460938,
        538.4368896484375,
        683.5394897460938
      ],
      "page_num": 17,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "양성이라 함은 혈중에 바이러스가 존재만 하고 염증을 일으키지 않는 상태부터 급",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.64020538330078,
        693.14111328125,
        538.4370727539062,
        705.14111328125
      ],
      "page_num": 17,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "성 및 만성 간염을 일으켜 심각한 문제를 야기하는 상태까지 다양하므로, HBsAg",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.64020538330078,
        714.73876953125,
        538.5062255859375,
        726.73876953125
      ],
      "page_num": 17,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "만으로는",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.64019775390625,
        736.3403930664062,
        538.5731811523438,
        748.3403930664062
      ],
      "page_num": 17,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "형 간염의 재발에 대하여 정확한 평가가 어려울 수 있어",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.64019775390625,
        736.3403930664062,
        538.5731811523438,
        748.3403930664062
      ],
      "page_num": 17,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "형 간염과",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.64019775390625,
        736.3403930664062,
        538.5731811523438,
        748.3403930664062
      ],
      "page_num": 17,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "B",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.64019775390625,
        736.3403930664062,
        538.5731811523438,
        748.3403930664062
      ],
      "page_num": 17,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "B",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.64019775390625,
        736.3403930664062,
        538.5731811523438,
        748.3403930664062
      ],
      "page_num": 17,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 10 -",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        280.5589904785156,
        789.4503784179688,
        314.6234130859375,
        799.4103393554688
      ],
      "page_num": 18,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "관련된 혈청학적 지표 예",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.6409912109375,
        99.14019775390625,
        538.4299926757812,
        111.14019775390625
      ],
      "page_num": 18,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "형 간염",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.6409912109375,
        99.14019775390625,
        538.4299926757812,
        111.14019775390625
      ],
      "page_num": 18,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "항원 항체",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.6409912109375,
        99.14019775390625,
        538.4299926757812,
        111.14019775390625
      ],
      "page_num": 18,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "[",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.6409912109375,
        99.14019775390625,
        538.4299926757812,
        111.14019775390625
      ],
      "page_num": 18,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ": HBV DNA, HBeAg, B",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.6409912109375,
        99.14019775390625,
        538.4299926757812,
        111.14019775390625
      ],
      "page_num": 18,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "e",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.6409912109375,
        99.14019775390625,
        538.4299926757812,
        111.14019775390625
      ],
      "page_num": 18,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(antibody",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.6409912109375,
        99.14019775390625,
        538.4299926757812,
        111.14019775390625
      ],
      "page_num": 18,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "to hepatitis B e antigen, anti-HBe)] 등을 고려하여야 한다.",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.64098358154297,
        120.7379150390625,
        421.3677978515625,
        132.7379150390625
      ],
      "page_num": 18,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "기타",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        110.6409912109375,
        163.9371337890625,
        538.4397583007812,
        175.9371337890625
      ],
      "page_num": 18,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "재발까지의 기간",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        110.6409912109375,
        163.9371337890625,
        538.4397583007812,
        175.9371337890625
      ],
      "page_num": 18,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "피험자의 생존율",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        110.6409912109375,
        163.9371337890625,
        538.4397583007812,
        175.9371337890625
      ],
      "page_num": 18,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "생존기간 등을 추가로 제시",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        110.6409912109375,
        163.9371337890625,
        538.4397583007812,
        175.9371337890625
      ],
      "page_num": 18,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "HBsAg",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        110.6409912109375,
        163.9371337890625,
        538.4397583007812,
        175.9371337890625
      ],
      "page_num": 18,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        110.6409912109375,
        163.9371337890625,
        538.4397583007812,
        175.9371337890625
      ],
      "page_num": 18,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        110.6409912109375,
        163.9371337890625,
        538.4397583007812,
        175.9371337890625
      ],
      "page_num": 18,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "할 수 있다.",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.6409912109375,
        185.53875732421875,
        144.6488037109375,
        197.53875732421875
      ],
      "page_num": 18,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 11 -",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        280.5589904785156,
        789.4503784179688,
        314.6234130859375,
        799.4103393554688
      ],
      "page_num": 19,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ". 참고문헌",
      "font_size": 15.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.640602111816406,
        99.08502197265625,
        144.12109375,
        114.08502197265625
      ],
      "page_num": 19,
      "block_type": "heading",
      "level": 7,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Ⅵ",
      "font_size": 15.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.640602111816406,
        99.08502197265625,
        144.12109375,
        114.08502197265625
      ],
      "page_num": 19,
      "block_type": "heading",
      "level": 7,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1. 혈장분획제제",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        62.640602111816406,
        153.1407470703125,
        538.4772338867188,
        165.1407470703125
      ],
      "page_num": 19,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "품질평가",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        62.640602111816406,
        153.1407470703125,
        538.4772338867188,
        165.1407470703125
      ],
      "page_num": 19,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "가이드 식품의약품안전청",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        62.640602111816406,
        153.1407470703125,
        538.4772338867188,
        165.1407470703125
      ],
      "page_num": 19,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "행정간행물",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        62.640602111816406,
        153.1407470703125,
        538.4772338867188,
        165.1407470703125
      ],
      "page_num": 19,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        62.640602111816406,
        153.1407470703125,
        538.4772338867188,
        165.1407470703125
      ],
      "page_num": 19,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "11-1470000-",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        62.640602111816406,
        153.1407470703125,
        538.4772338867188,
        165.1407470703125
      ],
      "page_num": 19,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "000154-01, 생물의약품평가가이드",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        79.55908203125,
        174.73846435546875,
        327.02520751953125,
        186.73846435546875
      ],
      "page_num": 19,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "4), 2002",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        79.55908203125,
        174.73846435546875,
        327.02520751953125,
        186.73846435546875
      ],
      "page_num": 19,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2. Note",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        62.641082763671875,
        201.37908935546875,
        538.524169921875,
        213.37908935546875
      ],
      "page_num": 19,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "for",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        62.641082763671875,
        201.37908935546875,
        538.524169921875,
        213.37908935546875
      ],
      "page_num": 19,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Guidance",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        62.641082763671875,
        201.37908935546875,
        538.524169921875,
        213.37908935546875
      ],
      "page_num": 19,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "on",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        62.641082763671875,
        201.37908935546875,
        538.524169921875,
        213.37908935546875
      ],
      "page_num": 19,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Plasma-Derived",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        62.641082763671875,
        201.37908935546875,
        538.524169921875,
        213.37908935546875
      ],
      "page_num": 19,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Medicinal",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        62.641082763671875,
        201.37908935546875,
        538.524169921875,
        213.37908935546875
      ],
      "page_num": 19,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Products(CPMP/BWP/",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        62.641082763671875,
        201.37908935546875,
        538.524169921875,
        213.37908935546875
      ],
      "page_num": 19,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "269/95 rev. 3), EMEA, 2001",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        79.55908203125,
        222.980712890625,
        243.1654815673828,
        234.980712890625
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3. 분획용 혈장 마스터 파일 가이드라인 식품의약품안전청 행정간행물",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        62.641082763671875,
        249.500244140625,
        538.4727783203125,
        261.500244140625
      ],
      "page_num": 19,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        62.641082763671875,
        249.500244140625,
        538.4727783203125,
        261.500244140625
      ],
      "page_num": 19,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "11-1470000",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        62.641082763671875,
        249.500244140625,
        538.4727783203125,
        261.500244140625
      ],
      "page_num": 19,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "-001506-01, 생물의약품평가가이드",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        79.55906677246094,
        271.09796142578125,
        341.421142578125,
        283.09796142578125
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "25), 2007",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        79.55906677246094,
        271.09796142578125,
        341.421142578125,
        283.09796142578125
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "4. 혈장분획제제",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        62.64106750488281,
        297.73858642578125,
        538.4957885742188,
        309.73858642578125
      ],
      "page_num": 19,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "등",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        62.64106750488281,
        297.73858642578125,
        538.4957885742188,
        309.73858642578125
      ],
      "page_num": 19,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "바이러스",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        62.64106750488281,
        297.73858642578125,
        538.4957885742188,
        309.73858642578125
      ],
      "page_num": 19,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "검증",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        62.64106750488281,
        297.73858642578125,
        538.4957885742188,
        309.73858642578125
      ],
      "page_num": 19,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "평가가이드 식품의약품안전청",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        62.64106750488281,
        297.73858642578125,
        538.4957885742188,
        309.73858642578125
      ],
      "page_num": 19,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "행정간행물",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        62.64106750488281,
        297.73858642578125,
        538.4957885742188,
        309.73858642578125
      ],
      "page_num": 19,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        62.64106750488281,
        297.73858642578125,
        538.4957885742188,
        309.73858642578125
      ],
      "page_num": 19,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "11-",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        62.64106750488281,
        297.73858642578125,
        538.4957885742188,
        309.73858642578125
      ],
      "page_num": 19,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1470000-001176-01, 생물의약품평가가이드",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        79.55903625488281,
        319.3402099609375,
        389.52459716796875,
        331.3402099609375
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "20), 2006",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        79.55903625488281,
        319.3402099609375,
        389.52459716796875,
        331.3402099609375
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "5. Note for Guidance on Virus Validation Studies: The Design, Contribution and",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        62.64103698730469,
        345.9808044433594,
        538.3331909179688,
        357.9808044433594
      ],
      "page_num": 19,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Interpretation of Studies Validating the Inactivation and Removal of Viruses",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.39804077148438,
        367.5784912109375,
        538.3359375,
        379.5784912109375
      ],
      "page_num": 19,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(CPMP/BWP/268/95), EMEA, 1996",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.39804077148438,
        389.1800842285156,
        279.0675354003906,
        401.1800842285156
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "6. Guideline",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        62.64024353027344,
        415.6995849609375,
        538.4259033203125,
        427.6995849609375
      ],
      "page_num": 19,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "on",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        62.64024353027344,
        415.6995849609375,
        538.4259033203125,
        427.6995849609375
      ],
      "page_num": 19,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "the",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        62.64024353027344,
        415.6995849609375,
        538.4259033203125,
        427.6995849609375
      ],
      "page_num": 19,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Clinical",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        62.64024353027344,
        415.6995849609375,
        538.4259033203125,
        427.6995849609375
      ],
      "page_num": 19,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Evaluation",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        62.64024353027344,
        415.6995849609375,
        538.4259033203125,
        427.6995849609375
      ],
      "page_num": 19,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "of",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        62.64024353027344,
        415.6995849609375,
        538.4259033203125,
        427.6995849609375
      ],
      "page_num": 19,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Medicinal",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        62.64024353027344,
        415.6995849609375,
        538.4259033203125,
        427.6995849609375
      ],
      "page_num": 19,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Products",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        62.64024353027344,
        415.6995849609375,
        538.4259033203125,
        427.6995849609375
      ],
      "page_num": 19,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Intended",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        62.64024353027344,
        415.6995849609375,
        538.4259033203125,
        427.6995849609375
      ],
      "page_num": 19,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "for",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        62.64024353027344,
        415.6995849609375,
        538.4259033203125,
        427.6995849609375
      ],
      "page_num": 19,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Treatment of Hepatitis B(CHMP/EWP/6172/03), EMEA, 2006",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        79.55825805664062,
        437.3011779785156,
        428.39227294921875,
        449.3011779785156
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "7. Note",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        62.6402587890625,
        463.9378662109375,
        538.4406127929688,
        475.9378662109375
      ],
      "page_num": 19,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "For",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        62.6402587890625,
        463.9378662109375,
        538.4406127929688,
        475.9378662109375
      ],
      "page_num": 19,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Guidance",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        62.6402587890625,
        463.9378662109375,
        538.4406127929688,
        475.9378662109375
      ],
      "page_num": 19,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "on",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        62.6402587890625,
        463.9378662109375,
        538.4406127929688,
        475.9378662109375
      ],
      "page_num": 19,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "the",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        62.6402587890625,
        463.9378662109375,
        538.4406127929688,
        475.9378662109375
      ],
      "page_num": 19,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Clinical",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        62.6402587890625,
        463.9378662109375,
        538.4406127929688,
        475.9378662109375
      ],
      "page_num": 19,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Investigation",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        62.6402587890625,
        463.9378662109375,
        538.4406127929688,
        475.9378662109375
      ],
      "page_num": 19,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "of",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        62.6402587890625,
        463.9378662109375,
        538.4406127929688,
        475.9378662109375
      ],
      "page_num": 19,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Human",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        62.6402587890625,
        463.9378662109375,
        538.4406127929688,
        475.9378662109375
      ],
      "page_num": 19,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Normal",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        62.6402587890625,
        463.9378662109375,
        538.4406127929688,
        475.9378662109375
      ],
      "page_num": 19,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Immunoglobulin for Intravenous Administration(IVIg)(CPMP/BPWG/388/95 rev.",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        79.55825805664062,
        485.5394592285156,
        538.453125,
        497.5394592285156
      ],
      "page_num": 19,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1), EMEA, 2000",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        79.55825805664062,
        507.14105224609375,
        171.04518127441406,
        519.1410522460938
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "8. Note",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        62.6402587890625,
        533.7777099609375,
        538.4406127929688,
        545.7777099609375
      ],
      "page_num": 19,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "For",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        62.6402587890625,
        533.7777099609375,
        538.4406127929688,
        545.7777099609375
      ],
      "page_num": 19,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Guidance",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        62.6402587890625,
        533.7777099609375,
        538.4406127929688,
        545.7777099609375
      ],
      "page_num": 19,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "on",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        62.6402587890625,
        533.7777099609375,
        538.4406127929688,
        545.7777099609375
      ],
      "page_num": 19,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "the",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        62.6402587890625,
        533.7777099609375,
        538.4406127929688,
        545.7777099609375
      ],
      "page_num": 19,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Clinical",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        62.6402587890625,
        533.7777099609375,
        538.4406127929688,
        545.7777099609375
      ],
      "page_num": 19,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Investigation",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        62.6402587890625,
        533.7777099609375,
        538.4406127929688,
        545.7777099609375
      ],
      "page_num": 19,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "of",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        62.6402587890625,
        533.7777099609375,
        538.4406127929688,
        545.7777099609375
      ],
      "page_num": 19,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Human",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        62.6402587890625,
        533.7777099609375,
        538.4406127929688,
        545.7777099609375
      ],
      "page_num": 19,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Normal",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        62.6402587890625,
        533.7777099609375,
        538.4406127929688,
        545.7777099609375
      ],
      "page_num": 19,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Immunoglobulin for Subcutaneous and Intramuscular Use(CPMP/BPWG/283/",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        79.55825805664062,
        555.3793334960938,
        538.5233154296875,
        567.3793334960938
      ],
      "page_num": 19,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "00), EMEA, 2003",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        79.55825805664062,
        576.98095703125,
        177.8861541748047,
        588.98095703125
      ],
      "page_num": 19,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "9. Safety,",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        62.6402587890625,
        603.5004272460938,
        538.4013671875,
        615.5004272460938
      ],
      "page_num": 19,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Efficacy,",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        62.6402587890625,
        603.5004272460938,
        538.4013671875,
        615.5004272460938
      ],
      "page_num": 19,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "and",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        62.6402587890625,
        603.5004272460938,
        538.4013671875,
        615.5004272460938
      ],
      "page_num": 19,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Pharmacokinetic",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        62.6402587890625,
        603.5004272460938,
        538.4013671875,
        615.5004272460938
      ],
      "page_num": 19,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Studies",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        62.6402587890625,
        603.5004272460938,
        538.4013671875,
        615.5004272460938
      ],
      "page_num": 19,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "to",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        62.6402587890625,
        603.5004272460938,
        538.4013671875,
        615.5004272460938
      ],
      "page_num": 19,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Support",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        62.6402587890625,
        603.5004272460938,
        538.4013671875,
        615.5004272460938
      ],
      "page_num": 19,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Marketing",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        62.6402587890625,
        603.5004272460938,
        538.4013671875,
        615.5004272460938
      ],
      "page_num": 19,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "of",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        62.6402587890625,
        603.5004272460938,
        538.4013671875,
        615.5004272460938
      ],
      "page_num": 19,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Immune Globulin Intravenous(Human)",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        79.55825805664062,
        625.09814453125,
        538.4202270507812,
        637.09814453125
      ],
      "page_num": 19,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "as Replacement Therapy",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        79.55825805664062,
        625.09814453125,
        538.4202270507812,
        637.09814453125
      ],
      "page_num": 19,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "for Primary",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        79.55825805664062,
        625.09814453125,
        538.4202270507812,
        637.09814453125
      ],
      "page_num": 19,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Humoral Immunodeficiency, CBER, FDA, 2008",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        79.55825805664062,
        646.69970703125,
        348.0018615722656,
        658.69970703125
      ],
      "page_num": 19,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "10. Guidance",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.6402587890625,
        673.34033203125,
        538.4133911132812,
        685.34033203125
      ],
      "page_num": 19,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "for Industry",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.6402587890625,
        673.34033203125,
        538.4133911132812,
        685.34033203125
      ],
      "page_num": 19,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Pharmacokinetics",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.6402587890625,
        673.34033203125,
        538.4133911132812,
        685.34033203125
      ],
      "page_num": 19,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "in Patients",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.6402587890625,
        673.34033203125,
        538.4133911132812,
        685.34033203125
      ],
      "page_num": 19,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "with Impaired",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.6402587890625,
        673.34033203125,
        538.4133911132812,
        685.34033203125
      ],
      "page_num": 19,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Hepatic",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.6402587890625,
        673.34033203125,
        538.4133911132812,
        685.34033203125
      ],
      "page_num": 19,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Function: Study Design, Data Analysis, and Impact on Dosing and Labeling,",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.39825439453125,
        694.9380493164062,
        538.4749145507812,
        706.9380493164062
      ],
      "page_num": 19,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "CDER, FDA, 2003",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.39828491210938,
        716.5396118164062,
        184.37982177734375,
        728.5396118164062
      ],
      "page_num": 19,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 12 -",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        280.5589904785156,
        789.4503784179688,
        314.6234130859375,
        799.4103393554688
      ],
      "page_num": 20,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "생물의약품국에서 발간한 행정간행물 목록",
      "font_size": 15.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        141.6020050048828,
        99.10098266601562,
        453.60107421875,
        115.06098937988281
      ],
      "page_num": 20,
      "block_type": "heading",
      "level": 6,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "생물의약품 국가표준품 카다로그 시리즈",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        64.68009948730469,
        148.71530151367188,
        323.4018249511719,
        161.67530822753906
      ],
      "page_num": 20,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1.",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        64.68009948730469,
        148.71530151367188,
        323.4018249511719,
        161.67530822753906
      ],
      "page_num": 20,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "생물의약품평가가이드 시리즈",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        64.68009948730469,
        416.914306640625,
        258.3627624511719,
        429.8742980957031
      ],
      "page_num": 20,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2.",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        64.68009948730469,
        416.914306640625,
        258.3627624511719,
        429.8742980957031
      ],
      "page_num": 20,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "행정간행물 제목",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        91.9218978881836,
        175.77035522460938,
        515.760986328125,
        198.80848693847656
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "발행",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        91.9218978881836,
        175.77035522460938,
        515.760986328125,
        198.80848693847656
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "연도",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        91.9218978881836,
        175.77035522460938,
        515.760986328125,
        198.80848693847656
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "행정간행물 번호",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        91.9218978881836,
        175.77035522460938,
        515.760986328125,
        198.80848693847656
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "발행과",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        91.9218978881836,
        175.77035522460938,
        515.760986328125,
        198.80848693847656
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "홈페이지",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        91.9218978881836,
        175.77035522460938,
        515.760986328125,
        198.80848693847656
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "게재 상태",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        91.9218978881836,
        175.77035522460938,
        515.760986328125,
        198.80848693847656
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "생물의약품 국가표준품",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.92193603515625,
        211.52810668945312,
        527.00634765625,
        234.4490509033203
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "카다로그 (2008)",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.92193603515625,
        211.52810668945312,
        527.00634765625,
        234.4490509033203
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2008",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.92193603515625,
        211.52810668945312,
        527.00634765625,
        234.4490509033203
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "11-1470000-000547-10",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.92193603515625,
        211.52810668945312,
        527.00634765625,
        234.4490509033203
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "생물진단의약품과",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.92193603515625,
        211.52810668945312,
        527.00634765625,
        234.4490509033203
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "자료실 간행물",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.92193603515625,
        211.52810668945312,
        527.00634765625,
        234.4490509033203
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "/",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.92193603515625,
        211.52810668945312,
        527.00634765625,
        234.4490509033203
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.92193603515625,
        211.52810668945312,
        527.00634765625,
        234.4490509033203
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "지침/",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.92193603515625,
        211.52810668945312,
        527.00634765625,
        234.4490509033203
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "생물의약품 국가표준품",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.92236328125,
        248.61007690429688,
        527.0067749023438,
        271.648193359375
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "카다로그 (2006)",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.92236328125,
        248.61007690429688,
        527.0067749023438,
        271.648193359375
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2006",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.92236328125,
        248.61007690429688,
        527.0067749023438,
        271.648193359375
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "11-1470000-000547-10",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.92236328125,
        248.61007690429688,
        527.0067749023438,
        271.648193359375
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "생물진단제제팀",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.92236328125,
        248.61007690429688,
        527.0067749023438,
        271.648193359375
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "자료실 간행물",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.92236328125,
        248.61007690429688,
        527.0067749023438,
        271.648193359375
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "/",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.92236328125,
        248.61007690429688,
        527.0067749023438,
        271.648193359375
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.92236328125,
        248.61007690429688,
        527.0067749023438,
        271.648193359375
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "지침/159",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.92236328125,
        248.61007690429688,
        527.0067749023438,
        271.648193359375
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "생물의약품 국가표준품",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.92205810546875,
        285.8092346191406,
        527.0064697265625,
        308.73016357421875
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "카다로그 (2004)",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.92205810546875,
        285.8092346191406,
        527.0064697265625,
        308.73016357421875
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2004",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.92205810546875,
        285.8092346191406,
        527.0064697265625,
        308.73016357421875
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "11-1470000-000547-10",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.92205810546875,
        285.8092346191406,
        527.0064697265625,
        308.73016357421875
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "생물의약품규격과",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.92205810546875,
        285.8092346191406,
        527.0064697265625,
        308.73016357421875
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "자료실 간행물",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.92205810546875,
        285.8092346191406,
        527.0064697265625,
        308.73016357421875
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "/",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.92205810546875,
        285.8092346191406,
        527.0064697265625,
        308.73016357421875
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.92205810546875,
        285.8092346191406,
        527.0064697265625,
        308.73016357421875
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "지침/56",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.92205810546875,
        285.8092346191406,
        527.0064697265625,
        308.73016357421875
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "생물의약품 국가표준품",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.92166137695312,
        322.89117431640625,
        527.0060424804688,
        345.8081970214844
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "카다로그 (2003)",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.92166137695312,
        322.89117431640625,
        527.0060424804688,
        345.8081970214844
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2003",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.92166137695312,
        322.89117431640625,
        527.0060424804688,
        345.8081970214844
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "11-1470000-000547-10",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.92166137695312,
        322.89117431640625,
        527.0060424804688,
        345.8081970214844
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "생물의약품규격과",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.92166137695312,
        322.89117431640625,
        527.0060424804688,
        345.8081970214844
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "자료실 간행물",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.92166137695312,
        322.89117431640625,
        527.0060424804688,
        345.8081970214844
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "/",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.92166137695312,
        322.89117431640625,
        527.0060424804688,
        345.8081970214844
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.92166137695312,
        322.89117431640625,
        527.0060424804688,
        345.8081970214844
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "지침/43",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.92166137695312,
        322.89117431640625,
        527.0060424804688,
        345.8081970214844
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "생물의약품 국가표준품",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.9212646484375,
        359.96917724609375,
        527.005126953125,
        383.0112609863281
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "카다로그 (2002)",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.9212646484375,
        359.96917724609375,
        527.005126953125,
        383.0112609863281
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2002",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.9212646484375,
        359.96917724609375,
        527.005126953125,
        383.0112609863281
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "11-1470000-000547-10",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.9212646484375,
        359.96917724609375,
        527.005126953125,
        383.0112609863281
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "백신과",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.9212646484375,
        359.96917724609375,
        527.005126953125,
        383.0112609863281
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "바이러스제제과",
      "font_size": 8.039999961853027,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.9212646484375,
        359.96917724609375,
        527.005126953125,
        383.0112609863281
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(",
      "font_size": 8.039999961853027,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.9212646484375,
        359.96917724609375,
        527.005126953125,
        383.0112609863281
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ")",
      "font_size": 8.039999961853027,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.9212646484375,
        359.96917724609375,
        527.005126953125,
        383.0112609863281
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "舊",
      "font_size": 8.039999961853027,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.9212646484375,
        359.96917724609375,
        527.005126953125,
        383.0112609863281
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "자료실 간행물",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.9212646484375,
        359.96917724609375,
        527.005126953125,
        383.0112609863281
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "/",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.9212646484375,
        359.96917724609375,
        527.005126953125,
        383.0112609863281
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.9212646484375,
        359.96917724609375,
        527.005126953125,
        383.0112609863281
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "지침/22, 23",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.9212646484375,
        359.96917724609375,
        527.005126953125,
        383.0112609863281
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "행정간행물 제목",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        91.9218978881836,
        439.5283508300781,
        515.760986328125,
        462.4492492675781
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "발행",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        91.9218978881836,
        439.5283508300781,
        515.760986328125,
        462.4492492675781
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "연도",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        91.9218978881836,
        439.5283508300781,
        515.760986328125,
        462.4492492675781
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "행정간행물 번호",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        91.9218978881836,
        439.5283508300781,
        515.760986328125,
        462.4492492675781
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "발행과",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        91.9218978881836,
        439.5283508300781,
        515.760986328125,
        462.4492492675781
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "홈페이지",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        91.9218978881836,
        439.5283508300781,
        515.760986328125,
        462.4492492675781
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "게재 상태",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        91.9218978881836,
        439.5283508300781,
        515.760986328125,
        462.4492492675781
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "생물의약품",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.68013763427734,
        486.8095703125,
        352.6916809082031,
        522.8085327148438
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "국제공통기술문서 작성",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.68013763427734,
        486.8095703125,
        352.6916809082031,
        522.8085327148438
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "가이드라인 해설",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.68013763427734,
        486.8095703125,
        352.6916809082031,
        522.8085327148438
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "-III. 품질",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.68013763427734,
        486.8095703125,
        352.6916809082031,
        522.8085327148438
      ],
      "page_num": 20,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2007",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.68013763427734,
        486.8095703125,
        352.6916809082031,
        522.8085327148438
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "11-1470000-001625-14",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.68013763427734,
        486.8095703125,
        352.6916809082031,
        522.8085327148438
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(생물의약품평가가이드",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.68013763427734,
        486.8095703125,
        352.6916809082031,
        522.8085327148438
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "34)",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.68013763427734,
        486.8095703125,
        352.6916809082031,
        522.8085327148438
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "재조합의약품과",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        362.0391845703125,
        473.8486022949219,
        452.0382385253906,
        535.7694091796875
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "바이러스백신과",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        362.0391845703125,
        473.8486022949219,
        452.0382385253906,
        535.7694091796875
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "혈액제제과",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        362.0391845703125,
        473.8486022949219,
        452.0382385253906,
        535.7694091796875
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "유전자치료제과",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        362.0391845703125,
        473.8486022949219,
        452.0382385253906,
        535.7694091796875
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "세포조직공학제제과",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        362.0391845703125,
        473.8486022949219,
        452.0382385253906,
        535.7694091796875
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "자료실 간행물",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        459.6016845703125,
        493.2899169921875,
        527.0064086914062,
        516.3280029296875
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "/",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        459.6016845703125,
        493.2899169921875,
        527.0064086914062,
        516.3280029296875
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        459.6016845703125,
        493.2899169921875,
        527.0064086914062,
        516.3280029296875
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "지침/315",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        459.6016845703125,
        493.2899169921875,
        527.0064086914062,
        516.3280029296875
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "HBsAg 진단제제의 기준",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        73.55888366699219,
        549.9304809570312,
        527.0064086914062,
        572.9685668945312
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "및 시험방법 작성 지침",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        73.55888366699219,
        549.9304809570312,
        527.0064086914062,
        572.9685668945312
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2008",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        73.55888366699219,
        549.9304809570312,
        527.0064086914062,
        572.9685668945312
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "11-1470000-000143-01",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        73.55888366699219,
        549.9304809570312,
        527.0064086914062,
        572.9685668945312
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(생물의약품평가가이드",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        73.55888366699219,
        549.9304809570312,
        527.0064086914062,
        572.9685668945312
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "33)",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        73.55888366699219,
        549.9304809570312,
        527.0064086914062,
        572.9685668945312
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "생물진단의약품과",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        73.55888366699219,
        549.9304809570312,
        527.0064086914062,
        572.9685668945312
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "자료실 간행물",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        73.55888366699219,
        549.9304809570312,
        527.0064086914062,
        572.9685668945312
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "/",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        73.55888366699219,
        549.9304809570312,
        527.0064086914062,
        572.9685668945312
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        73.55888366699219,
        549.9304809570312,
        527.0064086914062,
        572.9685668945312
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "지침/289",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        73.55888366699219,
        549.9304809570312,
        527.0064086914062,
        572.9685668945312
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "혈장수출업소 실태조사",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.92172241210938,
        587.129638671875,
        527.0057983398438,
        610.050537109375
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "지침",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.92172241210938,
        587.129638671875,
        527.0057983398438,
        610.050537109375
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2007",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.92172241210938,
        587.129638671875,
        527.0057983398438,
        610.050537109375
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "11-1470000-001627-01",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.92172241210938,
        587.129638671875,
        527.0057983398438,
        610.050537109375
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(생물의약품평가가이드",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.92172241210938,
        587.129638671875,
        527.0057983398438,
        610.050537109375
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "32)",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.92172241210938,
        587.129638671875,
        527.0057983398438,
        610.050537109375
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "생물의약품관리팀",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.92172241210938,
        587.129638671875,
        527.0057983398438,
        610.050537109375
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "혈액제제팀",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.92172241210938,
        587.129638671875,
        527.0057983398438,
        610.050537109375
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "자료실 간행물",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.92172241210938,
        587.129638671875,
        527.0057983398438,
        610.050537109375
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "/",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.92172241210938,
        587.129638671875,
        527.0057983398438,
        610.050537109375
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.92172241210938,
        587.129638671875,
        527.0057983398438,
        610.050537109375
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "지침/234",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.92172241210938,
        587.129638671875,
        527.0057983398438,
        610.050537109375
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "HIV, HBV, HCV, HTLV",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.07778930664062,
        622.770263671875,
        182.7565460205078,
        671.7301025390625
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "관련 체외진단용의약품",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.07778930664062,
        622.770263671875,
        182.7565460205078,
        671.7301025390625
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "안전성 유효성 심사평가",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.07778930664062,
        622.770263671875,
        182.7565460205078,
        671.7301025390625
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "․",
      "font_size": 9.960000038146973,
      "font_name": "TTA184C656tCID32K",
      "bbox": [
        76.07778930664062,
        622.770263671875,
        182.7565460205078,
        671.7301025390625
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "지침서",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.07778930664062,
        622.770263671875,
        182.7565460205078,
        671.7301025390625
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2007",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        196.5582275390625,
        635.7310791015625,
        527.0055541992188,
        658.7691650390625
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "11-1470000-001622-01",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        196.5582275390625,
        635.7310791015625,
        527.0055541992188,
        658.7691650390625
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(생물의약품평가가이드",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        196.5582275390625,
        635.7310791015625,
        527.0055541992188,
        658.7691650390625
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "31)",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        196.5582275390625,
        635.7310791015625,
        527.0055541992188,
        658.7691650390625
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "생물진단제제팀",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        196.5582275390625,
        635.7310791015625,
        527.0055541992188,
        658.7691650390625
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "자료실 간행물",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        196.5582275390625,
        635.7310791015625,
        527.0055541992188,
        658.7691650390625
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "/",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        196.5582275390625,
        635.7310791015625,
        527.0055541992188,
        658.7691650390625
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        196.5582275390625,
        635.7310791015625,
        527.0055541992188,
        658.7691650390625
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "지침/252",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        196.5582275390625,
        635.7310791015625,
        527.0055541992188,
        658.7691650390625
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "대유행 인플루엔자 백신의",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.4798583984375,
        684.44970703125,
        527.0053100585938,
        707.48779296875
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "임상시험 평가 가이드 안",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.4798583984375,
        684.44970703125,
        527.0053100585938,
        707.48779296875
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.4798583984375,
        684.44970703125,
        527.0053100585938,
        707.48779296875
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ")",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.4798583984375,
        684.44970703125,
        527.0053100585938,
        707.48779296875
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2007",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.4798583984375,
        684.44970703125,
        527.0053100585938,
        707.48779296875
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "11-1470000-001621-01",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.4798583984375,
        684.44970703125,
        527.0053100585938,
        707.48779296875
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(생물의약품평가가이드",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.4798583984375,
        684.44970703125,
        527.0053100585938,
        707.48779296875
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "30)",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.4798583984375,
        684.44970703125,
        527.0053100585938,
        707.48779296875
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "바이러스백신팀",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.4798583984375,
        684.44970703125,
        527.0053100585938,
        707.48779296875
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "자료실 간행물",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.4798583984375,
        684.44970703125,
        527.0053100585938,
        707.48779296875
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "/",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.4798583984375,
        684.44970703125,
        527.0053100585938,
        707.48779296875
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.4798583984375,
        684.44970703125,
        527.0053100585938,
        707.48779296875
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "지침/228",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.4798583984375,
        684.44970703125,
        527.0053100585938,
        707.48779296875
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "바이러스백신",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        75.71791076660156,
        721.6488037109375,
        527.005126953125,
        744.5697631835938
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "자가품질관리요약서(",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        75.71791076660156,
        721.6488037109375,
        527.005126953125,
        744.5697631835938
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Ⅰ)",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        75.71791076660156,
        721.6488037109375,
        527.005126953125,
        744.5697631835938
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2007",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        75.71791076660156,
        721.6488037109375,
        527.005126953125,
        744.5697631835938
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "11-1470000-001620-01",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        75.71791076660156,
        721.6488037109375,
        527.005126953125,
        744.5697631835938
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(생물의약품평가가이드",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        75.71791076660156,
        721.6488037109375,
        527.005126953125,
        744.5697631835938
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "29)",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        75.71791076660156,
        721.6488037109375,
        527.005126953125,
        744.5697631835938
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "바이러스백신팀",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        75.71791076660156,
        721.6488037109375,
        527.005126953125,
        744.5697631835938
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "자료실 간행물",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        75.71791076660156,
        721.6488037109375,
        527.005126953125,
        744.5697631835938
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "/",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        75.71791076660156,
        721.6488037109375,
        527.005126953125,
        744.5697631835938
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        75.71791076660156,
        721.6488037109375,
        527.005126953125,
        744.5697631835938
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "지침/227",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        75.71791076660156,
        721.6488037109375,
        527.005126953125,
        744.5697631835938
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 13 -",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        280.5589904785156,
        789.4503784179688,
        314.6234130859375,
        799.4103393554688
      ],
      "page_num": 21,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "행정간행물 제목",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        91.9218978881836,
        106.29037475585938,
        515.760986328125,
        129.2112579345703
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "발행",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        91.9218978881836,
        106.29037475585938,
        515.760986328125,
        129.2112579345703
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "연도",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        91.9218978881836,
        106.29037475585938,
        515.760986328125,
        129.2112579345703
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "행정간행물 번호",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        91.9218978881836,
        106.29037475585938,
        515.760986328125,
        129.2112579345703
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "발행과",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        91.9218978881836,
        106.29037475585938,
        515.760986328125,
        129.2112579345703
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "홈페이지",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        91.9218978881836,
        106.29037475585938,
        515.760986328125,
        129.2112579345703
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "게재 상태",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        91.9218978881836,
        106.29037475585938,
        515.760986328125,
        129.2112579345703
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "불활화 인플루엔자백신",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.92193603515625,
        140.61050415039062,
        527.0059814453125,
        163.53150939941406
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "평가 지침",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.92193603515625,
        140.61050415039062,
        527.0059814453125,
        163.53150939941406
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2007",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.92193603515625,
        140.61050415039062,
        527.0059814453125,
        163.53150939941406
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "11-1470000-001587-01",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.92193603515625,
        140.61050415039062,
        527.0059814453125,
        163.53150939941406
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(생물의약품평가가이드",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.92193603515625,
        140.61050415039062,
        527.0059814453125,
        163.53150939941406
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "28)",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.92193603515625,
        140.61050415039062,
        527.0059814453125,
        163.53150939941406
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "바이러스백신팀",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.92193603515625,
        140.61050415039062,
        527.0059814453125,
        163.53150939941406
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "자료실 간행물",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.92193603515625,
        140.61050415039062,
        527.0059814453125,
        163.53150939941406
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "/",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.92193603515625,
        140.61050415039062,
        527.0059814453125,
        163.53150939941406
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.92193603515625,
        140.61050415039062,
        527.0059814453125,
        163.53150939941406
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "지침/226",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.92193603515625,
        140.61050415039062,
        527.0059814453125,
        163.53150939941406
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "당단백질의약품의 당구조",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.99929809570312,
        177.68844604492188,
        527.0050659179688,
        200.6094512939453
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "분석 시험법 길라잡이",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.99929809570312,
        177.68844604492188,
        527.0050659179688,
        200.6094512939453
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2007",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.99929809570312,
        177.68844604492188,
        527.0050659179688,
        200.6094512939453
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "11-1470000-001589-01",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.99929809570312,
        177.68844604492188,
        527.0050659179688,
        200.6094512939453
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(생물의약품평가가이드",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.99929809570312,
        177.68844604492188,
        527.0050659179688,
        200.6094512939453
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "27)",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.99929809570312,
        177.68844604492188,
        527.0050659179688,
        200.6094512939453
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "재조합의약품팀",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.99929809570312,
        177.68844604492188,
        527.0050659179688,
        200.6094512939453
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "자료실 간행물",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.99929809570312,
        177.68844604492188,
        527.0050659179688,
        200.6094512939453
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "/",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.99929809570312,
        177.68844604492188,
        527.0050659179688,
        200.6094512939453
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.99929809570312,
        177.68844604492188,
        527.0050659179688,
        200.6094512939453
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "지침/280",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.99929809570312,
        177.68844604492188,
        527.0050659179688,
        200.6094512939453
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "류마티스관절염 치료제",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.92034912109375,
        214.77041625976562,
        527.00439453125,
        237.8085479736328
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "임상평가지침",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.92034912109375,
        214.77041625976562,
        527.00439453125,
        237.8085479736328
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2007",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.92034912109375,
        214.77041625976562,
        527.00439453125,
        237.8085479736328
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "11-1470000-001432-01",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.92034912109375,
        214.77041625976562,
        527.00439453125,
        237.8085479736328
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(생물의약품평가가이드",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.92034912109375,
        214.77041625976562,
        527.00439453125,
        237.8085479736328
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "26)",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.92034912109375,
        214.77041625976562,
        527.00439453125,
        237.8085479736328
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "재조합의약품팀",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.92034912109375,
        214.77041625976562,
        527.00439453125,
        237.8085479736328
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "자료실 간행물",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.92034912109375,
        214.77041625976562,
        527.00439453125,
        237.8085479736328
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "/",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.92034912109375,
        214.77041625976562,
        527.00439453125,
        237.8085479736328
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.92034912109375,
        214.77041625976562,
        527.00439453125,
        237.8085479736328
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "지침/190",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.92034912109375,
        214.77041625976562,
        527.00439453125,
        237.8085479736328
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "분획용 혈장 마스터 파일",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.99771118164062,
        251.96957397460938,
        527.0035400390625,
        274.8905029296875
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "가이드라인",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.99771118164062,
        251.96957397460938,
        527.0035400390625,
        274.8905029296875
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2007",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.99771118164062,
        251.96957397460938,
        527.0035400390625,
        274.8905029296875
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "11-1470000-001560-01",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.99771118164062,
        251.96957397460938,
        527.0035400390625,
        274.8905029296875
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(생물의약품평가가이드",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.99771118164062,
        251.96957397460938,
        527.0035400390625,
        274.8905029296875
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "25)",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.99771118164062,
        251.96957397460938,
        527.0035400390625,
        274.8905029296875
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "생물의약품관리팀",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.99771118164062,
        251.96957397460938,
        527.0035400390625,
        274.8905029296875
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "혈액제제팀",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.99771118164062,
        251.96957397460938,
        527.0035400390625,
        274.8905029296875
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "자료실 간행물",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.99771118164062,
        251.96957397460938,
        527.0035400390625,
        274.8905029296875
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "/",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.99771118164062,
        251.96957397460938,
        527.0035400390625,
        274.8905029296875
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.99771118164062,
        251.96957397460938,
        527.0035400390625,
        274.8905029296875
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "지침/210",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.99771118164062,
        251.96957397460938,
        527.0035400390625,
        274.8905029296875
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "인플루엔자백신의 자가",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.91885375976562,
        289.0515441894531,
        527.0028686523438,
        325.05047607421875
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "기준 및 시험방법 작성",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.91885375976562,
        289.0515441894531,
        527.0028686523438,
        325.05047607421875
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "지침 개정판",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.91885375976562,
        289.0515441894531,
        527.0028686523438,
        325.05047607421875
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.91885375976562,
        289.0515441894531,
        527.0028686523438,
        325.05047607421875
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ")",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.91885375976562,
        289.0515441894531,
        527.0028686523438,
        325.05047607421875
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2007",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.91885375976562,
        289.0515441894531,
        527.0028686523438,
        325.05047607421875
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "11-1470000-001468-01",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.91885375976562,
        289.0515441894531,
        527.0028686523438,
        325.05047607421875
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(생물의약품평가가이드",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.91885375976562,
        289.0515441894531,
        527.0028686523438,
        325.05047607421875
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "24)",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.91885375976562,
        289.0515441894531,
        527.0028686523438,
        325.05047607421875
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "바이러스백신팀",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.91885375976562,
        289.0515441894531,
        527.0028686523438,
        325.05047607421875
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "자료실 간행물",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.91885375976562,
        289.0515441894531,
        527.0028686523438,
        325.05047607421875
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "/",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.91885375976562,
        289.0515441894531,
        527.0028686523438,
        325.05047607421875
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.91885375976562,
        289.0515441894531,
        527.0028686523438,
        325.05047607421875
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "지침/197",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.91885375976562,
        289.0515441894531,
        527.0028686523438,
        325.05047607421875
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "HIV 항체 진단제제의",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        73.6763916015625,
        339.2076721191406,
        527.0027465820312,
        375.0894775390625
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "기준 및 시험방법",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        73.6763916015625,
        339.2076721191406,
        527.0027465820312,
        375.0894775390625
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "작성",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        73.6763916015625,
        339.2076721191406,
        527.0027465820312,
        375.0894775390625
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "‘",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        73.6763916015625,
        339.2076721191406,
        527.0027465820312,
        375.0894775390625
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "’",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        73.6763916015625,
        339.2076721191406,
        527.0027465820312,
        375.0894775390625
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "지침",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        73.6763916015625,
        339.2076721191406,
        527.0027465820312,
        375.0894775390625
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2007",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        73.6763916015625,
        339.2076721191406,
        527.0027465820312,
        375.0894775390625
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "11-1470000-001462-01",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        73.6763916015625,
        339.2076721191406,
        527.0027465820312,
        375.0894775390625
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(생물의약품평가가이드",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        73.6763916015625,
        339.2076721191406,
        527.0027465820312,
        375.0894775390625
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "23)",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        73.6763916015625,
        339.2076721191406,
        527.0027465820312,
        375.0894775390625
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "생물진단제제팀",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        73.6763916015625,
        339.2076721191406,
        527.0027465820312,
        375.0894775390625
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "자료실 간행물",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        73.6763916015625,
        339.2076721191406,
        527.0027465820312,
        375.0894775390625
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "/",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        73.6763916015625,
        339.2076721191406,
        527.0027465820312,
        375.0894775390625
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        73.6763916015625,
        339.2076721191406,
        527.0027465820312,
        375.0894775390625
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "지침/196",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        73.6763916015625,
        339.2076721191406,
        527.0027465820312,
        375.0894775390625
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "세균백신 자가 기준 및",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.91802978515625,
        389.2505187988281,
        527.0018310546875,
        412.2886657714844
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "시험방법 작성 지침서",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.91802978515625,
        389.2505187988281,
        527.0018310546875,
        412.2886657714844
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2007",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.91802978515625,
        389.2505187988281,
        527.0018310546875,
        412.2886657714844
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "11-1470000-001428-01",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.91802978515625,
        389.2505187988281,
        527.0018310546875,
        412.2886657714844
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(생물의약품평가가이드",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.91802978515625,
        389.2505187988281,
        527.0018310546875,
        412.2886657714844
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "22)",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.91802978515625,
        389.2505187988281,
        527.0018310546875,
        412.2886657714844
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "세균백신팀",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.91802978515625,
        389.2505187988281,
        527.0018310546875,
        412.2886657714844
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "자료실 간행물",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.91802978515625,
        389.2505187988281,
        527.0018310546875,
        412.2886657714844
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "/",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.91802978515625,
        389.2505187988281,
        527.0018310546875,
        412.2886657714844
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.91802978515625,
        389.2505187988281,
        527.0018310546875,
        412.2886657714844
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "지침/177",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.91802978515625,
        389.2505187988281,
        527.0018310546875,
        412.2886657714844
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "바이오 칩 평가 가이드",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.9171142578125,
        426.44970703125,
        527.0010986328125,
        462.3276062011719
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "-HPV DNA칩 기준 및",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.9171142578125,
        426.44970703125,
        527.0010986328125,
        462.3276062011719
      ],
      "page_num": 21,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "시험방법 작성 지침-",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.9171142578125,
        426.44970703125,
        527.0010986328125,
        462.3276062011719
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2006",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.9171142578125,
        426.44970703125,
        527.0010986328125,
        462.3276062011719
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "11-1470000-001165-01",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.9171142578125,
        426.44970703125,
        527.0010986328125,
        462.3276062011719
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(생물의약품평가가이드",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.9171142578125,
        426.44970703125,
        527.0010986328125,
        462.3276062011719
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "21)",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.9171142578125,
        426.44970703125,
        527.0010986328125,
        462.3276062011719
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "생물진단제제팀",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.9171142578125,
        426.44970703125,
        527.0010986328125,
        462.3276062011719
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "자료실 간행물",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.9171142578125,
        426.44970703125,
        527.0010986328125,
        462.3276062011719
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "/",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.9171142578125,
        426.44970703125,
        527.0010986328125,
        462.3276062011719
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.9171142578125,
        426.44970703125,
        527.0010986328125,
        462.3276062011719
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "지침/154",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.9171142578125,
        426.44970703125,
        527.0010986328125,
        462.3276062011719
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "혈장분획제제 등 바이러스",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.47540283203125,
        476.4886474609375,
        527.0006713867188,
        499.53070068359375
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "검증 평가 가이드",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.47540283203125,
        476.4886474609375,
        527.0006713867188,
        499.53070068359375
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2006",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.47540283203125,
        476.4886474609375,
        527.0006713867188,
        499.53070068359375
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "11-1470000-001176-01",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.47540283203125,
        476.4886474609375,
        527.0006713867188,
        499.53070068359375
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(생물의약품평가가이드",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.47540283203125,
        476.4886474609375,
        527.0006713867188,
        499.53070068359375
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "20)",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.47540283203125,
        476.4886474609375,
        527.0006713867188,
        499.53070068359375
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "혈액제제팀",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.47540283203125,
        476.4886474609375,
        527.0006713867188,
        499.53070068359375
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "자료실 간행물",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.47540283203125,
        476.4886474609375,
        527.0006713867188,
        499.53070068359375
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "/",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.47540283203125,
        476.4886474609375,
        527.0006713867188,
        499.53070068359375
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.47540283203125,
        476.4886474609375,
        527.0006713867188,
        499.53070068359375
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "지침/170",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.47540283203125,
        476.4886474609375,
        527.0006713867188,
        499.53070068359375
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "유전자재조합의약품",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.47494506835938,
        513.6878662109375,
        189.35682678222656,
        562.6477661132812
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "생산용 세포의 발현구조체",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.47494506835938,
        513.6878662109375,
        189.35682678222656,
        562.6477661132812
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "분석 및 안정성",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.47494506835938,
        513.6878662109375,
        189.35682678222656,
        562.6477661132812
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "평가가이드",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.47494506835938,
        513.6878662109375,
        189.35682678222656,
        562.6477661132812
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2006",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        196.55307006835938,
        526.648681640625,
        527.0004272460938,
        549.569580078125
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "11-1470000-001116-01",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        196.55307006835938,
        526.648681640625,
        527.0004272460938,
        549.569580078125
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(생물의약품평가가이드",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        196.55307006835938,
        526.648681640625,
        527.0004272460938,
        549.569580078125
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "19)",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        196.55307006835938,
        526.648681640625,
        527.0004272460938,
        549.569580078125
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "재조합의약품팀",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        196.55307006835938,
        526.648681640625,
        527.0004272460938,
        549.569580078125
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "자료실 간행물",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        196.55307006835938,
        526.648681640625,
        527.0004272460938,
        549.569580078125
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "/",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        196.55307006835938,
        526.648681640625,
        527.0004272460938,
        549.569580078125
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        196.55307006835938,
        526.648681640625,
        527.0004272460938,
        549.569580078125
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "지침/229",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        196.55307006835938,
        526.648681640625,
        527.0004272460938,
        549.569580078125
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "유전재재조합의약품 및",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.99382781982422,
        576.8087768554688,
        186.95382690429688,
        625.7686157226562
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "단클론항체의약품의 제조",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.99382781982422,
        576.8087768554688,
        186.95382690429688,
        625.7686157226562
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "및 품질관리 자료에 관한",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.99382781982422,
        576.8087768554688,
        186.95382690429688,
        625.7686157226562
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "평가가이드",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.99382781982422,
        576.8087768554688,
        186.95382690429688,
        625.7686157226562
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2006",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        196.55242919921875,
        589.7695922851562,
        526.9996948242188,
        612.6904907226562
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "11-1470000-000902-01",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        196.55242919921875,
        589.7695922851562,
        526.9996948242188,
        612.6904907226562
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(생물의약품평가가이드",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        196.55242919921875,
        589.7695922851562,
        526.9996948242188,
        612.6904907226562
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "18)",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        196.55242919921875,
        589.7695922851562,
        526.9996948242188,
        612.6904907226562
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "재조합의약품팀",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        196.55242919921875,
        589.7695922851562,
        526.9996948242188,
        612.6904907226562
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "생물의약품관리팀",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        196.55242919921875,
        589.7695922851562,
        526.9996948242188,
        612.6904907226562
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "자료실 간행물",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        196.55242919921875,
        589.7695922851562,
        526.9996948242188,
        612.6904907226562
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "/",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        196.55242919921875,
        589.7695922851562,
        526.9996948242188,
        612.6904907226562
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        196.55242919921875,
        589.7695922851562,
        526.9996948242188,
        612.6904907226562
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "지침/139",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        196.55242919921875,
        589.7695922851562,
        526.9996948242188,
        612.6904907226562
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "이종이식제제의 전임상 및",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.4739990234375,
        665.8477172851562,
        352.6846008300781,
        688.8897094726562
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "임상시험에 대한 가이드",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.4739990234375,
        665.8477172851562,
        352.6846008300781,
        688.8897094726562
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2006",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.4739990234375,
        665.8477172851562,
        352.6846008300781,
        688.8897094726562
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "11-1470000-001088-01",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.4739990234375,
        665.8477172851562,
        352.6846008300781,
        688.8897094726562
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(생물의약품평가가이드",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.4739990234375,
        665.8477172851562,
        352.6846008300781,
        688.8897094726562
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "17)",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.4739990234375,
        665.8477172851562,
        352.6846008300781,
        688.8897094726562
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "세포조직공학제제팀",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        362.0321044921875,
        639.9296875,
        452.0311584472656,
        714.8074951171875
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "재조합의약품팀",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        362.0321044921875,
        639.9296875,
        452.0311584472656,
        714.8074951171875
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "생물의약품안전팀",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        362.0321044921875,
        639.9296875,
        452.0311584472656,
        714.8074951171875
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "생물의약품관리팀",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        362.0321044921875,
        639.9296875,
        452.0311584472656,
        714.8074951171875
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "국립독성연구원",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        362.0321044921875,
        639.9296875,
        452.0311584472656,
        714.8074951171875
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "생명공학지원팀",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        362.0321044921875,
        639.9296875,
        452.0311584472656,
        714.8074951171875
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "자료실 간행물",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        459.5946044921875,
        672.3280029296875,
        526.9993286132812,
        695.3699951171875
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "/",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        459.5946044921875,
        672.3280029296875,
        526.9993286132812,
        695.3699951171875
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        459.5946044921875,
        672.3280029296875,
        526.9993286132812,
        695.3699951171875
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "지침/130",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        459.5946044921875,
        672.3280029296875,
        526.9993286132812,
        695.3699951171875
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 14 -",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        280.5589904785156,
        789.4503784179688,
        314.6234130859375,
        799.4103393554688
      ],
      "page_num": 22,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "행정간행물 제목",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        91.9218978881836,
        106.29037475585938,
        515.760986328125,
        129.2112579345703
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "발행",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        91.9218978881836,
        106.29037475585938,
        515.760986328125,
        129.2112579345703
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "연도",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        91.9218978881836,
        106.29037475585938,
        515.760986328125,
        129.2112579345703
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "행정간행물 번호",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        91.9218978881836,
        106.29037475585938,
        515.760986328125,
        129.2112579345703
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "발행과",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        91.9218978881836,
        106.29037475585938,
        515.760986328125,
        129.2112579345703
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "홈페이지",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        91.9218978881836,
        106.29037475585938,
        515.760986328125,
        129.2112579345703
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "게재 상태",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        91.9218978881836,
        106.29037475585938,
        515.760986328125,
        129.2112579345703
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "이종이식제제의 품질관리",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.99993896484375,
        160.05203247070312,
        352.691162109375,
        196.0509796142578
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "및 이식 후 감염관리에",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.99993896484375,
        160.05203247070312,
        352.691162109375,
        196.0509796142578
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "대한 가이드",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.99993896484375,
        160.05203247070312,
        352.691162109375,
        196.0509796142578
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2006",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.99993896484375,
        160.05203247070312,
        352.691162109375,
        196.0509796142578
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "11-1470000-001086-01",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.99993896484375,
        160.05203247070312,
        352.691162109375,
        196.0509796142578
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(생물의약품평가가이드",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.99993896484375,
        160.05203247070312,
        352.691162109375,
        196.0509796142578
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "16)",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.99993896484375,
        160.05203247070312,
        352.691162109375,
        196.0509796142578
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "세포조직공학제제팀",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        362.0386962890625,
        140.61050415039062,
        452.0377502441406,
        215.48817443847656
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "재조합의약품팀",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        362.0386962890625,
        140.61050415039062,
        452.0377502441406,
        215.48817443847656
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "생물의약품안전팀",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        362.0386962890625,
        140.61050415039062,
        452.0377502441406,
        215.48817443847656
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "생물의약품관리팀",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        362.0386962890625,
        140.61050415039062,
        452.0377502441406,
        215.48817443847656
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "국립독성연구원",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        362.0386962890625,
        140.61050415039062,
        452.0377502441406,
        215.48817443847656
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "생명공학지원팀",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        362.0386962890625,
        140.61050415039062,
        452.0377502441406,
        215.48817443847656
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "자료실 간행물",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        459.6011962890625,
        173.00869750976562,
        527.0059204101562,
        196.05067443847656
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "/",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        459.6011962890625,
        173.00869750976562,
        527.0059204101562,
        196.05067443847656
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        459.6011962890625,
        173.00869750976562,
        527.0059204101562,
        196.05067443847656
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "지침/130",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        459.6011962890625,
        173.00869750976562,
        527.0059204101562,
        196.05067443847656
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "이종이식제제의 범위 및",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.398193359375,
        255.68832397460938,
        352.6908264160156,
        278.6092529296875
      ],
      "page_num": 22,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "원료동물에 대한 가이드",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.398193359375,
        255.68832397460938,
        352.6908264160156,
        278.6092529296875
      ],
      "page_num": 22,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2006",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.398193359375,
        255.68832397460938,
        352.6908264160156,
        278.6092529296875
      ],
      "page_num": 22,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "11-1470000-001087-01",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.398193359375,
        255.68832397460938,
        352.6908264160156,
        278.6092529296875
      ],
      "page_num": 22,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(생물의약품평가가이드",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.398193359375,
        255.68832397460938,
        352.6908264160156,
        278.6092529296875
      ],
      "page_num": 22,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "15)",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.398193359375,
        255.68832397460938,
        352.6908264160156,
        278.6092529296875
      ],
      "page_num": 22,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "세포조직공학제제팀",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        362.038330078125,
        229.64920043945312,
        452.0373840332031,
        304.64794921875
      ],
      "page_num": 22,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "재조합의약품팀",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        362.038330078125,
        229.64920043945312,
        452.0373840332031,
        304.64794921875
      ],
      "page_num": 22,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "생물의약품안전팀",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        362.038330078125,
        229.64920043945312,
        452.0373840332031,
        304.64794921875
      ],
      "page_num": 22,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "생물의약품관리팀",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        362.038330078125,
        229.64920043945312,
        452.0373840332031,
        304.64794921875
      ],
      "page_num": 22,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "국립독성연구원",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        362.038330078125,
        229.64920043945312,
        452.0373840332031,
        304.64794921875
      ],
      "page_num": 22,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "생명공학지원팀",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        362.038330078125,
        229.64920043945312,
        452.0373840332031,
        304.64794921875
      ],
      "page_num": 22,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "자료실 간행물",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        459.600830078125,
        262.1684875488281,
        527.0055541992188,
        285.08935546875
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "/",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        459.600830078125,
        262.1684875488281,
        527.0055541992188,
        285.08935546875
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        459.600830078125,
        262.1684875488281,
        527.0055541992188,
        285.08935546875
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "지침/130",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        459.600830078125,
        262.1684875488281,
        527.0055541992188,
        285.08935546875
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "암치료를 위한 수지상",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        79.44082641601562,
        318.8090515136719,
        352.69061279296875,
        354.80804443359375
      ],
      "page_num": 22,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "세포치료제 평가 시",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        79.44082641601562,
        318.8090515136719,
        352.69061279296875,
        354.80804443359375
      ],
      "page_num": 22,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "고려사항",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        79.44082641601562,
        318.8090515136719,
        352.69061279296875,
        354.80804443359375
      ],
      "page_num": 22,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2005",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        79.44082641601562,
        318.8090515136719,
        352.69061279296875,
        354.80804443359375
      ],
      "page_num": 22,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "11-1470000-000888-01",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        79.44082641601562,
        318.8090515136719,
        352.69061279296875,
        354.80804443359375
      ],
      "page_num": 22,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(생물의약품평가가이드",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        79.44082641601562,
        318.8090515136719,
        352.69061279296875,
        354.80804443359375
      ],
      "page_num": 22,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "14)",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        79.44082641601562,
        318.8090515136719,
        352.69061279296875,
        354.80804443359375
      ],
      "page_num": 22,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "재조합의약품팀",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        362.0380859375,
        320.1293029785156,
        452.0371398925781,
        353.48779296875
      ],
      "page_num": 22,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "생명공학의약품과",
      "font_size": 8.039999961853027,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        362.0380859375,
        320.1293029785156,
        452.0371398925781,
        353.48779296875
      ],
      "page_num": 22,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(",
      "font_size": 8.039999961853027,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        362.0380859375,
        320.1293029785156,
        452.0371398925781,
        353.48779296875
      ],
      "page_num": 22,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ")",
      "font_size": 8.039999961853027,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        362.0380859375,
        320.1293029785156,
        452.0371398925781,
        353.48779296875
      ],
      "page_num": 22,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "舊",
      "font_size": 8.039999961853027,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        362.0380859375,
        320.1293029785156,
        452.0371398925781,
        353.48779296875
      ],
      "page_num": 22,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "세포조직공학제제팀",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        362.0380859375,
        320.1293029785156,
        452.0371398925781,
        353.48779296875
      ],
      "page_num": 22,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "자료실 간행물",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        459.6005859375,
        325.28948974609375,
        527.0053100585938,
        348.21038818359375
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "/",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        459.6005859375,
        325.28948974609375,
        527.0053100585938,
        348.21038818359375
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        459.6005859375,
        325.28948974609375,
        527.0053100585938,
        348.21038818359375
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "지침/116",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        459.6005859375,
        325.28948974609375,
        527.0053100585938,
        348.21038818359375
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "바이오칩 평가가이드",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        81.9595947265625,
        368.9692077636719,
        352.6898498535156,
        404.85101318359375
      ],
      "page_num": 22,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "-DNA칩의 기준 및",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        81.9595947265625,
        368.9692077636719,
        352.6898498535156,
        404.85101318359375
      ],
      "page_num": 22,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "시험방법 작성지침-",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        81.9595947265625,
        368.9692077636719,
        352.6898498535156,
        404.85101318359375
      ],
      "page_num": 22,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2005",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        81.9595947265625,
        368.9692077636719,
        352.6898498535156,
        404.85101318359375
      ],
      "page_num": 22,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "11-1470000-000896-01",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        81.9595947265625,
        368.9692077636719,
        352.6898498535156,
        404.85101318359375
      ],
      "page_num": 22,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(생물의약품평가가이드",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        81.9595947265625,
        368.9692077636719,
        352.6898498535156,
        404.85101318359375
      ],
      "page_num": 22,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "13)",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        81.9595947265625,
        368.9692077636719,
        352.6898498535156,
        404.85101318359375
      ],
      "page_num": 22,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "재조합의약품팀",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        366.119384765625,
        369.9300537109375,
        448.0953369140625,
        403.8564147949219
      ],
      "page_num": 22,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "생물진단제제팀",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        366.119384765625,
        369.9300537109375,
        448.0953369140625,
        403.8564147949219
      ],
      "page_num": 22,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "생물의약품규격과",
      "font_size": 8.039999961853027,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        366.119384765625,
        369.9300537109375,
        448.0953369140625,
        403.8564147949219
      ],
      "page_num": 22,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(",
      "font_size": 8.039999961853027,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        366.119384765625,
        369.9300537109375,
        448.0953369140625,
        403.8564147949219
      ],
      "page_num": 22,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ")",
      "font_size": 8.039999961853027,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        366.119384765625,
        369.9300537109375,
        448.0953369140625,
        403.8564147949219
      ],
      "page_num": 22,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "舊",
      "font_size": 8.039999961853027,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        366.119384765625,
        369.9300537109375,
        448.0953369140625,
        403.8564147949219
      ],
      "page_num": 22,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "자료실 간행물",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        459.5998840332031,
        375.449462890625,
        527.0045776367188,
        398.370361328125
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "/",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        459.5998840332031,
        375.449462890625,
        527.0045776367188,
        398.370361328125
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        459.5998840332031,
        375.449462890625,
        527.0045776367188,
        398.370361328125
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "지침/110",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        459.5998840332031,
        375.449462890625,
        527.0045776367188,
        398.370361328125
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "유전자치료제의 복제가능",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.99789428710938,
        419.008056640625,
        350.29132080078125,
        455.0109558105469
      ],
      "page_num": 22,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "바이러스 시험법에 관한",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.99789428710938,
        419.008056640625,
        350.29132080078125,
        455.0109558105469
      ],
      "page_num": 22,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "가이드",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.99789428710938,
        419.008056640625,
        350.29132080078125,
        455.0109558105469
      ],
      "page_num": 22,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2005",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.99789428710938,
        419.008056640625,
        350.29132080078125,
        455.0109558105469
      ],
      "page_num": 22,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "11-1470000-000877-01",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.99789428710938,
        419.008056640625,
        350.29132080078125,
        455.0109558105469
      ],
      "page_num": 22,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(생물의약품평가가이드",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.99789428710938,
        419.008056640625,
        350.29132080078125,
        455.0109558105469
      ],
      "page_num": 22,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "12)",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.99789428710938,
        419.008056640625,
        350.29132080078125,
        455.0109558105469
      ],
      "page_num": 22,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "재조합의약품팀",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        366.11907958984375,
        420.32830810546875,
        448.09503173828125,
        453.6907043457031
      ],
      "page_num": 22,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "생명공학의약품과",
      "font_size": 8.039999961853027,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        366.11907958984375,
        420.32830810546875,
        448.09503173828125,
        453.6907043457031
      ],
      "page_num": 22,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(",
      "font_size": 8.039999961853027,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        366.11907958984375,
        420.32830810546875,
        448.09503173828125,
        453.6907043457031
      ],
      "page_num": 22,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ")",
      "font_size": 8.039999961853027,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        366.11907958984375,
        420.32830810546875,
        448.09503173828125,
        453.6907043457031
      ],
      "page_num": 22,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "舊",
      "font_size": 8.039999961853027,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        366.11907958984375,
        420.32830810546875,
        448.09503173828125,
        453.6907043457031
      ],
      "page_num": 22,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "유전자치료제팀",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        366.11907958984375,
        420.32830810546875,
        448.09503173828125,
        453.6907043457031
      ],
      "page_num": 22,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "자료실 간행물",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        459.5995788574219,
        425.488525390625,
        527.0042724609375,
        448.530517578125
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "/",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        459.5995788574219,
        425.488525390625,
        527.0042724609375,
        448.530517578125
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        459.5995788574219,
        425.488525390625,
        527.0042724609375,
        448.530517578125
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "지침/118",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        459.5995788574219,
        425.488525390625,
        527.0042724609375,
        448.530517578125
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "임상시험용",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.3184814453125,
        469.168212890625,
        188.60595703125,
        518.1281127929688
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "유전자치료제의 특성분석,",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.3184814453125,
        469.168212890625,
        188.60595703125,
        518.1281127929688
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "제조 및 품질관리",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.3184814453125,
        469.168212890625,
        188.60595703125,
        518.1281127929688
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "평가가이드",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.3184814453125,
        469.168212890625,
        188.60595703125,
        518.1281127929688
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2005",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        196.556884765625,
        482.1290283203125,
        527.004150390625,
        505.1671447753906
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "11-1470000-000876-01",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        196.556884765625,
        482.1290283203125,
        527.004150390625,
        505.1671447753906
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(생물의약품평가가이드",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        196.556884765625,
        482.1290283203125,
        527.004150390625,
        505.1671447753906
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "11)",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        196.556884765625,
        482.1290283203125,
        527.004150390625,
        505.1671447753906
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "생명공학의약품과",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        196.556884765625,
        482.1290283203125,
        527.004150390625,
        505.1671447753906
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "자료실 간행물",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        196.556884765625,
        482.1290283203125,
        527.004150390625,
        505.1671447753906
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "/",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        196.556884765625,
        482.1290283203125,
        527.004150390625,
        505.1671447753906
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        196.556884765625,
        482.1290283203125,
        527.004150390625,
        505.1671447753906
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "지침/107",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        196.556884765625,
        482.1290283203125,
        527.004150390625,
        505.1671447753906
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "두창백신의 안전성 유효성",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.03643798828125,
        532.2891235351562,
        527.0034790039062,
        555.2100219726562
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "․",
      "font_size": 9.960000038146973,
      "font_name": "TTA184C656tCID32K",
      "bbox": [
        71.03643798828125,
        532.2891235351562,
        527.0034790039062,
        555.2100219726562
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "평가시 고려사항",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.03643798828125,
        532.2891235351562,
        527.0034790039062,
        555.2100219726562
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2005",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.03643798828125,
        532.2891235351562,
        527.0034790039062,
        555.2100219726562
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "11-1470000-000872-01",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.03643798828125,
        532.2891235351562,
        527.0034790039062,
        555.2100219726562
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(생물의약품평가가이드",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.03643798828125,
        532.2891235351562,
        527.0034790039062,
        555.2100219726562
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "10)",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.03643798828125,
        532.2891235351562,
        527.0034790039062,
        555.2100219726562
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "생물의약품평가과",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.03643798828125,
        532.2891235351562,
        527.0034790039062,
        555.2100219726562
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "자료실 간행물",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.03643798828125,
        532.2891235351562,
        527.0034790039062,
        555.2100219726562
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "/",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.03643798828125,
        532.2891235351562,
        527.0034790039062,
        555.2100219726562
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.03643798828125,
        532.2891235351562,
        527.0034790039062,
        555.2100219726562
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "지침/105",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.03643798828125,
        532.2891235351562,
        527.0034790039062,
        555.2100219726562
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "단클론항체의약품의",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        84.477783203125,
        582.4491577148438,
        349.8118591308594,
        605.3700561523438
      ],
      "page_num": 22,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "평가가이드",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        84.477783203125,
        582.4491577148438,
        349.8118591308594,
        605.3700561523438
      ],
      "page_num": 22,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2005",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        84.477783203125,
        582.4491577148438,
        349.8118591308594,
        605.3700561523438
      ],
      "page_num": 22,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "11-1470000-000851-01",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        84.477783203125,
        582.4491577148438,
        349.8118591308594,
        605.3700561523438
      ],
      "page_num": 22,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(생물의약품평가가이드",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        84.477783203125,
        582.4491577148438,
        349.8118591308594,
        605.3700561523438
      ],
      "page_num": 22,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "9)",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        84.477783203125,
        582.4491577148438,
        349.8118591308594,
        605.3700561523438
      ],
      "page_num": 22,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "생명공학의약품과",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        367.075927734375,
        569.3670654296875,
        446.9968566894531,
        618.3269653320312
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "생물의약품평가과",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        367.075927734375,
        569.3670654296875,
        446.9968566894531,
        618.3269653320312
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "국립독성연구원",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        367.075927734375,
        569.3670654296875,
        446.9968566894531,
        618.3269653320312
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "생화학약리과",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        367.075927734375,
        569.3670654296875,
        446.9968566894531,
        618.3269653320312
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "자료실 간행물",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        459.599365234375,
        582.448974609375,
        527.0040893554688,
        605.3698120117188
      ],
      "page_num": 22,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "/",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        459.599365234375,
        582.448974609375,
        527.0040893554688,
        605.3698120117188
      ],
      "page_num": 22,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ",",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        459.599365234375,
        582.448974609375,
        527.0040893554688,
        605.3698120117188
      ],
      "page_num": 22,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "지침/74",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        459.599365234375,
        582.448974609375,
        527.0040893554688,
        605.3698120117188
      ],
      "page_num": 22,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "TNF 길항제 사용시",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        85.07557678222656,
        632.4879150390625,
        527.0045166015625,
        655.5299682617188
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "잠복결핵 치료지침",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        85.07557678222656,
        632.4879150390625,
        527.0045166015625,
        655.5299682617188
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2005",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        85.07557678222656,
        632.4879150390625,
        527.0045166015625,
        655.5299682617188
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "11-1470000-000686-01",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        85.07557678222656,
        632.4879150390625,
        527.0045166015625,
        655.5299682617188
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(생물의약품평가가이드",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        85.07557678222656,
        632.4879150390625,
        527.0045166015625,
        655.5299682617188
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "8)",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        85.07557678222656,
        632.4879150390625,
        527.0045166015625,
        655.5299682617188
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "생물의약품평가과",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        85.07557678222656,
        632.4879150390625,
        527.0045166015625,
        655.5299682617188
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "자료실 간행물",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        85.07557678222656,
        632.4879150390625,
        527.0045166015625,
        655.5299682617188
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "/",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        85.07557678222656,
        632.4879150390625,
        527.0045166015625,
        655.5299682617188
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        85.07557678222656,
        632.4879150390625,
        527.0045166015625,
        655.5299682617188
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "지침/65",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        85.07557678222656,
        632.4879150390625,
        527.0045166015625,
        655.5299682617188
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "DNA 백신의 평가지침서",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.15813446044922,
        669.6871337890625,
        527.00439453125,
        692.6080322265625
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2004",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.15813446044922,
        669.6871337890625,
        527.00439453125,
        692.6080322265625
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "11-1470000-000669-01",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.15813446044922,
        669.6871337890625,
        527.00439453125,
        692.6080322265625
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(생물의약품평가가이드",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.15813446044922,
        669.6871337890625,
        527.00439453125,
        692.6080322265625
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "7)",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.15813446044922,
        669.6871337890625,
        527.00439453125,
        692.6080322265625
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "생명공학의약품과",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.15813446044922,
        669.6871337890625,
        527.00439453125,
        692.6080322265625
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "생물의약품평가과",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.15813446044922,
        669.6871337890625,
        527.00439453125,
        692.6080322265625
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "자료실 간행물",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.15813446044922,
        669.6871337890625,
        527.00439453125,
        692.6080322265625
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "/",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.15813446044922,
        669.6871337890625,
        527.00439453125,
        692.6080322265625
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.15813446044922,
        669.6871337890625,
        527.00439453125,
        692.6080322265625
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "지침/60",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.15813446044922,
        669.6871337890625,
        527.00439453125,
        692.6080322265625
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "생명공학의약품/",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.39651489257812,
        706.7691650390625,
        527.0045776367188,
        742.7681274414062
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "생물학적제제의",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.39651489257812,
        706.7691650390625,
        527.0045776367188,
        742.7681274414062
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "규격설정에 관한 가이드",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.39651489257812,
        706.7691650390625,
        527.0045776367188,
        742.7681274414062
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2004",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.39651489257812,
        706.7691650390625,
        527.0045776367188,
        742.7681274414062
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "11-1470000-000538-01",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.39651489257812,
        706.7691650390625,
        527.0045776367188,
        742.7681274414062
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(생물의약품평가가이드",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.39651489257812,
        706.7691650390625,
        527.0045776367188,
        742.7681274414062
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "6)",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.39651489257812,
        706.7691650390625,
        527.0045776367188,
        742.7681274414062
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "생명공학의약품과",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.39651489257812,
        706.7691650390625,
        527.0045776367188,
        742.7681274414062
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "자료실 간행물",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.39651489257812,
        706.7691650390625,
        527.0045776367188,
        742.7681274414062
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "/",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.39651489257812,
        706.7691650390625,
        527.0045776367188,
        742.7681274414062
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.39651489257812,
        706.7691650390625,
        527.0045776367188,
        742.7681274414062
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "지침/59",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.39651489257812,
        706.7691650390625,
        527.0045776367188,
        742.7681274414062
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 15 -",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        280.5589904785156,
        789.4503784179688,
        314.6234130859375,
        799.4103393554688
      ],
      "page_num": 23,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "생물의약품평가자료집 시리즈",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        64.67969512939453,
        384.8751525878906,
        258.36236572265625,
        397.83514404296875
      ],
      "page_num": 23,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "3.",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        64.67969512939453,
        384.8751525878906,
        258.36236572265625,
        397.83514404296875
      ],
      "page_num": 23,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "행정간행물 제목",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        91.9218978881836,
        106.29037475585938,
        515.760986328125,
        129.2112579345703
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "발행",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        91.9218978881836,
        106.29037475585938,
        515.760986328125,
        129.2112579345703
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "연도",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        91.9218978881836,
        106.29037475585938,
        515.760986328125,
        129.2112579345703
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "행정간행물 번호",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        91.9218978881836,
        106.29037475585938,
        515.760986328125,
        129.2112579345703
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "발행과",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        91.9218978881836,
        106.29037475585938,
        515.760986328125,
        129.2112579345703
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "홈페이지",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        91.9218978881836,
        106.29037475585938,
        515.760986328125,
        129.2112579345703
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "게재 상태",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        91.9218978881836,
        106.29037475585938,
        515.760986328125,
        129.2112579345703
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "핵산증폭검사법 검증",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        81.9609375,
        140.61050415039062,
        527.0067138671875,
        163.53150939941406
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "가이드라인",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        81.9609375,
        140.61050415039062,
        527.0067138671875,
        163.53150939941406
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2003",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        81.9609375,
        140.61050415039062,
        527.0067138671875,
        163.53150939941406
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "11-1470000-000277-01",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        81.9609375,
        140.61050415039062,
        527.0067138671875,
        163.53150939941406
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(생물의약품평가가이드",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        81.9609375,
        140.61050415039062,
        527.0067138671875,
        163.53150939941406
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "5)",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        81.9609375,
        140.61050415039062,
        527.0067138671875,
        163.53150939941406
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "혈액제제과",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        81.9609375,
        140.61050415039062,
        527.0067138671875,
        163.53150939941406
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "자료실 간행물",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        81.9609375,
        140.61050415039062,
        527.0067138671875,
        163.53150939941406
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "/",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        81.9609375,
        140.61050415039062,
        527.0067138671875,
        163.53150939941406
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        81.9609375,
        140.61050415039062,
        527.0067138671875,
        163.53150939941406
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "지침/44",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        81.9609375,
        140.61050415039062,
        527.0067138671875,
        163.53150939941406
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "혈장분획제제",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        91.92233276367188,
        177.68844604492188,
        527.0073852539062,
        200.6094512939453
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "품질평가 가이드",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        91.92233276367188,
        177.68844604492188,
        527.0073852539062,
        200.6094512939453
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2002",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        91.92233276367188,
        177.68844604492188,
        527.0073852539062,
        200.6094512939453
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "11-1470000-000154-01",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        91.92233276367188,
        177.68844604492188,
        527.0073852539062,
        200.6094512939453
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(생물의약품평가가이드",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        91.92233276367188,
        177.68844604492188,
        527.0073852539062,
        200.6094512939453
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "4)",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        91.92233276367188,
        177.68844604492188,
        527.0073852539062,
        200.6094512939453
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "혈액제제과",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        91.92233276367188,
        177.68844604492188,
        527.0073852539062,
        200.6094512939453
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "자료실 간행물",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        91.92233276367188,
        177.68844604492188,
        527.0073852539062,
        200.6094512939453
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "/",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        91.92233276367188,
        177.68844604492188,
        527.0073852539062,
        200.6094512939453
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        91.92233276367188,
        177.68844604492188,
        527.0073852539062,
        200.6094512939453
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "지침/27",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        91.92233276367188,
        177.68844604492188,
        527.0073852539062,
        200.6094512939453
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "세포주로부터 개발한",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        81.96160888671875,
        214.77041625976562,
        176.88255310058594,
        263.73028564453125
      ],
      "page_num": 23,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "생물공학제제의",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        81.96160888671875,
        214.77041625976562,
        176.88255310058594,
        263.73028564453125
      ],
      "page_num": 23,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "바이러스안전성 평가",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        81.96160888671875,
        214.77041625976562,
        176.88255310058594,
        263.73028564453125
      ],
      "page_num": 23,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "가이드",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        81.96160888671875,
        214.77041625976562,
        176.88255310058594,
        263.73028564453125
      ],
      "page_num": 23,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2002",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        196.5592041015625,
        227.84841918945312,
        527.00732421875,
        250.76930236816406
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "11-1470000-000144-01",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        196.5592041015625,
        227.84841918945312,
        527.00732421875,
        250.76930236816406
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(생물의약품평가가이드",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        196.5592041015625,
        227.84841918945312,
        527.00732421875,
        250.76930236816406
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "3)",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        196.5592041015625,
        227.84841918945312,
        527.00732421875,
        250.76930236816406
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "백신과",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        196.5592041015625,
        227.84841918945312,
        527.00732421875,
        250.76930236816406
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "바이러스제제과",
      "font_size": 8.039999961853027,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        196.5592041015625,
        227.84841918945312,
        527.00732421875,
        250.76930236816406
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(",
      "font_size": 8.039999961853027,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        196.5592041015625,
        227.84841918945312,
        527.00732421875,
        250.76930236816406
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ")",
      "font_size": 8.039999961853027,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        196.5592041015625,
        227.84841918945312,
        527.00732421875,
        250.76930236816406
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "舊",
      "font_size": 8.039999961853027,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        196.5592041015625,
        227.84841918945312,
        527.00732421875,
        250.76930236816406
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "자료실 간행물",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        196.5592041015625,
        227.84841918945312,
        527.00732421875,
        250.76930236816406
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "/",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        196.5592041015625,
        227.84841918945312,
        527.00732421875,
        250.76930236816406
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        196.5592041015625,
        227.84841918945312,
        527.00732421875,
        250.76930236816406
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "지침/19",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        196.5592041015625,
        227.84841918945312,
        527.00732421875,
        250.76930236816406
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "생물의약품의 생산에",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.9224853515625,
        277.8912658691406,
        527.0073852539062,
        313.8902587890625
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "사용되는 세포기질관리",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.9224853515625,
        277.8912658691406,
        527.0073852539062,
        313.8902587890625
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "가이드",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.9224853515625,
        277.8912658691406,
        527.0073852539062,
        313.8902587890625
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2002",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.9224853515625,
        277.8912658691406,
        527.0073852539062,
        313.8902587890625
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "11-1470000-000140-14",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.9224853515625,
        277.8912658691406,
        527.0073852539062,
        313.8902587890625
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(생물의약품평가가이드",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.9224853515625,
        277.8912658691406,
        527.0073852539062,
        313.8902587890625
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2)",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.9224853515625,
        277.8912658691406,
        527.0073852539062,
        313.8902587890625
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "생명공학의약품과",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.9224853515625,
        277.8912658691406,
        527.0073852539062,
        313.8902587890625
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "생물공학과",
      "font_size": 8.039999961853027,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.9224853515625,
        277.8912658691406,
        527.0073852539062,
        313.8902587890625
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(",
      "font_size": 8.039999961853027,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.9224853515625,
        277.8912658691406,
        527.0073852539062,
        313.8902587890625
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ")",
      "font_size": 8.039999961853027,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.9224853515625,
        277.8912658691406,
        527.0073852539062,
        313.8902587890625
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "舊",
      "font_size": 8.039999961853027,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.9224853515625,
        277.8912658691406,
        527.0073852539062,
        313.8902587890625
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "자료실 간행물",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.9224853515625,
        277.8912658691406,
        527.0073852539062,
        313.8902587890625
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "/",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.9224853515625,
        277.8912658691406,
        527.0073852539062,
        313.8902587890625
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.9224853515625,
        277.8912658691406,
        527.0073852539062,
        313.8902587890625
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "지침/17",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.9224853515625,
        277.8912658691406,
        527.0073852539062,
        313.8902587890625
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "유전자치료제의",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        91.92303466796875,
        328.0513610839844,
        527.0081787109375,
        350.9683837890625
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "품질평가 가이드",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        91.92303466796875,
        328.0513610839844,
        527.0081787109375,
        350.9683837890625
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2001",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        91.92303466796875,
        328.0513610839844,
        527.0081787109375,
        350.9683837890625
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "11-1470000-000074-14",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        91.92303466796875,
        328.0513610839844,
        527.0081787109375,
        350.9683837890625
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(생물의약품평가가이드",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        91.92303466796875,
        328.0513610839844,
        527.0081787109375,
        350.9683837890625
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1)",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        91.92303466796875,
        328.0513610839844,
        527.0081787109375,
        350.9683837890625
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "생명공학의약품과",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        91.92303466796875,
        328.0513610839844,
        527.0081787109375,
        350.9683837890625
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "생물공학과",
      "font_size": 8.039999961853027,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        91.92303466796875,
        328.0513610839844,
        527.0081787109375,
        350.9683837890625
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(",
      "font_size": 8.039999961853027,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        91.92303466796875,
        328.0513610839844,
        527.0081787109375,
        350.9683837890625
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ")",
      "font_size": 8.039999961853027,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        91.92303466796875,
        328.0513610839844,
        527.0081787109375,
        350.9683837890625
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "舊",
      "font_size": 8.039999961853027,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        91.92303466796875,
        328.0513610839844,
        527.0081787109375,
        350.9683837890625
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "자료실 간행물",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        91.92303466796875,
        328.0513610839844,
        527.0081787109375,
        350.9683837890625
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "/",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        91.92303466796875,
        328.0513610839844,
        527.0081787109375,
        350.9683837890625
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        91.92303466796875,
        328.0513610839844,
        527.0081787109375,
        350.9683837890625
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "지침/54",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        91.92303466796875,
        328.0513610839844,
        527.0081787109375,
        350.9683837890625
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "행정간행물 제목",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        91.32029724121094,
        411.329345703125,
        515.1589965820312,
        434.250244140625
      ],
      "page_num": 23,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "발행",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        91.32029724121094,
        411.329345703125,
        515.1589965820312,
        434.250244140625
      ],
      "page_num": 23,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "연도",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        91.32029724121094,
        411.329345703125,
        515.1589965820312,
        434.250244140625
      ],
      "page_num": 23,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "행정간행물 번호",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        91.32029724121094,
        411.329345703125,
        515.1589965820312,
        434.250244140625
      ],
      "page_num": 23,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "발행과",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        91.32029724121094,
        411.329345703125,
        515.1589965820312,
        434.250244140625
      ],
      "page_num": 23,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "홈페이지",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        91.32029724121094,
        411.329345703125,
        515.1589965820312,
        434.250244140625
      ],
      "page_num": 23,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "게재 상태",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        91.32029724121094,
        411.329345703125,
        515.1589965820312,
        434.250244140625
      ],
      "page_num": 23,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "세포치료제의 임상시험",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.3199462890625,
        447.09100341796875,
        526.4039916992188,
        470.011962890625
      ],
      "page_num": 23,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "사례분석",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.3199462890625,
        447.09100341796875,
        526.4039916992188,
        470.011962890625
      ],
      "page_num": 23,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2007",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.3199462890625,
        447.09100341796875,
        526.4039916992188,
        470.011962890625
      ],
      "page_num": 23,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "11-1470000-001586-14",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.3199462890625,
        447.09100341796875,
        526.4039916992188,
        470.011962890625
      ],
      "page_num": 23,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(생물의약품평가자료집",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.3199462890625,
        447.09100341796875,
        526.4039916992188,
        470.011962890625
      ],
      "page_num": 23,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "50)",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.3199462890625,
        447.09100341796875,
        526.4039916992188,
        470.011962890625
      ],
      "page_num": 23,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "세포조직공학제제팀 자료실 간행물",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.3199462890625,
        447.09100341796875,
        526.4039916992188,
        470.011962890625
      ],
      "page_num": 23,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "/",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.3199462890625,
        447.09100341796875,
        526.4039916992188,
        470.011962890625
      ],
      "page_num": 23,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ",",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.3199462890625,
        447.09100341796875,
        526.4039916992188,
        470.011962890625
      ],
      "page_num": 23,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "지침/259",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.3199462890625,
        447.09100341796875,
        526.4039916992188,
        470.011962890625
      ],
      "page_num": 23,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "세포치료제의 비임상시험",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.39730834960938,
        487.0518493652344,
        526.4032592773438,
        509.9689025878906
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "사례분석",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.39730834960938,
        487.0518493652344,
        526.4032592773438,
        509.9689025878906
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2007",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.39730834960938,
        487.0518493652344,
        526.4032592773438,
        509.9689025878906
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "11-1470000-001585-14",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.39730834960938,
        487.0518493652344,
        526.4032592773438,
        509.9689025878906
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(생물의약품평가자료집",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.39730834960938,
        487.0518493652344,
        526.4032592773438,
        509.9689025878906
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "49)",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.39730834960938,
        487.0518493652344,
        526.4032592773438,
        509.9689025878906
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "세포조직공학제제팀 자료실 간행물",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.39730834960938,
        487.0518493652344,
        526.4032592773438,
        509.9689025878906
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "/",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.39730834960938,
        487.0518493652344,
        526.4032592773438,
        509.9689025878906
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.39730834960938,
        487.0518493652344,
        526.4032592773438,
        509.9689025878906
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "지침/259",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.39730834960938,
        487.0518493652344,
        526.4032592773438,
        509.9689025878906
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "생명공학의약품",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        73.7994613647461,
        527.0088500976562,
        526.4030151367188,
        562.8906860351562
      ],
      "page_num": 23,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "생산세포주 관리를 위한",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        73.7994613647461,
        527.0088500976562,
        526.4030151367188,
        562.8906860351562
      ],
      "page_num": 23,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "시험방법",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        73.7994613647461,
        527.0088500976562,
        526.4030151367188,
        562.8906860351562
      ],
      "page_num": 23,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2007",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        73.7994613647461,
        527.0088500976562,
        526.4030151367188,
        562.8906860351562
      ],
      "page_num": 23,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "11-1470000-000903-01",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        73.7994613647461,
        527.0088500976562,
        526.4030151367188,
        562.8906860351562
      ],
      "page_num": 23,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(생물의약품평가자료집",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        73.7994613647461,
        527.0088500976562,
        526.4030151367188,
        562.8906860351562
      ],
      "page_num": 23,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "48)",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        73.7994613647461,
        527.0088500976562,
        526.4030151367188,
        562.8906860351562
      ],
      "page_num": 23,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "재조합의약품팀",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        73.7994613647461,
        527.0088500976562,
        526.4030151367188,
        562.8906860351562
      ],
      "page_num": 23,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "자료실 간행물",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        73.7994613647461,
        527.0088500976562,
        526.4030151367188,
        562.8906860351562
      ],
      "page_num": 23,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "/",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        73.7994613647461,
        527.0088500976562,
        526.4030151367188,
        562.8906860351562
      ],
      "page_num": 23,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ",",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        73.7994613647461,
        527.0088500976562,
        526.4030151367188,
        562.8906860351562
      ],
      "page_num": 23,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "지침/236",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        73.7994613647461,
        527.0088500976562,
        526.4030151367188,
        562.8906860351562
      ],
      "page_num": 23,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "혈액제제의 자가 기준 및",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.39633178710938,
        579.9306030273438,
        526.4021606445312,
        602.96875
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "시험방법 작성 지침",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.39633178710938,
        579.9306030273438,
        526.4021606445312,
        602.96875
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2007",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.39633178710938,
        579.9306030273438,
        526.4021606445312,
        602.96875
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "11-1470000-001457-01",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.39633178710938,
        579.9306030273438,
        526.4021606445312,
        602.96875
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(생물의약품평가자료집",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.39633178710938,
        579.9306030273438,
        526.4021606445312,
        602.96875
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "47)",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.39633178710938,
        579.9306030273438,
        526.4021606445312,
        602.96875
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "혈액제제팀",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.39633178710938,
        579.9306030273438,
        526.4021606445312,
        602.96875
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "자료실 간행물",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.39633178710938,
        579.9306030273438,
        526.4021606445312,
        602.96875
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "/",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.39633178710938,
        579.9306030273438,
        526.4021606445312,
        602.96875
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.39633178710938,
        579.9306030273438,
        526.4021606445312,
        602.96875
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "지침/195",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.39633178710938,
        579.9306030273438,
        526.4021606445312,
        602.96875
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "혈관질환 등의",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.07521057128906,
        619.8915405273438,
        526.4013671875,
        655.8905029296875
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "유전자치료제",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.07521057128906,
        619.8915405273438,
        526.4013671875,
        655.8905029296875
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "비임상 임상시험 사례분석",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.07521057128906,
        619.8915405273438,
        526.4013671875,
        655.8905029296875
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "∙",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.07521057128906,
        619.8915405273438,
        526.4013671875,
        655.8905029296875
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2007",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.07521057128906,
        619.8915405273438,
        526.4013671875,
        655.8905029296875
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "11-1470000-001441-10",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.07521057128906,
        619.8915405273438,
        526.4013671875,
        655.8905029296875
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(생물의약품평가자료집",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.07521057128906,
        619.8915405273438,
        526.4013671875,
        655.8905029296875
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "46)",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.07521057128906,
        619.8915405273438,
        526.4013671875,
        655.8905029296875
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "유전자치료제팀",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.07521057128906,
        619.8915405273438,
        526.4013671875,
        655.8905029296875
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "자료실 간행물",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.07521057128906,
        619.8915405273438,
        526.4013671875,
        655.8905029296875
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "/",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.07521057128906,
        619.8915405273438,
        526.4013671875,
        655.8905029296875
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.07521057128906,
        619.8915405273438,
        526.4013671875,
        655.8905029296875
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "지침/233",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.07521057128906,
        619.8915405273438,
        526.4013671875,
        655.8905029296875
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "항암 유전자치료제",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.07438659667969,
        672.9304809570312,
        526.4005126953125,
        695.8513793945312
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "비임상 임상시험 사례분석",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.07438659667969,
        672.9304809570312,
        526.4005126953125,
        695.8513793945312
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "∙",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.07438659667969,
        672.9304809570312,
        526.4005126953125,
        695.8513793945312
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2007",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.07438659667969,
        672.9304809570312,
        526.4005126953125,
        695.8513793945312
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "11-1470000-001440-10",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.07438659667969,
        672.9304809570312,
        526.4005126953125,
        695.8513793945312
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(생물의약품평가자료집",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.07438659667969,
        672.9304809570312,
        526.4005126953125,
        695.8513793945312
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "45)",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.07438659667969,
        672.9304809570312,
        526.4005126953125,
        695.8513793945312
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "유전자치료제팀",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.07438659667969,
        672.9304809570312,
        526.4005126953125,
        695.8513793945312
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "자료실 간행물",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.07438659667969,
        672.9304809570312,
        526.4005126953125,
        695.8513793945312
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "/",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.07438659667969,
        672.9304809570312,
        526.4005126953125,
        695.8513793945312
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.07438659667969,
        672.9304809570312,
        526.4005126953125,
        695.8513793945312
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "지침/209",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.07438659667969,
        672.9304809570312,
        526.4005126953125,
        695.8513793945312
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "백신 임상 평가 시",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.39382934570312,
        712.8912963867188,
        526.3997192382812,
        735.808349609375
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "고려사항 2007",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.39382934570312,
        712.8912963867188,
        526.3997192382812,
        735.808349609375
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2007",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.39382934570312,
        712.8912963867188,
        526.3997192382812,
        735.808349609375
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "11-1470000-001446-10",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.39382934570312,
        712.8912963867188,
        526.3997192382812,
        735.808349609375
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(생물의약품평가자료집",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.39382934570312,
        712.8912963867188,
        526.3997192382812,
        735.808349609375
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "44)",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.39382934570312,
        712.8912963867188,
        526.3997192382812,
        735.808349609375
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "세균백신팀",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.39382934570312,
        712.8912963867188,
        526.3997192382812,
        735.808349609375
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "자료실 간행물",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.39382934570312,
        712.8912963867188,
        526.3997192382812,
        735.808349609375
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "/",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.39382934570312,
        712.8912963867188,
        526.3997192382812,
        735.808349609375
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.39382934570312,
        712.8912963867188,
        526.3997192382812,
        735.808349609375
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "지침/192",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.39382934570312,
        712.8912963867188,
        526.3997192382812,
        735.808349609375
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 16 -",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        280.5589904785156,
        789.4503784179688,
        314.6234130859375,
        799.4103393554688
      ],
      "page_num": 24,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "행정간행물 제목",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        91.32029724121094,
        104.84835815429688,
        515.1589965820312,
        127.76924133300781
      ],
      "page_num": 24,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "발행",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        91.32029724121094,
        104.84835815429688,
        515.1589965820312,
        127.76924133300781
      ],
      "page_num": 24,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "연도",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        91.32029724121094,
        104.84835815429688,
        515.1589965820312,
        127.76924133300781
      ],
      "page_num": 24,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "행정간행물 번호",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        91.32029724121094,
        104.84835815429688,
        515.1589965820312,
        127.76924133300781
      ],
      "page_num": 24,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "발행과",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        91.32029724121094,
        104.84835815429688,
        515.1589965820312,
        127.76924133300781
      ],
      "page_num": 24,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "홈페이지",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        91.32029724121094,
        104.84835815429688,
        515.1589965820312,
        127.76924133300781
      ],
      "page_num": 24,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "게재 상태",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        91.32029724121094,
        104.84835815429688,
        515.1589965820312,
        127.76924133300781
      ],
      "page_num": 24,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "생바이러스 백신의",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.3198471069336,
        140.61001586914062,
        526.40380859375,
        176.4878692626953
      ],
      "page_num": 24,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "자가 기준 및 시험방법",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.3198471069336,
        140.61001586914062,
        526.40380859375,
        176.4878692626953
      ],
      "page_num": 24,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "작성 지침",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.3198471069336,
        140.61001586914062,
        526.40380859375,
        176.4878692626953
      ],
      "page_num": 24,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2007",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.3198471069336,
        140.61001586914062,
        526.40380859375,
        176.4878692626953
      ],
      "page_num": 24,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "11-1470000-001345-01",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.3198471069336,
        140.61001586914062,
        526.40380859375,
        176.4878692626953
      ],
      "page_num": 24,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(생물의약품평가자료집",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.3198471069336,
        140.61001586914062,
        526.40380859375,
        176.4878692626953
      ],
      "page_num": 24,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "43)",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.3198471069336,
        140.61001586914062,
        526.40380859375,
        176.4878692626953
      ],
      "page_num": 24,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "바이러스백신팀",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.3198471069336,
        140.61001586914062,
        526.40380859375,
        176.4878692626953
      ],
      "page_num": 24,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "자료실 간행물",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.3198471069336,
        140.61001586914062,
        526.40380859375,
        176.4878692626953
      ],
      "page_num": 24,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "/",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.3198471069336,
        140.61001586914062,
        526.40380859375,
        176.4878692626953
      ],
      "page_num": 24,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.3198471069336,
        140.61001586914062,
        526.40380859375,
        176.4878692626953
      ],
      "page_num": 24,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "지침/172",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.3198471069336,
        140.61001586914062,
        526.40380859375,
        176.4878692626953
      ],
      "page_num": 24,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "불활화 바이러스 백신의",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        73.80010986328125,
        193.52786254882812,
        526.403564453125,
        229.5307159423828
      ],
      "page_num": 24,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "자가 기준 및 시험방법",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        73.80010986328125,
        193.52786254882812,
        526.403564453125,
        229.5307159423828
      ],
      "page_num": 24,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "작성 지침",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        73.80010986328125,
        193.52786254882812,
        526.403564453125,
        229.5307159423828
      ],
      "page_num": 24,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2007",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        73.80010986328125,
        193.52786254882812,
        526.403564453125,
        229.5307159423828
      ],
      "page_num": 24,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "11-1470000-001346-01",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        73.80010986328125,
        193.52786254882812,
        526.403564453125,
        229.5307159423828
      ],
      "page_num": 24,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(생물의약품평가자료집",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        73.80010986328125,
        193.52786254882812,
        526.403564453125,
        229.5307159423828
      ],
      "page_num": 24,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "42)",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        73.80010986328125,
        193.52786254882812,
        526.403564453125,
        229.5307159423828
      ],
      "page_num": 24,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "바이러스백신팀",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        73.80010986328125,
        193.52786254882812,
        526.403564453125,
        229.5307159423828
      ],
      "page_num": 24,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "자료실 간행물",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        73.80010986328125,
        193.52786254882812,
        526.403564453125,
        229.5307159423828
      ],
      "page_num": 24,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "/",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        73.80010986328125,
        193.52786254882812,
        526.403564453125,
        229.5307159423828
      ],
      "page_num": 24,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        73.80010986328125,
        193.52786254882812,
        526.403564453125,
        229.5307159423828
      ],
      "page_num": 24,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "지침/173",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        73.80010986328125,
        193.52786254882812,
        526.403564453125,
        229.5307159423828
      ],
      "page_num": 24,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "백신의 임상 평가 시",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        81.35787963867188,
        246.44955444335938,
        526.4027709960938,
        269.4876708984375
      ],
      "page_num": 24,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "고려사항",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        81.35787963867188,
        246.44955444335938,
        526.4027709960938,
        269.4876708984375
      ],
      "page_num": 24,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2006",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        81.35787963867188,
        246.44955444335938,
        526.4027709960938,
        269.4876708984375
      ],
      "page_num": 24,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "11-1470000-001163-01",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        81.35787963867188,
        246.44955444335938,
        526.4027709960938,
        269.4876708984375
      ],
      "page_num": 24,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(생물의약품평가자료집",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        81.35787963867188,
        246.44955444335938,
        526.4027709960938,
        269.4876708984375
      ],
      "page_num": 24,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "41)",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        81.35787963867188,
        246.44955444335938,
        526.4027709960938,
        269.4876708984375
      ],
      "page_num": 24,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "바이러스백신팀",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        81.35787963867188,
        246.44955444335938,
        526.4027709960938,
        269.4876708984375
      ],
      "page_num": 24,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "세균백신팀",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        81.35787963867188,
        246.44955444335938,
        526.4027709960938,
        269.4876708984375
      ],
      "page_num": 24,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "자료실 간행물",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        81.35787963867188,
        246.44955444335938,
        526.4027709960938,
        269.4876708984375
      ],
      "page_num": 24,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "/",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        81.35787963867188,
        246.44955444335938,
        526.4027709960938,
        269.4876708984375
      ],
      "page_num": 24,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        81.35787963867188,
        246.44955444335938,
        526.4027709960938,
        269.4876708984375
      ],
      "page_num": 24,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "지침 150",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        81.35787963867188,
        246.44955444335938,
        526.4027709960938,
        269.4876708984375
      ],
      "page_num": 24,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "DNA 백신의 평가",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        84.35697937011719,
        286.5276794433594,
        526.4019165039062,
        322.409423828125
      ],
      "page_num": 24,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ":",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        84.35697937011719,
        286.5276794433594,
        526.4019165039062,
        322.409423828125
      ],
      "page_num": 24,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "WHO 및 미국",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        84.35697937011719,
        286.5276794433594,
        526.4019165039062,
        322.409423828125
      ],
      "page_num": 24,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "FDA",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        84.35697937011719,
        286.5276794433594,
        526.4019165039062,
        322.409423828125
      ],
      "page_num": 24,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "가이드라인",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        84.35697937011719,
        286.5276794433594,
        526.4019165039062,
        322.409423828125
      ],
      "page_num": 24,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2006",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        84.35697937011719,
        286.5276794433594,
        526.4019165039062,
        322.409423828125
      ],
      "page_num": 24,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "11-1470000-001142-01",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        84.35697937011719,
        286.5276794433594,
        526.4019165039062,
        322.409423828125
      ],
      "page_num": 24,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(생물의약품평가자료집",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        84.35697937011719,
        286.5276794433594,
        526.4019165039062,
        322.409423828125
      ],
      "page_num": 24,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "40)",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        84.35697937011719,
        286.5276794433594,
        526.4019165039062,
        322.409423828125
      ],
      "page_num": 24,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "유전자치료제팀",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        84.35697937011719,
        286.5276794433594,
        526.4019165039062,
        322.409423828125
      ],
      "page_num": 24,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "자료실 간행물",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        84.35697937011719,
        286.5276794433594,
        526.4019165039062,
        322.409423828125
      ],
      "page_num": 24,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "/",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        84.35697937011719,
        286.5276794433594,
        526.4019165039062,
        322.409423828125
      ],
      "page_num": 24,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        84.35697937011719,
        286.5276794433594,
        526.4019165039062,
        322.409423828125
      ],
      "page_num": 24,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "지침/168",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        84.35697937011719,
        286.5276794433594,
        526.4019165039062,
        322.409423828125
      ],
      "page_num": 24,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "유전자치료 임상시험-",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        68.87622833251953,
        339.44940185546875,
        526.4015502929688,
        375.4483947753906
      ],
      "page_num": 24,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "지연성 이상반응에 대비한",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        68.87622833251953,
        339.44940185546875,
        526.4015502929688,
        375.4483947753906
      ],
      "page_num": 24,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "환자 관찰",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        68.87622833251953,
        339.44940185546875,
        526.4015502929688,
        375.4483947753906
      ],
      "page_num": 24,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2006",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        68.87622833251953,
        339.44940185546875,
        526.4015502929688,
        375.4483947753906
      ],
      "page_num": 24,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "11-1470000-001141-01",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        68.87622833251953,
        339.44940185546875,
        526.4015502929688,
        375.4483947753906
      ],
      "page_num": 24,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(생물의약품평가자료집",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        68.87622833251953,
        339.44940185546875,
        526.4015502929688,
        375.4483947753906
      ],
      "page_num": 24,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "39)",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        68.87622833251953,
        339.44940185546875,
        526.4015502929688,
        375.4483947753906
      ],
      "page_num": 24,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "유전자치료제팀",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        68.87622833251953,
        339.44940185546875,
        526.4015502929688,
        375.4483947753906
      ],
      "page_num": 24,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "자료실 간행물",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        68.87622833251953,
        339.44940185546875,
        526.4015502929688,
        375.4483947753906
      ],
      "page_num": 24,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "/",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        68.87622833251953,
        339.44940185546875,
        526.4015502929688,
        375.4483947753906
      ],
      "page_num": 24,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        68.87622833251953,
        339.44940185546875,
        526.4015502929688,
        375.4483947753906
      ],
      "page_num": 24,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "지침/157",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        68.87622833251953,
        339.44940185546875,
        526.4015502929688,
        375.4483947753906
      ],
      "page_num": 24,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "유전자치료제의",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        89.87591552734375,
        392.36724853515625,
        526.4012451171875,
        415.4093017578125
      ],
      "page_num": 24,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "안전성평가 2006",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        89.87591552734375,
        392.36724853515625,
        526.4012451171875,
        415.4093017578125
      ],
      "page_num": 24,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2006",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        89.87591552734375,
        392.36724853515625,
        526.4012451171875,
        415.4093017578125
      ],
      "page_num": 24,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "11-1470000-001140-01",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        89.87591552734375,
        392.36724853515625,
        526.4012451171875,
        415.4093017578125
      ],
      "page_num": 24,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(생물의약품평가자료집",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        89.87591552734375,
        392.36724853515625,
        526.4012451171875,
        415.4093017578125
      ],
      "page_num": 24,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "38)",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        89.87591552734375,
        392.36724853515625,
        526.4012451171875,
        415.4093017578125
      ],
      "page_num": 24,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "유전자치료제팀",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        89.87591552734375,
        392.36724853515625,
        526.4012451171875,
        415.4093017578125
      ],
      "page_num": 24,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "자료실 간행물",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        89.87591552734375,
        392.36724853515625,
        526.4012451171875,
        415.4093017578125
      ],
      "page_num": 24,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "/",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        89.87591552734375,
        392.36724853515625,
        526.4012451171875,
        415.4093017578125
      ],
      "page_num": 24,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ",",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        89.87591552734375,
        392.36724853515625,
        526.4012451171875,
        415.4093017578125
      ],
      "page_num": 24,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "지침/169",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        89.87591552734375,
        392.36724853515625,
        526.4012451171875,
        415.4093017578125
      ],
      "page_num": 24,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "세포치료제의",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        77.99665069580078,
        432.3281555175781,
        526.4010009765625,
        468.3271484375
      ],
      "page_num": 24,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "안전성 유효성 및 품질",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        77.99665069580078,
        432.3281555175781,
        526.4010009765625,
        468.3271484375
      ],
      "page_num": 24,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "․",
      "font_size": 9.960000038146973,
      "font_name": "TTA184C656tCID32K",
      "bbox": [
        77.99665069580078,
        432.3281555175781,
        526.4010009765625,
        468.3271484375
      ],
      "page_num": 24,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "평가 2006",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        77.99665069580078,
        432.3281555175781,
        526.4010009765625,
        468.3271484375
      ],
      "page_num": 24,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2006",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        77.99665069580078,
        432.3281555175781,
        526.4010009765625,
        468.3271484375
      ],
      "page_num": 24,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "11-1470000-001146-01",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        77.99665069580078,
        432.3281555175781,
        526.4010009765625,
        468.3271484375
      ],
      "page_num": 24,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(생물의약품평가자료집",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        77.99665069580078,
        432.3281555175781,
        526.4010009765625,
        468.3271484375
      ],
      "page_num": 24,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "37)",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        77.99665069580078,
        432.3281555175781,
        526.4010009765625,
        468.3271484375
      ],
      "page_num": 24,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "세포조직공학제제팀 자료실 간행물",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        77.99665069580078,
        432.3281555175781,
        526.4010009765625,
        468.3271484375
      ],
      "page_num": 24,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "/",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        77.99665069580078,
        432.3281555175781,
        526.4010009765625,
        468.3271484375
      ],
      "page_num": 24,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ",",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        77.99665069580078,
        432.3281555175781,
        526.4010009765625,
        468.3271484375
      ],
      "page_num": 24,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "지침/148",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        77.99665069580078,
        432.3281555175781,
        526.4010009765625,
        468.3271484375
      ],
      "page_num": 24,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "세포치료제 안전성 유효성",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.43731689453125,
        485.3671569824219,
        526.4002685546875,
        521.3700561523438
      ],
      "page_num": 24,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "․",
      "font_size": 9.960000038146973,
      "font_name": "TTA184C656tCID32K",
      "bbox": [
        70.43731689453125,
        485.3671569824219,
        526.4002685546875,
        521.3700561523438
      ],
      "page_num": 24,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "및 품질 평가시 고려사항",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.43731689453125,
        485.3671569824219,
        526.4002685546875,
        521.3700561523438
      ],
      "page_num": 24,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2006",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.43731689453125,
        485.3671569824219,
        526.4002685546875,
        521.3700561523438
      ],
      "page_num": 24,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2006",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.43731689453125,
        485.3671569824219,
        526.4002685546875,
        521.3700561523438
      ],
      "page_num": 24,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "11-1470000-001145-01",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.43731689453125,
        485.3671569824219,
        526.4002685546875,
        521.3700561523438
      ],
      "page_num": 24,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(생물의약품평가자료집",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.43731689453125,
        485.3671569824219,
        526.4002685546875,
        521.3700561523438
      ],
      "page_num": 24,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "36)",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.43731689453125,
        485.3671569824219,
        526.4002685546875,
        521.3700561523438
      ],
      "page_num": 24,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "세포조직공학제제팀 자료실 간행물",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.43731689453125,
        485.3671569824219,
        526.4002685546875,
        521.3700561523438
      ],
      "page_num": 24,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "/",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.43731689453125,
        485.3671569824219,
        526.4002685546875,
        521.3700561523438
      ],
      "page_num": 24,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.43731689453125,
        485.3671569824219,
        526.4002685546875,
        521.3700561523438
      ],
      "page_num": 24,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "지침/147",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.43731689453125,
        485.3671569824219,
        526.4002685546875,
        521.3700561523438
      ],
      "page_num": 24,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "세포조직공학제제",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.4762191772461,
        551.3671264648438,
        188.15496826171875,
        600.3269653320312
      ],
      "page_num": 24,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(세포치료제",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.4762191772461,
        551.3671264648438,
        188.15496826171875,
        600.3269653320312
      ],
      "page_num": 24,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.4762191772461,
        551.3671264648438,
        188.15496826171875,
        600.3269653320312
      ],
      "page_num": 24,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "조직공학제제,",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.4762191772461,
        551.3671264648438,
        188.15496826171875,
        600.3269653320312
      ],
      "page_num": 24,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "이종이식제제",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.4762191772461,
        551.3671264648438,
        188.15496826171875,
        600.3269653320312
      ],
      "page_num": 24,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "가이드라인",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.4762191772461,
        551.3671264648438,
        188.15496826171875,
        600.3269653320312
      ],
      "page_num": 24,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ")",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.4762191772461,
        551.3671264648438,
        188.15496826171875,
        600.3269653320312
      ],
      "page_num": 24,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2006",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        195.95672607421875,
        564.3279418945312,
        352.08935546875,
        587.2488403320312
      ],
      "page_num": 24,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "11-1470000-001144-01",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        195.95672607421875,
        564.3279418945312,
        352.08935546875,
        587.2488403320312
      ],
      "page_num": 24,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(생물의약품평가자료집",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        195.95672607421875,
        564.3279418945312,
        352.08935546875,
        587.2488403320312
      ],
      "page_num": 24,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "35)",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        195.95672607421875,
        564.3279418945312,
        352.08935546875,
        587.2488403320312
      ],
      "page_num": 24,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "세포조직공학제제팀",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        361.4368896484375,
        538.2888793945312,
        451.4359436035156,
        613.2877197265625
      ],
      "page_num": 24,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "세균백신팀",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        361.4368896484375,
        538.2888793945312,
        451.4359436035156,
        613.2877197265625
      ],
      "page_num": 24,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "바이러스백신팀",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        361.4368896484375,
        538.2888793945312,
        451.4359436035156,
        613.2877197265625
      ],
      "page_num": 24,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "혈액제제팀",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        361.4368896484375,
        538.2888793945312,
        451.4359436035156,
        613.2877197265625
      ],
      "page_num": 24,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "재조합의약품팀",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        361.4368896484375,
        538.2888793945312,
        451.4359436035156,
        613.2877197265625
      ],
      "page_num": 24,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "유전자치료제팀",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        361.4368896484375,
        538.2888793945312,
        451.4359436035156,
        613.2877197265625
      ],
      "page_num": 24,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "자료실 간행물",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        458.99554443359375,
        564.3277587890625,
        526.4002685546875,
        587.2485961914062
      ],
      "page_num": 24,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "/",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        458.99554443359375,
        564.3277587890625,
        526.4002685546875,
        587.2485961914062
      ],
      "page_num": 24,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ",",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        458.99554443359375,
        564.3277587890625,
        526.4002685546875,
        587.2485961914062
      ],
      "page_num": 24,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "지침/146",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        458.99554443359375,
        564.3277587890625,
        526.4002685546875,
        587.2485961914062
      ],
      "page_num": 24,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "생물 생명공학의약품의",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.35494232177734,
        630.3276977539062,
        526.4000244140625,
        653.2485961914062
      ],
      "page_num": 24,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "․",
      "font_size": 9.960000038146973,
      "font_name": "TTA184C656tCID32K",
      "bbox": [
        72.35494232177734,
        630.3276977539062,
        526.4000244140625,
        653.2485961914062
      ],
      "page_num": 24,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "독성평가 사례분석 2006",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.35494232177734,
        630.3276977539062,
        526.4000244140625,
        653.2485961914062
      ],
      "page_num": 24,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2006",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.35494232177734,
        630.3276977539062,
        526.4000244140625,
        653.2485961914062
      ],
      "page_num": 24,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "11-1470000-001143-01",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.35494232177734,
        630.3276977539062,
        526.4000244140625,
        653.2485961914062
      ],
      "page_num": 24,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(생물의약품평가자료집",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.35494232177734,
        630.3276977539062,
        526.4000244140625,
        653.2485961914062
      ],
      "page_num": 24,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "34)",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.35494232177734,
        630.3276977539062,
        526.4000244140625,
        653.2485961914062
      ],
      "page_num": 24,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "세포조직공학제제팀 자료실 간행물",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.35494232177734,
        630.3276977539062,
        526.4000244140625,
        653.2485961914062
      ],
      "page_num": 24,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "/",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.35494232177734,
        630.3276977539062,
        526.4000244140625,
        653.2485961914062
      ],
      "page_num": 24,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.35494232177734,
        630.3276977539062,
        526.4000244140625,
        653.2485961914062
      ],
      "page_num": 24,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "지침/145",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.35494232177734,
        630.3276977539062,
        526.4000244140625,
        653.2485961914062
      ],
      "page_num": 24,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "만성 피부 궤양 및 화상",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        73.79629516601562,
        670.2886352539062,
        183.8344268798828,
        719.2484741210938
      ],
      "page_num": 24,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "치료제 개발을 위한",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        73.79629516601562,
        670.2886352539062,
        183.8344268798828,
        719.2484741210938
      ],
      "page_num": 24,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "전임상 및",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        73.79629516601562,
        670.2886352539062,
        183.8344268798828,
        719.2484741210938
      ],
      "page_num": 24,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "임상 관련",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        73.79629516601562,
        670.2886352539062,
        183.8344268798828,
        719.2484741210938
      ],
      "page_num": 24,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "고려사항",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        73.79629516601562,
        670.2886352539062,
        183.8344268798828,
        719.2484741210938
      ],
      "page_num": 24,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2006",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        195.95643615722656,
        683.2494506835938,
        526.39990234375,
        706.1664428710938
      ],
      "page_num": 24,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "11-1470000-001228-01",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        195.95643615722656,
        683.2494506835938,
        526.39990234375,
        706.1664428710938
      ],
      "page_num": 24,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(생물의약품평가자료집",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        195.95643615722656,
        683.2494506835938,
        526.39990234375,
        706.1664428710938
      ],
      "page_num": 24,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "33)",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        195.95643615722656,
        683.2494506835938,
        526.39990234375,
        706.1664428710938
      ],
      "page_num": 24,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "세포조직공학제제팀 자료실 간행물",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        195.95643615722656,
        683.2494506835938,
        526.39990234375,
        706.1664428710938
      ],
      "page_num": 24,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "/",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        195.95643615722656,
        683.2494506835938,
        526.39990234375,
        706.1664428710938
      ],
      "page_num": 24,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        195.95643615722656,
        683.2494506835938,
        526.39990234375,
        706.1664428710938
      ],
      "page_num": 24,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "지침/144",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        195.95643615722656,
        683.2494506835938,
        526.39990234375,
        706.1664428710938
      ],
      "page_num": 24,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 17 -",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        280.5589904785156,
        789.4503784179688,
        314.6234130859375,
        799.4103393554688
      ],
      "page_num": 25,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "행정간행물 제목",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        91.32029724121094,
        104.84835815429688,
        515.1589965820312,
        127.76924133300781
      ],
      "page_num": 25,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "발행",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        91.32029724121094,
        104.84835815429688,
        515.1589965820312,
        127.76924133300781
      ],
      "page_num": 25,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "연도",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        91.32029724121094,
        104.84835815429688,
        515.1589965820312,
        127.76924133300781
      ],
      "page_num": 25,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "행정간행물 번호",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        91.32029724121094,
        104.84835815429688,
        515.1589965820312,
        127.76924133300781
      ],
      "page_num": 25,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "발행과",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        91.32029724121094,
        104.84835815429688,
        515.1589965820312,
        127.76924133300781
      ],
      "page_num": 25,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "홈페이지",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        91.32029724121094,
        104.84835815429688,
        515.1589965820312,
        127.76924133300781
      ],
      "page_num": 25,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "게재 상태",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        91.32029724121094,
        104.84835815429688,
        515.1589965820312,
        127.76924133300781
      ],
      "page_num": 25,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "미국 약전 세포치료제,",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.83905792236328,
        140.61001586914062,
        184.79905700683594,
        202.5307159423828
      ],
      "page_num": 25,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "유전자치료제 및",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.83905792236328,
        140.61001586914062,
        184.79905700683594,
        202.5307159423828
      ],
      "page_num": 25,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "조직공학제제의 보조물질",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.83905792236328,
        140.61001586914062,
        184.79905700683594,
        202.5307159423828
      ],
      "page_num": 25,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(ancillary product)",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.83905792236328,
        140.61001586914062,
        184.79905700683594,
        202.5307159423828
      ],
      "page_num": 25,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "평가자료집",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.83905792236328,
        140.61001586914062,
        184.79905700683594,
        202.5307159423828
      ],
      "page_num": 25,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2006",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        195.96026611328125,
        160.05117797851562,
        526.4037475585938,
        182.96815490722656
      ],
      "page_num": 25,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "11-1470000-001109-01",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        195.96026611328125,
        160.05117797851562,
        526.4037475585938,
        182.96815490722656
      ],
      "page_num": 25,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(생물의약품평가자료집",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        195.96026611328125,
        160.05117797851562,
        526.4037475585938,
        182.96815490722656
      ],
      "page_num": 25,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "32)",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        195.96026611328125,
        160.05117797851562,
        526.4037475585938,
        182.96815490722656
      ],
      "page_num": 25,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "세포조직공학제제팀",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        195.96026611328125,
        160.05117797851562,
        526.4037475585938,
        182.96815490722656
      ],
      "page_num": 25,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "유전자치료제팀",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        195.96026611328125,
        160.05117797851562,
        526.4037475585938,
        182.96815490722656
      ],
      "page_num": 25,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "자료실 간행물",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        195.96026611328125,
        160.05117797851562,
        526.4037475585938,
        182.96815490722656
      ],
      "page_num": 25,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "/",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        195.96026611328125,
        160.05117797851562,
        526.4037475585938,
        182.96815490722656
      ],
      "page_num": 25,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        195.96026611328125,
        160.05117797851562,
        526.4037475585938,
        182.96815490722656
      ],
      "page_num": 25,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "지침/143",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        195.96026611328125,
        160.05117797851562,
        526.4037475585938,
        182.96815490722656
      ],
      "page_num": 25,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "미국 약전 세포치료제 및",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.3580322265625,
        219.57058715820312,
        526.403076171875,
        242.4876251220703
      ],
      "page_num": 25,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "유전자치료제",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.3580322265625,
        219.57058715820312,
        526.403076171875,
        242.4876251220703
      ],
      "page_num": 25,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2006",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.3580322265625,
        219.57058715820312,
        526.403076171875,
        242.4876251220703
      ],
      "page_num": 25,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "11-1470000-001108-01",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.3580322265625,
        219.57058715820312,
        526.403076171875,
        242.4876251220703
      ],
      "page_num": 25,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(생물의약품평가자료집",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.3580322265625,
        219.57058715820312,
        526.403076171875,
        242.4876251220703
      ],
      "page_num": 25,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "31)",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.3580322265625,
        219.57058715820312,
        526.403076171875,
        242.4876251220703
      ],
      "page_num": 25,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "세포조직공학제제팀",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.3580322265625,
        219.57058715820312,
        526.403076171875,
        242.4876251220703
      ],
      "page_num": 25,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "유전자치료제팀",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.3580322265625,
        219.57058715820312,
        526.403076171875,
        242.4876251220703
      ],
      "page_num": 25,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "자료실 간행물",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.3580322265625,
        219.57058715820312,
        526.403076171875,
        242.4876251220703
      ],
      "page_num": 25,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "/",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.3580322265625,
        219.57058715820312,
        526.403076171875,
        242.4876251220703
      ],
      "page_num": 25,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.3580322265625,
        219.57058715820312,
        526.403076171875,
        242.4876251220703
      ],
      "page_num": 25,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "지침 142",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.3580322265625,
        219.57058715820312,
        526.403076171875,
        242.4876251220703
      ],
      "page_num": 25,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "백신의 안전성 유효성",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.51797485351562,
        259.5274963378906,
        526.4027709960938,
        282.44842529296875
      ],
      "page_num": 25,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "․",
      "font_size": 9.960000038146973,
      "font_name": "TTA184C656tCID32K",
      "bbox": [
        80.51797485351562,
        259.5274963378906,
        526.4027709960938,
        282.44842529296875
      ],
      "page_num": 25,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "평가 2006",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.51797485351562,
        259.5274963378906,
        526.4027709960938,
        282.44842529296875
      ],
      "page_num": 25,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2006",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.51797485351562,
        259.5274963378906,
        526.4027709960938,
        282.44842529296875
      ],
      "page_num": 25,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "11-1470000-001125-01",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.51797485351562,
        259.5274963378906,
        526.4027709960938,
        282.44842529296875
      ],
      "page_num": 25,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(생물의약품평가자료집",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.51797485351562,
        259.5274963378906,
        526.4027709960938,
        282.44842529296875
      ],
      "page_num": 25,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "30)",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.51797485351562,
        259.5274963378906,
        526.4027709960938,
        282.44842529296875
      ],
      "page_num": 25,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "세균백신팀",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.51797485351562,
        259.5274963378906,
        526.4027709960938,
        282.44842529296875
      ],
      "page_num": 25,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "바이러스백신팀",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.51797485351562,
        259.5274963378906,
        526.4027709960938,
        282.44842529296875
      ],
      "page_num": 25,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "자료실 간행물",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.51797485351562,
        259.5274963378906,
        526.4027709960938,
        282.44842529296875
      ],
      "page_num": 25,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "/",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.51797485351562,
        259.5274963378906,
        526.4027709960938,
        282.44842529296875
      ],
      "page_num": 25,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.51797485351562,
        259.5274963378906,
        526.4027709960938,
        282.44842529296875
      ],
      "page_num": 25,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "지침/141",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.51797485351562,
        259.5274963378906,
        526.4027709960938,
        282.44842529296875
      ],
      "page_num": 25,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "인플루엔자 백신",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.31808471679688,
        299.4883728027344,
        526.4020385742188,
        335.4873352050781
      ],
      "page_num": 25,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "자가 기준 및 시험방법",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.31808471679688,
        299.4883728027344,
        526.4020385742188,
        335.4873352050781
      ],
      "page_num": 25,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "작성 지침",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.31808471679688,
        299.4883728027344,
        526.4020385742188,
        335.4873352050781
      ],
      "page_num": 25,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2006",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.31808471679688,
        299.4883728027344,
        526.4020385742188,
        335.4873352050781
      ],
      "page_num": 25,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "11-1470000-001114-01",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.31808471679688,
        299.4883728027344,
        526.4020385742188,
        335.4873352050781
      ],
      "page_num": 25,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(생물의약품평가자료집",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.31808471679688,
        299.4883728027344,
        526.4020385742188,
        335.4873352050781
      ],
      "page_num": 25,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "29)",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.31808471679688,
        299.4883728027344,
        526.4020385742188,
        335.4873352050781
      ],
      "page_num": 25,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "바이러스백신팀",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.31808471679688,
        299.4883728027344,
        526.4020385742188,
        335.4873352050781
      ],
      "page_num": 25,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "자료실 간행물",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.31808471679688,
        299.4883728027344,
        526.4020385742188,
        335.4873352050781
      ],
      "page_num": 25,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "/",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.31808471679688,
        299.4883728027344,
        526.4020385742188,
        335.4873352050781
      ],
      "page_num": 25,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.31808471679688,
        299.4883728027344,
        526.4020385742188,
        335.4873352050781
      ],
      "page_num": 25,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "지침/138",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.31808471679688,
        299.4883728027344,
        526.4020385742188,
        335.4873352050781
      ],
      "page_num": 25,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "생명공학의약품 허가를",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.31735229492188,
        352.4100646972656,
        526.4013061523438,
        375.44818115234375
      ],
      "page_num": 25,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "위한 Q&A",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.31735229492188,
        352.4100646972656,
        526.4013061523438,
        375.44818115234375
      ],
      "page_num": 25,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2006",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.31735229492188,
        352.4100646972656,
        526.4013061523438,
        375.44818115234375
      ],
      "page_num": 25,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "11-1470000-000895-01",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.31735229492188,
        352.4100646972656,
        526.4013061523438,
        375.44818115234375
      ],
      "page_num": 25,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(생물의약품평가자료집",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.31735229492188,
        352.4100646972656,
        526.4013061523438,
        375.44818115234375
      ],
      "page_num": 25,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "28)",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.31735229492188,
        352.4100646972656,
        526.4013061523438,
        375.44818115234375
      ],
      "page_num": 25,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "재조합의약품팀",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.31735229492188,
        352.4100646972656,
        526.4013061523438,
        375.44818115234375
      ],
      "page_num": 25,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "생명공학의약품과",
      "font_size": 8.039999961853027,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.31735229492188,
        352.4100646972656,
        526.4013061523438,
        375.44818115234375
      ],
      "page_num": 25,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(",
      "font_size": 8.039999961853027,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.31735229492188,
        352.4100646972656,
        526.4013061523438,
        375.44818115234375
      ],
      "page_num": 25,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ")",
      "font_size": 8.039999961853027,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.31735229492188,
        352.4100646972656,
        526.4013061523438,
        375.44818115234375
      ],
      "page_num": 25,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "舊",
      "font_size": 8.039999961853027,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.31735229492188,
        352.4100646972656,
        526.4013061523438,
        375.44818115234375
      ],
      "page_num": 25,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "자료실 간행물",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.31735229492188,
        352.4100646972656,
        526.4013061523438,
        375.44818115234375
      ],
      "page_num": 25,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "/",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.31735229492188,
        352.4100646972656,
        526.4013061523438,
        375.44818115234375
      ],
      "page_num": 25,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ",",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.31735229492188,
        352.4100646972656,
        526.4013061523438,
        375.44818115234375
      ],
      "page_num": 25,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "지침127",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.31735229492188,
        352.4100646972656,
        526.4013061523438,
        375.44818115234375
      ],
      "page_num": 25,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "생명공학의약품 길라잡이",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.39471435546875,
        392.3670959472656,
        526.4010620117188,
        415.4090881347656
      ],
      "page_num": 25,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2005",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.39471435546875,
        392.3670959472656,
        526.4010620117188,
        415.4090881347656
      ],
      "page_num": 25,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "11-1470000-000893-01",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.39471435546875,
        392.3670959472656,
        526.4010620117188,
        415.4090881347656
      ],
      "page_num": 25,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(생물의약품평가자료집",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.39471435546875,
        392.3670959472656,
        526.4010620117188,
        415.4090881347656
      ],
      "page_num": 25,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "27)",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.39471435546875,
        392.3670959472656,
        526.4010620117188,
        415.4090881347656
      ],
      "page_num": 25,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "재조합의약품팀",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.39471435546875,
        392.3670959472656,
        526.4010620117188,
        415.4090881347656
      ],
      "page_num": 25,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "생명공학의약품과",
      "font_size": 8.039999961853027,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.39471435546875,
        392.3670959472656,
        526.4010620117188,
        415.4090881347656
      ],
      "page_num": 25,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(",
      "font_size": 8.039999961853027,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.39471435546875,
        392.3670959472656,
        526.4010620117188,
        415.4090881347656
      ],
      "page_num": 25,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ")",
      "font_size": 8.039999961853027,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.39471435546875,
        392.3670959472656,
        526.4010620117188,
        415.4090881347656
      ],
      "page_num": 25,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "舊",
      "font_size": 8.039999961853027,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.39471435546875,
        392.3670959472656,
        526.4010620117188,
        415.4090881347656
      ],
      "page_num": 25,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "자료실 간행물",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.39471435546875,
        392.3670959472656,
        526.4010620117188,
        415.4090881347656
      ],
      "page_num": 25,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "/",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.39471435546875,
        392.3670959472656,
        526.4010620117188,
        415.4090881347656
      ],
      "page_num": 25,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.39471435546875,
        392.3670959472656,
        526.4010620117188,
        415.4090881347656
      ],
      "page_num": 25,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "지침/109",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.39471435546875,
        392.3670959472656,
        526.4010620117188,
        415.4090881347656
      ],
      "page_num": 25,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "KFDA Bio Handbook",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        79.31637573242188,
        432.3280334472656,
        526.4008178710938,
        455.3700256347656
      ],
      "page_num": 25,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2005",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        79.31637573242188,
        432.3280334472656,
        526.4008178710938,
        455.3700256347656
      ],
      "page_num": 25,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "11-1470000-000873-01",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        79.31637573242188,
        432.3280334472656,
        526.4008178710938,
        455.3700256347656
      ],
      "page_num": 25,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(생물의약품평가자료집",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        79.31637573242188,
        432.3280334472656,
        526.4008178710938,
        455.3700256347656
      ],
      "page_num": 25,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "26)",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        79.31637573242188,
        432.3280334472656,
        526.4008178710938,
        455.3700256347656
      ],
      "page_num": 25,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "생명공학의약품과",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        79.31637573242188,
        432.3280334472656,
        526.4008178710938,
        455.3700256347656
      ],
      "page_num": 25,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "생물의약품평가과",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        79.31637573242188,
        432.3280334472656,
        526.4008178710938,
        455.3700256347656
      ],
      "page_num": 25,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "자료실 간행물",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        79.31637573242188,
        432.3280334472656,
        526.4008178710938,
        455.3700256347656
      ],
      "page_num": 25,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "/",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        79.31637573242188,
        432.3280334472656,
        526.4008178710938,
        455.3700256347656
      ],
      "page_num": 25,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ",",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        79.31637573242188,
        432.3280334472656,
        526.4008178710938,
        455.3700256347656
      ],
      "page_num": 25,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "지침/91",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        79.31637573242188,
        432.3280334472656,
        526.4008178710938,
        455.3700256347656
      ],
      "page_num": 25,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "생명공학의약품의",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        79.91812133789062,
        472.4100341796875,
        177.8228302001953,
        521.3699340820312
      ],
      "page_num": 25,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "안전성 유효성 평가 -",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        79.91812133789062,
        472.4100341796875,
        177.8228302001953,
        521.3699340820312
      ],
      "page_num": 25,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "․",
      "font_size": 9.960000038146973,
      "font_name": "TTA184C656tCID32K",
      "bbox": [
        79.91812133789062,
        472.4100341796875,
        177.8228302001953,
        521.3699340820312
      ],
      "page_num": 25,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "비교동등성 평가시",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        79.91812133789062,
        472.4100341796875,
        177.8228302001953,
        521.3699340820312
      ],
      "page_num": 25,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "고려사항",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        79.91812133789062,
        472.4100341796875,
        177.8228302001953,
        521.3699340820312
      ],
      "page_num": 25,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2005",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        195.95721435546875,
        485.366943359375,
        526.4005737304688,
        508.2878723144531
      ],
      "page_num": 25,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "11-1470000-000871-01",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        195.95721435546875,
        485.366943359375,
        526.4005737304688,
        508.2878723144531
      ],
      "page_num": 25,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(생물의약품평가자료집",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        195.95721435546875,
        485.366943359375,
        526.4005737304688,
        508.2878723144531
      ],
      "page_num": 25,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "25)",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        195.95721435546875,
        485.366943359375,
        526.4005737304688,
        508.2878723144531
      ],
      "page_num": 25,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "생물의약품평가과",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        195.95721435546875,
        485.366943359375,
        526.4005737304688,
        508.2878723144531
      ],
      "page_num": 25,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "자료실 간행물",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        195.95721435546875,
        485.366943359375,
        526.4005737304688,
        508.2878723144531
      ],
      "page_num": 25,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "/",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        195.95721435546875,
        485.366943359375,
        526.4005737304688,
        508.2878723144531
      ],
      "page_num": 25,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ",",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        195.95721435546875,
        485.366943359375,
        526.4005737304688,
        508.2878723144531
      ],
      "page_num": 25,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "지침/103",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        195.95721435546875,
        485.366943359375,
        526.4005737304688,
        508.2878723144531
      ],
      "page_num": 25,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "유전자치료제의",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        89.87493896484375,
        538.2887573242188,
        526.4002685546875,
        561.3268432617188
      ],
      "page_num": 25,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "안전성평가 2005",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        89.87493896484375,
        538.2887573242188,
        526.4002685546875,
        561.3268432617188
      ],
      "page_num": 25,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2005",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        89.87493896484375,
        538.2887573242188,
        526.4002685546875,
        561.3268432617188
      ],
      "page_num": 25,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "11-1470000-000677-14",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        89.87493896484375,
        538.2887573242188,
        526.4002685546875,
        561.3268432617188
      ],
      "page_num": 25,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(생물의약품평가자료집",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        89.87493896484375,
        538.2887573242188,
        526.4002685546875,
        561.3268432617188
      ],
      "page_num": 25,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "24)",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        89.87493896484375,
        538.2887573242188,
        526.4002685546875,
        561.3268432617188
      ],
      "page_num": 25,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "생물의약품평가과",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        89.87493896484375,
        538.2887573242188,
        526.4002685546875,
        561.3268432617188
      ],
      "page_num": 25,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "자료실 간행물",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        89.87493896484375,
        538.2887573242188,
        526.4002685546875,
        561.3268432617188
      ],
      "page_num": 25,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "/",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        89.87493896484375,
        538.2887573242188,
        526.4002685546875,
        561.3268432617188
      ],
      "page_num": 25,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ",",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        89.87493896484375,
        538.2887573242188,
        526.4002685546875,
        561.3268432617188
      ],
      "page_num": 25,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "지침/104",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        89.87493896484375,
        538.2887573242188,
        526.4002685546875,
        561.3268432617188
      ],
      "page_num": 25,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "백신의 안전성 유효성",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.51556396484375,
        578.2495727539062,
        526.4003295898438,
        601.2876586914062
      ],
      "page_num": 25,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "․",
      "font_size": 9.960000038146973,
      "font_name": "TTA184C656tCID32K",
      "bbox": [
        80.51556396484375,
        578.2495727539062,
        526.4003295898438,
        601.2876586914062
      ],
      "page_num": 25,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "평가 2005",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.51556396484375,
        578.2495727539062,
        526.4003295898438,
        601.2876586914062
      ],
      "page_num": 25,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2005",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.51556396484375,
        578.2495727539062,
        526.4003295898438,
        601.2876586914062
      ],
      "page_num": 25,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "11-1470000-000870-01",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.51556396484375,
        578.2495727539062,
        526.4003295898438,
        601.2876586914062
      ],
      "page_num": 25,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(생물의약품평가자료집",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.51556396484375,
        578.2495727539062,
        526.4003295898438,
        601.2876586914062
      ],
      "page_num": 25,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "23)",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.51556396484375,
        578.2495727539062,
        526.4003295898438,
        601.2876586914062
      ],
      "page_num": 25,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "생물의약품평가과",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.51556396484375,
        578.2495727539062,
        526.4003295898438,
        601.2876586914062
      ],
      "page_num": 25,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "자료실 간행물",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.51556396484375,
        578.2495727539062,
        526.4003295898438,
        601.2876586914062
      ],
      "page_num": 25,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "/",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.51556396484375,
        578.2495727539062,
        526.4003295898438,
        601.2876586914062
      ],
      "page_num": 25,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ",",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.51556396484375,
        578.2495727539062,
        526.4003295898438,
        601.2876586914062
      ],
      "page_num": 25,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "지침/102",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.51556396484375,
        578.2495727539062,
        526.4003295898438,
        601.2876586914062
      ],
      "page_num": 25,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "탄저백신의 안전성 유효성",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.4366455078125,
        618.2064819335938,
        526.3994750976562,
        641.24853515625
      ],
      "page_num": 25,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "․",
      "font_size": 9.960000038146973,
      "font_name": "TTA184C656tCID32K",
      "bbox": [
        70.4366455078125,
        618.2064819335938,
        526.3994750976562,
        641.24853515625
      ],
      "page_num": 25,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "평가 2005",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.4366455078125,
        618.2064819335938,
        526.3994750976562,
        641.24853515625
      ],
      "page_num": 25,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2005",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.4366455078125,
        618.2064819335938,
        526.3994750976562,
        641.24853515625
      ],
      "page_num": 25,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "11-1470000-000867-01",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.4366455078125,
        618.2064819335938,
        526.3994750976562,
        641.24853515625
      ],
      "page_num": 25,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(생물의약품평가자료집",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.4366455078125,
        618.2064819335938,
        526.3994750976562,
        641.24853515625
      ],
      "page_num": 25,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "22)",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.4366455078125,
        618.2064819335938,
        526.3994750976562,
        641.24853515625
      ],
      "page_num": 25,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "생물의약품평가과",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.4366455078125,
        618.2064819335938,
        526.3994750976562,
        641.24853515625
      ],
      "page_num": 25,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "자료실 간행물",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.4366455078125,
        618.2064819335938,
        526.3994750976562,
        641.24853515625
      ],
      "page_num": 25,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "/",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.4366455078125,
        618.2064819335938,
        526.3994750976562,
        641.24853515625
      ],
      "page_num": 25,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.4366455078125,
        618.2064819335938,
        526.3994750976562,
        641.24853515625
      ],
      "page_num": 25,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "지침/99",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.4366455078125,
        618.2064819335938,
        526.3994750976562,
        641.24853515625
      ],
      "page_num": 25,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "인플루엔자백신의",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.51390075683594,
        658.2884521484375,
        526.3986206054688,
        681.2093505859375
      ],
      "page_num": 25,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "안전성 유효성 평가 2005",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.51390075683594,
        658.2884521484375,
        526.3986206054688,
        681.2093505859375
      ],
      "page_num": 25,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "․",
      "font_size": 9.960000038146973,
      "font_name": "TTA184C656tCID32K",
      "bbox": [
        71.51390075683594,
        658.2884521484375,
        526.3986206054688,
        681.2093505859375
      ],
      "page_num": 25,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2005",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.51390075683594,
        658.2884521484375,
        526.3986206054688,
        681.2093505859375
      ],
      "page_num": 25,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "11-1470000-000866-01",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.51390075683594,
        658.2884521484375,
        526.3986206054688,
        681.2093505859375
      ],
      "page_num": 25,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(생물의약품평가자료집",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.51390075683594,
        658.2884521484375,
        526.3986206054688,
        681.2093505859375
      ],
      "page_num": 25,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "21)",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.51390075683594,
        658.2884521484375,
        526.3986206054688,
        681.2093505859375
      ],
      "page_num": 25,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "생물의약품평가과",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.51390075683594,
        658.2884521484375,
        526.3986206054688,
        681.2093505859375
      ],
      "page_num": 25,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "자료실 간행물",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.51390075683594,
        658.2884521484375,
        526.3986206054688,
        681.2093505859375
      ],
      "page_num": 25,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "/",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.51390075683594,
        658.2884521484375,
        526.3986206054688,
        681.2093505859375
      ],
      "page_num": 25,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.51390075683594,
        658.2884521484375,
        526.3986206054688,
        681.2093505859375
      ],
      "page_num": 25,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "지침/98",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.51390075683594,
        658.2884521484375,
        526.3986206054688,
        681.2093505859375
      ],
      "page_num": 25,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "항암 생물의약품의",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        85.435791015625,
        698.249267578125,
        526.3986206054688,
        721.1663208007812
      ],
      "page_num": 25,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "안전성 유효성 평가",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        85.435791015625,
        698.249267578125,
        526.3986206054688,
        721.1663208007812
      ],
      "page_num": 25,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "․",
      "font_size": 9.960000038146973,
      "font_name": "TTA184C656tCID32K",
      "bbox": [
        85.435791015625,
        698.249267578125,
        526.3986206054688,
        721.1663208007812
      ],
      "page_num": 25,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2005",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        85.435791015625,
        698.249267578125,
        526.3986206054688,
        721.1663208007812
      ],
      "page_num": 25,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "11-1470000-000865-01",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        85.435791015625,
        698.249267578125,
        526.3986206054688,
        721.1663208007812
      ],
      "page_num": 25,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(생물의약품평가자료집",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        85.435791015625,
        698.249267578125,
        526.3986206054688,
        721.1663208007812
      ],
      "page_num": 25,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "20)",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        85.435791015625,
        698.249267578125,
        526.3986206054688,
        721.1663208007812
      ],
      "page_num": 25,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "생물의약품평가과",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        85.435791015625,
        698.249267578125,
        526.3986206054688,
        721.1663208007812
      ],
      "page_num": 25,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "자료실 간행물",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        85.435791015625,
        698.249267578125,
        526.3986206054688,
        721.1663208007812
      ],
      "page_num": 25,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "/",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        85.435791015625,
        698.249267578125,
        526.3986206054688,
        721.1663208007812
      ],
      "page_num": 25,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        85.435791015625,
        698.249267578125,
        526.3986206054688,
        721.1663208007812
      ],
      "page_num": 25,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "지침/101",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        85.435791015625,
        698.249267578125,
        526.3986206054688,
        721.1663208007812
      ],
      "page_num": 25,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 18 -",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        280.5589904785156,
        789.4503784179688,
        314.6234130859375,
        799.4103393554688
      ],
      "page_num": 26,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "행정간행물 제목",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        91.32029724121094,
        104.84835815429688,
        515.1589965820312,
        127.76924133300781
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "발행",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        91.32029724121094,
        104.84835815429688,
        515.1589965820312,
        127.76924133300781
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "연도",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        91.32029724121094,
        104.84835815429688,
        515.1589965820312,
        127.76924133300781
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "행정간행물 번호",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        91.32029724121094,
        104.84835815429688,
        515.1589965820312,
        127.76924133300781
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "발행과",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        91.32029724121094,
        104.84835815429688,
        515.1589965820312,
        127.76924133300781
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "홈페이지",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        91.32029724121094,
        104.84835815429688,
        515.1589965820312,
        127.76924133300781
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "게재 상태",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        91.32029724121094,
        104.84835815429688,
        515.1589965820312,
        127.76924133300781
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "우수심사기준",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        98.87893676757812,
        140.61001586914062,
        526.404296875,
        163.5309600830078
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2005",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        98.87893676757812,
        140.61001586914062,
        526.404296875,
        163.5309600830078
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "11-1470000-000684-01",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        98.87893676757812,
        140.61001586914062,
        526.404296875,
        163.5309600830078
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(생물의약품평가자료집",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        98.87893676757812,
        140.61001586914062,
        526.404296875,
        163.5309600830078
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "19)",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        98.87893676757812,
        140.61001586914062,
        526.404296875,
        163.5309600830078
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "생물의약품평가과",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        98.87893676757812,
        140.61001586914062,
        526.404296875,
        163.5309600830078
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "자료실 간행물",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        98.87893676757812,
        140.61001586914062,
        526.404296875,
        163.5309600830078
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "/",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        98.87893676757812,
        140.61001586914062,
        526.404296875,
        163.5309600830078
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        98.87893676757812,
        140.61001586914062,
        526.404296875,
        163.5309600830078
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "지침/100",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        98.87893676757812,
        140.61001586914062,
        526.404296875,
        163.5309600830078
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "사람 세포",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.55859375,
        180.57083129882812,
        526.8721313476562,
        216.44874572753906
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "조직",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.55859375,
        180.57083129882812,
        526.8721313476562,
        216.44874572753906
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "세포 및",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.55859375,
        180.57083129882812,
        526.8721313476562,
        216.44874572753906
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.55859375,
        180.57083129882812,
        526.8721313476562,
        216.44874572753906
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.55859375,
        180.57083129882812,
        526.8721313476562,
        216.44874572753906
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "조직유래제품",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.55859375,
        180.57083129882812,
        526.8721313476562,
        216.44874572753906
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ": 미",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.55859375,
        180.57083129882812,
        526.8721313476562,
        216.44874572753906
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "FDA",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.55859375,
        180.57083129882812,
        526.8721313476562,
        216.44874572753906
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "시설등록 및 등재 규정",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.55859375,
        180.57083129882812,
        526.8721313476562,
        216.44874572753906
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2005",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.55859375,
        180.57083129882812,
        526.8721313476562,
        216.44874572753906
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "11-1470000-000860-01",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.55859375,
        180.57083129882812,
        526.8721313476562,
        216.44874572753906
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(생물의약품평가자료집",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.55859375,
        180.57083129882812,
        526.8721313476562,
        216.44874572753906
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "18)",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.55859375,
        180.57083129882812,
        526.8721313476562,
        216.44874572753906
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "생명공학의약품과",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.55859375,
        180.57083129882812,
        526.8721313476562,
        216.44874572753906
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "인체조직정보",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.55859375,
        180.57083129882812,
        526.8721313476562,
        216.44874572753906
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "방 자료게시판",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.55859375,
        180.57083129882812,
        526.8721313476562,
        216.44874572753906
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "/",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.55859375,
        180.57083129882812,
        526.8721313476562,
        216.44874572753906
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "/",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.55859375,
        180.57083129882812,
        526.8721313476562,
        216.44874572753906
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "4",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.55859375,
        180.57083129882812,
        526.8721313476562,
        216.44874572753906
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "사람 세포",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.00022888183594,
        233.48861694335938,
        526.8720092773438,
        269.4876708984375
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "조직",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.00022888183594,
        233.48861694335938,
        526.8720092773438,
        269.4876708984375
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "세포 및",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.00022888183594,
        233.48861694335938,
        526.8720092773438,
        269.4876708984375
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.00022888183594,
        233.48861694335938,
        526.8720092773438,
        269.4876708984375
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.00022888183594,
        233.48861694335938,
        526.8720092773438,
        269.4876708984375
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "조직유래제품 제조시설의",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.00022888183594,
        233.48861694335938,
        526.8720092773438,
        269.4876708984375
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "미",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.00022888183594,
        233.48861694335938,
        526.8720092773438,
        269.4876708984375
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "FDA 우수조직관리기준",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.00022888183594,
        233.48861694335938,
        526.8720092773438,
        269.4876708984375
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2005",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.00022888183594,
        233.48861694335938,
        526.8720092773438,
        269.4876708984375
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "11-1470000-000859-01",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.00022888183594,
        233.48861694335938,
        526.8720092773438,
        269.4876708984375
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(생물의약품평가자료집",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.00022888183594,
        233.48861694335938,
        526.8720092773438,
        269.4876708984375
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "17)",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.00022888183594,
        233.48861694335938,
        526.8720092773438,
        269.4876708984375
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "생명공학의약품과",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.00022888183594,
        233.48861694335938,
        526.8720092773438,
        269.4876708984375
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "인체조직정보",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.00022888183594,
        233.48861694335938,
        526.8720092773438,
        269.4876708984375
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "방 자료게시판",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.00022888183594,
        233.48861694335938,
        526.8720092773438,
        269.4876708984375
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "/",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.00022888183594,
        233.48861694335938,
        526.8720092773438,
        269.4876708984375
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "/",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.00022888183594,
        233.48861694335938,
        526.8720092773438,
        269.4876708984375
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "5",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.00022888183594,
        233.48861694335938,
        526.8720092773438,
        269.4876708984375
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "세포치료제 및",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        81.3597412109375,
        286.5274963378906,
        526.4050903320312,
        309.448486328125
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "유전자치료제 자료집",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        81.3597412109375,
        286.5274963378906,
        526.4050903320312,
        309.448486328125
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2004",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        81.3597412109375,
        286.5274963378906,
        526.4050903320312,
        309.448486328125
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "11-1470000-000685-01",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        81.3597412109375,
        286.5274963378906,
        526.4050903320312,
        309.448486328125
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(생물의약품평가자료집",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        81.3597412109375,
        286.5274963378906,
        526.4050903320312,
        309.448486328125
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "16)",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        81.3597412109375,
        286.5274963378906,
        526.4050903320312,
        309.448486328125
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "생물의약품평가과",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        81.3597412109375,
        286.5274963378906,
        526.4050903320312,
        309.448486328125
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "자료실 간행물",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        81.3597412109375,
        286.5274963378906,
        526.4050903320312,
        309.448486328125
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "/",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        81.3597412109375,
        286.5274963378906,
        526.4050903320312,
        309.448486328125
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        81.3597412109375,
        286.5274963378906,
        526.4050903320312,
        309.448486328125
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "지침/78",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        81.3597412109375,
        286.5274963378906,
        526.4050903320312,
        309.448486328125
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "치료용",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.92229461669922,
        326.4883728027344,
        186.72213745117188,
        375.4482727050781
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "생명공학의약품등의",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.92229461669922,
        326.4883728027344,
        186.72213745117188,
        375.4482727050781
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2상",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.92229461669922,
        326.4883728027344,
        186.72213745117188,
        375.4482727050781
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "및",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.92229461669922,
        326.4883728027344,
        186.72213745117188,
        375.4482727050781
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3상 임상시험계획승인",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.92229461669922,
        326.4883728027344,
        186.72213745117188,
        375.4482727050781
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "신청시 고려사항",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.92229461669922,
        326.4883728027344,
        186.72213745117188,
        375.4482727050781
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2004",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        195.96173095703125,
        339.4491882324219,
        526.4050903320312,
        362.3701171875
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "11-1470000-000684-01",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        195.96173095703125,
        339.4491882324219,
        526.4050903320312,
        362.3701171875
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(생물의약품평가자료집",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        195.96173095703125,
        339.4491882324219,
        526.4050903320312,
        362.3701171875
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "15)",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        195.96173095703125,
        339.4491882324219,
        526.4050903320312,
        362.3701171875
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "생물의약품평가과",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        195.96173095703125,
        339.4491882324219,
        526.4050903320312,
        362.3701171875
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "자료실 간행물",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        195.96173095703125,
        339.4491882324219,
        526.4050903320312,
        362.3701171875
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "/",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        195.96173095703125,
        339.4491882324219,
        526.4050903320312,
        362.3701171875
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ",",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        195.96173095703125,
        339.4491882324219,
        526.4050903320312,
        362.3701171875
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "지침/84",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        195.96173095703125,
        339.4491882324219,
        526.4050903320312,
        362.3701171875
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "생명공학의약품등의",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        68.8788070678711,
        392.3670959472656,
        526.4041748046875,
        428.3699951171875
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1상",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        68.8788070678711,
        392.3670959472656,
        526.4041748046875,
        428.3699951171875
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "임상시험계획 승인 신청시",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        68.8788070678711,
        392.3670959472656,
        526.4041748046875,
        428.3699951171875
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "고려사항",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        68.8788070678711,
        392.3670959472656,
        526.4041748046875,
        428.3699951171875
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2004",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        68.8788070678711,
        392.3670959472656,
        526.4041748046875,
        428.3699951171875
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "11-1470000-000683-01",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        68.8788070678711,
        392.3670959472656,
        526.4041748046875,
        428.3699951171875
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(생물의약품평가자료집",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        68.8788070678711,
        392.3670959472656,
        526.4041748046875,
        428.3699951171875
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "14)",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        68.8788070678711,
        392.3670959472656,
        526.4041748046875,
        428.3699951171875
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "생물의약품평가과",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        68.8788070678711,
        392.3670959472656,
        526.4041748046875,
        428.3699951171875
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "자료실 간행물",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        68.8788070678711,
        392.3670959472656,
        526.4041748046875,
        428.3699951171875
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "/",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        68.8788070678711,
        392.3670959472656,
        526.4041748046875,
        428.3699951171875
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        68.8788070678711,
        392.3670959472656,
        526.4041748046875,
        428.3699951171875
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "지침/83",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        68.8788070678711,
        392.3670959472656,
        526.4041748046875,
        428.3699951171875
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "생물의약품등의",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        68.87848663330078,
        445.4099426269531,
        526.40380859375,
        468.3269958496094
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "효능입증을 위한 고려사항 2004",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        68.87848663330078,
        445.4099426269531,
        526.40380859375,
        468.3269958496094
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "11-1470000-000682-01",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        68.87848663330078,
        445.4099426269531,
        526.40380859375,
        468.3269958496094
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(생물의약품평가자료집",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        68.87848663330078,
        445.4099426269531,
        526.40380859375,
        468.3269958496094
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "13)",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        68.87848663330078,
        445.4099426269531,
        526.40380859375,
        468.3269958496094
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "생물의약품평가과",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        68.87848663330078,
        445.4099426269531,
        526.40380859375,
        468.3269958496094
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "자료실 간행물",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        68.87848663330078,
        445.4099426269531,
        526.40380859375,
        468.3269958496094
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "/",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        68.87848663330078,
        445.4099426269531,
        526.40380859375,
        468.3269958496094
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        68.87848663330078,
        445.4099426269531,
        526.40380859375,
        468.3269958496094
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "지침/82",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        68.87848663330078,
        445.4099426269531,
        526.40380859375,
        468.3269958496094
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "임상시험의 전반적인",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        81.3580322265625,
        485.36688232421875,
        526.4029541015625,
        508.287841796875
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "고려사항",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        81.3580322265625,
        485.36688232421875,
        526.4029541015625,
        508.287841796875
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2004",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        81.3580322265625,
        485.36688232421875,
        526.4029541015625,
        508.287841796875
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "11-1470000-000681-01",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        81.3580322265625,
        485.36688232421875,
        526.4029541015625,
        508.287841796875
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(생물의약품평가자료집",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        81.3580322265625,
        485.36688232421875,
        526.4029541015625,
        508.287841796875
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "12)",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        81.3580322265625,
        485.36688232421875,
        526.4029541015625,
        508.287841796875
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "생물의약품평가과",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        81.3580322265625,
        485.36688232421875,
        526.4029541015625,
        508.287841796875
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "자료실 간행물",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        81.3580322265625,
        485.36688232421875,
        526.4029541015625,
        508.287841796875
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "/",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        81.3580322265625,
        485.36688232421875,
        526.4029541015625,
        508.287841796875
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ",",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        81.3580322265625,
        485.36688232421875,
        526.4029541015625,
        508.287841796875
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "지침/79",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        81.3580322265625,
        485.36688232421875,
        526.4029541015625,
        508.287841796875
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "생물의약품의 독성평가",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.31817626953125,
        525.3277587890625,
        526.402099609375,
        548.2487182617188
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "사례분석",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.31817626953125,
        525.3277587890625,
        526.402099609375,
        548.2487182617188
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2004",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.31817626953125,
        525.3277587890625,
        526.402099609375,
        548.2487182617188
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "11-1470000-000680-01",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.31817626953125,
        525.3277587890625,
        526.402099609375,
        548.2487182617188
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(생물의약품평가자료집",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.31817626953125,
        525.3277587890625,
        526.402099609375,
        548.2487182617188
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "11)",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.31817626953125,
        525.3277587890625,
        526.402099609375,
        548.2487182617188
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "생물의약품평가과",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.31817626953125,
        525.3277587890625,
        526.402099609375,
        548.2487182617188
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "자료실 간행물",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.31817626953125,
        525.3277587890625,
        526.402099609375,
        548.2487182617188
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "/",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.31817626953125,
        525.3277587890625,
        526.402099609375,
        548.2487182617188
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ",",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.31817626953125,
        525.3277587890625,
        526.402099609375,
        548.2487182617188
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "지침/77",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.31817626953125,
        525.3277587890625,
        526.402099609375,
        548.2487182617188
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "혈액제제의 안전성 유효성",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.43832397460938,
        565.2886352539062,
        526.4011840820312,
        588.2095336914062
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "․",
      "font_size": 9.960000038146973,
      "font_name": "TTA184C656tCID32K",
      "bbox": [
        70.43832397460938,
        565.2886352539062,
        526.4011840820312,
        588.2095336914062
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "평가 2004",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.43832397460938,
        565.2886352539062,
        526.4011840820312,
        588.2095336914062
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2004",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.43832397460938,
        565.2886352539062,
        526.4011840820312,
        588.2095336914062
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "11-1470000-000679-14",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.43832397460938,
        565.2886352539062,
        526.4011840820312,
        588.2095336914062
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(생물의약품평가자료집",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.43832397460938,
        565.2886352539062,
        526.4011840820312,
        588.2095336914062
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "10)",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.43832397460938,
        565.2886352539062,
        526.4011840820312,
        588.2095336914062
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "생물의약품평가과",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.43832397460938,
        565.2886352539062,
        526.4011840820312,
        588.2095336914062
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "자료실 간행물",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.43832397460938,
        565.2886352539062,
        526.4011840820312,
        588.2095336914062
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "/",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.43832397460938,
        565.2886352539062,
        526.4011840820312,
        588.2095336914062
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.43832397460938,
        565.2886352539062,
        526.4011840820312,
        588.2095336914062
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "지침/76",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.43832397460938,
        565.2886352539062,
        526.4011840820312,
        588.2095336914062
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "세포치료제의",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.51599884033203,
        605.24951171875,
        526.400634765625,
        641.2484741210938
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "안전성 유효성 평가시",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.51599884033203,
        605.24951171875,
        526.400634765625,
        641.2484741210938
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "․",
      "font_size": 9.960000038146973,
      "font_name": "TTA184C656tCID32K",
      "bbox": [
        80.51599884033203,
        605.24951171875,
        526.400634765625,
        641.2484741210938
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "고려사항 2004",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.51599884033203,
        605.24951171875,
        526.400634765625,
        641.2484741210938
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2004",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.51599884033203,
        605.24951171875,
        526.400634765625,
        641.2484741210938
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "11-1470000-000678-14",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.51599884033203,
        605.24951171875,
        526.400634765625,
        641.2484741210938
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(생물의약품평가자료집",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.51599884033203,
        605.24951171875,
        526.400634765625,
        641.2484741210938
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "9)",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.51599884033203,
        605.24951171875,
        526.400634765625,
        641.2484741210938
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "생물의약품평가과",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.51599884033203,
        605.24951171875,
        526.400634765625,
        641.2484741210938
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "자료실 간행물",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.51599884033203,
        605.24951171875,
        526.400634765625,
        641.2484741210938
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "/",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.51599884033203,
        605.24951171875,
        526.400634765625,
        641.2484741210938
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.51599884033203,
        605.24951171875,
        526.400634765625,
        641.2484741210938
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "지침/75",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.51599884033203,
        605.24951171875,
        526.400634765625,
        641.2484741210938
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "유전자치료제의",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        89.87490844726562,
        658.2884521484375,
        526.400146484375,
        681.2094116210938
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "안전성평가 2004",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        89.87490844726562,
        658.2884521484375,
        526.400146484375,
        681.2094116210938
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2004",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        89.87490844726562,
        658.2884521484375,
        526.400146484375,
        681.2094116210938
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "11-1470000-000677-14",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        89.87490844726562,
        658.2884521484375,
        526.400146484375,
        681.2094116210938
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(생물의약품평가자료집",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        89.87490844726562,
        658.2884521484375,
        526.400146484375,
        681.2094116210938
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "8)",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        89.87490844726562,
        658.2884521484375,
        526.400146484375,
        681.2094116210938
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "생물의약품평가과",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        89.87490844726562,
        658.2884521484375,
        526.400146484375,
        681.2094116210938
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "자료실 간행물",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        89.87490844726562,
        658.2884521484375,
        526.400146484375,
        681.2094116210938
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "/",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        89.87490844726562,
        658.2884521484375,
        526.400146484375,
        681.2094116210938
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        89.87490844726562,
        658.2884521484375,
        526.400146484375,
        681.2094116210938
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "지침/72",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        89.87490844726562,
        658.2884521484375,
        526.400146484375,
        681.2094116210938
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "생명공학의약품의",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        88.79635620117188,
        698.2493286132812,
        526.3998413085938,
        721.1663208007812
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "안전성평가(4)",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        88.79635620117188,
        698.2493286132812,
        526.3998413085938,
        721.1663208007812
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2004",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        88.79635620117188,
        698.2493286132812,
        526.3998413085938,
        721.1663208007812
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "11-1470000-000676-14",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        88.79635620117188,
        698.2493286132812,
        526.3998413085938,
        721.1663208007812
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(생물의약품평가자료집",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        88.79635620117188,
        698.2493286132812,
        526.3998413085938,
        721.1663208007812
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "7)",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        88.79635620117188,
        698.2493286132812,
        526.3998413085938,
        721.1663208007812
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "생물의약품평가과",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        88.79635620117188,
        698.2493286132812,
        526.3998413085938,
        721.1663208007812
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "자료실 간행물",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        88.79635620117188,
        698.2493286132812,
        526.3998413085938,
        721.1663208007812
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "/",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        88.79635620117188,
        698.2493286132812,
        526.3998413085938,
        721.1663208007812
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        88.79635620117188,
        698.2493286132812,
        526.3998413085938,
        721.1663208007812
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "지침/71",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        88.79635620117188,
        698.2493286132812,
        526.3998413085938,
        721.1663208007812
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 19 -",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        280.5589904785156,
        789.4503784179688,
        314.6234130859375,
        799.4103393554688
      ],
      "page_num": 27,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "행정간행물 제목",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        91.32029724121094,
        104.84835815429688,
        515.1589965820312,
        127.76924133300781
      ],
      "page_num": 27,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "발행",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        91.32029724121094,
        104.84835815429688,
        515.1589965820312,
        127.76924133300781
      ],
      "page_num": 27,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "연도",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        91.32029724121094,
        104.84835815429688,
        515.1589965820312,
        127.76924133300781
      ],
      "page_num": 27,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "행정간행물 번호",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        91.32029724121094,
        104.84835815429688,
        515.1589965820312,
        127.76924133300781
      ],
      "page_num": 27,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "발행과",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        91.32029724121094,
        104.84835815429688,
        515.1589965820312,
        127.76924133300781
      ],
      "page_num": 27,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "홈페이지",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        91.32029724121094,
        104.84835815429688,
        515.1589965820312,
        127.76924133300781
      ],
      "page_num": 27,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "게재 상태",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        91.32029724121094,
        104.84835815429688,
        515.1589965820312,
        127.76924133300781
      ],
      "page_num": 27,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "생명공학의약품의",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        88.80093383789062,
        140.60989379882812,
        526.4044189453125,
        163.53089904785156
      ],
      "page_num": 27,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "안전성평가(3)",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        88.80093383789062,
        140.60989379882812,
        526.4044189453125,
        163.53089904785156
      ],
      "page_num": 27,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2004",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        88.80093383789062,
        140.60989379882812,
        526.4044189453125,
        163.53089904785156
      ],
      "page_num": 27,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "11-1470000-000676-14",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        88.80093383789062,
        140.60989379882812,
        526.4044189453125,
        163.53089904785156
      ],
      "page_num": 27,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(생물의약품평가자료집",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        88.80093383789062,
        140.60989379882812,
        526.4044189453125,
        163.53089904785156
      ],
      "page_num": 27,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "6)",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        88.80093383789062,
        140.60989379882812,
        526.4044189453125,
        163.53089904785156
      ],
      "page_num": 27,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "생물의약품평가과",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        88.80093383789062,
        140.60989379882812,
        526.4044189453125,
        163.53089904785156
      ],
      "page_num": 27,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "자료실 간행물",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        88.80093383789062,
        140.60989379882812,
        526.4044189453125,
        163.53089904785156
      ],
      "page_num": 27,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "/",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        88.80093383789062,
        140.60989379882812,
        526.4044189453125,
        163.53089904785156
      ],
      "page_num": 27,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        88.80093383789062,
        140.60989379882812,
        526.4044189453125,
        163.53089904785156
      ],
      "page_num": 27,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "지침/70",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        88.80093383789062,
        140.60989379882812,
        526.4044189453125,
        163.53089904785156
      ],
      "page_num": 27,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "생명공학의약품의",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        88.80062866210938,
        180.57064819335938,
        526.4041137695312,
        203.4877471923828
      ],
      "page_num": 27,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "안전성평가(2)",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        88.80062866210938,
        180.57064819335938,
        526.4041137695312,
        203.4877471923828
      ],
      "page_num": 27,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2004",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        88.80062866210938,
        180.57064819335938,
        526.4041137695312,
        203.4877471923828
      ],
      "page_num": 27,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "11-1470000-000676-14",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        88.80062866210938,
        180.57064819335938,
        526.4041137695312,
        203.4877471923828
      ],
      "page_num": 27,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(생물의약품평가자료집",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        88.80062866210938,
        180.57064819335938,
        526.4041137695312,
        203.4877471923828
      ],
      "page_num": 27,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "5)",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        88.80062866210938,
        180.57064819335938,
        526.4041137695312,
        203.4877471923828
      ],
      "page_num": 27,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "생물의약품평가과",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        88.80062866210938,
        180.57064819335938,
        526.4041137695312,
        203.4877471923828
      ],
      "page_num": 27,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "자료실 간행물",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        88.80062866210938,
        180.57064819335938,
        526.4041137695312,
        203.4877471923828
      ],
      "page_num": 27,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "/",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        88.80062866210938,
        180.57064819335938,
        526.4041137695312,
        203.4877471923828
      ],
      "page_num": 27,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        88.80062866210938,
        180.57064819335938,
        526.4041137695312,
        203.4877471923828
      ],
      "page_num": 27,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "지침/69",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        88.80062866210938,
        180.57064819335938,
        526.4041137695312,
        203.4877471923828
      ],
      "page_num": 27,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "생명공학의약품의",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        88.80032348632812,
        220.52749633789062,
        526.40380859375,
        243.44850158691406
      ],
      "page_num": 27,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "안전성평가(1)",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        88.80032348632812,
        220.52749633789062,
        526.40380859375,
        243.44850158691406
      ],
      "page_num": 27,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2004",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        88.80032348632812,
        220.52749633789062,
        526.40380859375,
        243.44850158691406
      ],
      "page_num": 27,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "11-1470000-000676-14",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        88.80032348632812,
        220.52749633789062,
        526.40380859375,
        243.44850158691406
      ],
      "page_num": 27,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(생물의약품평가자료집",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        88.80032348632812,
        220.52749633789062,
        526.40380859375,
        243.44850158691406
      ],
      "page_num": 27,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "4)",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        88.80032348632812,
        220.52749633789062,
        526.40380859375,
        243.44850158691406
      ],
      "page_num": 27,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "생물의약품평가과",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        88.80032348632812,
        220.52749633789062,
        526.40380859375,
        243.44850158691406
      ],
      "page_num": 27,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "자료실 간행물",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        88.80032348632812,
        220.52749633789062,
        526.40380859375,
        243.44850158691406
      ],
      "page_num": 27,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "/",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        88.80032348632812,
        220.52749633789062,
        526.40380859375,
        243.44850158691406
      ],
      "page_num": 27,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        88.80032348632812,
        220.52749633789062,
        526.40380859375,
        243.44850158691406
      ],
      "page_num": 27,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "지침/68",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        88.80032348632812,
        220.52749633789062,
        526.40380859375,
        243.44850158691406
      ],
      "page_num": 27,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "백신의 안전성평가 2004",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.3580322265625,
        260.4883728027344,
        526.4028930664062,
        283.4093017578125
      ],
      "page_num": 27,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2004",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.3580322265625,
        260.4883728027344,
        526.4028930664062,
        283.4093017578125
      ],
      "page_num": 27,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "11-1470000-000675-14",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.3580322265625,
        260.4883728027344,
        526.4028930664062,
        283.4093017578125
      ],
      "page_num": 27,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(생물의약품평가자료집",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.3580322265625,
        260.4883728027344,
        526.4028930664062,
        283.4093017578125
      ],
      "page_num": 27,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "3)",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.3580322265625,
        260.4883728027344,
        526.4028930664062,
        283.4093017578125
      ],
      "page_num": 27,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "생물의약품평가과",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.3580322265625,
        260.4883728027344,
        526.4028930664062,
        283.4093017578125
      ],
      "page_num": 27,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "자료실 간행물",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.3580322265625,
        260.4883728027344,
        526.4028930664062,
        283.4093017578125
      ],
      "page_num": 27,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "/",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.3580322265625,
        260.4883728027344,
        526.4028930664062,
        283.4093017578125
      ],
      "page_num": 27,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.3580322265625,
        260.4883728027344,
        526.4028930664062,
        283.4093017578125
      ],
      "page_num": 27,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "지침/67",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.3580322265625,
        260.4883728027344,
        526.4028930664062,
        283.4093017578125
      ],
      "page_num": 27,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "진단제제의",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.27931213378906,
        300.4491271972656,
        526.40234375,
        323.3701171875
      ],
      "page_num": 27,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "기준",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.27931213378906,
        300.4491271972656,
        526.40234375,
        323.3701171875
      ],
      "page_num": 27,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "HBsAg",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.27931213378906,
        300.4491271972656,
        526.40234375,
        323.3701171875
      ],
      "page_num": 27,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "‘",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.27931213378906,
        300.4491271972656,
        526.40234375,
        323.3701171875
      ],
      "page_num": 27,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "및 시험방법",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.27931213378906,
        300.4491271972656,
        526.40234375,
        323.3701171875
      ],
      "page_num": 27,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "’ 작성 지침",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.27931213378906,
        300.4491271972656,
        526.40234375,
        323.3701171875
      ],
      "page_num": 27,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2004",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.27931213378906,
        300.4491271972656,
        526.40234375,
        323.3701171875
      ],
      "page_num": 27,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "11-1470000-000143-01",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.27931213378906,
        300.4491271972656,
        526.40234375,
        323.3701171875
      ],
      "page_num": 27,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(생물의약품평가자료집",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.27931213378906,
        300.4491271972656,
        526.40234375,
        323.3701171875
      ],
      "page_num": 27,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2)",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.27931213378906,
        300.4491271972656,
        526.40234375,
        323.3701171875
      ],
      "page_num": 27,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "백신과",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.27931213378906,
        300.4491271972656,
        526.40234375,
        323.3701171875
      ],
      "page_num": 27,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "자료실 간행물",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.27931213378906,
        300.4491271972656,
        526.40234375,
        323.3701171875
      ],
      "page_num": 27,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "/",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.27931213378906,
        300.4491271972656,
        526.40234375,
        323.3701171875
      ],
      "page_num": 27,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.27931213378906,
        300.4491271972656,
        526.40234375,
        323.3701171875
      ],
      "page_num": 27,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "지침/48",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.27931213378906,
        300.4491271972656,
        526.40234375,
        323.3701171875
      ],
      "page_num": 27,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "세포치료제 조직공학제품",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.95852661132812,
        340.40997314453125,
        495.8235778808594,
        363.3269958496094
      ],
      "page_num": 27,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "․",
      "font_size": 9.960000038146973,
      "font_name": "TTA184C656tCID32K",
      "bbox": [
        72.95852661132812,
        340.40997314453125,
        495.8235778808594,
        363.3269958496094
      ],
      "page_num": 27,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "개발동향 및 안전관리",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.95852661132812,
        340.40997314453125,
        495.8235778808594,
        363.3269958496094
      ],
      "page_num": 27,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2003",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.95852661132812,
        340.40997314453125,
        495.8235778808594,
        363.3269958496094
      ],
      "page_num": 27,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "11-1470000-000275-01",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.95852661132812,
        340.40997314453125,
        495.8235778808594,
        363.3269958496094
      ],
      "page_num": 27,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(생물의약품평가자료집",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.95852661132812,
        340.40997314453125,
        495.8235778808594,
        363.3269958496094
      ],
      "page_num": 27,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1)",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.95852661132812,
        340.40997314453125,
        495.8235778808594,
        363.3269958496094
      ],
      "page_num": 27,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "생명공학의약품과",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.95852661132812,
        340.40997314453125,
        495.8235778808594,
        363.3269958496094
      ],
      "page_num": 27,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "생물공학과",
      "font_size": 8.039999961853027,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.95852661132812,
        340.40997314453125,
        495.8235778808594,
        363.3269958496094
      ],
      "page_num": 27,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(",
      "font_size": 8.039999961853027,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.95852661132812,
        340.40997314453125,
        495.8235778808594,
        363.3269958496094
      ],
      "page_num": 27,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ")",
      "font_size": 8.039999961853027,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.95852661132812,
        340.40997314453125,
        495.8235778808594,
        363.3269958496094
      ],
      "page_num": 27,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "舊",
      "font_size": 8.039999961853027,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.95852661132812,
        340.40997314453125,
        495.8235778808594,
        363.3269958496094
      ],
      "page_num": 27,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "-",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.95852661132812,
        340.40997314453125,
        495.8235778808594,
        363.3269958496094
      ],
      "page_num": 27,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "편 집 위 원 장",
      "font_size": 12.0,
      "font_name": "TT6B7C195EtCID",
      "bbox": [
        106.31999969482422,
        198.01922607421875,
        266.3980712890625,
        210.01922607421875
      ],
      "page_num": 28,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "김 승 희",
      "font_size": 12.0,
      "font_name": "TT6B7C195EtCID",
      "bbox": [
        106.31999969482422,
        198.01922607421875,
        266.3980712890625,
        210.01922607421875
      ],
      "page_num": 28,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ":",
      "font_size": 12.0,
      "font_name": "TT6B7C195EtCID",
      "bbox": [
        106.31999969482422,
        198.01922607421875,
        266.3980712890625,
        210.01922607421875
      ],
      "page_num": 28,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "편",
      "font_size": 12.0,
      "font_name": "TT6B7C195EtCID",
      "bbox": [
        106.32000732421875,
        241.21844482421875,
        394.4639587402344,
        253.21844482421875
      ],
      "page_num": 28,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "집",
      "font_size": 12.0,
      "font_name": "TT6B7C195EtCID",
      "bbox": [
        106.32000732421875,
        241.21844482421875,
        394.4639587402344,
        253.21844482421875
      ],
      "page_num": 28,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "위",
      "font_size": 12.0,
      "font_name": "TT6B7C195EtCID",
      "bbox": [
        106.32000732421875,
        241.21844482421875,
        394.4639587402344,
        253.21844482421875
      ],
      "page_num": 28,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "원",
      "font_size": 12.0,
      "font_name": "TT6B7C195EtCID",
      "bbox": [
        106.32000732421875,
        241.21844482421875,
        394.4639587402344,
        253.21844482421875
      ],
      "page_num": 28,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "강석연 김순남 오호정",
      "font_size": 12.0,
      "font_name": "TT6B7C195EtCID",
      "bbox": [
        106.32000732421875,
        241.21844482421875,
        394.4639587402344,
        253.21844482421875
      ],
      "page_num": 28,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "조민주",
      "font_size": 12.0,
      "font_name": "TT6B7C195EtCID",
      "bbox": [
        106.32000732421875,
        241.21844482421875,
        394.4639587402344,
        253.21844482421875
      ],
      "page_num": 28,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ":",
      "font_size": 12.0,
      "font_name": "TT6B7C195EtCID",
      "bbox": [
        106.32000732421875,
        241.21844482421875,
        394.4639587402344,
        253.21844482421875
      ],
      "page_num": 28,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ",",
      "font_size": 12.0,
      "font_name": "TT6B7C195EtCID",
      "bbox": [
        106.32000732421875,
        241.21844482421875,
        394.4639587402344,
        253.21844482421875
      ],
      "page_num": 28,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ",",
      "font_size": 12.0,
      "font_name": "TT6B7C195EtCID",
      "bbox": [
        106.32000732421875,
        241.21844482421875,
        394.4639587402344,
        253.21844482421875
      ],
      "page_num": 28,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ",",
      "font_size": 12.0,
      "font_name": "TT6B7C195EtCID",
      "bbox": [
        106.32000732421875,
        241.21844482421875,
        394.4639587402344,
        253.21844482421875
      ],
      "page_num": 28,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ",",
      "font_size": 12.0,
      "font_name": "TT6B7C195EtCID",
      "bbox": [
        106.32000732421875,
        241.21844482421875,
        394.4639587402344,
        253.21844482421875
      ],
      "page_num": 28,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "김판순",
      "font_size": 12.0,
      "font_name": "TT6B7C195EtCID",
      "bbox": [
        220.32000732421875,
        262.820068359375,
        438.483154296875,
        274.820068359375
      ],
      "page_num": 28,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "이내리 김관수 김정환",
      "font_size": 12.0,
      "font_name": "TT6B7C195EtCID",
      "bbox": [
        220.32000732421875,
        262.820068359375,
        438.483154296875,
        274.820068359375
      ],
      "page_num": 28,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "김진아",
      "font_size": 12.0,
      "font_name": "TT6B7C195EtCID",
      "bbox": [
        220.32000732421875,
        262.820068359375,
        438.483154296875,
        274.820068359375
      ],
      "page_num": 28,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ",",
      "font_size": 12.0,
      "font_name": "TT6B7C195EtCID",
      "bbox": [
        220.32000732421875,
        262.820068359375,
        438.483154296875,
        274.820068359375
      ],
      "page_num": 28,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ",",
      "font_size": 12.0,
      "font_name": "TT6B7C195EtCID",
      "bbox": [
        220.32000732421875,
        262.820068359375,
        438.483154296875,
        274.820068359375
      ],
      "page_num": 28,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ",",
      "font_size": 12.0,
      "font_name": "TT6B7C195EtCID",
      "bbox": [
        220.32000732421875,
        262.820068359375,
        438.483154296875,
        274.820068359375
      ],
      "page_num": 28,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ",",
      "font_size": 12.0,
      "font_name": "TT6B7C195EtCID",
      "bbox": [
        220.32000732421875,
        262.820068359375,
        438.483154296875,
        274.820068359375
      ],
      "page_num": 28,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "정맥주사용",
      "font_size": 20.040000915527344,
      "font_name": "TTBB48454EtCID",
      "bbox": [
        85.80079650878906,
        476.1177062988281,
        509.3993225097656,
        522.1968383789062
      ],
      "page_num": 28,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "B형 간염 사람면역글로불린제제의",
      "font_size": 20.040000915527344,
      "font_name": "TTBB48454EtCID",
      "bbox": [
        85.80079650878906,
        476.1177062988281,
        509.3993225097656,
        522.1968383789062
      ],
      "page_num": 28,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "안전성․유효성 평가 가이드라인",
      "font_size": 20.040000915527344,
      "font_name": "TTBB48454EtCID",
      "bbox": [
        85.80079650878906,
        476.1177062988281,
        509.3993225097656,
        522.1968383789062
      ],
      "page_num": 28,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "════════════════════════════════════════════",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        77.640380859375,
        528.3289794921875,
        517.5613403320312,
        538.2889404296875
      ],
      "page_num": 28,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "발",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        106.32008361816406,
        546.2732543945312,
        298.3192443847656,
        559.2332153320312
      ],
      "page_num": 28,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "행",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        106.32008361816406,
        546.2732543945312,
        298.3192443847656,
        559.2332153320312
      ],
      "page_num": 28,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "일",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        106.32008361816406,
        546.2732543945312,
        298.3192443847656,
        559.2332153320312
      ],
      "page_num": 28,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "년",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        106.32008361816406,
        546.2732543945312,
        298.3192443847656,
        559.2332153320312
      ],
      "page_num": 28,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "월",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        106.32008361816406,
        546.2732543945312,
        298.3192443847656,
        559.2332153320312
      ],
      "page_num": 28,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ":",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        106.32008361816406,
        546.2732543945312,
        298.3192443847656,
        559.2332153320312
      ],
      "page_num": 28,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2008",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        106.32008361816406,
        546.2732543945312,
        298.3192443847656,
        559.2332153320312
      ],
      "page_num": 28,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "12",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        106.32008361816406,
        546.2732543945312,
        298.3192443847656,
        559.2332153320312
      ],
      "page_num": 28,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "발",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        106.32008361816406,
        569.6755981445312,
        324.9637451171875,
        582.6355590820312
      ],
      "page_num": 28,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "행",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        106.32008361816406,
        569.6755981445312,
        324.9637451171875,
        582.6355590820312
      ],
      "page_num": 28,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "기",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        106.32008361816406,
        569.6755981445312,
        324.9637451171875,
        582.6355590820312
      ],
      "page_num": 28,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "관",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        106.32008361816406,
        569.6755981445312,
        324.9637451171875,
        582.6355590820312
      ],
      "page_num": 28,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "식품의약품안전청",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        106.32008361816406,
        569.6755981445312,
        324.9637451171875,
        582.6355590820312
      ],
      "page_num": 28,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ":",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        106.32008361816406,
        569.6755981445312,
        324.9637451171875,
        582.6355590820312
      ],
      "page_num": 28,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "발",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        106.32007598876953,
        593.0740356445312,
        370.4442138671875,
        606.0339965820312
      ],
      "page_num": 28,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "행",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        106.32007598876953,
        593.0740356445312,
        370.4442138671875,
        606.0339965820312
      ],
      "page_num": 28,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "부",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        106.32007598876953,
        593.0740356445312,
        370.4442138671875,
        606.0339965820312
      ],
      "page_num": 28,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "서",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        106.32007598876953,
        593.0740356445312,
        370.4442138671875,
        606.0339965820312
      ],
      "page_num": 28,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "생물의약품국 혈액제제과",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        106.32007598876953,
        593.0740356445312,
        370.4442138671875,
        606.0339965820312
      ],
      "page_num": 28,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ":",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        106.32007598876953,
        593.0740356445312,
        370.4442138671875,
        606.0339965820312
      ],
      "page_num": 28,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "════════════════════════════════════════════",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        77.64047241210938,
        616.5281372070312,
        517.5614013671875,
        626.4880981445312
      ],
      "page_num": 28,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "연",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        106.32017517089844,
        634.476318359375,
        396.4796142578125,
        647.436279296875
      ],
      "page_num": 28,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "락",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        106.32017517089844,
        634.476318359375,
        396.4796142578125,
        647.436279296875
      ],
      "page_num": 28,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "처",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        106.32017517089844,
        634.476318359375,
        396.4796142578125,
        647.436279296875
      ],
      "page_num": 28,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "식품의약품안전청 혈액제제과",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        106.32017517089844,
        634.476318359375,
        396.4796142578125,
        647.436279296875
      ],
      "page_num": 28,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ":",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        106.32017517089844,
        634.476318359375,
        396.4796142578125,
        647.436279296875
      ],
      "page_num": 28,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "전",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        106.32017517089844,
        657.8746948242188,
        348.5798034667969,
        670.8346557617188
      ],
      "page_num": 28,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "화",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        106.32017517089844,
        657.8746948242188,
        348.5798034667969,
        670.8346557617188
      ],
      "page_num": 28,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "번",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        106.32017517089844,
        657.8746948242188,
        348.5798034667969,
        670.8346557617188
      ],
      "page_num": 28,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "호 :",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        106.32017517089844,
        657.8746948242188,
        348.5798034667969,
        670.8346557617188
      ],
      "page_num": 28,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "02) 380-1715, 1765",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        106.32017517089844,
        657.8746948242188,
        348.5798034667969,
        670.8346557617188
      ],
      "page_num": 28,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "팩",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        106.3201675415039,
        681.2731323242188,
        307.7862548828125,
        694.2330932617188
      ],
      "page_num": 28,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "스",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        106.3201675415039,
        681.2731323242188,
        307.7862548828125,
        694.2330932617188
      ],
      "page_num": 28,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "번",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        106.3201675415039,
        681.2731323242188,
        307.7862548828125,
        694.2330932617188
      ],
      "page_num": 28,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "호 :",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        106.3201675415039,
        681.2731323242188,
        307.7862548828125,
        694.2330932617188
      ],
      "page_num": 28,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "02) 386-6584",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        106.3201675415039,
        681.2731323242188,
        307.7862548828125,
        694.2330932617188
      ],
      "page_num": 28,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    }
  ],
  "markdown_content": "<!-- PAGE_1 -->\n# Biopharmaceuticals\n\n<!-- PAGE_1 -->\n# Biopharmaceuticals\n\n<!-- PAGE_1 -->\n# 정맥주사용 B형 간염 사람면역글로불린\n\n<!-- PAGE_1 -->\n# 제제의 안전성·유효성 평가 가이드라인\n\n<!-- PAGE_1 -->\n# [민원인 안내서]\n\n<!-- PAGE_1 -->\n# Biopharmaceuticals\n\n<!-- PAGE_1 -->\n# Biopharmaceuticals\n\n- 2008.12.\n제·개정 이력서\n\n<!-- PAGE_2 -->\n###### 연번\n\n<!-- PAGE_2 -->\n###### 제·개정번호\n\n<!-- PAGE_2 -->\n###### 승인일자\n\n<!-- PAGE_2 -->\n###### 주요내용\n\n<!-- PAGE_2 -->\n###### 1\n\n<!-- PAGE_2 -->\n###### B1-2008-3-020\n\n<!-- PAGE_2 -->\n###### 2008.12\n\n<!-- PAGE_2 -->\n###### 제정\n\n<!-- PAGE_2 -->\n###### 2\n\n<!-- PAGE_2 -->\n###### 안내서-0256-01\n\n<!-- PAGE_2 -->\n###### 2017.06.01\n\n<!-- PAGE_2 -->\n###### 「식품의약품안전처 지침서등의 관리에 관한\n\n<!-- PAGE_2 -->\n###### 규정」 개정에 따른 등록번호 일괄 정비\n\n<!-- PAGE_2 -->\n###### 정맥주사용 B형 간염 사람면역글로불린제제의\n\n<!-- PAGE_2 -->\n###### 안전성·유효성 평가 가이드라인(민원인 안내서)\n\n지침‧가이드라인‧해설서 (지침 등) 재분류 점검표\n\n<!-- PAGE_3 -->\n###### 지침 등 명칭\n\n<!-- PAGE_3 -->\n###### 정맥주사용 B형 간염 사람면역글로불린제제의 안전성·유효성 평가 가이드라인(민원인 안내서)\n\n<!-- PAGE_3 -->\n###### 아래에 해당하는 사항에 체크하여 주시기 바랍니다.\n\n**[표 시작]**\n\n| □ 법령(법‧시행령‧시행규칙) 또는 행정규칙(고시‧훈령‧예규) 등을 | □ 예 | ■ 아니오 |\n| --- | --- | --- |\n| 스제와 | HBIG의 병용요법이 이용되고 있다 | . | 편 집 위 원 장 | 김 승 희 | : |\n**및 수술 후의 투여 용량을 신중하게 결정하여야 한다.**\n**나열하는 것입니까?**\n| 세포주로부터 개발한 | 생물공학제제의 | 바이러스안전성 평가 | 가이드 |\n| 269/95 rev. 3), EMEA, 2001 | □ 단순한 사실을 대외적으로 알리는 공고의 내용입니까? | □ 예 | ■ 아니오 |\n| 자인 등을 이용하여 적응증에 대한 용량 반응 관계를 확정하여야 한다 | - | . | 세포조직공학제제팀 | 재조합의약품팀 | 생물의약품안전팀 | 생물의약품관리팀 | 국립독성연구원 | 생명공학지원팀 |\n| 편 | 집 | 위 | 원 | 강석연 김순남 오호정 | 조민주 | : | , | , | , | , |\n| 25, 2007)”을 참고할 수 있다 | . |\n| 이종이식제제의 범위 및 | 원료동물에 대한 가이드 | 2006 | 11-1470000-001087-01 | (생물의약품평가가이드 | 15) | 투여 기간 | 4.3. | □ 일회성 지시 또는 일일 명령에 해당하는 내용입니까? | □ 예 | ■ 아니오 |\n| 정 및 바이러스 불활화 제거 공정을 추가하게 된다 | / | . |\n| 폐지대상 | 김판순 | 이내리 김관수 김정환 | 김진아 | , | , | , | , |\n| -001506-01, 생물의약품평가가이드 | 25), 2007 |\n| 여부 | □ 외국 규정을 번역하거나 설명하는 내용입니까? | □ 예 | ■ 아니오 |\n| 안전성유효성 평가 가이드라인 | ․ |\n**증에 맞는 임상시험을 수행하여야 한다.**\n| □ 정보제공 등 직원 교육용 자료입니까? | □ 예 | ■ 아니오 |\n| 암치료를 위한 수지상 | 세포치료제 평가 시 | 고려사항 | 2005 | 11-1470000-000888-01 | (생물의약품평가가이드 | 14) | 1470000-001176-01, 생물의약품평가가이드 | 20), 2006 | 재조합의약품팀 | 생명공학의약품과 | ( | ) | 舊 | 세포조직공학제제팀 |\n| 치료용 | 생명공학의약품등의 | 2상 | 및 | 3상 임상시험계획승인 | 신청시 고려사항 |\n| 피험자의 선정 | 4.1. |\n| 상기 사항 중 어느 하나라도 ‘예’에 해당되는 경우에 폐지 대상입니다. | 폐지 대상에 해당합니까? | □ 예 | ■ 아니오 |\n| 세포치료제 조직공학제품 | ․ | 개발동향 및 안전관리 | 2003 | 11-1470000-000275-01 | (생물의약품평가자료집 | 1) | 생명공학의약품과 | 생물공학과 | ( | ) | 舊 | - |\n| of Human Hepatitis B Immunoglobulin | □ 내부적으로 행정사무의 통일을 기하기 위하여 반복적으로 행정 | 2008 | □ 예 | ■ 아니오 |\n| 바이오칩 평가가이드 | -DNA칩의 기준 및 | 시험방법 작성지침- | 2005 | 11-1470000-000896-01 | (생물의약품평가가이드 | 13) | 재조합의약품팀 | 생물진단제제팀 | 생물의약품규격과 | ( | ) | 舊 |\n| 식 수술 예정인 자로서 | 간 이식 수술 전에 | 양성인 환자이어야 한다 | , | HBsAg | . |\n**사무의 세부기준이나 절차를 제시하는 것입니까? (지침)**\n| 공정 흐름도를 제출하여야 한다. | 려진 경우에는 독성시험을 수행하지 않아도 된다. |\n**(CPMP/BWP/268/95), EMEA, 1996**\n| □ 대내외적으로 특정한 사안 등에 대하여 식약처의 입장을 기술 | for Intravenous Administration | ■ 예 | □ 아니오 |\n**등을 참고할 수 있다.**\n| 국에서 수행되는 임상시험들은 | 년 이상 | 을 하고 있다 | 2~3 | follow-up | . |\n**하는 것입니까? (가이드라인)**\n| 유전자치료제의 복제가능 | 바이러스 시험법에 관한 | 가이드 | 2005 | 11-1470000-000877-01 | (생물의약품평가가이드 | 12) | 에 의견을 제시하여 주시기 바랍니다. | □ 법령, 고시‧훈령‧예규와 같은 규정 또는 식약처장이 정한 특정한 | 재조합의약품팀 | 생명공학의약품과 | ( | ) | 舊 | 유전자치료제팀 |\n| 등록대상 | 세부정보 | □ 예 | ■ 아니오 |\n| Treatment of Hepatitis B(CHMP/EWP/6172/03), EMEA, 2006 | 사안에 대하여 그 절차 등의 내용을 알기 쉽게 풀어 설명하거나 | 질의‧응답하는 형태입니까? (해설서) |\n**출하여야 한다.**\n| 본 지침서에 대한 의견 및 제안이 있으시면 | 연락주시기 바랍니다. |\n| □ 내부 직원용(위임‧위탁기관 직원 포함)에 해당합니까? | (“예”인 경우, 지침에 해당) | □ 예 | ■ 아니오 |\n**하는데 필요한 정보를 제공하여야 한다.**\n| □ 외부(관련 협회, 민원인 등) 참고용에 해당합니까? | (“예”인 경우, 가이드라인 또는 해설서에 해당) | ■ 예 | □ 아니오 |\n| 의약품의 시험성적서를 제출하고 | , 제품 규격의 일관성을 입증하여야 한다 | . |\n**1), EMEA, 2000**\n\n**[표 끝]**\n\n<!-- PAGE_3 -->\n###### 등록번호\n\n<!-- PAGE_3 -->\n###### B1-2008-3-020\n\n<!-- PAGE_3 -->\n###### 현행분류\n\n<!-- PAGE_3 -->\n###### □ 지침\n\n<!-- PAGE_3 -->\n###### ■ 가이드라인\n\n<!-- PAGE_3 -->\n###### □ 해설서\n\n<!-- PAGE_3 -->\n###### 분류\n\n<!-- PAGE_3 -->\n###### 적정성\n\n<!-- PAGE_3 -->\n###### □ 해당 지침 등의 분류가 적정합니까?\n\n<!-- PAGE_3 -->\n###### ■ 예\n\n<!-- PAGE_3 -->\n###### □ 아니오\n\n<!-- PAGE_3 -->\n###### □ “아니오”인 경우 변경분류 사항에 체크하여 주십시오\n\n<!-- PAGE_3 -->\n###### □ 지침         □ 가이드라인      □ 해설서\n\n<!-- PAGE_3 -->\n###### □ 지침에 해당하는 경우, 예규로 전환이 필요합니까?\n\n*“예규“란 행정사무의 통일을 기하기 위한 것으로 반복적 행정사무의 처리\n\n기준을 제시하는 행정규칙의 형태로, 식약처 전 부서에 해당하는 사항임\n\n<!-- PAGE_3 -->\n###### □ 예\n\n<!-- PAGE_3 -->\n###### □ 아니오\n\n<!-- PAGE_3 -->\n###### 상기 사항에 대하여 확인하였음.\n\n<!-- PAGE_3 -->\n###### 2017년   06월   01일\n\n<!-- PAGE_3 -->\n###### 확  인(부서장)\n\n<!-- PAGE_3 -->\n###### 정 혜 주 (서   명)\n\n<!-- PAGE_4 -->\n###### 이 안내서는 바이오, 생약, 화장품의 허가 관련 질의에 대하여 알기 쉽게\n\n<!-- PAGE_4 -->\n###### 설명하거나 식품의약품안전처의 입장을 기술한 것입니다.\n\n<!-- PAGE_4 -->\n###### 본 안내서는 대외적으로 법적 효력을 가지는 것이 아니므로 본문의 기술\n\n<!-- PAGE_4 -->\n###### 방식(‘∼하여야 한다’ 등)에도 불구하고 민원인 여러분께서 반드시 준수하셔야\n\n<!-- PAGE_4 -->\n###### 하는 사항이 아님을 알려드립니다. 또한, 본 안내서는 2015년 12월 31일 현재의\n\n<!-- PAGE_4 -->\n###### 과학적ㆍ기술적 사실 및 유효한 법규를 토대로 작성되었으므로 이후 최신\n\n<!-- PAGE_4 -->\n###### 개정 법규 내용 및 구체적인 사실관계 등에 따라 달리 적용될 수 있음을 알려드립니다.\n\n<!-- PAGE_4 -->\n###### ※ “민원인 안내서”란 대내외적으로 법령 또는 고시ㆍ훈령ㆍ예규 등을 알기\n\n<!-- PAGE_4 -->\n###### 쉽게 풀어서 설명하거나 특정한 사안에 대하여 식품의약품안전처의 입장을\n\n<!-- PAGE_4 -->\n###### 기술하는 것(식품의약품안전처 지침서등의 관리에 관한 규정 제2조)\n\n<!-- PAGE_4 -->\n###### ※ 본 안내서에 대한 의견이나 문의사항이 있을 경우 식품의약품안전평가원\n\n<!-- PAGE_4 -->\n###### 바이오생약심사부 생물제제과에 문의하시기 바랍니다.\n\n<!-- PAGE_4 -->\n###### 전화번호 : 043-719-3451\n\n<!-- PAGE_4 -->\n###### 팩스번호 : 043-719-3450\n\n<!-- PAGE_5 -->\n## 정맥주사용\n\n<!-- PAGE_5 -->\n## 형 간염 사람면역글로불린제제의\n\n<!-- PAGE_5 -->\n## B\n\n<!-- PAGE_5 -->\n#### Guideline on the Safety and Efficacy Evaluation\n\n<!-- PAGE_5 -->\n#### 2008\n\n<!-- PAGE_5 -->\n###### 생 물 의 약 품 국\n\n<!-- PAGE_5 -->\n###### 행정간행물 등록번호\n\n11-1470000-001752-14\n\n<!-- PAGE_6 -->\n## 정맥주사용\n\n<!-- PAGE_6 -->\n## B형 간염 사람면역글로불린제제의\n\n<!-- PAGE_6 -->\n## 안전성유효성 평가 가이드라인\n\n<!-- PAGE_6 -->\n## ․\n\n<!-- PAGE_6 -->\n#### Guideline on the Safety and Efficacy Evaluation\n\n<!-- PAGE_6 -->\n#### of Human Hepatitis B Immunoglobulin\n\n<!-- PAGE_6 -->\n#### for Intravenous Administration\n\n<!-- PAGE_6 -->\n###### 담당부서\n\n<!-- PAGE_6 -->\n###### 생물의약품국 혈액제제과\n\n<!-- PAGE_6 -->\n###### ：\n\n<!-- PAGE_6 -->\n###### 담 당 자\n\n<!-- PAGE_6 -->\n###### 조민주\n\n<!-- PAGE_6 -->\n###### ：\n\n<!-- PAGE_6 -->\n###### 연 락 처\n\n<!-- PAGE_6 -->\n###### 서울시 은평구 통일로 194\n\n<!-- PAGE_6 -->\n###### ：\n\n<!-- PAGE_6 -->\n###### (전화\n\n<!-- PAGE_6 -->\n###### ) 02-380-1715, 65\n\n<!-- PAGE_6 -->\n###### (FAX) 02-386-6584\n\n<!-- PAGE_6 -->\n###### (E-mail) luck00@kfda.go.kr\n\n<!-- PAGE_6 -->\n###### 생 물 의 약 품 국\n\n<!-- PAGE_7 -->\n###### 본 가이드라인은 현재까지의 경험과 과학적 사실에 근거하여 식품의약\n\n<!-- PAGE_7 -->\n###### 품안전처의 입장을 기술하고 있습니다. 이 가이드라인에 기술된 사항은 법\n\n<!-- PAGE_7 -->\n###### 적 효력이 있는 것은 아니며, 법령이나 행정규칙 등에서 정하고 있는 사항\n\n<!-- PAGE_7 -->\n###### 외에는 식품의약품안전처의 권고사항입니다. 이는 새로운 과학적 근거가\n\n<!-- PAGE_7 -->\n###### 있을 경우 개정될 수 있으므로 이러한 사항이 있을 경우 식품의약품안전처\n\n<!-- PAGE_8 -->\n### 목\n\n<!-- PAGE_8 -->\n### 차\n\n<!-- PAGE_8 -->\n###### Ⅰ. 서론\n\n<!-- PAGE_8 -->\n###### ······························································································································1\n\n<!-- PAGE_8 -->\n###### 구조 물리화학적 성질\n\n<!-- PAGE_8 -->\n###### 제조 및 품질관리\n\n<!-- PAGE_8 -->\n###### .\n\n<!-- PAGE_8 -->\n###### ,\n\n<!-- PAGE_8 -->\n###### Ⅱ\n\n<!-- PAGE_8 -->\n###### ․\n\n<!-- PAGE_8 -->\n###### ····························································2\n\n<!-- PAGE_8 -->\n###### 구조결정\n\n<!-- PAGE_8 -->\n###### 물리화학적 성질\n\n<!-- PAGE_8 -->\n###### 1.\n\n<!-- PAGE_8 -->\n###### ,\n\n<!-- PAGE_8 -->\n###### ················································································2\n\n<!-- PAGE_8 -->\n###### 2. 원료물질의 수집 및 관리\n\n<!-- PAGE_8 -->\n###### ···················································································2\n\n<!-- PAGE_8 -->\n###### 3. 제조공정\n\n<!-- PAGE_8 -->\n###### ·················································································································3\n\n<!-- PAGE_8 -->\n###### 4. 품질관리\n\n<!-- PAGE_8 -->\n###### ·················································································································4\n\n<!-- PAGE_8 -->\n###### III. 안정성시험\n\n<!-- PAGE_8 -->\n###### ··················································································································5\n\n<!-- PAGE_8 -->\n###### Ⅳ. 비임상시험\n\n<!-- PAGE_8 -->\n###### ··················································································································5\n\n<!-- PAGE_8 -->\n###### 1. 일반적 고려사항\n\n<!-- PAGE_8 -->\n###### ···································································································5\n\n<!-- PAGE_8 -->\n###### 2. 독성시험\n\n<!-- PAGE_8 -->\n###### ·················································································································6\n\n<!-- PAGE_8 -->\n###### 3. 약리시험\n\n<!-- PAGE_8 -->\n###### ·················································································································6\n\n<!-- PAGE_8 -->\n###### Ⅴ. 임상시험\n\n<!-- PAGE_8 -->\n###### ······················································································································7\n\n<!-- PAGE_8 -->\n###### 1. 일반적 고려사항\n\n<!-- PAGE_8 -->\n###### ···································································································7\n\n<!-- PAGE_8 -->\n###### 2. 임상약리시험\n\n<!-- PAGE_8 -->\n###### ·········································································································7\n\n<!-- PAGE_8 -->\n###### 3. 치료적 탐색 임상시험\n\n<!-- PAGE_8 -->\n###### ·························································································8\n\n<!-- PAGE_8 -->\n###### 4. 치료적 확증 임상시험\n\n<!-- PAGE_8 -->\n###### ·························································································8\n\n<!-- PAGE_8 -->\n###### Ⅵ. 참고문헌\n\n<!-- PAGE_8 -->\n###### ·················································································································11\n\n- - 1 -\n<!-- PAGE_9 -->\n##### 정맥주사용\n\n<!-- PAGE_9 -->\n##### B형 간염 사람면\n\n<!-- PAGE_9 -->\n##### 역글로불린제제의\n\n<!-- PAGE_9 -->\n##### 안전성 유효성 평가 가이드라인\n\n<!-- PAGE_9 -->\n##### ․\n\n<!-- PAGE_9 -->\n###### . 서론\n\n<!-- PAGE_9 -->\n###### Ⅰ\n\n<!-- PAGE_9 -->\n###### 최근 국내에서 높은\n\n<!-- PAGE_9 -->\n###### 형 간염 유병율과 함께 말기 간질환 환자에 대한 간 이식 수\n\n<!-- PAGE_9 -->\n###### B\n\n<!-- PAGE_9 -->\n###### 술이 급격히 증가하고 있으나\n\n<!-- PAGE_9 -->\n###### 수술 이후\n\n<!-- PAGE_9 -->\n###### 형 간염의 재발이 보고됨에 따라 간 이식\n\n<!-- PAGE_9 -->\n###### ,\n\n<!-- PAGE_9 -->\n###### B\n\n<!-- PAGE_9 -->\n###### 후\n\n<!-- PAGE_9 -->\n###### 형 간염 재발 방지가 중요한 문제로 대두되었다\n\n<!-- PAGE_9 -->\n###### 형 간염 환자에서 간 이식 후\n\n<!-- PAGE_9 -->\n###### B\n\n<!-- PAGE_9 -->\n###### . B\n\n<!-- PAGE_9 -->\n###### 간염 재발방지 요법을 시행하지 않은 경우\n\n<!-- PAGE_9 -->\n###### 년 후 재발율은\n\n<!-- PAGE_9 -->\n###### 이상에 이른다\n\n<!-- PAGE_9 -->\n###### 간\n\n<!-- PAGE_9 -->\n###### 2\n\n<!-- PAGE_9 -->\n###### 70%\n\n<!-- PAGE_9 -->\n###### .\n\n<!-- PAGE_9 -->\n###### 이식 후\n\n<!-- PAGE_9 -->\n###### 형 간염 바이러스\n\n<!-- PAGE_9 -->\n###### 의 재감염을 막기 위해서는 주로\n\n<!-- PAGE_9 -->\n###### B\n\n<!-- PAGE_9 -->\n###### (hepatitis B virus, HBV)\n\n<!-- PAGE_9 -->\n###### 형 간염 사람면역글로불린제제\n\n<!-- PAGE_9 -->\n###### 를 단독\n\n<!-- PAGE_9 -->\n###### B\n\n<!-- PAGE_9 -->\n###### (human hepatitis B immunoglobulin, HBIG)\n\n<!-- PAGE_9 -->\n###### 투여하거나 항바이러스제와\n\n<!-- PAGE_9 -->\n###### 의 병용요법이 이용되고 있으며 이 경우 재발율은\n\n<!-- PAGE_9 -->\n###### HBIG\n\n<!-- PAGE_9 -->\n###### 20% 이하로 낮아진다\n\n<!-- PAGE_9 -->\n###### .\n\n<!-- PAGE_9 -->\n###### 이미 외국에서는 고용량의 정맥주사용\n\n<!-- PAGE_9 -->\n###### 를 이용한 예방요법이 보편화되어 있으\n\n<!-- PAGE_9 -->\n###### HBIG\n\n<!-- PAGE_9 -->\n###### 나\n\n<!-- PAGE_9 -->\n###### 우리나라에서는\n\n<!-- PAGE_9 -->\n###### 형 간염 표면항원\n\n<!-- PAGE_9 -->\n###### 양성 혈\n\n<!-- PAGE_9 -->\n###### ,\n\n<!-- PAGE_9 -->\n###### B\n\n<!-- PAGE_9 -->\n###### (hepatitis B surface antigen, HBsAg)\n\n<!-- PAGE_9 -->\n###### 액 오염사고 후의\n\n<!-- PAGE_9 -->\n###### 형 간염 발증의 예방 및 신생아의\n\n<!-- PAGE_9 -->\n###### 형 간염 예방 목적으로 근육주\n\n<!-- PAGE_9 -->\n###### B\n\n<!-- PAGE_9 -->\n###### B\n\n<!-- PAGE_9 -->\n###### 사용\n\n<!-- PAGE_9 -->\n###### 만이 허가되어\n\n<!-- PAGE_9 -->\n###### 근육주사용\n\n<!-- PAGE_9 -->\n###### 를 간 이식 시 고용량으로 정맥주사 해왔\n\n<!-- PAGE_9 -->\n###### HBIG\n\n<!-- PAGE_9 -->\n###### ,\n\n<!-- PAGE_9 -->\n###### HBIG\n\n<!-- PAGE_9 -->\n###### 다.\n\n<!-- PAGE_9 -->\n###### 현재 간 이식 뿐만 아니라 수동면역에도 정맥주사용\n\n<!-- PAGE_9 -->\n###### 가 세계적인 추세이고 국\n\n<!-- PAGE_9 -->\n###### HBIG\n\n<!-- PAGE_9 -->\n###### 내 간 이식 수술 건수의 증가 및 수술 후\n\n<!-- PAGE_9 -->\n###### 형 간염 재발 방지를 위하여\n\n<!-- PAGE_9 -->\n###### 기존의 근육\n\n<!-- PAGE_9 -->\n###### B\n\n<!-- PAGE_9 -->\n###### ,\n\n<!-- PAGE_9 -->\n###### 주사용 제제보다 품질이 우수하고 바이러스 안전성이 확보된 정맥주사용 제제 개발이\n\n<!-- PAGE_9 -->\n###### 필요하게 되었다.\n\n<!-- PAGE_9 -->\n###### 본 가이드라인은 혈장 유래 정맥주사용\n\n<!-- PAGE_9 -->\n###### HBIG의 품질과 안전성 유효성 심사 시 비임\n\n<!-- PAGE_9 -->\n###### ․\n\n<!-- PAGE_9 -->\n###### 상 및 임상시험자료 평가를 위한 지침으로서\n\n<!-- PAGE_9 -->\n###### 심사자 및 제조자에게 정보를 제공함과\n\n<!-- PAGE_9 -->\n###### ,\n\n<!-- PAGE_9 -->\n###### 동시에 자료 요건의 투명성을 제고하는데 그 목적이 있다.\n\n- - 2 -\n<!-- PAGE_10 -->\n###### 구조 물리화학적 성질\n\n<!-- PAGE_10 -->\n###### 제조 및 품질관리\n\n<!-- PAGE_10 -->\n###### .\n\n<!-- PAGE_10 -->\n###### ,\n\n<!-- PAGE_10 -->\n###### Ⅱ\n\n<!-- PAGE_10 -->\n###### ․\n\n<!-- PAGE_10 -->\n###### 면역글로불린제제의 제조에 있어서 제조사는 원료물질의 특성\n\n<!-- PAGE_10 -->\n###### , 제조 및 정제공정\n\n<!-- PAGE_10 -->\n###### ,\n\n<!-- PAGE_10 -->\n###### 그리고 안전성과 관련된 중요한 인자들을 고려해야 한다\n\n<!-- PAGE_10 -->\n###### 면역글로불린제제는 많은 사\n\n<!-- PAGE_10 -->\n###### .\n\n<!-- PAGE_10 -->\n###### 람의 헌혈 혈장을 풀링하여 생산하기 때문에 한 사람의 헌혈 혈장의 바이러스 오염은\n\n<!-- PAGE_10 -->\n###### 면역글로불린제제를 사용하는 다수의 환자에게 바이러스성 질병을 전염시킬 수 있다.\n\n<!-- PAGE_10 -->\n###### 따라서 원료혈장의 오염을 최소화하면서 제조공정 중 혈액매개 바이러스의 불활화 제\n\n<!-- PAGE_10 -->\n###### /\n\n<!-- PAGE_10 -->\n###### 거 효율을 극대화하기 위한 조치를 취하여 면역글로불린제제의 바이러스 안전성을 반\n\n<!-- PAGE_10 -->\n###### 드시 확보하여야 한다.\n\n<!-- PAGE_10 -->\n###### 면역글로불린제제 품질평가 전반에 관해서는\n\n<!-- PAGE_10 -->\n###### “혈장분획제제 품질평가 가이드 생물\n\n<!-- PAGE_10 -->\n###### (\n\n<!-- PAGE_10 -->\n###### 의약품평가가이드\n\n<!-- PAGE_10 -->\n###### 와\n\n<!-- PAGE_10 -->\n###### 의\n\n<!-- PAGE_10 -->\n###### 4, 2002)”\n\n<!-- PAGE_10 -->\n###### EMEA\n\n<!-- PAGE_10 -->\n###### “Note for Guidance on Plasma-Derived\n\n<!-- PAGE_10 -->\n###### Medicinal Products(CPMP/BWP/269/95 rev. 3, 2001)” 등을 참고할 수 있다\n\n<!-- PAGE_10 -->\n###### .\n\n<!-- PAGE_10 -->\n###### 구조결정\n\n<!-- PAGE_10 -->\n###### 물리화학적 성질\n\n<!-- PAGE_10 -->\n###### 1.\n\n<!-- PAGE_10 -->\n###### ,\n\n<!-- PAGE_10 -->\n###### 주성분의 구성 성분 및 그 특성에 관한 자료\n\n<!-- PAGE_10 -->\n###### 물리화학적 성질에 관한 자료\n\n<!-- PAGE_10 -->\n###### 면\n\n<!-- PAGE_10 -->\n###### ,\n\n<!-- PAGE_10 -->\n###### ,\n\n<!-- PAGE_10 -->\n###### 역학적 성질에 관한 자료 및 생물학적 성질에 관한 자료를 제출하여야 한다\n\n<!-- PAGE_10 -->\n###### 또한\n\n<!-- PAGE_10 -->\n###### .\n\n<!-- PAGE_10 -->\n###### 기타 첨가제 또는 첨부용제의 성분 및 그 특성에 관한 자료를 제출하여야 한다.\n\n<!-- PAGE_10 -->\n###### 원료물질의 수집 및 관리\n\n<!-- PAGE_10 -->\n###### 2.\n\n<!-- PAGE_10 -->\n###### 원료물질의 수집 및 관리는 혈장분획제제의 제조 및 품질보증에서 매우 중요한\n\n<!-- PAGE_10 -->\n###### 요소이다\n\n<!-- PAGE_10 -->\n###### 바이러스 위해성을 줄이기 위한 방법으로 원료물질에 대한 세심한 관리\n\n<!-- PAGE_10 -->\n###### .\n\n<!-- PAGE_10 -->\n###### 가 필요하다.\n\n<!-- PAGE_10 -->\n###### 원료물질의 수집 및 관리에 관한 상세 정보를 기록하여 제공하여야 한다\n\n<!-- PAGE_10 -->\n###### 즉\n\n<!-- PAGE_10 -->\n###### 원\n\n<!-- PAGE_10 -->\n###### .\n\n<!-- PAGE_10 -->\n###### ,\n\n<!-- PAGE_10 -->\n###### 료혈장의 종류\n\n<!-- PAGE_10 -->\n###### 개별혈장 및 수집혈장의 풀링 사이즈\n\n<!-- PAGE_10 -->\n###### 풀링 방법\n\n<!-- PAGE_10 -->\n###### 품질관리 항목 및\n\n<!-- PAGE_10 -->\n###### ,\n\n<!-- PAGE_10 -->\n###### ,\n\n<!-- PAGE_10 -->\n###### ,\n\n<!-- PAGE_10 -->\n###### 기준\n\n<!-- PAGE_10 -->\n###### 보관 및 운송 등에 관한 정보를 제공하여야 한다\n\n<!-- PAGE_10 -->\n###### 이 때 분획용 혈장 마스터\n\n<!-- PAGE_10 -->\n###### ,\n\n<!-- PAGE_10 -->\n###### .\n\n<!-- PAGE_10 -->\n###### 파일\n\n<!-- PAGE_10 -->\n###### 의 형태로 정보를 제공할 수 있다\n\n<!-- PAGE_10 -->\n###### 주성분과 첨가제\n\n<!-- PAGE_10 -->\n###### (plasma master file, PMF)\n\n<!-- PAGE_10 -->\n###### .\n\n<!-- PAGE_10 -->\n###### 의 분량\n\n<!-- PAGE_10 -->\n###### 규격 등에 관한 모든 관련 정보가 필요하다\n\n<!-- PAGE_10 -->\n###### 원료물질을 혈장으로 공급받\n\n<!-- PAGE_10 -->\n###### ,\n\n<!-- PAGE_10 -->\n###### .\n\n- - 3 -\n<!-- PAGE_11 -->\n###### 는지 또는 부분적으로 분획한 중간산물의 형태로 공급받는지에 대한 정보를 제공하\n\n<!-- PAGE_11 -->\n###### 여야 한다.\n\n<!-- PAGE_11 -->\n###### 는\n\n<!-- PAGE_11 -->\n###### 형 간염 항체 양성인 건강한 사람의 혈장을 원료로 사용하므로 면역방\n\n<!-- PAGE_11 -->\n###### HBIG\n\n<!-- PAGE_11 -->\n###### B\n\n<!-- PAGE_11 -->\n###### 법 등 원료혈장의 생산 경로를 기술하여야 한다.\n\n<!-- PAGE_11 -->\n###### 에 관해서는\n\n<!-- PAGE_11 -->\n###### 분획용 혈장 마스터 파일 가이드라인 생물의약품평가가이드\n\n<!-- PAGE_11 -->\n###### PMF\n\n<!-- PAGE_11 -->\n###### “\n\n<!-- PAGE_11 -->\n###### (\n\n<!-- PAGE_11 -->\n###### 제조공정\n\n<!-- PAGE_11 -->\n###### 3.\n\n<!-- PAGE_11 -->\n###### 면역글로불린제제의 제조방법은 제품의 품질과 안전성을 확보하는데 중요한 부분\n\n<!-- PAGE_11 -->\n###### 이다\n\n<!-- PAGE_11 -->\n###### . 제조공정은 제조사에 따라 다양하지만 보통 몇 단계의 분획 정제공정과 바이\n\n<!-- PAGE_11 -->\n###### /\n\n<!-- PAGE_11 -->\n###### 러스 불활화 제거를 위한 특별 공정이 필요하다\n\n<!-- PAGE_11 -->\n###### 제조공정은 상세히 기술하고 제조\n\n<!-- PAGE_11 -->\n###### /\n\n<!-- PAGE_11 -->\n###### .\n\n<!-- PAGE_11 -->\n###### 면역글로불린제제 제조는\n\n<!-- PAGE_11 -->\n###### 의 에탄올 분획법이 가장 널리 사용되고 있다\n\n<!-- PAGE_11 -->\n###### 에\n\n<!-- PAGE_11 -->\n###### Cohn\n\n<!-- PAGE_11 -->\n###### .\n\n<!-- PAGE_11 -->\n###### 탄올 분획법은 특정 요구조건에 맞는 몇 개의 개별 단계로 되어 있으며\n\n<!-- PAGE_11 -->\n###### 각 개별\n\n<!-- PAGE_11 -->\n###### ,\n\n<!-- PAGE_11 -->\n###### 단계는 제품의 품질에 매우 중요하고 그 중 일부 개별 단계는 잠재적인 바이러스\n\n<!-- PAGE_11 -->\n###### 오염을 효과적으로 감소시킬 수 있다\n\n<!-- PAGE_11 -->\n###### 따라서 에탄올 농도\n\n<!-- PAGE_11 -->\n###### 단백질 농도\n\n<!-- PAGE_11 -->\n###### 온도\n\n<!-- PAGE_11 -->\n###### .\n\n<!-- PAGE_11 -->\n###### ,\n\n<!-- PAGE_11 -->\n###### ,\n\n<!-- PAGE_11 -->\n###### , pH,\n\n<!-- PAGE_11 -->\n###### 이온 강도 및 처리 시간 등에 대한 명확한 기준\n\n<!-- PAGE_11 -->\n###### 허용 오차범위 및 관리 방법을 제\n\n<!-- PAGE_11 -->\n###### ,\n\n<!-- PAGE_11 -->\n###### 시하여야 한다.\n\n<!-- PAGE_11 -->\n###### 크로마토그래피 등을 이용한 단백질의 분리 및 수율은 칼럼의 능력\n\n<!-- PAGE_11 -->\n###### 단백질의 특\n\n<!-- PAGE_11 -->\n###### ,\n\n<!-- PAGE_11 -->\n###### 성 및 농도\n\n<!-- PAGE_11 -->\n###### 완충액의 이온 강도 및\n\n<!-- PAGE_11 -->\n###### 유속 및 온도와 같은 여러 인자들에 따라\n\n<!-- PAGE_11 -->\n###### ,\n\n<!-- PAGE_11 -->\n###### pH,\n\n<!-- PAGE_11 -->\n###### 크게 좌우된다\n\n<!-- PAGE_11 -->\n###### 따라서 적절한 규격과 기준을 명시하여야 한다\n\n<!-- PAGE_11 -->\n###### 칼럼의 보관\n\n<!-- PAGE_11 -->\n###### 칼럼\n\n<!-- PAGE_11 -->\n###### .\n\n<!-- PAGE_11 -->\n###### .\n\n<!-- PAGE_11 -->\n###### ,\n\n<!-- PAGE_11 -->\n###### 보존제의 사용 및 재생방법 등을 기술하여야 하고\n\n<!-- PAGE_11 -->\n###### 무균여과\n\n<!-- PAGE_11 -->\n###### 투석여과\n\n<!-- PAGE_11 -->\n###### ,\n\n<!-- PAGE_11 -->\n###### ,\n\n<!-- PAGE_11 -->\n###### (diafiltration)\n\n<!-- PAGE_11 -->\n###### 또는 한외여과\n\n<!-- PAGE_11 -->\n###### (ultrafiltration) 등에 관한 상세한 설명도 필요하다\n\n<!-- PAGE_11 -->\n###### .\n\n<!-- PAGE_11 -->\n###### 근육주사용\n\n<!-- PAGE_11 -->\n###### 는 정맥 내 투여 시 부작용을 야기할 수 있다\n\n<!-- PAGE_11 -->\n###### 만약 근육주사용\n\n<!-- PAGE_11 -->\n###### HBIG\n\n<!-- PAGE_11 -->\n###### .\n\n<!-- PAGE_11 -->\n###### 의 제조방법을 변경하여 정맥주사용\n\n<!-- PAGE_11 -->\n###### 를 제조하는 경우에는 주성분에는\n\n<!-- PAGE_11 -->\n###### HBIG\n\n<!-- PAGE_11 -->\n###### HBIG\n\n- - 4 -\n<!-- PAGE_12 -->\n###### 영향을 미치지 않으면서 순도를 높여 부작용을 감소시킬 수 있는 다양한 공정을 거\n\n<!-- PAGE_12 -->\n###### 쳐야 한다\n\n<!-- PAGE_12 -->\n###### 따라서 이 때 사용한 물질 및 공정과 이들의 적합성에 대한 근거를 제\n\n<!-- PAGE_12 -->\n###### .\n\n<!-- PAGE_12 -->\n###### 시하고 기술하여야 한다.\n\n<!-- PAGE_12 -->\n###### 바이러스 불활화 제거 공정은 각각 최소\n\n<!-- PAGE_12 -->\n###### 단계 이상의 공정을 포함하도록 하며\n\n<!-- PAGE_12 -->\n###### /\n\n<!-- PAGE_12 -->\n###### 1\n\n<!-- PAGE_12 -->\n###### ,\n\n<!-- PAGE_12 -->\n###### 온도\n\n<!-- PAGE_12 -->\n###### , pH, 시간 등 바이러스 불활화 제거 조건을 상세히 기술하고 제조공정 흐름도\n\n<!-- PAGE_12 -->\n###### /\n\n<!-- PAGE_12 -->\n###### 에 표시하여야 한다\n\n<!-- PAGE_12 -->\n###### . 바이러스 불활화 제거 공정의 유효성을 입증하기 위하여 바이\n\n<!-- PAGE_12 -->\n###### /\n\n<!-- PAGE_12 -->\n###### 러스 검증 자료를 제출하여야 한다\n\n<!-- PAGE_12 -->\n###### . 개별 바이러스 불활화 제거 공정의 효과를 평가\n\n<!-- PAGE_12 -->\n###### /\n\n<!-- PAGE_12 -->\n###### 한 후\n\n<!-- PAGE_12 -->\n###### , 전 제조공정에서의 바이러스 불활화 제거 능력의 추정치를 제공하여야 한다\n\n<!-- PAGE_12 -->\n###### /\n\n<!-- PAGE_12 -->\n###### .\n\n<!-- PAGE_12 -->\n###### 바이러스 검증 평가와 관련하여서는\n\n<!-- PAGE_12 -->\n###### 혈장분획제제 등 바이러스 검증 평가가이드\n\n<!-- PAGE_12 -->\n###### “\n\n<!-- PAGE_12 -->\n###### 생물의약품평가가이드\n\n<!-- PAGE_12 -->\n###### 와\n\n<!-- PAGE_12 -->\n###### 의\n\n<!-- PAGE_12 -->\n###### (\n\n<!-- PAGE_12 -->\n###### 20,\n\n<!-- PAGE_12 -->\n###### 2006)”\n\n<!-- PAGE_12 -->\n###### EMEA\n\n<!-- PAGE_12 -->\n###### “Note\n\n<!-- PAGE_12 -->\n###### for\n\n<!-- PAGE_12 -->\n###### Guidance\n\n<!-- PAGE_12 -->\n###### on\n\n<!-- PAGE_12 -->\n###### Virus\n\n<!-- PAGE_12 -->\n###### Validation\n\n<!-- PAGE_12 -->\n###### Studies:\n\n<!-- PAGE_12 -->\n###### The\n\n<!-- PAGE_12 -->\n###### Design,\n\n<!-- PAGE_12 -->\n###### Contribution\n\n<!-- PAGE_12 -->\n###### and\n\n<!-- PAGE_12 -->\n###### Interpretation\n\n<!-- PAGE_12 -->\n###### of\n\n<!-- PAGE_12 -->\n###### Studies\n\n<!-- PAGE_12 -->\n###### Validating the Inactivation and Removal of Viruses(CPMP/BWP/268/95, 1996)”\n\n<!-- PAGE_12 -->\n###### 품질관리\n\n<!-- PAGE_12 -->\n###### 4.\n\n<!-- PAGE_12 -->\n###### 최소한 연속적인\n\n<!-- PAGE_12 -->\n###### 개 로트에 대해 검증된 시험법으로 시험한 원료의약품 및 완제\n\n<!-- PAGE_12 -->\n###### 3\n\n<!-- PAGE_12 -->\n###### 또한 공정 중 관리\n\n<!-- PAGE_12 -->\n###### 시험항목과 기준을 제시하고\n\n<!-- PAGE_12 -->\n###### 제형\n\n<!-- PAGE_12 -->\n###### (in-process control, IPC)\n\n<!-- PAGE_12 -->\n###### ,\n\n<!-- PAGE_12 -->\n###### 화 과정 중 또는 생산 중 사용한 물질을 측정하고 예\n\n<!-- PAGE_12 -->\n###### 잔류용매\n\n<!-- PAGE_12 -->\n###### 계면활성제 등\n\n<!-- PAGE_12 -->\n###### (\n\n<!-- PAGE_12 -->\n###### :\n\n<!-- PAGE_12 -->\n###### ,\n\n<!-- PAGE_12 -->\n###### ),\n\n<!-- PAGE_12 -->\n###### 최소한 연속적인\n\n<!-- PAGE_12 -->\n###### 3개 로트에 대해 분석한 후 파라미터의 기준을 설정하여야 한다\n\n<!-- PAGE_12 -->\n###### .\n\n<!-- PAGE_12 -->\n###### 제조공정 중 또는 완제의약품에 잠재적 감염 위험이 있는 동물유래 물질을 사용\n\n<!-- PAGE_12 -->\n###### 하는 경우에는 기원 동물 및 사용 부위를 기재하여야 하며\n\n<!-- PAGE_12 -->\n###### 반추동물 유래 성분의\n\n<!-- PAGE_12 -->\n###### ,\n\n<!-- PAGE_12 -->\n###### 경우에는 전염성 해면상 뇌증\n\n<!-- PAGE_12 -->\n###### 감\n\n<!-- PAGE_12 -->\n###### (transmissible spongiform encephalopathy, TSE)\n\n<!-- PAGE_12 -->\n###### 염을 방지하기 위한 원료 선택 반추동물의 원산국\n\n<!-- PAGE_12 -->\n###### 반추동물의 연령 등\n\n<!-- PAGE_12 -->\n###### 또는 처리\n\n<!-- PAGE_12 -->\n###### (\n\n<!-- PAGE_12 -->\n###### ,\n\n<!-- PAGE_12 -->\n###### )\n\n<!-- PAGE_12 -->\n###### 방법 등을 기술하고\n\n<!-- PAGE_12 -->\n###### , 제품이 외래성 물질로부터 안전함을 입증하여야 한다\n\n<!-- PAGE_12 -->\n###### .\n\n- - 5 -\n<!-- PAGE_13 -->\n###### . 안정성시험\n\n<!-- PAGE_13 -->\n###### Ⅲ\n\n<!-- PAGE_13 -->\n###### 안정성시험은 제제의 물리화학적 상태 예\n\n<!-- PAGE_13 -->\n###### 분해물\n\n<!-- PAGE_13 -->\n###### 또는 중합물\n\n<!-- PAGE_13 -->\n###### [\n\n<!-- PAGE_13 -->\n###### :\n\n<!-- PAGE_13 -->\n###### (fragment)\n\n<!-- PAGE_13 -->\n###### (trimer\n\n<!-- PAGE_13 -->\n###### 이상의\n\n<!-- PAGE_13 -->\n###### 역가\n\n<!-- PAGE_13 -->\n###### 등 안정성에 대하여 설정기간 동안 일정한 간격으로 시험\n\n<!-- PAGE_13 -->\n###### polymer)],\n\n<!-- PAGE_13 -->\n###### , pH\n\n<!-- PAGE_13 -->\n###### 하도록 적절히 고안되어야 한다.\n\n<!-- PAGE_13 -->\n###### 품목허가를 위해서는 유통에 사용할 용기와 밀봉 형태로 충진된 완제의약품에 대하\n\n<!-- PAGE_13 -->\n###### 여 유효기간을 입증할 수 있는 안정성시험을 수행하여야 한다\n\n<!-- PAGE_13 -->\n###### 원료의약품 및 중간산\n\n<!-- PAGE_13 -->\n###### .\n\n<!-- PAGE_13 -->\n###### 물을 보관할 경우 이에 대한 저장 및 유효기간도 안정성시험에 의해 입증하여야 한다.\n\n<!-- PAGE_13 -->\n###### 가속시험은 어떠한 시험항목이 안정성의 지표가 되는지를 확인하고 확립하는데 도\n\n<!-- PAGE_13 -->\n###### 움을 줄 수 있으며\n\n<!-- PAGE_13 -->\n###### , 장기보존시험 자료를 보완할 수는 있지만 대체하지는 못한다\n\n<!-- PAGE_13 -->\n###### .\n\n<!-- PAGE_13 -->\n###### . 비임상시험\n\n<!-- PAGE_13 -->\n###### Ⅳ\n\n<!-- PAGE_13 -->\n###### 일반적 고려사항\n\n<!-- PAGE_13 -->\n###### 1.\n\n<!-- PAGE_13 -->\n###### 비임상시험의 목적은 사람에 있어서의 잠재적 부작용 및 독성을 확인하고 가능하\n\n<!-- PAGE_13 -->\n###### 다면 임상시험에서의 안전한 초회 투여 용량 등을 결정하기 위함이다\n\n<!-- PAGE_13 -->\n###### 임상시험 실\n\n<!-- PAGE_13 -->\n###### .\n\n<!-- PAGE_13 -->\n###### 시 이전뿐만 아니라 임상시험 전 단계를 통해서 약리 및 독성학적 특성을 파악할\n\n<!-- PAGE_13 -->\n###### 수 있다.\n\n<!-- PAGE_13 -->\n###### 면역글로불린제제는 사람의 혈장을 원료로 하여 혈장 내 면역글로불린이 변질되\n\n<!-- PAGE_13 -->\n###### 지 않도록 에탄올로 분획\n\n<!-- PAGE_13 -->\n###### 정제하여 제조한 사람 유래 단백질제제이다\n\n<!-- PAGE_13 -->\n###### 따라서 독성\n\n<!-- PAGE_13 -->\n###### ,\n\n<!-- PAGE_13 -->\n###### .\n\n<!-- PAGE_13 -->\n###### 시험이 간소화 될 수 있으며\n\n<!-- PAGE_13 -->\n###### 동물에 투여했을 때 면역원성을 일으킬 수 있으므로\n\n<!-- PAGE_13 -->\n###### ,\n\n<!-- PAGE_13 -->\n###### 이를 고려하여야 한다.\n\n<!-- PAGE_13 -->\n###### 독성시험 및 안전성약리시험은\n\n<!-- PAGE_13 -->\n###### “비임상시험관리기준\n\n<!-- PAGE_13 -->\n###### (Good Laboratory Practice,\n\n<!-- PAGE_13 -->\n###### 식품의약품안전청 고시\n\n<!-- PAGE_13 -->\n###### 에 적합하게 실시되어야 한다\n\n<!-- PAGE_13 -->\n###### 그러나\n\n<!-- PAGE_13 -->\n###### 에 준하여\n\n<!-- PAGE_13 -->\n###### GLP)(\n\n<!-- PAGE_13 -->\n###### )”\n\n<!-- PAGE_13 -->\n###### .\n\n<!-- PAGE_13 -->\n###### GLP\n\n<!-- PAGE_13 -->\n###### 수행하지 않은 시험인 경우에는 시험방법 및 평가 기준 등이 과학적 합리적으로 타\n\n<!-- PAGE_13 -->\n###### ․\n\n- - 6 -\n<!-- PAGE_14 -->\n###### 당성이 인정되어야 하며\n\n<!-- PAGE_14 -->\n###### 에 적합하지 않은 부분을 명확히 하고 안전성평가 전\n\n<!-- PAGE_14 -->\n###### , GLP\n\n<!-- PAGE_14 -->\n###### 체에 대한 중요성에 대하여 평가해야 한다.\n\n<!-- PAGE_14 -->\n###### 독성시험\n\n<!-- PAGE_14 -->\n###### 2.\n\n<!-- PAGE_14 -->\n###### 근육주사용\n\n<!-- PAGE_14 -->\n###### 는 이미 사용 경험이 풍부한 제제이다\n\n<!-- PAGE_14 -->\n###### 정맥주사용\n\n<!-- PAGE_14 -->\n###### 는 근\n\n<!-- PAGE_14 -->\n###### HBIG\n\n<!-- PAGE_14 -->\n###### .\n\n<!-- PAGE_14 -->\n###### HBIG\n\n<!-- PAGE_14 -->\n###### 육주사용\n\n<!-- PAGE_14 -->\n###### 와 주성분은 동일하나 정맥주사용으로 사용하기 위하여 주성분의 물\n\n<!-- PAGE_14 -->\n###### HBIG\n\n<!-- PAGE_14 -->\n###### 리화학적 성질에는 거의 영향을 미치지 않으면서 순도를 향상시키기 위하여 정제공\n\n<!-- PAGE_14 -->\n###### 이에 따라 새로운 투여 경로 및 용법 용량에 대한 추가적인 독성시험이 요구된다.\n\n<!-- PAGE_14 -->\n###### ․\n\n<!-- PAGE_14 -->\n###### 또한 제조공정 중에 새로이 사용한 물질 예\n\n<!-- PAGE_14 -->\n###### 유기용매\n\n<!-- PAGE_14 -->\n###### 계면활성제 등 이 있는 경\n\n<!-- PAGE_14 -->\n###### (\n\n<!-- PAGE_14 -->\n###### :\n\n<!-- PAGE_14 -->\n###### ,\n\n<!-- PAGE_14 -->\n###### )\n\n<!-- PAGE_14 -->\n###### 우에는 그 물질에 대해 최대 잔류량에서 나타날 수 있는 독성시험 자료가 추가로\n\n<!-- PAGE_14 -->\n###### 요구된다\n\n<!-- PAGE_14 -->\n###### 만약 사용한 물질이나 첨가제가 제품 사용량에서 독성이 없는 것으로 알\n\n<!-- PAGE_14 -->\n###### .\n\n<!-- PAGE_14 -->\n###### 만약 정맥주사용\n\n<!-- PAGE_14 -->\n###### 를 처음 개발하는 경우에는 그에 따른 독성시험 자료를 제\n\n<!-- PAGE_14 -->\n###### HBIG\n\n<!-- PAGE_14 -->\n###### 약리시험\n\n<!-- PAGE_14 -->\n###### 3.\n\n<!-- PAGE_14 -->\n###### 정맥주사용\n\n<!-- PAGE_14 -->\n###### 는 사람의 혈장을 에탄올로 분획\n\n<!-- PAGE_14 -->\n###### 정제하여 제조한 사람면역글\n\n<!-- PAGE_14 -->\n###### HBIG\n\n<!-- PAGE_14 -->\n###### ,\n\n<!-- PAGE_14 -->\n###### 로불린으로 이러한 제조공정이 면역글로불린 분자의 물리화학적 성질에는 거의 영\n\n<!-- PAGE_14 -->\n###### 향을 미치지 않아 천연의 면역글로불린과 유사한 대사적 반감기를 나타낼 것으로\n\n<!-- PAGE_14 -->\n###### 판단된다.\n\n<!-- PAGE_14 -->\n###### 이미 허가되어 사용 경험이 풍부한 근육주사용\n\n<!-- PAGE_14 -->\n###### 의 제조방법을 변경하여 정\n\n<!-- PAGE_14 -->\n###### HBIG\n\n<!-- PAGE_14 -->\n###### 맥주사용\n\n<!-- PAGE_14 -->\n###### 를 제조하는 경우에는 주성분이 동일하여 추가적인 효력이나 약리시\n\n<!-- PAGE_14 -->\n###### HBIG\n\n<!-- PAGE_14 -->\n###### 험은 필요하지 않을 수 있으며 제품의 역가는 임상시험이나 역가시험으로 확인할\n\n<!-- PAGE_14 -->\n###### 수 있으나\n\n<!-- PAGE_14 -->\n###### , 새로운 효능 효과에 대해서는 효력시험자료가 요구될 수 있다\n\n<!-- PAGE_14 -->\n###### .\n\n<!-- PAGE_14 -->\n###### ․\n\n- - 7 -\n<!-- PAGE_15 -->\n###### . 임상시험\n\n<!-- PAGE_15 -->\n###### Ⅴ\n\n<!-- PAGE_15 -->\n###### 일반적 고려사항\n\n<!-- PAGE_15 -->\n###### 1.\n\n<!-- PAGE_15 -->\n###### 간 이식 후\n\n<!-- PAGE_15 -->\n###### 형 간염의 재발을 막기 위해서는\n\n<!-- PAGE_15 -->\n###### 를 단독 투여하거나 항바이러\n\n<!-- PAGE_15 -->\n###### B\n\n<!-- PAGE_15 -->\n###### HBIG\n\n<!-- PAGE_15 -->\n###### 본 가이드라인에서는 간 이식 환자의\n\n<!-- PAGE_15 -->\n###### 형 간염 재발의 예방 목적으로 사용되는\n\n<!-- PAGE_15 -->\n###### B\n\n<!-- PAGE_15 -->\n###### 정맥주사용\n\n<!-- PAGE_15 -->\n###### 단독 투여에 의한 임상시험을 위주로 언급하고자 한다\n\n<!-- PAGE_15 -->\n###### 만약\n\n<!-- PAGE_15 -->\n###### HBIG\n\n<!-- PAGE_15 -->\n###### .\n\n<!-- PAGE_15 -->\n###### HBV\n\n<!-- PAGE_15 -->\n###### 에 노출된 후\n\n<!-- PAGE_15 -->\n###### 형 간염 발증의 예방 목적으로 사용하고자 하는 경우에는 해당 적응\n\n<!-- PAGE_15 -->\n###### B\n\n<!-- PAGE_15 -->\n###### 임상약리시험\n\n<!-- PAGE_15 -->\n###### 2.\n\n<!-- PAGE_15 -->\n###### 사람에서 실시되는 첫 임상시험으로서 주된 목적은 안전성을 평가하는 것이다.\n\n<!-- PAGE_15 -->\n###### 일반적으로 치료를 목적으로 하지 않으며 건강한 지원자를 대상으로 실시한다 본\n\n<!-- PAGE_15 -->\n###### (\n\n<!-- PAGE_15 -->\n###### 제제는 항암제 등과 같이 세포독성 등의 심각한 잠재적 독성을 갖고 있지 않으므로\n\n<!-- PAGE_15 -->\n###### 환자를 대상으로 하지 아니한다\n\n<!-- PAGE_15 -->\n###### 단기간의 안전성 및 내약성 평가\n\n<!-- PAGE_15 -->\n###### 약동학 및 약력\n\n<!-- PAGE_15 -->\n###### ).\n\n<!-- PAGE_15 -->\n###### ,\n\n<!-- PAGE_15 -->\n###### 학적 정보를 제공하여 치료적 탐색 임상시험의 적절한 용량 범위와 투여 일정을 정\n\n<!-- PAGE_15 -->\n###### 약물의 흡수\n\n<!-- PAGE_15 -->\n###### 분포\n\n<!-- PAGE_15 -->\n###### 대사 및 배설에 대한 특성 규명을 위한 독립된 연구 또는 안\n\n<!-- PAGE_15 -->\n###### ,\n\n<!-- PAGE_15 -->\n###### ,\n\n<!-- PAGE_15 -->\n###### 전성 유효성 및 내약성 연구의 한 부분으로 약동학적 임상시험을 수행하여야 한다.\n\n<!-- PAGE_15 -->\n###### ․\n\n<!-- PAGE_15 -->\n###### 일반적인 약동학적 평가에서 고려되어야 하는 고령자\n\n<!-- PAGE_15 -->\n###### 여성 등과 같은 특수 집단에\n\n<!-- PAGE_15 -->\n###### ,\n\n<!-- PAGE_15 -->\n###### 서의 약동학적 정보를 제공하여야 한다.\n\n<!-- PAGE_15 -->\n###### 정맥주사용\n\n<!-- PAGE_15 -->\n###### 는 분자량이 큰 면역글로불린제제이므로 간이나 신장 등에서 여\n\n<!-- PAGE_15 -->\n###### HBIG\n\n<!-- PAGE_15 -->\n###### 과되거나 해독되지 않고 혈중을 다니다가 세망내피계(reticuloendothelial system,\n\n<!-- PAGE_15 -->\n###### 에서 탐식 당해 비장\n\n<!-- PAGE_15 -->\n###### 림프절\n\n<!-- PAGE_15 -->\n###### 골수 등에서 제거되므로 신장애 환자에 대한 약\n\n<!-- PAGE_15 -->\n###### RES)\n\n<!-- PAGE_15 -->\n###### ,\n\n<!-- PAGE_15 -->\n###### ,\n\n<!-- PAGE_15 -->\n###### 동학 정보의 확보는 필수사항은 아니다.\n\n- - 8 -\n<!-- PAGE_16 -->\n###### 치료적 탐색 임상시험\n\n<!-- PAGE_16 -->\n###### 3.\n\n<!-- PAGE_16 -->\n###### 치료적 유효성을 탐색하여 가능한 용량과 투여 기간 설정 등 다양한 정보 수집을\n\n<!-- PAGE_16 -->\n###### 목적으로 하며\n\n<!-- PAGE_16 -->\n###### 비교적 철저한 선정기준에 의해 모집된 환자군을 대상으로 수행하\n\n<!-- PAGE_16 -->\n###### ,\n\n<!-- PAGE_16 -->\n###### 여야 한다.\n\n<!-- PAGE_16 -->\n###### 치료적 확증 임상시험의 용량 및 용법을 결정하기 위하여 용량의 단계적 증량 디\n\n<!-- PAGE_16 -->\n###### 치료적 확증 임상시험\n\n<!-- PAGE_16 -->\n###### 4.\n\n<!-- PAGE_16 -->\n###### 감염에 의한 간경변증\n\n<!-- PAGE_16 -->\n###### 간암\n\n<!-- PAGE_16 -->\n###### 전격성 간부전 등 말기 간질환으로 간 이\n\n<!-- PAGE_16 -->\n###### HBV\n\n<!-- PAGE_16 -->\n###### ,\n\n<!-- PAGE_16 -->\n###### ,\n\n<!-- PAGE_16 -->\n###### 면역글로불린제제는 단백질의\n\n<!-- PAGE_16 -->\n###### 90% 이상이 면역글로불린\n\n<!-- PAGE_16 -->\n###### G(immunoglobulin\n\n<!-- PAGE_16 -->\n###### 이며 소량의\n\n<!-- PAGE_16 -->\n###### 및\n\n<!-- PAGE_16 -->\n###### 이 함유되어 있다\n\n<!-- PAGE_16 -->\n###### 최근 정제공정의 변경 또는 추\n\n<!-- PAGE_16 -->\n###### G, IgG)\n\n<!-- PAGE_16 -->\n###### IgA\n\n<!-- PAGE_16 -->\n###### IgM\n\n<!-- PAGE_16 -->\n###### .\n\n<!-- PAGE_16 -->\n###### 가로\n\n<!-- PAGE_16 -->\n###### 함량이 총 단백질의\n\n<!-- PAGE_16 -->\n###### 이상으로 순도가 개선되어\n\n<!-- PAGE_16 -->\n###### 정맥주사용\n\n<!-- PAGE_16 -->\n###### IgG\n\n<!-- PAGE_16 -->\n###### 98%\n\n<!-- PAGE_16 -->\n###### ,\n\n<!-- PAGE_16 -->\n###### HBIG\n\n<!-- PAGE_16 -->\n###### 의\n\n<!-- PAGE_16 -->\n###### 함량은\n\n<!-- PAGE_16 -->\n###### 함량 대비\n\n<!-- PAGE_16 -->\n###### 미만이고 이는 근육주사용\n\n<!-- PAGE_16 -->\n###### 에 비해서 매\n\n<!-- PAGE_16 -->\n###### IgA\n\n<!-- PAGE_16 -->\n###### IgG\n\n<!-- PAGE_16 -->\n###### 0.1%\n\n<!-- PAGE_16 -->\n###### HBIG\n\n<!-- PAGE_16 -->\n###### 우 낮은 수준이다\n\n<!-- PAGE_16 -->\n###### 그러나\n\n<!-- PAGE_16 -->\n###### 에 대한 항체를 갖고 있는\n\n<!-- PAGE_16 -->\n###### 결핍증 환자는 면역\n\n<!-- PAGE_16 -->\n###### .\n\n<!-- PAGE_16 -->\n###### IgA\n\n<!-- PAGE_16 -->\n###### IgA\n\n<!-- PAGE_16 -->\n###### 글로불린제제 투여로 제품에 함유되어 있는\n\n<!-- PAGE_16 -->\n###### IgA로 인한 항원 항체 반응 때문에 과\n\n<!-- PAGE_16 -->\n###### -\n\n<!-- PAGE_16 -->\n###### 민반응이 생길 수 있으므로 투여해서는 안 된다.\n\n<!-- PAGE_16 -->\n###### 투여 용량\n\n<!-- PAGE_16 -->\n###### 4.2.\n\n<!-- PAGE_16 -->\n###### 일반적으로 간 이식 후\n\n<!-- PAGE_16 -->\n###### 형 간염 재발 예방을 위한 투여 용량은 간 이식 전\n\n<!-- PAGE_16 -->\n###### B\n\n<!-- PAGE_16 -->\n###### 바이러스의 상태에 영향을 받는다\n\n<!-- PAGE_16 -->\n###### 대개의 경우 간 이식 전에\n\n<!-- PAGE_16 -->\n###### 가 양성인\n\n<!-- PAGE_16 -->\n###### .\n\n<!-- PAGE_16 -->\n###### HBV DNA\n\n<!-- PAGE_16 -->\n###### 경우에는\n\n<!-- PAGE_16 -->\n###### B형 간염 표면항체\n\n<!-- PAGE_16 -->\n###### (antibody to hepatitis B surface antigen, anti-HBs)\n\n<!-- PAGE_16 -->\n###### 농도를\n\n<!-- PAGE_16 -->\n###### 이상으로 유지하고\n\n<!-- PAGE_16 -->\n###### 가 음성인 경우에는 이보다 적은\n\n<!-- PAGE_16 -->\n###### 500 IU/L\n\n<!-- PAGE_16 -->\n###### , HBV DNA\n\n<!-- PAGE_16 -->\n###### 농도로 유지할 수 있다\n\n<!-- PAGE_16 -->\n###### 외에\n\n<!-- PAGE_16 -->\n###### 형 간염\n\n<!-- PAGE_16 -->\n###### 항원\n\n<!-- PAGE_16 -->\n###### . HBV DNA\n\n<!-- PAGE_16 -->\n###### B\n\n<!-- PAGE_16 -->\n###### e\n\n<!-- PAGE_16 -->\n###### (hepatitis B e antigen,\n\n<!-- PAGE_16 -->\n###### HBeAg)의 유 무도 고려하여 투여 용량을 결정하여야 한다\n\n<!-- PAGE_16 -->\n###### .\n\n<!-- PAGE_16 -->\n###### ․\n\n- - 9 -\n<!-- PAGE_17 -->\n###### 환자마다 다양한 반감기를 보일 수 있으므로 간 이식 전 바이러스의 상태를\n\n<!-- PAGE_17 -->\n###### 고려하여 순환하는\n\n<!-- PAGE_17 -->\n###### 를 중화할 수 있는 안전한 농도를 투여하여야 하며\n\n<!-- PAGE_17 -->\n###### 정기\n\n<!-- PAGE_17 -->\n###### HBV\n\n<!-- PAGE_17 -->\n###### ,\n\n<!-- PAGE_17 -->\n###### 적으로 혈중\n\n<!-- PAGE_17 -->\n###### anti-HBs 농도를 모니터링 하여야 한다\n\n<!-- PAGE_17 -->\n###### .\n\n<!-- PAGE_17 -->\n###### 상기 사항들을 고려하여 수술 중 무간기\n\n<!-- PAGE_17 -->\n###### 의 초회 투여 용량\n\n<!-- PAGE_17 -->\n###### (anheptic phase)\n\n<!-- PAGE_17 -->\n###### 간 이식 환자의\n\n<!-- PAGE_17 -->\n###### 형 간염 재발을 예방하기 위한 본 제제의 투여 기간은 현\n\n<!-- PAGE_17 -->\n###### B\n\n<!-- PAGE_17 -->\n###### 재까지 정해진 바 없으나\n\n<!-- PAGE_17 -->\n###### 의사의 판단과 환자의 여건에 따라 간 이식 수술 후 짧\n\n<!-- PAGE_17 -->\n###### ,\n\n<!-- PAGE_17 -->\n###### 게는\n\n<!-- PAGE_17 -->\n###### 년에서 길게는 평생 투여되고 있다\n\n<!-- PAGE_17 -->\n###### 따라서 치료적 확증 임상시험 시\n\n<!-- PAGE_17 -->\n###### 년\n\n<!-- PAGE_17 -->\n###### 1\n\n<!-- PAGE_17 -->\n###### .\n\n<!-- PAGE_17 -->\n###### 1\n\n<!-- PAGE_17 -->\n###### 이상 장기간 투여가 요구되며\n\n<!-- PAGE_17 -->\n###### 이에 따라 전 연령층에 대하여 의약품의 품목허가\n\n<!-- PAGE_17 -->\n###### ,\n\n<!-- PAGE_17 -->\n###### 에 필요한 정보 예\n\n<!-- PAGE_17 -->\n###### 병용약물 요법\n\n<!-- PAGE_17 -->\n###### 약물 상호작용 등 가 충분히 확보되어야 한\n\n<!-- PAGE_17 -->\n###### (\n\n<!-- PAGE_17 -->\n###### :\n\n<!-- PAGE_17 -->\n###### ,\n\n<!-- PAGE_17 -->\n###### )\n\n<!-- PAGE_17 -->\n###### 다\n\n<!-- PAGE_17 -->\n###### 간 이식 수술 후\n\n<!-- PAGE_17 -->\n###### 년 내에\n\n<!-- PAGE_17 -->\n###### 형 간염의 재발이 빈번히 나타나므로\n\n<!-- PAGE_17 -->\n###### 최근 외\n\n<!-- PAGE_17 -->\n###### .\n\n<!-- PAGE_17 -->\n###### 2~3\n\n<!-- PAGE_17 -->\n###### B\n\n<!-- PAGE_17 -->\n###### ,\n\n<!-- PAGE_17 -->\n###### 간 이식 수술 중 및 수술 후 관리를 위한 목적의 투여 기간에 대한 정확한\n\n<!-- PAGE_17 -->\n###### 가이드가 확립되어 있지 않으므로\n\n<!-- PAGE_17 -->\n###### 간 이식 전후로 투여되는 다른 약물과의 상호\n\n<!-- PAGE_17 -->\n###### ,\n\n<!-- PAGE_17 -->\n###### 작용뿐만 아니라 간 이식 후에도 지속적인 모니터링을 통해 약물의 단독 및 잠재\n\n<!-- PAGE_17 -->\n###### 적 약물 약물 상호작용을 확인하여야 한다\n\n<!-- PAGE_17 -->\n###### -\n\n<!-- PAGE_17 -->\n###### .\n\n<!-- PAGE_17 -->\n###### 효과 평가기준\n\n<!-- PAGE_17 -->\n###### 4.4.\n\n<!-- PAGE_17 -->\n###### 정맥주사용\n\n<!-- PAGE_17 -->\n###### 의 유효성 평가는 간 이식 수술 후 혈청\n\n<!-- PAGE_17 -->\n###### 의 재발율\n\n<!-- PAGE_17 -->\n###### HBIG\n\n<!-- PAGE_17 -->\n###### HBsAg\n\n<!-- PAGE_17 -->\n###### ,\n\n<!-- PAGE_17 -->\n###### 즉\n\n<!-- PAGE_17 -->\n###### 간 이식 후\n\n<!-- PAGE_17 -->\n###### 가 음성에서 양성으로 재발한 피험자의 백분율로 설정하고\n\n<!-- PAGE_17 -->\n###### ,\n\n<!-- PAGE_17 -->\n###### HBsAg\n\n<!-- PAGE_17 -->\n###### 95% 신뢰구간을 제시하여야 한다\n\n<!-- PAGE_17 -->\n###### .\n\n<!-- PAGE_17 -->\n###### 그러나\n\n<!-- PAGE_17 -->\n###### 투여로 인해\n\n<!-- PAGE_17 -->\n###### 존재가 마스킹 될 우려가 있고\n\n<!-- PAGE_17 -->\n###### 가\n\n<!-- PAGE_17 -->\n###### HBIG\n\n<!-- PAGE_17 -->\n###### HBsAg\n\n<!-- PAGE_17 -->\n###### HBsAg\n\n<!-- PAGE_17 -->\n###### 양성이라 함은 혈중에 바이러스가 존재만 하고 염증을 일으키지 않는 상태부터 급\n\n<!-- PAGE_17 -->\n###### 성 및 만성 간염을 일으켜 심각한 문제를 야기하는 상태까지 다양하므로, HBsAg\n\n<!-- PAGE_17 -->\n###### 만으로는\n\n<!-- PAGE_17 -->\n###### 형 간염의 재발에 대하여 정확한 평가가 어려울 수 있어\n\n<!-- PAGE_17 -->\n###### 형 간염과\n\n<!-- PAGE_17 -->\n###### B\n\n<!-- PAGE_17 -->\n###### B\n\n- - 10 -\n<!-- PAGE_18 -->\n###### 관련된 혈청학적 지표 예\n\n<!-- PAGE_18 -->\n###### 형 간염\n\n<!-- PAGE_18 -->\n###### 항원 항체\n\n<!-- PAGE_18 -->\n###### [\n\n<!-- PAGE_18 -->\n###### : HBV DNA, HBeAg, B\n\n<!-- PAGE_18 -->\n###### e\n\n<!-- PAGE_18 -->\n###### (antibody\n\n<!-- PAGE_18 -->\n###### to hepatitis B e antigen, anti-HBe)] 등을 고려하여야 한다.\n\n<!-- PAGE_18 -->\n###### 기타\n\n<!-- PAGE_18 -->\n###### 재발까지의 기간\n\n<!-- PAGE_18 -->\n###### 피험자의 생존율\n\n<!-- PAGE_18 -->\n###### 생존기간 등을 추가로 제시\n\n<!-- PAGE_18 -->\n###### HBsAg\n\n<!-- PAGE_18 -->\n###### ,\n\n<!-- PAGE_18 -->\n###### ,\n\n<!-- PAGE_18 -->\n###### 할 수 있다.\n\n- - 11 -\n<!-- PAGE_19 -->\n###### . 참고문헌\n\n<!-- PAGE_19 -->\n###### Ⅵ\n\n<!-- PAGE_19 -->\n###### 1. 혈장분획제제\n\n<!-- PAGE_19 -->\n###### 품질평가\n\n<!-- PAGE_19 -->\n###### 가이드 식품의약품안전청\n\n<!-- PAGE_19 -->\n###### 행정간행물\n\n<!-- PAGE_19 -->\n###### (\n\n<!-- PAGE_19 -->\n###### 11-1470000-\n\n<!-- PAGE_19 -->\n###### 000154-01, 생물의약품평가가이드\n\n<!-- PAGE_19 -->\n###### 4), 2002\n\n<!-- PAGE_19 -->\n###### 2. Note\n\n<!-- PAGE_19 -->\n###### for\n\n<!-- PAGE_19 -->\n###### Guidance\n\n<!-- PAGE_19 -->\n###### on\n\n<!-- PAGE_19 -->\n###### Plasma-Derived\n\n<!-- PAGE_19 -->\n###### Medicinal\n\n<!-- PAGE_19 -->\n###### Products(CPMP/BWP/\n\n<!-- PAGE_19 -->\n###### 3. 분획용 혈장 마스터 파일 가이드라인 식품의약품안전청 행정간행물\n\n<!-- PAGE_19 -->\n###### (\n\n<!-- PAGE_19 -->\n###### 11-1470000\n\n<!-- PAGE_19 -->\n###### 4. 혈장분획제제\n\n<!-- PAGE_19 -->\n###### 등\n\n<!-- PAGE_19 -->\n###### 바이러스\n\n<!-- PAGE_19 -->\n###### 검증\n\n<!-- PAGE_19 -->\n###### 평가가이드 식품의약품안전청\n\n<!-- PAGE_19 -->\n###### 행정간행물\n\n<!-- PAGE_19 -->\n###### (\n\n<!-- PAGE_19 -->\n###### 11-\n\n<!-- PAGE_19 -->\n###### 5. Note for Guidance on Virus Validation Studies: The Design, Contribution and\n\n<!-- PAGE_19 -->\n###### Interpretation of Studies Validating the Inactivation and Removal of Viruses\n\n<!-- PAGE_19 -->\n###### 6. Guideline\n\n<!-- PAGE_19 -->\n###### on\n\n<!-- PAGE_19 -->\n###### the\n\n<!-- PAGE_19 -->\n###### Clinical\n\n<!-- PAGE_19 -->\n###### Evaluation\n\n<!-- PAGE_19 -->\n###### of\n\n<!-- PAGE_19 -->\n###### Medicinal\n\n<!-- PAGE_19 -->\n###### Products\n\n<!-- PAGE_19 -->\n###### Intended\n\n<!-- PAGE_19 -->\n###### for\n\n<!-- PAGE_19 -->\n###### 7. Note\n\n<!-- PAGE_19 -->\n###### For\n\n<!-- PAGE_19 -->\n###### Guidance\n\n<!-- PAGE_19 -->\n###### on\n\n<!-- PAGE_19 -->\n###### the\n\n<!-- PAGE_19 -->\n###### Clinical\n\n<!-- PAGE_19 -->\n###### Investigation\n\n<!-- PAGE_19 -->\n###### of\n\n<!-- PAGE_19 -->\n###### Human\n\n<!-- PAGE_19 -->\n###### Normal\n\n<!-- PAGE_19 -->\n###### Immunoglobulin for Intravenous Administration(IVIg)(CPMP/BPWG/388/95 rev.\n\n<!-- PAGE_19 -->\n###### 8. Note\n\n<!-- PAGE_19 -->\n###### For\n\n<!-- PAGE_19 -->\n###### Guidance\n\n<!-- PAGE_19 -->\n###### on\n\n<!-- PAGE_19 -->\n###### the\n\n<!-- PAGE_19 -->\n###### Clinical\n\n<!-- PAGE_19 -->\n###### Investigation\n\n<!-- PAGE_19 -->\n###### of\n\n<!-- PAGE_19 -->\n###### Human\n\n<!-- PAGE_19 -->\n###### Normal\n\n<!-- PAGE_19 -->\n###### Immunoglobulin for Subcutaneous and Intramuscular Use(CPMP/BPWG/283/\n\n<!-- PAGE_19 -->\n###### 00), EMEA, 2003\n\n<!-- PAGE_19 -->\n###### 9. Safety,\n\n<!-- PAGE_19 -->\n###### Efficacy,\n\n<!-- PAGE_19 -->\n###### and\n\n<!-- PAGE_19 -->\n###### Pharmacokinetic\n\n<!-- PAGE_19 -->\n###### Studies\n\n<!-- PAGE_19 -->\n###### to\n\n<!-- PAGE_19 -->\n###### Support\n\n<!-- PAGE_19 -->\n###### Marketing\n\n<!-- PAGE_19 -->\n###### of\n\n<!-- PAGE_19 -->\n###### Immune Globulin Intravenous(Human)\n\n<!-- PAGE_19 -->\n###### as Replacement Therapy\n\n<!-- PAGE_19 -->\n###### for Primary\n\n<!-- PAGE_19 -->\n###### Humoral Immunodeficiency, CBER, FDA, 2008\n\n<!-- PAGE_19 -->\n###### 10. Guidance\n\n<!-- PAGE_19 -->\n###### for Industry\n\n<!-- PAGE_19 -->\n###### Pharmacokinetics\n\n<!-- PAGE_19 -->\n###### in Patients\n\n<!-- PAGE_19 -->\n###### with Impaired\n\n<!-- PAGE_19 -->\n###### Hepatic\n\n<!-- PAGE_19 -->\n###### Function: Study Design, Data Analysis, and Impact on Dosing and Labeling,\n\n<!-- PAGE_19 -->\n###### CDER, FDA, 2003\n\n- - 12 -\n<!-- PAGE_20 -->\n###### 생물의약품국에서 발간한 행정간행물 목록\n\n<!-- PAGE_20 -->\n###### 생물의약품 국가표준품 카다로그 시리즈\n\n<!-- PAGE_20 -->\n###### 1.\n\n<!-- PAGE_20 -->\n###### 생물의약품평가가이드 시리즈\n\n<!-- PAGE_20 -->\n###### 2.\n\n행정간행물 제목\n\n발행\n\n연도\n\n행정간행물 번호\n\n발행과\n\n홈페이지\n\n게재 상태\n\n생물의약품 국가표준품\n\n카다로그 (2008)\n\n2008\n\n11-1470000-000547-10\n\n생물진단의약품과\n\n자료실 간행물\n\n/\n\n,\n\n지침/\n\n생물의약품 국가표준품\n\n카다로그 (2006)\n\n2006\n\n11-1470000-000547-10\n\n생물진단제제팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/159\n\n생물의약품 국가표준품\n\n카다로그 (2004)\n\n2004\n\n11-1470000-000547-10\n\n생물의약품규격과\n\n자료실 간행물\n\n/\n\n,\n\n지침/56\n\n생물의약품 국가표준품\n\n카다로그 (2003)\n\n2003\n\n11-1470000-000547-10\n\n생물의약품규격과\n\n자료실 간행물\n\n/\n\n,\n\n지침/43\n\n생물의약품 국가표준품\n\n카다로그 (2002)\n\n2002\n\n11-1470000-000547-10\n\n백신과\n\n바이러스제제과\n\n(\n\n)\n\n舊\n\n자료실 간행물\n\n/\n\n,\n\n지침/22, 23\n\n행정간행물 제목\n\n발행\n\n연도\n\n행정간행물 번호\n\n발행과\n\n홈페이지\n\n게재 상태\n\n생물의약품\n\n국제공통기술문서 작성\n\n가이드라인 해설\n\n- -III. 품질\n2007\n\n11-1470000-001625-14\n\n(생물의약품평가가이드\n\n34)\n\n재조합의약품과\n\n바이러스백신과\n\n혈액제제과\n\n유전자치료제과\n\n세포조직공학제제과\n\n자료실 간행물\n\n/\n\n,\n\n지침/315\n\nHBsAg 진단제제의 기준\n\n및 시험방법 작성 지침\n\n2008\n\n11-1470000-000143-01\n\n(생물의약품평가가이드\n\n33)\n\n생물진단의약품과\n\n자료실 간행물\n\n/\n\n,\n\n지침/289\n\n혈장수출업소 실태조사\n\n지침\n\n2007\n\n11-1470000-001627-01\n\n(생물의약품평가가이드\n\n32)\n\n생물의약품관리팀\n\n혈액제제팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/234\n\nHIV, HBV, HCV, HTLV\n\n관련 체외진단용의약품\n\n안전성 유효성 심사평가\n\n․\n\n지침서\n\n2007\n\n11-1470000-001622-01\n\n(생물의약품평가가이드\n\n31)\n\n생물진단제제팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/252\n\n대유행 인플루엔자 백신의\n\n임상시험 평가 가이드 안\n\n(\n\n)\n\n2007\n\n11-1470000-001621-01\n\n(생물의약품평가가이드\n\n30)\n\n바이러스백신팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/228\n\n바이러스백신\n\n자가품질관리요약서(\n\nⅠ)\n\n2007\n\n11-1470000-001620-01\n\n(생물의약품평가가이드\n\n29)\n\n바이러스백신팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/227\n\n- - 13 -\n행정간행물 제목\n\n발행\n\n연도\n\n행정간행물 번호\n\n발행과\n\n홈페이지\n\n게재 상태\n\n불활화 인플루엔자백신\n\n평가 지침\n\n2007\n\n11-1470000-001587-01\n\n(생물의약품평가가이드\n\n28)\n\n바이러스백신팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/226\n\n당단백질의약품의 당구조\n\n분석 시험법 길라잡이\n\n2007\n\n11-1470000-001589-01\n\n(생물의약품평가가이드\n\n27)\n\n재조합의약품팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/280\n\n류마티스관절염 치료제\n\n임상평가지침\n\n2007\n\n11-1470000-001432-01\n\n(생물의약품평가가이드\n\n26)\n\n재조합의약품팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/190\n\n분획용 혈장 마스터 파일\n\n가이드라인\n\n2007\n\n11-1470000-001560-01\n\n(생물의약품평가가이드\n\n25)\n\n생물의약품관리팀\n\n혈액제제팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/210\n\n인플루엔자백신의 자가\n\n기준 및 시험방법 작성\n\n지침 개정판\n\n(\n\n)\n\n2007\n\n11-1470000-001468-01\n\n(생물의약품평가가이드\n\n24)\n\n바이러스백신팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/197\n\nHIV 항체 진단제제의\n\n기준 및 시험방법\n\n작성\n\n‘\n\n’\n\n지침\n\n2007\n\n11-1470000-001462-01\n\n(생물의약품평가가이드\n\n23)\n\n생물진단제제팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/196\n\n세균백신 자가 기준 및\n\n시험방법 작성 지침서\n\n2007\n\n11-1470000-001428-01\n\n(생물의약품평가가이드\n\n22)\n\n세균백신팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/177\n\n바이오 칩 평가 가이드\n\n- -HPV DNA칩 기준 및\n시험방법 작성 지침-\n\n2006\n\n11-1470000-001165-01\n\n(생물의약품평가가이드\n\n21)\n\n생물진단제제팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/154\n\n혈장분획제제 등 바이러스\n\n검증 평가 가이드\n\n2006\n\n11-1470000-001176-01\n\n(생물의약품평가가이드\n\n20)\n\n혈액제제팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/170\n\n유전자재조합의약품\n\n생산용 세포의 발현구조체\n\n분석 및 안정성\n\n평가가이드\n\n2006\n\n11-1470000-001116-01\n\n(생물의약품평가가이드\n\n19)\n\n재조합의약품팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/229\n\n유전재재조합의약품 및\n\n단클론항체의약품의 제조\n\n및 품질관리 자료에 관한\n\n평가가이드\n\n2006\n\n11-1470000-000902-01\n\n(생물의약품평가가이드\n\n18)\n\n재조합의약품팀\n\n생물의약품관리팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/139\n\n이종이식제제의 전임상 및\n\n임상시험에 대한 가이드\n\n2006\n\n11-1470000-001088-01\n\n(생물의약품평가가이드\n\n17)\n\n세포조직공학제제팀\n\n재조합의약품팀\n\n생물의약품안전팀\n\n생물의약품관리팀\n\n국립독성연구원\n\n생명공학지원팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/130\n\n- - 14 -\n행정간행물 제목\n\n발행\n\n연도\n\n행정간행물 번호\n\n발행과\n\n홈페이지\n\n게재 상태\n\n이종이식제제의 품질관리\n\n및 이식 후 감염관리에\n\n대한 가이드\n\n2006\n\n11-1470000-001086-01\n\n(생물의약품평가가이드\n\n16)\n\n세포조직공학제제팀\n\n재조합의약품팀\n\n생물의약품안전팀\n\n생물의약품관리팀\n\n국립독성연구원\n\n생명공학지원팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/130\n\n자료실 간행물\n\n/\n\n,\n\n지침/130\n\n자료실 간행물\n\n/\n\n,\n\n지침/116\n\n자료실 간행물\n\n/\n\n,\n\n지침/110\n\n자료실 간행물\n\n/\n\n,\n\n지침/118\n\n임상시험용\n\n유전자치료제의 특성분석,\n\n제조 및 품질관리\n\n평가가이드\n\n2005\n\n11-1470000-000876-01\n\n(생물의약품평가가이드\n\n11)\n\n생명공학의약품과\n\n자료실 간행물\n\n/\n\n,\n\n지침/107\n\n두창백신의 안전성 유효성\n\n․\n\n평가시 고려사항\n\n2005\n\n11-1470000-000872-01\n\n(생물의약품평가가이드\n\n10)\n\n생물의약품평가과\n\n자료실 간행물\n\n/\n\n,\n\n지침/105\n\n**[표 시작]**\n\n| 2004 | 11-1470000-000684-01 | (생물의약품평가자료집 | 15) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/84 |\n| --- | --- | --- | --- | --- | --- | --- | --- | --- |\n| 생명공학의약품 허가를 | 위한 Q&A | 2006 | 11-1470000-000895-01 | (생물의약품평가자료집 | 28) | 재조합의약품팀 | 생명공학의약품과 | ( | ) | 舊 | 자료실 간행물 | / | , | 지침127 |\n| 유전자치료제의 | 안전성평가 2006 | 2006 | 11-1470000-001140-01 | (생물의약품평가자료집 | 38) | 유전자치료제팀 | 자료실 간행물 | / | , | 지침/169 |\n| 행정간행물 제목 | 발행 | 연도 | 행정간행물 번호 | 발행과 | 홈페이지 | 게재 상태 |\n| 세포치료제의 | 안전성 유효성 및 품질 | ․ | 평가 2006 | 2006 | 11-1470000-001146-01 | (생물의약품평가자료집 | 37) | 세포조직공학제제팀 자료실 간행물 | / | , | 지침/148 | KFDA Bio Handbook | 2005 | 11-1470000-000873-01 | (생물의약품평가자료집 | 26) | 생명공학의약품과 | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/91 |\n| 세포치료제의 임상시험 | 사례분석 | 2007 | 11-1470000-001586-14 | (생물의약품평가자료집 | 50) | 세포조직공학제제팀 자료실 간행물 | / | , | 지침/259 |\n| 생명공학의약품의 | 안전성 유효성 평가 - | ․ | 비교동등성 평가시 | 고려사항 |\n| 정맥주사용 | B형 간염 사람면역글로불린제제의 | 안전성․유효성 평가 가이드라인 |\n| 임상시험의 전반적인 | 고려사항 | 2004 | 11-1470000-000681-01 | (생물의약품평가자료집 | 12) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/79 | 2005 | 11-1470000-000871-01 | (생물의약품평가자료집 | 25) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/103 |\n| 생명공학의약품 | 생산세포주 관리를 위한 | 시험방법 | 2007 | 11-1470000-000903-01 | (생물의약품평가자료집 | 48) | 재조합의약품팀 | 자료실 간행물 | / | , | 지침/236 | 생물의약품의 독성평가 | 사례분석 | 2004 | 11-1470000-000680-01 | (생물의약품평가자료집 | 11) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/77 |\n**════════════════════════════════════════════**\n| 유전자치료제의 | 안전성평가 2005 | 2005 | 11-1470000-000677-14 | (생물의약품평가자료집 | 24) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/104 |\n| 발 | 행 | 일 | 년 | 월 | : | 2008 | 12 |\n| 2006 | 11-1470000-001144-01 | (생물의약품평가자료집 | 35) | 자료실 간행물 | / | , | 지침/146 |\n| 발 | 행 | 기 | 관 | 식품의약품안전청 | : |\n| 백신의 안전성 유효성 | ․ | 평가 2005 | 2005 | 11-1470000-000870-01 | (생물의약품평가자료집 | 23) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/102 | 단클론항체의약품의 | 평가가이드 | 2005 | 11-1470000-000851-01 | (생물의약품평가가이드 | 9) | 자료실 간행물 | / | , | 지침/74 |\n\n**[표 끝]**\n\n생명공학의약품과\n\n생물의약품평가과\n\n국립독성연구원\n\n생화학약리과\n\nTNF 길항제 사용시\n\n잠복결핵 치료지침\n\n2005\n\n11-1470000-000686-01\n\n(생물의약품평가가이드\n\n8)\n\n생물의약품평가과\n\n자료실 간행물\n\n/\n\n,\n\n지침/65\n\nDNA 백신의 평가지침서\n\n2004\n\n11-1470000-000669-01\n\n(생물의약품평가가이드\n\n7)\n\n생명공학의약품과\n\n생물의약품평가과\n\n자료실 간행물\n\n/\n\n,\n\n지침/60\n\n생명공학의약품/\n\n생물학적제제의\n\n규격설정에 관한 가이드\n\n2004\n\n11-1470000-000538-01\n\n(생물의약품평가가이드\n\n6)\n\n생명공학의약품과\n\n자료실 간행물\n\n/\n\n,\n\n지침/59\n\n- - 15 -\n<!-- PAGE_23 -->\n###### 생물의약품평가자료집 시리즈\n\n<!-- PAGE_23 -->\n###### 3.\n\n행정간행물 제목\n\n발행\n\n연도\n\n행정간행물 번호\n\n발행과\n\n홈페이지\n\n게재 상태\n\n핵산증폭검사법 검증\n\n가이드라인\n\n2003\n\n11-1470000-000277-01\n\n(생물의약품평가가이드\n\n5)\n\n혈액제제과\n\n자료실 간행물\n\n/\n\n,\n\n지침/44\n\n혈장분획제제\n\n품질평가 가이드\n\n2002\n\n11-1470000-000154-01\n\n(생물의약품평가가이드\n\n4)\n\n혈액제제과\n\n자료실 간행물\n\n/\n\n,\n\n지침/27\n\n2002\n\n11-1470000-000144-01\n\n(생물의약품평가가이드\n\n3)\n\n백신과\n\n바이러스제제과\n\n(\n\n)\n\n舊\n\n자료실 간행물\n\n/\n\n,\n\n지침/19\n\n생물의약품의 생산에\n\n사용되는 세포기질관리\n\n가이드\n\n2002\n\n11-1470000-000140-14\n\n(생물의약품평가가이드\n\n2)\n\n생명공학의약품과\n\n생물공학과\n\n(\n\n)\n\n舊\n\n자료실 간행물\n\n/\n\n,\n\n지침/17\n\n유전자치료제의\n\n품질평가 가이드\n\n2001\n\n11-1470000-000074-14\n\n(생물의약품평가가이드\n\n1)\n\n생명공학의약품과\n\n생물공학과\n\n(\n\n)\n\n舊\n\n자료실 간행물\n\n/\n\n,\n\n지침/54\n\n세포치료제의 비임상시험\n\n사례분석\n\n2007\n\n11-1470000-001585-14\n\n(생물의약품평가자료집\n\n49)\n\n세포조직공학제제팀 자료실 간행물\n\n/\n\n,\n\n지침/259\n\n혈액제제의 자가 기준 및\n\n시험방법 작성 지침\n\n2007\n\n11-1470000-001457-01\n\n(생물의약품평가자료집\n\n47)\n\n혈액제제팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/195\n\n혈관질환 등의\n\n유전자치료제\n\n비임상 임상시험 사례분석\n\n∙\n\n2007\n\n11-1470000-001441-10\n\n(생물의약품평가자료집\n\n46)\n\n유전자치료제팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/233\n\n항암 유전자치료제\n\n비임상 임상시험 사례분석\n\n∙\n\n2007\n\n11-1470000-001440-10\n\n(생물의약품평가자료집\n\n45)\n\n유전자치료제팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/209\n\n백신 임상 평가 시\n\n고려사항 2007\n\n2007\n\n11-1470000-001446-10\n\n(생물의약품평가자료집\n\n44)\n\n세균백신팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/192\n\n- - 16 -\n행정간행물 제목\n\n발행\n\n연도\n\n행정간행물 번호\n\n발행과\n\n홈페이지\n\n게재 상태\n\n생바이러스 백신의\n\n자가 기준 및 시험방법\n\n작성 지침\n\n2007\n\n11-1470000-001345-01\n\n(생물의약품평가자료집\n\n43)\n\n바이러스백신팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/172\n\n불활화 바이러스 백신의\n\n자가 기준 및 시험방법\n\n작성 지침\n\n2007\n\n11-1470000-001346-01\n\n(생물의약품평가자료집\n\n42)\n\n바이러스백신팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/173\n\n백신의 임상 평가 시\n\n고려사항\n\n2006\n\n11-1470000-001163-01\n\n(생물의약품평가자료집\n\n41)\n\n바이러스백신팀\n\n세균백신팀\n\n자료실 간행물\n\n/\n\n,\n\n지침 150\n\nDNA 백신의 평가\n\n:\n\nWHO 및 미국\n\nFDA\n\n가이드라인\n\n2006\n\n11-1470000-001142-01\n\n(생물의약품평가자료집\n\n40)\n\n유전자치료제팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/168\n\n유전자치료 임상시험-\n\n지연성 이상반응에 대비한\n\n환자 관찰\n\n2006\n\n11-1470000-001141-01\n\n(생물의약품평가자료집\n\n39)\n\n유전자치료제팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/157\n\n세포치료제 안전성 유효성\n\n․\n\n및 품질 평가시 고려사항\n\n2006\n\n2006\n\n11-1470000-001145-01\n\n(생물의약품평가자료집\n\n36)\n\n세포조직공학제제팀 자료실 간행물\n\n/\n\n,\n\n지침/147\n\n세포조직공학제제\n\n(세포치료제\n\n,\n\n조직공학제제,\n\n이종이식제제\n\n가이드라인\n\n)\n\n세포조직공학제제팀\n\n세균백신팀\n\n바이러스백신팀\n\n혈액제제팀\n\n재조합의약품팀\n\n유전자치료제팀\n\n생물 생명공학의약품의\n\n․\n\n독성평가 사례분석 2006\n\n2006\n\n11-1470000-001143-01\n\n(생물의약품평가자료집\n\n34)\n\n세포조직공학제제팀 자료실 간행물\n\n/\n\n,\n\n지침/145\n\n만성 피부 궤양 및 화상\n\n치료제 개발을 위한\n\n전임상 및\n\n임상 관련\n\n고려사항\n\n2006\n\n11-1470000-001228-01\n\n(생물의약품평가자료집\n\n33)\n\n세포조직공학제제팀 자료실 간행물\n\n/\n\n,\n\n지침/144\n\n- - 17 -\n행정간행물 제목\n\n발행\n\n연도\n\n행정간행물 번호\n\n발행과\n\n홈페이지\n\n게재 상태\n\n미국 약전 세포치료제,\n\n유전자치료제 및\n\n조직공학제제의 보조물질\n\n(ancillary product)\n\n평가자료집\n\n2006\n\n11-1470000-001109-01\n\n(생물의약품평가자료집\n\n32)\n\n세포조직공학제제팀\n\n유전자치료제팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/143\n\n미국 약전 세포치료제 및\n\n유전자치료제\n\n2006\n\n11-1470000-001108-01\n\n(생물의약품평가자료집\n\n31)\n\n세포조직공학제제팀\n\n유전자치료제팀\n\n자료실 간행물\n\n/\n\n,\n\n지침 142\n\n백신의 안전성 유효성\n\n․\n\n평가 2006\n\n2006\n\n11-1470000-001125-01\n\n(생물의약품평가자료집\n\n30)\n\n세균백신팀\n\n바이러스백신팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/141\n\n인플루엔자 백신\n\n자가 기준 및 시험방법\n\n작성 지침\n\n2006\n\n11-1470000-001114-01\n\n(생물의약품평가자료집\n\n29)\n\n바이러스백신팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/138\n\n생명공학의약품 길라잡이\n\n2005\n\n11-1470000-000893-01\n\n(생물의약품평가자료집\n\n27)\n\n재조합의약품팀\n\n생명공학의약품과\n\n(\n\n)\n\n舊\n\n자료실 간행물\n\n/\n\n,\n\n지침/109\n\n탄저백신의 안전성 유효성\n\n․\n\n평가 2005\n\n2005\n\n11-1470000-000867-01\n\n(생물의약품평가자료집\n\n22)\n\n생물의약품평가과\n\n자료실 간행물\n\n/\n\n,\n\n지침/99\n\n인플루엔자백신의\n\n안전성 유효성 평가 2005\n\n․\n\n2005\n\n11-1470000-000866-01\n\n(생물의약품평가자료집\n\n21)\n\n생물의약품평가과\n\n자료실 간행물\n\n/\n\n,\n\n지침/98\n\n항암 생물의약품의\n\n안전성 유효성 평가\n\n․\n\n2005\n\n11-1470000-000865-01\n\n(생물의약품평가자료집\n\n20)\n\n생물의약품평가과\n\n자료실 간행물\n\n/\n\n,\n\n지침/101\n\n- - 18 -\n행정간행물 제목\n\n발행\n\n연도\n\n행정간행물 번호\n\n발행과\n\n홈페이지\n\n게재 상태\n\n우수심사기준\n\n2005\n\n11-1470000-000684-01\n\n(생물의약품평가자료집\n\n19)\n\n생물의약품평가과\n\n자료실 간행물\n\n/\n\n,\n\n지침/100\n\n사람 세포\n\n조직\n\n세포 및\n\n,\n\n,\n\n조직유래제품\n\n: 미\n\nFDA\n\n시설등록 및 등재 규정\n\n2005\n\n11-1470000-000860-01\n\n(생물의약품평가자료집\n\n18)\n\n생명공학의약품과\n\n인체조직정보\n\n방 자료게시판\n\n/\n\n/\n\n4\n\n사람 세포\n\n조직\n\n세포 및\n\n,\n\n,\n\n조직유래제품 제조시설의\n\n미\n\nFDA 우수조직관리기준\n\n2005\n\n11-1470000-000859-01\n\n(생물의약품평가자료집\n\n17)\n\n생명공학의약품과\n\n인체조직정보\n\n방 자료게시판\n\n/\n\n/\n\n5\n\n세포치료제 및\n\n유전자치료제 자료집\n\n2004\n\n11-1470000-000685-01\n\n(생물의약품평가자료집\n\n16)\n\n생물의약품평가과\n\n자료실 간행물\n\n/\n\n,\n\n지침/78\n\n생명공학의약품등의\n\n1상\n\n임상시험계획 승인 신청시\n\n고려사항\n\n2004\n\n11-1470000-000683-01\n\n(생물의약품평가자료집\n\n14)\n\n생물의약품평가과\n\n자료실 간행물\n\n/\n\n,\n\n지침/83\n\n생물의약품등의\n\n효능입증을 위한 고려사항 2004\n\n11-1470000-000682-01\n\n(생물의약품평가자료집\n\n13)\n\n생물의약품평가과\n\n자료실 간행물\n\n/\n\n,\n\n지침/82\n\n혈액제제의 안전성 유효성\n\n․\n\n평가 2004\n\n2004\n\n11-1470000-000679-14\n\n(생물의약품평가자료집\n\n10)\n\n생물의약품평가과\n\n자료실 간행물\n\n/\n\n,\n\n지침/76\n\n세포치료제의\n\n안전성 유효성 평가시\n\n․\n\n고려사항 2004\n\n2004\n\n11-1470000-000678-14\n\n(생물의약품평가자료집\n\n9)\n\n생물의약품평가과\n\n자료실 간행물\n\n/\n\n,\n\n지침/75\n\n유전자치료제의\n\n안전성평가 2004\n\n2004\n\n11-1470000-000677-14\n\n(생물의약품평가자료집\n\n8)\n\n생물의약품평가과\n\n자료실 간행물\n\n/\n\n,\n\n지침/72\n\n생명공학의약품의\n\n안전성평가(4)\n\n2004\n\n11-1470000-000676-14\n\n(생물의약품평가자료집\n\n7)\n\n생물의약품평가과\n\n자료실 간행물\n\n/\n\n,\n\n지침/71\n\n- - 19 -\n행정간행물 제목\n\n발행\n\n연도\n\n행정간행물 번호\n\n발행과\n\n홈페이지\n\n게재 상태\n\n생명공학의약품의\n\n안전성평가(3)\n\n2004\n\n11-1470000-000676-14\n\n(생물의약품평가자료집\n\n6)\n\n생물의약품평가과\n\n자료실 간행물\n\n/\n\n,\n\n지침/70\n\n생명공학의약품의\n\n안전성평가(2)\n\n2004\n\n11-1470000-000676-14\n\n(생물의약품평가자료집\n\n5)\n\n생물의약품평가과\n\n자료실 간행물\n\n/\n\n,\n\n지침/69\n\n생명공학의약품의\n\n안전성평가(1)\n\n2004\n\n11-1470000-000676-14\n\n(생물의약품평가자료집\n\n4)\n\n생물의약품평가과\n\n자료실 간행물\n\n/\n\n,\n\n지침/68\n\n백신의 안전성평가 2004\n\n2004\n\n11-1470000-000675-14\n\n(생물의약품평가자료집\n\n3)\n\n생물의약품평가과\n\n자료실 간행물\n\n/\n\n,\n\n지침/67\n\n진단제제의\n\n기준\n\nHBsAg\n\n‘\n\n및 시험방법\n\n’ 작성 지침\n\n2004\n\n11-1470000-000143-01\n\n(생물의약품평가자료집\n\n2)\n\n백신과\n\n자료실 간행물\n\n/\n\n,\n\n지침/48\n\n<!-- PAGE_28 -->\n###### 발\n\n<!-- PAGE_28 -->\n###### 행\n\n<!-- PAGE_28 -->\n###### 부\n\n<!-- PAGE_28 -->\n###### 서\n\n<!-- PAGE_28 -->\n###### 생물의약품국 혈액제제과\n\n<!-- PAGE_28 -->\n###### :\n\n════════════════════════════════════════════\n\n<!-- PAGE_28 -->\n###### 연\n\n<!-- PAGE_28 -->\n###### 락\n\n<!-- PAGE_28 -->\n###### 처\n\n<!-- PAGE_28 -->\n###### 식품의약품안전청 혈액제제과\n\n<!-- PAGE_28 -->\n###### :\n\n<!-- PAGE_28 -->\n###### 전\n\n<!-- PAGE_28 -->\n###### 화\n\n<!-- PAGE_28 -->\n###### 번\n\n<!-- PAGE_28 -->\n###### 호 :\n\n<!-- PAGE_28 -->\n###### 02) 380-1715, 1765\n\n<!-- PAGE_28 -->\n###### 팩\n\n<!-- PAGE_28 -->\n###### 스\n\n<!-- PAGE_28 -->\n###### 번\n\n<!-- PAGE_28 -->\n###### 호 :\n\n<!-- PAGE_28 -->\n###### 02) 386-6584\n",
  "chunks": [
    {
      "chunk_id": "chunk_001",
      "text": "<!-- PAGE_1 -->\n# Biopharmaceuticals\n\n<!-- PAGE_1 -->\n# Biopharmaceuticals\n\n<!-- PAGE_1 -->\n# 정맥주사용 B형 간염 사람면역글로불린\n\n<!-- PAGE_1 -->\n# 제제의 안전성·유효성 평가 가이드라인\n\n<!-- PAGE_1 -->\n# [민원인 안내서]\n\n<!-- PAGE_1 -->\n# Biopharmaceuticals\n\n<!-- PAGE_1 -->\n# Biopharmaceuticals\n\n- 2008.12.\n",
      "metadata": {
        "source": "(가이드라인-005)_정맥주사용+B형간염+사람면역글로불린제제의+안전성유효성+평가+가이드라인.pdf",
        "chunk_index": 0,
        "window_size": 3,
        "char_count": 272,
        "word_count": 44,
        "page_number": 1,
        "window_text": "<!-- PAGE_1 -->\n# Biopharmaceuticals\n\n<!-- PAGE_1 -->\n# Biopharmaceuticals\n\n<!-- PAGE_1 -->\n# 정맥주사용 B형 간염 사람면역글로불린\n\n<!-- PAGE_1 -->\n# 제제의 안전성·유효성 평가 가이드라인\n\n<!-- PAGE_1 -->\n# [민원인 안내서]\n\n<!-- PAGE_1 -->\n# Biopharmaceuticals\n\n<!-- PAGE_1 -->\n# Biopharmaceuticals\n\n- 2008.12.\n 제·개정 이력서\n\n<!-- PAGE_2 -->\n###### 연번\n\n<!-- PAGE_2 -->\n###### 제·개정번호\n\n<!-- PAGE_2 -->\n###### 승인일자\n\n<!-- PAGE_2 -->\n###### 주요내용\n\n<!-- PAGE_2 -->\n###### 1\n\n<!-- PAGE_2 -->\n###### B1-2008-3-020\n\n<!-- PAGE_2 -->\n###### 2008.12\n\n<!-- PAGE_2 -->\n###### 제정\n\n<!-- PAGE_2 -->\n###### 2\n\n<!-- PAGE_2 -->\n###### 안내서-0256-01\n\n<!-- PAGE_2 -->\n###### 2017.06.01\n\n<!-- PAGE_2 -->\n###### 「식품의약품안전처 지침서등의 관리에 관한\n\n<!-- PAGE_2 -->\n###### 규정」 개정에 따른 등록번호 일괄 정비\n\n<!-- PAGE_2 -->\n###### 정맥주사용 B형 간염 사람면역글로불린제제의\n\n<!-- PAGE_2 -->\n###### 안전성·유효성 평가 가이드라인(민원인 안내서)\n\n지침‧가이드라인‧해설서 (지침 등) 재분류 점검표\n\n<!-- PAGE_3 -->\n###### 지침 등 명칭\n\n<!-- PAGE_3 -->\n###### 정맥주사용 B형 간염 사람면역글로불린제제의 안전성·유효성 평가 가이드라인(민원인 안내서)\n\n<!-- PAGE_3 -->\n###### 아래에 해당하는 사항에 체크하여 주시기 바랍니다.\n\n **[표 시작]**\n\n| □ 법령(법‧시행령‧시행규칙) 또는 행정규칙(고시‧훈령‧예규) 등을 | □ 예 | ■ 아니오 |\n| --- | --- | --- |\n| 스제와 | HBIG의 병용요법이 이용되고 있다 | .  | 편 집 위 원 장 | 김 승 희 | : |\n**및 수술 후의 투여 용량을 신중하게 결정하여야 한다.",
        "original_sentence": "<!-- PAGE_1 -->\n# Biopharmaceuticals\n\n<!-- PAGE_1 -->\n# Biopharmaceuticals\n\n<!-- PAGE_1 -->\n# 정맥주사용 B형 간염 사람면역글로불린\n\n<!-- PAGE_1 -->\n# 제제의 안전성·유효성 평가 가이드라인\n\n<!-- PAGE_1 -->\n# [민원인 안내서]\n\n<!-- PAGE_1 -->\n# Biopharmaceuticals\n\n<!-- PAGE_1 -->\n# Biopharmaceuticals\n\n- 2008.12.\n"
      }
    },
    {
      "chunk_id": "chunk_002",
      "text": "제·개정 이력서\n\n<!-- PAGE_2 -->\n###### 연번\n\n<!-- PAGE_2 -->\n###### 제·개정번호\n\n<!-- PAGE_2 -->\n###### 승인일자\n\n<!-- PAGE_2 -->\n###### 주요내용\n\n<!-- PAGE_2 -->\n###### 1\n\n<!-- PAGE_2 -->\n###### B1-2008-3-020\n\n<!-- PAGE_2 -->\n###### 2008.12\n\n<!-- PAGE_2 -->\n###### 제정\n\n<!-- PAGE_2 -->\n###### 2\n\n<!-- PAGE_2 -->\n###### 안내서-0256-01\n\n<!-- PAGE_2 -->\n###### 2017.06.01\n\n<!-- PAGE_2 -->\n###### 「식품의약품안전처 지침서등의 관리에 관한\n\n<!-- PAGE_2 -->\n###### 규정」 개정에 따른 등록번호 일괄 정비\n\n<!-- PAGE_2 -->\n###### 정맥주사용 B형 간염 사람면역글로불린제제의\n\n<!-- PAGE_2 -->\n###### 안전성·유효성 평가 가이드라인(민원인 안내서)\n\n지침‧가이드라인‧해설서 (지침 등) 재분류 점검표\n\n<!-- PAGE_3 -->\n###### 지침 등 명칭\n\n<!-- PAGE_3 -->\n###### 정맥주사용 B형 간염 사람면역글로불린제제의 안전성·유효성 평가 가이드라인(민원인 안내서)\n\n<!-- PAGE_3 -->\n###### 아래에 해당하는 사항에 체크하여 주시기 바랍니다.\n\n",
      "metadata": {
        "source": "(가이드라인-005)_정맥주사용+B형간염+사람면역글로불린제제의+안전성유효성+평가+가이드라인.pdf",
        "chunk_index": 1,
        "window_size": 3,
        "char_count": 724,
        "word_count": 125,
        "page_number": 2,
        "window_text": "<!-- PAGE_1 -->\n# Biopharmaceuticals\n\n<!-- PAGE_1 -->\n# Biopharmaceuticals\n\n<!-- PAGE_1 -->\n# 정맥주사용 B형 간염 사람면역글로불린\n\n<!-- PAGE_1 -->\n# 제제의 안전성·유효성 평가 가이드라인\n\n<!-- PAGE_1 -->\n# [민원인 안내서]\n\n<!-- PAGE_1 -->\n# Biopharmaceuticals\n\n<!-- PAGE_1 -->\n# Biopharmaceuticals\n\n- 2008.12.\n 제·개정 이력서\n\n<!-- PAGE_2 -->\n###### 연번\n\n<!-- PAGE_2 -->\n###### 제·개정번호\n\n<!-- PAGE_2 -->\n###### 승인일자\n\n<!-- PAGE_2 -->\n###### 주요내용\n\n<!-- PAGE_2 -->\n###### 1\n\n<!-- PAGE_2 -->\n###### B1-2008-3-020\n\n<!-- PAGE_2 -->\n###### 2008.12\n\n<!-- PAGE_2 -->\n###### 제정\n\n<!-- PAGE_2 -->\n###### 2\n\n<!-- PAGE_2 -->\n###### 안내서-0256-01\n\n<!-- PAGE_2 -->\n###### 2017.06.01\n\n<!-- PAGE_2 -->\n###### 「식품의약품안전처 지침서등의 관리에 관한\n\n<!-- PAGE_2 -->\n###### 규정」 개정에 따른 등록번호 일괄 정비\n\n<!-- PAGE_2 -->\n###### 정맥주사용 B형 간염 사람면역글로불린제제의\n\n<!-- PAGE_2 -->\n###### 안전성·유효성 평가 가이드라인(민원인 안내서)\n\n지침‧가이드라인‧해설서 (지침 등) 재분류 점검표\n\n<!-- PAGE_3 -->\n###### 지침 등 명칭\n\n<!-- PAGE_3 -->\n###### 정맥주사용 B형 간염 사람면역글로불린제제의 안전성·유효성 평가 가이드라인(민원인 안내서)\n\n<!-- PAGE_3 -->\n###### 아래에 해당하는 사항에 체크하여 주시기 바랍니다.\n\n **[표 시작]**\n\n| □ 법령(법‧시행령‧시행규칙) 또는 행정규칙(고시‧훈령‧예규) 등을 | □ 예 | ■ 아니오 |\n| --- | --- | --- |\n| 스제와 | HBIG의 병용요법이 이용되고 있다 | .  | 편 집 위 원 장 | 김 승 희 | : |\n**및 수술 후의 투여 용량을 신중하게 결정하여야 한다. **\n**나열하는 것입니까?",
        "original_sentence": "제·개정 이력서\n\n<!-- PAGE_2 -->\n###### 연번\n\n<!-- PAGE_2 -->\n###### 제·개정번호\n\n<!-- PAGE_2 -->\n###### 승인일자\n\n<!-- PAGE_2 -->\n###### 주요내용\n\n<!-- PAGE_2 -->\n###### 1\n\n<!-- PAGE_2 -->\n###### B1-2008-3-020\n\n<!-- PAGE_2 -->\n###### 2008.12\n\n<!-- PAGE_2 -->\n###### 제정\n\n<!-- PAGE_2 -->\n###### 2\n\n<!-- PAGE_2 -->\n###### 안내서-0256-01\n\n<!-- PAGE_2 -->\n###### 2017.06.01\n\n<!-- PAGE_2 -->\n###### 「식품의약품안전처 지침서등의 관리에 관한\n\n<!-- PAGE_2 -->\n###### 규정」 개정에 따른 등록번호 일괄 정비\n\n<!-- PAGE_2 -->\n###### 정맥주사용 B형 간염 사람면역글로불린제제의\n\n<!-- PAGE_2 -->\n###### 안전성·유효성 평가 가이드라인(민원인 안내서)\n\n지침‧가이드라인‧해설서 (지침 등) 재분류 점검표\n\n<!-- PAGE_3 -->\n###### 지침 등 명칭\n\n<!-- PAGE_3 -->\n###### 정맥주사용 B형 간염 사람면역글로불린제제의 안전성·유효성 평가 가이드라인(민원인 안내서)\n\n<!-- PAGE_3 -->\n###### 아래에 해당하는 사항에 체크하여 주시기 바랍니다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_003",
      "text": "**[표 시작]**\n\n| □ 법령(법‧시행령‧시행규칙) 또는 행정규칙(고시‧훈령‧예규) 등을 | □ 예 | ■ 아니오 |\n| --- | --- | --- |\n| 스제와 | HBIG의 병용요법이 이용되고 있다 | . ",
      "metadata": {
        "source": "(가이드라인-005)_정맥주사용+B형간염+사람면역글로불린제제의+안전성유효성+평가+가이드라인.pdf",
        "chunk_index": 2,
        "window_size": 3,
        "char_count": 120,
        "word_count": 31,
        "page_number": 10,
        "window_text": "<!-- PAGE_1 -->\n# Biopharmaceuticals\n\n<!-- PAGE_1 -->\n# Biopharmaceuticals\n\n<!-- PAGE_1 -->\n# 정맥주사용 B형 간염 사람면역글로불린\n\n<!-- PAGE_1 -->\n# 제제의 안전성·유효성 평가 가이드라인\n\n<!-- PAGE_1 -->\n# [민원인 안내서]\n\n<!-- PAGE_1 -->\n# Biopharmaceuticals\n\n<!-- PAGE_1 -->\n# Biopharmaceuticals\n\n- 2008.12.\n 제·개정 이력서\n\n<!-- PAGE_2 -->\n###### 연번\n\n<!-- PAGE_2 -->\n###### 제·개정번호\n\n<!-- PAGE_2 -->\n###### 승인일자\n\n<!-- PAGE_2 -->\n###### 주요내용\n\n<!-- PAGE_2 -->\n###### 1\n\n<!-- PAGE_2 -->\n###### B1-2008-3-020\n\n<!-- PAGE_2 -->\n###### 2008.12\n\n<!-- PAGE_2 -->\n###### 제정\n\n<!-- PAGE_2 -->\n###### 2\n\n<!-- PAGE_2 -->\n###### 안내서-0256-01\n\n<!-- PAGE_2 -->\n###### 2017.06.01\n\n<!-- PAGE_2 -->\n###### 「식품의약품안전처 지침서등의 관리에 관한\n\n<!-- PAGE_2 -->\n###### 규정」 개정에 따른 등록번호 일괄 정비\n\n<!-- PAGE_2 -->\n###### 정맥주사용 B형 간염 사람면역글로불린제제의\n\n<!-- PAGE_2 -->\n###### 안전성·유효성 평가 가이드라인(민원인 안내서)\n\n지침‧가이드라인‧해설서 (지침 등) 재분류 점검표\n\n<!-- PAGE_3 -->\n###### 지침 등 명칭\n\n<!-- PAGE_3 -->\n###### 정맥주사용 B형 간염 사람면역글로불린제제의 안전성·유효성 평가 가이드라인(민원인 안내서)\n\n<!-- PAGE_3 -->\n###### 아래에 해당하는 사항에 체크하여 주시기 바랍니다.\n\n **[표 시작]**\n\n| □ 법령(법‧시행령‧시행규칙) 또는 행정규칙(고시‧훈령‧예규) 등을 | □ 예 | ■ 아니오 |\n| --- | --- | --- |\n| 스제와 | HBIG의 병용요법이 이용되고 있다 | .  | 편 집 위 원 장 | 김 승 희 | : |\n**및 수술 후의 투여 용량을 신중하게 결정하여야 한다. **\n**나열하는 것입니까? **\n| 세포주로부터 개발한 | 생물공학제제의 | 바이러스안전성 평가 | 가이드 |\n| 269/95 rev. ",
        "original_sentence": "**[표 시작]**\n\n| □ 법령(법‧시행령‧시행규칙) 또는 행정규칙(고시‧훈령‧예규) 등을 | □ 예 | ■ 아니오 |\n| --- | --- | --- |\n| 스제와 | HBIG의 병용요법이 이용되고 있다 | . "
      }
    },
    {
      "chunk_id": "chunk_004",
      "text": "| 편 집 위 원 장 | 김 승 희 | : |\n**및 수술 후의 투여 용량을 신중하게 결정하여야 한다.",
      "metadata": {
        "source": "(가이드라인-005)_정맥주사용+B형간염+사람면역글로불린제제의+안전성유효성+평가+가이드라인.pdf",
        "chunk_index": 3,
        "window_size": 3,
        "char_count": 57,
        "word_count": 21,
        "page_number": 9,
        "window_text": "<!-- PAGE_1 -->\n# Biopharmaceuticals\n\n<!-- PAGE_1 -->\n# Biopharmaceuticals\n\n<!-- PAGE_1 -->\n# 정맥주사용 B형 간염 사람면역글로불린\n\n<!-- PAGE_1 -->\n# 제제의 안전성·유효성 평가 가이드라인\n\n<!-- PAGE_1 -->\n# [민원인 안내서]\n\n<!-- PAGE_1 -->\n# Biopharmaceuticals\n\n<!-- PAGE_1 -->\n# Biopharmaceuticals\n\n- 2008.12.\n 제·개정 이력서\n\n<!-- PAGE_2 -->\n###### 연번\n\n<!-- PAGE_2 -->\n###### 제·개정번호\n\n<!-- PAGE_2 -->\n###### 승인일자\n\n<!-- PAGE_2 -->\n###### 주요내용\n\n<!-- PAGE_2 -->\n###### 1\n\n<!-- PAGE_2 -->\n###### B1-2008-3-020\n\n<!-- PAGE_2 -->\n###### 2008.12\n\n<!-- PAGE_2 -->\n###### 제정\n\n<!-- PAGE_2 -->\n###### 2\n\n<!-- PAGE_2 -->\n###### 안내서-0256-01\n\n<!-- PAGE_2 -->\n###### 2017.06.01\n\n<!-- PAGE_2 -->\n###### 「식품의약품안전처 지침서등의 관리에 관한\n\n<!-- PAGE_2 -->\n###### 규정」 개정에 따른 등록번호 일괄 정비\n\n<!-- PAGE_2 -->\n###### 정맥주사용 B형 간염 사람면역글로불린제제의\n\n<!-- PAGE_2 -->\n###### 안전성·유효성 평가 가이드라인(민원인 안내서)\n\n지침‧가이드라인‧해설서 (지침 등) 재분류 점검표\n\n<!-- PAGE_3 -->\n###### 지침 등 명칭\n\n<!-- PAGE_3 -->\n###### 정맥주사용 B형 간염 사람면역글로불린제제의 안전성·유효성 평가 가이드라인(민원인 안내서)\n\n<!-- PAGE_3 -->\n###### 아래에 해당하는 사항에 체크하여 주시기 바랍니다.\n\n **[표 시작]**\n\n| □ 법령(법‧시행령‧시행규칙) 또는 행정규칙(고시‧훈령‧예규) 등을 | □ 예 | ■ 아니오 |\n| --- | --- | --- |\n| 스제와 | HBIG의 병용요법이 이용되고 있다 | .  | 편 집 위 원 장 | 김 승 희 | : |\n**및 수술 후의 투여 용량을 신중하게 결정하여야 한다. **\n**나열하는 것입니까? **\n| 세포주로부터 개발한 | 생물공학제제의 | 바이러스안전성 평가 | 가이드 |\n| 269/95 rev.  3), EMEA, 2001 | □ 단순한 사실을 대외적으로 알리는 공고의 내용입니까? ",
        "original_sentence": "| 편 집 위 원 장 | 김 승 희 | : |\n**및 수술 후의 투여 용량을 신중하게 결정하여야 한다."
      }
    },
    {
      "chunk_id": "chunk_005",
      "text": "**\n**나열하는 것입니까?",
      "metadata": {
        "source": "(가이드라인-005)_정맥주사용+B형간염+사람면역글로불린제제의+안전성유효성+평가+가이드라인.pdf",
        "chunk_index": 4,
        "window_size": 3,
        "char_count": 15,
        "word_count": 3,
        "page_number": 3,
        "window_text": "제·개정 이력서\n\n<!-- PAGE_2 -->\n###### 연번\n\n<!-- PAGE_2 -->\n###### 제·개정번호\n\n<!-- PAGE_2 -->\n###### 승인일자\n\n<!-- PAGE_2 -->\n###### 주요내용\n\n<!-- PAGE_2 -->\n###### 1\n\n<!-- PAGE_2 -->\n###### B1-2008-3-020\n\n<!-- PAGE_2 -->\n###### 2008.12\n\n<!-- PAGE_2 -->\n###### 제정\n\n<!-- PAGE_2 -->\n###### 2\n\n<!-- PAGE_2 -->\n###### 안내서-0256-01\n\n<!-- PAGE_2 -->\n###### 2017.06.01\n\n<!-- PAGE_2 -->\n###### 「식품의약품안전처 지침서등의 관리에 관한\n\n<!-- PAGE_2 -->\n###### 규정」 개정에 따른 등록번호 일괄 정비\n\n<!-- PAGE_2 -->\n###### 정맥주사용 B형 간염 사람면역글로불린제제의\n\n<!-- PAGE_2 -->\n###### 안전성·유효성 평가 가이드라인(민원인 안내서)\n\n지침‧가이드라인‧해설서 (지침 등) 재분류 점검표\n\n<!-- PAGE_3 -->\n###### 지침 등 명칭\n\n<!-- PAGE_3 -->\n###### 정맥주사용 B형 간염 사람면역글로불린제제의 안전성·유효성 평가 가이드라인(민원인 안내서)\n\n<!-- PAGE_3 -->\n###### 아래에 해당하는 사항에 체크하여 주시기 바랍니다.\n\n **[표 시작]**\n\n| □ 법령(법‧시행령‧시행규칙) 또는 행정규칙(고시‧훈령‧예규) 등을 | □ 예 | ■ 아니오 |\n| --- | --- | --- |\n| 스제와 | HBIG의 병용요법이 이용되고 있다 | .  | 편 집 위 원 장 | 김 승 희 | : |\n**및 수술 후의 투여 용량을 신중하게 결정하여야 한다. **\n**나열하는 것입니까? **\n| 세포주로부터 개발한 | 생물공학제제의 | 바이러스안전성 평가 | 가이드 |\n| 269/95 rev.  3), EMEA, 2001 | □ 단순한 사실을 대외적으로 알리는 공고의 내용입니까?  | □ 예 | ■ 아니오 |\n| 자인 등을 이용하여 적응증에 대한 용량 반응 관계를 확정하여야 한다 | - | . ",
        "original_sentence": "**\n**나열하는 것입니까?"
      }
    },
    {
      "chunk_id": "chunk_006",
      "text": "**\n| 세포주로부터 개발한 | 생물공학제제의 | 바이러스안전성 평가 | 가이드 |\n| 269/95 rev. ",
      "metadata": {
        "source": "(가이드라인-005)_정맥주사용+B형간염+사람면역글로불린제제의+안전성유효성+평가+가이드라인.pdf",
        "chunk_index": 5,
        "window_size": 3,
        "char_count": 61,
        "word_count": 15,
        "page_number": 2,
        "window_text": "**[표 시작]**\n\n| □ 법령(법‧시행령‧시행규칙) 또는 행정규칙(고시‧훈령‧예규) 등을 | □ 예 | ■ 아니오 |\n| --- | --- | --- |\n| 스제와 | HBIG의 병용요법이 이용되고 있다 | .  | 편 집 위 원 장 | 김 승 희 | : |\n**및 수술 후의 투여 용량을 신중하게 결정하여야 한다. **\n**나열하는 것입니까? **\n| 세포주로부터 개발한 | 생물공학제제의 | 바이러스안전성 평가 | 가이드 |\n| 269/95 rev.  3), EMEA, 2001 | □ 단순한 사실을 대외적으로 알리는 공고의 내용입니까?  | □ 예 | ■ 아니오 |\n| 자인 등을 이용하여 적응증에 대한 용량 반응 관계를 확정하여야 한다 | - | .  | 세포조직공학제제팀 | 재조합의약품팀 | 생물의약품안전팀 | 생물의약품관리팀 | 국립독성연구원 | 생명공학지원팀 |\n| 편 | 집 | 위 | 원 | 강석연 김순남 오호정 | 조민주 | : | , | , | , | , |\n| 25, 2007)”을 참고할 수 있다 | . ",
        "original_sentence": "**\n| 세포주로부터 개발한 | 생물공학제제의 | 바이러스안전성 평가 | 가이드 |\n| 269/95 rev. "
      }
    },
    {
      "chunk_id": "chunk_007",
      "text": "3), EMEA, 2001 | □ 단순한 사실을 대외적으로 알리는 공고의 내용입니까? ",
      "metadata": {
        "source": "(가이드라인-005)_정맥주사용+B형간염+사람면역글로불린제제의+안전성유효성+평가+가이드라인.pdf",
        "chunk_index": 6,
        "window_size": 3,
        "char_count": 48,
        "word_count": 11,
        "page_number": 2,
        "window_text": "| 편 집 위 원 장 | 김 승 희 | : |\n**및 수술 후의 투여 용량을 신중하게 결정하여야 한다. **\n**나열하는 것입니까? **\n| 세포주로부터 개발한 | 생물공학제제의 | 바이러스안전성 평가 | 가이드 |\n| 269/95 rev.  3), EMEA, 2001 | □ 단순한 사실을 대외적으로 알리는 공고의 내용입니까?  | □ 예 | ■ 아니오 |\n| 자인 등을 이용하여 적응증에 대한 용량 반응 관계를 확정하여야 한다 | - | .  | 세포조직공학제제팀 | 재조합의약품팀 | 생물의약품안전팀 | 생물의약품관리팀 | 국립독성연구원 | 생명공학지원팀 |\n| 편 | 집 | 위 | 원 | 강석연 김순남 오호정 | 조민주 | : | , | , | , | , |\n| 25, 2007)”을 참고할 수 있다 | .  |\n| 이종이식제제의 범위 및 | 원료동물에 대한 가이드 | 2006 | 11-1470000-001087-01 | (생물의약품평가가이드 | 15) | 투여 기간 | 4.3. ",
        "original_sentence": "3), EMEA, 2001 | □ 단순한 사실을 대외적으로 알리는 공고의 내용입니까? "
      }
    },
    {
      "chunk_id": "chunk_008",
      "text": "| □ 예 | ■ 아니오 |\n| 자인 등을 이용하여 적응증에 대한 용량 반응 관계를 확정하여야 한다 | - | . ",
      "metadata": {
        "source": "(가이드라인-005)_정맥주사용+B형간염+사람면역글로불린제제의+안전성유효성+평가+가이드라인.pdf",
        "chunk_index": 7,
        "window_size": 3,
        "char_count": 64,
        "word_count": 22,
        "page_number": 3,
        "window_text": "**\n**나열하는 것입니까? **\n| 세포주로부터 개발한 | 생물공학제제의 | 바이러스안전성 평가 | 가이드 |\n| 269/95 rev.  3), EMEA, 2001 | □ 단순한 사실을 대외적으로 알리는 공고의 내용입니까?  | □ 예 | ■ 아니오 |\n| 자인 등을 이용하여 적응증에 대한 용량 반응 관계를 확정하여야 한다 | - | .  | 세포조직공학제제팀 | 재조합의약품팀 | 생물의약품안전팀 | 생물의약품관리팀 | 국립독성연구원 | 생명공학지원팀 |\n| 편 | 집 | 위 | 원 | 강석연 김순남 오호정 | 조민주 | : | , | , | , | , |\n| 25, 2007)”을 참고할 수 있다 | .  |\n| 이종이식제제의 범위 및 | 원료동물에 대한 가이드 | 2006 | 11-1470000-001087-01 | (생물의약품평가가이드 | 15) | 투여 기간 | 4.3.  | □ 일회성 지시 또는 일일 명령에 해당하는 내용입니까? ",
        "original_sentence": "| □ 예 | ■ 아니오 |\n| 자인 등을 이용하여 적응증에 대한 용량 반응 관계를 확정하여야 한다 | - | . "
      }
    },
    {
      "chunk_id": "chunk_009",
      "text": "| 세포조직공학제제팀 | 재조합의약품팀 | 생물의약품안전팀 | 생물의약품관리팀 | 국립독성연구원 | 생명공학지원팀 |\n| 편 | 집 | 위 | 원 | 강석연 김순남 오호정 | 조민주 | : | , | , | , | , |\n| 25, 2007)”을 참고할 수 있다 | . ",
      "metadata": {
        "source": "(가이드라인-005)_정맥주사용+B형간염+사람면역글로불린제제의+안전성유효성+평가+가이드라인.pdf",
        "chunk_index": 8,
        "window_size": 3,
        "char_count": 151,
        "word_count": 46,
        "page_number": 10,
        "window_text": "**\n| 세포주로부터 개발한 | 생물공학제제의 | 바이러스안전성 평가 | 가이드 |\n| 269/95 rev.  3), EMEA, 2001 | □ 단순한 사실을 대외적으로 알리는 공고의 내용입니까?  | □ 예 | ■ 아니오 |\n| 자인 등을 이용하여 적응증에 대한 용량 반응 관계를 확정하여야 한다 | - | .  | 세포조직공학제제팀 | 재조합의약품팀 | 생물의약품안전팀 | 생물의약품관리팀 | 국립독성연구원 | 생명공학지원팀 |\n| 편 | 집 | 위 | 원 | 강석연 김순남 오호정 | 조민주 | : | , | , | , | , |\n| 25, 2007)”을 참고할 수 있다 | .  |\n| 이종이식제제의 범위 및 | 원료동물에 대한 가이드 | 2006 | 11-1470000-001087-01 | (생물의약품평가가이드 | 15) | 투여 기간 | 4.3.  | □ 일회성 지시 또는 일일 명령에 해당하는 내용입니까?  | □ 예 | ■ 아니오 |\n| 정 및 바이러스 불활화 제거 공정을 추가하게 된다 | / | . ",
        "original_sentence": "| 세포조직공학제제팀 | 재조합의약품팀 | 생물의약품안전팀 | 생물의약품관리팀 | 국립독성연구원 | 생명공학지원팀 |\n| 편 | 집 | 위 | 원 | 강석연 김순남 오호정 | 조민주 | : | , | , | , | , |\n| 25, 2007)”을 참고할 수 있다 | . "
      }
    },
    {
      "chunk_id": "chunk_010",
      "text": "|\n| 이종이식제제의 범위 및 | 원료동물에 대한 가이드 | 2006 | 11-1470000-001087-01 | (생물의약품평가가이드 | 15) | 투여 기간 | 4.3. ",
      "metadata": {
        "source": "(가이드라인-005)_정맥주사용+B형간염+사람면역글로불린제제의+안전성유효성+평가+가이드라인.pdf",
        "chunk_index": 9,
        "window_size": 3,
        "char_count": 97,
        "word_count": 22,
        "page_number": 2,
        "window_text": "3), EMEA, 2001 | □ 단순한 사실을 대외적으로 알리는 공고의 내용입니까?  | □ 예 | ■ 아니오 |\n| 자인 등을 이용하여 적응증에 대한 용량 반응 관계를 확정하여야 한다 | - | .  | 세포조직공학제제팀 | 재조합의약품팀 | 생물의약품안전팀 | 생물의약품관리팀 | 국립독성연구원 | 생명공학지원팀 |\n| 편 | 집 | 위 | 원 | 강석연 김순남 오호정 | 조민주 | : | , | , | , | , |\n| 25, 2007)”을 참고할 수 있다 | .  |\n| 이종이식제제의 범위 및 | 원료동물에 대한 가이드 | 2006 | 11-1470000-001087-01 | (생물의약품평가가이드 | 15) | 투여 기간 | 4.3.  | □ 일회성 지시 또는 일일 명령에 해당하는 내용입니까?  | □ 예 | ■ 아니오 |\n| 정 및 바이러스 불활화 제거 공정을 추가하게 된다 | / | .  |\n| 폐지대상 | 김판순 | 이내리 김관수 김정환 | 김진아 | , | , | , | , |\n| -001506-01, 생물의약품평가가이드 | 25), 2007 |\n| 여부 | □ 외국 규정을 번역하거나 설명하는 내용입니까? ",
        "original_sentence": "|\n| 이종이식제제의 범위 및 | 원료동물에 대한 가이드 | 2006 | 11-1470000-001087-01 | (생물의약품평가가이드 | 15) | 투여 기간 | 4.3. "
      }
    },
    {
      "chunk_id": "chunk_011",
      "text": "| □ 일회성 지시 또는 일일 명령에 해당하는 내용입니까? ",
      "metadata": {
        "source": "(가이드라인-005)_정맥주사용+B형간염+사람면역글로불린제제의+안전성유효성+평가+가이드라인.pdf",
        "chunk_index": 10,
        "window_size": 3,
        "char_count": 33,
        "word_count": 9,
        "page_number": 3,
        "window_text": "| □ 예 | ■ 아니오 |\n| 자인 등을 이용하여 적응증에 대한 용량 반응 관계를 확정하여야 한다 | - | .  | 세포조직공학제제팀 | 재조합의약품팀 | 생물의약품안전팀 | 생물의약품관리팀 | 국립독성연구원 | 생명공학지원팀 |\n| 편 | 집 | 위 | 원 | 강석연 김순남 오호정 | 조민주 | : | , | , | , | , |\n| 25, 2007)”을 참고할 수 있다 | .  |\n| 이종이식제제의 범위 및 | 원료동물에 대한 가이드 | 2006 | 11-1470000-001087-01 | (생물의약품평가가이드 | 15) | 투여 기간 | 4.3.  | □ 일회성 지시 또는 일일 명령에 해당하는 내용입니까?  | □ 예 | ■ 아니오 |\n| 정 및 바이러스 불활화 제거 공정을 추가하게 된다 | / | .  |\n| 폐지대상 | 김판순 | 이내리 김관수 김정환 | 김진아 | , | , | , | , |\n| -001506-01, 생물의약품평가가이드 | 25), 2007 |\n| 여부 | □ 외국 규정을 번역하거나 설명하는 내용입니까?  | □ 예 | ■ 아니오 |\n| 안전성유효성 평가 가이드라인 | ․ |\n**증에 맞는 임상시험을 수행하여야 한다.",
        "original_sentence": "| □ 일회성 지시 또는 일일 명령에 해당하는 내용입니까? "
      }
    },
    {
      "chunk_id": "chunk_012",
      "text": "| □ 예 | ■ 아니오 |\n| 정 및 바이러스 불활화 제거 공정을 추가하게 된다 | / | . ",
      "metadata": {
        "source": "(가이드라인-005)_정맥주사용+B형간염+사람면역글로불린제제의+안전성유효성+평가+가이드라인.pdf",
        "chunk_index": 11,
        "window_size": 3,
        "char_count": 54,
        "word_count": 20,
        "page_number": 3,
        "window_text": "| 세포조직공학제제팀 | 재조합의약품팀 | 생물의약품안전팀 | 생물의약품관리팀 | 국립독성연구원 | 생명공학지원팀 |\n| 편 | 집 | 위 | 원 | 강석연 김순남 오호정 | 조민주 | : | , | , | , | , |\n| 25, 2007)”을 참고할 수 있다 | .  |\n| 이종이식제제의 범위 및 | 원료동물에 대한 가이드 | 2006 | 11-1470000-001087-01 | (생물의약품평가가이드 | 15) | 투여 기간 | 4.3.  | □ 일회성 지시 또는 일일 명령에 해당하는 내용입니까?  | □ 예 | ■ 아니오 |\n| 정 및 바이러스 불활화 제거 공정을 추가하게 된다 | / | .  |\n| 폐지대상 | 김판순 | 이내리 김관수 김정환 | 김진아 | , | , | , | , |\n| -001506-01, 생물의약품평가가이드 | 25), 2007 |\n| 여부 | □ 외국 규정을 번역하거나 설명하는 내용입니까?  | □ 예 | ■ 아니오 |\n| 안전성유효성 평가 가이드라인 | ․ |\n**증에 맞는 임상시험을 수행하여야 한다. **\n| □ 정보제공 등 직원 교육용 자료입니까? ",
        "original_sentence": "| □ 예 | ■ 아니오 |\n| 정 및 바이러스 불활화 제거 공정을 추가하게 된다 | / | . "
      }
    },
    {
      "chunk_id": "chunk_013",
      "text": "|\n| 폐지대상 | 김판순 | 이내리 김관수 김정환 | 김진아 | , | , | , | , |\n| -001506-01, 생물의약품평가가이드 | 25), 2007 |\n| 여부 | □ 외국 규정을 번역하거나 설명하는 내용입니까? ",
      "metadata": {
        "source": "(가이드라인-005)_정맥주사용+B형간염+사람면역글로불린제제의+안전성유효성+평가+가이드라인.pdf",
        "chunk_index": 12,
        "window_size": 3,
        "char_count": 126,
        "word_count": 36,
        "page_number": 3,
        "window_text": "|\n| 이종이식제제의 범위 및 | 원료동물에 대한 가이드 | 2006 | 11-1470000-001087-01 | (생물의약품평가가이드 | 15) | 투여 기간 | 4.3.  | □ 일회성 지시 또는 일일 명령에 해당하는 내용입니까?  | □ 예 | ■ 아니오 |\n| 정 및 바이러스 불활화 제거 공정을 추가하게 된다 | / | .  |\n| 폐지대상 | 김판순 | 이내리 김관수 김정환 | 김진아 | , | , | , | , |\n| -001506-01, 생물의약품평가가이드 | 25), 2007 |\n| 여부 | □ 외국 규정을 번역하거나 설명하는 내용입니까?  | □ 예 | ■ 아니오 |\n| 안전성유효성 평가 가이드라인 | ․ |\n**증에 맞는 임상시험을 수행하여야 한다. **\n| □ 정보제공 등 직원 교육용 자료입니까?  | □ 예 | ■ 아니오 |\n| 암치료를 위한 수지상 | 세포치료제 평가 시 | 고려사항 | 2005 | 11-1470000-000888-01 | (생물의약품평가가이드 | 14) | 1470000-001176-01, 생물의약품평가가이드 | 20), 2006 | 재조합의약품팀 | 생명공학의약품과 | ( | ) | 舊 | 세포조직공학제제팀 |\n| 치료용 | 생명공학의약품등의 | 2상 | 및 | 3상 임상시험계획승인 | 신청시 고려사항 |\n| 피험자의 선정 | 4.1. ",
        "original_sentence": "|\n| 폐지대상 | 김판순 | 이내리 김관수 김정환 | 김진아 | , | , | , | , |\n| -001506-01, 생물의약품평가가이드 | 25), 2007 |\n| 여부 | □ 외국 규정을 번역하거나 설명하는 내용입니까? "
      }
    },
    {
      "chunk_id": "chunk_014",
      "text": "| □ 예 | ■ 아니오 |\n| 안전성유효성 평가 가이드라인 | ․ |\n**증에 맞는 임상시험을 수행하여야 한다.",
      "metadata": {
        "source": "(가이드라인-005)_정맥주사용+B형간염+사람면역글로불린제제의+안전성유효성+평가+가이드라인.pdf",
        "chunk_index": 13,
        "window_size": 3,
        "char_count": 63,
        "word_count": 19,
        "page_number": 3,
        "window_text": "| □ 일회성 지시 또는 일일 명령에 해당하는 내용입니까?  | □ 예 | ■ 아니오 |\n| 정 및 바이러스 불활화 제거 공정을 추가하게 된다 | / | .  |\n| 폐지대상 | 김판순 | 이내리 김관수 김정환 | 김진아 | , | , | , | , |\n| -001506-01, 생물의약품평가가이드 | 25), 2007 |\n| 여부 | □ 외국 규정을 번역하거나 설명하는 내용입니까?  | □ 예 | ■ 아니오 |\n| 안전성유효성 평가 가이드라인 | ․ |\n**증에 맞는 임상시험을 수행하여야 한다. **\n| □ 정보제공 등 직원 교육용 자료입니까?  | □ 예 | ■ 아니오 |\n| 암치료를 위한 수지상 | 세포치료제 평가 시 | 고려사항 | 2005 | 11-1470000-000888-01 | (생물의약품평가가이드 | 14) | 1470000-001176-01, 생물의약품평가가이드 | 20), 2006 | 재조합의약품팀 | 생명공학의약품과 | ( | ) | 舊 | 세포조직공학제제팀 |\n| 치료용 | 생명공학의약품등의 | 2상 | 및 | 3상 임상시험계획승인 | 신청시 고려사항 |\n| 피험자의 선정 | 4.1.  |\n| 상기 사항 중 어느 하나라도 ‘예’에 해당되는 경우에 폐지 대상입니다. ",
        "original_sentence": "| □ 예 | ■ 아니오 |\n| 안전성유효성 평가 가이드라인 | ․ |\n**증에 맞는 임상시험을 수행하여야 한다."
      }
    },
    {
      "chunk_id": "chunk_015",
      "text": "**\n| □ 정보제공 등 직원 교육용 자료입니까? ",
      "metadata": {
        "source": "(가이드라인-005)_정맥주사용+B형간염+사람면역글로불린제제의+안전성유효성+평가+가이드라인.pdf",
        "chunk_index": 14,
        "window_size": 3,
        "char_count": 28,
        "word_count": 8,
        "page_number": 3,
        "window_text": "| □ 예 | ■ 아니오 |\n| 정 및 바이러스 불활화 제거 공정을 추가하게 된다 | / | .  |\n| 폐지대상 | 김판순 | 이내리 김관수 김정환 | 김진아 | , | , | , | , |\n| -001506-01, 생물의약품평가가이드 | 25), 2007 |\n| 여부 | □ 외국 규정을 번역하거나 설명하는 내용입니까?  | □ 예 | ■ 아니오 |\n| 안전성유효성 평가 가이드라인 | ․ |\n**증에 맞는 임상시험을 수행하여야 한다. **\n| □ 정보제공 등 직원 교육용 자료입니까?  | □ 예 | ■ 아니오 |\n| 암치료를 위한 수지상 | 세포치료제 평가 시 | 고려사항 | 2005 | 11-1470000-000888-01 | (생물의약품평가가이드 | 14) | 1470000-001176-01, 생물의약품평가가이드 | 20), 2006 | 재조합의약품팀 | 생명공학의약품과 | ( | ) | 舊 | 세포조직공학제제팀 |\n| 치료용 | 생명공학의약품등의 | 2상 | 및 | 3상 임상시험계획승인 | 신청시 고려사항 |\n| 피험자의 선정 | 4.1.  |\n| 상기 사항 중 어느 하나라도 ‘예’에 해당되는 경우에 폐지 대상입니다.  | 폐지 대상에 해당합니까? ",
        "original_sentence": "**\n| □ 정보제공 등 직원 교육용 자료입니까? "
      }
    },
    {
      "chunk_id": "chunk_016",
      "text": "| □ 예 | ■ 아니오 |\n| 암치료를 위한 수지상 | 세포치료제 평가 시 | 고려사항 | 2005 | 11-1470000-000888-01 | (생물의약품평가가이드 | 14) | 1470000-001176-01, 생물의약품평가가이드 | 20), 2006 | 재조합의약품팀 | 생명공학의약품과 | ( | ) | 舊 | 세포조직공학제제팀 |\n| 치료용 | 생명공학의약품등의 | 2상 | 및 | 3상 임상시험계획승인 | 신청시 고려사항 |\n| 피험자의 선정 | 4.1. ",
      "metadata": {
        "source": "(가이드라인-005)_정맥주사용+B형간염+사람면역글로불린제제의+안전성유효성+평가+가이드라인.pdf",
        "chunk_index": 15,
        "window_size": 3,
        "char_count": 262,
        "word_count": 64,
        "page_number": 3,
        "window_text": "|\n| 폐지대상 | 김판순 | 이내리 김관수 김정환 | 김진아 | , | , | , | , |\n| -001506-01, 생물의약품평가가이드 | 25), 2007 |\n| 여부 | □ 외국 규정을 번역하거나 설명하는 내용입니까?  | □ 예 | ■ 아니오 |\n| 안전성유효성 평가 가이드라인 | ․ |\n**증에 맞는 임상시험을 수행하여야 한다. **\n| □ 정보제공 등 직원 교육용 자료입니까?  | □ 예 | ■ 아니오 |\n| 암치료를 위한 수지상 | 세포치료제 평가 시 | 고려사항 | 2005 | 11-1470000-000888-01 | (생물의약품평가가이드 | 14) | 1470000-001176-01, 생물의약품평가가이드 | 20), 2006 | 재조합의약품팀 | 생명공학의약품과 | ( | ) | 舊 | 세포조직공학제제팀 |\n| 치료용 | 생명공학의약품등의 | 2상 | 및 | 3상 임상시험계획승인 | 신청시 고려사항 |\n| 피험자의 선정 | 4.1.  |\n| 상기 사항 중 어느 하나라도 ‘예’에 해당되는 경우에 폐지 대상입니다.  | 폐지 대상에 해당합니까?  | □ 예 | ■ 아니오 |\n| 세포치료제 조직공학제품 | ․ | 개발동향 및 안전관리 | 2003 | 11-1470000-000275-01 | (생물의약품평가자료집 | 1) | 생명공학의약품과 | 생물공학과 | ( | ) | 舊 | - |\n| of Human Hepatitis B Immunoglobulin | □ 내부적으로 행정사무의 통일을 기하기 위하여 반복적으로 행정 | 2008 | □ 예 | ■ 아니오 |\n| 바이오칩 평가가이드 | -DNA칩의 기준 및 | 시험방법 작성지침- | 2005 | 11-1470000-000896-01 | (생물의약품평가가이드 | 13) | 재조합의약품팀 | 생물진단제제팀 | 생물의약품규격과 | ( | ) | 舊 |\n| 식 수술 예정인 자로서 | 간 이식 수술 전에 | 양성인 환자이어야 한다 | , | HBsAg | . ",
        "original_sentence": "| □ 예 | ■ 아니오 |\n| 암치료를 위한 수지상 | 세포치료제 평가 시 | 고려사항 | 2005 | 11-1470000-000888-01 | (생물의약품평가가이드 | 14) | 1470000-001176-01, 생물의약품평가가이드 | 20), 2006 | 재조합의약품팀 | 생명공학의약품과 | ( | ) | 舊 | 세포조직공학제제팀 |\n| 치료용 | 생명공학의약품등의 | 2상 | 및 | 3상 임상시험계획승인 | 신청시 고려사항 |\n| 피험자의 선정 | 4.1. "
      }
    },
    {
      "chunk_id": "chunk_017",
      "text": "|\n| 상기 사항 중 어느 하나라도 ‘예’에 해당되는 경우에 폐지 대상입니다. ",
      "metadata": {
        "source": "(가이드라인-005)_정맥주사용+B형간염+사람면역글로불린제제의+안전성유효성+평가+가이드라인.pdf",
        "chunk_index": 16,
        "window_size": 3,
        "char_count": 44,
        "word_count": 12,
        "page_number": 3,
        "window_text": "| □ 예 | ■ 아니오 |\n| 안전성유효성 평가 가이드라인 | ․ |\n**증에 맞는 임상시험을 수행하여야 한다. **\n| □ 정보제공 등 직원 교육용 자료입니까?  | □ 예 | ■ 아니오 |\n| 암치료를 위한 수지상 | 세포치료제 평가 시 | 고려사항 | 2005 | 11-1470000-000888-01 | (생물의약품평가가이드 | 14) | 1470000-001176-01, 생물의약품평가가이드 | 20), 2006 | 재조합의약품팀 | 생명공학의약품과 | ( | ) | 舊 | 세포조직공학제제팀 |\n| 치료용 | 생명공학의약품등의 | 2상 | 및 | 3상 임상시험계획승인 | 신청시 고려사항 |\n| 피험자의 선정 | 4.1.  |\n| 상기 사항 중 어느 하나라도 ‘예’에 해당되는 경우에 폐지 대상입니다.  | 폐지 대상에 해당합니까?  | □ 예 | ■ 아니오 |\n| 세포치료제 조직공학제품 | ․ | 개발동향 및 안전관리 | 2003 | 11-1470000-000275-01 | (생물의약품평가자료집 | 1) | 생명공학의약품과 | 생물공학과 | ( | ) | 舊 | - |\n| of Human Hepatitis B Immunoglobulin | □ 내부적으로 행정사무의 통일을 기하기 위하여 반복적으로 행정 | 2008 | □ 예 | ■ 아니오 |\n| 바이오칩 평가가이드 | -DNA칩의 기준 및 | 시험방법 작성지침- | 2005 | 11-1470000-000896-01 | (생물의약품평가가이드 | 13) | 재조합의약품팀 | 생물진단제제팀 | 생물의약품규격과 | ( | ) | 舊 |\n| 식 수술 예정인 자로서 | 간 이식 수술 전에 | 양성인 환자이어야 한다 | , | HBsAg | .  |\n**사무의 세부기준이나 절차를 제시하는 것입니까? ",
        "original_sentence": "|\n| 상기 사항 중 어느 하나라도 ‘예’에 해당되는 경우에 폐지 대상입니다. "
      }
    },
    {
      "chunk_id": "chunk_018",
      "text": "| 폐지 대상에 해당합니까? ",
      "metadata": {
        "source": "(가이드라인-005)_정맥주사용+B형간염+사람면역글로불린제제의+안전성유효성+평가+가이드라인.pdf",
        "chunk_index": 17,
        "window_size": 3,
        "char_count": 16,
        "word_count": 4,
        "page_number": 3,
        "window_text": "**\n| □ 정보제공 등 직원 교육용 자료입니까?  | □ 예 | ■ 아니오 |\n| 암치료를 위한 수지상 | 세포치료제 평가 시 | 고려사항 | 2005 | 11-1470000-000888-01 | (생물의약품평가가이드 | 14) | 1470000-001176-01, 생물의약품평가가이드 | 20), 2006 | 재조합의약품팀 | 생명공학의약품과 | ( | ) | 舊 | 세포조직공학제제팀 |\n| 치료용 | 생명공학의약품등의 | 2상 | 및 | 3상 임상시험계획승인 | 신청시 고려사항 |\n| 피험자의 선정 | 4.1.  |\n| 상기 사항 중 어느 하나라도 ‘예’에 해당되는 경우에 폐지 대상입니다.  | 폐지 대상에 해당합니까?  | □ 예 | ■ 아니오 |\n| 세포치료제 조직공학제품 | ․ | 개발동향 및 안전관리 | 2003 | 11-1470000-000275-01 | (생물의약품평가자료집 | 1) | 생명공학의약품과 | 생물공학과 | ( | ) | 舊 | - |\n| of Human Hepatitis B Immunoglobulin | □ 내부적으로 행정사무의 통일을 기하기 위하여 반복적으로 행정 | 2008 | □ 예 | ■ 아니오 |\n| 바이오칩 평가가이드 | -DNA칩의 기준 및 | 시험방법 작성지침- | 2005 | 11-1470000-000896-01 | (생물의약품평가가이드 | 13) | 재조합의약품팀 | 생물진단제제팀 | 생물의약품규격과 | ( | ) | 舊 |\n| 식 수술 예정인 자로서 | 간 이식 수술 전에 | 양성인 환자이어야 한다 | , | HBsAg | .  |\n**사무의 세부기준이나 절차를 제시하는 것입니까?  (지침)**\n| 공정 흐름도를 제출하여야 한다. ",
        "original_sentence": "| 폐지 대상에 해당합니까? "
      }
    },
    {
      "chunk_id": "chunk_019",
      "text": "| □ 예 | ■ 아니오 |\n| 세포치료제 조직공학제품 | ․ | 개발동향 및 안전관리 | 2003 | 11-1470000-000275-01 | (생물의약품평가자료집 | 1) | 생명공학의약품과 | 생물공학과 | ( | ) | 舊 | - |\n| of Human Hepatitis B Immunoglobulin | □ 내부적으로 행정사무의 통일을 기하기 위하여 반복적으로 행정 | 2008 | □ 예 | ■ 아니오 |\n| 바이오칩 평가가이드 | -DNA칩의 기준 및 | 시험방법 작성지침- | 2005 | 11-1470000-000896-01 | (생물의약품평가가이드 | 13) | 재조합의약품팀 | 생물진단제제팀 | 생물의약품규격과 | ( | ) | 舊 |\n| 식 수술 예정인 자로서 | 간 이식 수술 전에 | 양성인 환자이어야 한다 | , | HBsAg | . ",
      "metadata": {
        "source": "(가이드라인-005)_정맥주사용+B형간염+사람면역글로불린제제의+안전성유효성+평가+가이드라인.pdf",
        "chunk_index": 18,
        "window_size": 3,
        "char_count": 427,
        "word_count": 112,
        "page_number": 3,
        "window_text": "| □ 예 | ■ 아니오 |\n| 암치료를 위한 수지상 | 세포치료제 평가 시 | 고려사항 | 2005 | 11-1470000-000888-01 | (생물의약품평가가이드 | 14) | 1470000-001176-01, 생물의약품평가가이드 | 20), 2006 | 재조합의약품팀 | 생명공학의약품과 | ( | ) | 舊 | 세포조직공학제제팀 |\n| 치료용 | 생명공학의약품등의 | 2상 | 및 | 3상 임상시험계획승인 | 신청시 고려사항 |\n| 피험자의 선정 | 4.1.  |\n| 상기 사항 중 어느 하나라도 ‘예’에 해당되는 경우에 폐지 대상입니다.  | 폐지 대상에 해당합니까?  | □ 예 | ■ 아니오 |\n| 세포치료제 조직공학제품 | ․ | 개발동향 및 안전관리 | 2003 | 11-1470000-000275-01 | (생물의약품평가자료집 | 1) | 생명공학의약품과 | 생물공학과 | ( | ) | 舊 | - |\n| of Human Hepatitis B Immunoglobulin | □ 내부적으로 행정사무의 통일을 기하기 위하여 반복적으로 행정 | 2008 | □ 예 | ■ 아니오 |\n| 바이오칩 평가가이드 | -DNA칩의 기준 및 | 시험방법 작성지침- | 2005 | 11-1470000-000896-01 | (생물의약품평가가이드 | 13) | 재조합의약품팀 | 생물진단제제팀 | 생물의약품규격과 | ( | ) | 舊 |\n| 식 수술 예정인 자로서 | 간 이식 수술 전에 | 양성인 환자이어야 한다 | , | HBsAg | .  |\n**사무의 세부기준이나 절차를 제시하는 것입니까?  (지침)**\n| 공정 흐름도를 제출하여야 한다.  | 려진 경우에는 독성시험을 수행하지 않아도 된다. ",
        "original_sentence": "| □ 예 | ■ 아니오 |\n| 세포치료제 조직공학제품 | ․ | 개발동향 및 안전관리 | 2003 | 11-1470000-000275-01 | (생물의약품평가자료집 | 1) | 생명공학의약품과 | 생물공학과 | ( | ) | 舊 | - |\n| of Human Hepatitis B Immunoglobulin | □ 내부적으로 행정사무의 통일을 기하기 위하여 반복적으로 행정 | 2008 | □ 예 | ■ 아니오 |\n| 바이오칩 평가가이드 | -DNA칩의 기준 및 | 시험방법 작성지침- | 2005 | 11-1470000-000896-01 | (생물의약품평가가이드 | 13) | 재조합의약품팀 | 생물진단제제팀 | 생물의약품규격과 | ( | ) | 舊 |\n| 식 수술 예정인 자로서 | 간 이식 수술 전에 | 양성인 환자이어야 한다 | , | HBsAg | . "
      }
    },
    {
      "chunk_id": "chunk_020",
      "text": "|\n**사무의 세부기준이나 절차를 제시하는 것입니까? ",
      "metadata": {
        "source": "(가이드라인-005)_정맥주사용+B형간염+사람면역글로불린제제의+안전성유효성+평가+가이드라인.pdf",
        "chunk_index": 19,
        "window_size": 3,
        "char_count": 30,
        "word_count": 6,
        "page_number": 8,
        "window_text": "|\n| 상기 사항 중 어느 하나라도 ‘예’에 해당되는 경우에 폐지 대상입니다.  | 폐지 대상에 해당합니까?  | □ 예 | ■ 아니오 |\n| 세포치료제 조직공학제품 | ․ | 개발동향 및 안전관리 | 2003 | 11-1470000-000275-01 | (생물의약품평가자료집 | 1) | 생명공학의약품과 | 생물공학과 | ( | ) | 舊 | - |\n| of Human Hepatitis B Immunoglobulin | □ 내부적으로 행정사무의 통일을 기하기 위하여 반복적으로 행정 | 2008 | □ 예 | ■ 아니오 |\n| 바이오칩 평가가이드 | -DNA칩의 기준 및 | 시험방법 작성지침- | 2005 | 11-1470000-000896-01 | (생물의약품평가가이드 | 13) | 재조합의약품팀 | 생물진단제제팀 | 생물의약품규격과 | ( | ) | 舊 |\n| 식 수술 예정인 자로서 | 간 이식 수술 전에 | 양성인 환자이어야 한다 | , | HBsAg | .  |\n**사무의 세부기준이나 절차를 제시하는 것입니까?  (지침)**\n| 공정 흐름도를 제출하여야 한다.  | 려진 경우에는 독성시험을 수행하지 않아도 된다.  |\n**(CPMP/BWP/268/95), EMEA, 1996**\n| □ 대내외적으로 특정한 사안 등에 대하여 식약처의 입장을 기술 | for Intravenous Administration | ■ 예 | □ 아니오 |\n**등을 참고할 수 있다.",
        "original_sentence": "|\n**사무의 세부기준이나 절차를 제시하는 것입니까? "
      }
    },
    {
      "chunk_id": "chunk_021",
      "text": "(지침)**\n| 공정 흐름도를 제출하여야 한다. ",
      "metadata": {
        "source": "(가이드라인-005)_정맥주사용+B형간염+사람면역글로불린제제의+안전성유효성+평가+가이드라인.pdf",
        "chunk_index": 20,
        "window_size": 3,
        "char_count": 27,
        "word_count": 6,
        "page_number": 8,
        "window_text": "| 폐지 대상에 해당합니까?  | □ 예 | ■ 아니오 |\n| 세포치료제 조직공학제품 | ․ | 개발동향 및 안전관리 | 2003 | 11-1470000-000275-01 | (생물의약품평가자료집 | 1) | 생명공학의약품과 | 생물공학과 | ( | ) | 舊 | - |\n| of Human Hepatitis B Immunoglobulin | □ 내부적으로 행정사무의 통일을 기하기 위하여 반복적으로 행정 | 2008 | □ 예 | ■ 아니오 |\n| 바이오칩 평가가이드 | -DNA칩의 기준 및 | 시험방법 작성지침- | 2005 | 11-1470000-000896-01 | (생물의약품평가가이드 | 13) | 재조합의약품팀 | 생물진단제제팀 | 생물의약품규격과 | ( | ) | 舊 |\n| 식 수술 예정인 자로서 | 간 이식 수술 전에 | 양성인 환자이어야 한다 | , | HBsAg | .  |\n**사무의 세부기준이나 절차를 제시하는 것입니까?  (지침)**\n| 공정 흐름도를 제출하여야 한다.  | 려진 경우에는 독성시험을 수행하지 않아도 된다.  |\n**(CPMP/BWP/268/95), EMEA, 1996**\n| □ 대내외적으로 특정한 사안 등에 대하여 식약처의 입장을 기술 | for Intravenous Administration | ■ 예 | □ 아니오 |\n**등을 참고할 수 있다. **\n| 국에서 수행되는 임상시험들은 | 년 이상 | 을 하고 있다 | 2~3 | follow-up | . ",
        "original_sentence": "(지침)**\n| 공정 흐름도를 제출하여야 한다. "
      }
    },
    {
      "chunk_id": "chunk_022",
      "text": "| 려진 경우에는 독성시험을 수행하지 않아도 된다. ",
      "metadata": {
        "source": "(가이드라인-005)_정맥주사용+B형간염+사람면역글로불린제제의+안전성유효성+평가+가이드라인.pdf",
        "chunk_index": 21,
        "window_size": 3,
        "char_count": 29,
        "word_count": 7,
        "page_number": 8,
        "window_text": "| □ 예 | ■ 아니오 |\n| 세포치료제 조직공학제품 | ․ | 개발동향 및 안전관리 | 2003 | 11-1470000-000275-01 | (생물의약품평가자료집 | 1) | 생명공학의약품과 | 생물공학과 | ( | ) | 舊 | - |\n| of Human Hepatitis B Immunoglobulin | □ 내부적으로 행정사무의 통일을 기하기 위하여 반복적으로 행정 | 2008 | □ 예 | ■ 아니오 |\n| 바이오칩 평가가이드 | -DNA칩의 기준 및 | 시험방법 작성지침- | 2005 | 11-1470000-000896-01 | (생물의약품평가가이드 | 13) | 재조합의약품팀 | 생물진단제제팀 | 생물의약품규격과 | ( | ) | 舊 |\n| 식 수술 예정인 자로서 | 간 이식 수술 전에 | 양성인 환자이어야 한다 | , | HBsAg | .  |\n**사무의 세부기준이나 절차를 제시하는 것입니까?  (지침)**\n| 공정 흐름도를 제출하여야 한다.  | 려진 경우에는 독성시험을 수행하지 않아도 된다.  |\n**(CPMP/BWP/268/95), EMEA, 1996**\n| □ 대내외적으로 특정한 사안 등에 대하여 식약처의 입장을 기술 | for Intravenous Administration | ■ 예 | □ 아니오 |\n**등을 참고할 수 있다. **\n| 국에서 수행되는 임상시험들은 | 년 이상 | 을 하고 있다 | 2~3 | follow-up | .  |\n**하는 것입니까? ",
        "original_sentence": "| 려진 경우에는 독성시험을 수행하지 않아도 된다. "
      }
    },
    {
      "chunk_id": "chunk_023",
      "text": "|\n**(CPMP/BWP/268/95), EMEA, 1996**\n| □ 대내외적으로 특정한 사안 등에 대하여 식약처의 입장을 기술 | for Intravenous Administration | ■ 예 | □ 아니오 |\n**등을 참고할 수 있다.",
      "metadata": {
        "source": "(가이드라인-005)_정맥주사용+B형간염+사람면역글로불린제제의+안전성유효성+평가+가이드라인.pdf",
        "chunk_index": 22,
        "window_size": 3,
        "char_count": 136,
        "word_count": 29,
        "page_number": 2,
        "window_text": "|\n**사무의 세부기준이나 절차를 제시하는 것입니까?  (지침)**\n| 공정 흐름도를 제출하여야 한다.  | 려진 경우에는 독성시험을 수행하지 않아도 된다.  |\n**(CPMP/BWP/268/95), EMEA, 1996**\n| □ 대내외적으로 특정한 사안 등에 대하여 식약처의 입장을 기술 | for Intravenous Administration | ■ 예 | □ 아니오 |\n**등을 참고할 수 있다. **\n| 국에서 수행되는 임상시험들은 | 년 이상 | 을 하고 있다 | 2~3 | follow-up | .  |\n**하는 것입니까?  (가이드라인)**\n| 유전자치료제의 복제가능 | 바이러스 시험법에 관한 | 가이드 | 2005 | 11-1470000-000877-01 | (생물의약품평가가이드 | 12) | 에 의견을 제시하여 주시기 바랍니다. ",
        "original_sentence": "|\n**(CPMP/BWP/268/95), EMEA, 1996**\n| □ 대내외적으로 특정한 사안 등에 대하여 식약처의 입장을 기술 | for Intravenous Administration | ■ 예 | □ 아니오 |\n**등을 참고할 수 있다."
      }
    },
    {
      "chunk_id": "chunk_024",
      "text": "**\n| 국에서 수행되는 임상시험들은 | 년 이상 | 을 하고 있다 | 2~3 | follow-up | . ",
      "metadata": {
        "source": "(가이드라인-005)_정맥주사용+B형간염+사람면역글로불린제제의+안전성유효성+평가+가이드라인.pdf",
        "chunk_index": 23,
        "window_size": 3,
        "char_count": 60,
        "word_count": 18,
        "page_number": 2,
        "window_text": "(지침)**\n| 공정 흐름도를 제출하여야 한다.  | 려진 경우에는 독성시험을 수행하지 않아도 된다.  |\n**(CPMP/BWP/268/95), EMEA, 1996**\n| □ 대내외적으로 특정한 사안 등에 대하여 식약처의 입장을 기술 | for Intravenous Administration | ■ 예 | □ 아니오 |\n**등을 참고할 수 있다. **\n| 국에서 수행되는 임상시험들은 | 년 이상 | 을 하고 있다 | 2~3 | follow-up | .  |\n**하는 것입니까?  (가이드라인)**\n| 유전자치료제의 복제가능 | 바이러스 시험법에 관한 | 가이드 | 2005 | 11-1470000-000877-01 | (생물의약품평가가이드 | 12) | 에 의견을 제시하여 주시기 바랍니다.  | □ 법령, 고시‧훈령‧예규와 같은 규정 또는 식약처장이 정한 특정한 | 재조합의약품팀 | 생명공학의약품과 | ( | ) | 舊 | 유전자치료제팀 |\n| 등록대상 | 세부정보 | □ 예 | ■ 아니오 |\n| Treatment of Hepatitis B(CHMP/EWP/6172/03), EMEA, 2006 | 사안에 대하여 그 절차 등의 내용을 알기 쉽게 풀어 설명하거나 | 질의‧응답하는 형태입니까? ",
        "original_sentence": "**\n| 국에서 수행되는 임상시험들은 | 년 이상 | 을 하고 있다 | 2~3 | follow-up | . "
      }
    },
    {
      "chunk_id": "chunk_025",
      "text": "|\n**하는 것입니까? ",
      "metadata": {
        "source": "(가이드라인-005)_정맥주사용+B형간염+사람면역글로불린제제의+안전성유효성+평가+가이드라인.pdf",
        "chunk_index": 24,
        "window_size": 3,
        "char_count": 13,
        "word_count": 3,
        "page_number": 11,
        "window_text": "| 려진 경우에는 독성시험을 수행하지 않아도 된다.  |\n**(CPMP/BWP/268/95), EMEA, 1996**\n| □ 대내외적으로 특정한 사안 등에 대하여 식약처의 입장을 기술 | for Intravenous Administration | ■ 예 | □ 아니오 |\n**등을 참고할 수 있다. **\n| 국에서 수행되는 임상시험들은 | 년 이상 | 을 하고 있다 | 2~3 | follow-up | .  |\n**하는 것입니까?  (가이드라인)**\n| 유전자치료제의 복제가능 | 바이러스 시험법에 관한 | 가이드 | 2005 | 11-1470000-000877-01 | (생물의약품평가가이드 | 12) | 에 의견을 제시하여 주시기 바랍니다.  | □ 법령, 고시‧훈령‧예규와 같은 규정 또는 식약처장이 정한 특정한 | 재조합의약품팀 | 생명공학의약품과 | ( | ) | 舊 | 유전자치료제팀 |\n| 등록대상 | 세부정보 | □ 예 | ■ 아니오 |\n| Treatment of Hepatitis B(CHMP/EWP/6172/03), EMEA, 2006 | 사안에 대하여 그 절차 등의 내용을 알기 쉽게 풀어 설명하거나 | 질의‧응답하는 형태입니까?  (해설서) |\n**출하여야 한다.",
        "original_sentence": "|\n**하는 것입니까? "
      }
    },
    {
      "chunk_id": "chunk_026",
      "text": "(가이드라인)**\n| 유전자치료제의 복제가능 | 바이러스 시험법에 관한 | 가이드 | 2005 | 11-1470000-000877-01 | (생물의약품평가가이드 | 12) | 에 의견을 제시하여 주시기 바랍니다. ",
      "metadata": {
        "source": "(가이드라인-005)_정맥주사용+B형간염+사람면역글로불린제제의+안전성유효성+평가+가이드라인.pdf",
        "chunk_index": 25,
        "window_size": 3,
        "char_count": 119,
        "word_count": 24,
        "page_number": 2,
        "window_text": "|\n**(CPMP/BWP/268/95), EMEA, 1996**\n| □ 대내외적으로 특정한 사안 등에 대하여 식약처의 입장을 기술 | for Intravenous Administration | ■ 예 | □ 아니오 |\n**등을 참고할 수 있다. **\n| 국에서 수행되는 임상시험들은 | 년 이상 | 을 하고 있다 | 2~3 | follow-up | .  |\n**하는 것입니까?  (가이드라인)**\n| 유전자치료제의 복제가능 | 바이러스 시험법에 관한 | 가이드 | 2005 | 11-1470000-000877-01 | (생물의약품평가가이드 | 12) | 에 의견을 제시하여 주시기 바랍니다.  | □ 법령, 고시‧훈령‧예규와 같은 규정 또는 식약처장이 정한 특정한 | 재조합의약품팀 | 생명공학의약품과 | ( | ) | 舊 | 유전자치료제팀 |\n| 등록대상 | 세부정보 | □ 예 | ■ 아니오 |\n| Treatment of Hepatitis B(CHMP/EWP/6172/03), EMEA, 2006 | 사안에 대하여 그 절차 등의 내용을 알기 쉽게 풀어 설명하거나 | 질의‧응답하는 형태입니까?  (해설서) |\n**출하여야 한다. **\n| 본 지침서에 대한 의견 및 제안이 있으시면 | 연락주시기 바랍니다. ",
        "original_sentence": "(가이드라인)**\n| 유전자치료제의 복제가능 | 바이러스 시험법에 관한 | 가이드 | 2005 | 11-1470000-000877-01 | (생물의약품평가가이드 | 12) | 에 의견을 제시하여 주시기 바랍니다. "
      }
    },
    {
      "chunk_id": "chunk_027",
      "text": "| □ 법령, 고시‧훈령‧예규와 같은 규정 또는 식약처장이 정한 특정한 | 재조합의약품팀 | 생명공학의약품과 | ( | ) | 舊 | 유전자치료제팀 |\n| 등록대상 | 세부정보 | □ 예 | ■ 아니오 |\n| Treatment of Hepatitis B(CHMP/EWP/6172/03), EMEA, 2006 | 사안에 대하여 그 절차 등의 내용을 알기 쉽게 풀어 설명하거나 | 질의‧응답하는 형태입니까? ",
      "metadata": {
        "source": "(가이드라인-005)_정맥주사용+B형간염+사람면역글로불린제제의+안전성유효성+평가+가이드라인.pdf",
        "chunk_index": 26,
        "window_size": 3,
        "char_count": 226,
        "word_count": 55,
        "page_number": 3,
        "window_text": "**\n| 국에서 수행되는 임상시험들은 | 년 이상 | 을 하고 있다 | 2~3 | follow-up | .  |\n**하는 것입니까?  (가이드라인)**\n| 유전자치료제의 복제가능 | 바이러스 시험법에 관한 | 가이드 | 2005 | 11-1470000-000877-01 | (생물의약품평가가이드 | 12) | 에 의견을 제시하여 주시기 바랍니다.  | □ 법령, 고시‧훈령‧예규와 같은 규정 또는 식약처장이 정한 특정한 | 재조합의약품팀 | 생명공학의약품과 | ( | ) | 舊 | 유전자치료제팀 |\n| 등록대상 | 세부정보 | □ 예 | ■ 아니오 |\n| Treatment of Hepatitis B(CHMP/EWP/6172/03), EMEA, 2006 | 사안에 대하여 그 절차 등의 내용을 알기 쉽게 풀어 설명하거나 | 질의‧응답하는 형태입니까?  (해설서) |\n**출하여야 한다. **\n| 본 지침서에 대한 의견 및 제안이 있으시면 | 연락주시기 바랍니다.  |\n| □ 내부 직원용(위임‧위탁기관 직원 포함)에 해당합니까? ",
        "original_sentence": "| □ 법령, 고시‧훈령‧예규와 같은 규정 또는 식약처장이 정한 특정한 | 재조합의약품팀 | 생명공학의약품과 | ( | ) | 舊 | 유전자치료제팀 |\n| 등록대상 | 세부정보 | □ 예 | ■ 아니오 |\n| Treatment of Hepatitis B(CHMP/EWP/6172/03), EMEA, 2006 | 사안에 대하여 그 절차 등의 내용을 알기 쉽게 풀어 설명하거나 | 질의‧응답하는 형태입니까? "
      }
    },
    {
      "chunk_id": "chunk_028",
      "text": "(해설서) |\n**출하여야 한다.",
      "metadata": {
        "source": "(가이드라인-005)_정맥주사용+B형간염+사람면역글로불린제제의+안전성유효성+평가+가이드라인.pdf",
        "chunk_index": 27,
        "window_size": 3,
        "char_count": 18,
        "word_count": 4,
        "page_number": 8,
        "window_text": "|\n**하는 것입니까?  (가이드라인)**\n| 유전자치료제의 복제가능 | 바이러스 시험법에 관한 | 가이드 | 2005 | 11-1470000-000877-01 | (생물의약품평가가이드 | 12) | 에 의견을 제시하여 주시기 바랍니다.  | □ 법령, 고시‧훈령‧예규와 같은 규정 또는 식약처장이 정한 특정한 | 재조합의약품팀 | 생명공학의약품과 | ( | ) | 舊 | 유전자치료제팀 |\n| 등록대상 | 세부정보 | □ 예 | ■ 아니오 |\n| Treatment of Hepatitis B(CHMP/EWP/6172/03), EMEA, 2006 | 사안에 대하여 그 절차 등의 내용을 알기 쉽게 풀어 설명하거나 | 질의‧응답하는 형태입니까?  (해설서) |\n**출하여야 한다. **\n| 본 지침서에 대한 의견 및 제안이 있으시면 | 연락주시기 바랍니다.  |\n| □ 내부 직원용(위임‧위탁기관 직원 포함)에 해당합니까?  | (“예”인 경우, 지침에 해당) | □ 예 | ■ 아니오 |\n**하는데 필요한 정보를 제공하여야 한다.",
        "original_sentence": "(해설서) |\n**출하여야 한다."
      }
    },
    {
      "chunk_id": "chunk_029",
      "text": "**\n| 본 지침서에 대한 의견 및 제안이 있으시면 | 연락주시기 바랍니다. ",
      "metadata": {
        "source": "(가이드라인-005)_정맥주사용+B형간염+사람면역글로불린제제의+안전성유효성+평가+가이드라인.pdf",
        "chunk_index": 28,
        "window_size": 3,
        "char_count": 43,
        "word_count": 12,
        "page_number": 6,
        "window_text": "(가이드라인)**\n| 유전자치료제의 복제가능 | 바이러스 시험법에 관한 | 가이드 | 2005 | 11-1470000-000877-01 | (생물의약품평가가이드 | 12) | 에 의견을 제시하여 주시기 바랍니다.  | □ 법령, 고시‧훈령‧예규와 같은 규정 또는 식약처장이 정한 특정한 | 재조합의약품팀 | 생명공학의약품과 | ( | ) | 舊 | 유전자치료제팀 |\n| 등록대상 | 세부정보 | □ 예 | ■ 아니오 |\n| Treatment of Hepatitis B(CHMP/EWP/6172/03), EMEA, 2006 | 사안에 대하여 그 절차 등의 내용을 알기 쉽게 풀어 설명하거나 | 질의‧응답하는 형태입니까?  (해설서) |\n**출하여야 한다. **\n| 본 지침서에 대한 의견 및 제안이 있으시면 | 연락주시기 바랍니다.  |\n| □ 내부 직원용(위임‧위탁기관 직원 포함)에 해당합니까?  | (“예”인 경우, 지침에 해당) | □ 예 | ■ 아니오 |\n**하는데 필요한 정보를 제공하여야 한다. **\n| □ 외부(관련 협회, 민원인 등) 참고용에 해당합니까? ",
        "original_sentence": "**\n| 본 지침서에 대한 의견 및 제안이 있으시면 | 연락주시기 바랍니다. "
      }
    },
    {
      "chunk_id": "chunk_030",
      "text": "|\n| □ 내부 직원용(위임‧위탁기관 직원 포함)에 해당합니까? ",
      "metadata": {
        "source": "(가이드라인-005)_정맥주사용+B형간염+사람면역글로불린제제의+안전성유효성+평가+가이드라인.pdf",
        "chunk_index": 29,
        "window_size": 3,
        "char_count": 36,
        "word_count": 8,
        "page_number": 3,
        "window_text": "| □ 법령, 고시‧훈령‧예규와 같은 규정 또는 식약처장이 정한 특정한 | 재조합의약품팀 | 생명공학의약품과 | ( | ) | 舊 | 유전자치료제팀 |\n| 등록대상 | 세부정보 | □ 예 | ■ 아니오 |\n| Treatment of Hepatitis B(CHMP/EWP/6172/03), EMEA, 2006 | 사안에 대하여 그 절차 등의 내용을 알기 쉽게 풀어 설명하거나 | 질의‧응답하는 형태입니까?  (해설서) |\n**출하여야 한다. **\n| 본 지침서에 대한 의견 및 제안이 있으시면 | 연락주시기 바랍니다.  |\n| □ 내부 직원용(위임‧위탁기관 직원 포함)에 해당합니까?  | (“예”인 경우, 지침에 해당) | □ 예 | ■ 아니오 |\n**하는데 필요한 정보를 제공하여야 한다. **\n| □ 외부(관련 협회, 민원인 등) 참고용에 해당합니까?  | (“예”인 경우, 가이드라인 또는 해설서에 해당) | ■ 예 | □ 아니오 |\n| 의약품의 시험성적서를 제출하고 | , 제품 규격의 일관성을 입증하여야 한다 | . ",
        "original_sentence": "|\n| □ 내부 직원용(위임‧위탁기관 직원 포함)에 해당합니까? "
      }
    },
    {
      "chunk_id": "chunk_031",
      "text": "| (“예”인 경우, 지침에 해당) | □ 예 | ■ 아니오 |\n**하는데 필요한 정보를 제공하여야 한다.",
      "metadata": {
        "source": "(가이드라인-005)_정맥주사용+B형간염+사람면역글로불린제제의+안전성유효성+평가+가이드라인.pdf",
        "chunk_index": 30,
        "window_size": 3,
        "char_count": 59,
        "word_count": 17,
        "page_number": 3,
        "window_text": "(해설서) |\n**출하여야 한다. **\n| 본 지침서에 대한 의견 및 제안이 있으시면 | 연락주시기 바랍니다.  |\n| □ 내부 직원용(위임‧위탁기관 직원 포함)에 해당합니까?  | (“예”인 경우, 지침에 해당) | □ 예 | ■ 아니오 |\n**하는데 필요한 정보를 제공하여야 한다. **\n| □ 외부(관련 협회, 민원인 등) 참고용에 해당합니까?  | (“예”인 경우, 가이드라인 또는 해설서에 해당) | ■ 예 | □ 아니오 |\n| 의약품의 시험성적서를 제출하고 | , 제품 규격의 일관성을 입증하여야 한다 | .  |\n**1), EMEA, 2000**\n\n**[표 끝]**\n\n<!-- PAGE_3 -->\n###### 등록번호\n\n<!-- PAGE_3 -->\n###### B1-2008-3-020\n\n<!-- PAGE_3 -->\n###### 현행분류\n\n<!-- PAGE_3 -->\n###### □ 지침\n\n<!-- PAGE_3 -->\n###### ■ 가이드라인\n\n<!-- PAGE_3 -->\n###### □ 해설서\n\n<!-- PAGE_3 -->\n###### 분류\n\n<!-- PAGE_3 -->\n###### 적정성\n\n<!-- PAGE_3 -->\n###### □ 해당 지침 등의 분류가 적정합니까?\n\n",
        "original_sentence": "| (“예”인 경우, 지침에 해당) | □ 예 | ■ 아니오 |\n**하는데 필요한 정보를 제공하여야 한다."
      }
    },
    {
      "chunk_id": "chunk_032",
      "text": "**\n| □ 외부(관련 협회, 민원인 등) 참고용에 해당합니까? ",
      "metadata": {
        "source": "(가이드라인-005)_정맥주사용+B형간염+사람면역글로불린제제의+안전성유효성+평가+가이드라인.pdf",
        "chunk_index": 31,
        "window_size": 3,
        "char_count": 36,
        "word_count": 9,
        "page_number": 3,
        "window_text": "**\n| 본 지침서에 대한 의견 및 제안이 있으시면 | 연락주시기 바랍니다.  |\n| □ 내부 직원용(위임‧위탁기관 직원 포함)에 해당합니까?  | (“예”인 경우, 지침에 해당) | □ 예 | ■ 아니오 |\n**하는데 필요한 정보를 제공하여야 한다. **\n| □ 외부(관련 협회, 민원인 등) 참고용에 해당합니까?  | (“예”인 경우, 가이드라인 또는 해설서에 해당) | ■ 예 | □ 아니오 |\n| 의약품의 시험성적서를 제출하고 | , 제품 규격의 일관성을 입증하여야 한다 | .  |\n**1), EMEA, 2000**\n\n**[표 끝]**\n\n<!-- PAGE_3 -->\n###### 등록번호\n\n<!-- PAGE_3 -->\n###### B1-2008-3-020\n\n<!-- PAGE_3 -->\n###### 현행분류\n\n<!-- PAGE_3 -->\n###### □ 지침\n\n<!-- PAGE_3 -->\n###### ■ 가이드라인\n\n<!-- PAGE_3 -->\n###### □ 해설서\n\n<!-- PAGE_3 -->\n###### 분류\n\n<!-- PAGE_3 -->\n###### 적정성\n\n<!-- PAGE_3 -->\n###### □ 해당 지침 등의 분류가 적정합니까?\n\n <!-- PAGE_3 -->\n###### ■ 예\n\n<!-- PAGE_3 -->\n###### □ 아니오\n\n<!-- PAGE_3 -->\n###### □ “아니오”인 경우 변경분류 사항에 체크하여 주십시오\n\n<!-- PAGE_3 -->\n###### □ 지침         □ 가이드라인      □ 해설서\n\n<!-- PAGE_3 -->\n###### □ 지침에 해당하는 경우, 예규로 전환이 필요합니까?\n\n",
        "original_sentence": "**\n| □ 외부(관련 협회, 민원인 등) 참고용에 해당합니까? "
      }
    },
    {
      "chunk_id": "chunk_033",
      "text": "| (“예”인 경우, 가이드라인 또는 해설서에 해당) | ■ 예 | □ 아니오 |\n| 의약품의 시험성적서를 제출하고 | , 제품 규격의 일관성을 입증하여야 한다 | . ",
      "metadata": {
        "source": "(가이드라인-005)_정맥주사용+B형간염+사람면역글로불린제제의+안전성유효성+평가+가이드라인.pdf",
        "chunk_index": 32,
        "window_size": 3,
        "char_count": 94,
        "word_count": 27,
        "page_number": 3,
        "window_text": "|\n| □ 내부 직원용(위임‧위탁기관 직원 포함)에 해당합니까?  | (“예”인 경우, 지침에 해당) | □ 예 | ■ 아니오 |\n**하는데 필요한 정보를 제공하여야 한다. **\n| □ 외부(관련 협회, 민원인 등) 참고용에 해당합니까?  | (“예”인 경우, 가이드라인 또는 해설서에 해당) | ■ 예 | □ 아니오 |\n| 의약품의 시험성적서를 제출하고 | , 제품 규격의 일관성을 입증하여야 한다 | .  |\n**1), EMEA, 2000**\n\n**[표 끝]**\n\n<!-- PAGE_3 -->\n###### 등록번호\n\n<!-- PAGE_3 -->\n###### B1-2008-3-020\n\n<!-- PAGE_3 -->\n###### 현행분류\n\n<!-- PAGE_3 -->\n###### □ 지침\n\n<!-- PAGE_3 -->\n###### ■ 가이드라인\n\n<!-- PAGE_3 -->\n###### □ 해설서\n\n<!-- PAGE_3 -->\n###### 분류\n\n<!-- PAGE_3 -->\n###### 적정성\n\n<!-- PAGE_3 -->\n###### □ 해당 지침 등의 분류가 적정합니까?\n\n <!-- PAGE_3 -->\n###### ■ 예\n\n<!-- PAGE_3 -->\n###### □ 아니오\n\n<!-- PAGE_3 -->\n###### □ “아니오”인 경우 변경분류 사항에 체크하여 주십시오\n\n<!-- PAGE_3 -->\n###### □ 지침         □ 가이드라인      □ 해설서\n\n<!-- PAGE_3 -->\n###### □ 지침에 해당하는 경우, 예규로 전환이 필요합니까?\n\n *“예규“란 행정사무의 통일을 기하기 위한 것으로 반복적 행정사무의 처리\n\n기준을 제시하는 행정규칙의 형태로, 식약처 전 부서에 해당하는 사항임\n\n<!-- PAGE_3 -->\n###### □ 예\n\n<!-- PAGE_3 -->\n###### □ 아니오\n\n<!-- PAGE_3 -->\n###### 상기 사항에 대하여 확인하였음.\n\n",
        "original_sentence": "| (“예”인 경우, 가이드라인 또는 해설서에 해당) | ■ 예 | □ 아니오 |\n| 의약품의 시험성적서를 제출하고 | , 제품 규격의 일관성을 입증하여야 한다 | . "
      }
    },
    {
      "chunk_id": "chunk_034",
      "text": "|\n**1), EMEA, 2000**\n\n**[표 끝]**\n\n<!-- PAGE_3 -->\n###### 등록번호\n\n<!-- PAGE_3 -->\n###### B1-2008-3-020\n\n<!-- PAGE_3 -->\n###### 현행분류\n\n<!-- PAGE_3 -->\n###### □ 지침\n\n<!-- PAGE_3 -->\n###### ■ 가이드라인\n\n<!-- PAGE_3 -->\n###### □ 해설서\n\n<!-- PAGE_3 -->\n###### 분류\n\n<!-- PAGE_3 -->\n###### 적정성\n\n<!-- PAGE_3 -->\n###### □ 해당 지침 등의 분류가 적정합니까?\n\n",
      "metadata": {
        "source": "(가이드라인-005)_정맥주사용+B형간염+사람면역글로불린제제의+안전성유효성+평가+가이드라인.pdf",
        "chunk_index": 33,
        "window_size": 3,
        "char_count": 321,
        "word_count": 59,
        "page_number": 3,
        "window_text": "| (“예”인 경우, 지침에 해당) | □ 예 | ■ 아니오 |\n**하는데 필요한 정보를 제공하여야 한다. **\n| □ 외부(관련 협회, 민원인 등) 참고용에 해당합니까?  | (“예”인 경우, 가이드라인 또는 해설서에 해당) | ■ 예 | □ 아니오 |\n| 의약품의 시험성적서를 제출하고 | , 제품 규격의 일관성을 입증하여야 한다 | .  |\n**1), EMEA, 2000**\n\n**[표 끝]**\n\n<!-- PAGE_3 -->\n###### 등록번호\n\n<!-- PAGE_3 -->\n###### B1-2008-3-020\n\n<!-- PAGE_3 -->\n###### 현행분류\n\n<!-- PAGE_3 -->\n###### □ 지침\n\n<!-- PAGE_3 -->\n###### ■ 가이드라인\n\n<!-- PAGE_3 -->\n###### □ 해설서\n\n<!-- PAGE_3 -->\n###### 분류\n\n<!-- PAGE_3 -->\n###### 적정성\n\n<!-- PAGE_3 -->\n###### □ 해당 지침 등의 분류가 적정합니까?\n\n <!-- PAGE_3 -->\n###### ■ 예\n\n<!-- PAGE_3 -->\n###### □ 아니오\n\n<!-- PAGE_3 -->\n###### □ “아니오”인 경우 변경분류 사항에 체크하여 주십시오\n\n<!-- PAGE_3 -->\n###### □ 지침         □ 가이드라인      □ 해설서\n\n<!-- PAGE_3 -->\n###### □ 지침에 해당하는 경우, 예규로 전환이 필요합니까?\n\n *“예규“란 행정사무의 통일을 기하기 위한 것으로 반복적 행정사무의 처리\n\n기준을 제시하는 행정규칙의 형태로, 식약처 전 부서에 해당하는 사항임\n\n<!-- PAGE_3 -->\n###### □ 예\n\n<!-- PAGE_3 -->\n###### □ 아니오\n\n<!-- PAGE_3 -->\n###### 상기 사항에 대하여 확인하였음.\n\n <!-- PAGE_3 -->\n###### 2017년   06월   01일\n\n<!-- PAGE_3 -->\n###### 확  인(부서장)\n\n<!-- PAGE_3 -->\n###### 정 혜 주 (서   명)\n\n<!-- PAGE_4 -->\n###### 이 안내서는 바이오, 생약, 화장품의 허가 관련 질의에 대하여 알기 쉽게\n\n<!-- PAGE_4 -->\n###### 설명하거나 식품의약품안전처의 입장을 기술한 것입니다.\n\n",
        "original_sentence": "|\n**1), EMEA, 2000**\n\n**[표 끝]**\n\n<!-- PAGE_3 -->\n###### 등록번호\n\n<!-- PAGE_3 -->\n###### B1-2008-3-020\n\n<!-- PAGE_3 -->\n###### 현행분류\n\n<!-- PAGE_3 -->\n###### □ 지침\n\n<!-- PAGE_3 -->\n###### ■ 가이드라인\n\n<!-- PAGE_3 -->\n###### □ 해설서\n\n<!-- PAGE_3 -->\n###### 분류\n\n<!-- PAGE_3 -->\n###### 적정성\n\n<!-- PAGE_3 -->\n###### □ 해당 지침 등의 분류가 적정합니까?\n\n"
      }
    },
    {
      "chunk_id": "chunk_035",
      "text": "<!-- PAGE_3 -->\n###### ■ 예\n\n<!-- PAGE_3 -->\n###### □ 아니오\n\n<!-- PAGE_3 -->\n###### □ “아니오”인 경우 변경분류 사항에 체크하여 주십시오\n\n<!-- PAGE_3 -->\n###### □ 지침         □ 가이드라인      □ 해설서\n\n<!-- PAGE_3 -->\n###### □ 지침에 해당하는 경우, 예규로 전환이 필요합니까?\n\n",
      "metadata": {
        "source": "(가이드라인-005)_정맥주사용+B형간염+사람면역글로불린제제의+안전성유효성+평가+가이드라인.pdf",
        "chunk_index": 34,
        "window_size": 3,
        "char_count": 223,
        "word_count": 44,
        "page_number": 3,
        "window_text": "**\n| □ 외부(관련 협회, 민원인 등) 참고용에 해당합니까?  | (“예”인 경우, 가이드라인 또는 해설서에 해당) | ■ 예 | □ 아니오 |\n| 의약품의 시험성적서를 제출하고 | , 제품 규격의 일관성을 입증하여야 한다 | .  |\n**1), EMEA, 2000**\n\n**[표 끝]**\n\n<!-- PAGE_3 -->\n###### 등록번호\n\n<!-- PAGE_3 -->\n###### B1-2008-3-020\n\n<!-- PAGE_3 -->\n###### 현행분류\n\n<!-- PAGE_3 -->\n###### □ 지침\n\n<!-- PAGE_3 -->\n###### ■ 가이드라인\n\n<!-- PAGE_3 -->\n###### □ 해설서\n\n<!-- PAGE_3 -->\n###### 분류\n\n<!-- PAGE_3 -->\n###### 적정성\n\n<!-- PAGE_3 -->\n###### □ 해당 지침 등의 분류가 적정합니까?\n\n <!-- PAGE_3 -->\n###### ■ 예\n\n<!-- PAGE_3 -->\n###### □ 아니오\n\n<!-- PAGE_3 -->\n###### □ “아니오”인 경우 변경분류 사항에 체크하여 주십시오\n\n<!-- PAGE_3 -->\n###### □ 지침         □ 가이드라인      □ 해설서\n\n<!-- PAGE_3 -->\n###### □ 지침에 해당하는 경우, 예규로 전환이 필요합니까?\n\n *“예규“란 행정사무의 통일을 기하기 위한 것으로 반복적 행정사무의 처리\n\n기준을 제시하는 행정규칙의 형태로, 식약처 전 부서에 해당하는 사항임\n\n<!-- PAGE_3 -->\n###### □ 예\n\n<!-- PAGE_3 -->\n###### □ 아니오\n\n<!-- PAGE_3 -->\n###### 상기 사항에 대하여 확인하였음.\n\n <!-- PAGE_3 -->\n###### 2017년   06월   01일\n\n<!-- PAGE_3 -->\n###### 확  인(부서장)\n\n<!-- PAGE_3 -->\n###### 정 혜 주 (서   명)\n\n<!-- PAGE_4 -->\n###### 이 안내서는 바이오, 생약, 화장품의 허가 관련 질의에 대하여 알기 쉽게\n\n<!-- PAGE_4 -->\n###### 설명하거나 식품의약품안전처의 입장을 기술한 것입니다.\n\n <!-- PAGE_4 -->\n###### 본 안내서는 대외적으로 법적 효력을 가지는 것이 아니므로 본문의 기술\n\n<!-- PAGE_4 -->\n###### 방식(‘∼하여야 한다’ 등)에도 불구하고 민원인 여러분께서 반드시 준수하셔야\n\n<!-- PAGE_4 -->\n###### 하는 사항이 아님을 알려드립니다. ",
        "original_sentence": "<!-- PAGE_3 -->\n###### ■ 예\n\n<!-- PAGE_3 -->\n###### □ 아니오\n\n<!-- PAGE_3 -->\n###### □ “아니오”인 경우 변경분류 사항에 체크하여 주십시오\n\n<!-- PAGE_3 -->\n###### □ 지침         □ 가이드라인      □ 해설서\n\n<!-- PAGE_3 -->\n###### □ 지침에 해당하는 경우, 예규로 전환이 필요합니까?\n\n"
      }
    },
    {
      "chunk_id": "chunk_036",
      "text": "*“예규“란 행정사무의 통일을 기하기 위한 것으로 반복적 행정사무의 처리\n\n기준을 제시하는 행정규칙의 형태로, 식약처 전 부서에 해당하는 사항임\n\n<!-- PAGE_3 -->\n###### □ 예\n\n<!-- PAGE_3 -->\n###### □ 아니오\n\n<!-- PAGE_3 -->\n###### 상기 사항에 대하여 확인하였음.\n\n",
      "metadata": {
        "source": "(가이드라인-005)_정맥주사용+B형간염+사람면역글로불린제제의+안전성유효성+평가+가이드라인.pdf",
        "chunk_index": 35,
        "window_size": 3,
        "char_count": 182,
        "word_count": 38,
        "page_number": 3,
        "window_text": "| (“예”인 경우, 가이드라인 또는 해설서에 해당) | ■ 예 | □ 아니오 |\n| 의약품의 시험성적서를 제출하고 | , 제품 규격의 일관성을 입증하여야 한다 | .  |\n**1), EMEA, 2000**\n\n**[표 끝]**\n\n<!-- PAGE_3 -->\n###### 등록번호\n\n<!-- PAGE_3 -->\n###### B1-2008-3-020\n\n<!-- PAGE_3 -->\n###### 현행분류\n\n<!-- PAGE_3 -->\n###### □ 지침\n\n<!-- PAGE_3 -->\n###### ■ 가이드라인\n\n<!-- PAGE_3 -->\n###### □ 해설서\n\n<!-- PAGE_3 -->\n###### 분류\n\n<!-- PAGE_3 -->\n###### 적정성\n\n<!-- PAGE_3 -->\n###### □ 해당 지침 등의 분류가 적정합니까?\n\n <!-- PAGE_3 -->\n###### ■ 예\n\n<!-- PAGE_3 -->\n###### □ 아니오\n\n<!-- PAGE_3 -->\n###### □ “아니오”인 경우 변경분류 사항에 체크하여 주십시오\n\n<!-- PAGE_3 -->\n###### □ 지침         □ 가이드라인      □ 해설서\n\n<!-- PAGE_3 -->\n###### □ 지침에 해당하는 경우, 예규로 전환이 필요합니까?\n\n *“예규“란 행정사무의 통일을 기하기 위한 것으로 반복적 행정사무의 처리\n\n기준을 제시하는 행정규칙의 형태로, 식약처 전 부서에 해당하는 사항임\n\n<!-- PAGE_3 -->\n###### □ 예\n\n<!-- PAGE_3 -->\n###### □ 아니오\n\n<!-- PAGE_3 -->\n###### 상기 사항에 대하여 확인하였음.\n\n <!-- PAGE_3 -->\n###### 2017년   06월   01일\n\n<!-- PAGE_3 -->\n###### 확  인(부서장)\n\n<!-- PAGE_3 -->\n###### 정 혜 주 (서   명)\n\n<!-- PAGE_4 -->\n###### 이 안내서는 바이오, 생약, 화장품의 허가 관련 질의에 대하여 알기 쉽게\n\n<!-- PAGE_4 -->\n###### 설명하거나 식품의약품안전처의 입장을 기술한 것입니다.\n\n <!-- PAGE_4 -->\n###### 본 안내서는 대외적으로 법적 효력을 가지는 것이 아니므로 본문의 기술\n\n<!-- PAGE_4 -->\n###### 방식(‘∼하여야 한다’ 등)에도 불구하고 민원인 여러분께서 반드시 준수하셔야\n\n<!-- PAGE_4 -->\n###### 하는 사항이 아님을 알려드립니다.  또한, 본 안내서는 2015년 12월 31일 현재의\n\n<!-- PAGE_4 -->\n###### 과학적ㆍ기술적 사실 및 유효한 법규를 토대로 작성되었으므로 이후 최신\n\n<!-- PAGE_4 -->\n###### 개정 법규 내용 및 구체적인 사실관계 등에 따라 달리 적용될 수 있음을 알려드립니다.\n\n",
        "original_sentence": "*“예규“란 행정사무의 통일을 기하기 위한 것으로 반복적 행정사무의 처리\n\n기준을 제시하는 행정규칙의 형태로, 식약처 전 부서에 해당하는 사항임\n\n<!-- PAGE_3 -->\n###### □ 예\n\n<!-- PAGE_3 -->\n###### □ 아니오\n\n<!-- PAGE_3 -->\n###### 상기 사항에 대하여 확인하였음.\n\n"
      }
    },
    {
      "chunk_id": "chunk_037",
      "text": "<!-- PAGE_3 -->\n###### 2017년   06월   01일\n\n<!-- PAGE_3 -->\n###### 확  인(부서장)\n\n<!-- PAGE_3 -->\n###### 정 혜 주 (서   명)\n\n<!-- PAGE_4 -->\n###### 이 안내서는 바이오, 생약, 화장품의 허가 관련 질의에 대하여 알기 쉽게\n\n<!-- PAGE_4 -->\n###### 설명하거나 식품의약품안전처의 입장을 기술한 것입니다.\n\n",
      "metadata": {
        "source": "(가이드라인-005)_정맥주사용+B형간염+사람면역글로불린제제의+안전성유효성+평가+가이드라인.pdf",
        "chunk_index": 36,
        "window_size": 3,
        "char_count": 233,
        "word_count": 46,
        "page_number": 3,
        "window_text": "|\n**1), EMEA, 2000**\n\n**[표 끝]**\n\n<!-- PAGE_3 -->\n###### 등록번호\n\n<!-- PAGE_3 -->\n###### B1-2008-3-020\n\n<!-- PAGE_3 -->\n###### 현행분류\n\n<!-- PAGE_3 -->\n###### □ 지침\n\n<!-- PAGE_3 -->\n###### ■ 가이드라인\n\n<!-- PAGE_3 -->\n###### □ 해설서\n\n<!-- PAGE_3 -->\n###### 분류\n\n<!-- PAGE_3 -->\n###### 적정성\n\n<!-- PAGE_3 -->\n###### □ 해당 지침 등의 분류가 적정합니까?\n\n <!-- PAGE_3 -->\n###### ■ 예\n\n<!-- PAGE_3 -->\n###### □ 아니오\n\n<!-- PAGE_3 -->\n###### □ “아니오”인 경우 변경분류 사항에 체크하여 주십시오\n\n<!-- PAGE_3 -->\n###### □ 지침         □ 가이드라인      □ 해설서\n\n<!-- PAGE_3 -->\n###### □ 지침에 해당하는 경우, 예규로 전환이 필요합니까?\n\n *“예규“란 행정사무의 통일을 기하기 위한 것으로 반복적 행정사무의 처리\n\n기준을 제시하는 행정규칙의 형태로, 식약처 전 부서에 해당하는 사항임\n\n<!-- PAGE_3 -->\n###### □ 예\n\n<!-- PAGE_3 -->\n###### □ 아니오\n\n<!-- PAGE_3 -->\n###### 상기 사항에 대하여 확인하였음.\n\n <!-- PAGE_3 -->\n###### 2017년   06월   01일\n\n<!-- PAGE_3 -->\n###### 확  인(부서장)\n\n<!-- PAGE_3 -->\n###### 정 혜 주 (서   명)\n\n<!-- PAGE_4 -->\n###### 이 안내서는 바이오, 생약, 화장품의 허가 관련 질의에 대하여 알기 쉽게\n\n<!-- PAGE_4 -->\n###### 설명하거나 식품의약품안전처의 입장을 기술한 것입니다.\n\n <!-- PAGE_4 -->\n###### 본 안내서는 대외적으로 법적 효력을 가지는 것이 아니므로 본문의 기술\n\n<!-- PAGE_4 -->\n###### 방식(‘∼하여야 한다’ 등)에도 불구하고 민원인 여러분께서 반드시 준수하셔야\n\n<!-- PAGE_4 -->\n###### 하는 사항이 아님을 알려드립니다.  또한, 본 안내서는 2015년 12월 31일 현재의\n\n<!-- PAGE_4 -->\n###### 과학적ㆍ기술적 사실 및 유효한 법규를 토대로 작성되었으므로 이후 최신\n\n<!-- PAGE_4 -->\n###### 개정 법규 내용 및 구체적인 사실관계 등에 따라 달리 적용될 수 있음을 알려드립니다.\n\n <!-- PAGE_4 -->\n###### ※ “민원인 안내서”란 대내외적으로 법령 또는 고시ㆍ훈령ㆍ예규 등을 알기\n\n<!-- PAGE_4 -->\n###### 쉽게 풀어서 설명하거나 특정한 사안에 대하여 식품의약품안전처의 입장을\n\n<!-- PAGE_4 -->\n###### 기술하는 것(식품의약품안전처 지침서등의 관리에 관한 규정 제2조)\n\n<!-- PAGE_4 -->\n###### ※ 본 안내서에 대한 의견이나 문의사항이 있을 경우 식품의약품안전평가원\n\n<!-- PAGE_4 -->\n###### 바이오생약심사부 생물제제과에 문의하시기 바랍니다.\n\n",
        "original_sentence": "<!-- PAGE_3 -->\n###### 2017년   06월   01일\n\n<!-- PAGE_3 -->\n###### 확  인(부서장)\n\n<!-- PAGE_3 -->\n###### 정 혜 주 (서   명)\n\n<!-- PAGE_4 -->\n###### 이 안내서는 바이오, 생약, 화장품의 허가 관련 질의에 대하여 알기 쉽게\n\n<!-- PAGE_4 -->\n###### 설명하거나 식품의약품안전처의 입장을 기술한 것입니다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_038",
      "text": "<!-- PAGE_4 -->\n###### 본 안내서는 대외적으로 법적 효력을 가지는 것이 아니므로 본문의 기술\n\n<!-- PAGE_4 -->\n###### 방식(‘∼하여야 한다’ 등)에도 불구하고 민원인 여러분께서 반드시 준수하셔야\n\n<!-- PAGE_4 -->\n###### 하는 사항이 아님을 알려드립니다. ",
      "metadata": {
        "source": "(가이드라인-005)_정맥주사용+B형간염+사람면역글로불린제제의+안전성유효성+평가+가이드라인.pdf",
        "chunk_index": 37,
        "window_size": 3,
        "char_count": 172,
        "word_count": 34,
        "page_number": 4,
        "window_text": "<!-- PAGE_3 -->\n###### ■ 예\n\n<!-- PAGE_3 -->\n###### □ 아니오\n\n<!-- PAGE_3 -->\n###### □ “아니오”인 경우 변경분류 사항에 체크하여 주십시오\n\n<!-- PAGE_3 -->\n###### □ 지침         □ 가이드라인      □ 해설서\n\n<!-- PAGE_3 -->\n###### □ 지침에 해당하는 경우, 예규로 전환이 필요합니까?\n\n *“예규“란 행정사무의 통일을 기하기 위한 것으로 반복적 행정사무의 처리\n\n기준을 제시하는 행정규칙의 형태로, 식약처 전 부서에 해당하는 사항임\n\n<!-- PAGE_3 -->\n###### □ 예\n\n<!-- PAGE_3 -->\n###### □ 아니오\n\n<!-- PAGE_3 -->\n###### 상기 사항에 대하여 확인하였음.\n\n <!-- PAGE_3 -->\n###### 2017년   06월   01일\n\n<!-- PAGE_3 -->\n###### 확  인(부서장)\n\n<!-- PAGE_3 -->\n###### 정 혜 주 (서   명)\n\n<!-- PAGE_4 -->\n###### 이 안내서는 바이오, 생약, 화장품의 허가 관련 질의에 대하여 알기 쉽게\n\n<!-- PAGE_4 -->\n###### 설명하거나 식품의약품안전처의 입장을 기술한 것입니다.\n\n <!-- PAGE_4 -->\n###### 본 안내서는 대외적으로 법적 효력을 가지는 것이 아니므로 본문의 기술\n\n<!-- PAGE_4 -->\n###### 방식(‘∼하여야 한다’ 등)에도 불구하고 민원인 여러분께서 반드시 준수하셔야\n\n<!-- PAGE_4 -->\n###### 하는 사항이 아님을 알려드립니다.  또한, 본 안내서는 2015년 12월 31일 현재의\n\n<!-- PAGE_4 -->\n###### 과학적ㆍ기술적 사실 및 유효한 법규를 토대로 작성되었으므로 이후 최신\n\n<!-- PAGE_4 -->\n###### 개정 법규 내용 및 구체적인 사실관계 등에 따라 달리 적용될 수 있음을 알려드립니다.\n\n <!-- PAGE_4 -->\n###### ※ “민원인 안내서”란 대내외적으로 법령 또는 고시ㆍ훈령ㆍ예규 등을 알기\n\n<!-- PAGE_4 -->\n###### 쉽게 풀어서 설명하거나 특정한 사안에 대하여 식품의약품안전처의 입장을\n\n<!-- PAGE_4 -->\n###### 기술하는 것(식품의약품안전처 지침서등의 관리에 관한 규정 제2조)\n\n<!-- PAGE_4 -->\n###### ※ 본 안내서에 대한 의견이나 문의사항이 있을 경우 식품의약품안전평가원\n\n<!-- PAGE_4 -->\n###### 바이오생약심사부 생물제제과에 문의하시기 바랍니다.\n\n <!-- PAGE_4 -->\n###### 전화번호 : 043-719-3451\n\n<!-- PAGE_4 -->\n###### 팩스번호 : 043-719-3450\n\n<!-- PAGE_5 -->\n## 정맥주사용\n\n<!-- PAGE_5 -->\n## 형 간염 사람면역글로불린제제의\n\n<!-- PAGE_5 -->\n## B\n\n<!-- PAGE_5 -->\n#### Guideline on the Safety and Efficacy Evaluation\n\n<!-- PAGE_5 -->\n#### 2008\n\n<!-- PAGE_5 -->\n###### 생 물 의 약 품 국\n\n<!-- PAGE_5 -->\n###### 행정간행물 등록번호\n\n11-1470000-001752-14\n\n<!-- PAGE_6 -->\n## 정맥주사용\n\n<!-- PAGE_6 -->\n## B형 간염 사람면역글로불린제제의\n\n<!-- PAGE_6 -->\n## 안전성유효성 평가 가이드라인\n\n<!-- PAGE_6 -->\n## ․\n\n<!-- PAGE_6 -->\n#### Guideline on the Safety and Efficacy Evaluation\n\n<!-- PAGE_6 -->\n#### of Human Hepatitis B Immunoglobulin\n\n<!-- PAGE_6 -->\n#### for Intravenous Administration\n\n<!-- PAGE_6 -->\n###### 담당부서\n\n<!-- PAGE_6 -->\n###### 생물의약품국 혈액제제과\n\n<!-- PAGE_6 -->\n###### ：\n\n<!-- PAGE_6 -->\n###### 담 당 자\n\n<!-- PAGE_6 -->\n###### 조민주\n\n<!-- PAGE_6 -->\n###### ：\n\n<!-- PAGE_6 -->\n###### 연 락 처\n\n<!-- PAGE_6 -->\n###### 서울시 은평구 통일로 194\n\n<!-- PAGE_6 -->\n###### ：\n\n<!-- PAGE_6 -->\n###### (전화\n\n<!-- PAGE_6 -->\n###### ) 02-380-1715, 65\n\n<!-- PAGE_6 -->\n###### (FAX) 02-386-6584\n\n<!-- PAGE_6 -->\n###### (E-mail) luck00@kfda.go.kr\n\n<!-- PAGE_6 -->\n###### 생 물 의 약 품 국\n\n<!-- PAGE_7 -->\n###### 본 가이드라인은 현재까지의 경험과 과학적 사실에 근거하여 식품의약\n\n<!-- PAGE_7 -->\n###### 품안전처의 입장을 기술하고 있습니다. ",
        "original_sentence": "<!-- PAGE_4 -->\n###### 본 안내서는 대외적으로 법적 효력을 가지는 것이 아니므로 본문의 기술\n\n<!-- PAGE_4 -->\n###### 방식(‘∼하여야 한다’ 등)에도 불구하고 민원인 여러분께서 반드시 준수하셔야\n\n<!-- PAGE_4 -->\n###### 하는 사항이 아님을 알려드립니다. "
      }
    },
    {
      "chunk_id": "chunk_039",
      "text": "또한, 본 안내서는 2015년 12월 31일 현재의\n\n<!-- PAGE_4 -->\n###### 과학적ㆍ기술적 사실 및 유효한 법규를 토대로 작성되었으므로 이후 최신\n\n<!-- PAGE_4 -->\n###### 개정 법규 내용 및 구체적인 사실관계 등에 따라 달리 적용될 수 있음을 알려드립니다.\n\n",
      "metadata": {
        "source": "(가이드라인-005)_정맥주사용+B형간염+사람면역글로불린제제의+안전성유효성+평가+가이드라인.pdf",
        "chunk_index": 38,
        "window_size": 3,
        "char_count": 165,
        "word_count": 37,
        "page_number": 4,
        "window_text": "*“예규“란 행정사무의 통일을 기하기 위한 것으로 반복적 행정사무의 처리\n\n기준을 제시하는 행정규칙의 형태로, 식약처 전 부서에 해당하는 사항임\n\n<!-- PAGE_3 -->\n###### □ 예\n\n<!-- PAGE_3 -->\n###### □ 아니오\n\n<!-- PAGE_3 -->\n###### 상기 사항에 대하여 확인하였음.\n\n <!-- PAGE_3 -->\n###### 2017년   06월   01일\n\n<!-- PAGE_3 -->\n###### 확  인(부서장)\n\n<!-- PAGE_3 -->\n###### 정 혜 주 (서   명)\n\n<!-- PAGE_4 -->\n###### 이 안내서는 바이오, 생약, 화장품의 허가 관련 질의에 대하여 알기 쉽게\n\n<!-- PAGE_4 -->\n###### 설명하거나 식품의약품안전처의 입장을 기술한 것입니다.\n\n <!-- PAGE_4 -->\n###### 본 안내서는 대외적으로 법적 효력을 가지는 것이 아니므로 본문의 기술\n\n<!-- PAGE_4 -->\n###### 방식(‘∼하여야 한다’ 등)에도 불구하고 민원인 여러분께서 반드시 준수하셔야\n\n<!-- PAGE_4 -->\n###### 하는 사항이 아님을 알려드립니다.  또한, 본 안내서는 2015년 12월 31일 현재의\n\n<!-- PAGE_4 -->\n###### 과학적ㆍ기술적 사실 및 유효한 법규를 토대로 작성되었으므로 이후 최신\n\n<!-- PAGE_4 -->\n###### 개정 법규 내용 및 구체적인 사실관계 등에 따라 달리 적용될 수 있음을 알려드립니다.\n\n <!-- PAGE_4 -->\n###### ※ “민원인 안내서”란 대내외적으로 법령 또는 고시ㆍ훈령ㆍ예규 등을 알기\n\n<!-- PAGE_4 -->\n###### 쉽게 풀어서 설명하거나 특정한 사안에 대하여 식품의약품안전처의 입장을\n\n<!-- PAGE_4 -->\n###### 기술하는 것(식품의약품안전처 지침서등의 관리에 관한 규정 제2조)\n\n<!-- PAGE_4 -->\n###### ※ 본 안내서에 대한 의견이나 문의사항이 있을 경우 식품의약품안전평가원\n\n<!-- PAGE_4 -->\n###### 바이오생약심사부 생물제제과에 문의하시기 바랍니다.\n\n <!-- PAGE_4 -->\n###### 전화번호 : 043-719-3451\n\n<!-- PAGE_4 -->\n###### 팩스번호 : 043-719-3450\n\n<!-- PAGE_5 -->\n## 정맥주사용\n\n<!-- PAGE_5 -->\n## 형 간염 사람면역글로불린제제의\n\n<!-- PAGE_5 -->\n## B\n\n<!-- PAGE_5 -->\n#### Guideline on the Safety and Efficacy Evaluation\n\n<!-- PAGE_5 -->\n#### 2008\n\n<!-- PAGE_5 -->\n###### 생 물 의 약 품 국\n\n<!-- PAGE_5 -->\n###### 행정간행물 등록번호\n\n11-1470000-001752-14\n\n<!-- PAGE_6 -->\n## 정맥주사용\n\n<!-- PAGE_6 -->\n## B형 간염 사람면역글로불린제제의\n\n<!-- PAGE_6 -->\n## 안전성유효성 평가 가이드라인\n\n<!-- PAGE_6 -->\n## ․\n\n<!-- PAGE_6 -->\n#### Guideline on the Safety and Efficacy Evaluation\n\n<!-- PAGE_6 -->\n#### of Human Hepatitis B Immunoglobulin\n\n<!-- PAGE_6 -->\n#### for Intravenous Administration\n\n<!-- PAGE_6 -->\n###### 담당부서\n\n<!-- PAGE_6 -->\n###### 생물의약품국 혈액제제과\n\n<!-- PAGE_6 -->\n###### ：\n\n<!-- PAGE_6 -->\n###### 담 당 자\n\n<!-- PAGE_6 -->\n###### 조민주\n\n<!-- PAGE_6 -->\n###### ：\n\n<!-- PAGE_6 -->\n###### 연 락 처\n\n<!-- PAGE_6 -->\n###### 서울시 은평구 통일로 194\n\n<!-- PAGE_6 -->\n###### ：\n\n<!-- PAGE_6 -->\n###### (전화\n\n<!-- PAGE_6 -->\n###### ) 02-380-1715, 65\n\n<!-- PAGE_6 -->\n###### (FAX) 02-386-6584\n\n<!-- PAGE_6 -->\n###### (E-mail) luck00@kfda.go.kr\n\n<!-- PAGE_6 -->\n###### 생 물 의 약 품 국\n\n<!-- PAGE_7 -->\n###### 본 가이드라인은 현재까지의 경험과 과학적 사실에 근거하여 식품의약\n\n<!-- PAGE_7 -->\n###### 품안전처의 입장을 기술하고 있습니다.  이 가이드라인에 기술된 사항은 법\n\n<!-- PAGE_7 -->\n###### 적 효력이 있는 것은 아니며, 법령이나 행정규칙 등에서 정하고 있는 사항\n\n<!-- PAGE_7 -->\n###### 외에는 식품의약품안전처의 권고사항입니다. ",
        "original_sentence": "또한, 본 안내서는 2015년 12월 31일 현재의\n\n<!-- PAGE_4 -->\n###### 과학적ㆍ기술적 사실 및 유효한 법규를 토대로 작성되었으므로 이후 최신\n\n<!-- PAGE_4 -->\n###### 개정 법규 내용 및 구체적인 사실관계 등에 따라 달리 적용될 수 있음을 알려드립니다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_040",
      "text": "<!-- PAGE_4 -->\n###### ※ “민원인 안내서”란 대내외적으로 법령 또는 고시ㆍ훈령ㆍ예규 등을 알기\n\n<!-- PAGE_4 -->\n###### 쉽게 풀어서 설명하거나 특정한 사안에 대하여 식품의약품안전처의 입장을\n\n<!-- PAGE_4 -->\n###### 기술하는 것(식품의약품안전처 지침서등의 관리에 관한 규정 제2조)\n\n<!-- PAGE_4 -->\n###### ※ 본 안내서에 대한 의견이나 문의사항이 있을 경우 식품의약품안전평가원\n\n<!-- PAGE_4 -->\n###### 바이오생약심사부 생물제제과에 문의하시기 바랍니다.\n\n",
      "metadata": {
        "source": "(가이드라인-005)_정맥주사용+B형간염+사람면역글로불린제제의+안전성유효성+평가+가이드라인.pdf",
        "chunk_index": 39,
        "window_size": 3,
        "char_count": 305,
        "word_count": 57,
        "page_number": 4,
        "window_text": "<!-- PAGE_3 -->\n###### 2017년   06월   01일\n\n<!-- PAGE_3 -->\n###### 확  인(부서장)\n\n<!-- PAGE_3 -->\n###### 정 혜 주 (서   명)\n\n<!-- PAGE_4 -->\n###### 이 안내서는 바이오, 생약, 화장품의 허가 관련 질의에 대하여 알기 쉽게\n\n<!-- PAGE_4 -->\n###### 설명하거나 식품의약품안전처의 입장을 기술한 것입니다.\n\n <!-- PAGE_4 -->\n###### 본 안내서는 대외적으로 법적 효력을 가지는 것이 아니므로 본문의 기술\n\n<!-- PAGE_4 -->\n###### 방식(‘∼하여야 한다’ 등)에도 불구하고 민원인 여러분께서 반드시 준수하셔야\n\n<!-- PAGE_4 -->\n###### 하는 사항이 아님을 알려드립니다.  또한, 본 안내서는 2015년 12월 31일 현재의\n\n<!-- PAGE_4 -->\n###### 과학적ㆍ기술적 사실 및 유효한 법규를 토대로 작성되었으므로 이후 최신\n\n<!-- PAGE_4 -->\n###### 개정 법규 내용 및 구체적인 사실관계 등에 따라 달리 적용될 수 있음을 알려드립니다.\n\n <!-- PAGE_4 -->\n###### ※ “민원인 안내서”란 대내외적으로 법령 또는 고시ㆍ훈령ㆍ예규 등을 알기\n\n<!-- PAGE_4 -->\n###### 쉽게 풀어서 설명하거나 특정한 사안에 대하여 식품의약품안전처의 입장을\n\n<!-- PAGE_4 -->\n###### 기술하는 것(식품의약품안전처 지침서등의 관리에 관한 규정 제2조)\n\n<!-- PAGE_4 -->\n###### ※ 본 안내서에 대한 의견이나 문의사항이 있을 경우 식품의약품안전평가원\n\n<!-- PAGE_4 -->\n###### 바이오생약심사부 생물제제과에 문의하시기 바랍니다.\n\n <!-- PAGE_4 -->\n###### 전화번호 : 043-719-3451\n\n<!-- PAGE_4 -->\n###### 팩스번호 : 043-719-3450\n\n<!-- PAGE_5 -->\n## 정맥주사용\n\n<!-- PAGE_5 -->\n## 형 간염 사람면역글로불린제제의\n\n<!-- PAGE_5 -->\n## B\n\n<!-- PAGE_5 -->\n#### Guideline on the Safety and Efficacy Evaluation\n\n<!-- PAGE_5 -->\n#### 2008\n\n<!-- PAGE_5 -->\n###### 생 물 의 약 품 국\n\n<!-- PAGE_5 -->\n###### 행정간행물 등록번호\n\n11-1470000-001752-14\n\n<!-- PAGE_6 -->\n## 정맥주사용\n\n<!-- PAGE_6 -->\n## B형 간염 사람면역글로불린제제의\n\n<!-- PAGE_6 -->\n## 안전성유효성 평가 가이드라인\n\n<!-- PAGE_6 -->\n## ․\n\n<!-- PAGE_6 -->\n#### Guideline on the Safety and Efficacy Evaluation\n\n<!-- PAGE_6 -->\n#### of Human Hepatitis B Immunoglobulin\n\n<!-- PAGE_6 -->\n#### for Intravenous Administration\n\n<!-- PAGE_6 -->\n###### 담당부서\n\n<!-- PAGE_6 -->\n###### 생물의약품국 혈액제제과\n\n<!-- PAGE_6 -->\n###### ：\n\n<!-- PAGE_6 -->\n###### 담 당 자\n\n<!-- PAGE_6 -->\n###### 조민주\n\n<!-- PAGE_6 -->\n###### ：\n\n<!-- PAGE_6 -->\n###### 연 락 처\n\n<!-- PAGE_6 -->\n###### 서울시 은평구 통일로 194\n\n<!-- PAGE_6 -->\n###### ：\n\n<!-- PAGE_6 -->\n###### (전화\n\n<!-- PAGE_6 -->\n###### ) 02-380-1715, 65\n\n<!-- PAGE_6 -->\n###### (FAX) 02-386-6584\n\n<!-- PAGE_6 -->\n###### (E-mail) luck00@kfda.go.kr\n\n<!-- PAGE_6 -->\n###### 생 물 의 약 품 국\n\n<!-- PAGE_7 -->\n###### 본 가이드라인은 현재까지의 경험과 과학적 사실에 근거하여 식품의약\n\n<!-- PAGE_7 -->\n###### 품안전처의 입장을 기술하고 있습니다.  이 가이드라인에 기술된 사항은 법\n\n<!-- PAGE_7 -->\n###### 적 효력이 있는 것은 아니며, 법령이나 행정규칙 등에서 정하고 있는 사항\n\n<!-- PAGE_7 -->\n###### 외에는 식품의약품안전처의 권고사항입니다.  이는 새로운 과학적 근거가\n\n<!-- PAGE_7 -->\n###### 있을 경우 개정될 수 있으므로 이러한 사항이 있을 경우 식품의약품안전처\n\n<!-- PAGE_8 -->\n### 목\n\n<!-- PAGE_8 -->\n### 차\n\n<!-- PAGE_8 -->\n###### Ⅰ. ",
        "original_sentence": "<!-- PAGE_4 -->\n###### ※ “민원인 안내서”란 대내외적으로 법령 또는 고시ㆍ훈령ㆍ예규 등을 알기\n\n<!-- PAGE_4 -->\n###### 쉽게 풀어서 설명하거나 특정한 사안에 대하여 식품의약품안전처의 입장을\n\n<!-- PAGE_4 -->\n###### 기술하는 것(식품의약품안전처 지침서등의 관리에 관한 규정 제2조)\n\n<!-- PAGE_4 -->\n###### ※ 본 안내서에 대한 의견이나 문의사항이 있을 경우 식품의약품안전평가원\n\n<!-- PAGE_4 -->\n###### 바이오생약심사부 생물제제과에 문의하시기 바랍니다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_041",
      "text": "<!-- PAGE_4 -->\n###### 전화번호 : 043-719-3451\n\n<!-- PAGE_4 -->\n###### 팩스번호 : 043-719-3450\n\n<!-- PAGE_5 -->\n## 정맥주사용\n\n<!-- PAGE_5 -->\n## 형 간염 사람면역글로불린제제의\n\n<!-- PAGE_5 -->\n## B\n\n<!-- PAGE_5 -->\n#### Guideline on the Safety and Efficacy Evaluation\n\n<!-- PAGE_5 -->\n#### 2008\n\n<!-- PAGE_5 -->\n###### 생 물 의 약 품 국\n\n<!-- PAGE_5 -->\n###### 행정간행물 등록번호\n\n11-1470000-001752-14\n\n<!-- PAGE_6 -->\n## 정맥주사용\n\n<!-- PAGE_6 -->\n## B형 간염 사람면역글로불린제제의\n\n<!-- PAGE_6 -->\n## 안전성유효성 평가 가이드라인\n\n<!-- PAGE_6 -->\n## ․\n\n<!-- PAGE_6 -->\n#### Guideline on the Safety and Efficacy Evaluation\n\n<!-- PAGE_6 -->\n#### of Human Hepatitis B Immunoglobulin\n\n<!-- PAGE_6 -->\n#### for Intravenous Administration\n\n<!-- PAGE_6 -->\n###### 담당부서\n\n<!-- PAGE_6 -->\n###### 생물의약품국 혈액제제과\n\n<!-- PAGE_6 -->\n###### ：\n\n<!-- PAGE_6 -->\n###### 담 당 자\n\n<!-- PAGE_6 -->\n###### 조민주\n\n<!-- PAGE_6 -->\n###### ：\n\n<!-- PAGE_6 -->\n###### 연 락 처\n\n<!-- PAGE_6 -->\n###### 서울시 은평구 통일로 194\n\n<!-- PAGE_6 -->\n###### ：\n\n<!-- PAGE_6 -->\n###### (전화\n\n<!-- PAGE_6 -->\n###### ) 02-380-1715, 65\n\n<!-- PAGE_6 -->\n###### (FAX) 02-386-6584\n\n<!-- PAGE_6 -->\n###### (E-mail) luck00@kfda.go.kr\n\n<!-- PAGE_6 -->\n###### 생 물 의 약 품 국\n\n<!-- PAGE_7 -->\n###### 본 가이드라인은 현재까지의 경험과 과학적 사실에 근거하여 식품의약\n\n<!-- PAGE_7 -->\n###### 품안전처의 입장을 기술하고 있습니다. ",
      "metadata": {
        "source": "(가이드라인-005)_정맥주사용+B형간염+사람면역글로불린제제의+안전성유효성+평가+가이드라인.pdf",
        "chunk_index": 40,
        "window_size": 3,
        "char_count": 1242,
        "word_count": 222,
        "page_number": 4,
        "window_text": "<!-- PAGE_4 -->\n###### 본 안내서는 대외적으로 법적 효력을 가지는 것이 아니므로 본문의 기술\n\n<!-- PAGE_4 -->\n###### 방식(‘∼하여야 한다’ 등)에도 불구하고 민원인 여러분께서 반드시 준수하셔야\n\n<!-- PAGE_4 -->\n###### 하는 사항이 아님을 알려드립니다.  또한, 본 안내서는 2015년 12월 31일 현재의\n\n<!-- PAGE_4 -->\n###### 과학적ㆍ기술적 사실 및 유효한 법규를 토대로 작성되었으므로 이후 최신\n\n<!-- PAGE_4 -->\n###### 개정 법규 내용 및 구체적인 사실관계 등에 따라 달리 적용될 수 있음을 알려드립니다.\n\n <!-- PAGE_4 -->\n###### ※ “민원인 안내서”란 대내외적으로 법령 또는 고시ㆍ훈령ㆍ예규 등을 알기\n\n<!-- PAGE_4 -->\n###### 쉽게 풀어서 설명하거나 특정한 사안에 대하여 식품의약품안전처의 입장을\n\n<!-- PAGE_4 -->\n###### 기술하는 것(식품의약품안전처 지침서등의 관리에 관한 규정 제2조)\n\n<!-- PAGE_4 -->\n###### ※ 본 안내서에 대한 의견이나 문의사항이 있을 경우 식품의약품안전평가원\n\n<!-- PAGE_4 -->\n###### 바이오생약심사부 생물제제과에 문의하시기 바랍니다.\n\n <!-- PAGE_4 -->\n###### 전화번호 : 043-719-3451\n\n<!-- PAGE_4 -->\n###### 팩스번호 : 043-719-3450\n\n<!-- PAGE_5 -->\n## 정맥주사용\n\n<!-- PAGE_5 -->\n## 형 간염 사람면역글로불린제제의\n\n<!-- PAGE_5 -->\n## B\n\n<!-- PAGE_5 -->\n#### Guideline on the Safety and Efficacy Evaluation\n\n<!-- PAGE_5 -->\n#### 2008\n\n<!-- PAGE_5 -->\n###### 생 물 의 약 품 국\n\n<!-- PAGE_5 -->\n###### 행정간행물 등록번호\n\n11-1470000-001752-14\n\n<!-- PAGE_6 -->\n## 정맥주사용\n\n<!-- PAGE_6 -->\n## B형 간염 사람면역글로불린제제의\n\n<!-- PAGE_6 -->\n## 안전성유효성 평가 가이드라인\n\n<!-- PAGE_6 -->\n## ․\n\n<!-- PAGE_6 -->\n#### Guideline on the Safety and Efficacy Evaluation\n\n<!-- PAGE_6 -->\n#### of Human Hepatitis B Immunoglobulin\n\n<!-- PAGE_6 -->\n#### for Intravenous Administration\n\n<!-- PAGE_6 -->\n###### 담당부서\n\n<!-- PAGE_6 -->\n###### 생물의약품국 혈액제제과\n\n<!-- PAGE_6 -->\n###### ：\n\n<!-- PAGE_6 -->\n###### 담 당 자\n\n<!-- PAGE_6 -->\n###### 조민주\n\n<!-- PAGE_6 -->\n###### ：\n\n<!-- PAGE_6 -->\n###### 연 락 처\n\n<!-- PAGE_6 -->\n###### 서울시 은평구 통일로 194\n\n<!-- PAGE_6 -->\n###### ：\n\n<!-- PAGE_6 -->\n###### (전화\n\n<!-- PAGE_6 -->\n###### ) 02-380-1715, 65\n\n<!-- PAGE_6 -->\n###### (FAX) 02-386-6584\n\n<!-- PAGE_6 -->\n###### (E-mail) luck00@kfda.go.kr\n\n<!-- PAGE_6 -->\n###### 생 물 의 약 품 국\n\n<!-- PAGE_7 -->\n###### 본 가이드라인은 현재까지의 경험과 과학적 사실에 근거하여 식품의약\n\n<!-- PAGE_7 -->\n###### 품안전처의 입장을 기술하고 있습니다.  이 가이드라인에 기술된 사항은 법\n\n<!-- PAGE_7 -->\n###### 적 효력이 있는 것은 아니며, 법령이나 행정규칙 등에서 정하고 있는 사항\n\n<!-- PAGE_7 -->\n###### 외에는 식품의약품안전처의 권고사항입니다.  이는 새로운 과학적 근거가\n\n<!-- PAGE_7 -->\n###### 있을 경우 개정될 수 있으므로 이러한 사항이 있을 경우 식품의약품안전처\n\n<!-- PAGE_8 -->\n### 목\n\n<!-- PAGE_8 -->\n### 차\n\n<!-- PAGE_8 -->\n###### Ⅰ.  서론\n\n<!-- PAGE_8 -->\n###### ······························································································································1\n\n<!-- PAGE_8 -->\n###### 구조 물리화학적 성질\n\n<!-- PAGE_8 -->\n###### 제조 및 품질관리\n\n<!-- PAGE_8 -->\n###### .\n\n",
        "original_sentence": "<!-- PAGE_4 -->\n###### 전화번호 : 043-719-3451\n\n<!-- PAGE_4 -->\n###### 팩스번호 : 043-719-3450\n\n<!-- PAGE_5 -->\n## 정맥주사용\n\n<!-- PAGE_5 -->\n## 형 간염 사람면역글로불린제제의\n\n<!-- PAGE_5 -->\n## B\n\n<!-- PAGE_5 -->\n#### Guideline on the Safety and Efficacy Evaluation\n\n<!-- PAGE_5 -->\n#### 2008\n\n<!-- PAGE_5 -->\n###### 생 물 의 약 품 국\n\n<!-- PAGE_5 -->\n###### 행정간행물 등록번호\n\n11-1470000-001752-14\n\n<!-- PAGE_6 -->\n## 정맥주사용\n\n<!-- PAGE_6 -->\n## B형 간염 사람면역글로불린제제의\n\n<!-- PAGE_6 -->\n## 안전성유효성 평가 가이드라인\n\n<!-- PAGE_6 -->\n## ․\n\n<!-- PAGE_6 -->\n#### Guideline on the Safety and Efficacy Evaluation\n\n<!-- PAGE_6 -->\n#### of Human Hepatitis B Immunoglobulin\n\n<!-- PAGE_6 -->\n#### for Intravenous Administration\n\n<!-- PAGE_6 -->\n###### 담당부서\n\n<!-- PAGE_6 -->\n###### 생물의약품국 혈액제제과\n\n<!-- PAGE_6 -->\n###### ：\n\n<!-- PAGE_6 -->\n###### 담 당 자\n\n<!-- PAGE_6 -->\n###### 조민주\n\n<!-- PAGE_6 -->\n###### ：\n\n<!-- PAGE_6 -->\n###### 연 락 처\n\n<!-- PAGE_6 -->\n###### 서울시 은평구 통일로 194\n\n<!-- PAGE_6 -->\n###### ：\n\n<!-- PAGE_6 -->\n###### (전화\n\n<!-- PAGE_6 -->\n###### ) 02-380-1715, 65\n\n<!-- PAGE_6 -->\n###### (FAX) 02-386-6584\n\n<!-- PAGE_6 -->\n###### (E-mail) luck00@kfda.go.kr\n\n<!-- PAGE_6 -->\n###### 생 물 의 약 품 국\n\n<!-- PAGE_7 -->\n###### 본 가이드라인은 현재까지의 경험과 과학적 사실에 근거하여 식품의약\n\n<!-- PAGE_7 -->\n###### 품안전처의 입장을 기술하고 있습니다. "
      }
    },
    {
      "chunk_id": "chunk_042",
      "text": "이 가이드라인에 기술된 사항은 법\n\n<!-- PAGE_7 -->\n###### 적 효력이 있는 것은 아니며, 법령이나 행정규칙 등에서 정하고 있는 사항\n\n<!-- PAGE_7 -->\n###### 외에는 식품의약품안전처의 권고사항입니다. ",
      "metadata": {
        "source": "(가이드라인-005)_정맥주사용+B형간염+사람면역글로불린제제의+안전성유효성+평가+가이드라인.pdf",
        "chunk_index": 41,
        "window_size": 3,
        "char_count": 131,
        "word_count": 27,
        "page_number": 7,
        "window_text": "또한, 본 안내서는 2015년 12월 31일 현재의\n\n<!-- PAGE_4 -->\n###### 과학적ㆍ기술적 사실 및 유효한 법규를 토대로 작성되었으므로 이후 최신\n\n<!-- PAGE_4 -->\n###### 개정 법규 내용 및 구체적인 사실관계 등에 따라 달리 적용될 수 있음을 알려드립니다.\n\n <!-- PAGE_4 -->\n###### ※ “민원인 안내서”란 대내외적으로 법령 또는 고시ㆍ훈령ㆍ예규 등을 알기\n\n<!-- PAGE_4 -->\n###### 쉽게 풀어서 설명하거나 특정한 사안에 대하여 식품의약품안전처의 입장을\n\n<!-- PAGE_4 -->\n###### 기술하는 것(식품의약품안전처 지침서등의 관리에 관한 규정 제2조)\n\n<!-- PAGE_4 -->\n###### ※ 본 안내서에 대한 의견이나 문의사항이 있을 경우 식품의약품안전평가원\n\n<!-- PAGE_4 -->\n###### 바이오생약심사부 생물제제과에 문의하시기 바랍니다.\n\n <!-- PAGE_4 -->\n###### 전화번호 : 043-719-3451\n\n<!-- PAGE_4 -->\n###### 팩스번호 : 043-719-3450\n\n<!-- PAGE_5 -->\n## 정맥주사용\n\n<!-- PAGE_5 -->\n## 형 간염 사람면역글로불린제제의\n\n<!-- PAGE_5 -->\n## B\n\n<!-- PAGE_5 -->\n#### Guideline on the Safety and Efficacy Evaluation\n\n<!-- PAGE_5 -->\n#### 2008\n\n<!-- PAGE_5 -->\n###### 생 물 의 약 품 국\n\n<!-- PAGE_5 -->\n###### 행정간행물 등록번호\n\n11-1470000-001752-14\n\n<!-- PAGE_6 -->\n## 정맥주사용\n\n<!-- PAGE_6 -->\n## B형 간염 사람면역글로불린제제의\n\n<!-- PAGE_6 -->\n## 안전성유효성 평가 가이드라인\n\n<!-- PAGE_6 -->\n## ․\n\n<!-- PAGE_6 -->\n#### Guideline on the Safety and Efficacy Evaluation\n\n<!-- PAGE_6 -->\n#### of Human Hepatitis B Immunoglobulin\n\n<!-- PAGE_6 -->\n#### for Intravenous Administration\n\n<!-- PAGE_6 -->\n###### 담당부서\n\n<!-- PAGE_6 -->\n###### 생물의약품국 혈액제제과\n\n<!-- PAGE_6 -->\n###### ：\n\n<!-- PAGE_6 -->\n###### 담 당 자\n\n<!-- PAGE_6 -->\n###### 조민주\n\n<!-- PAGE_6 -->\n###### ：\n\n<!-- PAGE_6 -->\n###### 연 락 처\n\n<!-- PAGE_6 -->\n###### 서울시 은평구 통일로 194\n\n<!-- PAGE_6 -->\n###### ：\n\n<!-- PAGE_6 -->\n###### (전화\n\n<!-- PAGE_6 -->\n###### ) 02-380-1715, 65\n\n<!-- PAGE_6 -->\n###### (FAX) 02-386-6584\n\n<!-- PAGE_6 -->\n###### (E-mail) luck00@kfda.go.kr\n\n<!-- PAGE_6 -->\n###### 생 물 의 약 품 국\n\n<!-- PAGE_7 -->\n###### 본 가이드라인은 현재까지의 경험과 과학적 사실에 근거하여 식품의약\n\n<!-- PAGE_7 -->\n###### 품안전처의 입장을 기술하고 있습니다.  이 가이드라인에 기술된 사항은 법\n\n<!-- PAGE_7 -->\n###### 적 효력이 있는 것은 아니며, 법령이나 행정규칙 등에서 정하고 있는 사항\n\n<!-- PAGE_7 -->\n###### 외에는 식품의약품안전처의 권고사항입니다.  이는 새로운 과학적 근거가\n\n<!-- PAGE_7 -->\n###### 있을 경우 개정될 수 있으므로 이러한 사항이 있을 경우 식품의약품안전처\n\n<!-- PAGE_8 -->\n### 목\n\n<!-- PAGE_8 -->\n### 차\n\n<!-- PAGE_8 -->\n###### Ⅰ.  서론\n\n<!-- PAGE_8 -->\n###### ······························································································································1\n\n<!-- PAGE_8 -->\n###### 구조 물리화학적 성질\n\n<!-- PAGE_8 -->\n###### 제조 및 품질관리\n\n<!-- PAGE_8 -->\n###### .\n\n <!-- PAGE_8 -->\n###### ,\n\n<!-- PAGE_8 -->\n###### Ⅱ\n\n<!-- PAGE_8 -->\n###### ․\n\n<!-- PAGE_8 -->\n###### ····························································2\n\n<!-- PAGE_8 -->\n###### 구조결정\n\n<!-- PAGE_8 -->\n###### 물리화학적 성질\n\n<!-- PAGE_8 -->\n###### 1.\n\n",
        "original_sentence": "이 가이드라인에 기술된 사항은 법\n\n<!-- PAGE_7 -->\n###### 적 효력이 있는 것은 아니며, 법령이나 행정규칙 등에서 정하고 있는 사항\n\n<!-- PAGE_7 -->\n###### 외에는 식품의약품안전처의 권고사항입니다. "
      }
    },
    {
      "chunk_id": "chunk_043",
      "text": "이는 새로운 과학적 근거가\n\n<!-- PAGE_7 -->\n###### 있을 경우 개정될 수 있으므로 이러한 사항이 있을 경우 식품의약품안전처\n\n<!-- PAGE_8 -->\n### 목\n\n<!-- PAGE_8 -->\n### 차\n\n<!-- PAGE_8 -->\n###### Ⅰ. ",
      "metadata": {
        "source": "(가이드라인-005)_정맥주사용+B형간염+사람면역글로불린제제의+안전성유효성+평가+가이드라인.pdf",
        "chunk_index": 42,
        "window_size": 3,
        "char_count": 152,
        "word_count": 33,
        "page_number": 7,
        "window_text": "<!-- PAGE_4 -->\n###### ※ “민원인 안내서”란 대내외적으로 법령 또는 고시ㆍ훈령ㆍ예규 등을 알기\n\n<!-- PAGE_4 -->\n###### 쉽게 풀어서 설명하거나 특정한 사안에 대하여 식품의약품안전처의 입장을\n\n<!-- PAGE_4 -->\n###### 기술하는 것(식품의약품안전처 지침서등의 관리에 관한 규정 제2조)\n\n<!-- PAGE_4 -->\n###### ※ 본 안내서에 대한 의견이나 문의사항이 있을 경우 식품의약품안전평가원\n\n<!-- PAGE_4 -->\n###### 바이오생약심사부 생물제제과에 문의하시기 바랍니다.\n\n <!-- PAGE_4 -->\n###### 전화번호 : 043-719-3451\n\n<!-- PAGE_4 -->\n###### 팩스번호 : 043-719-3450\n\n<!-- PAGE_5 -->\n## 정맥주사용\n\n<!-- PAGE_5 -->\n## 형 간염 사람면역글로불린제제의\n\n<!-- PAGE_5 -->\n## B\n\n<!-- PAGE_5 -->\n#### Guideline on the Safety and Efficacy Evaluation\n\n<!-- PAGE_5 -->\n#### 2008\n\n<!-- PAGE_5 -->\n###### 생 물 의 약 품 국\n\n<!-- PAGE_5 -->\n###### 행정간행물 등록번호\n\n11-1470000-001752-14\n\n<!-- PAGE_6 -->\n## 정맥주사용\n\n<!-- PAGE_6 -->\n## B형 간염 사람면역글로불린제제의\n\n<!-- PAGE_6 -->\n## 안전성유효성 평가 가이드라인\n\n<!-- PAGE_6 -->\n## ․\n\n<!-- PAGE_6 -->\n#### Guideline on the Safety and Efficacy Evaluation\n\n<!-- PAGE_6 -->\n#### of Human Hepatitis B Immunoglobulin\n\n<!-- PAGE_6 -->\n#### for Intravenous Administration\n\n<!-- PAGE_6 -->\n###### 담당부서\n\n<!-- PAGE_6 -->\n###### 생물의약품국 혈액제제과\n\n<!-- PAGE_6 -->\n###### ：\n\n<!-- PAGE_6 -->\n###### 담 당 자\n\n<!-- PAGE_6 -->\n###### 조민주\n\n<!-- PAGE_6 -->\n###### ：\n\n<!-- PAGE_6 -->\n###### 연 락 처\n\n<!-- PAGE_6 -->\n###### 서울시 은평구 통일로 194\n\n<!-- PAGE_6 -->\n###### ：\n\n<!-- PAGE_6 -->\n###### (전화\n\n<!-- PAGE_6 -->\n###### ) 02-380-1715, 65\n\n<!-- PAGE_6 -->\n###### (FAX) 02-386-6584\n\n<!-- PAGE_6 -->\n###### (E-mail) luck00@kfda.go.kr\n\n<!-- PAGE_6 -->\n###### 생 물 의 약 품 국\n\n<!-- PAGE_7 -->\n###### 본 가이드라인은 현재까지의 경험과 과학적 사실에 근거하여 식품의약\n\n<!-- PAGE_7 -->\n###### 품안전처의 입장을 기술하고 있습니다.  이 가이드라인에 기술된 사항은 법\n\n<!-- PAGE_7 -->\n###### 적 효력이 있는 것은 아니며, 법령이나 행정규칙 등에서 정하고 있는 사항\n\n<!-- PAGE_7 -->\n###### 외에는 식품의약품안전처의 권고사항입니다.  이는 새로운 과학적 근거가\n\n<!-- PAGE_7 -->\n###### 있을 경우 개정될 수 있으므로 이러한 사항이 있을 경우 식품의약품안전처\n\n<!-- PAGE_8 -->\n### 목\n\n<!-- PAGE_8 -->\n### 차\n\n<!-- PAGE_8 -->\n###### Ⅰ.  서론\n\n<!-- PAGE_8 -->\n###### ······························································································································1\n\n<!-- PAGE_8 -->\n###### 구조 물리화학적 성질\n\n<!-- PAGE_8 -->\n###### 제조 및 품질관리\n\n<!-- PAGE_8 -->\n###### .\n\n <!-- PAGE_8 -->\n###### ,\n\n<!-- PAGE_8 -->\n###### Ⅱ\n\n<!-- PAGE_8 -->\n###### ․\n\n<!-- PAGE_8 -->\n###### ····························································2\n\n<!-- PAGE_8 -->\n###### 구조결정\n\n<!-- PAGE_8 -->\n###### 물리화학적 성질\n\n<!-- PAGE_8 -->\n###### 1.\n\n <!-- PAGE_8 -->\n###### ,\n\n<!-- PAGE_8 -->\n###### ················································································2\n\n<!-- PAGE_8 -->\n###### 2. ",
        "original_sentence": "이는 새로운 과학적 근거가\n\n<!-- PAGE_7 -->\n###### 있을 경우 개정될 수 있으므로 이러한 사항이 있을 경우 식품의약품안전처\n\n<!-- PAGE_8 -->\n### 목\n\n<!-- PAGE_8 -->\n### 차\n\n<!-- PAGE_8 -->\n###### Ⅰ. "
      }
    },
    {
      "chunk_id": "chunk_044",
      "text": "서론\n\n<!-- PAGE_8 -->\n###### ······························································································································1\n\n<!-- PAGE_8 -->\n###### 구조 물리화학적 성질\n\n<!-- PAGE_8 -->\n###### 제조 및 품질관리\n\n<!-- PAGE_8 -->\n###### .\n\n",
      "metadata": {
        "source": "(가이드라인-005)_정맥주사용+B형간염+사람면역글로불린제제의+안전성유효성+평가+가이드라인.pdf",
        "chunk_index": 43,
        "window_size": 3,
        "char_count": 252,
        "word_count": 25,
        "page_number": 8,
        "window_text": "<!-- PAGE_4 -->\n###### 전화번호 : 043-719-3451\n\n<!-- PAGE_4 -->\n###### 팩스번호 : 043-719-3450\n\n<!-- PAGE_5 -->\n## 정맥주사용\n\n<!-- PAGE_5 -->\n## 형 간염 사람면역글로불린제제의\n\n<!-- PAGE_5 -->\n## B\n\n<!-- PAGE_5 -->\n#### Guideline on the Safety and Efficacy Evaluation\n\n<!-- PAGE_5 -->\n#### 2008\n\n<!-- PAGE_5 -->\n###### 생 물 의 약 품 국\n\n<!-- PAGE_5 -->\n###### 행정간행물 등록번호\n\n11-1470000-001752-14\n\n<!-- PAGE_6 -->\n## 정맥주사용\n\n<!-- PAGE_6 -->\n## B형 간염 사람면역글로불린제제의\n\n<!-- PAGE_6 -->\n## 안전성유효성 평가 가이드라인\n\n<!-- PAGE_6 -->\n## ․\n\n<!-- PAGE_6 -->\n#### Guideline on the Safety and Efficacy Evaluation\n\n<!-- PAGE_6 -->\n#### of Human Hepatitis B Immunoglobulin\n\n<!-- PAGE_6 -->\n#### for Intravenous Administration\n\n<!-- PAGE_6 -->\n###### 담당부서\n\n<!-- PAGE_6 -->\n###### 생물의약품국 혈액제제과\n\n<!-- PAGE_6 -->\n###### ：\n\n<!-- PAGE_6 -->\n###### 담 당 자\n\n<!-- PAGE_6 -->\n###### 조민주\n\n<!-- PAGE_6 -->\n###### ：\n\n<!-- PAGE_6 -->\n###### 연 락 처\n\n<!-- PAGE_6 -->\n###### 서울시 은평구 통일로 194\n\n<!-- PAGE_6 -->\n###### ：\n\n<!-- PAGE_6 -->\n###### (전화\n\n<!-- PAGE_6 -->\n###### ) 02-380-1715, 65\n\n<!-- PAGE_6 -->\n###### (FAX) 02-386-6584\n\n<!-- PAGE_6 -->\n###### (E-mail) luck00@kfda.go.kr\n\n<!-- PAGE_6 -->\n###### 생 물 의 약 품 국\n\n<!-- PAGE_7 -->\n###### 본 가이드라인은 현재까지의 경험과 과학적 사실에 근거하여 식품의약\n\n<!-- PAGE_7 -->\n###### 품안전처의 입장을 기술하고 있습니다.  이 가이드라인에 기술된 사항은 법\n\n<!-- PAGE_7 -->\n###### 적 효력이 있는 것은 아니며, 법령이나 행정규칙 등에서 정하고 있는 사항\n\n<!-- PAGE_7 -->\n###### 외에는 식품의약품안전처의 권고사항입니다.  이는 새로운 과학적 근거가\n\n<!-- PAGE_7 -->\n###### 있을 경우 개정될 수 있으므로 이러한 사항이 있을 경우 식품의약품안전처\n\n<!-- PAGE_8 -->\n### 목\n\n<!-- PAGE_8 -->\n### 차\n\n<!-- PAGE_8 -->\n###### Ⅰ.  서론\n\n<!-- PAGE_8 -->\n###### ······························································································································1\n\n<!-- PAGE_8 -->\n###### 구조 물리화학적 성질\n\n<!-- PAGE_8 -->\n###### 제조 및 품질관리\n\n<!-- PAGE_8 -->\n###### .\n\n <!-- PAGE_8 -->\n###### ,\n\n<!-- PAGE_8 -->\n###### Ⅱ\n\n<!-- PAGE_8 -->\n###### ․\n\n<!-- PAGE_8 -->\n###### ····························································2\n\n<!-- PAGE_8 -->\n###### 구조결정\n\n<!-- PAGE_8 -->\n###### 물리화학적 성질\n\n<!-- PAGE_8 -->\n###### 1.\n\n <!-- PAGE_8 -->\n###### ,\n\n<!-- PAGE_8 -->\n###### ················································································2\n\n<!-- PAGE_8 -->\n###### 2.  원료물질의 수집 및 관리\n\n<!-- PAGE_8 -->\n###### ···················································································2\n\n<!-- PAGE_8 -->\n###### 3. ",
        "original_sentence": "서론\n\n<!-- PAGE_8 -->\n###### ······························································································································1\n\n<!-- PAGE_8 -->\n###### 구조 물리화학적 성질\n\n<!-- PAGE_8 -->\n###### 제조 및 품질관리\n\n<!-- PAGE_8 -->\n###### .\n\n"
      }
    },
    {
      "chunk_id": "chunk_045",
      "text": "<!-- PAGE_8 -->\n###### ,\n\n<!-- PAGE_8 -->\n###### Ⅱ\n\n<!-- PAGE_8 -->\n###### ․\n\n<!-- PAGE_8 -->\n###### ····························································2\n\n<!-- PAGE_8 -->\n###### 구조결정\n\n<!-- PAGE_8 -->\n###### 물리화학적 성질\n\n<!-- PAGE_8 -->\n###### 1.\n\n",
      "metadata": {
        "source": "(가이드라인-005)_정맥주사용+B형간염+사람면역글로불린제제의+안전성유효성+평가+가이드라인.pdf",
        "chunk_index": 44,
        "window_size": 3,
        "char_count": 253,
        "word_count": 36,
        "page_number": 8,
        "window_text": "이 가이드라인에 기술된 사항은 법\n\n<!-- PAGE_7 -->\n###### 적 효력이 있는 것은 아니며, 법령이나 행정규칙 등에서 정하고 있는 사항\n\n<!-- PAGE_7 -->\n###### 외에는 식품의약품안전처의 권고사항입니다.  이는 새로운 과학적 근거가\n\n<!-- PAGE_7 -->\n###### 있을 경우 개정될 수 있으므로 이러한 사항이 있을 경우 식품의약품안전처\n\n<!-- PAGE_8 -->\n### 목\n\n<!-- PAGE_8 -->\n### 차\n\n<!-- PAGE_8 -->\n###### Ⅰ.  서론\n\n<!-- PAGE_8 -->\n###### ······························································································································1\n\n<!-- PAGE_8 -->\n###### 구조 물리화학적 성질\n\n<!-- PAGE_8 -->\n###### 제조 및 품질관리\n\n<!-- PAGE_8 -->\n###### .\n\n <!-- PAGE_8 -->\n###### ,\n\n<!-- PAGE_8 -->\n###### Ⅱ\n\n<!-- PAGE_8 -->\n###### ․\n\n<!-- PAGE_8 -->\n###### ····························································2\n\n<!-- PAGE_8 -->\n###### 구조결정\n\n<!-- PAGE_8 -->\n###### 물리화학적 성질\n\n<!-- PAGE_8 -->\n###### 1.\n\n <!-- PAGE_8 -->\n###### ,\n\n<!-- PAGE_8 -->\n###### ················································································2\n\n<!-- PAGE_8 -->\n###### 2.  원료물질의 수집 및 관리\n\n<!-- PAGE_8 -->\n###### ···················································································2\n\n<!-- PAGE_8 -->\n###### 3.  제조공정\n\n<!-- PAGE_8 -->\n###### ·················································································································3\n\n<!-- PAGE_8 -->\n###### 4. ",
        "original_sentence": "<!-- PAGE_8 -->\n###### ,\n\n<!-- PAGE_8 -->\n###### Ⅱ\n\n<!-- PAGE_8 -->\n###### ․\n\n<!-- PAGE_8 -->\n###### ····························································2\n\n<!-- PAGE_8 -->\n###### 구조결정\n\n<!-- PAGE_8 -->\n###### 물리화학적 성질\n\n<!-- PAGE_8 -->\n###### 1.\n\n"
      }
    },
    {
      "chunk_id": "chunk_046",
      "text": "<!-- PAGE_8 -->\n###### ,\n\n<!-- PAGE_8 -->\n###### ················································································2\n\n<!-- PAGE_8 -->\n###### 2. ",
      "metadata": {
        "source": "(가이드라인-005)_정맥주사용+B형간염+사람면역글로불린제제의+안전성유효성+평가+가이드라인.pdf",
        "chunk_index": 45,
        "window_size": 3,
        "char_count": 158,
        "word_count": 15,
        "page_number": 8,
        "window_text": "이는 새로운 과학적 근거가\n\n<!-- PAGE_7 -->\n###### 있을 경우 개정될 수 있으므로 이러한 사항이 있을 경우 식품의약품안전처\n\n<!-- PAGE_8 -->\n### 목\n\n<!-- PAGE_8 -->\n### 차\n\n<!-- PAGE_8 -->\n###### Ⅰ.  서론\n\n<!-- PAGE_8 -->\n###### ······························································································································1\n\n<!-- PAGE_8 -->\n###### 구조 물리화학적 성질\n\n<!-- PAGE_8 -->\n###### 제조 및 품질관리\n\n<!-- PAGE_8 -->\n###### .\n\n <!-- PAGE_8 -->\n###### ,\n\n<!-- PAGE_8 -->\n###### Ⅱ\n\n<!-- PAGE_8 -->\n###### ․\n\n<!-- PAGE_8 -->\n###### ····························································2\n\n<!-- PAGE_8 -->\n###### 구조결정\n\n<!-- PAGE_8 -->\n###### 물리화학적 성질\n\n<!-- PAGE_8 -->\n###### 1.\n\n <!-- PAGE_8 -->\n###### ,\n\n<!-- PAGE_8 -->\n###### ················································································2\n\n<!-- PAGE_8 -->\n###### 2.  원료물질의 수집 및 관리\n\n<!-- PAGE_8 -->\n###### ···················································································2\n\n<!-- PAGE_8 -->\n###### 3.  제조공정\n\n<!-- PAGE_8 -->\n###### ·················································································································3\n\n<!-- PAGE_8 -->\n###### 4.  품질관리\n\n<!-- PAGE_8 -->\n###### ·················································································································4\n\n<!-- PAGE_8 -->\n###### III. ",
        "original_sentence": "<!-- PAGE_8 -->\n###### ,\n\n<!-- PAGE_8 -->\n###### ················································································2\n\n<!-- PAGE_8 -->\n###### 2. "
      }
    },
    {
      "chunk_id": "chunk_047",
      "text": "원료물질의 수집 및 관리\n\n<!-- PAGE_8 -->\n###### ···················································································2\n\n<!-- PAGE_8 -->\n###### 3. ",
      "metadata": {
        "source": "(가이드라인-005)_정맥주사용+B형간염+사람면역글로불린제제의+안전성유효성+평가+가이드라인.pdf",
        "chunk_index": 46,
        "window_size": 3,
        "char_count": 150,
        "word_count": 14,
        "page_number": 8,
        "window_text": "서론\n\n<!-- PAGE_8 -->\n###### ······························································································································1\n\n<!-- PAGE_8 -->\n###### 구조 물리화학적 성질\n\n<!-- PAGE_8 -->\n###### 제조 및 품질관리\n\n<!-- PAGE_8 -->\n###### .\n\n <!-- PAGE_8 -->\n###### ,\n\n<!-- PAGE_8 -->\n###### Ⅱ\n\n<!-- PAGE_8 -->\n###### ․\n\n<!-- PAGE_8 -->\n###### ····························································2\n\n<!-- PAGE_8 -->\n###### 구조결정\n\n<!-- PAGE_8 -->\n###### 물리화학적 성질\n\n<!-- PAGE_8 -->\n###### 1.\n\n <!-- PAGE_8 -->\n###### ,\n\n<!-- PAGE_8 -->\n###### ················································································2\n\n<!-- PAGE_8 -->\n###### 2.  원료물질의 수집 및 관리\n\n<!-- PAGE_8 -->\n###### ···················································································2\n\n<!-- PAGE_8 -->\n###### 3.  제조공정\n\n<!-- PAGE_8 -->\n###### ·················································································································3\n\n<!-- PAGE_8 -->\n###### 4.  품질관리\n\n<!-- PAGE_8 -->\n###### ·················································································································4\n\n<!-- PAGE_8 -->\n###### III.  안정성시험\n\n<!-- PAGE_8 -->\n###### ··················································································································5\n\n<!-- PAGE_8 -->\n###### Ⅳ. ",
        "original_sentence": "원료물질의 수집 및 관리\n\n<!-- PAGE_8 -->\n###### ···················································································2\n\n<!-- PAGE_8 -->\n###### 3. "
      }
    },
    {
      "chunk_id": "chunk_048",
      "text": "제조공정\n\n<!-- PAGE_8 -->\n###### ·················································································································3\n\n<!-- PAGE_8 -->\n###### 4. ",
      "metadata": {
        "source": "(가이드라인-005)_정맥주사용+B형간염+사람면역글로불린제제의+안전성유효성+평가+가이드라인.pdf",
        "chunk_index": 47,
        "window_size": 3,
        "char_count": 171,
        "word_count": 11,
        "page_number": 8,
        "window_text": "<!-- PAGE_8 -->\n###### ,\n\n<!-- PAGE_8 -->\n###### Ⅱ\n\n<!-- PAGE_8 -->\n###### ․\n\n<!-- PAGE_8 -->\n###### ····························································2\n\n<!-- PAGE_8 -->\n###### 구조결정\n\n<!-- PAGE_8 -->\n###### 물리화학적 성질\n\n<!-- PAGE_8 -->\n###### 1.\n\n <!-- PAGE_8 -->\n###### ,\n\n<!-- PAGE_8 -->\n###### ················································································2\n\n<!-- PAGE_8 -->\n###### 2.  원료물질의 수집 및 관리\n\n<!-- PAGE_8 -->\n###### ···················································································2\n\n<!-- PAGE_8 -->\n###### 3.  제조공정\n\n<!-- PAGE_8 -->\n###### ·················································································································3\n\n<!-- PAGE_8 -->\n###### 4.  품질관리\n\n<!-- PAGE_8 -->\n###### ·················································································································4\n\n<!-- PAGE_8 -->\n###### III.  안정성시험\n\n<!-- PAGE_8 -->\n###### ··················································································································5\n\n<!-- PAGE_8 -->\n###### Ⅳ.  비임상시험\n\n<!-- PAGE_8 -->\n###### ··················································································································5\n\n<!-- PAGE_8 -->\n###### 1. ",
        "original_sentence": "제조공정\n\n<!-- PAGE_8 -->\n###### ·················································································································3\n\n<!-- PAGE_8 -->\n###### 4. "
      }
    },
    {
      "chunk_id": "chunk_049",
      "text": "품질관리\n\n<!-- PAGE_8 -->\n###### ·················································································································4\n\n<!-- PAGE_8 -->\n###### III. ",
      "metadata": {
        "source": "(가이드라인-005)_정맥주사용+B형간염+사람면역글로불린제제의+안전성유효성+평가+가이드라인.pdf",
        "chunk_index": 48,
        "window_size": 3,
        "char_count": 173,
        "word_count": 11,
        "page_number": 8,
        "window_text": "<!-- PAGE_8 -->\n###### ,\n\n<!-- PAGE_8 -->\n###### ················································································2\n\n<!-- PAGE_8 -->\n###### 2.  원료물질의 수집 및 관리\n\n<!-- PAGE_8 -->\n###### ···················································································2\n\n<!-- PAGE_8 -->\n###### 3.  제조공정\n\n<!-- PAGE_8 -->\n###### ·················································································································3\n\n<!-- PAGE_8 -->\n###### 4.  품질관리\n\n<!-- PAGE_8 -->\n###### ·················································································································4\n\n<!-- PAGE_8 -->\n###### III.  안정성시험\n\n<!-- PAGE_8 -->\n###### ··················································································································5\n\n<!-- PAGE_8 -->\n###### Ⅳ.  비임상시험\n\n<!-- PAGE_8 -->\n###### ··················································································································5\n\n<!-- PAGE_8 -->\n###### 1.  일반적 고려사항\n\n<!-- PAGE_8 -->\n###### ···································································································5\n\n<!-- PAGE_8 -->\n###### 2. ",
        "original_sentence": "품질관리\n\n<!-- PAGE_8 -->\n###### ·················································································································4\n\n<!-- PAGE_8 -->\n###### III. "
      }
    },
    {
      "chunk_id": "chunk_050",
      "text": "안정성시험\n\n<!-- PAGE_8 -->\n###### ··················································································································5\n\n<!-- PAGE_8 -->\n###### Ⅳ. ",
      "metadata": {
        "source": "(가이드라인-005)_정맥주사용+B형간염+사람면역글로불린제제의+안전성유효성+평가+가이드라인.pdf",
        "chunk_index": 49,
        "window_size": 3,
        "char_count": 173,
        "word_count": 11,
        "page_number": 8,
        "window_text": "원료물질의 수집 및 관리\n\n<!-- PAGE_8 -->\n###### ···················································································2\n\n<!-- PAGE_8 -->\n###### 3.  제조공정\n\n<!-- PAGE_8 -->\n###### ·················································································································3\n\n<!-- PAGE_8 -->\n###### 4.  품질관리\n\n<!-- PAGE_8 -->\n###### ·················································································································4\n\n<!-- PAGE_8 -->\n###### III.  안정성시험\n\n<!-- PAGE_8 -->\n###### ··················································································································5\n\n<!-- PAGE_8 -->\n###### Ⅳ.  비임상시험\n\n<!-- PAGE_8 -->\n###### ··················································································································5\n\n<!-- PAGE_8 -->\n###### 1.  일반적 고려사항\n\n<!-- PAGE_8 -->\n###### ···································································································5\n\n<!-- PAGE_8 -->\n###### 2.  독성시험\n\n<!-- PAGE_8 -->\n###### ·················································································································6\n\n<!-- PAGE_8 -->\n###### 3. ",
        "original_sentence": "안정성시험\n\n<!-- PAGE_8 -->\n###### ··················································································································5\n\n<!-- PAGE_8 -->\n###### Ⅳ. "
      }
    },
    {
      "chunk_id": "chunk_051",
      "text": "비임상시험\n\n<!-- PAGE_8 -->\n###### ··················································································································5\n\n<!-- PAGE_8 -->\n###### 1. ",
      "metadata": {
        "source": "(가이드라인-005)_정맥주사용+B형간염+사람면역글로불린제제의+안전성유효성+평가+가이드라인.pdf",
        "chunk_index": 50,
        "window_size": 3,
        "char_count": 173,
        "word_count": 11,
        "page_number": 8,
        "window_text": "제조공정\n\n<!-- PAGE_8 -->\n###### ·················································································································3\n\n<!-- PAGE_8 -->\n###### 4.  품질관리\n\n<!-- PAGE_8 -->\n###### ·················································································································4\n\n<!-- PAGE_8 -->\n###### III.  안정성시험\n\n<!-- PAGE_8 -->\n###### ··················································································································5\n\n<!-- PAGE_8 -->\n###### Ⅳ.  비임상시험\n\n<!-- PAGE_8 -->\n###### ··················································································································5\n\n<!-- PAGE_8 -->\n###### 1.  일반적 고려사항\n\n<!-- PAGE_8 -->\n###### ···································································································5\n\n<!-- PAGE_8 -->\n###### 2.  독성시험\n\n<!-- PAGE_8 -->\n###### ·················································································································6\n\n<!-- PAGE_8 -->\n###### 3.  약리시험\n\n<!-- PAGE_8 -->\n###### ·················································································································6\n\n<!-- PAGE_8 -->\n###### Ⅴ. ",
        "original_sentence": "비임상시험\n\n<!-- PAGE_8 -->\n###### ··················································································································5\n\n<!-- PAGE_8 -->\n###### 1. "
      }
    },
    {
      "chunk_id": "chunk_052",
      "text": "일반적 고려사항\n\n<!-- PAGE_8 -->\n###### ···································································································5\n\n<!-- PAGE_8 -->\n###### 2. ",
      "metadata": {
        "source": "(가이드라인-005)_정맥주사용+B형간염+사람면역글로불린제제의+안전성유효성+평가+가이드라인.pdf",
        "chunk_index": 51,
        "window_size": 3,
        "char_count": 161,
        "word_count": 12,
        "page_number": 8,
        "window_text": "품질관리\n\n<!-- PAGE_8 -->\n###### ·················································································································4\n\n<!-- PAGE_8 -->\n###### III.  안정성시험\n\n<!-- PAGE_8 -->\n###### ··················································································································5\n\n<!-- PAGE_8 -->\n###### Ⅳ.  비임상시험\n\n<!-- PAGE_8 -->\n###### ··················································································································5\n\n<!-- PAGE_8 -->\n###### 1.  일반적 고려사항\n\n<!-- PAGE_8 -->\n###### ···································································································5\n\n<!-- PAGE_8 -->\n###### 2.  독성시험\n\n<!-- PAGE_8 -->\n###### ·················································································································6\n\n<!-- PAGE_8 -->\n###### 3.  약리시험\n\n<!-- PAGE_8 -->\n###### ·················································································································6\n\n<!-- PAGE_8 -->\n###### Ⅴ.  임상시험\n\n<!-- PAGE_8 -->\n###### ······················································································································7\n\n<!-- PAGE_8 -->\n###### 1. ",
        "original_sentence": "일반적 고려사항\n\n<!-- PAGE_8 -->\n###### ···································································································5\n\n<!-- PAGE_8 -->\n###### 2. "
      }
    },
    {
      "chunk_id": "chunk_053",
      "text": "독성시험\n\n<!-- PAGE_8 -->\n###### ·················································································································6\n\n<!-- PAGE_8 -->\n###### 3. ",
      "metadata": {
        "source": "(가이드라인-005)_정맥주사용+B형간염+사람면역글로불린제제의+안전성유효성+평가+가이드라인.pdf",
        "chunk_index": 52,
        "window_size": 3,
        "char_count": 171,
        "word_count": 11,
        "page_number": 8,
        "window_text": "안정성시험\n\n<!-- PAGE_8 -->\n###### ··················································································································5\n\n<!-- PAGE_8 -->\n###### Ⅳ.  비임상시험\n\n<!-- PAGE_8 -->\n###### ··················································································································5\n\n<!-- PAGE_8 -->\n###### 1.  일반적 고려사항\n\n<!-- PAGE_8 -->\n###### ···································································································5\n\n<!-- PAGE_8 -->\n###### 2.  독성시험\n\n<!-- PAGE_8 -->\n###### ·················································································································6\n\n<!-- PAGE_8 -->\n###### 3.  약리시험\n\n<!-- PAGE_8 -->\n###### ·················································································································6\n\n<!-- PAGE_8 -->\n###### Ⅴ.  임상시험\n\n<!-- PAGE_8 -->\n###### ······················································································································7\n\n<!-- PAGE_8 -->\n###### 1.  일반적 고려사항\n\n<!-- PAGE_8 -->\n###### ···································································································7\n\n<!-- PAGE_8 -->\n###### 2. ",
        "original_sentence": "독성시험\n\n<!-- PAGE_8 -->\n###### ·················································································································6\n\n<!-- PAGE_8 -->\n###### 3. "
      }
    },
    {
      "chunk_id": "chunk_054",
      "text": "약리시험\n\n<!-- PAGE_8 -->\n###### ·················································································································6\n\n<!-- PAGE_8 -->\n###### Ⅴ. ",
      "metadata": {
        "source": "(가이드라인-005)_정맥주사용+B형간염+사람면역글로불린제제의+안전성유효성+평가+가이드라인.pdf",
        "chunk_index": 53,
        "window_size": 3,
        "char_count": 171,
        "word_count": 11,
        "page_number": 8,
        "window_text": "비임상시험\n\n<!-- PAGE_8 -->\n###### ··················································································································5\n\n<!-- PAGE_8 -->\n###### 1.  일반적 고려사항\n\n<!-- PAGE_8 -->\n###### ···································································································5\n\n<!-- PAGE_8 -->\n###### 2.  독성시험\n\n<!-- PAGE_8 -->\n###### ·················································································································6\n\n<!-- PAGE_8 -->\n###### 3.  약리시험\n\n<!-- PAGE_8 -->\n###### ·················································································································6\n\n<!-- PAGE_8 -->\n###### Ⅴ.  임상시험\n\n<!-- PAGE_8 -->\n###### ······················································································································7\n\n<!-- PAGE_8 -->\n###### 1.  일반적 고려사항\n\n<!-- PAGE_8 -->\n###### ···································································································7\n\n<!-- PAGE_8 -->\n###### 2.  임상약리시험\n\n<!-- PAGE_8 -->\n###### ·········································································································7\n\n<!-- PAGE_8 -->\n###### 3. ",
        "original_sentence": "약리시험\n\n<!-- PAGE_8 -->\n###### ·················································································································6\n\n<!-- PAGE_8 -->\n###### Ⅴ. "
      }
    },
    {
      "chunk_id": "chunk_055",
      "text": "임상시험\n\n<!-- PAGE_8 -->\n###### ······················································································································7\n\n<!-- PAGE_8 -->\n###### 1. ",
      "metadata": {
        "source": "(가이드라인-005)_정맥주사용+B형간염+사람면역글로불린제제의+안전성유효성+평가+가이드라인.pdf",
        "chunk_index": 54,
        "window_size": 3,
        "char_count": 176,
        "word_count": 11,
        "page_number": 8,
        "window_text": "일반적 고려사항\n\n<!-- PAGE_8 -->\n###### ···································································································5\n\n<!-- PAGE_8 -->\n###### 2.  독성시험\n\n<!-- PAGE_8 -->\n###### ·················································································································6\n\n<!-- PAGE_8 -->\n###### 3.  약리시험\n\n<!-- PAGE_8 -->\n###### ·················································································································6\n\n<!-- PAGE_8 -->\n###### Ⅴ.  임상시험\n\n<!-- PAGE_8 -->\n###### ······················································································································7\n\n<!-- PAGE_8 -->\n###### 1.  일반적 고려사항\n\n<!-- PAGE_8 -->\n###### ···································································································7\n\n<!-- PAGE_8 -->\n###### 2.  임상약리시험\n\n<!-- PAGE_8 -->\n###### ·········································································································7\n\n<!-- PAGE_8 -->\n###### 3.  치료적 탐색 임상시험\n\n<!-- PAGE_8 -->\n###### ·························································································8\n\n<!-- PAGE_8 -->\n###### 4. ",
        "original_sentence": "임상시험\n\n<!-- PAGE_8 -->\n###### ······················································································································7\n\n<!-- PAGE_8 -->\n###### 1. "
      }
    },
    {
      "chunk_id": "chunk_056",
      "text": "일반적 고려사항\n\n<!-- PAGE_8 -->\n###### ···································································································7\n\n<!-- PAGE_8 -->\n###### 2. ",
      "metadata": {
        "source": "(가이드라인-005)_정맥주사용+B형간염+사람면역글로불린제제의+안전성유효성+평가+가이드라인.pdf",
        "chunk_index": 55,
        "window_size": 3,
        "char_count": 161,
        "word_count": 12,
        "page_number": 8,
        "window_text": "독성시험\n\n<!-- PAGE_8 -->\n###### ·················································································································6\n\n<!-- PAGE_8 -->\n###### 3.  약리시험\n\n<!-- PAGE_8 -->\n###### ·················································································································6\n\n<!-- PAGE_8 -->\n###### Ⅴ.  임상시험\n\n<!-- PAGE_8 -->\n###### ······················································································································7\n\n<!-- PAGE_8 -->\n###### 1.  일반적 고려사항\n\n<!-- PAGE_8 -->\n###### ···································································································7\n\n<!-- PAGE_8 -->\n###### 2.  임상약리시험\n\n<!-- PAGE_8 -->\n###### ·········································································································7\n\n<!-- PAGE_8 -->\n###### 3.  치료적 탐색 임상시험\n\n<!-- PAGE_8 -->\n###### ·························································································8\n\n<!-- PAGE_8 -->\n###### 4.  치료적 확증 임상시험\n\n<!-- PAGE_8 -->\n###### ·························································································8\n\n<!-- PAGE_8 -->\n###### Ⅵ. ",
        "original_sentence": "일반적 고려사항\n\n<!-- PAGE_8 -->\n###### ···································································································7\n\n<!-- PAGE_8 -->\n###### 2. "
      }
    },
    {
      "chunk_id": "chunk_057",
      "text": "임상약리시험\n\n<!-- PAGE_8 -->\n###### ·········································································································7\n\n<!-- PAGE_8 -->\n###### 3. ",
      "metadata": {
        "source": "(가이드라인-005)_정맥주사용+B형간염+사람면역글로불린제제의+안전성유효성+평가+가이드라인.pdf",
        "chunk_index": 56,
        "window_size": 3,
        "char_count": 165,
        "word_count": 11,
        "page_number": 8,
        "window_text": "약리시험\n\n<!-- PAGE_8 -->\n###### ·················································································································6\n\n<!-- PAGE_8 -->\n###### Ⅴ.  임상시험\n\n<!-- PAGE_8 -->\n###### ······················································································································7\n\n<!-- PAGE_8 -->\n###### 1.  일반적 고려사항\n\n<!-- PAGE_8 -->\n###### ···································································································7\n\n<!-- PAGE_8 -->\n###### 2.  임상약리시험\n\n<!-- PAGE_8 -->\n###### ·········································································································7\n\n<!-- PAGE_8 -->\n###### 3.  치료적 탐색 임상시험\n\n<!-- PAGE_8 -->\n###### ·························································································8\n\n<!-- PAGE_8 -->\n###### 4.  치료적 확증 임상시험\n\n<!-- PAGE_8 -->\n###### ·························································································8\n\n<!-- PAGE_8 -->\n###### Ⅵ.  참고문헌\n\n<!-- PAGE_8 -->\n###### ·················································································································11\n\n- - 1 -\n<!-- PAGE_9 -->\n##### 정맥주사용\n\n<!-- PAGE_9 -->\n##### B형 간염 사람면\n\n<!-- PAGE_9 -->\n##### 역글로불린제제의\n\n<!-- PAGE_9 -->\n##### 안전성 유효성 평가 가이드라인\n\n<!-- PAGE_9 -->\n##### ․\n\n<!-- PAGE_9 -->\n###### . ",
        "original_sentence": "임상약리시험\n\n<!-- PAGE_8 -->\n###### ·········································································································7\n\n<!-- PAGE_8 -->\n###### 3. "
      }
    },
    {
      "chunk_id": "chunk_058",
      "text": "치료적 탐색 임상시험\n\n<!-- PAGE_8 -->\n###### ·························································································8\n\n<!-- PAGE_8 -->\n###### 4. ",
      "metadata": {
        "source": "(가이드라인-005)_정맥주사용+B형간염+사람면역글로불린제제의+안전성유효성+평가+가이드라인.pdf",
        "chunk_index": 57,
        "window_size": 3,
        "char_count": 154,
        "word_count": 13,
        "page_number": 8,
        "window_text": "임상시험\n\n<!-- PAGE_8 -->\n###### ······················································································································7\n\n<!-- PAGE_8 -->\n###### 1.  일반적 고려사항\n\n<!-- PAGE_8 -->\n###### ···································································································7\n\n<!-- PAGE_8 -->\n###### 2.  임상약리시험\n\n<!-- PAGE_8 -->\n###### ·········································································································7\n\n<!-- PAGE_8 -->\n###### 3.  치료적 탐색 임상시험\n\n<!-- PAGE_8 -->\n###### ·························································································8\n\n<!-- PAGE_8 -->\n###### 4.  치료적 확증 임상시험\n\n<!-- PAGE_8 -->\n###### ·························································································8\n\n<!-- PAGE_8 -->\n###### Ⅵ.  참고문헌\n\n<!-- PAGE_8 -->\n###### ·················································································································11\n\n- - 1 -\n<!-- PAGE_9 -->\n##### 정맥주사용\n\n<!-- PAGE_9 -->\n##### B형 간염 사람면\n\n<!-- PAGE_9 -->\n##### 역글로불린제제의\n\n<!-- PAGE_9 -->\n##### 안전성 유효성 평가 가이드라인\n\n<!-- PAGE_9 -->\n##### ․\n\n<!-- PAGE_9 -->\n###### .  서론\n\n<!-- PAGE_9 -->\n###### Ⅰ\n\n<!-- PAGE_9 -->\n###### 최근 국내에서 높은\n\n<!-- PAGE_9 -->\n###### 형 간염 유병율과 함께 말기 간질환 환자에 대한 간 이식 수\n\n<!-- PAGE_9 -->\n###### B\n\n<!-- PAGE_9 -->\n###### 술이 급격히 증가하고 있으나\n\n<!-- PAGE_9 -->\n###### 수술 이후\n\n<!-- PAGE_9 -->\n###### 형 간염의 재발이 보고됨에 따라 간 이식\n\n<!-- PAGE_9 -->\n###### ,\n\n<!-- PAGE_9 -->\n###### B\n\n<!-- PAGE_9 -->\n###### 후\n\n<!-- PAGE_9 -->\n###### 형 간염 재발 방지가 중요한 문제로 대두되었다\n\n<!-- PAGE_9 -->\n###### 형 간염 환자에서 간 이식 후\n\n<!-- PAGE_9 -->\n###### B\n\n<!-- PAGE_9 -->\n###### . ",
        "original_sentence": "치료적 탐색 임상시험\n\n<!-- PAGE_8 -->\n###### ·························································································8\n\n<!-- PAGE_8 -->\n###### 4. "
      }
    },
    {
      "chunk_id": "chunk_059",
      "text": "치료적 확증 임상시험\n\n<!-- PAGE_8 -->\n###### ·························································································8\n\n<!-- PAGE_8 -->\n###### Ⅵ. ",
      "metadata": {
        "source": "(가이드라인-005)_정맥주사용+B형간염+사람면역글로불린제제의+안전성유효성+평가+가이드라인.pdf",
        "chunk_index": 58,
        "window_size": 3,
        "char_count": 154,
        "word_count": 13,
        "page_number": 8,
        "window_text": "일반적 고려사항\n\n<!-- PAGE_8 -->\n###### ···································································································7\n\n<!-- PAGE_8 -->\n###### 2.  임상약리시험\n\n<!-- PAGE_8 -->\n###### ·········································································································7\n\n<!-- PAGE_8 -->\n###### 3.  치료적 탐색 임상시험\n\n<!-- PAGE_8 -->\n###### ·························································································8\n\n<!-- PAGE_8 -->\n###### 4.  치료적 확증 임상시험\n\n<!-- PAGE_8 -->\n###### ·························································································8\n\n<!-- PAGE_8 -->\n###### Ⅵ.  참고문헌\n\n<!-- PAGE_8 -->\n###### ·················································································································11\n\n- - 1 -\n<!-- PAGE_9 -->\n##### 정맥주사용\n\n<!-- PAGE_9 -->\n##### B형 간염 사람면\n\n<!-- PAGE_9 -->\n##### 역글로불린제제의\n\n<!-- PAGE_9 -->\n##### 안전성 유효성 평가 가이드라인\n\n<!-- PAGE_9 -->\n##### ․\n\n<!-- PAGE_9 -->\n###### .  서론\n\n<!-- PAGE_9 -->\n###### Ⅰ\n\n<!-- PAGE_9 -->\n###### 최근 국내에서 높은\n\n<!-- PAGE_9 -->\n###### 형 간염 유병율과 함께 말기 간질환 환자에 대한 간 이식 수\n\n<!-- PAGE_9 -->\n###### B\n\n<!-- PAGE_9 -->\n###### 술이 급격히 증가하고 있으나\n\n<!-- PAGE_9 -->\n###### 수술 이후\n\n<!-- PAGE_9 -->\n###### 형 간염의 재발이 보고됨에 따라 간 이식\n\n<!-- PAGE_9 -->\n###### ,\n\n<!-- PAGE_9 -->\n###### B\n\n<!-- PAGE_9 -->\n###### 후\n\n<!-- PAGE_9 -->\n###### 형 간염 재발 방지가 중요한 문제로 대두되었다\n\n<!-- PAGE_9 -->\n###### 형 간염 환자에서 간 이식 후\n\n<!-- PAGE_9 -->\n###### B\n\n<!-- PAGE_9 -->\n###### .  B\n\n<!-- PAGE_9 -->\n###### 간염 재발방지 요법을 시행하지 않은 경우\n\n<!-- PAGE_9 -->\n###### 년 후 재발율은\n\n<!-- PAGE_9 -->\n###### 이상에 이른다\n\n<!-- PAGE_9 -->\n###### 간\n\n<!-- PAGE_9 -->\n###### 2\n\n<!-- PAGE_9 -->\n###### 70%\n\n<!-- PAGE_9 -->\n###### .\n\n",
        "original_sentence": "치료적 확증 임상시험\n\n<!-- PAGE_8 -->\n###### ·························································································8\n\n<!-- PAGE_8 -->\n###### Ⅵ. "
      }
    },
    {
      "chunk_id": "chunk_060",
      "text": "참고문헌\n\n<!-- PAGE_8 -->\n###### ·················································································································11\n\n- - 1 -\n<!-- PAGE_9 -->\n##### 정맥주사용\n\n<!-- PAGE_9 -->\n##### B형 간염 사람면\n\n<!-- PAGE_9 -->\n##### 역글로불린제제의\n\n<!-- PAGE_9 -->\n##### 안전성 유효성 평가 가이드라인\n\n<!-- PAGE_9 -->\n##### ․\n\n<!-- PAGE_9 -->\n###### . ",
      "metadata": {
        "source": "(가이드라인-005)_정맥주사용+B형간염+사람면역글로불린제제의+안전성유효성+평가+가이드라인.pdf",
        "chunk_index": 59,
        "window_size": 3,
        "char_count": 338,
        "word_count": 45,
        "page_number": 8,
        "window_text": "임상약리시험\n\n<!-- PAGE_8 -->\n###### ·········································································································7\n\n<!-- PAGE_8 -->\n###### 3.  치료적 탐색 임상시험\n\n<!-- PAGE_8 -->\n###### ·························································································8\n\n<!-- PAGE_8 -->\n###### 4.  치료적 확증 임상시험\n\n<!-- PAGE_8 -->\n###### ·························································································8\n\n<!-- PAGE_8 -->\n###### Ⅵ.  참고문헌\n\n<!-- PAGE_8 -->\n###### ·················································································································11\n\n- - 1 -\n<!-- PAGE_9 -->\n##### 정맥주사용\n\n<!-- PAGE_9 -->\n##### B형 간염 사람면\n\n<!-- PAGE_9 -->\n##### 역글로불린제제의\n\n<!-- PAGE_9 -->\n##### 안전성 유효성 평가 가이드라인\n\n<!-- PAGE_9 -->\n##### ․\n\n<!-- PAGE_9 -->\n###### .  서론\n\n<!-- PAGE_9 -->\n###### Ⅰ\n\n<!-- PAGE_9 -->\n###### 최근 국내에서 높은\n\n<!-- PAGE_9 -->\n###### 형 간염 유병율과 함께 말기 간질환 환자에 대한 간 이식 수\n\n<!-- PAGE_9 -->\n###### B\n\n<!-- PAGE_9 -->\n###### 술이 급격히 증가하고 있으나\n\n<!-- PAGE_9 -->\n###### 수술 이후\n\n<!-- PAGE_9 -->\n###### 형 간염의 재발이 보고됨에 따라 간 이식\n\n<!-- PAGE_9 -->\n###### ,\n\n<!-- PAGE_9 -->\n###### B\n\n<!-- PAGE_9 -->\n###### 후\n\n<!-- PAGE_9 -->\n###### 형 간염 재발 방지가 중요한 문제로 대두되었다\n\n<!-- PAGE_9 -->\n###### 형 간염 환자에서 간 이식 후\n\n<!-- PAGE_9 -->\n###### B\n\n<!-- PAGE_9 -->\n###### .  B\n\n<!-- PAGE_9 -->\n###### 간염 재발방지 요법을 시행하지 않은 경우\n\n<!-- PAGE_9 -->\n###### 년 후 재발율은\n\n<!-- PAGE_9 -->\n###### 이상에 이른다\n\n<!-- PAGE_9 -->\n###### 간\n\n<!-- PAGE_9 -->\n###### 2\n\n<!-- PAGE_9 -->\n###### 70%\n\n<!-- PAGE_9 -->\n###### .\n\n <!-- PAGE_9 -->\n###### 이식 후\n\n<!-- PAGE_9 -->\n###### 형 간염 바이러스\n\n<!-- PAGE_9 -->\n###### 의 재감염을 막기 위해서는 주로\n\n<!-- PAGE_9 -->\n###### B\n\n<!-- PAGE_9 -->\n###### (hepatitis B virus, HBV)\n\n<!-- PAGE_9 -->\n###### 형 간염 사람면역글로불린제제\n\n<!-- PAGE_9 -->\n###### 를 단독\n\n<!-- PAGE_9 -->\n###### B\n\n<!-- PAGE_9 -->\n###### (human hepatitis B immunoglobulin, HBIG)\n\n<!-- PAGE_9 -->\n###### 투여하거나 항바이러스제와\n\n<!-- PAGE_9 -->\n###### 의 병용요법이 이용되고 있으며 이 경우 재발율은\n\n<!-- PAGE_9 -->\n###### HBIG\n\n<!-- PAGE_9 -->\n###### 20% 이하로 낮아진다\n\n<!-- PAGE_9 -->\n###### .\n\n",
        "original_sentence": "참고문헌\n\n<!-- PAGE_8 -->\n###### ·················································································································11\n\n- - 1 -\n<!-- PAGE_9 -->\n##### 정맥주사용\n\n<!-- PAGE_9 -->\n##### B형 간염 사람면\n\n<!-- PAGE_9 -->\n##### 역글로불린제제의\n\n<!-- PAGE_9 -->\n##### 안전성 유효성 평가 가이드라인\n\n<!-- PAGE_9 -->\n##### ․\n\n<!-- PAGE_9 -->\n###### . "
      }
    },
    {
      "chunk_id": "chunk_061",
      "text": "서론\n\n<!-- PAGE_9 -->\n###### Ⅰ\n\n<!-- PAGE_9 -->\n###### 최근 국내에서 높은\n\n<!-- PAGE_9 -->\n###### 형 간염 유병율과 함께 말기 간질환 환자에 대한 간 이식 수\n\n<!-- PAGE_9 -->\n###### B\n\n<!-- PAGE_9 -->\n###### 술이 급격히 증가하고 있으나\n\n<!-- PAGE_9 -->\n###### 수술 이후\n\n<!-- PAGE_9 -->\n###### 형 간염의 재발이 보고됨에 따라 간 이식\n\n<!-- PAGE_9 -->\n###### ,\n\n<!-- PAGE_9 -->\n###### B\n\n<!-- PAGE_9 -->\n###### 후\n\n<!-- PAGE_9 -->\n###### 형 간염 재발 방지가 중요한 문제로 대두되었다\n\n<!-- PAGE_9 -->\n###### 형 간염 환자에서 간 이식 후\n\n<!-- PAGE_9 -->\n###### B\n\n<!-- PAGE_9 -->\n###### . ",
      "metadata": {
        "source": "(가이드라인-005)_정맥주사용+B형간염+사람면역글로불린제제의+안전성유효성+평가+가이드라인.pdf",
        "chunk_index": 60,
        "window_size": 3,
        "char_count": 486,
        "word_count": 104,
        "page_number": 9,
        "window_text": "치료적 탐색 임상시험\n\n<!-- PAGE_8 -->\n###### ·························································································8\n\n<!-- PAGE_8 -->\n###### 4.  치료적 확증 임상시험\n\n<!-- PAGE_8 -->\n###### ·························································································8\n\n<!-- PAGE_8 -->\n###### Ⅵ.  참고문헌\n\n<!-- PAGE_8 -->\n###### ·················································································································11\n\n- - 1 -\n<!-- PAGE_9 -->\n##### 정맥주사용\n\n<!-- PAGE_9 -->\n##### B형 간염 사람면\n\n<!-- PAGE_9 -->\n##### 역글로불린제제의\n\n<!-- PAGE_9 -->\n##### 안전성 유효성 평가 가이드라인\n\n<!-- PAGE_9 -->\n##### ․\n\n<!-- PAGE_9 -->\n###### .  서론\n\n<!-- PAGE_9 -->\n###### Ⅰ\n\n<!-- PAGE_9 -->\n###### 최근 국내에서 높은\n\n<!-- PAGE_9 -->\n###### 형 간염 유병율과 함께 말기 간질환 환자에 대한 간 이식 수\n\n<!-- PAGE_9 -->\n###### B\n\n<!-- PAGE_9 -->\n###### 술이 급격히 증가하고 있으나\n\n<!-- PAGE_9 -->\n###### 수술 이후\n\n<!-- PAGE_9 -->\n###### 형 간염의 재발이 보고됨에 따라 간 이식\n\n<!-- PAGE_9 -->\n###### ,\n\n<!-- PAGE_9 -->\n###### B\n\n<!-- PAGE_9 -->\n###### 후\n\n<!-- PAGE_9 -->\n###### 형 간염 재발 방지가 중요한 문제로 대두되었다\n\n<!-- PAGE_9 -->\n###### 형 간염 환자에서 간 이식 후\n\n<!-- PAGE_9 -->\n###### B\n\n<!-- PAGE_9 -->\n###### .  B\n\n<!-- PAGE_9 -->\n###### 간염 재발방지 요법을 시행하지 않은 경우\n\n<!-- PAGE_9 -->\n###### 년 후 재발율은\n\n<!-- PAGE_9 -->\n###### 이상에 이른다\n\n<!-- PAGE_9 -->\n###### 간\n\n<!-- PAGE_9 -->\n###### 2\n\n<!-- PAGE_9 -->\n###### 70%\n\n<!-- PAGE_9 -->\n###### .\n\n <!-- PAGE_9 -->\n###### 이식 후\n\n<!-- PAGE_9 -->\n###### 형 간염 바이러스\n\n<!-- PAGE_9 -->\n###### 의 재감염을 막기 위해서는 주로\n\n<!-- PAGE_9 -->\n###### B\n\n<!-- PAGE_9 -->\n###### (hepatitis B virus, HBV)\n\n<!-- PAGE_9 -->\n###### 형 간염 사람면역글로불린제제\n\n<!-- PAGE_9 -->\n###### 를 단독\n\n<!-- PAGE_9 -->\n###### B\n\n<!-- PAGE_9 -->\n###### (human hepatitis B immunoglobulin, HBIG)\n\n<!-- PAGE_9 -->\n###### 투여하거나 항바이러스제와\n\n<!-- PAGE_9 -->\n###### 의 병용요법이 이용되고 있으며 이 경우 재발율은\n\n<!-- PAGE_9 -->\n###### HBIG\n\n<!-- PAGE_9 -->\n###### 20% 이하로 낮아진다\n\n<!-- PAGE_9 -->\n###### .\n\n <!-- PAGE_9 -->\n###### 이미 외국에서는 고용량의 정맥주사용\n\n<!-- PAGE_9 -->\n###### 를 이용한 예방요법이 보편화되어 있으\n\n<!-- PAGE_9 -->\n###### HBIG\n\n<!-- PAGE_9 -->\n###### 나\n\n<!-- PAGE_9 -->\n###### 우리나라에서는\n\n<!-- PAGE_9 -->\n###### 형 간염 표면항원\n\n<!-- PAGE_9 -->\n###### 양성 혈\n\n<!-- PAGE_9 -->\n###### ,\n\n<!-- PAGE_9 -->\n###### B\n\n<!-- PAGE_9 -->\n###### (hepatitis B surface antigen, HBsAg)\n\n<!-- PAGE_9 -->\n###### 액 오염사고 후의\n\n<!-- PAGE_9 -->\n###### 형 간염 발증의 예방 및 신생아의\n\n<!-- PAGE_9 -->\n###### 형 간염 예방 목적으로 근육주\n\n<!-- PAGE_9 -->\n###### B\n\n<!-- PAGE_9 -->\n###### B\n\n<!-- PAGE_9 -->\n###### 사용\n\n<!-- PAGE_9 -->\n###### 만이 허가되어\n\n<!-- PAGE_9 -->\n###### 근육주사용\n\n<!-- PAGE_9 -->\n###### 를 간 이식 시 고용량으로 정맥주사 해왔\n\n<!-- PAGE_9 -->\n###### HBIG\n\n<!-- PAGE_9 -->\n###### ,\n\n<!-- PAGE_9 -->\n###### HBIG\n\n<!-- PAGE_9 -->\n###### 다.\n\n",
        "original_sentence": "서론\n\n<!-- PAGE_9 -->\n###### Ⅰ\n\n<!-- PAGE_9 -->\n###### 최근 국내에서 높은\n\n<!-- PAGE_9 -->\n###### 형 간염 유병율과 함께 말기 간질환 환자에 대한 간 이식 수\n\n<!-- PAGE_9 -->\n###### B\n\n<!-- PAGE_9 -->\n###### 술이 급격히 증가하고 있으나\n\n<!-- PAGE_9 -->\n###### 수술 이후\n\n<!-- PAGE_9 -->\n###### 형 간염의 재발이 보고됨에 따라 간 이식\n\n<!-- PAGE_9 -->\n###### ,\n\n<!-- PAGE_9 -->\n###### B\n\n<!-- PAGE_9 -->\n###### 후\n\n<!-- PAGE_9 -->\n###### 형 간염 재발 방지가 중요한 문제로 대두되었다\n\n<!-- PAGE_9 -->\n###### 형 간염 환자에서 간 이식 후\n\n<!-- PAGE_9 -->\n###### B\n\n<!-- PAGE_9 -->\n###### . "
      }
    },
    {
      "chunk_id": "chunk_062",
      "text": "B\n\n<!-- PAGE_9 -->\n###### 간염 재발방지 요법을 시행하지 않은 경우\n\n<!-- PAGE_9 -->\n###### 년 후 재발율은\n\n<!-- PAGE_9 -->\n###### 이상에 이른다\n\n<!-- PAGE_9 -->\n###### 간\n\n<!-- PAGE_9 -->\n###### 2\n\n<!-- PAGE_9 -->\n###### 70%\n\n<!-- PAGE_9 -->\n###### .\n\n",
      "metadata": {
        "source": "(가이드라인-005)_정맥주사용+B형간염+사람면역글로불린제제의+안전성유효성+평가+가이드라인.pdf",
        "chunk_index": 61,
        "window_size": 3,
        "char_count": 221,
        "word_count": 44,
        "page_number": 9,
        "window_text": "치료적 확증 임상시험\n\n<!-- PAGE_8 -->\n###### ·························································································8\n\n<!-- PAGE_8 -->\n###### Ⅵ.  참고문헌\n\n<!-- PAGE_8 -->\n###### ·················································································································11\n\n- - 1 -\n<!-- PAGE_9 -->\n##### 정맥주사용\n\n<!-- PAGE_9 -->\n##### B형 간염 사람면\n\n<!-- PAGE_9 -->\n##### 역글로불린제제의\n\n<!-- PAGE_9 -->\n##### 안전성 유효성 평가 가이드라인\n\n<!-- PAGE_9 -->\n##### ․\n\n<!-- PAGE_9 -->\n###### .  서론\n\n<!-- PAGE_9 -->\n###### Ⅰ\n\n<!-- PAGE_9 -->\n###### 최근 국내에서 높은\n\n<!-- PAGE_9 -->\n###### 형 간염 유병율과 함께 말기 간질환 환자에 대한 간 이식 수\n\n<!-- PAGE_9 -->\n###### B\n\n<!-- PAGE_9 -->\n###### 술이 급격히 증가하고 있으나\n\n<!-- PAGE_9 -->\n###### 수술 이후\n\n<!-- PAGE_9 -->\n###### 형 간염의 재발이 보고됨에 따라 간 이식\n\n<!-- PAGE_9 -->\n###### ,\n\n<!-- PAGE_9 -->\n###### B\n\n<!-- PAGE_9 -->\n###### 후\n\n<!-- PAGE_9 -->\n###### 형 간염 재발 방지가 중요한 문제로 대두되었다\n\n<!-- PAGE_9 -->\n###### 형 간염 환자에서 간 이식 후\n\n<!-- PAGE_9 -->\n###### B\n\n<!-- PAGE_9 -->\n###### .  B\n\n<!-- PAGE_9 -->\n###### 간염 재발방지 요법을 시행하지 않은 경우\n\n<!-- PAGE_9 -->\n###### 년 후 재발율은\n\n<!-- PAGE_9 -->\n###### 이상에 이른다\n\n<!-- PAGE_9 -->\n###### 간\n\n<!-- PAGE_9 -->\n###### 2\n\n<!-- PAGE_9 -->\n###### 70%\n\n<!-- PAGE_9 -->\n###### .\n\n <!-- PAGE_9 -->\n###### 이식 후\n\n<!-- PAGE_9 -->\n###### 형 간염 바이러스\n\n<!-- PAGE_9 -->\n###### 의 재감염을 막기 위해서는 주로\n\n<!-- PAGE_9 -->\n###### B\n\n<!-- PAGE_9 -->\n###### (hepatitis B virus, HBV)\n\n<!-- PAGE_9 -->\n###### 형 간염 사람면역글로불린제제\n\n<!-- PAGE_9 -->\n###### 를 단독\n\n<!-- PAGE_9 -->\n###### B\n\n<!-- PAGE_9 -->\n###### (human hepatitis B immunoglobulin, HBIG)\n\n<!-- PAGE_9 -->\n###### 투여하거나 항바이러스제와\n\n<!-- PAGE_9 -->\n###### 의 병용요법이 이용되고 있으며 이 경우 재발율은\n\n<!-- PAGE_9 -->\n###### HBIG\n\n<!-- PAGE_9 -->\n###### 20% 이하로 낮아진다\n\n<!-- PAGE_9 -->\n###### .\n\n <!-- PAGE_9 -->\n###### 이미 외국에서는 고용량의 정맥주사용\n\n<!-- PAGE_9 -->\n###### 를 이용한 예방요법이 보편화되어 있으\n\n<!-- PAGE_9 -->\n###### HBIG\n\n<!-- PAGE_9 -->\n###### 나\n\n<!-- PAGE_9 -->\n###### 우리나라에서는\n\n<!-- PAGE_9 -->\n###### 형 간염 표면항원\n\n<!-- PAGE_9 -->\n###### 양성 혈\n\n<!-- PAGE_9 -->\n###### ,\n\n<!-- PAGE_9 -->\n###### B\n\n<!-- PAGE_9 -->\n###### (hepatitis B surface antigen, HBsAg)\n\n<!-- PAGE_9 -->\n###### 액 오염사고 후의\n\n<!-- PAGE_9 -->\n###### 형 간염 발증의 예방 및 신생아의\n\n<!-- PAGE_9 -->\n###### 형 간염 예방 목적으로 근육주\n\n<!-- PAGE_9 -->\n###### B\n\n<!-- PAGE_9 -->\n###### B\n\n<!-- PAGE_9 -->\n###### 사용\n\n<!-- PAGE_9 -->\n###### 만이 허가되어\n\n<!-- PAGE_9 -->\n###### 근육주사용\n\n<!-- PAGE_9 -->\n###### 를 간 이식 시 고용량으로 정맥주사 해왔\n\n<!-- PAGE_9 -->\n###### HBIG\n\n<!-- PAGE_9 -->\n###### ,\n\n<!-- PAGE_9 -->\n###### HBIG\n\n<!-- PAGE_9 -->\n###### 다.\n\n <!-- PAGE_9 -->\n###### 현재 간 이식 뿐만 아니라 수동면역에도 정맥주사용\n\n<!-- PAGE_9 -->\n###### 가 세계적인 추세이고 국\n\n<!-- PAGE_9 -->\n###### HBIG\n\n<!-- PAGE_9 -->\n###### 내 간 이식 수술 건수의 증가 및 수술 후\n\n<!-- PAGE_9 -->\n###### 형 간염 재발 방지를 위하여\n\n<!-- PAGE_9 -->\n###### 기존의 근육\n\n<!-- PAGE_9 -->\n###### B\n\n<!-- PAGE_9 -->\n###### ,\n\n<!-- PAGE_9 -->\n###### 주사용 제제보다 품질이 우수하고 바이러스 안전성이 확보된 정맥주사용 제제 개발이\n\n<!-- PAGE_9 -->\n###### 필요하게 되었다.\n\n",
        "original_sentence": "B\n\n<!-- PAGE_9 -->\n###### 간염 재발방지 요법을 시행하지 않은 경우\n\n<!-- PAGE_9 -->\n###### 년 후 재발율은\n\n<!-- PAGE_9 -->\n###### 이상에 이른다\n\n<!-- PAGE_9 -->\n###### 간\n\n<!-- PAGE_9 -->\n###### 2\n\n<!-- PAGE_9 -->\n###### 70%\n\n<!-- PAGE_9 -->\n###### .\n\n"
      }
    },
    {
      "chunk_id": "chunk_063",
      "text": "<!-- PAGE_9 -->\n###### 이식 후\n\n<!-- PAGE_9 -->\n###### 형 간염 바이러스\n\n<!-- PAGE_9 -->\n###### 의 재감염을 막기 위해서는 주로\n\n<!-- PAGE_9 -->\n###### B\n\n<!-- PAGE_9 -->\n###### (hepatitis B virus, HBV)\n\n<!-- PAGE_9 -->\n###### 형 간염 사람면역글로불린제제\n\n<!-- PAGE_9 -->\n###### 를 단독\n\n<!-- PAGE_9 -->\n###### B\n\n<!-- PAGE_9 -->\n###### (human hepatitis B immunoglobulin, HBIG)\n\n<!-- PAGE_9 -->\n###### 투여하거나 항바이러스제와\n\n<!-- PAGE_9 -->\n###### 의 병용요법이 이용되고 있으며 이 경우 재발율은\n\n<!-- PAGE_9 -->\n###### HBIG\n\n<!-- PAGE_9 -->\n###### 20% 이하로 낮아진다\n\n<!-- PAGE_9 -->\n###### .\n\n",
      "metadata": {
        "source": "(가이드라인-005)_정맥주사용+B형간염+사람면역글로불린제제의+안전성유효성+평가+가이드라인.pdf",
        "chunk_index": 62,
        "window_size": 3,
        "char_count": 521,
        "word_count": 96,
        "page_number": 9,
        "window_text": "참고문헌\n\n<!-- PAGE_8 -->\n###### ·················································································································11\n\n- - 1 -\n<!-- PAGE_9 -->\n##### 정맥주사용\n\n<!-- PAGE_9 -->\n##### B형 간염 사람면\n\n<!-- PAGE_9 -->\n##### 역글로불린제제의\n\n<!-- PAGE_9 -->\n##### 안전성 유효성 평가 가이드라인\n\n<!-- PAGE_9 -->\n##### ․\n\n<!-- PAGE_9 -->\n###### .  서론\n\n<!-- PAGE_9 -->\n###### Ⅰ\n\n<!-- PAGE_9 -->\n###### 최근 국내에서 높은\n\n<!-- PAGE_9 -->\n###### 형 간염 유병율과 함께 말기 간질환 환자에 대한 간 이식 수\n\n<!-- PAGE_9 -->\n###### B\n\n<!-- PAGE_9 -->\n###### 술이 급격히 증가하고 있으나\n\n<!-- PAGE_9 -->\n###### 수술 이후\n\n<!-- PAGE_9 -->\n###### 형 간염의 재발이 보고됨에 따라 간 이식\n\n<!-- PAGE_9 -->\n###### ,\n\n<!-- PAGE_9 -->\n###### B\n\n<!-- PAGE_9 -->\n###### 후\n\n<!-- PAGE_9 -->\n###### 형 간염 재발 방지가 중요한 문제로 대두되었다\n\n<!-- PAGE_9 -->\n###### 형 간염 환자에서 간 이식 후\n\n<!-- PAGE_9 -->\n###### B\n\n<!-- PAGE_9 -->\n###### .  B\n\n<!-- PAGE_9 -->\n###### 간염 재발방지 요법을 시행하지 않은 경우\n\n<!-- PAGE_9 -->\n###### 년 후 재발율은\n\n<!-- PAGE_9 -->\n###### 이상에 이른다\n\n<!-- PAGE_9 -->\n###### 간\n\n<!-- PAGE_9 -->\n###### 2\n\n<!-- PAGE_9 -->\n###### 70%\n\n<!-- PAGE_9 -->\n###### .\n\n <!-- PAGE_9 -->\n###### 이식 후\n\n<!-- PAGE_9 -->\n###### 형 간염 바이러스\n\n<!-- PAGE_9 -->\n###### 의 재감염을 막기 위해서는 주로\n\n<!-- PAGE_9 -->\n###### B\n\n<!-- PAGE_9 -->\n###### (hepatitis B virus, HBV)\n\n<!-- PAGE_9 -->\n###### 형 간염 사람면역글로불린제제\n\n<!-- PAGE_9 -->\n###### 를 단독\n\n<!-- PAGE_9 -->\n###### B\n\n<!-- PAGE_9 -->\n###### (human hepatitis B immunoglobulin, HBIG)\n\n<!-- PAGE_9 -->\n###### 투여하거나 항바이러스제와\n\n<!-- PAGE_9 -->\n###### 의 병용요법이 이용되고 있으며 이 경우 재발율은\n\n<!-- PAGE_9 -->\n###### HBIG\n\n<!-- PAGE_9 -->\n###### 20% 이하로 낮아진다\n\n<!-- PAGE_9 -->\n###### .\n\n <!-- PAGE_9 -->\n###### 이미 외국에서는 고용량의 정맥주사용\n\n<!-- PAGE_9 -->\n###### 를 이용한 예방요법이 보편화되어 있으\n\n<!-- PAGE_9 -->\n###### HBIG\n\n<!-- PAGE_9 -->\n###### 나\n\n<!-- PAGE_9 -->\n###### 우리나라에서는\n\n<!-- PAGE_9 -->\n###### 형 간염 표면항원\n\n<!-- PAGE_9 -->\n###### 양성 혈\n\n<!-- PAGE_9 -->\n###### ,\n\n<!-- PAGE_9 -->\n###### B\n\n<!-- PAGE_9 -->\n###### (hepatitis B surface antigen, HBsAg)\n\n<!-- PAGE_9 -->\n###### 액 오염사고 후의\n\n<!-- PAGE_9 -->\n###### 형 간염 발증의 예방 및 신생아의\n\n<!-- PAGE_9 -->\n###### 형 간염 예방 목적으로 근육주\n\n<!-- PAGE_9 -->\n###### B\n\n<!-- PAGE_9 -->\n###### B\n\n<!-- PAGE_9 -->\n###### 사용\n\n<!-- PAGE_9 -->\n###### 만이 허가되어\n\n<!-- PAGE_9 -->\n###### 근육주사용\n\n<!-- PAGE_9 -->\n###### 를 간 이식 시 고용량으로 정맥주사 해왔\n\n<!-- PAGE_9 -->\n###### HBIG\n\n<!-- PAGE_9 -->\n###### ,\n\n<!-- PAGE_9 -->\n###### HBIG\n\n<!-- PAGE_9 -->\n###### 다.\n\n <!-- PAGE_9 -->\n###### 현재 간 이식 뿐만 아니라 수동면역에도 정맥주사용\n\n<!-- PAGE_9 -->\n###### 가 세계적인 추세이고 국\n\n<!-- PAGE_9 -->\n###### HBIG\n\n<!-- PAGE_9 -->\n###### 내 간 이식 수술 건수의 증가 및 수술 후\n\n<!-- PAGE_9 -->\n###### 형 간염 재발 방지를 위하여\n\n<!-- PAGE_9 -->\n###### 기존의 근육\n\n<!-- PAGE_9 -->\n###### B\n\n<!-- PAGE_9 -->\n###### ,\n\n<!-- PAGE_9 -->\n###### 주사용 제제보다 품질이 우수하고 바이러스 안전성이 확보된 정맥주사용 제제 개발이\n\n<!-- PAGE_9 -->\n###### 필요하게 되었다.\n\n <!-- PAGE_9 -->\n###### 본 가이드라인은 혈장 유래 정맥주사용\n\n<!-- PAGE_9 -->\n###### HBIG의 품질과 안전성 유효성 심사 시 비임\n\n<!-- PAGE_9 -->\n###### ․\n\n<!-- PAGE_9 -->\n###### 상 및 임상시험자료 평가를 위한 지침으로서\n\n<!-- PAGE_9 -->\n###### 심사자 및 제조자에게 정보를 제공함과\n\n<!-- PAGE_9 -->\n###### ,\n\n<!-- PAGE_9 -->\n###### 동시에 자료 요건의 투명성을 제고하는데 그 목적이 있다.\n\n",
        "original_sentence": "<!-- PAGE_9 -->\n###### 이식 후\n\n<!-- PAGE_9 -->\n###### 형 간염 바이러스\n\n<!-- PAGE_9 -->\n###### 의 재감염을 막기 위해서는 주로\n\n<!-- PAGE_9 -->\n###### B\n\n<!-- PAGE_9 -->\n###### (hepatitis B virus, HBV)\n\n<!-- PAGE_9 -->\n###### 형 간염 사람면역글로불린제제\n\n<!-- PAGE_9 -->\n###### 를 단독\n\n<!-- PAGE_9 -->\n###### B\n\n<!-- PAGE_9 -->\n###### (human hepatitis B immunoglobulin, HBIG)\n\n<!-- PAGE_9 -->\n###### 투여하거나 항바이러스제와\n\n<!-- PAGE_9 -->\n###### 의 병용요법이 이용되고 있으며 이 경우 재발율은\n\n<!-- PAGE_9 -->\n###### HBIG\n\n<!-- PAGE_9 -->\n###### 20% 이하로 낮아진다\n\n<!-- PAGE_9 -->\n###### .\n\n"
      }
    },
    {
      "chunk_id": "chunk_064",
      "text": "<!-- PAGE_9 -->\n###### 이미 외국에서는 고용량의 정맥주사용\n\n<!-- PAGE_9 -->\n###### 를 이용한 예방요법이 보편화되어 있으\n\n<!-- PAGE_9 -->\n###### HBIG\n\n<!-- PAGE_9 -->\n###### 나\n\n<!-- PAGE_9 -->\n###### 우리나라에서는\n\n<!-- PAGE_9 -->\n###### 형 간염 표면항원\n\n<!-- PAGE_9 -->\n###### 양성 혈\n\n<!-- PAGE_9 -->\n###### ,\n\n<!-- PAGE_9 -->\n###### B\n\n<!-- PAGE_9 -->\n###### (hepatitis B surface antigen, HBsAg)\n\n<!-- PAGE_9 -->\n###### 액 오염사고 후의\n\n<!-- PAGE_9 -->\n###### 형 간염 발증의 예방 및 신생아의\n\n<!-- PAGE_9 -->\n###### 형 간염 예방 목적으로 근육주\n\n<!-- PAGE_9 -->\n###### B\n\n<!-- PAGE_9 -->\n###### B\n\n<!-- PAGE_9 -->\n###### 사용\n\n<!-- PAGE_9 -->\n###### 만이 허가되어\n\n<!-- PAGE_9 -->\n###### 근육주사용\n\n<!-- PAGE_9 -->\n###### 를 간 이식 시 고용량으로 정맥주사 해왔\n\n<!-- PAGE_9 -->\n###### HBIG\n\n<!-- PAGE_9 -->\n###### ,\n\n<!-- PAGE_9 -->\n###### HBIG\n\n<!-- PAGE_9 -->\n###### 다.\n\n",
      "metadata": {
        "source": "(가이드라인-005)_정맥주사용+B형간염+사람면역글로불린제제의+안전성유효성+평가+가이드라인.pdf",
        "chunk_index": 63,
        "window_size": 3,
        "char_count": 769,
        "word_count": 147,
        "page_number": 9,
        "window_text": "서론\n\n<!-- PAGE_9 -->\n###### Ⅰ\n\n<!-- PAGE_9 -->\n###### 최근 국내에서 높은\n\n<!-- PAGE_9 -->\n###### 형 간염 유병율과 함께 말기 간질환 환자에 대한 간 이식 수\n\n<!-- PAGE_9 -->\n###### B\n\n<!-- PAGE_9 -->\n###### 술이 급격히 증가하고 있으나\n\n<!-- PAGE_9 -->\n###### 수술 이후\n\n<!-- PAGE_9 -->\n###### 형 간염의 재발이 보고됨에 따라 간 이식\n\n<!-- PAGE_9 -->\n###### ,\n\n<!-- PAGE_9 -->\n###### B\n\n<!-- PAGE_9 -->\n###### 후\n\n<!-- PAGE_9 -->\n###### 형 간염 재발 방지가 중요한 문제로 대두되었다\n\n<!-- PAGE_9 -->\n###### 형 간염 환자에서 간 이식 후\n\n<!-- PAGE_9 -->\n###### B\n\n<!-- PAGE_9 -->\n###### .  B\n\n<!-- PAGE_9 -->\n###### 간염 재발방지 요법을 시행하지 않은 경우\n\n<!-- PAGE_9 -->\n###### 년 후 재발율은\n\n<!-- PAGE_9 -->\n###### 이상에 이른다\n\n<!-- PAGE_9 -->\n###### 간\n\n<!-- PAGE_9 -->\n###### 2\n\n<!-- PAGE_9 -->\n###### 70%\n\n<!-- PAGE_9 -->\n###### .\n\n <!-- PAGE_9 -->\n###### 이식 후\n\n<!-- PAGE_9 -->\n###### 형 간염 바이러스\n\n<!-- PAGE_9 -->\n###### 의 재감염을 막기 위해서는 주로\n\n<!-- PAGE_9 -->\n###### B\n\n<!-- PAGE_9 -->\n###### (hepatitis B virus, HBV)\n\n<!-- PAGE_9 -->\n###### 형 간염 사람면역글로불린제제\n\n<!-- PAGE_9 -->\n###### 를 단독\n\n<!-- PAGE_9 -->\n###### B\n\n<!-- PAGE_9 -->\n###### (human hepatitis B immunoglobulin, HBIG)\n\n<!-- PAGE_9 -->\n###### 투여하거나 항바이러스제와\n\n<!-- PAGE_9 -->\n###### 의 병용요법이 이용되고 있으며 이 경우 재발율은\n\n<!-- PAGE_9 -->\n###### HBIG\n\n<!-- PAGE_9 -->\n###### 20% 이하로 낮아진다\n\n<!-- PAGE_9 -->\n###### .\n\n <!-- PAGE_9 -->\n###### 이미 외국에서는 고용량의 정맥주사용\n\n<!-- PAGE_9 -->\n###### 를 이용한 예방요법이 보편화되어 있으\n\n<!-- PAGE_9 -->\n###### HBIG\n\n<!-- PAGE_9 -->\n###### 나\n\n<!-- PAGE_9 -->\n###### 우리나라에서는\n\n<!-- PAGE_9 -->\n###### 형 간염 표면항원\n\n<!-- PAGE_9 -->\n###### 양성 혈\n\n<!-- PAGE_9 -->\n###### ,\n\n<!-- PAGE_9 -->\n###### B\n\n<!-- PAGE_9 -->\n###### (hepatitis B surface antigen, HBsAg)\n\n<!-- PAGE_9 -->\n###### 액 오염사고 후의\n\n<!-- PAGE_9 -->\n###### 형 간염 발증의 예방 및 신생아의\n\n<!-- PAGE_9 -->\n###### 형 간염 예방 목적으로 근육주\n\n<!-- PAGE_9 -->\n###### B\n\n<!-- PAGE_9 -->\n###### B\n\n<!-- PAGE_9 -->\n###### 사용\n\n<!-- PAGE_9 -->\n###### 만이 허가되어\n\n<!-- PAGE_9 -->\n###### 근육주사용\n\n<!-- PAGE_9 -->\n###### 를 간 이식 시 고용량으로 정맥주사 해왔\n\n<!-- PAGE_9 -->\n###### HBIG\n\n<!-- PAGE_9 -->\n###### ,\n\n<!-- PAGE_9 -->\n###### HBIG\n\n<!-- PAGE_9 -->\n###### 다.\n\n <!-- PAGE_9 -->\n###### 현재 간 이식 뿐만 아니라 수동면역에도 정맥주사용\n\n<!-- PAGE_9 -->\n###### 가 세계적인 추세이고 국\n\n<!-- PAGE_9 -->\n###### HBIG\n\n<!-- PAGE_9 -->\n###### 내 간 이식 수술 건수의 증가 및 수술 후\n\n<!-- PAGE_9 -->\n###### 형 간염 재발 방지를 위하여\n\n<!-- PAGE_9 -->\n###### 기존의 근육\n\n<!-- PAGE_9 -->\n###### B\n\n<!-- PAGE_9 -->\n###### ,\n\n<!-- PAGE_9 -->\n###### 주사용 제제보다 품질이 우수하고 바이러스 안전성이 확보된 정맥주사용 제제 개발이\n\n<!-- PAGE_9 -->\n###### 필요하게 되었다.\n\n <!-- PAGE_9 -->\n###### 본 가이드라인은 혈장 유래 정맥주사용\n\n<!-- PAGE_9 -->\n###### HBIG의 품질과 안전성 유효성 심사 시 비임\n\n<!-- PAGE_9 -->\n###### ․\n\n<!-- PAGE_9 -->\n###### 상 및 임상시험자료 평가를 위한 지침으로서\n\n<!-- PAGE_9 -->\n###### 심사자 및 제조자에게 정보를 제공함과\n\n<!-- PAGE_9 -->\n###### ,\n\n<!-- PAGE_9 -->\n###### 동시에 자료 요건의 투명성을 제고하는데 그 목적이 있다.\n\n - - 2 -\n<!-- PAGE_10 -->\n###### 구조 물리화학적 성질\n\n<!-- PAGE_10 -->\n###### 제조 및 품질관리\n\n<!-- PAGE_10 -->\n###### .\n\n",
        "original_sentence": "<!-- PAGE_9 -->\n###### 이미 외국에서는 고용량의 정맥주사용\n\n<!-- PAGE_9 -->\n###### 를 이용한 예방요법이 보편화되어 있으\n\n<!-- PAGE_9 -->\n###### HBIG\n\n<!-- PAGE_9 -->\n###### 나\n\n<!-- PAGE_9 -->\n###### 우리나라에서는\n\n<!-- PAGE_9 -->\n###### 형 간염 표면항원\n\n<!-- PAGE_9 -->\n###### 양성 혈\n\n<!-- PAGE_9 -->\n###### ,\n\n<!-- PAGE_9 -->\n###### B\n\n<!-- PAGE_9 -->\n###### (hepatitis B surface antigen, HBsAg)\n\n<!-- PAGE_9 -->\n###### 액 오염사고 후의\n\n<!-- PAGE_9 -->\n###### 형 간염 발증의 예방 및 신생아의\n\n<!-- PAGE_9 -->\n###### 형 간염 예방 목적으로 근육주\n\n<!-- PAGE_9 -->\n###### B\n\n<!-- PAGE_9 -->\n###### B\n\n<!-- PAGE_9 -->\n###### 사용\n\n<!-- PAGE_9 -->\n###### 만이 허가되어\n\n<!-- PAGE_9 -->\n###### 근육주사용\n\n<!-- PAGE_9 -->\n###### 를 간 이식 시 고용량으로 정맥주사 해왔\n\n<!-- PAGE_9 -->\n###### HBIG\n\n<!-- PAGE_9 -->\n###### ,\n\n<!-- PAGE_9 -->\n###### HBIG\n\n<!-- PAGE_9 -->\n###### 다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_065",
      "text": "<!-- PAGE_9 -->\n###### 현재 간 이식 뿐만 아니라 수동면역에도 정맥주사용\n\n<!-- PAGE_9 -->\n###### 가 세계적인 추세이고 국\n\n<!-- PAGE_9 -->\n###### HBIG\n\n<!-- PAGE_9 -->\n###### 내 간 이식 수술 건수의 증가 및 수술 후\n\n<!-- PAGE_9 -->\n###### 형 간염 재발 방지를 위하여\n\n<!-- PAGE_9 -->\n###### 기존의 근육\n\n<!-- PAGE_9 -->\n###### B\n\n<!-- PAGE_9 -->\n###### ,\n\n<!-- PAGE_9 -->\n###### 주사용 제제보다 품질이 우수하고 바이러스 안전성이 확보된 정맥주사용 제제 개발이\n\n<!-- PAGE_9 -->\n###### 필요하게 되었다.\n\n",
      "metadata": {
        "source": "(가이드라인-005)_정맥주사용+B형간염+사람면역글로불린제제의+안전성유효성+평가+가이드라인.pdf",
        "chunk_index": 64,
        "window_size": 3,
        "char_count": 393,
        "word_count": 82,
        "page_number": 9,
        "window_text": "B\n\n<!-- PAGE_9 -->\n###### 간염 재발방지 요법을 시행하지 않은 경우\n\n<!-- PAGE_9 -->\n###### 년 후 재발율은\n\n<!-- PAGE_9 -->\n###### 이상에 이른다\n\n<!-- PAGE_9 -->\n###### 간\n\n<!-- PAGE_9 -->\n###### 2\n\n<!-- PAGE_9 -->\n###### 70%\n\n<!-- PAGE_9 -->\n###### .\n\n <!-- PAGE_9 -->\n###### 이식 후\n\n<!-- PAGE_9 -->\n###### 형 간염 바이러스\n\n<!-- PAGE_9 -->\n###### 의 재감염을 막기 위해서는 주로\n\n<!-- PAGE_9 -->\n###### B\n\n<!-- PAGE_9 -->\n###### (hepatitis B virus, HBV)\n\n<!-- PAGE_9 -->\n###### 형 간염 사람면역글로불린제제\n\n<!-- PAGE_9 -->\n###### 를 단독\n\n<!-- PAGE_9 -->\n###### B\n\n<!-- PAGE_9 -->\n###### (human hepatitis B immunoglobulin, HBIG)\n\n<!-- PAGE_9 -->\n###### 투여하거나 항바이러스제와\n\n<!-- PAGE_9 -->\n###### 의 병용요법이 이용되고 있으며 이 경우 재발율은\n\n<!-- PAGE_9 -->\n###### HBIG\n\n<!-- PAGE_9 -->\n###### 20% 이하로 낮아진다\n\n<!-- PAGE_9 -->\n###### .\n\n <!-- PAGE_9 -->\n###### 이미 외국에서는 고용량의 정맥주사용\n\n<!-- PAGE_9 -->\n###### 를 이용한 예방요법이 보편화되어 있으\n\n<!-- PAGE_9 -->\n###### HBIG\n\n<!-- PAGE_9 -->\n###### 나\n\n<!-- PAGE_9 -->\n###### 우리나라에서는\n\n<!-- PAGE_9 -->\n###### 형 간염 표면항원\n\n<!-- PAGE_9 -->\n###### 양성 혈\n\n<!-- PAGE_9 -->\n###### ,\n\n<!-- PAGE_9 -->\n###### B\n\n<!-- PAGE_9 -->\n###### (hepatitis B surface antigen, HBsAg)\n\n<!-- PAGE_9 -->\n###### 액 오염사고 후의\n\n<!-- PAGE_9 -->\n###### 형 간염 발증의 예방 및 신생아의\n\n<!-- PAGE_9 -->\n###### 형 간염 예방 목적으로 근육주\n\n<!-- PAGE_9 -->\n###### B\n\n<!-- PAGE_9 -->\n###### B\n\n<!-- PAGE_9 -->\n###### 사용\n\n<!-- PAGE_9 -->\n###### 만이 허가되어\n\n<!-- PAGE_9 -->\n###### 근육주사용\n\n<!-- PAGE_9 -->\n###### 를 간 이식 시 고용량으로 정맥주사 해왔\n\n<!-- PAGE_9 -->\n###### HBIG\n\n<!-- PAGE_9 -->\n###### ,\n\n<!-- PAGE_9 -->\n###### HBIG\n\n<!-- PAGE_9 -->\n###### 다.\n\n <!-- PAGE_9 -->\n###### 현재 간 이식 뿐만 아니라 수동면역에도 정맥주사용\n\n<!-- PAGE_9 -->\n###### 가 세계적인 추세이고 국\n\n<!-- PAGE_9 -->\n###### HBIG\n\n<!-- PAGE_9 -->\n###### 내 간 이식 수술 건수의 증가 및 수술 후\n\n<!-- PAGE_9 -->\n###### 형 간염 재발 방지를 위하여\n\n<!-- PAGE_9 -->\n###### 기존의 근육\n\n<!-- PAGE_9 -->\n###### B\n\n<!-- PAGE_9 -->\n###### ,\n\n<!-- PAGE_9 -->\n###### 주사용 제제보다 품질이 우수하고 바이러스 안전성이 확보된 정맥주사용 제제 개발이\n\n<!-- PAGE_9 -->\n###### 필요하게 되었다.\n\n <!-- PAGE_9 -->\n###### 본 가이드라인은 혈장 유래 정맥주사용\n\n<!-- PAGE_9 -->\n###### HBIG의 품질과 안전성 유효성 심사 시 비임\n\n<!-- PAGE_9 -->\n###### ․\n\n<!-- PAGE_9 -->\n###### 상 및 임상시험자료 평가를 위한 지침으로서\n\n<!-- PAGE_9 -->\n###### 심사자 및 제조자에게 정보를 제공함과\n\n<!-- PAGE_9 -->\n###### ,\n\n<!-- PAGE_9 -->\n###### 동시에 자료 요건의 투명성을 제고하는데 그 목적이 있다.\n\n - - 2 -\n<!-- PAGE_10 -->\n###### 구조 물리화학적 성질\n\n<!-- PAGE_10 -->\n###### 제조 및 품질관리\n\n<!-- PAGE_10 -->\n###### .\n\n <!-- PAGE_10 -->\n###### ,\n\n<!-- PAGE_10 -->\n###### Ⅱ\n\n<!-- PAGE_10 -->\n###### ․\n\n<!-- PAGE_10 -->\n###### 면역글로불린제제의 제조에 있어서 제조사는 원료물질의 특성\n\n<!-- PAGE_10 -->\n###### , 제조 및 정제공정\n\n<!-- PAGE_10 -->\n###### ,\n\n<!-- PAGE_10 -->\n###### 그리고 안전성과 관련된 중요한 인자들을 고려해야 한다\n\n<!-- PAGE_10 -->\n###### 면역글로불린제제는 많은 사\n\n<!-- PAGE_10 -->\n###### .\n\n",
        "original_sentence": "<!-- PAGE_9 -->\n###### 현재 간 이식 뿐만 아니라 수동면역에도 정맥주사용\n\n<!-- PAGE_9 -->\n###### 가 세계적인 추세이고 국\n\n<!-- PAGE_9 -->\n###### HBIG\n\n<!-- PAGE_9 -->\n###### 내 간 이식 수술 건수의 증가 및 수술 후\n\n<!-- PAGE_9 -->\n###### 형 간염 재발 방지를 위하여\n\n<!-- PAGE_9 -->\n###### 기존의 근육\n\n<!-- PAGE_9 -->\n###### B\n\n<!-- PAGE_9 -->\n###### ,\n\n<!-- PAGE_9 -->\n###### 주사용 제제보다 품질이 우수하고 바이러스 안전성이 확보된 정맥주사용 제제 개발이\n\n<!-- PAGE_9 -->\n###### 필요하게 되었다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_066",
      "text": "<!-- PAGE_9 -->\n###### 본 가이드라인은 혈장 유래 정맥주사용\n\n<!-- PAGE_9 -->\n###### HBIG의 품질과 안전성 유효성 심사 시 비임\n\n<!-- PAGE_9 -->\n###### ․\n\n<!-- PAGE_9 -->\n###### 상 및 임상시험자료 평가를 위한 지침으로서\n\n<!-- PAGE_9 -->\n###### 심사자 및 제조자에게 정보를 제공함과\n\n<!-- PAGE_9 -->\n###### ,\n\n<!-- PAGE_9 -->\n###### 동시에 자료 요건의 투명성을 제고하는데 그 목적이 있다.\n\n",
      "metadata": {
        "source": "(가이드라인-005)_정맥주사용+B형간염+사람면역글로불린제제의+안전성유효성+평가+가이드라인.pdf",
        "chunk_index": 65,
        "window_size": 3,
        "char_count": 296,
        "word_count": 61,
        "page_number": 9,
        "window_text": "<!-- PAGE_9 -->\n###### 이식 후\n\n<!-- PAGE_9 -->\n###### 형 간염 바이러스\n\n<!-- PAGE_9 -->\n###### 의 재감염을 막기 위해서는 주로\n\n<!-- PAGE_9 -->\n###### B\n\n<!-- PAGE_9 -->\n###### (hepatitis B virus, HBV)\n\n<!-- PAGE_9 -->\n###### 형 간염 사람면역글로불린제제\n\n<!-- PAGE_9 -->\n###### 를 단독\n\n<!-- PAGE_9 -->\n###### B\n\n<!-- PAGE_9 -->\n###### (human hepatitis B immunoglobulin, HBIG)\n\n<!-- PAGE_9 -->\n###### 투여하거나 항바이러스제와\n\n<!-- PAGE_9 -->\n###### 의 병용요법이 이용되고 있으며 이 경우 재발율은\n\n<!-- PAGE_9 -->\n###### HBIG\n\n<!-- PAGE_9 -->\n###### 20% 이하로 낮아진다\n\n<!-- PAGE_9 -->\n###### .\n\n <!-- PAGE_9 -->\n###### 이미 외국에서는 고용량의 정맥주사용\n\n<!-- PAGE_9 -->\n###### 를 이용한 예방요법이 보편화되어 있으\n\n<!-- PAGE_9 -->\n###### HBIG\n\n<!-- PAGE_9 -->\n###### 나\n\n<!-- PAGE_9 -->\n###### 우리나라에서는\n\n<!-- PAGE_9 -->\n###### 형 간염 표면항원\n\n<!-- PAGE_9 -->\n###### 양성 혈\n\n<!-- PAGE_9 -->\n###### ,\n\n<!-- PAGE_9 -->\n###### B\n\n<!-- PAGE_9 -->\n###### (hepatitis B surface antigen, HBsAg)\n\n<!-- PAGE_9 -->\n###### 액 오염사고 후의\n\n<!-- PAGE_9 -->\n###### 형 간염 발증의 예방 및 신생아의\n\n<!-- PAGE_9 -->\n###### 형 간염 예방 목적으로 근육주\n\n<!-- PAGE_9 -->\n###### B\n\n<!-- PAGE_9 -->\n###### B\n\n<!-- PAGE_9 -->\n###### 사용\n\n<!-- PAGE_9 -->\n###### 만이 허가되어\n\n<!-- PAGE_9 -->\n###### 근육주사용\n\n<!-- PAGE_9 -->\n###### 를 간 이식 시 고용량으로 정맥주사 해왔\n\n<!-- PAGE_9 -->\n###### HBIG\n\n<!-- PAGE_9 -->\n###### ,\n\n<!-- PAGE_9 -->\n###### HBIG\n\n<!-- PAGE_9 -->\n###### 다.\n\n <!-- PAGE_9 -->\n###### 현재 간 이식 뿐만 아니라 수동면역에도 정맥주사용\n\n<!-- PAGE_9 -->\n###### 가 세계적인 추세이고 국\n\n<!-- PAGE_9 -->\n###### HBIG\n\n<!-- PAGE_9 -->\n###### 내 간 이식 수술 건수의 증가 및 수술 후\n\n<!-- PAGE_9 -->\n###### 형 간염 재발 방지를 위하여\n\n<!-- PAGE_9 -->\n###### 기존의 근육\n\n<!-- PAGE_9 -->\n###### B\n\n<!-- PAGE_9 -->\n###### ,\n\n<!-- PAGE_9 -->\n###### 주사용 제제보다 품질이 우수하고 바이러스 안전성이 확보된 정맥주사용 제제 개발이\n\n<!-- PAGE_9 -->\n###### 필요하게 되었다.\n\n <!-- PAGE_9 -->\n###### 본 가이드라인은 혈장 유래 정맥주사용\n\n<!-- PAGE_9 -->\n###### HBIG의 품질과 안전성 유효성 심사 시 비임\n\n<!-- PAGE_9 -->\n###### ․\n\n<!-- PAGE_9 -->\n###### 상 및 임상시험자료 평가를 위한 지침으로서\n\n<!-- PAGE_9 -->\n###### 심사자 및 제조자에게 정보를 제공함과\n\n<!-- PAGE_9 -->\n###### ,\n\n<!-- PAGE_9 -->\n###### 동시에 자료 요건의 투명성을 제고하는데 그 목적이 있다.\n\n - - 2 -\n<!-- PAGE_10 -->\n###### 구조 물리화학적 성질\n\n<!-- PAGE_10 -->\n###### 제조 및 품질관리\n\n<!-- PAGE_10 -->\n###### .\n\n <!-- PAGE_10 -->\n###### ,\n\n<!-- PAGE_10 -->\n###### Ⅱ\n\n<!-- PAGE_10 -->\n###### ․\n\n<!-- PAGE_10 -->\n###### 면역글로불린제제의 제조에 있어서 제조사는 원료물질의 특성\n\n<!-- PAGE_10 -->\n###### , 제조 및 정제공정\n\n<!-- PAGE_10 -->\n###### ,\n\n<!-- PAGE_10 -->\n###### 그리고 안전성과 관련된 중요한 인자들을 고려해야 한다\n\n<!-- PAGE_10 -->\n###### 면역글로불린제제는 많은 사\n\n<!-- PAGE_10 -->\n###### .\n\n <!-- PAGE_10 -->\n###### 람의 헌혈 혈장을 풀링하여 생산하기 때문에 한 사람의 헌혈 혈장의 바이러스 오염은\n\n<!-- PAGE_10 -->\n###### 면역글로불린제제를 사용하는 다수의 환자에게 바이러스성 질병을 전염시킬 수 있다.\n\n",
        "original_sentence": "<!-- PAGE_9 -->\n###### 본 가이드라인은 혈장 유래 정맥주사용\n\n<!-- PAGE_9 -->\n###### HBIG의 품질과 안전성 유효성 심사 시 비임\n\n<!-- PAGE_9 -->\n###### ․\n\n<!-- PAGE_9 -->\n###### 상 및 임상시험자료 평가를 위한 지침으로서\n\n<!-- PAGE_9 -->\n###### 심사자 및 제조자에게 정보를 제공함과\n\n<!-- PAGE_9 -->\n###### ,\n\n<!-- PAGE_9 -->\n###### 동시에 자료 요건의 투명성을 제고하는데 그 목적이 있다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_067",
      "text": "- - 2 -\n<!-- PAGE_10 -->\n###### 구조 물리화학적 성질\n\n<!-- PAGE_10 -->\n###### 제조 및 품질관리\n\n<!-- PAGE_10 -->\n###### .\n\n",
      "metadata": {
        "source": "(가이드라인-005)_정맥주사용+B형간염+사람면역글로불린제제의+안전성유효성+평가+가이드라인.pdf",
        "chunk_index": 66,
        "window_size": 3,
        "char_count": 107,
        "word_count": 23,
        "page_number": 10,
        "window_text": "<!-- PAGE_9 -->\n###### 이미 외국에서는 고용량의 정맥주사용\n\n<!-- PAGE_9 -->\n###### 를 이용한 예방요법이 보편화되어 있으\n\n<!-- PAGE_9 -->\n###### HBIG\n\n<!-- PAGE_9 -->\n###### 나\n\n<!-- PAGE_9 -->\n###### 우리나라에서는\n\n<!-- PAGE_9 -->\n###### 형 간염 표면항원\n\n<!-- PAGE_9 -->\n###### 양성 혈\n\n<!-- PAGE_9 -->\n###### ,\n\n<!-- PAGE_9 -->\n###### B\n\n<!-- PAGE_9 -->\n###### (hepatitis B surface antigen, HBsAg)\n\n<!-- PAGE_9 -->\n###### 액 오염사고 후의\n\n<!-- PAGE_9 -->\n###### 형 간염 발증의 예방 및 신생아의\n\n<!-- PAGE_9 -->\n###### 형 간염 예방 목적으로 근육주\n\n<!-- PAGE_9 -->\n###### B\n\n<!-- PAGE_9 -->\n###### B\n\n<!-- PAGE_9 -->\n###### 사용\n\n<!-- PAGE_9 -->\n###### 만이 허가되어\n\n<!-- PAGE_9 -->\n###### 근육주사용\n\n<!-- PAGE_9 -->\n###### 를 간 이식 시 고용량으로 정맥주사 해왔\n\n<!-- PAGE_9 -->\n###### HBIG\n\n<!-- PAGE_9 -->\n###### ,\n\n<!-- PAGE_9 -->\n###### HBIG\n\n<!-- PAGE_9 -->\n###### 다.\n\n <!-- PAGE_9 -->\n###### 현재 간 이식 뿐만 아니라 수동면역에도 정맥주사용\n\n<!-- PAGE_9 -->\n###### 가 세계적인 추세이고 국\n\n<!-- PAGE_9 -->\n###### HBIG\n\n<!-- PAGE_9 -->\n###### 내 간 이식 수술 건수의 증가 및 수술 후\n\n<!-- PAGE_9 -->\n###### 형 간염 재발 방지를 위하여\n\n<!-- PAGE_9 -->\n###### 기존의 근육\n\n<!-- PAGE_9 -->\n###### B\n\n<!-- PAGE_9 -->\n###### ,\n\n<!-- PAGE_9 -->\n###### 주사용 제제보다 품질이 우수하고 바이러스 안전성이 확보된 정맥주사용 제제 개발이\n\n<!-- PAGE_9 -->\n###### 필요하게 되었다.\n\n <!-- PAGE_9 -->\n###### 본 가이드라인은 혈장 유래 정맥주사용\n\n<!-- PAGE_9 -->\n###### HBIG의 품질과 안전성 유효성 심사 시 비임\n\n<!-- PAGE_9 -->\n###### ․\n\n<!-- PAGE_9 -->\n###### 상 및 임상시험자료 평가를 위한 지침으로서\n\n<!-- PAGE_9 -->\n###### 심사자 및 제조자에게 정보를 제공함과\n\n<!-- PAGE_9 -->\n###### ,\n\n<!-- PAGE_9 -->\n###### 동시에 자료 요건의 투명성을 제고하는데 그 목적이 있다.\n\n - - 2 -\n<!-- PAGE_10 -->\n###### 구조 물리화학적 성질\n\n<!-- PAGE_10 -->\n###### 제조 및 품질관리\n\n<!-- PAGE_10 -->\n###### .\n\n <!-- PAGE_10 -->\n###### ,\n\n<!-- PAGE_10 -->\n###### Ⅱ\n\n<!-- PAGE_10 -->\n###### ․\n\n<!-- PAGE_10 -->\n###### 면역글로불린제제의 제조에 있어서 제조사는 원료물질의 특성\n\n<!-- PAGE_10 -->\n###### , 제조 및 정제공정\n\n<!-- PAGE_10 -->\n###### ,\n\n<!-- PAGE_10 -->\n###### 그리고 안전성과 관련된 중요한 인자들을 고려해야 한다\n\n<!-- PAGE_10 -->\n###### 면역글로불린제제는 많은 사\n\n<!-- PAGE_10 -->\n###### .\n\n <!-- PAGE_10 -->\n###### 람의 헌혈 혈장을 풀링하여 생산하기 때문에 한 사람의 헌혈 혈장의 바이러스 오염은\n\n<!-- PAGE_10 -->\n###### 면역글로불린제제를 사용하는 다수의 환자에게 바이러스성 질병을 전염시킬 수 있다.\n\n <!-- PAGE_10 -->\n###### 따라서 원료혈장의 오염을 최소화하면서 제조공정 중 혈액매개 바이러스의 불활화 제\n\n<!-- PAGE_10 -->\n###### /\n\n<!-- PAGE_10 -->\n###### 거 효율을 극대화하기 위한 조치를 취하여 면역글로불린제제의 바이러스 안전성을 반\n\n<!-- PAGE_10 -->\n###### 드시 확보하여야 한다.\n\n",
        "original_sentence": "- - 2 -\n<!-- PAGE_10 -->\n###### 구조 물리화학적 성질\n\n<!-- PAGE_10 -->\n###### 제조 및 품질관리\n\n<!-- PAGE_10 -->\n###### .\n\n"
      }
    },
    {
      "chunk_id": "chunk_068",
      "text": "<!-- PAGE_10 -->\n###### ,\n\n<!-- PAGE_10 -->\n###### Ⅱ\n\n<!-- PAGE_10 -->\n###### ․\n\n<!-- PAGE_10 -->\n###### 면역글로불린제제의 제조에 있어서 제조사는 원료물질의 특성\n\n<!-- PAGE_10 -->\n###### , 제조 및 정제공정\n\n<!-- PAGE_10 -->\n###### ,\n\n<!-- PAGE_10 -->\n###### 그리고 안전성과 관련된 중요한 인자들을 고려해야 한다\n\n<!-- PAGE_10 -->\n###### 면역글로불린제제는 많은 사\n\n<!-- PAGE_10 -->\n###### .\n\n",
      "metadata": {
        "source": "(가이드라인-005)_정맥주사용+B형간염+사람면역글로불린제제의+안전성유효성+평가+가이드라인.pdf",
        "chunk_index": 67,
        "window_size": 3,
        "char_count": 324,
        "word_count": 61,
        "page_number": 10,
        "window_text": "<!-- PAGE_9 -->\n###### 현재 간 이식 뿐만 아니라 수동면역에도 정맥주사용\n\n<!-- PAGE_9 -->\n###### 가 세계적인 추세이고 국\n\n<!-- PAGE_9 -->\n###### HBIG\n\n<!-- PAGE_9 -->\n###### 내 간 이식 수술 건수의 증가 및 수술 후\n\n<!-- PAGE_9 -->\n###### 형 간염 재발 방지를 위하여\n\n<!-- PAGE_9 -->\n###### 기존의 근육\n\n<!-- PAGE_9 -->\n###### B\n\n<!-- PAGE_9 -->\n###### ,\n\n<!-- PAGE_9 -->\n###### 주사용 제제보다 품질이 우수하고 바이러스 안전성이 확보된 정맥주사용 제제 개발이\n\n<!-- PAGE_9 -->\n###### 필요하게 되었다.\n\n <!-- PAGE_9 -->\n###### 본 가이드라인은 혈장 유래 정맥주사용\n\n<!-- PAGE_9 -->\n###### HBIG의 품질과 안전성 유효성 심사 시 비임\n\n<!-- PAGE_9 -->\n###### ․\n\n<!-- PAGE_9 -->\n###### 상 및 임상시험자료 평가를 위한 지침으로서\n\n<!-- PAGE_9 -->\n###### 심사자 및 제조자에게 정보를 제공함과\n\n<!-- PAGE_9 -->\n###### ,\n\n<!-- PAGE_9 -->\n###### 동시에 자료 요건의 투명성을 제고하는데 그 목적이 있다.\n\n - - 2 -\n<!-- PAGE_10 -->\n###### 구조 물리화학적 성질\n\n<!-- PAGE_10 -->\n###### 제조 및 품질관리\n\n<!-- PAGE_10 -->\n###### .\n\n <!-- PAGE_10 -->\n###### ,\n\n<!-- PAGE_10 -->\n###### Ⅱ\n\n<!-- PAGE_10 -->\n###### ․\n\n<!-- PAGE_10 -->\n###### 면역글로불린제제의 제조에 있어서 제조사는 원료물질의 특성\n\n<!-- PAGE_10 -->\n###### , 제조 및 정제공정\n\n<!-- PAGE_10 -->\n###### ,\n\n<!-- PAGE_10 -->\n###### 그리고 안전성과 관련된 중요한 인자들을 고려해야 한다\n\n<!-- PAGE_10 -->\n###### 면역글로불린제제는 많은 사\n\n<!-- PAGE_10 -->\n###### .\n\n <!-- PAGE_10 -->\n###### 람의 헌혈 혈장을 풀링하여 생산하기 때문에 한 사람의 헌혈 혈장의 바이러스 오염은\n\n<!-- PAGE_10 -->\n###### 면역글로불린제제를 사용하는 다수의 환자에게 바이러스성 질병을 전염시킬 수 있다.\n\n <!-- PAGE_10 -->\n###### 따라서 원료혈장의 오염을 최소화하면서 제조공정 중 혈액매개 바이러스의 불활화 제\n\n<!-- PAGE_10 -->\n###### /\n\n<!-- PAGE_10 -->\n###### 거 효율을 극대화하기 위한 조치를 취하여 면역글로불린제제의 바이러스 안전성을 반\n\n<!-- PAGE_10 -->\n###### 드시 확보하여야 한다.\n\n <!-- PAGE_10 -->\n###### 면역글로불린제제 품질평가 전반에 관해서는\n\n<!-- PAGE_10 -->\n###### “혈장분획제제 품질평가 가이드 생물\n\n<!-- PAGE_10 -->\n###### (\n\n<!-- PAGE_10 -->\n###### 의약품평가가이드\n\n<!-- PAGE_10 -->\n###### 와\n\n<!-- PAGE_10 -->\n###### 의\n\n<!-- PAGE_10 -->\n###### 4, 2002)”\n\n<!-- PAGE_10 -->\n###### EMEA\n\n<!-- PAGE_10 -->\n###### “Note for Guidance on Plasma-Derived\n\n<!-- PAGE_10 -->\n###### Medicinal Products(CPMP/BWP/269/95 rev. ",
        "original_sentence": "<!-- PAGE_10 -->\n###### ,\n\n<!-- PAGE_10 -->\n###### Ⅱ\n\n<!-- PAGE_10 -->\n###### ․\n\n<!-- PAGE_10 -->\n###### 면역글로불린제제의 제조에 있어서 제조사는 원료물질의 특성\n\n<!-- PAGE_10 -->\n###### , 제조 및 정제공정\n\n<!-- PAGE_10 -->\n###### ,\n\n<!-- PAGE_10 -->\n###### 그리고 안전성과 관련된 중요한 인자들을 고려해야 한다\n\n<!-- PAGE_10 -->\n###### 면역글로불린제제는 많은 사\n\n<!-- PAGE_10 -->\n###### .\n\n"
      }
    },
    {
      "chunk_id": "chunk_069",
      "text": "<!-- PAGE_10 -->\n###### 람의 헌혈 혈장을 풀링하여 생산하기 때문에 한 사람의 헌혈 혈장의 바이러스 오염은\n\n<!-- PAGE_10 -->\n###### 면역글로불린제제를 사용하는 다수의 환자에게 바이러스성 질병을 전염시킬 수 있다.\n\n",
      "metadata": {
        "source": "(가이드라인-005)_정맥주사용+B형간염+사람면역글로불린제제의+안전성유효성+평가+가이드라인.pdf",
        "chunk_index": 68,
        "window_size": 3,
        "char_count": 141,
        "word_count": 29,
        "page_number": 10,
        "window_text": "<!-- PAGE_9 -->\n###### 본 가이드라인은 혈장 유래 정맥주사용\n\n<!-- PAGE_9 -->\n###### HBIG의 품질과 안전성 유효성 심사 시 비임\n\n<!-- PAGE_9 -->\n###### ․\n\n<!-- PAGE_9 -->\n###### 상 및 임상시험자료 평가를 위한 지침으로서\n\n<!-- PAGE_9 -->\n###### 심사자 및 제조자에게 정보를 제공함과\n\n<!-- PAGE_9 -->\n###### ,\n\n<!-- PAGE_9 -->\n###### 동시에 자료 요건의 투명성을 제고하는데 그 목적이 있다.\n\n - - 2 -\n<!-- PAGE_10 -->\n###### 구조 물리화학적 성질\n\n<!-- PAGE_10 -->\n###### 제조 및 품질관리\n\n<!-- PAGE_10 -->\n###### .\n\n <!-- PAGE_10 -->\n###### ,\n\n<!-- PAGE_10 -->\n###### Ⅱ\n\n<!-- PAGE_10 -->\n###### ․\n\n<!-- PAGE_10 -->\n###### 면역글로불린제제의 제조에 있어서 제조사는 원료물질의 특성\n\n<!-- PAGE_10 -->\n###### , 제조 및 정제공정\n\n<!-- PAGE_10 -->\n###### ,\n\n<!-- PAGE_10 -->\n###### 그리고 안전성과 관련된 중요한 인자들을 고려해야 한다\n\n<!-- PAGE_10 -->\n###### 면역글로불린제제는 많은 사\n\n<!-- PAGE_10 -->\n###### .\n\n <!-- PAGE_10 -->\n###### 람의 헌혈 혈장을 풀링하여 생산하기 때문에 한 사람의 헌혈 혈장의 바이러스 오염은\n\n<!-- PAGE_10 -->\n###### 면역글로불린제제를 사용하는 다수의 환자에게 바이러스성 질병을 전염시킬 수 있다.\n\n <!-- PAGE_10 -->\n###### 따라서 원료혈장의 오염을 최소화하면서 제조공정 중 혈액매개 바이러스의 불활화 제\n\n<!-- PAGE_10 -->\n###### /\n\n<!-- PAGE_10 -->\n###### 거 효율을 극대화하기 위한 조치를 취하여 면역글로불린제제의 바이러스 안전성을 반\n\n<!-- PAGE_10 -->\n###### 드시 확보하여야 한다.\n\n <!-- PAGE_10 -->\n###### 면역글로불린제제 품질평가 전반에 관해서는\n\n<!-- PAGE_10 -->\n###### “혈장분획제제 품질평가 가이드 생물\n\n<!-- PAGE_10 -->\n###### (\n\n<!-- PAGE_10 -->\n###### 의약품평가가이드\n\n<!-- PAGE_10 -->\n###### 와\n\n<!-- PAGE_10 -->\n###### 의\n\n<!-- PAGE_10 -->\n###### 4, 2002)”\n\n<!-- PAGE_10 -->\n###### EMEA\n\n<!-- PAGE_10 -->\n###### “Note for Guidance on Plasma-Derived\n\n<!-- PAGE_10 -->\n###### Medicinal Products(CPMP/BWP/269/95 rev.  3, 2001)” 등을 참고할 수 있다\n\n<!-- PAGE_10 -->\n###### .\n\n",
        "original_sentence": "<!-- PAGE_10 -->\n###### 람의 헌혈 혈장을 풀링하여 생산하기 때문에 한 사람의 헌혈 혈장의 바이러스 오염은\n\n<!-- PAGE_10 -->\n###### 면역글로불린제제를 사용하는 다수의 환자에게 바이러스성 질병을 전염시킬 수 있다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_070",
      "text": "<!-- PAGE_10 -->\n###### 따라서 원료혈장의 오염을 최소화하면서 제조공정 중 혈액매개 바이러스의 불활화 제\n\n<!-- PAGE_10 -->\n###### /\n\n<!-- PAGE_10 -->\n###### 거 효율을 극대화하기 위한 조치를 취하여 면역글로불린제제의 바이러스 안전성을 반\n\n<!-- PAGE_10 -->\n###### 드시 확보하여야 한다.\n\n",
      "metadata": {
        "source": "(가이드라인-005)_정맥주사용+B형간염+사람면역글로불린제제의+안전성유효성+평가+가이드라인.pdf",
        "chunk_index": 69,
        "window_size": 3,
        "char_count": 205,
        "word_count": 40,
        "page_number": 10,
        "window_text": "- - 2 -\n<!-- PAGE_10 -->\n###### 구조 물리화학적 성질\n\n<!-- PAGE_10 -->\n###### 제조 및 품질관리\n\n<!-- PAGE_10 -->\n###### .\n\n <!-- PAGE_10 -->\n###### ,\n\n<!-- PAGE_10 -->\n###### Ⅱ\n\n<!-- PAGE_10 -->\n###### ․\n\n<!-- PAGE_10 -->\n###### 면역글로불린제제의 제조에 있어서 제조사는 원료물질의 특성\n\n<!-- PAGE_10 -->\n###### , 제조 및 정제공정\n\n<!-- PAGE_10 -->\n###### ,\n\n<!-- PAGE_10 -->\n###### 그리고 안전성과 관련된 중요한 인자들을 고려해야 한다\n\n<!-- PAGE_10 -->\n###### 면역글로불린제제는 많은 사\n\n<!-- PAGE_10 -->\n###### .\n\n <!-- PAGE_10 -->\n###### 람의 헌혈 혈장을 풀링하여 생산하기 때문에 한 사람의 헌혈 혈장의 바이러스 오염은\n\n<!-- PAGE_10 -->\n###### 면역글로불린제제를 사용하는 다수의 환자에게 바이러스성 질병을 전염시킬 수 있다.\n\n <!-- PAGE_10 -->\n###### 따라서 원료혈장의 오염을 최소화하면서 제조공정 중 혈액매개 바이러스의 불활화 제\n\n<!-- PAGE_10 -->\n###### /\n\n<!-- PAGE_10 -->\n###### 거 효율을 극대화하기 위한 조치를 취하여 면역글로불린제제의 바이러스 안전성을 반\n\n<!-- PAGE_10 -->\n###### 드시 확보하여야 한다.\n\n <!-- PAGE_10 -->\n###### 면역글로불린제제 품질평가 전반에 관해서는\n\n<!-- PAGE_10 -->\n###### “혈장분획제제 품질평가 가이드 생물\n\n<!-- PAGE_10 -->\n###### (\n\n<!-- PAGE_10 -->\n###### 의약품평가가이드\n\n<!-- PAGE_10 -->\n###### 와\n\n<!-- PAGE_10 -->\n###### 의\n\n<!-- PAGE_10 -->\n###### 4, 2002)”\n\n<!-- PAGE_10 -->\n###### EMEA\n\n<!-- PAGE_10 -->\n###### “Note for Guidance on Plasma-Derived\n\n<!-- PAGE_10 -->\n###### Medicinal Products(CPMP/BWP/269/95 rev.  3, 2001)” 등을 참고할 수 있다\n\n<!-- PAGE_10 -->\n###### .\n\n <!-- PAGE_10 -->\n###### 구조결정\n\n<!-- PAGE_10 -->\n###### 물리화학적 성질\n\n<!-- PAGE_10 -->\n###### 1.\n\n",
        "original_sentence": "<!-- PAGE_10 -->\n###### 따라서 원료혈장의 오염을 최소화하면서 제조공정 중 혈액매개 바이러스의 불활화 제\n\n<!-- PAGE_10 -->\n###### /\n\n<!-- PAGE_10 -->\n###### 거 효율을 극대화하기 위한 조치를 취하여 면역글로불린제제의 바이러스 안전성을 반\n\n<!-- PAGE_10 -->\n###### 드시 확보하여야 한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_071",
      "text": "<!-- PAGE_10 -->\n###### 면역글로불린제제 품질평가 전반에 관해서는\n\n<!-- PAGE_10 -->\n###### “혈장분획제제 품질평가 가이드 생물\n\n<!-- PAGE_10 -->\n###### (\n\n<!-- PAGE_10 -->\n###### 의약품평가가이드\n\n<!-- PAGE_10 -->\n###### 와\n\n<!-- PAGE_10 -->\n###### 의\n\n<!-- PAGE_10 -->\n###### 4, 2002)”\n\n<!-- PAGE_10 -->\n###### EMEA\n\n<!-- PAGE_10 -->\n###### “Note for Guidance on Plasma-Derived\n\n<!-- PAGE_10 -->\n###### Medicinal Products(CPMP/BWP/269/95 rev. ",
      "metadata": {
        "source": "(가이드라인-005)_정맥주사용+B형간염+사람면역글로불린제제의+안전성유효성+평가+가이드라인.pdf",
        "chunk_index": 70,
        "window_size": 3,
        "char_count": 399,
        "word_count": 63,
        "page_number": 10,
        "window_text": "<!-- PAGE_10 -->\n###### ,\n\n<!-- PAGE_10 -->\n###### Ⅱ\n\n<!-- PAGE_10 -->\n###### ․\n\n<!-- PAGE_10 -->\n###### 면역글로불린제제의 제조에 있어서 제조사는 원료물질의 특성\n\n<!-- PAGE_10 -->\n###### , 제조 및 정제공정\n\n<!-- PAGE_10 -->\n###### ,\n\n<!-- PAGE_10 -->\n###### 그리고 안전성과 관련된 중요한 인자들을 고려해야 한다\n\n<!-- PAGE_10 -->\n###### 면역글로불린제제는 많은 사\n\n<!-- PAGE_10 -->\n###### .\n\n <!-- PAGE_10 -->\n###### 람의 헌혈 혈장을 풀링하여 생산하기 때문에 한 사람의 헌혈 혈장의 바이러스 오염은\n\n<!-- PAGE_10 -->\n###### 면역글로불린제제를 사용하는 다수의 환자에게 바이러스성 질병을 전염시킬 수 있다.\n\n <!-- PAGE_10 -->\n###### 따라서 원료혈장의 오염을 최소화하면서 제조공정 중 혈액매개 바이러스의 불활화 제\n\n<!-- PAGE_10 -->\n###### /\n\n<!-- PAGE_10 -->\n###### 거 효율을 극대화하기 위한 조치를 취하여 면역글로불린제제의 바이러스 안전성을 반\n\n<!-- PAGE_10 -->\n###### 드시 확보하여야 한다.\n\n <!-- PAGE_10 -->\n###### 면역글로불린제제 품질평가 전반에 관해서는\n\n<!-- PAGE_10 -->\n###### “혈장분획제제 품질평가 가이드 생물\n\n<!-- PAGE_10 -->\n###### (\n\n<!-- PAGE_10 -->\n###### 의약품평가가이드\n\n<!-- PAGE_10 -->\n###### 와\n\n<!-- PAGE_10 -->\n###### 의\n\n<!-- PAGE_10 -->\n###### 4, 2002)”\n\n<!-- PAGE_10 -->\n###### EMEA\n\n<!-- PAGE_10 -->\n###### “Note for Guidance on Plasma-Derived\n\n<!-- PAGE_10 -->\n###### Medicinal Products(CPMP/BWP/269/95 rev.  3, 2001)” 등을 참고할 수 있다\n\n<!-- PAGE_10 -->\n###### .\n\n <!-- PAGE_10 -->\n###### 구조결정\n\n<!-- PAGE_10 -->\n###### 물리화학적 성질\n\n<!-- PAGE_10 -->\n###### 1.\n\n <!-- PAGE_10 -->\n###### ,\n\n<!-- PAGE_10 -->\n###### 주성분의 구성 성분 및 그 특성에 관한 자료\n\n<!-- PAGE_10 -->\n###### 물리화학적 성질에 관한 자료\n\n<!-- PAGE_10 -->\n###### 면\n\n<!-- PAGE_10 -->\n###### ,\n\n<!-- PAGE_10 -->\n###### ,\n\n<!-- PAGE_10 -->\n###### 역학적 성질에 관한 자료 및 생물학적 성질에 관한 자료를 제출하여야 한다\n\n<!-- PAGE_10 -->\n###### 또한\n\n<!-- PAGE_10 -->\n###### .\n\n",
        "original_sentence": "<!-- PAGE_10 -->\n###### 면역글로불린제제 품질평가 전반에 관해서는\n\n<!-- PAGE_10 -->\n###### “혈장분획제제 품질평가 가이드 생물\n\n<!-- PAGE_10 -->\n###### (\n\n<!-- PAGE_10 -->\n###### 의약품평가가이드\n\n<!-- PAGE_10 -->\n###### 와\n\n<!-- PAGE_10 -->\n###### 의\n\n<!-- PAGE_10 -->\n###### 4, 2002)”\n\n<!-- PAGE_10 -->\n###### EMEA\n\n<!-- PAGE_10 -->\n###### “Note for Guidance on Plasma-Derived\n\n<!-- PAGE_10 -->\n###### Medicinal Products(CPMP/BWP/269/95 rev. "
      }
    },
    {
      "chunk_id": "chunk_072",
      "text": "3, 2001)” 등을 참고할 수 있다\n\n<!-- PAGE_10 -->\n###### .\n\n",
      "metadata": {
        "source": "(가이드라인-005)_정맥주사용+B형간염+사람면역글로불린제제의+안전성유효성+평가+가이드라인.pdf",
        "chunk_index": 71,
        "window_size": 3,
        "char_count": 50,
        "word_count": 11,
        "page_number": 10,
        "window_text": "<!-- PAGE_10 -->\n###### 람의 헌혈 혈장을 풀링하여 생산하기 때문에 한 사람의 헌혈 혈장의 바이러스 오염은\n\n<!-- PAGE_10 -->\n###### 면역글로불린제제를 사용하는 다수의 환자에게 바이러스성 질병을 전염시킬 수 있다.\n\n <!-- PAGE_10 -->\n###### 따라서 원료혈장의 오염을 최소화하면서 제조공정 중 혈액매개 바이러스의 불활화 제\n\n<!-- PAGE_10 -->\n###### /\n\n<!-- PAGE_10 -->\n###### 거 효율을 극대화하기 위한 조치를 취하여 면역글로불린제제의 바이러스 안전성을 반\n\n<!-- PAGE_10 -->\n###### 드시 확보하여야 한다.\n\n <!-- PAGE_10 -->\n###### 면역글로불린제제 품질평가 전반에 관해서는\n\n<!-- PAGE_10 -->\n###### “혈장분획제제 품질평가 가이드 생물\n\n<!-- PAGE_10 -->\n###### (\n\n<!-- PAGE_10 -->\n###### 의약품평가가이드\n\n<!-- PAGE_10 -->\n###### 와\n\n<!-- PAGE_10 -->\n###### 의\n\n<!-- PAGE_10 -->\n###### 4, 2002)”\n\n<!-- PAGE_10 -->\n###### EMEA\n\n<!-- PAGE_10 -->\n###### “Note for Guidance on Plasma-Derived\n\n<!-- PAGE_10 -->\n###### Medicinal Products(CPMP/BWP/269/95 rev.  3, 2001)” 등을 참고할 수 있다\n\n<!-- PAGE_10 -->\n###### .\n\n <!-- PAGE_10 -->\n###### 구조결정\n\n<!-- PAGE_10 -->\n###### 물리화학적 성질\n\n<!-- PAGE_10 -->\n###### 1.\n\n <!-- PAGE_10 -->\n###### ,\n\n<!-- PAGE_10 -->\n###### 주성분의 구성 성분 및 그 특성에 관한 자료\n\n<!-- PAGE_10 -->\n###### 물리화학적 성질에 관한 자료\n\n<!-- PAGE_10 -->\n###### 면\n\n<!-- PAGE_10 -->\n###### ,\n\n<!-- PAGE_10 -->\n###### ,\n\n<!-- PAGE_10 -->\n###### 역학적 성질에 관한 자료 및 생물학적 성질에 관한 자료를 제출하여야 한다\n\n<!-- PAGE_10 -->\n###### 또한\n\n<!-- PAGE_10 -->\n###### .\n\n <!-- PAGE_10 -->\n###### 기타 첨가제 또는 첨부용제의 성분 및 그 특성에 관한 자료를 제출하여야 한다.\n\n",
        "original_sentence": "3, 2001)” 등을 참고할 수 있다\n\n<!-- PAGE_10 -->\n###### .\n\n"
      }
    },
    {
      "chunk_id": "chunk_073",
      "text": "<!-- PAGE_10 -->\n###### 구조결정\n\n<!-- PAGE_10 -->\n###### 물리화학적 성질\n\n<!-- PAGE_10 -->\n###### 1.\n\n",
      "metadata": {
        "source": "(가이드라인-005)_정맥주사용+B형간염+사람면역글로불린제제의+안전성유효성+평가+가이드라인.pdf",
        "chunk_index": 72,
        "window_size": 3,
        "char_count": 92,
        "word_count": 16,
        "page_number": 10,
        "window_text": "<!-- PAGE_10 -->\n###### 따라서 원료혈장의 오염을 최소화하면서 제조공정 중 혈액매개 바이러스의 불활화 제\n\n<!-- PAGE_10 -->\n###### /\n\n<!-- PAGE_10 -->\n###### 거 효율을 극대화하기 위한 조치를 취하여 면역글로불린제제의 바이러스 안전성을 반\n\n<!-- PAGE_10 -->\n###### 드시 확보하여야 한다.\n\n <!-- PAGE_10 -->\n###### 면역글로불린제제 품질평가 전반에 관해서는\n\n<!-- PAGE_10 -->\n###### “혈장분획제제 품질평가 가이드 생물\n\n<!-- PAGE_10 -->\n###### (\n\n<!-- PAGE_10 -->\n###### 의약품평가가이드\n\n<!-- PAGE_10 -->\n###### 와\n\n<!-- PAGE_10 -->\n###### 의\n\n<!-- PAGE_10 -->\n###### 4, 2002)”\n\n<!-- PAGE_10 -->\n###### EMEA\n\n<!-- PAGE_10 -->\n###### “Note for Guidance on Plasma-Derived\n\n<!-- PAGE_10 -->\n###### Medicinal Products(CPMP/BWP/269/95 rev.  3, 2001)” 등을 참고할 수 있다\n\n<!-- PAGE_10 -->\n###### .\n\n <!-- PAGE_10 -->\n###### 구조결정\n\n<!-- PAGE_10 -->\n###### 물리화학적 성질\n\n<!-- PAGE_10 -->\n###### 1.\n\n <!-- PAGE_10 -->\n###### ,\n\n<!-- PAGE_10 -->\n###### 주성분의 구성 성분 및 그 특성에 관한 자료\n\n<!-- PAGE_10 -->\n###### 물리화학적 성질에 관한 자료\n\n<!-- PAGE_10 -->\n###### 면\n\n<!-- PAGE_10 -->\n###### ,\n\n<!-- PAGE_10 -->\n###### ,\n\n<!-- PAGE_10 -->\n###### 역학적 성질에 관한 자료 및 생물학적 성질에 관한 자료를 제출하여야 한다\n\n<!-- PAGE_10 -->\n###### 또한\n\n<!-- PAGE_10 -->\n###### .\n\n <!-- PAGE_10 -->\n###### 기타 첨가제 또는 첨부용제의 성분 및 그 특성에 관한 자료를 제출하여야 한다.\n\n <!-- PAGE_10 -->\n###### 원료물질의 수집 및 관리\n\n<!-- PAGE_10 -->\n###### 2.\n\n",
        "original_sentence": "<!-- PAGE_10 -->\n###### 구조결정\n\n<!-- PAGE_10 -->\n###### 물리화학적 성질\n\n<!-- PAGE_10 -->\n###### 1.\n\n"
      }
    },
    {
      "chunk_id": "chunk_074",
      "text": "<!-- PAGE_10 -->\n###### ,\n\n<!-- PAGE_10 -->\n###### 주성분의 구성 성분 및 그 특성에 관한 자료\n\n<!-- PAGE_10 -->\n###### 물리화학적 성질에 관한 자료\n\n<!-- PAGE_10 -->\n###### 면\n\n<!-- PAGE_10 -->\n###### ,\n\n<!-- PAGE_10 -->\n###### ,\n\n<!-- PAGE_10 -->\n###### 역학적 성질에 관한 자료 및 생물학적 성질에 관한 자료를 제출하여야 한다\n\n<!-- PAGE_10 -->\n###### 또한\n\n<!-- PAGE_10 -->\n###### .\n\n",
      "metadata": {
        "source": "(가이드라인-005)_정맥주사용+B형간염+사람면역글로불린제제의+안전성유효성+평가+가이드라인.pdf",
        "chunk_index": 73,
        "window_size": 3,
        "char_count": 320,
        "word_count": 65,
        "page_number": 10,
        "window_text": "<!-- PAGE_10 -->\n###### 면역글로불린제제 품질평가 전반에 관해서는\n\n<!-- PAGE_10 -->\n###### “혈장분획제제 품질평가 가이드 생물\n\n<!-- PAGE_10 -->\n###### (\n\n<!-- PAGE_10 -->\n###### 의약품평가가이드\n\n<!-- PAGE_10 -->\n###### 와\n\n<!-- PAGE_10 -->\n###### 의\n\n<!-- PAGE_10 -->\n###### 4, 2002)”\n\n<!-- PAGE_10 -->\n###### EMEA\n\n<!-- PAGE_10 -->\n###### “Note for Guidance on Plasma-Derived\n\n<!-- PAGE_10 -->\n###### Medicinal Products(CPMP/BWP/269/95 rev.  3, 2001)” 등을 참고할 수 있다\n\n<!-- PAGE_10 -->\n###### .\n\n <!-- PAGE_10 -->\n###### 구조결정\n\n<!-- PAGE_10 -->\n###### 물리화학적 성질\n\n<!-- PAGE_10 -->\n###### 1.\n\n <!-- PAGE_10 -->\n###### ,\n\n<!-- PAGE_10 -->\n###### 주성분의 구성 성분 및 그 특성에 관한 자료\n\n<!-- PAGE_10 -->\n###### 물리화학적 성질에 관한 자료\n\n<!-- PAGE_10 -->\n###### 면\n\n<!-- PAGE_10 -->\n###### ,\n\n<!-- PAGE_10 -->\n###### ,\n\n<!-- PAGE_10 -->\n###### 역학적 성질에 관한 자료 및 생물학적 성질에 관한 자료를 제출하여야 한다\n\n<!-- PAGE_10 -->\n###### 또한\n\n<!-- PAGE_10 -->\n###### .\n\n <!-- PAGE_10 -->\n###### 기타 첨가제 또는 첨부용제의 성분 및 그 특성에 관한 자료를 제출하여야 한다.\n\n <!-- PAGE_10 -->\n###### 원료물질의 수집 및 관리\n\n<!-- PAGE_10 -->\n###### 2.\n\n <!-- PAGE_10 -->\n###### 원료물질의 수집 및 관리는 혈장분획제제의 제조 및 품질보증에서 매우 중요한\n\n<!-- PAGE_10 -->\n###### 요소이다\n\n<!-- PAGE_10 -->\n###### 바이러스 위해성을 줄이기 위한 방법으로 원료물질에 대한 세심한 관리\n\n<!-- PAGE_10 -->\n###### .\n\n",
        "original_sentence": "<!-- PAGE_10 -->\n###### ,\n\n<!-- PAGE_10 -->\n###### 주성분의 구성 성분 및 그 특성에 관한 자료\n\n<!-- PAGE_10 -->\n###### 물리화학적 성질에 관한 자료\n\n<!-- PAGE_10 -->\n###### 면\n\n<!-- PAGE_10 -->\n###### ,\n\n<!-- PAGE_10 -->\n###### ,\n\n<!-- PAGE_10 -->\n###### 역학적 성질에 관한 자료 및 생물학적 성질에 관한 자료를 제출하여야 한다\n\n<!-- PAGE_10 -->\n###### 또한\n\n<!-- PAGE_10 -->\n###### .\n\n"
      }
    },
    {
      "chunk_id": "chunk_075",
      "text": "<!-- PAGE_10 -->\n###### 기타 첨가제 또는 첨부용제의 성분 및 그 특성에 관한 자료를 제출하여야 한다.\n\n",
      "metadata": {
        "source": "(가이드라인-005)_정맥주사용+B형간염+사람면역글로불린제제의+안전성유효성+평가+가이드라인.pdf",
        "chunk_index": 74,
        "window_size": 3,
        "char_count": 69,
        "word_count": 16,
        "page_number": 10,
        "window_text": "3, 2001)” 등을 참고할 수 있다\n\n<!-- PAGE_10 -->\n###### .\n\n <!-- PAGE_10 -->\n###### 구조결정\n\n<!-- PAGE_10 -->\n###### 물리화학적 성질\n\n<!-- PAGE_10 -->\n###### 1.\n\n <!-- PAGE_10 -->\n###### ,\n\n<!-- PAGE_10 -->\n###### 주성분의 구성 성분 및 그 특성에 관한 자료\n\n<!-- PAGE_10 -->\n###### 물리화학적 성질에 관한 자료\n\n<!-- PAGE_10 -->\n###### 면\n\n<!-- PAGE_10 -->\n###### ,\n\n<!-- PAGE_10 -->\n###### ,\n\n<!-- PAGE_10 -->\n###### 역학적 성질에 관한 자료 및 생물학적 성질에 관한 자료를 제출하여야 한다\n\n<!-- PAGE_10 -->\n###### 또한\n\n<!-- PAGE_10 -->\n###### .\n\n <!-- PAGE_10 -->\n###### 기타 첨가제 또는 첨부용제의 성분 및 그 특성에 관한 자료를 제출하여야 한다.\n\n <!-- PAGE_10 -->\n###### 원료물질의 수집 및 관리\n\n<!-- PAGE_10 -->\n###### 2.\n\n <!-- PAGE_10 -->\n###### 원료물질의 수집 및 관리는 혈장분획제제의 제조 및 품질보증에서 매우 중요한\n\n<!-- PAGE_10 -->\n###### 요소이다\n\n<!-- PAGE_10 -->\n###### 바이러스 위해성을 줄이기 위한 방법으로 원료물질에 대한 세심한 관리\n\n<!-- PAGE_10 -->\n###### .\n\n <!-- PAGE_10 -->\n###### 가 필요하다.\n\n",
        "original_sentence": "<!-- PAGE_10 -->\n###### 기타 첨가제 또는 첨부용제의 성분 및 그 특성에 관한 자료를 제출하여야 한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_076",
      "text": "<!-- PAGE_10 -->\n###### 원료물질의 수집 및 관리\n\n<!-- PAGE_10 -->\n###### 2.\n\n",
      "metadata": {
        "source": "(가이드라인-005)_정맥주사용+B형간염+사람면역글로불린제제의+안전성유효성+평가+가이드라인.pdf",
        "chunk_index": 75,
        "window_size": 3,
        "char_count": 67,
        "word_count": 13,
        "page_number": 10,
        "window_text": "<!-- PAGE_10 -->\n###### 구조결정\n\n<!-- PAGE_10 -->\n###### 물리화학적 성질\n\n<!-- PAGE_10 -->\n###### 1.\n\n <!-- PAGE_10 -->\n###### ,\n\n<!-- PAGE_10 -->\n###### 주성분의 구성 성분 및 그 특성에 관한 자료\n\n<!-- PAGE_10 -->\n###### 물리화학적 성질에 관한 자료\n\n<!-- PAGE_10 -->\n###### 면\n\n<!-- PAGE_10 -->\n###### ,\n\n<!-- PAGE_10 -->\n###### ,\n\n<!-- PAGE_10 -->\n###### 역학적 성질에 관한 자료 및 생물학적 성질에 관한 자료를 제출하여야 한다\n\n<!-- PAGE_10 -->\n###### 또한\n\n<!-- PAGE_10 -->\n###### .\n\n <!-- PAGE_10 -->\n###### 기타 첨가제 또는 첨부용제의 성분 및 그 특성에 관한 자료를 제출하여야 한다.\n\n <!-- PAGE_10 -->\n###### 원료물질의 수집 및 관리\n\n<!-- PAGE_10 -->\n###### 2.\n\n <!-- PAGE_10 -->\n###### 원료물질의 수집 및 관리는 혈장분획제제의 제조 및 품질보증에서 매우 중요한\n\n<!-- PAGE_10 -->\n###### 요소이다\n\n<!-- PAGE_10 -->\n###### 바이러스 위해성을 줄이기 위한 방법으로 원료물질에 대한 세심한 관리\n\n<!-- PAGE_10 -->\n###### .\n\n <!-- PAGE_10 -->\n###### 가 필요하다.\n\n <!-- PAGE_10 -->\n###### 원료물질의 수집 및 관리에 관한 상세 정보를 기록하여 제공하여야 한다\n\n<!-- PAGE_10 -->\n###### 즉\n\n<!-- PAGE_10 -->\n###### 원\n\n<!-- PAGE_10 -->\n###### .\n\n",
        "original_sentence": "<!-- PAGE_10 -->\n###### 원료물질의 수집 및 관리\n\n<!-- PAGE_10 -->\n###### 2.\n\n"
      }
    },
    {
      "chunk_id": "chunk_077",
      "text": "<!-- PAGE_10 -->\n###### 원료물질의 수집 및 관리는 혈장분획제제의 제조 및 품질보증에서 매우 중요한\n\n<!-- PAGE_10 -->\n###### 요소이다\n\n<!-- PAGE_10 -->\n###### 바이러스 위해성을 줄이기 위한 방법으로 원료물질에 대한 세심한 관리\n\n<!-- PAGE_10 -->\n###### .\n\n",
      "metadata": {
        "source": "(가이드라인-005)_정맥주사용+B형간염+사람면역글로불린제제의+안전성유효성+평가+가이드라인.pdf",
        "chunk_index": 76,
        "window_size": 3,
        "char_count": 187,
        "word_count": 37,
        "page_number": 10,
        "window_text": "<!-- PAGE_10 -->\n###### ,\n\n<!-- PAGE_10 -->\n###### 주성분의 구성 성분 및 그 특성에 관한 자료\n\n<!-- PAGE_10 -->\n###### 물리화학적 성질에 관한 자료\n\n<!-- PAGE_10 -->\n###### 면\n\n<!-- PAGE_10 -->\n###### ,\n\n<!-- PAGE_10 -->\n###### ,\n\n<!-- PAGE_10 -->\n###### 역학적 성질에 관한 자료 및 생물학적 성질에 관한 자료를 제출하여야 한다\n\n<!-- PAGE_10 -->\n###### 또한\n\n<!-- PAGE_10 -->\n###### .\n\n <!-- PAGE_10 -->\n###### 기타 첨가제 또는 첨부용제의 성분 및 그 특성에 관한 자료를 제출하여야 한다.\n\n <!-- PAGE_10 -->\n###### 원료물질의 수집 및 관리\n\n<!-- PAGE_10 -->\n###### 2.\n\n <!-- PAGE_10 -->\n###### 원료물질의 수집 및 관리는 혈장분획제제의 제조 및 품질보증에서 매우 중요한\n\n<!-- PAGE_10 -->\n###### 요소이다\n\n<!-- PAGE_10 -->\n###### 바이러스 위해성을 줄이기 위한 방법으로 원료물질에 대한 세심한 관리\n\n<!-- PAGE_10 -->\n###### .\n\n <!-- PAGE_10 -->\n###### 가 필요하다.\n\n <!-- PAGE_10 -->\n###### 원료물질의 수집 및 관리에 관한 상세 정보를 기록하여 제공하여야 한다\n\n<!-- PAGE_10 -->\n###### 즉\n\n<!-- PAGE_10 -->\n###### 원\n\n<!-- PAGE_10 -->\n###### .\n\n <!-- PAGE_10 -->\n###### ,\n\n<!-- PAGE_10 -->\n###### 료혈장의 종류\n\n<!-- PAGE_10 -->\n###### 개별혈장 및 수집혈장의 풀링 사이즈\n\n<!-- PAGE_10 -->\n###### 풀링 방법\n\n<!-- PAGE_10 -->\n###### 품질관리 항목 및\n\n<!-- PAGE_10 -->\n###### ,\n\n<!-- PAGE_10 -->\n###### ,\n\n<!-- PAGE_10 -->\n###### ,\n\n<!-- PAGE_10 -->\n###### 기준\n\n<!-- PAGE_10 -->\n###### 보관 및 운송 등에 관한 정보를 제공하여야 한다\n\n<!-- PAGE_10 -->\n###### 이 때 분획용 혈장 마스터\n\n<!-- PAGE_10 -->\n###### ,\n\n<!-- PAGE_10 -->\n###### .\n\n",
        "original_sentence": "<!-- PAGE_10 -->\n###### 원료물질의 수집 및 관리는 혈장분획제제의 제조 및 품질보증에서 매우 중요한\n\n<!-- PAGE_10 -->\n###### 요소이다\n\n<!-- PAGE_10 -->\n###### 바이러스 위해성을 줄이기 위한 방법으로 원료물질에 대한 세심한 관리\n\n<!-- PAGE_10 -->\n###### .\n\n"
      }
    },
    {
      "chunk_id": "chunk_078",
      "text": "<!-- PAGE_10 -->\n###### 가 필요하다.\n\n",
      "metadata": {
        "source": "(가이드라인-005)_정맥주사용+B형간염+사람면역글로불린제제의+안전성유효성+평가+가이드라인.pdf",
        "chunk_index": 77,
        "window_size": 3,
        "char_count": 33,
        "word_count": 6,
        "page_number": 10,
        "window_text": "<!-- PAGE_10 -->\n###### 기타 첨가제 또는 첨부용제의 성분 및 그 특성에 관한 자료를 제출하여야 한다.\n\n <!-- PAGE_10 -->\n###### 원료물질의 수집 및 관리\n\n<!-- PAGE_10 -->\n###### 2.\n\n <!-- PAGE_10 -->\n###### 원료물질의 수집 및 관리는 혈장분획제제의 제조 및 품질보증에서 매우 중요한\n\n<!-- PAGE_10 -->\n###### 요소이다\n\n<!-- PAGE_10 -->\n###### 바이러스 위해성을 줄이기 위한 방법으로 원료물질에 대한 세심한 관리\n\n<!-- PAGE_10 -->\n###### .\n\n <!-- PAGE_10 -->\n###### 가 필요하다.\n\n <!-- PAGE_10 -->\n###### 원료물질의 수집 및 관리에 관한 상세 정보를 기록하여 제공하여야 한다\n\n<!-- PAGE_10 -->\n###### 즉\n\n<!-- PAGE_10 -->\n###### 원\n\n<!-- PAGE_10 -->\n###### .\n\n <!-- PAGE_10 -->\n###### ,\n\n<!-- PAGE_10 -->\n###### 료혈장의 종류\n\n<!-- PAGE_10 -->\n###### 개별혈장 및 수집혈장의 풀링 사이즈\n\n<!-- PAGE_10 -->\n###### 풀링 방법\n\n<!-- PAGE_10 -->\n###### 품질관리 항목 및\n\n<!-- PAGE_10 -->\n###### ,\n\n<!-- PAGE_10 -->\n###### ,\n\n<!-- PAGE_10 -->\n###### ,\n\n<!-- PAGE_10 -->\n###### 기준\n\n<!-- PAGE_10 -->\n###### 보관 및 운송 등에 관한 정보를 제공하여야 한다\n\n<!-- PAGE_10 -->\n###### 이 때 분획용 혈장 마스터\n\n<!-- PAGE_10 -->\n###### ,\n\n<!-- PAGE_10 -->\n###### .\n\n <!-- PAGE_10 -->\n###### 파일\n\n<!-- PAGE_10 -->\n###### 의 형태로 정보를 제공할 수 있다\n\n<!-- PAGE_10 -->\n###### 주성분과 첨가제\n\n<!-- PAGE_10 -->\n###### (plasma master file, PMF)\n\n<!-- PAGE_10 -->\n###### .\n\n",
        "original_sentence": "<!-- PAGE_10 -->\n###### 가 필요하다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_079",
      "text": "<!-- PAGE_10 -->\n###### 원료물질의 수집 및 관리에 관한 상세 정보를 기록하여 제공하여야 한다\n\n<!-- PAGE_10 -->\n###### 즉\n\n<!-- PAGE_10 -->\n###### 원\n\n<!-- PAGE_10 -->\n###### .\n\n",
      "metadata": {
        "source": "(가이드라인-005)_정맥주사용+B형간염+사람면역글로불린제제의+안전성유효성+평가+가이드라인.pdf",
        "chunk_index": 78,
        "window_size": 3,
        "char_count": 145,
        "word_count": 29,
        "page_number": 10,
        "window_text": "<!-- PAGE_10 -->\n###### 원료물질의 수집 및 관리\n\n<!-- PAGE_10 -->\n###### 2.\n\n <!-- PAGE_10 -->\n###### 원료물질의 수집 및 관리는 혈장분획제제의 제조 및 품질보증에서 매우 중요한\n\n<!-- PAGE_10 -->\n###### 요소이다\n\n<!-- PAGE_10 -->\n###### 바이러스 위해성을 줄이기 위한 방법으로 원료물질에 대한 세심한 관리\n\n<!-- PAGE_10 -->\n###### .\n\n <!-- PAGE_10 -->\n###### 가 필요하다.\n\n <!-- PAGE_10 -->\n###### 원료물질의 수집 및 관리에 관한 상세 정보를 기록하여 제공하여야 한다\n\n<!-- PAGE_10 -->\n###### 즉\n\n<!-- PAGE_10 -->\n###### 원\n\n<!-- PAGE_10 -->\n###### .\n\n <!-- PAGE_10 -->\n###### ,\n\n<!-- PAGE_10 -->\n###### 료혈장의 종류\n\n<!-- PAGE_10 -->\n###### 개별혈장 및 수집혈장의 풀링 사이즈\n\n<!-- PAGE_10 -->\n###### 풀링 방법\n\n<!-- PAGE_10 -->\n###### 품질관리 항목 및\n\n<!-- PAGE_10 -->\n###### ,\n\n<!-- PAGE_10 -->\n###### ,\n\n<!-- PAGE_10 -->\n###### ,\n\n<!-- PAGE_10 -->\n###### 기준\n\n<!-- PAGE_10 -->\n###### 보관 및 운송 등에 관한 정보를 제공하여야 한다\n\n<!-- PAGE_10 -->\n###### 이 때 분획용 혈장 마스터\n\n<!-- PAGE_10 -->\n###### ,\n\n<!-- PAGE_10 -->\n###### .\n\n <!-- PAGE_10 -->\n###### 파일\n\n<!-- PAGE_10 -->\n###### 의 형태로 정보를 제공할 수 있다\n\n<!-- PAGE_10 -->\n###### 주성분과 첨가제\n\n<!-- PAGE_10 -->\n###### (plasma master file, PMF)\n\n<!-- PAGE_10 -->\n###### .\n\n <!-- PAGE_10 -->\n###### 의 분량\n\n<!-- PAGE_10 -->\n###### 규격 등에 관한 모든 관련 정보가 필요하다\n\n<!-- PAGE_10 -->\n###### 원료물질을 혈장으로 공급받\n\n<!-- PAGE_10 -->\n###### ,\n\n<!-- PAGE_10 -->\n###### .\n\n",
        "original_sentence": "<!-- PAGE_10 -->\n###### 원료물질의 수집 및 관리에 관한 상세 정보를 기록하여 제공하여야 한다\n\n<!-- PAGE_10 -->\n###### 즉\n\n<!-- PAGE_10 -->\n###### 원\n\n<!-- PAGE_10 -->\n###### .\n\n"
      }
    },
    {
      "chunk_id": "chunk_080",
      "text": "<!-- PAGE_10 -->\n###### ,\n\n<!-- PAGE_10 -->\n###### 료혈장의 종류\n\n<!-- PAGE_10 -->\n###### 개별혈장 및 수집혈장의 풀링 사이즈\n\n<!-- PAGE_10 -->\n###### 풀링 방법\n\n<!-- PAGE_10 -->\n###### 품질관리 항목 및\n\n<!-- PAGE_10 -->\n###### ,\n\n<!-- PAGE_10 -->\n###### ,\n\n<!-- PAGE_10 -->\n###### ,\n\n<!-- PAGE_10 -->\n###### 기준\n\n<!-- PAGE_10 -->\n###### 보관 및 운송 등에 관한 정보를 제공하여야 한다\n\n<!-- PAGE_10 -->\n###### 이 때 분획용 혈장 마스터\n\n<!-- PAGE_10 -->\n###### ,\n\n<!-- PAGE_10 -->\n###### .\n\n",
      "metadata": {
        "source": "(가이드라인-005)_정맥주사용+B형간염+사람면역글로불린제제의+안전성유효성+평가+가이드라인.pdf",
        "chunk_index": 79,
        "window_size": 3,
        "char_count": 426,
        "word_count": 84,
        "page_number": 10,
        "window_text": "<!-- PAGE_10 -->\n###### 원료물질의 수집 및 관리는 혈장분획제제의 제조 및 품질보증에서 매우 중요한\n\n<!-- PAGE_10 -->\n###### 요소이다\n\n<!-- PAGE_10 -->\n###### 바이러스 위해성을 줄이기 위한 방법으로 원료물질에 대한 세심한 관리\n\n<!-- PAGE_10 -->\n###### .\n\n <!-- PAGE_10 -->\n###### 가 필요하다.\n\n <!-- PAGE_10 -->\n###### 원료물질의 수집 및 관리에 관한 상세 정보를 기록하여 제공하여야 한다\n\n<!-- PAGE_10 -->\n###### 즉\n\n<!-- PAGE_10 -->\n###### 원\n\n<!-- PAGE_10 -->\n###### .\n\n <!-- PAGE_10 -->\n###### ,\n\n<!-- PAGE_10 -->\n###### 료혈장의 종류\n\n<!-- PAGE_10 -->\n###### 개별혈장 및 수집혈장의 풀링 사이즈\n\n<!-- PAGE_10 -->\n###### 풀링 방법\n\n<!-- PAGE_10 -->\n###### 품질관리 항목 및\n\n<!-- PAGE_10 -->\n###### ,\n\n<!-- PAGE_10 -->\n###### ,\n\n<!-- PAGE_10 -->\n###### ,\n\n<!-- PAGE_10 -->\n###### 기준\n\n<!-- PAGE_10 -->\n###### 보관 및 운송 등에 관한 정보를 제공하여야 한다\n\n<!-- PAGE_10 -->\n###### 이 때 분획용 혈장 마스터\n\n<!-- PAGE_10 -->\n###### ,\n\n<!-- PAGE_10 -->\n###### .\n\n <!-- PAGE_10 -->\n###### 파일\n\n<!-- PAGE_10 -->\n###### 의 형태로 정보를 제공할 수 있다\n\n<!-- PAGE_10 -->\n###### 주성분과 첨가제\n\n<!-- PAGE_10 -->\n###### (plasma master file, PMF)\n\n<!-- PAGE_10 -->\n###### .\n\n <!-- PAGE_10 -->\n###### 의 분량\n\n<!-- PAGE_10 -->\n###### 규격 등에 관한 모든 관련 정보가 필요하다\n\n<!-- PAGE_10 -->\n###### 원료물질을 혈장으로 공급받\n\n<!-- PAGE_10 -->\n###### ,\n\n<!-- PAGE_10 -->\n###### .\n\n - - 3 -\n<!-- PAGE_11 -->\n###### 는지 또는 부분적으로 분획한 중간산물의 형태로 공급받는지에 대한 정보를 제공하\n\n<!-- PAGE_11 -->\n###### 여야 한다.\n\n",
        "original_sentence": "<!-- PAGE_10 -->\n###### ,\n\n<!-- PAGE_10 -->\n###### 료혈장의 종류\n\n<!-- PAGE_10 -->\n###### 개별혈장 및 수집혈장의 풀링 사이즈\n\n<!-- PAGE_10 -->\n###### 풀링 방법\n\n<!-- PAGE_10 -->\n###### 품질관리 항목 및\n\n<!-- PAGE_10 -->\n###### ,\n\n<!-- PAGE_10 -->\n###### ,\n\n<!-- PAGE_10 -->\n###### ,\n\n<!-- PAGE_10 -->\n###### 기준\n\n<!-- PAGE_10 -->\n###### 보관 및 운송 등에 관한 정보를 제공하여야 한다\n\n<!-- PAGE_10 -->\n###### 이 때 분획용 혈장 마스터\n\n<!-- PAGE_10 -->\n###### ,\n\n<!-- PAGE_10 -->\n###### .\n\n"
      }
    },
    {
      "chunk_id": "chunk_081",
      "text": "<!-- PAGE_10 -->\n###### 파일\n\n<!-- PAGE_10 -->\n###### 의 형태로 정보를 제공할 수 있다\n\n<!-- PAGE_10 -->\n###### 주성분과 첨가제\n\n<!-- PAGE_10 -->\n###### (plasma master file, PMF)\n\n<!-- PAGE_10 -->\n###### .\n\n",
      "metadata": {
        "source": "(가이드라인-005)_정맥주사용+B형간염+사람면역글로불린제제의+안전성유효성+평가+가이드라인.pdf",
        "chunk_index": 80,
        "window_size": 3,
        "char_count": 184,
        "word_count": 34,
        "page_number": 10,
        "window_text": "<!-- PAGE_10 -->\n###### 가 필요하다.\n\n <!-- PAGE_10 -->\n###### 원료물질의 수집 및 관리에 관한 상세 정보를 기록하여 제공하여야 한다\n\n<!-- PAGE_10 -->\n###### 즉\n\n<!-- PAGE_10 -->\n###### 원\n\n<!-- PAGE_10 -->\n###### .\n\n <!-- PAGE_10 -->\n###### ,\n\n<!-- PAGE_10 -->\n###### 료혈장의 종류\n\n<!-- PAGE_10 -->\n###### 개별혈장 및 수집혈장의 풀링 사이즈\n\n<!-- PAGE_10 -->\n###### 풀링 방법\n\n<!-- PAGE_10 -->\n###### 품질관리 항목 및\n\n<!-- PAGE_10 -->\n###### ,\n\n<!-- PAGE_10 -->\n###### ,\n\n<!-- PAGE_10 -->\n###### ,\n\n<!-- PAGE_10 -->\n###### 기준\n\n<!-- PAGE_10 -->\n###### 보관 및 운송 등에 관한 정보를 제공하여야 한다\n\n<!-- PAGE_10 -->\n###### 이 때 분획용 혈장 마스터\n\n<!-- PAGE_10 -->\n###### ,\n\n<!-- PAGE_10 -->\n###### .\n\n <!-- PAGE_10 -->\n###### 파일\n\n<!-- PAGE_10 -->\n###### 의 형태로 정보를 제공할 수 있다\n\n<!-- PAGE_10 -->\n###### 주성분과 첨가제\n\n<!-- PAGE_10 -->\n###### (plasma master file, PMF)\n\n<!-- PAGE_10 -->\n###### .\n\n <!-- PAGE_10 -->\n###### 의 분량\n\n<!-- PAGE_10 -->\n###### 규격 등에 관한 모든 관련 정보가 필요하다\n\n<!-- PAGE_10 -->\n###### 원료물질을 혈장으로 공급받\n\n<!-- PAGE_10 -->\n###### ,\n\n<!-- PAGE_10 -->\n###### .\n\n - - 3 -\n<!-- PAGE_11 -->\n###### 는지 또는 부분적으로 분획한 중간산물의 형태로 공급받는지에 대한 정보를 제공하\n\n<!-- PAGE_11 -->\n###### 여야 한다.\n\n <!-- PAGE_11 -->\n###### 는\n\n<!-- PAGE_11 -->\n###### 형 간염 항체 양성인 건강한 사람의 혈장을 원료로 사용하므로 면역방\n\n<!-- PAGE_11 -->\n###### HBIG\n\n<!-- PAGE_11 -->\n###### B\n\n<!-- PAGE_11 -->\n###### 법 등 원료혈장의 생산 경로를 기술하여야 한다.\n\n",
        "original_sentence": "<!-- PAGE_10 -->\n###### 파일\n\n<!-- PAGE_10 -->\n###### 의 형태로 정보를 제공할 수 있다\n\n<!-- PAGE_10 -->\n###### 주성분과 첨가제\n\n<!-- PAGE_10 -->\n###### (plasma master file, PMF)\n\n<!-- PAGE_10 -->\n###### .\n\n"
      }
    },
    {
      "chunk_id": "chunk_082",
      "text": "<!-- PAGE_10 -->\n###### 의 분량\n\n<!-- PAGE_10 -->\n###### 규격 등에 관한 모든 관련 정보가 필요하다\n\n<!-- PAGE_10 -->\n###### 원료물질을 혈장으로 공급받\n\n<!-- PAGE_10 -->\n###### ,\n\n<!-- PAGE_10 -->\n###### .\n\n",
      "metadata": {
        "source": "(가이드라인-005)_정맥주사용+B형간염+사람면역글로불린제제의+안전성유효성+평가+가이드라인.pdf",
        "chunk_index": 81,
        "window_size": 3,
        "char_count": 173,
        "word_count": 34,
        "page_number": 10,
        "window_text": "<!-- PAGE_10 -->\n###### 원료물질의 수집 및 관리에 관한 상세 정보를 기록하여 제공하여야 한다\n\n<!-- PAGE_10 -->\n###### 즉\n\n<!-- PAGE_10 -->\n###### 원\n\n<!-- PAGE_10 -->\n###### .\n\n <!-- PAGE_10 -->\n###### ,\n\n<!-- PAGE_10 -->\n###### 료혈장의 종류\n\n<!-- PAGE_10 -->\n###### 개별혈장 및 수집혈장의 풀링 사이즈\n\n<!-- PAGE_10 -->\n###### 풀링 방법\n\n<!-- PAGE_10 -->\n###### 품질관리 항목 및\n\n<!-- PAGE_10 -->\n###### ,\n\n<!-- PAGE_10 -->\n###### ,\n\n<!-- PAGE_10 -->\n###### ,\n\n<!-- PAGE_10 -->\n###### 기준\n\n<!-- PAGE_10 -->\n###### 보관 및 운송 등에 관한 정보를 제공하여야 한다\n\n<!-- PAGE_10 -->\n###### 이 때 분획용 혈장 마스터\n\n<!-- PAGE_10 -->\n###### ,\n\n<!-- PAGE_10 -->\n###### .\n\n <!-- PAGE_10 -->\n###### 파일\n\n<!-- PAGE_10 -->\n###### 의 형태로 정보를 제공할 수 있다\n\n<!-- PAGE_10 -->\n###### 주성분과 첨가제\n\n<!-- PAGE_10 -->\n###### (plasma master file, PMF)\n\n<!-- PAGE_10 -->\n###### .\n\n <!-- PAGE_10 -->\n###### 의 분량\n\n<!-- PAGE_10 -->\n###### 규격 등에 관한 모든 관련 정보가 필요하다\n\n<!-- PAGE_10 -->\n###### 원료물질을 혈장으로 공급받\n\n<!-- PAGE_10 -->\n###### ,\n\n<!-- PAGE_10 -->\n###### .\n\n - - 3 -\n<!-- PAGE_11 -->\n###### 는지 또는 부분적으로 분획한 중간산물의 형태로 공급받는지에 대한 정보를 제공하\n\n<!-- PAGE_11 -->\n###### 여야 한다.\n\n <!-- PAGE_11 -->\n###### 는\n\n<!-- PAGE_11 -->\n###### 형 간염 항체 양성인 건강한 사람의 혈장을 원료로 사용하므로 면역방\n\n<!-- PAGE_11 -->\n###### HBIG\n\n<!-- PAGE_11 -->\n###### B\n\n<!-- PAGE_11 -->\n###### 법 등 원료혈장의 생산 경로를 기술하여야 한다.\n\n <!-- PAGE_11 -->\n###### 에 관해서는\n\n<!-- PAGE_11 -->\n###### 분획용 혈장 마스터 파일 가이드라인 생물의약품평가가이드\n\n<!-- PAGE_11 -->\n###### PMF\n\n<!-- PAGE_11 -->\n###### “\n\n<!-- PAGE_11 -->\n###### (\n\n<!-- PAGE_11 -->\n###### 제조공정\n\n<!-- PAGE_11 -->\n###### 3.\n\n",
        "original_sentence": "<!-- PAGE_10 -->\n###### 의 분량\n\n<!-- PAGE_10 -->\n###### 규격 등에 관한 모든 관련 정보가 필요하다\n\n<!-- PAGE_10 -->\n###### 원료물질을 혈장으로 공급받\n\n<!-- PAGE_10 -->\n###### ,\n\n<!-- PAGE_10 -->\n###### .\n\n"
      }
    },
    {
      "chunk_id": "chunk_083",
      "text": "- - 3 -\n<!-- PAGE_11 -->\n###### 는지 또는 부분적으로 분획한 중간산물의 형태로 공급받는지에 대한 정보를 제공하\n\n<!-- PAGE_11 -->\n###### 여야 한다.\n\n",
      "metadata": {
        "source": "(가이드라인-005)_정맥주사용+B형간염+사람면역글로불린제제의+안전성유효성+평가+가이드라인.pdf",
        "chunk_index": 82,
        "window_size": 3,
        "char_count": 109,
        "word_count": 24,
        "page_number": 11,
        "window_text": "<!-- PAGE_10 -->\n###### ,\n\n<!-- PAGE_10 -->\n###### 료혈장의 종류\n\n<!-- PAGE_10 -->\n###### 개별혈장 및 수집혈장의 풀링 사이즈\n\n<!-- PAGE_10 -->\n###### 풀링 방법\n\n<!-- PAGE_10 -->\n###### 품질관리 항목 및\n\n<!-- PAGE_10 -->\n###### ,\n\n<!-- PAGE_10 -->\n###### ,\n\n<!-- PAGE_10 -->\n###### ,\n\n<!-- PAGE_10 -->\n###### 기준\n\n<!-- PAGE_10 -->\n###### 보관 및 운송 등에 관한 정보를 제공하여야 한다\n\n<!-- PAGE_10 -->\n###### 이 때 분획용 혈장 마스터\n\n<!-- PAGE_10 -->\n###### ,\n\n<!-- PAGE_10 -->\n###### .\n\n <!-- PAGE_10 -->\n###### 파일\n\n<!-- PAGE_10 -->\n###### 의 형태로 정보를 제공할 수 있다\n\n<!-- PAGE_10 -->\n###### 주성분과 첨가제\n\n<!-- PAGE_10 -->\n###### (plasma master file, PMF)\n\n<!-- PAGE_10 -->\n###### .\n\n <!-- PAGE_10 -->\n###### 의 분량\n\n<!-- PAGE_10 -->\n###### 규격 등에 관한 모든 관련 정보가 필요하다\n\n<!-- PAGE_10 -->\n###### 원료물질을 혈장으로 공급받\n\n<!-- PAGE_10 -->\n###### ,\n\n<!-- PAGE_10 -->\n###### .\n\n - - 3 -\n<!-- PAGE_11 -->\n###### 는지 또는 부분적으로 분획한 중간산물의 형태로 공급받는지에 대한 정보를 제공하\n\n<!-- PAGE_11 -->\n###### 여야 한다.\n\n <!-- PAGE_11 -->\n###### 는\n\n<!-- PAGE_11 -->\n###### 형 간염 항체 양성인 건강한 사람의 혈장을 원료로 사용하므로 면역방\n\n<!-- PAGE_11 -->\n###### HBIG\n\n<!-- PAGE_11 -->\n###### B\n\n<!-- PAGE_11 -->\n###### 법 등 원료혈장의 생산 경로를 기술하여야 한다.\n\n <!-- PAGE_11 -->\n###### 에 관해서는\n\n<!-- PAGE_11 -->\n###### 분획용 혈장 마스터 파일 가이드라인 생물의약품평가가이드\n\n<!-- PAGE_11 -->\n###### PMF\n\n<!-- PAGE_11 -->\n###### “\n\n<!-- PAGE_11 -->\n###### (\n\n<!-- PAGE_11 -->\n###### 제조공정\n\n<!-- PAGE_11 -->\n###### 3.\n\n <!-- PAGE_11 -->\n###### 면역글로불린제제의 제조방법은 제품의 품질과 안전성을 확보하는데 중요한 부분\n\n<!-- PAGE_11 -->\n###### 이다\n\n<!-- PAGE_11 -->\n###### . ",
        "original_sentence": "- - 3 -\n<!-- PAGE_11 -->\n###### 는지 또는 부분적으로 분획한 중간산물의 형태로 공급받는지에 대한 정보를 제공하\n\n<!-- PAGE_11 -->\n###### 여야 한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_084",
      "text": "<!-- PAGE_11 -->\n###### 는\n\n<!-- PAGE_11 -->\n###### 형 간염 항체 양성인 건강한 사람의 혈장을 원료로 사용하므로 면역방\n\n<!-- PAGE_11 -->\n###### HBIG\n\n<!-- PAGE_11 -->\n###### B\n\n<!-- PAGE_11 -->\n###### 법 등 원료혈장의 생산 경로를 기술하여야 한다.\n\n",
      "metadata": {
        "source": "(가이드라인-005)_정맥주사용+B형간염+사람면역글로불린제제의+안전성유효성+평가+가이드라인.pdf",
        "chunk_index": 83,
        "window_size": 3,
        "char_count": 199,
        "word_count": 40,
        "page_number": 11,
        "window_text": "<!-- PAGE_10 -->\n###### 파일\n\n<!-- PAGE_10 -->\n###### 의 형태로 정보를 제공할 수 있다\n\n<!-- PAGE_10 -->\n###### 주성분과 첨가제\n\n<!-- PAGE_10 -->\n###### (plasma master file, PMF)\n\n<!-- PAGE_10 -->\n###### .\n\n <!-- PAGE_10 -->\n###### 의 분량\n\n<!-- PAGE_10 -->\n###### 규격 등에 관한 모든 관련 정보가 필요하다\n\n<!-- PAGE_10 -->\n###### 원료물질을 혈장으로 공급받\n\n<!-- PAGE_10 -->\n###### ,\n\n<!-- PAGE_10 -->\n###### .\n\n - - 3 -\n<!-- PAGE_11 -->\n###### 는지 또는 부분적으로 분획한 중간산물의 형태로 공급받는지에 대한 정보를 제공하\n\n<!-- PAGE_11 -->\n###### 여야 한다.\n\n <!-- PAGE_11 -->\n###### 는\n\n<!-- PAGE_11 -->\n###### 형 간염 항체 양성인 건강한 사람의 혈장을 원료로 사용하므로 면역방\n\n<!-- PAGE_11 -->\n###### HBIG\n\n<!-- PAGE_11 -->\n###### B\n\n<!-- PAGE_11 -->\n###### 법 등 원료혈장의 생산 경로를 기술하여야 한다.\n\n <!-- PAGE_11 -->\n###### 에 관해서는\n\n<!-- PAGE_11 -->\n###### 분획용 혈장 마스터 파일 가이드라인 생물의약품평가가이드\n\n<!-- PAGE_11 -->\n###### PMF\n\n<!-- PAGE_11 -->\n###### “\n\n<!-- PAGE_11 -->\n###### (\n\n<!-- PAGE_11 -->\n###### 제조공정\n\n<!-- PAGE_11 -->\n###### 3.\n\n <!-- PAGE_11 -->\n###### 면역글로불린제제의 제조방법은 제품의 품질과 안전성을 확보하는데 중요한 부분\n\n<!-- PAGE_11 -->\n###### 이다\n\n<!-- PAGE_11 -->\n###### .  제조공정은 제조사에 따라 다양하지만 보통 몇 단계의 분획 정제공정과 바이\n\n<!-- PAGE_11 -->\n###### /\n\n<!-- PAGE_11 -->\n###### 러스 불활화 제거를 위한 특별 공정이 필요하다\n\n<!-- PAGE_11 -->\n###### 제조공정은 상세히 기술하고 제조\n\n<!-- PAGE_11 -->\n###### /\n\n<!-- PAGE_11 -->\n###### .\n\n",
        "original_sentence": "<!-- PAGE_11 -->\n###### 는\n\n<!-- PAGE_11 -->\n###### 형 간염 항체 양성인 건강한 사람의 혈장을 원료로 사용하므로 면역방\n\n<!-- PAGE_11 -->\n###### HBIG\n\n<!-- PAGE_11 -->\n###### B\n\n<!-- PAGE_11 -->\n###### 법 등 원료혈장의 생산 경로를 기술하여야 한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_085",
      "text": "<!-- PAGE_11 -->\n###### 에 관해서는\n\n<!-- PAGE_11 -->\n###### 분획용 혈장 마스터 파일 가이드라인 생물의약품평가가이드\n\n<!-- PAGE_11 -->\n###### PMF\n\n<!-- PAGE_11 -->\n###### “\n\n<!-- PAGE_11 -->\n###### (\n\n<!-- PAGE_11 -->\n###### 제조공정\n\n<!-- PAGE_11 -->\n###### 3.\n\n",
      "metadata": {
        "source": "(가이드라인-005)_정맥주사용+B형간염+사람면역글로불린제제의+안전성유효성+평가+가이드라인.pdf",
        "chunk_index": 84,
        "window_size": 3,
        "char_count": 229,
        "word_count": 41,
        "page_number": 11,
        "window_text": "<!-- PAGE_10 -->\n###### 의 분량\n\n<!-- PAGE_10 -->\n###### 규격 등에 관한 모든 관련 정보가 필요하다\n\n<!-- PAGE_10 -->\n###### 원료물질을 혈장으로 공급받\n\n<!-- PAGE_10 -->\n###### ,\n\n<!-- PAGE_10 -->\n###### .\n\n - - 3 -\n<!-- PAGE_11 -->\n###### 는지 또는 부분적으로 분획한 중간산물의 형태로 공급받는지에 대한 정보를 제공하\n\n<!-- PAGE_11 -->\n###### 여야 한다.\n\n <!-- PAGE_11 -->\n###### 는\n\n<!-- PAGE_11 -->\n###### 형 간염 항체 양성인 건강한 사람의 혈장을 원료로 사용하므로 면역방\n\n<!-- PAGE_11 -->\n###### HBIG\n\n<!-- PAGE_11 -->\n###### B\n\n<!-- PAGE_11 -->\n###### 법 등 원료혈장의 생산 경로를 기술하여야 한다.\n\n <!-- PAGE_11 -->\n###### 에 관해서는\n\n<!-- PAGE_11 -->\n###### 분획용 혈장 마스터 파일 가이드라인 생물의약품평가가이드\n\n<!-- PAGE_11 -->\n###### PMF\n\n<!-- PAGE_11 -->\n###### “\n\n<!-- PAGE_11 -->\n###### (\n\n<!-- PAGE_11 -->\n###### 제조공정\n\n<!-- PAGE_11 -->\n###### 3.\n\n <!-- PAGE_11 -->\n###### 면역글로불린제제의 제조방법은 제품의 품질과 안전성을 확보하는데 중요한 부분\n\n<!-- PAGE_11 -->\n###### 이다\n\n<!-- PAGE_11 -->\n###### .  제조공정은 제조사에 따라 다양하지만 보통 몇 단계의 분획 정제공정과 바이\n\n<!-- PAGE_11 -->\n###### /\n\n<!-- PAGE_11 -->\n###### 러스 불활화 제거를 위한 특별 공정이 필요하다\n\n<!-- PAGE_11 -->\n###### 제조공정은 상세히 기술하고 제조\n\n<!-- PAGE_11 -->\n###### /\n\n<!-- PAGE_11 -->\n###### .\n\n <!-- PAGE_11 -->\n###### 면역글로불린제제 제조는\n\n<!-- PAGE_11 -->\n###### 의 에탄올 분획법이 가장 널리 사용되고 있다\n\n<!-- PAGE_11 -->\n###### 에\n\n<!-- PAGE_11 -->\n###### Cohn\n\n<!-- PAGE_11 -->\n###### .\n\n",
        "original_sentence": "<!-- PAGE_11 -->\n###### 에 관해서는\n\n<!-- PAGE_11 -->\n###### 분획용 혈장 마스터 파일 가이드라인 생물의약품평가가이드\n\n<!-- PAGE_11 -->\n###### PMF\n\n<!-- PAGE_11 -->\n###### “\n\n<!-- PAGE_11 -->\n###### (\n\n<!-- PAGE_11 -->\n###### 제조공정\n\n<!-- PAGE_11 -->\n###### 3.\n\n"
      }
    },
    {
      "chunk_id": "chunk_086",
      "text": "<!-- PAGE_11 -->\n###### 면역글로불린제제의 제조방법은 제품의 품질과 안전성을 확보하는데 중요한 부분\n\n<!-- PAGE_11 -->\n###### 이다\n\n<!-- PAGE_11 -->\n###### . ",
      "metadata": {
        "source": "(가이드라인-005)_정맥주사용+B형간염+사람면역글로불린제제의+안전성유효성+평가+가이드라인.pdf",
        "chunk_index": 85,
        "window_size": 3,
        "char_count": 121,
        "word_count": 22,
        "page_number": 11,
        "window_text": "- - 3 -\n<!-- PAGE_11 -->\n###### 는지 또는 부분적으로 분획한 중간산물의 형태로 공급받는지에 대한 정보를 제공하\n\n<!-- PAGE_11 -->\n###### 여야 한다.\n\n <!-- PAGE_11 -->\n###### 는\n\n<!-- PAGE_11 -->\n###### 형 간염 항체 양성인 건강한 사람의 혈장을 원료로 사용하므로 면역방\n\n<!-- PAGE_11 -->\n###### HBIG\n\n<!-- PAGE_11 -->\n###### B\n\n<!-- PAGE_11 -->\n###### 법 등 원료혈장의 생산 경로를 기술하여야 한다.\n\n <!-- PAGE_11 -->\n###### 에 관해서는\n\n<!-- PAGE_11 -->\n###### 분획용 혈장 마스터 파일 가이드라인 생물의약품평가가이드\n\n<!-- PAGE_11 -->\n###### PMF\n\n<!-- PAGE_11 -->\n###### “\n\n<!-- PAGE_11 -->\n###### (\n\n<!-- PAGE_11 -->\n###### 제조공정\n\n<!-- PAGE_11 -->\n###### 3.\n\n <!-- PAGE_11 -->\n###### 면역글로불린제제의 제조방법은 제품의 품질과 안전성을 확보하는데 중요한 부분\n\n<!-- PAGE_11 -->\n###### 이다\n\n<!-- PAGE_11 -->\n###### .  제조공정은 제조사에 따라 다양하지만 보통 몇 단계의 분획 정제공정과 바이\n\n<!-- PAGE_11 -->\n###### /\n\n<!-- PAGE_11 -->\n###### 러스 불활화 제거를 위한 특별 공정이 필요하다\n\n<!-- PAGE_11 -->\n###### 제조공정은 상세히 기술하고 제조\n\n<!-- PAGE_11 -->\n###### /\n\n<!-- PAGE_11 -->\n###### .\n\n <!-- PAGE_11 -->\n###### 면역글로불린제제 제조는\n\n<!-- PAGE_11 -->\n###### 의 에탄올 분획법이 가장 널리 사용되고 있다\n\n<!-- PAGE_11 -->\n###### 에\n\n<!-- PAGE_11 -->\n###### Cohn\n\n<!-- PAGE_11 -->\n###### .\n\n <!-- PAGE_11 -->\n###### 탄올 분획법은 특정 요구조건에 맞는 몇 개의 개별 단계로 되어 있으며\n\n<!-- PAGE_11 -->\n###### 각 개별\n\n<!-- PAGE_11 -->\n###### ,\n\n<!-- PAGE_11 -->\n###### 단계는 제품의 품질에 매우 중요하고 그 중 일부 개별 단계는 잠재적인 바이러스\n\n<!-- PAGE_11 -->\n###### 오염을 효과적으로 감소시킬 수 있다\n\n<!-- PAGE_11 -->\n###### 따라서 에탄올 농도\n\n<!-- PAGE_11 -->\n###### 단백질 농도\n\n<!-- PAGE_11 -->\n###### 온도\n\n<!-- PAGE_11 -->\n###### .\n\n",
        "original_sentence": "<!-- PAGE_11 -->\n###### 면역글로불린제제의 제조방법은 제품의 품질과 안전성을 확보하는데 중요한 부분\n\n<!-- PAGE_11 -->\n###### 이다\n\n<!-- PAGE_11 -->\n###### . "
      }
    },
    {
      "chunk_id": "chunk_087",
      "text": "제조공정은 제조사에 따라 다양하지만 보통 몇 단계의 분획 정제공정과 바이\n\n<!-- PAGE_11 -->\n###### /\n\n<!-- PAGE_11 -->\n###### 러스 불활화 제거를 위한 특별 공정이 필요하다\n\n<!-- PAGE_11 -->\n###### 제조공정은 상세히 기술하고 제조\n\n<!-- PAGE_11 -->\n###### /\n\n<!-- PAGE_11 -->\n###### .\n\n",
      "metadata": {
        "source": "(가이드라인-005)_정맥주사용+B형간염+사람면역글로불린제제의+안전성유효성+평가+가이드라인.pdf",
        "chunk_index": 86,
        "window_size": 3,
        "char_count": 217,
        "word_count": 44,
        "page_number": 11,
        "window_text": "<!-- PAGE_11 -->\n###### 는\n\n<!-- PAGE_11 -->\n###### 형 간염 항체 양성인 건강한 사람의 혈장을 원료로 사용하므로 면역방\n\n<!-- PAGE_11 -->\n###### HBIG\n\n<!-- PAGE_11 -->\n###### B\n\n<!-- PAGE_11 -->\n###### 법 등 원료혈장의 생산 경로를 기술하여야 한다.\n\n <!-- PAGE_11 -->\n###### 에 관해서는\n\n<!-- PAGE_11 -->\n###### 분획용 혈장 마스터 파일 가이드라인 생물의약품평가가이드\n\n<!-- PAGE_11 -->\n###### PMF\n\n<!-- PAGE_11 -->\n###### “\n\n<!-- PAGE_11 -->\n###### (\n\n<!-- PAGE_11 -->\n###### 제조공정\n\n<!-- PAGE_11 -->\n###### 3.\n\n <!-- PAGE_11 -->\n###### 면역글로불린제제의 제조방법은 제품의 품질과 안전성을 확보하는데 중요한 부분\n\n<!-- PAGE_11 -->\n###### 이다\n\n<!-- PAGE_11 -->\n###### .  제조공정은 제조사에 따라 다양하지만 보통 몇 단계의 분획 정제공정과 바이\n\n<!-- PAGE_11 -->\n###### /\n\n<!-- PAGE_11 -->\n###### 러스 불활화 제거를 위한 특별 공정이 필요하다\n\n<!-- PAGE_11 -->\n###### 제조공정은 상세히 기술하고 제조\n\n<!-- PAGE_11 -->\n###### /\n\n<!-- PAGE_11 -->\n###### .\n\n <!-- PAGE_11 -->\n###### 면역글로불린제제 제조는\n\n<!-- PAGE_11 -->\n###### 의 에탄올 분획법이 가장 널리 사용되고 있다\n\n<!-- PAGE_11 -->\n###### 에\n\n<!-- PAGE_11 -->\n###### Cohn\n\n<!-- PAGE_11 -->\n###### .\n\n <!-- PAGE_11 -->\n###### 탄올 분획법은 특정 요구조건에 맞는 몇 개의 개별 단계로 되어 있으며\n\n<!-- PAGE_11 -->\n###### 각 개별\n\n<!-- PAGE_11 -->\n###### ,\n\n<!-- PAGE_11 -->\n###### 단계는 제품의 품질에 매우 중요하고 그 중 일부 개별 단계는 잠재적인 바이러스\n\n<!-- PAGE_11 -->\n###### 오염을 효과적으로 감소시킬 수 있다\n\n<!-- PAGE_11 -->\n###### 따라서 에탄올 농도\n\n<!-- PAGE_11 -->\n###### 단백질 농도\n\n<!-- PAGE_11 -->\n###### 온도\n\n<!-- PAGE_11 -->\n###### .\n\n <!-- PAGE_11 -->\n###### ,\n\n<!-- PAGE_11 -->\n###### ,\n\n<!-- PAGE_11 -->\n###### , pH,\n\n<!-- PAGE_11 -->\n###### 이온 강도 및 처리 시간 등에 대한 명확한 기준\n\n<!-- PAGE_11 -->\n###### 허용 오차범위 및 관리 방법을 제\n\n<!-- PAGE_11 -->\n###### ,\n\n<!-- PAGE_11 -->\n###### 시하여야 한다.\n\n",
        "original_sentence": "제조공정은 제조사에 따라 다양하지만 보통 몇 단계의 분획 정제공정과 바이\n\n<!-- PAGE_11 -->\n###### /\n\n<!-- PAGE_11 -->\n###### 러스 불활화 제거를 위한 특별 공정이 필요하다\n\n<!-- PAGE_11 -->\n###### 제조공정은 상세히 기술하고 제조\n\n<!-- PAGE_11 -->\n###### /\n\n<!-- PAGE_11 -->\n###### .\n\n"
      }
    },
    {
      "chunk_id": "chunk_088",
      "text": "<!-- PAGE_11 -->\n###### 면역글로불린제제 제조는\n\n<!-- PAGE_11 -->\n###### 의 에탄올 분획법이 가장 널리 사용되고 있다\n\n<!-- PAGE_11 -->\n###### 에\n\n<!-- PAGE_11 -->\n###### Cohn\n\n<!-- PAGE_11 -->\n###### .\n\n",
      "metadata": {
        "source": "(가이드라인-005)_정맥주사용+B형간염+사람면역글로불린제제의+안전성유효성+평가+가이드라인.pdf",
        "chunk_index": 87,
        "window_size": 3,
        "char_count": 172,
        "word_count": 32,
        "page_number": 11,
        "window_text": "<!-- PAGE_11 -->\n###### 에 관해서는\n\n<!-- PAGE_11 -->\n###### 분획용 혈장 마스터 파일 가이드라인 생물의약품평가가이드\n\n<!-- PAGE_11 -->\n###### PMF\n\n<!-- PAGE_11 -->\n###### “\n\n<!-- PAGE_11 -->\n###### (\n\n<!-- PAGE_11 -->\n###### 제조공정\n\n<!-- PAGE_11 -->\n###### 3.\n\n <!-- PAGE_11 -->\n###### 면역글로불린제제의 제조방법은 제품의 품질과 안전성을 확보하는데 중요한 부분\n\n<!-- PAGE_11 -->\n###### 이다\n\n<!-- PAGE_11 -->\n###### .  제조공정은 제조사에 따라 다양하지만 보통 몇 단계의 분획 정제공정과 바이\n\n<!-- PAGE_11 -->\n###### /\n\n<!-- PAGE_11 -->\n###### 러스 불활화 제거를 위한 특별 공정이 필요하다\n\n<!-- PAGE_11 -->\n###### 제조공정은 상세히 기술하고 제조\n\n<!-- PAGE_11 -->\n###### /\n\n<!-- PAGE_11 -->\n###### .\n\n <!-- PAGE_11 -->\n###### 면역글로불린제제 제조는\n\n<!-- PAGE_11 -->\n###### 의 에탄올 분획법이 가장 널리 사용되고 있다\n\n<!-- PAGE_11 -->\n###### 에\n\n<!-- PAGE_11 -->\n###### Cohn\n\n<!-- PAGE_11 -->\n###### .\n\n <!-- PAGE_11 -->\n###### 탄올 분획법은 특정 요구조건에 맞는 몇 개의 개별 단계로 되어 있으며\n\n<!-- PAGE_11 -->\n###### 각 개별\n\n<!-- PAGE_11 -->\n###### ,\n\n<!-- PAGE_11 -->\n###### 단계는 제품의 품질에 매우 중요하고 그 중 일부 개별 단계는 잠재적인 바이러스\n\n<!-- PAGE_11 -->\n###### 오염을 효과적으로 감소시킬 수 있다\n\n<!-- PAGE_11 -->\n###### 따라서 에탄올 농도\n\n<!-- PAGE_11 -->\n###### 단백질 농도\n\n<!-- PAGE_11 -->\n###### 온도\n\n<!-- PAGE_11 -->\n###### .\n\n <!-- PAGE_11 -->\n###### ,\n\n<!-- PAGE_11 -->\n###### ,\n\n<!-- PAGE_11 -->\n###### , pH,\n\n<!-- PAGE_11 -->\n###### 이온 강도 및 처리 시간 등에 대한 명확한 기준\n\n<!-- PAGE_11 -->\n###### 허용 오차범위 및 관리 방법을 제\n\n<!-- PAGE_11 -->\n###### ,\n\n<!-- PAGE_11 -->\n###### 시하여야 한다.\n\n <!-- PAGE_11 -->\n###### 크로마토그래피 등을 이용한 단백질의 분리 및 수율은 칼럼의 능력\n\n<!-- PAGE_11 -->\n###### 단백질의 특\n\n<!-- PAGE_11 -->\n###### ,\n\n<!-- PAGE_11 -->\n###### 성 및 농도\n\n<!-- PAGE_11 -->\n###### 완충액의 이온 강도 및\n\n<!-- PAGE_11 -->\n###### 유속 및 온도와 같은 여러 인자들에 따라\n\n<!-- PAGE_11 -->\n###### ,\n\n<!-- PAGE_11 -->\n###### pH,\n\n<!-- PAGE_11 -->\n###### 크게 좌우된다\n\n<!-- PAGE_11 -->\n###### 따라서 적절한 규격과 기준을 명시하여야 한다\n\n<!-- PAGE_11 -->\n###### 칼럼의 보관\n\n<!-- PAGE_11 -->\n###### 칼럼\n\n<!-- PAGE_11 -->\n###### .\n\n",
        "original_sentence": "<!-- PAGE_11 -->\n###### 면역글로불린제제 제조는\n\n<!-- PAGE_11 -->\n###### 의 에탄올 분획법이 가장 널리 사용되고 있다\n\n<!-- PAGE_11 -->\n###### 에\n\n<!-- PAGE_11 -->\n###### Cohn\n\n<!-- PAGE_11 -->\n###### .\n\n"
      }
    },
    {
      "chunk_id": "chunk_089",
      "text": "<!-- PAGE_11 -->\n###### 탄올 분획법은 특정 요구조건에 맞는 몇 개의 개별 단계로 되어 있으며\n\n<!-- PAGE_11 -->\n###### 각 개별\n\n<!-- PAGE_11 -->\n###### ,\n\n<!-- PAGE_11 -->\n###### 단계는 제품의 품질에 매우 중요하고 그 중 일부 개별 단계는 잠재적인 바이러스\n\n<!-- PAGE_11 -->\n###### 오염을 효과적으로 감소시킬 수 있다\n\n<!-- PAGE_11 -->\n###### 따라서 에탄올 농도\n\n<!-- PAGE_11 -->\n###### 단백질 농도\n\n<!-- PAGE_11 -->\n###### 온도\n\n<!-- PAGE_11 -->\n###### .\n\n",
      "metadata": {
        "source": "(가이드라인-005)_정맥주사용+B형간염+사람면역글로불린제제의+안전성유효성+평가+가이드라인.pdf",
        "chunk_index": 88,
        "window_size": 3,
        "char_count": 358,
        "word_count": 74,
        "page_number": 11,
        "window_text": "<!-- PAGE_11 -->\n###### 면역글로불린제제의 제조방법은 제품의 품질과 안전성을 확보하는데 중요한 부분\n\n<!-- PAGE_11 -->\n###### 이다\n\n<!-- PAGE_11 -->\n###### .  제조공정은 제조사에 따라 다양하지만 보통 몇 단계의 분획 정제공정과 바이\n\n<!-- PAGE_11 -->\n###### /\n\n<!-- PAGE_11 -->\n###### 러스 불활화 제거를 위한 특별 공정이 필요하다\n\n<!-- PAGE_11 -->\n###### 제조공정은 상세히 기술하고 제조\n\n<!-- PAGE_11 -->\n###### /\n\n<!-- PAGE_11 -->\n###### .\n\n <!-- PAGE_11 -->\n###### 면역글로불린제제 제조는\n\n<!-- PAGE_11 -->\n###### 의 에탄올 분획법이 가장 널리 사용되고 있다\n\n<!-- PAGE_11 -->\n###### 에\n\n<!-- PAGE_11 -->\n###### Cohn\n\n<!-- PAGE_11 -->\n###### .\n\n <!-- PAGE_11 -->\n###### 탄올 분획법은 특정 요구조건에 맞는 몇 개의 개별 단계로 되어 있으며\n\n<!-- PAGE_11 -->\n###### 각 개별\n\n<!-- PAGE_11 -->\n###### ,\n\n<!-- PAGE_11 -->\n###### 단계는 제품의 품질에 매우 중요하고 그 중 일부 개별 단계는 잠재적인 바이러스\n\n<!-- PAGE_11 -->\n###### 오염을 효과적으로 감소시킬 수 있다\n\n<!-- PAGE_11 -->\n###### 따라서 에탄올 농도\n\n<!-- PAGE_11 -->\n###### 단백질 농도\n\n<!-- PAGE_11 -->\n###### 온도\n\n<!-- PAGE_11 -->\n###### .\n\n <!-- PAGE_11 -->\n###### ,\n\n<!-- PAGE_11 -->\n###### ,\n\n<!-- PAGE_11 -->\n###### , pH,\n\n<!-- PAGE_11 -->\n###### 이온 강도 및 처리 시간 등에 대한 명확한 기준\n\n<!-- PAGE_11 -->\n###### 허용 오차범위 및 관리 방법을 제\n\n<!-- PAGE_11 -->\n###### ,\n\n<!-- PAGE_11 -->\n###### 시하여야 한다.\n\n <!-- PAGE_11 -->\n###### 크로마토그래피 등을 이용한 단백질의 분리 및 수율은 칼럼의 능력\n\n<!-- PAGE_11 -->\n###### 단백질의 특\n\n<!-- PAGE_11 -->\n###### ,\n\n<!-- PAGE_11 -->\n###### 성 및 농도\n\n<!-- PAGE_11 -->\n###### 완충액의 이온 강도 및\n\n<!-- PAGE_11 -->\n###### 유속 및 온도와 같은 여러 인자들에 따라\n\n<!-- PAGE_11 -->\n###### ,\n\n<!-- PAGE_11 -->\n###### pH,\n\n<!-- PAGE_11 -->\n###### 크게 좌우된다\n\n<!-- PAGE_11 -->\n###### 따라서 적절한 규격과 기준을 명시하여야 한다\n\n<!-- PAGE_11 -->\n###### 칼럼의 보관\n\n<!-- PAGE_11 -->\n###### 칼럼\n\n<!-- PAGE_11 -->\n###### .\n\n <!-- PAGE_11 -->\n###### .\n\n",
        "original_sentence": "<!-- PAGE_11 -->\n###### 탄올 분획법은 특정 요구조건에 맞는 몇 개의 개별 단계로 되어 있으며\n\n<!-- PAGE_11 -->\n###### 각 개별\n\n<!-- PAGE_11 -->\n###### ,\n\n<!-- PAGE_11 -->\n###### 단계는 제품의 품질에 매우 중요하고 그 중 일부 개별 단계는 잠재적인 바이러스\n\n<!-- PAGE_11 -->\n###### 오염을 효과적으로 감소시킬 수 있다\n\n<!-- PAGE_11 -->\n###### 따라서 에탄올 농도\n\n<!-- PAGE_11 -->\n###### 단백질 농도\n\n<!-- PAGE_11 -->\n###### 온도\n\n<!-- PAGE_11 -->\n###### .\n\n"
      }
    },
    {
      "chunk_id": "chunk_090",
      "text": "<!-- PAGE_11 -->\n###### ,\n\n<!-- PAGE_11 -->\n###### ,\n\n<!-- PAGE_11 -->\n###### , pH,\n\n<!-- PAGE_11 -->\n###### 이온 강도 및 처리 시간 등에 대한 명확한 기준\n\n<!-- PAGE_11 -->\n###### 허용 오차범위 및 관리 방법을 제\n\n<!-- PAGE_11 -->\n###### ,\n\n<!-- PAGE_11 -->\n###### 시하여야 한다.\n\n",
      "metadata": {
        "source": "(가이드라인-005)_정맥주사용+B형간염+사람면역글로불린제제의+안전성유효성+평가+가이드라인.pdf",
        "chunk_index": 89,
        "window_size": 3,
        "char_count": 242,
        "word_count": 50,
        "page_number": 11,
        "window_text": "제조공정은 제조사에 따라 다양하지만 보통 몇 단계의 분획 정제공정과 바이\n\n<!-- PAGE_11 -->\n###### /\n\n<!-- PAGE_11 -->\n###### 러스 불활화 제거를 위한 특별 공정이 필요하다\n\n<!-- PAGE_11 -->\n###### 제조공정은 상세히 기술하고 제조\n\n<!-- PAGE_11 -->\n###### /\n\n<!-- PAGE_11 -->\n###### .\n\n <!-- PAGE_11 -->\n###### 면역글로불린제제 제조는\n\n<!-- PAGE_11 -->\n###### 의 에탄올 분획법이 가장 널리 사용되고 있다\n\n<!-- PAGE_11 -->\n###### 에\n\n<!-- PAGE_11 -->\n###### Cohn\n\n<!-- PAGE_11 -->\n###### .\n\n <!-- PAGE_11 -->\n###### 탄올 분획법은 특정 요구조건에 맞는 몇 개의 개별 단계로 되어 있으며\n\n<!-- PAGE_11 -->\n###### 각 개별\n\n<!-- PAGE_11 -->\n###### ,\n\n<!-- PAGE_11 -->\n###### 단계는 제품의 품질에 매우 중요하고 그 중 일부 개별 단계는 잠재적인 바이러스\n\n<!-- PAGE_11 -->\n###### 오염을 효과적으로 감소시킬 수 있다\n\n<!-- PAGE_11 -->\n###### 따라서 에탄올 농도\n\n<!-- PAGE_11 -->\n###### 단백질 농도\n\n<!-- PAGE_11 -->\n###### 온도\n\n<!-- PAGE_11 -->\n###### .\n\n <!-- PAGE_11 -->\n###### ,\n\n<!-- PAGE_11 -->\n###### ,\n\n<!-- PAGE_11 -->\n###### , pH,\n\n<!-- PAGE_11 -->\n###### 이온 강도 및 처리 시간 등에 대한 명확한 기준\n\n<!-- PAGE_11 -->\n###### 허용 오차범위 및 관리 방법을 제\n\n<!-- PAGE_11 -->\n###### ,\n\n<!-- PAGE_11 -->\n###### 시하여야 한다.\n\n <!-- PAGE_11 -->\n###### 크로마토그래피 등을 이용한 단백질의 분리 및 수율은 칼럼의 능력\n\n<!-- PAGE_11 -->\n###### 단백질의 특\n\n<!-- PAGE_11 -->\n###### ,\n\n<!-- PAGE_11 -->\n###### 성 및 농도\n\n<!-- PAGE_11 -->\n###### 완충액의 이온 강도 및\n\n<!-- PAGE_11 -->\n###### 유속 및 온도와 같은 여러 인자들에 따라\n\n<!-- PAGE_11 -->\n###### ,\n\n<!-- PAGE_11 -->\n###### pH,\n\n<!-- PAGE_11 -->\n###### 크게 좌우된다\n\n<!-- PAGE_11 -->\n###### 따라서 적절한 규격과 기준을 명시하여야 한다\n\n<!-- PAGE_11 -->\n###### 칼럼의 보관\n\n<!-- PAGE_11 -->\n###### 칼럼\n\n<!-- PAGE_11 -->\n###### .\n\n <!-- PAGE_11 -->\n###### .\n\n <!-- PAGE_11 -->\n###### ,\n\n<!-- PAGE_11 -->\n###### 보존제의 사용 및 재생방법 등을 기술하여야 하고\n\n<!-- PAGE_11 -->\n###### 무균여과\n\n<!-- PAGE_11 -->\n###### 투석여과\n\n<!-- PAGE_11 -->\n###### ,\n\n<!-- PAGE_11 -->\n###### ,\n\n<!-- PAGE_11 -->\n###### (diafiltration)\n\n<!-- PAGE_11 -->\n###### 또는 한외여과\n\n<!-- PAGE_11 -->\n###### (ultrafiltration) 등에 관한 상세한 설명도 필요하다\n\n<!-- PAGE_11 -->\n###### .\n\n",
        "original_sentence": "<!-- PAGE_11 -->\n###### ,\n\n<!-- PAGE_11 -->\n###### ,\n\n<!-- PAGE_11 -->\n###### , pH,\n\n<!-- PAGE_11 -->\n###### 이온 강도 및 처리 시간 등에 대한 명확한 기준\n\n<!-- PAGE_11 -->\n###### 허용 오차범위 및 관리 방법을 제\n\n<!-- PAGE_11 -->\n###### ,\n\n<!-- PAGE_11 -->\n###### 시하여야 한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_091",
      "text": "<!-- PAGE_11 -->\n###### 크로마토그래피 등을 이용한 단백질의 분리 및 수율은 칼럼의 능력\n\n<!-- PAGE_11 -->\n###### 단백질의 특\n\n<!-- PAGE_11 -->\n###### ,\n\n<!-- PAGE_11 -->\n###### 성 및 농도\n\n<!-- PAGE_11 -->\n###### 완충액의 이온 강도 및\n\n<!-- PAGE_11 -->\n###### 유속 및 온도와 같은 여러 인자들에 따라\n\n<!-- PAGE_11 -->\n###### ,\n\n<!-- PAGE_11 -->\n###### pH,\n\n<!-- PAGE_11 -->\n###### 크게 좌우된다\n\n<!-- PAGE_11 -->\n###### 따라서 적절한 규격과 기준을 명시하여야 한다\n\n<!-- PAGE_11 -->\n###### 칼럼의 보관\n\n<!-- PAGE_11 -->\n###### 칼럼\n\n<!-- PAGE_11 -->\n###### .\n\n",
      "metadata": {
        "source": "(가이드라인-005)_정맥주사용+B형간염+사람면역글로불린제제의+안전성유효성+평가+가이드라인.pdf",
        "chunk_index": 90,
        "window_size": 3,
        "char_count": 464,
        "word_count": 92,
        "page_number": 11,
        "window_text": "<!-- PAGE_11 -->\n###### 면역글로불린제제 제조는\n\n<!-- PAGE_11 -->\n###### 의 에탄올 분획법이 가장 널리 사용되고 있다\n\n<!-- PAGE_11 -->\n###### 에\n\n<!-- PAGE_11 -->\n###### Cohn\n\n<!-- PAGE_11 -->\n###### .\n\n <!-- PAGE_11 -->\n###### 탄올 분획법은 특정 요구조건에 맞는 몇 개의 개별 단계로 되어 있으며\n\n<!-- PAGE_11 -->\n###### 각 개별\n\n<!-- PAGE_11 -->\n###### ,\n\n<!-- PAGE_11 -->\n###### 단계는 제품의 품질에 매우 중요하고 그 중 일부 개별 단계는 잠재적인 바이러스\n\n<!-- PAGE_11 -->\n###### 오염을 효과적으로 감소시킬 수 있다\n\n<!-- PAGE_11 -->\n###### 따라서 에탄올 농도\n\n<!-- PAGE_11 -->\n###### 단백질 농도\n\n<!-- PAGE_11 -->\n###### 온도\n\n<!-- PAGE_11 -->\n###### .\n\n <!-- PAGE_11 -->\n###### ,\n\n<!-- PAGE_11 -->\n###### ,\n\n<!-- PAGE_11 -->\n###### , pH,\n\n<!-- PAGE_11 -->\n###### 이온 강도 및 처리 시간 등에 대한 명확한 기준\n\n<!-- PAGE_11 -->\n###### 허용 오차범위 및 관리 방법을 제\n\n<!-- PAGE_11 -->\n###### ,\n\n<!-- PAGE_11 -->\n###### 시하여야 한다.\n\n <!-- PAGE_11 -->\n###### 크로마토그래피 등을 이용한 단백질의 분리 및 수율은 칼럼의 능력\n\n<!-- PAGE_11 -->\n###### 단백질의 특\n\n<!-- PAGE_11 -->\n###### ,\n\n<!-- PAGE_11 -->\n###### 성 및 농도\n\n<!-- PAGE_11 -->\n###### 완충액의 이온 강도 및\n\n<!-- PAGE_11 -->\n###### 유속 및 온도와 같은 여러 인자들에 따라\n\n<!-- PAGE_11 -->\n###### ,\n\n<!-- PAGE_11 -->\n###### pH,\n\n<!-- PAGE_11 -->\n###### 크게 좌우된다\n\n<!-- PAGE_11 -->\n###### 따라서 적절한 규격과 기준을 명시하여야 한다\n\n<!-- PAGE_11 -->\n###### 칼럼의 보관\n\n<!-- PAGE_11 -->\n###### 칼럼\n\n<!-- PAGE_11 -->\n###### .\n\n <!-- PAGE_11 -->\n###### .\n\n <!-- PAGE_11 -->\n###### ,\n\n<!-- PAGE_11 -->\n###### 보존제의 사용 및 재생방법 등을 기술하여야 하고\n\n<!-- PAGE_11 -->\n###### 무균여과\n\n<!-- PAGE_11 -->\n###### 투석여과\n\n<!-- PAGE_11 -->\n###### ,\n\n<!-- PAGE_11 -->\n###### ,\n\n<!-- PAGE_11 -->\n###### (diafiltration)\n\n<!-- PAGE_11 -->\n###### 또는 한외여과\n\n<!-- PAGE_11 -->\n###### (ultrafiltration) 등에 관한 상세한 설명도 필요하다\n\n<!-- PAGE_11 -->\n###### .\n\n <!-- PAGE_11 -->\n###### 근육주사용\n\n<!-- PAGE_11 -->\n###### 는 정맥 내 투여 시 부작용을 야기할 수 있다\n\n<!-- PAGE_11 -->\n###### 만약 근육주사용\n\n<!-- PAGE_11 -->\n###### HBIG\n\n<!-- PAGE_11 -->\n###### .\n\n",
        "original_sentence": "<!-- PAGE_11 -->\n###### 크로마토그래피 등을 이용한 단백질의 분리 및 수율은 칼럼의 능력\n\n<!-- PAGE_11 -->\n###### 단백질의 특\n\n<!-- PAGE_11 -->\n###### ,\n\n<!-- PAGE_11 -->\n###### 성 및 농도\n\n<!-- PAGE_11 -->\n###### 완충액의 이온 강도 및\n\n<!-- PAGE_11 -->\n###### 유속 및 온도와 같은 여러 인자들에 따라\n\n<!-- PAGE_11 -->\n###### ,\n\n<!-- PAGE_11 -->\n###### pH,\n\n<!-- PAGE_11 -->\n###### 크게 좌우된다\n\n<!-- PAGE_11 -->\n###### 따라서 적절한 규격과 기준을 명시하여야 한다\n\n<!-- PAGE_11 -->\n###### 칼럼의 보관\n\n<!-- PAGE_11 -->\n###### 칼럼\n\n<!-- PAGE_11 -->\n###### .\n\n"
      }
    },
    {
      "chunk_id": "chunk_092",
      "text": "<!-- PAGE_11 -->\n###### .\n\n",
      "metadata": {
        "source": "(가이드라인-005)_정맥주사용+B형간염+사람면역글로불린제제의+안전성유효성+평가+가이드라인.pdf",
        "chunk_index": 91,
        "window_size": 3,
        "char_count": 27,
        "word_count": 5,
        "page_number": 11,
        "window_text": "<!-- PAGE_11 -->\n###### 탄올 분획법은 특정 요구조건에 맞는 몇 개의 개별 단계로 되어 있으며\n\n<!-- PAGE_11 -->\n###### 각 개별\n\n<!-- PAGE_11 -->\n###### ,\n\n<!-- PAGE_11 -->\n###### 단계는 제품의 품질에 매우 중요하고 그 중 일부 개별 단계는 잠재적인 바이러스\n\n<!-- PAGE_11 -->\n###### 오염을 효과적으로 감소시킬 수 있다\n\n<!-- PAGE_11 -->\n###### 따라서 에탄올 농도\n\n<!-- PAGE_11 -->\n###### 단백질 농도\n\n<!-- PAGE_11 -->\n###### 온도\n\n<!-- PAGE_11 -->\n###### .\n\n <!-- PAGE_11 -->\n###### ,\n\n<!-- PAGE_11 -->\n###### ,\n\n<!-- PAGE_11 -->\n###### , pH,\n\n<!-- PAGE_11 -->\n###### 이온 강도 및 처리 시간 등에 대한 명확한 기준\n\n<!-- PAGE_11 -->\n###### 허용 오차범위 및 관리 방법을 제\n\n<!-- PAGE_11 -->\n###### ,\n\n<!-- PAGE_11 -->\n###### 시하여야 한다.\n\n <!-- PAGE_11 -->\n###### 크로마토그래피 등을 이용한 단백질의 분리 및 수율은 칼럼의 능력\n\n<!-- PAGE_11 -->\n###### 단백질의 특\n\n<!-- PAGE_11 -->\n###### ,\n\n<!-- PAGE_11 -->\n###### 성 및 농도\n\n<!-- PAGE_11 -->\n###### 완충액의 이온 강도 및\n\n<!-- PAGE_11 -->\n###### 유속 및 온도와 같은 여러 인자들에 따라\n\n<!-- PAGE_11 -->\n###### ,\n\n<!-- PAGE_11 -->\n###### pH,\n\n<!-- PAGE_11 -->\n###### 크게 좌우된다\n\n<!-- PAGE_11 -->\n###### 따라서 적절한 규격과 기준을 명시하여야 한다\n\n<!-- PAGE_11 -->\n###### 칼럼의 보관\n\n<!-- PAGE_11 -->\n###### 칼럼\n\n<!-- PAGE_11 -->\n###### .\n\n <!-- PAGE_11 -->\n###### .\n\n <!-- PAGE_11 -->\n###### ,\n\n<!-- PAGE_11 -->\n###### 보존제의 사용 및 재생방법 등을 기술하여야 하고\n\n<!-- PAGE_11 -->\n###### 무균여과\n\n<!-- PAGE_11 -->\n###### 투석여과\n\n<!-- PAGE_11 -->\n###### ,\n\n<!-- PAGE_11 -->\n###### ,\n\n<!-- PAGE_11 -->\n###### (diafiltration)\n\n<!-- PAGE_11 -->\n###### 또는 한외여과\n\n<!-- PAGE_11 -->\n###### (ultrafiltration) 등에 관한 상세한 설명도 필요하다\n\n<!-- PAGE_11 -->\n###### .\n\n <!-- PAGE_11 -->\n###### 근육주사용\n\n<!-- PAGE_11 -->\n###### 는 정맥 내 투여 시 부작용을 야기할 수 있다\n\n<!-- PAGE_11 -->\n###### 만약 근육주사용\n\n<!-- PAGE_11 -->\n###### HBIG\n\n<!-- PAGE_11 -->\n###### .\n\n <!-- PAGE_11 -->\n###### 의 제조방법을 변경하여 정맥주사용\n\n<!-- PAGE_11 -->\n###### 를 제조하는 경우에는 주성분에는\n\n<!-- PAGE_11 -->\n###### HBIG\n\n<!-- PAGE_11 -->\n###### HBIG\n\n- - 4 -\n<!-- PAGE_12 -->\n###### 영향을 미치지 않으면서 순도를 높여 부작용을 감소시킬 수 있는 다양한 공정을 거\n\n<!-- PAGE_12 -->\n###### 쳐야 한다\n\n<!-- PAGE_12 -->\n###### 따라서 이 때 사용한 물질 및 공정과 이들의 적합성에 대한 근거를 제\n\n<!-- PAGE_12 -->\n###### .\n\n",
        "original_sentence": "<!-- PAGE_11 -->\n###### .\n\n"
      }
    },
    {
      "chunk_id": "chunk_093",
      "text": "<!-- PAGE_11 -->\n###### ,\n\n<!-- PAGE_11 -->\n###### 보존제의 사용 및 재생방법 등을 기술하여야 하고\n\n<!-- PAGE_11 -->\n###### 무균여과\n\n<!-- PAGE_11 -->\n###### 투석여과\n\n<!-- PAGE_11 -->\n###### ,\n\n<!-- PAGE_11 -->\n###### ,\n\n<!-- PAGE_11 -->\n###### (diafiltration)\n\n<!-- PAGE_11 -->\n###### 또는 한외여과\n\n<!-- PAGE_11 -->\n###### (ultrafiltration) 등에 관한 상세한 설명도 필요하다\n\n<!-- PAGE_11 -->\n###### .\n\n",
      "metadata": {
        "source": "(가이드라인-005)_정맥주사용+B형간염+사람면역글로불린제제의+안전성유효성+평가+가이드라인.pdf",
        "chunk_index": 92,
        "window_size": 3,
        "char_count": 356,
        "word_count": 62,
        "page_number": 11,
        "window_text": "<!-- PAGE_11 -->\n###### ,\n\n<!-- PAGE_11 -->\n###### ,\n\n<!-- PAGE_11 -->\n###### , pH,\n\n<!-- PAGE_11 -->\n###### 이온 강도 및 처리 시간 등에 대한 명확한 기준\n\n<!-- PAGE_11 -->\n###### 허용 오차범위 및 관리 방법을 제\n\n<!-- PAGE_11 -->\n###### ,\n\n<!-- PAGE_11 -->\n###### 시하여야 한다.\n\n <!-- PAGE_11 -->\n###### 크로마토그래피 등을 이용한 단백질의 분리 및 수율은 칼럼의 능력\n\n<!-- PAGE_11 -->\n###### 단백질의 특\n\n<!-- PAGE_11 -->\n###### ,\n\n<!-- PAGE_11 -->\n###### 성 및 농도\n\n<!-- PAGE_11 -->\n###### 완충액의 이온 강도 및\n\n<!-- PAGE_11 -->\n###### 유속 및 온도와 같은 여러 인자들에 따라\n\n<!-- PAGE_11 -->\n###### ,\n\n<!-- PAGE_11 -->\n###### pH,\n\n<!-- PAGE_11 -->\n###### 크게 좌우된다\n\n<!-- PAGE_11 -->\n###### 따라서 적절한 규격과 기준을 명시하여야 한다\n\n<!-- PAGE_11 -->\n###### 칼럼의 보관\n\n<!-- PAGE_11 -->\n###### 칼럼\n\n<!-- PAGE_11 -->\n###### .\n\n <!-- PAGE_11 -->\n###### .\n\n <!-- PAGE_11 -->\n###### ,\n\n<!-- PAGE_11 -->\n###### 보존제의 사용 및 재생방법 등을 기술하여야 하고\n\n<!-- PAGE_11 -->\n###### 무균여과\n\n<!-- PAGE_11 -->\n###### 투석여과\n\n<!-- PAGE_11 -->\n###### ,\n\n<!-- PAGE_11 -->\n###### ,\n\n<!-- PAGE_11 -->\n###### (diafiltration)\n\n<!-- PAGE_11 -->\n###### 또는 한외여과\n\n<!-- PAGE_11 -->\n###### (ultrafiltration) 등에 관한 상세한 설명도 필요하다\n\n<!-- PAGE_11 -->\n###### .\n\n <!-- PAGE_11 -->\n###### 근육주사용\n\n<!-- PAGE_11 -->\n###### 는 정맥 내 투여 시 부작용을 야기할 수 있다\n\n<!-- PAGE_11 -->\n###### 만약 근육주사용\n\n<!-- PAGE_11 -->\n###### HBIG\n\n<!-- PAGE_11 -->\n###### .\n\n <!-- PAGE_11 -->\n###### 의 제조방법을 변경하여 정맥주사용\n\n<!-- PAGE_11 -->\n###### 를 제조하는 경우에는 주성분에는\n\n<!-- PAGE_11 -->\n###### HBIG\n\n<!-- PAGE_11 -->\n###### HBIG\n\n- - 4 -\n<!-- PAGE_12 -->\n###### 영향을 미치지 않으면서 순도를 높여 부작용을 감소시킬 수 있는 다양한 공정을 거\n\n<!-- PAGE_12 -->\n###### 쳐야 한다\n\n<!-- PAGE_12 -->\n###### 따라서 이 때 사용한 물질 및 공정과 이들의 적합성에 대한 근거를 제\n\n<!-- PAGE_12 -->\n###### .\n\n <!-- PAGE_12 -->\n###### 시하고 기술하여야 한다.\n\n",
        "original_sentence": "<!-- PAGE_11 -->\n###### ,\n\n<!-- PAGE_11 -->\n###### 보존제의 사용 및 재생방법 등을 기술하여야 하고\n\n<!-- PAGE_11 -->\n###### 무균여과\n\n<!-- PAGE_11 -->\n###### 투석여과\n\n<!-- PAGE_11 -->\n###### ,\n\n<!-- PAGE_11 -->\n###### ,\n\n<!-- PAGE_11 -->\n###### (diafiltration)\n\n<!-- PAGE_11 -->\n###### 또는 한외여과\n\n<!-- PAGE_11 -->\n###### (ultrafiltration) 등에 관한 상세한 설명도 필요하다\n\n<!-- PAGE_11 -->\n###### .\n\n"
      }
    },
    {
      "chunk_id": "chunk_094",
      "text": "<!-- PAGE_11 -->\n###### 근육주사용\n\n<!-- PAGE_11 -->\n###### 는 정맥 내 투여 시 부작용을 야기할 수 있다\n\n<!-- PAGE_11 -->\n###### 만약 근육주사용\n\n<!-- PAGE_11 -->\n###### HBIG\n\n<!-- PAGE_11 -->\n###### .\n\n",
      "metadata": {
        "source": "(가이드라인-005)_정맥주사용+B형간염+사람면역글로불린제제의+안전성유효성+평가+가이드라인.pdf",
        "chunk_index": 93,
        "window_size": 3,
        "char_count": 173,
        "word_count": 34,
        "page_number": 11,
        "window_text": "<!-- PAGE_11 -->\n###### 크로마토그래피 등을 이용한 단백질의 분리 및 수율은 칼럼의 능력\n\n<!-- PAGE_11 -->\n###### 단백질의 특\n\n<!-- PAGE_11 -->\n###### ,\n\n<!-- PAGE_11 -->\n###### 성 및 농도\n\n<!-- PAGE_11 -->\n###### 완충액의 이온 강도 및\n\n<!-- PAGE_11 -->\n###### 유속 및 온도와 같은 여러 인자들에 따라\n\n<!-- PAGE_11 -->\n###### ,\n\n<!-- PAGE_11 -->\n###### pH,\n\n<!-- PAGE_11 -->\n###### 크게 좌우된다\n\n<!-- PAGE_11 -->\n###### 따라서 적절한 규격과 기준을 명시하여야 한다\n\n<!-- PAGE_11 -->\n###### 칼럼의 보관\n\n<!-- PAGE_11 -->\n###### 칼럼\n\n<!-- PAGE_11 -->\n###### .\n\n <!-- PAGE_11 -->\n###### .\n\n <!-- PAGE_11 -->\n###### ,\n\n<!-- PAGE_11 -->\n###### 보존제의 사용 및 재생방법 등을 기술하여야 하고\n\n<!-- PAGE_11 -->\n###### 무균여과\n\n<!-- PAGE_11 -->\n###### 투석여과\n\n<!-- PAGE_11 -->\n###### ,\n\n<!-- PAGE_11 -->\n###### ,\n\n<!-- PAGE_11 -->\n###### (diafiltration)\n\n<!-- PAGE_11 -->\n###### 또는 한외여과\n\n<!-- PAGE_11 -->\n###### (ultrafiltration) 등에 관한 상세한 설명도 필요하다\n\n<!-- PAGE_11 -->\n###### .\n\n <!-- PAGE_11 -->\n###### 근육주사용\n\n<!-- PAGE_11 -->\n###### 는 정맥 내 투여 시 부작용을 야기할 수 있다\n\n<!-- PAGE_11 -->\n###### 만약 근육주사용\n\n<!-- PAGE_11 -->\n###### HBIG\n\n<!-- PAGE_11 -->\n###### .\n\n <!-- PAGE_11 -->\n###### 의 제조방법을 변경하여 정맥주사용\n\n<!-- PAGE_11 -->\n###### 를 제조하는 경우에는 주성분에는\n\n<!-- PAGE_11 -->\n###### HBIG\n\n<!-- PAGE_11 -->\n###### HBIG\n\n- - 4 -\n<!-- PAGE_12 -->\n###### 영향을 미치지 않으면서 순도를 높여 부작용을 감소시킬 수 있는 다양한 공정을 거\n\n<!-- PAGE_12 -->\n###### 쳐야 한다\n\n<!-- PAGE_12 -->\n###### 따라서 이 때 사용한 물질 및 공정과 이들의 적합성에 대한 근거를 제\n\n<!-- PAGE_12 -->\n###### .\n\n <!-- PAGE_12 -->\n###### 시하고 기술하여야 한다.\n\n <!-- PAGE_12 -->\n###### 바이러스 불활화 제거 공정은 각각 최소\n\n<!-- PAGE_12 -->\n###### 단계 이상의 공정을 포함하도록 하며\n\n<!-- PAGE_12 -->\n###### /\n\n<!-- PAGE_12 -->\n###### 1\n\n<!-- PAGE_12 -->\n###### ,\n\n<!-- PAGE_12 -->\n###### 온도\n\n<!-- PAGE_12 -->\n###### , pH, 시간 등 바이러스 불활화 제거 조건을 상세히 기술하고 제조공정 흐름도\n\n<!-- PAGE_12 -->\n###### /\n\n<!-- PAGE_12 -->\n###### 에 표시하여야 한다\n\n<!-- PAGE_12 -->\n###### . ",
        "original_sentence": "<!-- PAGE_11 -->\n###### 근육주사용\n\n<!-- PAGE_11 -->\n###### 는 정맥 내 투여 시 부작용을 야기할 수 있다\n\n<!-- PAGE_11 -->\n###### 만약 근육주사용\n\n<!-- PAGE_11 -->\n###### HBIG\n\n<!-- PAGE_11 -->\n###### .\n\n"
      }
    },
    {
      "chunk_id": "chunk_095",
      "text": "<!-- PAGE_11 -->\n###### 의 제조방법을 변경하여 정맥주사용\n\n<!-- PAGE_11 -->\n###### 를 제조하는 경우에는 주성분에는\n\n<!-- PAGE_11 -->\n###### HBIG\n\n<!-- PAGE_11 -->\n###### HBIG\n\n- - 4 -\n<!-- PAGE_12 -->\n###### 영향을 미치지 않으면서 순도를 높여 부작용을 감소시킬 수 있는 다양한 공정을 거\n\n<!-- PAGE_12 -->\n###### 쳐야 한다\n\n<!-- PAGE_12 -->\n###### 따라서 이 때 사용한 물질 및 공정과 이들의 적합성에 대한 근거를 제\n\n<!-- PAGE_12 -->\n###### .\n\n",
      "metadata": {
        "source": "(가이드라인-005)_정맥주사용+B형간염+사람면역글로불린제제의+안전성유효성+평가+가이드라인.pdf",
        "chunk_index": 94,
        "window_size": 3,
        "char_count": 347,
        "word_count": 73,
        "page_number": 11,
        "window_text": "<!-- PAGE_11 -->\n###### .\n\n <!-- PAGE_11 -->\n###### ,\n\n<!-- PAGE_11 -->\n###### 보존제의 사용 및 재생방법 등을 기술하여야 하고\n\n<!-- PAGE_11 -->\n###### 무균여과\n\n<!-- PAGE_11 -->\n###### 투석여과\n\n<!-- PAGE_11 -->\n###### ,\n\n<!-- PAGE_11 -->\n###### ,\n\n<!-- PAGE_11 -->\n###### (diafiltration)\n\n<!-- PAGE_11 -->\n###### 또는 한외여과\n\n<!-- PAGE_11 -->\n###### (ultrafiltration) 등에 관한 상세한 설명도 필요하다\n\n<!-- PAGE_11 -->\n###### .\n\n <!-- PAGE_11 -->\n###### 근육주사용\n\n<!-- PAGE_11 -->\n###### 는 정맥 내 투여 시 부작용을 야기할 수 있다\n\n<!-- PAGE_11 -->\n###### 만약 근육주사용\n\n<!-- PAGE_11 -->\n###### HBIG\n\n<!-- PAGE_11 -->\n###### .\n\n <!-- PAGE_11 -->\n###### 의 제조방법을 변경하여 정맥주사용\n\n<!-- PAGE_11 -->\n###### 를 제조하는 경우에는 주성분에는\n\n<!-- PAGE_11 -->\n###### HBIG\n\n<!-- PAGE_11 -->\n###### HBIG\n\n- - 4 -\n<!-- PAGE_12 -->\n###### 영향을 미치지 않으면서 순도를 높여 부작용을 감소시킬 수 있는 다양한 공정을 거\n\n<!-- PAGE_12 -->\n###### 쳐야 한다\n\n<!-- PAGE_12 -->\n###### 따라서 이 때 사용한 물질 및 공정과 이들의 적합성에 대한 근거를 제\n\n<!-- PAGE_12 -->\n###### .\n\n <!-- PAGE_12 -->\n###### 시하고 기술하여야 한다.\n\n <!-- PAGE_12 -->\n###### 바이러스 불활화 제거 공정은 각각 최소\n\n<!-- PAGE_12 -->\n###### 단계 이상의 공정을 포함하도록 하며\n\n<!-- PAGE_12 -->\n###### /\n\n<!-- PAGE_12 -->\n###### 1\n\n<!-- PAGE_12 -->\n###### ,\n\n<!-- PAGE_12 -->\n###### 온도\n\n<!-- PAGE_12 -->\n###### , pH, 시간 등 바이러스 불활화 제거 조건을 상세히 기술하고 제조공정 흐름도\n\n<!-- PAGE_12 -->\n###### /\n\n<!-- PAGE_12 -->\n###### 에 표시하여야 한다\n\n<!-- PAGE_12 -->\n###### .  바이러스 불활화 제거 공정의 유효성을 입증하기 위하여 바이\n\n<!-- PAGE_12 -->\n###### /\n\n<!-- PAGE_12 -->\n###### 러스 검증 자료를 제출하여야 한다\n\n<!-- PAGE_12 -->\n###### . ",
        "original_sentence": "<!-- PAGE_11 -->\n###### 의 제조방법을 변경하여 정맥주사용\n\n<!-- PAGE_11 -->\n###### 를 제조하는 경우에는 주성분에는\n\n<!-- PAGE_11 -->\n###### HBIG\n\n<!-- PAGE_11 -->\n###### HBIG\n\n- - 4 -\n<!-- PAGE_12 -->\n###### 영향을 미치지 않으면서 순도를 높여 부작용을 감소시킬 수 있는 다양한 공정을 거\n\n<!-- PAGE_12 -->\n###### 쳐야 한다\n\n<!-- PAGE_12 -->\n###### 따라서 이 때 사용한 물질 및 공정과 이들의 적합성에 대한 근거를 제\n\n<!-- PAGE_12 -->\n###### .\n\n"
      }
    },
    {
      "chunk_id": "chunk_096",
      "text": "<!-- PAGE_12 -->\n###### 시하고 기술하여야 한다.\n\n",
      "metadata": {
        "source": "(가이드라인-005)_정맥주사용+B형간염+사람면역글로불린제제의+안전성유효성+평가+가이드라인.pdf",
        "chunk_index": 95,
        "window_size": 3,
        "char_count": 39,
        "word_count": 7,
        "page_number": 12,
        "window_text": "<!-- PAGE_11 -->\n###### ,\n\n<!-- PAGE_11 -->\n###### 보존제의 사용 및 재생방법 등을 기술하여야 하고\n\n<!-- PAGE_11 -->\n###### 무균여과\n\n<!-- PAGE_11 -->\n###### 투석여과\n\n<!-- PAGE_11 -->\n###### ,\n\n<!-- PAGE_11 -->\n###### ,\n\n<!-- PAGE_11 -->\n###### (diafiltration)\n\n<!-- PAGE_11 -->\n###### 또는 한외여과\n\n<!-- PAGE_11 -->\n###### (ultrafiltration) 등에 관한 상세한 설명도 필요하다\n\n<!-- PAGE_11 -->\n###### .\n\n <!-- PAGE_11 -->\n###### 근육주사용\n\n<!-- PAGE_11 -->\n###### 는 정맥 내 투여 시 부작용을 야기할 수 있다\n\n<!-- PAGE_11 -->\n###### 만약 근육주사용\n\n<!-- PAGE_11 -->\n###### HBIG\n\n<!-- PAGE_11 -->\n###### .\n\n <!-- PAGE_11 -->\n###### 의 제조방법을 변경하여 정맥주사용\n\n<!-- PAGE_11 -->\n###### 를 제조하는 경우에는 주성분에는\n\n<!-- PAGE_11 -->\n###### HBIG\n\n<!-- PAGE_11 -->\n###### HBIG\n\n- - 4 -\n<!-- PAGE_12 -->\n###### 영향을 미치지 않으면서 순도를 높여 부작용을 감소시킬 수 있는 다양한 공정을 거\n\n<!-- PAGE_12 -->\n###### 쳐야 한다\n\n<!-- PAGE_12 -->\n###### 따라서 이 때 사용한 물질 및 공정과 이들의 적합성에 대한 근거를 제\n\n<!-- PAGE_12 -->\n###### .\n\n <!-- PAGE_12 -->\n###### 시하고 기술하여야 한다.\n\n <!-- PAGE_12 -->\n###### 바이러스 불활화 제거 공정은 각각 최소\n\n<!-- PAGE_12 -->\n###### 단계 이상의 공정을 포함하도록 하며\n\n<!-- PAGE_12 -->\n###### /\n\n<!-- PAGE_12 -->\n###### 1\n\n<!-- PAGE_12 -->\n###### ,\n\n<!-- PAGE_12 -->\n###### 온도\n\n<!-- PAGE_12 -->\n###### , pH, 시간 등 바이러스 불활화 제거 조건을 상세히 기술하고 제조공정 흐름도\n\n<!-- PAGE_12 -->\n###### /\n\n<!-- PAGE_12 -->\n###### 에 표시하여야 한다\n\n<!-- PAGE_12 -->\n###### .  바이러스 불활화 제거 공정의 유효성을 입증하기 위하여 바이\n\n<!-- PAGE_12 -->\n###### /\n\n<!-- PAGE_12 -->\n###### 러스 검증 자료를 제출하여야 한다\n\n<!-- PAGE_12 -->\n###### .  개별 바이러스 불활화 제거 공정의 효과를 평가\n\n<!-- PAGE_12 -->\n###### /\n\n<!-- PAGE_12 -->\n###### 한 후\n\n<!-- PAGE_12 -->\n###### , 전 제조공정에서의 바이러스 불활화 제거 능력의 추정치를 제공하여야 한다\n\n<!-- PAGE_12 -->\n###### /\n\n<!-- PAGE_12 -->\n###### .\n\n",
        "original_sentence": "<!-- PAGE_12 -->\n###### 시하고 기술하여야 한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_097",
      "text": "<!-- PAGE_12 -->\n###### 바이러스 불활화 제거 공정은 각각 최소\n\n<!-- PAGE_12 -->\n###### 단계 이상의 공정을 포함하도록 하며\n\n<!-- PAGE_12 -->\n###### /\n\n<!-- PAGE_12 -->\n###### 1\n\n<!-- PAGE_12 -->\n###### ,\n\n<!-- PAGE_12 -->\n###### 온도\n\n<!-- PAGE_12 -->\n###### , pH, 시간 등 바이러스 불활화 제거 조건을 상세히 기술하고 제조공정 흐름도\n\n<!-- PAGE_12 -->\n###### /\n\n<!-- PAGE_12 -->\n###### 에 표시하여야 한다\n\n<!-- PAGE_12 -->\n###### . ",
      "metadata": {
        "source": "(가이드라인-005)_정맥주사용+B형간염+사람면역글로불린제제의+안전성유효성+평가+가이드라인.pdf",
        "chunk_index": 96,
        "window_size": 3,
        "char_count": 360,
        "word_count": 72,
        "page_number": 12,
        "window_text": "<!-- PAGE_11 -->\n###### 근육주사용\n\n<!-- PAGE_11 -->\n###### 는 정맥 내 투여 시 부작용을 야기할 수 있다\n\n<!-- PAGE_11 -->\n###### 만약 근육주사용\n\n<!-- PAGE_11 -->\n###### HBIG\n\n<!-- PAGE_11 -->\n###### .\n\n <!-- PAGE_11 -->\n###### 의 제조방법을 변경하여 정맥주사용\n\n<!-- PAGE_11 -->\n###### 를 제조하는 경우에는 주성분에는\n\n<!-- PAGE_11 -->\n###### HBIG\n\n<!-- PAGE_11 -->\n###### HBIG\n\n- - 4 -\n<!-- PAGE_12 -->\n###### 영향을 미치지 않으면서 순도를 높여 부작용을 감소시킬 수 있는 다양한 공정을 거\n\n<!-- PAGE_12 -->\n###### 쳐야 한다\n\n<!-- PAGE_12 -->\n###### 따라서 이 때 사용한 물질 및 공정과 이들의 적합성에 대한 근거를 제\n\n<!-- PAGE_12 -->\n###### .\n\n <!-- PAGE_12 -->\n###### 시하고 기술하여야 한다.\n\n <!-- PAGE_12 -->\n###### 바이러스 불활화 제거 공정은 각각 최소\n\n<!-- PAGE_12 -->\n###### 단계 이상의 공정을 포함하도록 하며\n\n<!-- PAGE_12 -->\n###### /\n\n<!-- PAGE_12 -->\n###### 1\n\n<!-- PAGE_12 -->\n###### ,\n\n<!-- PAGE_12 -->\n###### 온도\n\n<!-- PAGE_12 -->\n###### , pH, 시간 등 바이러스 불활화 제거 조건을 상세히 기술하고 제조공정 흐름도\n\n<!-- PAGE_12 -->\n###### /\n\n<!-- PAGE_12 -->\n###### 에 표시하여야 한다\n\n<!-- PAGE_12 -->\n###### .  바이러스 불활화 제거 공정의 유효성을 입증하기 위하여 바이\n\n<!-- PAGE_12 -->\n###### /\n\n<!-- PAGE_12 -->\n###### 러스 검증 자료를 제출하여야 한다\n\n<!-- PAGE_12 -->\n###### .  개별 바이러스 불활화 제거 공정의 효과를 평가\n\n<!-- PAGE_12 -->\n###### /\n\n<!-- PAGE_12 -->\n###### 한 후\n\n<!-- PAGE_12 -->\n###### , 전 제조공정에서의 바이러스 불활화 제거 능력의 추정치를 제공하여야 한다\n\n<!-- PAGE_12 -->\n###### /\n\n<!-- PAGE_12 -->\n###### .\n\n <!-- PAGE_12 -->\n###### 바이러스 검증 평가와 관련하여서는\n\n<!-- PAGE_12 -->\n###### 혈장분획제제 등 바이러스 검증 평가가이드\n\n<!-- PAGE_12 -->\n###### “\n\n<!-- PAGE_12 -->\n###### 생물의약품평가가이드\n\n<!-- PAGE_12 -->\n###### 와\n\n<!-- PAGE_12 -->\n###### 의\n\n<!-- PAGE_12 -->\n###### (\n\n<!-- PAGE_12 -->\n###### 20,\n\n<!-- PAGE_12 -->\n###### 2006)”\n\n<!-- PAGE_12 -->\n###### EMEA\n\n<!-- PAGE_12 -->\n###### “Note\n\n<!-- PAGE_12 -->\n###### for\n\n<!-- PAGE_12 -->\n###### Guidance\n\n<!-- PAGE_12 -->\n###### on\n\n<!-- PAGE_12 -->\n###### Virus\n\n<!-- PAGE_12 -->\n###### Validation\n\n<!-- PAGE_12 -->\n###### Studies:\n\n<!-- PAGE_12 -->\n###### The\n\n<!-- PAGE_12 -->\n###### Design,\n\n<!-- PAGE_12 -->\n###### Contribution\n\n<!-- PAGE_12 -->\n###### and\n\n<!-- PAGE_12 -->\n###### Interpretation\n\n<!-- PAGE_12 -->\n###### of\n\n<!-- PAGE_12 -->\n###### Studies\n\n<!-- PAGE_12 -->\n###### Validating the Inactivation and Removal of Viruses(CPMP/BWP/268/95, 1996)”\n\n<!-- PAGE_12 -->\n###### 품질관리\n\n<!-- PAGE_12 -->\n###### 4.\n\n",
        "original_sentence": "<!-- PAGE_12 -->\n###### 바이러스 불활화 제거 공정은 각각 최소\n\n<!-- PAGE_12 -->\n###### 단계 이상의 공정을 포함하도록 하며\n\n<!-- PAGE_12 -->\n###### /\n\n<!-- PAGE_12 -->\n###### 1\n\n<!-- PAGE_12 -->\n###### ,\n\n<!-- PAGE_12 -->\n###### 온도\n\n<!-- PAGE_12 -->\n###### , pH, 시간 등 바이러스 불활화 제거 조건을 상세히 기술하고 제조공정 흐름도\n\n<!-- PAGE_12 -->\n###### /\n\n<!-- PAGE_12 -->\n###### 에 표시하여야 한다\n\n<!-- PAGE_12 -->\n###### . "
      }
    },
    {
      "chunk_id": "chunk_098",
      "text": "바이러스 불활화 제거 공정의 유효성을 입증하기 위하여 바이\n\n<!-- PAGE_12 -->\n###### /\n\n<!-- PAGE_12 -->\n###### 러스 검증 자료를 제출하여야 한다\n\n<!-- PAGE_12 -->\n###### . ",
      "metadata": {
        "source": "(가이드라인-005)_정맥주사용+B형간염+사람면역글로불린제제의+안전성유효성+평가+가이드라인.pdf",
        "chunk_index": 97,
        "window_size": 3,
        "char_count": 131,
        "word_count": 27,
        "page_number": 12,
        "window_text": "<!-- PAGE_11 -->\n###### 의 제조방법을 변경하여 정맥주사용\n\n<!-- PAGE_11 -->\n###### 를 제조하는 경우에는 주성분에는\n\n<!-- PAGE_11 -->\n###### HBIG\n\n<!-- PAGE_11 -->\n###### HBIG\n\n- - 4 -\n<!-- PAGE_12 -->\n###### 영향을 미치지 않으면서 순도를 높여 부작용을 감소시킬 수 있는 다양한 공정을 거\n\n<!-- PAGE_12 -->\n###### 쳐야 한다\n\n<!-- PAGE_12 -->\n###### 따라서 이 때 사용한 물질 및 공정과 이들의 적합성에 대한 근거를 제\n\n<!-- PAGE_12 -->\n###### .\n\n <!-- PAGE_12 -->\n###### 시하고 기술하여야 한다.\n\n <!-- PAGE_12 -->\n###### 바이러스 불활화 제거 공정은 각각 최소\n\n<!-- PAGE_12 -->\n###### 단계 이상의 공정을 포함하도록 하며\n\n<!-- PAGE_12 -->\n###### /\n\n<!-- PAGE_12 -->\n###### 1\n\n<!-- PAGE_12 -->\n###### ,\n\n<!-- PAGE_12 -->\n###### 온도\n\n<!-- PAGE_12 -->\n###### , pH, 시간 등 바이러스 불활화 제거 조건을 상세히 기술하고 제조공정 흐름도\n\n<!-- PAGE_12 -->\n###### /\n\n<!-- PAGE_12 -->\n###### 에 표시하여야 한다\n\n<!-- PAGE_12 -->\n###### .  바이러스 불활화 제거 공정의 유효성을 입증하기 위하여 바이\n\n<!-- PAGE_12 -->\n###### /\n\n<!-- PAGE_12 -->\n###### 러스 검증 자료를 제출하여야 한다\n\n<!-- PAGE_12 -->\n###### .  개별 바이러스 불활화 제거 공정의 효과를 평가\n\n<!-- PAGE_12 -->\n###### /\n\n<!-- PAGE_12 -->\n###### 한 후\n\n<!-- PAGE_12 -->\n###### , 전 제조공정에서의 바이러스 불활화 제거 능력의 추정치를 제공하여야 한다\n\n<!-- PAGE_12 -->\n###### /\n\n<!-- PAGE_12 -->\n###### .\n\n <!-- PAGE_12 -->\n###### 바이러스 검증 평가와 관련하여서는\n\n<!-- PAGE_12 -->\n###### 혈장분획제제 등 바이러스 검증 평가가이드\n\n<!-- PAGE_12 -->\n###### “\n\n<!-- PAGE_12 -->\n###### 생물의약품평가가이드\n\n<!-- PAGE_12 -->\n###### 와\n\n<!-- PAGE_12 -->\n###### 의\n\n<!-- PAGE_12 -->\n###### (\n\n<!-- PAGE_12 -->\n###### 20,\n\n<!-- PAGE_12 -->\n###### 2006)”\n\n<!-- PAGE_12 -->\n###### EMEA\n\n<!-- PAGE_12 -->\n###### “Note\n\n<!-- PAGE_12 -->\n###### for\n\n<!-- PAGE_12 -->\n###### Guidance\n\n<!-- PAGE_12 -->\n###### on\n\n<!-- PAGE_12 -->\n###### Virus\n\n<!-- PAGE_12 -->\n###### Validation\n\n<!-- PAGE_12 -->\n###### Studies:\n\n<!-- PAGE_12 -->\n###### The\n\n<!-- PAGE_12 -->\n###### Design,\n\n<!-- PAGE_12 -->\n###### Contribution\n\n<!-- PAGE_12 -->\n###### and\n\n<!-- PAGE_12 -->\n###### Interpretation\n\n<!-- PAGE_12 -->\n###### of\n\n<!-- PAGE_12 -->\n###### Studies\n\n<!-- PAGE_12 -->\n###### Validating the Inactivation and Removal of Viruses(CPMP/BWP/268/95, 1996)”\n\n<!-- PAGE_12 -->\n###### 품질관리\n\n<!-- PAGE_12 -->\n###### 4.\n\n <!-- PAGE_12 -->\n###### 최소한 연속적인\n\n<!-- PAGE_12 -->\n###### 개 로트에 대해 검증된 시험법으로 시험한 원료의약품 및 완제\n\n<!-- PAGE_12 -->\n###### 3\n\n<!-- PAGE_12 -->\n###### 또한 공정 중 관리\n\n<!-- PAGE_12 -->\n###### 시험항목과 기준을 제시하고\n\n<!-- PAGE_12 -->\n###### 제형\n\n<!-- PAGE_12 -->\n###### (in-process control, IPC)\n\n<!-- PAGE_12 -->\n###### ,\n\n<!-- PAGE_12 -->\n###### 화 과정 중 또는 생산 중 사용한 물질을 측정하고 예\n\n<!-- PAGE_12 -->\n###### 잔류용매\n\n<!-- PAGE_12 -->\n###### 계면활성제 등\n\n<!-- PAGE_12 -->\n###### (\n\n<!-- PAGE_12 -->\n###### :\n\n<!-- PAGE_12 -->\n###### ,\n\n<!-- PAGE_12 -->\n###### ),\n\n<!-- PAGE_12 -->\n###### 최소한 연속적인\n\n<!-- PAGE_12 -->\n###### 3개 로트에 대해 분석한 후 파라미터의 기준을 설정하여야 한다\n\n<!-- PAGE_12 -->\n###### .\n\n",
        "original_sentence": "바이러스 불활화 제거 공정의 유효성을 입증하기 위하여 바이\n\n<!-- PAGE_12 -->\n###### /\n\n<!-- PAGE_12 -->\n###### 러스 검증 자료를 제출하여야 한다\n\n<!-- PAGE_12 -->\n###### . "
      }
    },
    {
      "chunk_id": "chunk_099",
      "text": "개별 바이러스 불활화 제거 공정의 효과를 평가\n\n<!-- PAGE_12 -->\n###### /\n\n<!-- PAGE_12 -->\n###### 한 후\n\n<!-- PAGE_12 -->\n###### , 전 제조공정에서의 바이러스 불활화 제거 능력의 추정치를 제공하여야 한다\n\n<!-- PAGE_12 -->\n###### /\n\n<!-- PAGE_12 -->\n###### .\n\n",
      "metadata": {
        "source": "(가이드라인-005)_정맥주사용+B형간염+사람면역글로불린제제의+안전성유효성+평가+가이드라인.pdf",
        "chunk_index": 98,
        "window_size": 3,
        "char_count": 204,
        "word_count": 42,
        "page_number": 12,
        "window_text": "<!-- PAGE_12 -->\n###### 시하고 기술하여야 한다.\n\n <!-- PAGE_12 -->\n###### 바이러스 불활화 제거 공정은 각각 최소\n\n<!-- PAGE_12 -->\n###### 단계 이상의 공정을 포함하도록 하며\n\n<!-- PAGE_12 -->\n###### /\n\n<!-- PAGE_12 -->\n###### 1\n\n<!-- PAGE_12 -->\n###### ,\n\n<!-- PAGE_12 -->\n###### 온도\n\n<!-- PAGE_12 -->\n###### , pH, 시간 등 바이러스 불활화 제거 조건을 상세히 기술하고 제조공정 흐름도\n\n<!-- PAGE_12 -->\n###### /\n\n<!-- PAGE_12 -->\n###### 에 표시하여야 한다\n\n<!-- PAGE_12 -->\n###### .  바이러스 불활화 제거 공정의 유효성을 입증하기 위하여 바이\n\n<!-- PAGE_12 -->\n###### /\n\n<!-- PAGE_12 -->\n###### 러스 검증 자료를 제출하여야 한다\n\n<!-- PAGE_12 -->\n###### .  개별 바이러스 불활화 제거 공정의 효과를 평가\n\n<!-- PAGE_12 -->\n###### /\n\n<!-- PAGE_12 -->\n###### 한 후\n\n<!-- PAGE_12 -->\n###### , 전 제조공정에서의 바이러스 불활화 제거 능력의 추정치를 제공하여야 한다\n\n<!-- PAGE_12 -->\n###### /\n\n<!-- PAGE_12 -->\n###### .\n\n <!-- PAGE_12 -->\n###### 바이러스 검증 평가와 관련하여서는\n\n<!-- PAGE_12 -->\n###### 혈장분획제제 등 바이러스 검증 평가가이드\n\n<!-- PAGE_12 -->\n###### “\n\n<!-- PAGE_12 -->\n###### 생물의약품평가가이드\n\n<!-- PAGE_12 -->\n###### 와\n\n<!-- PAGE_12 -->\n###### 의\n\n<!-- PAGE_12 -->\n###### (\n\n<!-- PAGE_12 -->\n###### 20,\n\n<!-- PAGE_12 -->\n###### 2006)”\n\n<!-- PAGE_12 -->\n###### EMEA\n\n<!-- PAGE_12 -->\n###### “Note\n\n<!-- PAGE_12 -->\n###### for\n\n<!-- PAGE_12 -->\n###### Guidance\n\n<!-- PAGE_12 -->\n###### on\n\n<!-- PAGE_12 -->\n###### Virus\n\n<!-- PAGE_12 -->\n###### Validation\n\n<!-- PAGE_12 -->\n###### Studies:\n\n<!-- PAGE_12 -->\n###### The\n\n<!-- PAGE_12 -->\n###### Design,\n\n<!-- PAGE_12 -->\n###### Contribution\n\n<!-- PAGE_12 -->\n###### and\n\n<!-- PAGE_12 -->\n###### Interpretation\n\n<!-- PAGE_12 -->\n###### of\n\n<!-- PAGE_12 -->\n###### Studies\n\n<!-- PAGE_12 -->\n###### Validating the Inactivation and Removal of Viruses(CPMP/BWP/268/95, 1996)”\n\n<!-- PAGE_12 -->\n###### 품질관리\n\n<!-- PAGE_12 -->\n###### 4.\n\n <!-- PAGE_12 -->\n###### 최소한 연속적인\n\n<!-- PAGE_12 -->\n###### 개 로트에 대해 검증된 시험법으로 시험한 원료의약품 및 완제\n\n<!-- PAGE_12 -->\n###### 3\n\n<!-- PAGE_12 -->\n###### 또한 공정 중 관리\n\n<!-- PAGE_12 -->\n###### 시험항목과 기준을 제시하고\n\n<!-- PAGE_12 -->\n###### 제형\n\n<!-- PAGE_12 -->\n###### (in-process control, IPC)\n\n<!-- PAGE_12 -->\n###### ,\n\n<!-- PAGE_12 -->\n###### 화 과정 중 또는 생산 중 사용한 물질을 측정하고 예\n\n<!-- PAGE_12 -->\n###### 잔류용매\n\n<!-- PAGE_12 -->\n###### 계면활성제 등\n\n<!-- PAGE_12 -->\n###### (\n\n<!-- PAGE_12 -->\n###### :\n\n<!-- PAGE_12 -->\n###### ,\n\n<!-- PAGE_12 -->\n###### ),\n\n<!-- PAGE_12 -->\n###### 최소한 연속적인\n\n<!-- PAGE_12 -->\n###### 3개 로트에 대해 분석한 후 파라미터의 기준을 설정하여야 한다\n\n<!-- PAGE_12 -->\n###### .\n\n <!-- PAGE_12 -->\n###### 제조공정 중 또는 완제의약품에 잠재적 감염 위험이 있는 동물유래 물질을 사용\n\n<!-- PAGE_12 -->\n###### 하는 경우에는 기원 동물 및 사용 부위를 기재하여야 하며\n\n<!-- PAGE_12 -->\n###### 반추동물 유래 성분의\n\n<!-- PAGE_12 -->\n###### ,\n\n<!-- PAGE_12 -->\n###### 경우에는 전염성 해면상 뇌증\n\n<!-- PAGE_12 -->\n###### 감\n\n<!-- PAGE_12 -->\n###### (transmissible spongiform encephalopathy, TSE)\n\n<!-- PAGE_12 -->\n###### 염을 방지하기 위한 원료 선택 반추동물의 원산국\n\n<!-- PAGE_12 -->\n###### 반추동물의 연령 등\n\n<!-- PAGE_12 -->\n###### 또는 처리\n\n<!-- PAGE_12 -->\n###### (\n\n<!-- PAGE_12 -->\n###### ,\n\n<!-- PAGE_12 -->\n###### )\n\n<!-- PAGE_12 -->\n###### 방법 등을 기술하고\n\n<!-- PAGE_12 -->\n###### , 제품이 외래성 물질로부터 안전함을 입증하여야 한다\n\n<!-- PAGE_12 -->\n###### .\n\n",
        "original_sentence": "개별 바이러스 불활화 제거 공정의 효과를 평가\n\n<!-- PAGE_12 -->\n###### /\n\n<!-- PAGE_12 -->\n###### 한 후\n\n<!-- PAGE_12 -->\n###### , 전 제조공정에서의 바이러스 불활화 제거 능력의 추정치를 제공하여야 한다\n\n<!-- PAGE_12 -->\n###### /\n\n<!-- PAGE_12 -->\n###### .\n\n"
      }
    },
    {
      "chunk_id": "chunk_100",
      "text": "<!-- PAGE_12 -->\n###### 바이러스 검증 평가와 관련하여서는\n\n<!-- PAGE_12 -->\n###### 혈장분획제제 등 바이러스 검증 평가가이드\n\n<!-- PAGE_12 -->\n###### “\n\n<!-- PAGE_12 -->\n###### 생물의약품평가가이드\n\n<!-- PAGE_12 -->\n###### 와\n\n<!-- PAGE_12 -->\n###### 의\n\n<!-- PAGE_12 -->\n###### (\n\n<!-- PAGE_12 -->\n###### 20,\n\n<!-- PAGE_12 -->\n###### 2006)”\n\n<!-- PAGE_12 -->\n###### EMEA\n\n<!-- PAGE_12 -->\n###### “Note\n\n<!-- PAGE_12 -->\n###### for\n\n<!-- PAGE_12 -->\n###### Guidance\n\n<!-- PAGE_12 -->\n###### on\n\n<!-- PAGE_12 -->\n###### Virus\n\n<!-- PAGE_12 -->\n###### Validation\n\n<!-- PAGE_12 -->\n###### Studies:\n\n<!-- PAGE_12 -->\n###### The\n\n<!-- PAGE_12 -->\n###### Design,\n\n<!-- PAGE_12 -->\n###### Contribution\n\n<!-- PAGE_12 -->\n###### and\n\n<!-- PAGE_12 -->\n###### Interpretation\n\n<!-- PAGE_12 -->\n###### of\n\n<!-- PAGE_12 -->\n###### Studies\n\n<!-- PAGE_12 -->\n###### Validating the Inactivation and Removal of Viruses(CPMP/BWP/268/95, 1996)”\n\n<!-- PAGE_12 -->\n###### 품질관리\n\n<!-- PAGE_12 -->\n###### 4.\n\n",
      "metadata": {
        "source": "(가이드라인-005)_정맥주사용+B형간염+사람면역글로불린제제의+안전성유효성+평가+가이드라인.pdf",
        "chunk_index": 99,
        "window_size": 3,
        "char_count": 938,
        "word_count": 149,
        "page_number": 12,
        "window_text": "<!-- PAGE_12 -->\n###### 바이러스 불활화 제거 공정은 각각 최소\n\n<!-- PAGE_12 -->\n###### 단계 이상의 공정을 포함하도록 하며\n\n<!-- PAGE_12 -->\n###### /\n\n<!-- PAGE_12 -->\n###### 1\n\n<!-- PAGE_12 -->\n###### ,\n\n<!-- PAGE_12 -->\n###### 온도\n\n<!-- PAGE_12 -->\n###### , pH, 시간 등 바이러스 불활화 제거 조건을 상세히 기술하고 제조공정 흐름도\n\n<!-- PAGE_12 -->\n###### /\n\n<!-- PAGE_12 -->\n###### 에 표시하여야 한다\n\n<!-- PAGE_12 -->\n###### .  바이러스 불활화 제거 공정의 유효성을 입증하기 위하여 바이\n\n<!-- PAGE_12 -->\n###### /\n\n<!-- PAGE_12 -->\n###### 러스 검증 자료를 제출하여야 한다\n\n<!-- PAGE_12 -->\n###### .  개별 바이러스 불활화 제거 공정의 효과를 평가\n\n<!-- PAGE_12 -->\n###### /\n\n<!-- PAGE_12 -->\n###### 한 후\n\n<!-- PAGE_12 -->\n###### , 전 제조공정에서의 바이러스 불활화 제거 능력의 추정치를 제공하여야 한다\n\n<!-- PAGE_12 -->\n###### /\n\n<!-- PAGE_12 -->\n###### .\n\n <!-- PAGE_12 -->\n###### 바이러스 검증 평가와 관련하여서는\n\n<!-- PAGE_12 -->\n###### 혈장분획제제 등 바이러스 검증 평가가이드\n\n<!-- PAGE_12 -->\n###### “\n\n<!-- PAGE_12 -->\n###### 생물의약품평가가이드\n\n<!-- PAGE_12 -->\n###### 와\n\n<!-- PAGE_12 -->\n###### 의\n\n<!-- PAGE_12 -->\n###### (\n\n<!-- PAGE_12 -->\n###### 20,\n\n<!-- PAGE_12 -->\n###### 2006)”\n\n<!-- PAGE_12 -->\n###### EMEA\n\n<!-- PAGE_12 -->\n###### “Note\n\n<!-- PAGE_12 -->\n###### for\n\n<!-- PAGE_12 -->\n###### Guidance\n\n<!-- PAGE_12 -->\n###### on\n\n<!-- PAGE_12 -->\n###### Virus\n\n<!-- PAGE_12 -->\n###### Validation\n\n<!-- PAGE_12 -->\n###### Studies:\n\n<!-- PAGE_12 -->\n###### The\n\n<!-- PAGE_12 -->\n###### Design,\n\n<!-- PAGE_12 -->\n###### Contribution\n\n<!-- PAGE_12 -->\n###### and\n\n<!-- PAGE_12 -->\n###### Interpretation\n\n<!-- PAGE_12 -->\n###### of\n\n<!-- PAGE_12 -->\n###### Studies\n\n<!-- PAGE_12 -->\n###### Validating the Inactivation and Removal of Viruses(CPMP/BWP/268/95, 1996)”\n\n<!-- PAGE_12 -->\n###### 품질관리\n\n<!-- PAGE_12 -->\n###### 4.\n\n <!-- PAGE_12 -->\n###### 최소한 연속적인\n\n<!-- PAGE_12 -->\n###### 개 로트에 대해 검증된 시험법으로 시험한 원료의약품 및 완제\n\n<!-- PAGE_12 -->\n###### 3\n\n<!-- PAGE_12 -->\n###### 또한 공정 중 관리\n\n<!-- PAGE_12 -->\n###### 시험항목과 기준을 제시하고\n\n<!-- PAGE_12 -->\n###### 제형\n\n<!-- PAGE_12 -->\n###### (in-process control, IPC)\n\n<!-- PAGE_12 -->\n###### ,\n\n<!-- PAGE_12 -->\n###### 화 과정 중 또는 생산 중 사용한 물질을 측정하고 예\n\n<!-- PAGE_12 -->\n###### 잔류용매\n\n<!-- PAGE_12 -->\n###### 계면활성제 등\n\n<!-- PAGE_12 -->\n###### (\n\n<!-- PAGE_12 -->\n###### :\n\n<!-- PAGE_12 -->\n###### ,\n\n<!-- PAGE_12 -->\n###### ),\n\n<!-- PAGE_12 -->\n###### 최소한 연속적인\n\n<!-- PAGE_12 -->\n###### 3개 로트에 대해 분석한 후 파라미터의 기준을 설정하여야 한다\n\n<!-- PAGE_12 -->\n###### .\n\n <!-- PAGE_12 -->\n###### 제조공정 중 또는 완제의약품에 잠재적 감염 위험이 있는 동물유래 물질을 사용\n\n<!-- PAGE_12 -->\n###### 하는 경우에는 기원 동물 및 사용 부위를 기재하여야 하며\n\n<!-- PAGE_12 -->\n###### 반추동물 유래 성분의\n\n<!-- PAGE_12 -->\n###### ,\n\n<!-- PAGE_12 -->\n###### 경우에는 전염성 해면상 뇌증\n\n<!-- PAGE_12 -->\n###### 감\n\n<!-- PAGE_12 -->\n###### (transmissible spongiform encephalopathy, TSE)\n\n<!-- PAGE_12 -->\n###### 염을 방지하기 위한 원료 선택 반추동물의 원산국\n\n<!-- PAGE_12 -->\n###### 반추동물의 연령 등\n\n<!-- PAGE_12 -->\n###### 또는 처리\n\n<!-- PAGE_12 -->\n###### (\n\n<!-- PAGE_12 -->\n###### ,\n\n<!-- PAGE_12 -->\n###### )\n\n<!-- PAGE_12 -->\n###### 방법 등을 기술하고\n\n<!-- PAGE_12 -->\n###### , 제품이 외래성 물질로부터 안전함을 입증하여야 한다\n\n<!-- PAGE_12 -->\n###### .\n\n - - 5 -\n<!-- PAGE_13 -->\n###### . ",
        "original_sentence": "<!-- PAGE_12 -->\n###### 바이러스 검증 평가와 관련하여서는\n\n<!-- PAGE_12 -->\n###### 혈장분획제제 등 바이러스 검증 평가가이드\n\n<!-- PAGE_12 -->\n###### “\n\n<!-- PAGE_12 -->\n###### 생물의약품평가가이드\n\n<!-- PAGE_12 -->\n###### 와\n\n<!-- PAGE_12 -->\n###### 의\n\n<!-- PAGE_12 -->\n###### (\n\n<!-- PAGE_12 -->\n###### 20,\n\n<!-- PAGE_12 -->\n###### 2006)”\n\n<!-- PAGE_12 -->\n###### EMEA\n\n<!-- PAGE_12 -->\n###### “Note\n\n<!-- PAGE_12 -->\n###### for\n\n<!-- PAGE_12 -->\n###### Guidance\n\n<!-- PAGE_12 -->\n###### on\n\n<!-- PAGE_12 -->\n###### Virus\n\n<!-- PAGE_12 -->\n###### Validation\n\n<!-- PAGE_12 -->\n###### Studies:\n\n<!-- PAGE_12 -->\n###### The\n\n<!-- PAGE_12 -->\n###### Design,\n\n<!-- PAGE_12 -->\n###### Contribution\n\n<!-- PAGE_12 -->\n###### and\n\n<!-- PAGE_12 -->\n###### Interpretation\n\n<!-- PAGE_12 -->\n###### of\n\n<!-- PAGE_12 -->\n###### Studies\n\n<!-- PAGE_12 -->\n###### Validating the Inactivation and Removal of Viruses(CPMP/BWP/268/95, 1996)”\n\n<!-- PAGE_12 -->\n###### 품질관리\n\n<!-- PAGE_12 -->\n###### 4.\n\n"
      }
    },
    {
      "chunk_id": "chunk_101",
      "text": "<!-- PAGE_12 -->\n###### 최소한 연속적인\n\n<!-- PAGE_12 -->\n###### 개 로트에 대해 검증된 시험법으로 시험한 원료의약품 및 완제\n\n<!-- PAGE_12 -->\n###### 3\n\n<!-- PAGE_12 -->\n###### 또한 공정 중 관리\n\n<!-- PAGE_12 -->\n###### 시험항목과 기준을 제시하고\n\n<!-- PAGE_12 -->\n###### 제형\n\n<!-- PAGE_12 -->\n###### (in-process control, IPC)\n\n<!-- PAGE_12 -->\n###### ,\n\n<!-- PAGE_12 -->\n###### 화 과정 중 또는 생산 중 사용한 물질을 측정하고 예\n\n<!-- PAGE_12 -->\n###### 잔류용매\n\n<!-- PAGE_12 -->\n###### 계면활성제 등\n\n<!-- PAGE_12 -->\n###### (\n\n<!-- PAGE_12 -->\n###### :\n\n<!-- PAGE_12 -->\n###### ,\n\n<!-- PAGE_12 -->\n###### ),\n\n<!-- PAGE_12 -->\n###### 최소한 연속적인\n\n<!-- PAGE_12 -->\n###### 3개 로트에 대해 분석한 후 파라미터의 기준을 설정하여야 한다\n\n<!-- PAGE_12 -->\n###### .\n\n",
      "metadata": {
        "source": "(가이드라인-005)_정맥주사용+B형간염+사람면역글로불린제제의+안전성유효성+평가+가이드라인.pdf",
        "chunk_index": 100,
        "window_size": 3,
        "char_count": 650,
        "word_count": 125,
        "page_number": 12,
        "window_text": "바이러스 불활화 제거 공정의 유효성을 입증하기 위하여 바이\n\n<!-- PAGE_12 -->\n###### /\n\n<!-- PAGE_12 -->\n###### 러스 검증 자료를 제출하여야 한다\n\n<!-- PAGE_12 -->\n###### .  개별 바이러스 불활화 제거 공정의 효과를 평가\n\n<!-- PAGE_12 -->\n###### /\n\n<!-- PAGE_12 -->\n###### 한 후\n\n<!-- PAGE_12 -->\n###### , 전 제조공정에서의 바이러스 불활화 제거 능력의 추정치를 제공하여야 한다\n\n<!-- PAGE_12 -->\n###### /\n\n<!-- PAGE_12 -->\n###### .\n\n <!-- PAGE_12 -->\n###### 바이러스 검증 평가와 관련하여서는\n\n<!-- PAGE_12 -->\n###### 혈장분획제제 등 바이러스 검증 평가가이드\n\n<!-- PAGE_12 -->\n###### “\n\n<!-- PAGE_12 -->\n###### 생물의약품평가가이드\n\n<!-- PAGE_12 -->\n###### 와\n\n<!-- PAGE_12 -->\n###### 의\n\n<!-- PAGE_12 -->\n###### (\n\n<!-- PAGE_12 -->\n###### 20,\n\n<!-- PAGE_12 -->\n###### 2006)”\n\n<!-- PAGE_12 -->\n###### EMEA\n\n<!-- PAGE_12 -->\n###### “Note\n\n<!-- PAGE_12 -->\n###### for\n\n<!-- PAGE_12 -->\n###### Guidance\n\n<!-- PAGE_12 -->\n###### on\n\n<!-- PAGE_12 -->\n###### Virus\n\n<!-- PAGE_12 -->\n###### Validation\n\n<!-- PAGE_12 -->\n###### Studies:\n\n<!-- PAGE_12 -->\n###### The\n\n<!-- PAGE_12 -->\n###### Design,\n\n<!-- PAGE_12 -->\n###### Contribution\n\n<!-- PAGE_12 -->\n###### and\n\n<!-- PAGE_12 -->\n###### Interpretation\n\n<!-- PAGE_12 -->\n###### of\n\n<!-- PAGE_12 -->\n###### Studies\n\n<!-- PAGE_12 -->\n###### Validating the Inactivation and Removal of Viruses(CPMP/BWP/268/95, 1996)”\n\n<!-- PAGE_12 -->\n###### 품질관리\n\n<!-- PAGE_12 -->\n###### 4.\n\n <!-- PAGE_12 -->\n###### 최소한 연속적인\n\n<!-- PAGE_12 -->\n###### 개 로트에 대해 검증된 시험법으로 시험한 원료의약품 및 완제\n\n<!-- PAGE_12 -->\n###### 3\n\n<!-- PAGE_12 -->\n###### 또한 공정 중 관리\n\n<!-- PAGE_12 -->\n###### 시험항목과 기준을 제시하고\n\n<!-- PAGE_12 -->\n###### 제형\n\n<!-- PAGE_12 -->\n###### (in-process control, IPC)\n\n<!-- PAGE_12 -->\n###### ,\n\n<!-- PAGE_12 -->\n###### 화 과정 중 또는 생산 중 사용한 물질을 측정하고 예\n\n<!-- PAGE_12 -->\n###### 잔류용매\n\n<!-- PAGE_12 -->\n###### 계면활성제 등\n\n<!-- PAGE_12 -->\n###### (\n\n<!-- PAGE_12 -->\n###### :\n\n<!-- PAGE_12 -->\n###### ,\n\n<!-- PAGE_12 -->\n###### ),\n\n<!-- PAGE_12 -->\n###### 최소한 연속적인\n\n<!-- PAGE_12 -->\n###### 3개 로트에 대해 분석한 후 파라미터의 기준을 설정하여야 한다\n\n<!-- PAGE_12 -->\n###### .\n\n <!-- PAGE_12 -->\n###### 제조공정 중 또는 완제의약품에 잠재적 감염 위험이 있는 동물유래 물질을 사용\n\n<!-- PAGE_12 -->\n###### 하는 경우에는 기원 동물 및 사용 부위를 기재하여야 하며\n\n<!-- PAGE_12 -->\n###### 반추동물 유래 성분의\n\n<!-- PAGE_12 -->\n###### ,\n\n<!-- PAGE_12 -->\n###### 경우에는 전염성 해면상 뇌증\n\n<!-- PAGE_12 -->\n###### 감\n\n<!-- PAGE_12 -->\n###### (transmissible spongiform encephalopathy, TSE)\n\n<!-- PAGE_12 -->\n###### 염을 방지하기 위한 원료 선택 반추동물의 원산국\n\n<!-- PAGE_12 -->\n###### 반추동물의 연령 등\n\n<!-- PAGE_12 -->\n###### 또는 처리\n\n<!-- PAGE_12 -->\n###### (\n\n<!-- PAGE_12 -->\n###### ,\n\n<!-- PAGE_12 -->\n###### )\n\n<!-- PAGE_12 -->\n###### 방법 등을 기술하고\n\n<!-- PAGE_12 -->\n###### , 제품이 외래성 물질로부터 안전함을 입증하여야 한다\n\n<!-- PAGE_12 -->\n###### .\n\n - - 5 -\n<!-- PAGE_13 -->\n###### .  안정성시험\n\n<!-- PAGE_13 -->\n###### Ⅲ\n\n<!-- PAGE_13 -->\n###### 안정성시험은 제제의 물리화학적 상태 예\n\n<!-- PAGE_13 -->\n###### 분해물\n\n<!-- PAGE_13 -->\n###### 또는 중합물\n\n<!-- PAGE_13 -->\n###### [\n\n<!-- PAGE_13 -->\n###### :\n\n<!-- PAGE_13 -->\n###### (fragment)\n\n<!-- PAGE_13 -->\n###### (trimer\n\n<!-- PAGE_13 -->\n###### 이상의\n\n<!-- PAGE_13 -->\n###### 역가\n\n<!-- PAGE_13 -->\n###### 등 안정성에 대하여 설정기간 동안 일정한 간격으로 시험\n\n<!-- PAGE_13 -->\n###### polymer)],\n\n<!-- PAGE_13 -->\n###### , pH\n\n<!-- PAGE_13 -->\n###### 하도록 적절히 고안되어야 한다.\n\n",
        "original_sentence": "<!-- PAGE_12 -->\n###### 최소한 연속적인\n\n<!-- PAGE_12 -->\n###### 개 로트에 대해 검증된 시험법으로 시험한 원료의약품 및 완제\n\n<!-- PAGE_12 -->\n###### 3\n\n<!-- PAGE_12 -->\n###### 또한 공정 중 관리\n\n<!-- PAGE_12 -->\n###### 시험항목과 기준을 제시하고\n\n<!-- PAGE_12 -->\n###### 제형\n\n<!-- PAGE_12 -->\n###### (in-process control, IPC)\n\n<!-- PAGE_12 -->\n###### ,\n\n<!-- PAGE_12 -->\n###### 화 과정 중 또는 생산 중 사용한 물질을 측정하고 예\n\n<!-- PAGE_12 -->\n###### 잔류용매\n\n<!-- PAGE_12 -->\n###### 계면활성제 등\n\n<!-- PAGE_12 -->\n###### (\n\n<!-- PAGE_12 -->\n###### :\n\n<!-- PAGE_12 -->\n###### ,\n\n<!-- PAGE_12 -->\n###### ),\n\n<!-- PAGE_12 -->\n###### 최소한 연속적인\n\n<!-- PAGE_12 -->\n###### 3개 로트에 대해 분석한 후 파라미터의 기준을 설정하여야 한다\n\n<!-- PAGE_12 -->\n###### .\n\n"
      }
    },
    {
      "chunk_id": "chunk_102",
      "text": "<!-- PAGE_12 -->\n###### 제조공정 중 또는 완제의약품에 잠재적 감염 위험이 있는 동물유래 물질을 사용\n\n<!-- PAGE_12 -->\n###### 하는 경우에는 기원 동물 및 사용 부위를 기재하여야 하며\n\n<!-- PAGE_12 -->\n###### 반추동물 유래 성분의\n\n<!-- PAGE_12 -->\n###### ,\n\n<!-- PAGE_12 -->\n###### 경우에는 전염성 해면상 뇌증\n\n<!-- PAGE_12 -->\n###### 감\n\n<!-- PAGE_12 -->\n###### (transmissible spongiform encephalopathy, TSE)\n\n<!-- PAGE_12 -->\n###### 염을 방지하기 위한 원료 선택 반추동물의 원산국\n\n<!-- PAGE_12 -->\n###### 반추동물의 연령 등\n\n<!-- PAGE_12 -->\n###### 또는 처리\n\n<!-- PAGE_12 -->\n###### (\n\n<!-- PAGE_12 -->\n###### ,\n\n<!-- PAGE_12 -->\n###### )\n\n<!-- PAGE_12 -->\n###### 방법 등을 기술하고\n\n<!-- PAGE_12 -->\n###### , 제품이 외래성 물질로부터 안전함을 입증하여야 한다\n\n<!-- PAGE_12 -->\n###### .\n\n",
      "metadata": {
        "source": "(가이드라인-005)_정맥주사용+B형간염+사람면역글로불린제제의+안전성유효성+평가+가이드라인.pdf",
        "chunk_index": 101,
        "window_size": 3,
        "char_count": 647,
        "word_count": 123,
        "page_number": 12,
        "window_text": "개별 바이러스 불활화 제거 공정의 효과를 평가\n\n<!-- PAGE_12 -->\n###### /\n\n<!-- PAGE_12 -->\n###### 한 후\n\n<!-- PAGE_12 -->\n###### , 전 제조공정에서의 바이러스 불활화 제거 능력의 추정치를 제공하여야 한다\n\n<!-- PAGE_12 -->\n###### /\n\n<!-- PAGE_12 -->\n###### .\n\n <!-- PAGE_12 -->\n###### 바이러스 검증 평가와 관련하여서는\n\n<!-- PAGE_12 -->\n###### 혈장분획제제 등 바이러스 검증 평가가이드\n\n<!-- PAGE_12 -->\n###### “\n\n<!-- PAGE_12 -->\n###### 생물의약품평가가이드\n\n<!-- PAGE_12 -->\n###### 와\n\n<!-- PAGE_12 -->\n###### 의\n\n<!-- PAGE_12 -->\n###### (\n\n<!-- PAGE_12 -->\n###### 20,\n\n<!-- PAGE_12 -->\n###### 2006)”\n\n<!-- PAGE_12 -->\n###### EMEA\n\n<!-- PAGE_12 -->\n###### “Note\n\n<!-- PAGE_12 -->\n###### for\n\n<!-- PAGE_12 -->\n###### Guidance\n\n<!-- PAGE_12 -->\n###### on\n\n<!-- PAGE_12 -->\n###### Virus\n\n<!-- PAGE_12 -->\n###### Validation\n\n<!-- PAGE_12 -->\n###### Studies:\n\n<!-- PAGE_12 -->\n###### The\n\n<!-- PAGE_12 -->\n###### Design,\n\n<!-- PAGE_12 -->\n###### Contribution\n\n<!-- PAGE_12 -->\n###### and\n\n<!-- PAGE_12 -->\n###### Interpretation\n\n<!-- PAGE_12 -->\n###### of\n\n<!-- PAGE_12 -->\n###### Studies\n\n<!-- PAGE_12 -->\n###### Validating the Inactivation and Removal of Viruses(CPMP/BWP/268/95, 1996)”\n\n<!-- PAGE_12 -->\n###### 품질관리\n\n<!-- PAGE_12 -->\n###### 4.\n\n <!-- PAGE_12 -->\n###### 최소한 연속적인\n\n<!-- PAGE_12 -->\n###### 개 로트에 대해 검증된 시험법으로 시험한 원료의약품 및 완제\n\n<!-- PAGE_12 -->\n###### 3\n\n<!-- PAGE_12 -->\n###### 또한 공정 중 관리\n\n<!-- PAGE_12 -->\n###### 시험항목과 기준을 제시하고\n\n<!-- PAGE_12 -->\n###### 제형\n\n<!-- PAGE_12 -->\n###### (in-process control, IPC)\n\n<!-- PAGE_12 -->\n###### ,\n\n<!-- PAGE_12 -->\n###### 화 과정 중 또는 생산 중 사용한 물질을 측정하고 예\n\n<!-- PAGE_12 -->\n###### 잔류용매\n\n<!-- PAGE_12 -->\n###### 계면활성제 등\n\n<!-- PAGE_12 -->\n###### (\n\n<!-- PAGE_12 -->\n###### :\n\n<!-- PAGE_12 -->\n###### ,\n\n<!-- PAGE_12 -->\n###### ),\n\n<!-- PAGE_12 -->\n###### 최소한 연속적인\n\n<!-- PAGE_12 -->\n###### 3개 로트에 대해 분석한 후 파라미터의 기준을 설정하여야 한다\n\n<!-- PAGE_12 -->\n###### .\n\n <!-- PAGE_12 -->\n###### 제조공정 중 또는 완제의약품에 잠재적 감염 위험이 있는 동물유래 물질을 사용\n\n<!-- PAGE_12 -->\n###### 하는 경우에는 기원 동물 및 사용 부위를 기재하여야 하며\n\n<!-- PAGE_12 -->\n###### 반추동물 유래 성분의\n\n<!-- PAGE_12 -->\n###### ,\n\n<!-- PAGE_12 -->\n###### 경우에는 전염성 해면상 뇌증\n\n<!-- PAGE_12 -->\n###### 감\n\n<!-- PAGE_12 -->\n###### (transmissible spongiform encephalopathy, TSE)\n\n<!-- PAGE_12 -->\n###### 염을 방지하기 위한 원료 선택 반추동물의 원산국\n\n<!-- PAGE_12 -->\n###### 반추동물의 연령 등\n\n<!-- PAGE_12 -->\n###### 또는 처리\n\n<!-- PAGE_12 -->\n###### (\n\n<!-- PAGE_12 -->\n###### ,\n\n<!-- PAGE_12 -->\n###### )\n\n<!-- PAGE_12 -->\n###### 방법 등을 기술하고\n\n<!-- PAGE_12 -->\n###### , 제품이 외래성 물질로부터 안전함을 입증하여야 한다\n\n<!-- PAGE_12 -->\n###### .\n\n - - 5 -\n<!-- PAGE_13 -->\n###### .  안정성시험\n\n<!-- PAGE_13 -->\n###### Ⅲ\n\n<!-- PAGE_13 -->\n###### 안정성시험은 제제의 물리화학적 상태 예\n\n<!-- PAGE_13 -->\n###### 분해물\n\n<!-- PAGE_13 -->\n###### 또는 중합물\n\n<!-- PAGE_13 -->\n###### [\n\n<!-- PAGE_13 -->\n###### :\n\n<!-- PAGE_13 -->\n###### (fragment)\n\n<!-- PAGE_13 -->\n###### (trimer\n\n<!-- PAGE_13 -->\n###### 이상의\n\n<!-- PAGE_13 -->\n###### 역가\n\n<!-- PAGE_13 -->\n###### 등 안정성에 대하여 설정기간 동안 일정한 간격으로 시험\n\n<!-- PAGE_13 -->\n###### polymer)],\n\n<!-- PAGE_13 -->\n###### , pH\n\n<!-- PAGE_13 -->\n###### 하도록 적절히 고안되어야 한다.\n\n <!-- PAGE_13 -->\n###### 품목허가를 위해서는 유통에 사용할 용기와 밀봉 형태로 충진된 완제의약품에 대하\n\n<!-- PAGE_13 -->\n###### 여 유효기간을 입증할 수 있는 안정성시험을 수행하여야 한다\n\n<!-- PAGE_13 -->\n###### 원료의약품 및 중간산\n\n<!-- PAGE_13 -->\n###### .\n\n",
        "original_sentence": "<!-- PAGE_12 -->\n###### 제조공정 중 또는 완제의약품에 잠재적 감염 위험이 있는 동물유래 물질을 사용\n\n<!-- PAGE_12 -->\n###### 하는 경우에는 기원 동물 및 사용 부위를 기재하여야 하며\n\n<!-- PAGE_12 -->\n###### 반추동물 유래 성분의\n\n<!-- PAGE_12 -->\n###### ,\n\n<!-- PAGE_12 -->\n###### 경우에는 전염성 해면상 뇌증\n\n<!-- PAGE_12 -->\n###### 감\n\n<!-- PAGE_12 -->\n###### (transmissible spongiform encephalopathy, TSE)\n\n<!-- PAGE_12 -->\n###### 염을 방지하기 위한 원료 선택 반추동물의 원산국\n\n<!-- PAGE_12 -->\n###### 반추동물의 연령 등\n\n<!-- PAGE_12 -->\n###### 또는 처리\n\n<!-- PAGE_12 -->\n###### (\n\n<!-- PAGE_12 -->\n###### ,\n\n<!-- PAGE_12 -->\n###### )\n\n<!-- PAGE_12 -->\n###### 방법 등을 기술하고\n\n<!-- PAGE_12 -->\n###### , 제품이 외래성 물질로부터 안전함을 입증하여야 한다\n\n<!-- PAGE_12 -->\n###### .\n\n"
      }
    },
    {
      "chunk_id": "chunk_103",
      "text": "- - 5 -\n<!-- PAGE_13 -->\n###### . ",
      "metadata": {
        "source": "(가이드라인-005)_정맥주사용+B형간염+사람면역글로불린제제의+안전성유효성+평가+가이드라인.pdf",
        "chunk_index": 102,
        "window_size": 3,
        "char_count": 34,
        "word_count": 9,
        "page_number": 13,
        "window_text": "<!-- PAGE_12 -->\n###### 바이러스 검증 평가와 관련하여서는\n\n<!-- PAGE_12 -->\n###### 혈장분획제제 등 바이러스 검증 평가가이드\n\n<!-- PAGE_12 -->\n###### “\n\n<!-- PAGE_12 -->\n###### 생물의약품평가가이드\n\n<!-- PAGE_12 -->\n###### 와\n\n<!-- PAGE_12 -->\n###### 의\n\n<!-- PAGE_12 -->\n###### (\n\n<!-- PAGE_12 -->\n###### 20,\n\n<!-- PAGE_12 -->\n###### 2006)”\n\n<!-- PAGE_12 -->\n###### EMEA\n\n<!-- PAGE_12 -->\n###### “Note\n\n<!-- PAGE_12 -->\n###### for\n\n<!-- PAGE_12 -->\n###### Guidance\n\n<!-- PAGE_12 -->\n###### on\n\n<!-- PAGE_12 -->\n###### Virus\n\n<!-- PAGE_12 -->\n###### Validation\n\n<!-- PAGE_12 -->\n###### Studies:\n\n<!-- PAGE_12 -->\n###### The\n\n<!-- PAGE_12 -->\n###### Design,\n\n<!-- PAGE_12 -->\n###### Contribution\n\n<!-- PAGE_12 -->\n###### and\n\n<!-- PAGE_12 -->\n###### Interpretation\n\n<!-- PAGE_12 -->\n###### of\n\n<!-- PAGE_12 -->\n###### Studies\n\n<!-- PAGE_12 -->\n###### Validating the Inactivation and Removal of Viruses(CPMP/BWP/268/95, 1996)”\n\n<!-- PAGE_12 -->\n###### 품질관리\n\n<!-- PAGE_12 -->\n###### 4.\n\n <!-- PAGE_12 -->\n###### 최소한 연속적인\n\n<!-- PAGE_12 -->\n###### 개 로트에 대해 검증된 시험법으로 시험한 원료의약품 및 완제\n\n<!-- PAGE_12 -->\n###### 3\n\n<!-- PAGE_12 -->\n###### 또한 공정 중 관리\n\n<!-- PAGE_12 -->\n###### 시험항목과 기준을 제시하고\n\n<!-- PAGE_12 -->\n###### 제형\n\n<!-- PAGE_12 -->\n###### (in-process control, IPC)\n\n<!-- PAGE_12 -->\n###### ,\n\n<!-- PAGE_12 -->\n###### 화 과정 중 또는 생산 중 사용한 물질을 측정하고 예\n\n<!-- PAGE_12 -->\n###### 잔류용매\n\n<!-- PAGE_12 -->\n###### 계면활성제 등\n\n<!-- PAGE_12 -->\n###### (\n\n<!-- PAGE_12 -->\n###### :\n\n<!-- PAGE_12 -->\n###### ,\n\n<!-- PAGE_12 -->\n###### ),\n\n<!-- PAGE_12 -->\n###### 최소한 연속적인\n\n<!-- PAGE_12 -->\n###### 3개 로트에 대해 분석한 후 파라미터의 기준을 설정하여야 한다\n\n<!-- PAGE_12 -->\n###### .\n\n <!-- PAGE_12 -->\n###### 제조공정 중 또는 완제의약품에 잠재적 감염 위험이 있는 동물유래 물질을 사용\n\n<!-- PAGE_12 -->\n###### 하는 경우에는 기원 동물 및 사용 부위를 기재하여야 하며\n\n<!-- PAGE_12 -->\n###### 반추동물 유래 성분의\n\n<!-- PAGE_12 -->\n###### ,\n\n<!-- PAGE_12 -->\n###### 경우에는 전염성 해면상 뇌증\n\n<!-- PAGE_12 -->\n###### 감\n\n<!-- PAGE_12 -->\n###### (transmissible spongiform encephalopathy, TSE)\n\n<!-- PAGE_12 -->\n###### 염을 방지하기 위한 원료 선택 반추동물의 원산국\n\n<!-- PAGE_12 -->\n###### 반추동물의 연령 등\n\n<!-- PAGE_12 -->\n###### 또는 처리\n\n<!-- PAGE_12 -->\n###### (\n\n<!-- PAGE_12 -->\n###### ,\n\n<!-- PAGE_12 -->\n###### )\n\n<!-- PAGE_12 -->\n###### 방법 등을 기술하고\n\n<!-- PAGE_12 -->\n###### , 제품이 외래성 물질로부터 안전함을 입증하여야 한다\n\n<!-- PAGE_12 -->\n###### .\n\n - - 5 -\n<!-- PAGE_13 -->\n###### .  안정성시험\n\n<!-- PAGE_13 -->\n###### Ⅲ\n\n<!-- PAGE_13 -->\n###### 안정성시험은 제제의 물리화학적 상태 예\n\n<!-- PAGE_13 -->\n###### 분해물\n\n<!-- PAGE_13 -->\n###### 또는 중합물\n\n<!-- PAGE_13 -->\n###### [\n\n<!-- PAGE_13 -->\n###### :\n\n<!-- PAGE_13 -->\n###### (fragment)\n\n<!-- PAGE_13 -->\n###### (trimer\n\n<!-- PAGE_13 -->\n###### 이상의\n\n<!-- PAGE_13 -->\n###### 역가\n\n<!-- PAGE_13 -->\n###### 등 안정성에 대하여 설정기간 동안 일정한 간격으로 시험\n\n<!-- PAGE_13 -->\n###### polymer)],\n\n<!-- PAGE_13 -->\n###### , pH\n\n<!-- PAGE_13 -->\n###### 하도록 적절히 고안되어야 한다.\n\n <!-- PAGE_13 -->\n###### 품목허가를 위해서는 유통에 사용할 용기와 밀봉 형태로 충진된 완제의약품에 대하\n\n<!-- PAGE_13 -->\n###### 여 유효기간을 입증할 수 있는 안정성시험을 수행하여야 한다\n\n<!-- PAGE_13 -->\n###### 원료의약품 및 중간산\n\n<!-- PAGE_13 -->\n###### .\n\n <!-- PAGE_13 -->\n###### 물을 보관할 경우 이에 대한 저장 및 유효기간도 안정성시험에 의해 입증하여야 한다.\n\n",
        "original_sentence": "- - 5 -\n<!-- PAGE_13 -->\n###### . "
      }
    },
    {
      "chunk_id": "chunk_104",
      "text": "안정성시험\n\n<!-- PAGE_13 -->\n###### Ⅲ\n\n<!-- PAGE_13 -->\n###### 안정성시험은 제제의 물리화학적 상태 예\n\n<!-- PAGE_13 -->\n###### 분해물\n\n<!-- PAGE_13 -->\n###### 또는 중합물\n\n<!-- PAGE_13 -->\n###### [\n\n<!-- PAGE_13 -->\n###### :\n\n<!-- PAGE_13 -->\n###### (fragment)\n\n<!-- PAGE_13 -->\n###### (trimer\n\n<!-- PAGE_13 -->\n###### 이상의\n\n<!-- PAGE_13 -->\n###### 역가\n\n<!-- PAGE_13 -->\n###### 등 안정성에 대하여 설정기간 동안 일정한 간격으로 시험\n\n<!-- PAGE_13 -->\n###### polymer)],\n\n<!-- PAGE_13 -->\n###### , pH\n\n<!-- PAGE_13 -->\n###### 하도록 적절히 고안되어야 한다.\n\n",
      "metadata": {
        "source": "(가이드라인-005)_정맥주사용+B형간염+사람면역글로불린제제의+안전성유효성+평가+가이드라인.pdf",
        "chunk_index": 103,
        "window_size": 3,
        "char_count": 487,
        "word_count": 87,
        "page_number": 13,
        "window_text": "<!-- PAGE_12 -->\n###### 최소한 연속적인\n\n<!-- PAGE_12 -->\n###### 개 로트에 대해 검증된 시험법으로 시험한 원료의약품 및 완제\n\n<!-- PAGE_12 -->\n###### 3\n\n<!-- PAGE_12 -->\n###### 또한 공정 중 관리\n\n<!-- PAGE_12 -->\n###### 시험항목과 기준을 제시하고\n\n<!-- PAGE_12 -->\n###### 제형\n\n<!-- PAGE_12 -->\n###### (in-process control, IPC)\n\n<!-- PAGE_12 -->\n###### ,\n\n<!-- PAGE_12 -->\n###### 화 과정 중 또는 생산 중 사용한 물질을 측정하고 예\n\n<!-- PAGE_12 -->\n###### 잔류용매\n\n<!-- PAGE_12 -->\n###### 계면활성제 등\n\n<!-- PAGE_12 -->\n###### (\n\n<!-- PAGE_12 -->\n###### :\n\n<!-- PAGE_12 -->\n###### ,\n\n<!-- PAGE_12 -->\n###### ),\n\n<!-- PAGE_12 -->\n###### 최소한 연속적인\n\n<!-- PAGE_12 -->\n###### 3개 로트에 대해 분석한 후 파라미터의 기준을 설정하여야 한다\n\n<!-- PAGE_12 -->\n###### .\n\n <!-- PAGE_12 -->\n###### 제조공정 중 또는 완제의약품에 잠재적 감염 위험이 있는 동물유래 물질을 사용\n\n<!-- PAGE_12 -->\n###### 하는 경우에는 기원 동물 및 사용 부위를 기재하여야 하며\n\n<!-- PAGE_12 -->\n###### 반추동물 유래 성분의\n\n<!-- PAGE_12 -->\n###### ,\n\n<!-- PAGE_12 -->\n###### 경우에는 전염성 해면상 뇌증\n\n<!-- PAGE_12 -->\n###### 감\n\n<!-- PAGE_12 -->\n###### (transmissible spongiform encephalopathy, TSE)\n\n<!-- PAGE_12 -->\n###### 염을 방지하기 위한 원료 선택 반추동물의 원산국\n\n<!-- PAGE_12 -->\n###### 반추동물의 연령 등\n\n<!-- PAGE_12 -->\n###### 또는 처리\n\n<!-- PAGE_12 -->\n###### (\n\n<!-- PAGE_12 -->\n###### ,\n\n<!-- PAGE_12 -->\n###### )\n\n<!-- PAGE_12 -->\n###### 방법 등을 기술하고\n\n<!-- PAGE_12 -->\n###### , 제품이 외래성 물질로부터 안전함을 입증하여야 한다\n\n<!-- PAGE_12 -->\n###### .\n\n - - 5 -\n<!-- PAGE_13 -->\n###### .  안정성시험\n\n<!-- PAGE_13 -->\n###### Ⅲ\n\n<!-- PAGE_13 -->\n###### 안정성시험은 제제의 물리화학적 상태 예\n\n<!-- PAGE_13 -->\n###### 분해물\n\n<!-- PAGE_13 -->\n###### 또는 중합물\n\n<!-- PAGE_13 -->\n###### [\n\n<!-- PAGE_13 -->\n###### :\n\n<!-- PAGE_13 -->\n###### (fragment)\n\n<!-- PAGE_13 -->\n###### (trimer\n\n<!-- PAGE_13 -->\n###### 이상의\n\n<!-- PAGE_13 -->\n###### 역가\n\n<!-- PAGE_13 -->\n###### 등 안정성에 대하여 설정기간 동안 일정한 간격으로 시험\n\n<!-- PAGE_13 -->\n###### polymer)],\n\n<!-- PAGE_13 -->\n###### , pH\n\n<!-- PAGE_13 -->\n###### 하도록 적절히 고안되어야 한다.\n\n <!-- PAGE_13 -->\n###### 품목허가를 위해서는 유통에 사용할 용기와 밀봉 형태로 충진된 완제의약품에 대하\n\n<!-- PAGE_13 -->\n###### 여 유효기간을 입증할 수 있는 안정성시험을 수행하여야 한다\n\n<!-- PAGE_13 -->\n###### 원료의약품 및 중간산\n\n<!-- PAGE_13 -->\n###### .\n\n <!-- PAGE_13 -->\n###### 물을 보관할 경우 이에 대한 저장 및 유효기간도 안정성시험에 의해 입증하여야 한다.\n\n <!-- PAGE_13 -->\n###### 가속시험은 어떠한 시험항목이 안정성의 지표가 되는지를 확인하고 확립하는데 도\n\n<!-- PAGE_13 -->\n###### 움을 줄 수 있으며\n\n<!-- PAGE_13 -->\n###### , 장기보존시험 자료를 보완할 수는 있지만 대체하지는 못한다\n\n<!-- PAGE_13 -->\n###### .\n\n",
        "original_sentence": "안정성시험\n\n<!-- PAGE_13 -->\n###### Ⅲ\n\n<!-- PAGE_13 -->\n###### 안정성시험은 제제의 물리화학적 상태 예\n\n<!-- PAGE_13 -->\n###### 분해물\n\n<!-- PAGE_13 -->\n###### 또는 중합물\n\n<!-- PAGE_13 -->\n###### [\n\n<!-- PAGE_13 -->\n###### :\n\n<!-- PAGE_13 -->\n###### (fragment)\n\n<!-- PAGE_13 -->\n###### (trimer\n\n<!-- PAGE_13 -->\n###### 이상의\n\n<!-- PAGE_13 -->\n###### 역가\n\n<!-- PAGE_13 -->\n###### 등 안정성에 대하여 설정기간 동안 일정한 간격으로 시험\n\n<!-- PAGE_13 -->\n###### polymer)],\n\n<!-- PAGE_13 -->\n###### , pH\n\n<!-- PAGE_13 -->\n###### 하도록 적절히 고안되어야 한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_105",
      "text": "<!-- PAGE_13 -->\n###### 품목허가를 위해서는 유통에 사용할 용기와 밀봉 형태로 충진된 완제의약품에 대하\n\n<!-- PAGE_13 -->\n###### 여 유효기간을 입증할 수 있는 안정성시험을 수행하여야 한다\n\n<!-- PAGE_13 -->\n###### 원료의약품 및 중간산\n\n<!-- PAGE_13 -->\n###### .\n\n",
      "metadata": {
        "source": "(가이드라인-005)_정맥주사용+B형간염+사람면역글로불린제제의+안전성유효성+평가+가이드라인.pdf",
        "chunk_index": 104,
        "window_size": 3,
        "char_count": 191,
        "word_count": 38,
        "page_number": 13,
        "window_text": "<!-- PAGE_12 -->\n###### 제조공정 중 또는 완제의약품에 잠재적 감염 위험이 있는 동물유래 물질을 사용\n\n<!-- PAGE_12 -->\n###### 하는 경우에는 기원 동물 및 사용 부위를 기재하여야 하며\n\n<!-- PAGE_12 -->\n###### 반추동물 유래 성분의\n\n<!-- PAGE_12 -->\n###### ,\n\n<!-- PAGE_12 -->\n###### 경우에는 전염성 해면상 뇌증\n\n<!-- PAGE_12 -->\n###### 감\n\n<!-- PAGE_12 -->\n###### (transmissible spongiform encephalopathy, TSE)\n\n<!-- PAGE_12 -->\n###### 염을 방지하기 위한 원료 선택 반추동물의 원산국\n\n<!-- PAGE_12 -->\n###### 반추동물의 연령 등\n\n<!-- PAGE_12 -->\n###### 또는 처리\n\n<!-- PAGE_12 -->\n###### (\n\n<!-- PAGE_12 -->\n###### ,\n\n<!-- PAGE_12 -->\n###### )\n\n<!-- PAGE_12 -->\n###### 방법 등을 기술하고\n\n<!-- PAGE_12 -->\n###### , 제품이 외래성 물질로부터 안전함을 입증하여야 한다\n\n<!-- PAGE_12 -->\n###### .\n\n - - 5 -\n<!-- PAGE_13 -->\n###### .  안정성시험\n\n<!-- PAGE_13 -->\n###### Ⅲ\n\n<!-- PAGE_13 -->\n###### 안정성시험은 제제의 물리화학적 상태 예\n\n<!-- PAGE_13 -->\n###### 분해물\n\n<!-- PAGE_13 -->\n###### 또는 중합물\n\n<!-- PAGE_13 -->\n###### [\n\n<!-- PAGE_13 -->\n###### :\n\n<!-- PAGE_13 -->\n###### (fragment)\n\n<!-- PAGE_13 -->\n###### (trimer\n\n<!-- PAGE_13 -->\n###### 이상의\n\n<!-- PAGE_13 -->\n###### 역가\n\n<!-- PAGE_13 -->\n###### 등 안정성에 대하여 설정기간 동안 일정한 간격으로 시험\n\n<!-- PAGE_13 -->\n###### polymer)],\n\n<!-- PAGE_13 -->\n###### , pH\n\n<!-- PAGE_13 -->\n###### 하도록 적절히 고안되어야 한다.\n\n <!-- PAGE_13 -->\n###### 품목허가를 위해서는 유통에 사용할 용기와 밀봉 형태로 충진된 완제의약품에 대하\n\n<!-- PAGE_13 -->\n###### 여 유효기간을 입증할 수 있는 안정성시험을 수행하여야 한다\n\n<!-- PAGE_13 -->\n###### 원료의약품 및 중간산\n\n<!-- PAGE_13 -->\n###### .\n\n <!-- PAGE_13 -->\n###### 물을 보관할 경우 이에 대한 저장 및 유효기간도 안정성시험에 의해 입증하여야 한다.\n\n <!-- PAGE_13 -->\n###### 가속시험은 어떠한 시험항목이 안정성의 지표가 되는지를 확인하고 확립하는데 도\n\n<!-- PAGE_13 -->\n###### 움을 줄 수 있으며\n\n<!-- PAGE_13 -->\n###### , 장기보존시험 자료를 보완할 수는 있지만 대체하지는 못한다\n\n<!-- PAGE_13 -->\n###### .\n\n <!-- PAGE_13 -->\n###### . ",
        "original_sentence": "<!-- PAGE_13 -->\n###### 품목허가를 위해서는 유통에 사용할 용기와 밀봉 형태로 충진된 완제의약품에 대하\n\n<!-- PAGE_13 -->\n###### 여 유효기간을 입증할 수 있는 안정성시험을 수행하여야 한다\n\n<!-- PAGE_13 -->\n###### 원료의약품 및 중간산\n\n<!-- PAGE_13 -->\n###### .\n\n"
      }
    },
    {
      "chunk_id": "chunk_106",
      "text": "<!-- PAGE_13 -->\n###### 물을 보관할 경우 이에 대한 저장 및 유효기간도 안정성시험에 의해 입증하여야 한다.\n\n",
      "metadata": {
        "source": "(가이드라인-005)_정맥주사용+B형간염+사람면역글로불린제제의+안전성유효성+평가+가이드라인.pdf",
        "chunk_index": 105,
        "window_size": 3,
        "char_count": 72,
        "word_count": 16,
        "page_number": 13,
        "window_text": "- - 5 -\n<!-- PAGE_13 -->\n###### .  안정성시험\n\n<!-- PAGE_13 -->\n###### Ⅲ\n\n<!-- PAGE_13 -->\n###### 안정성시험은 제제의 물리화학적 상태 예\n\n<!-- PAGE_13 -->\n###### 분해물\n\n<!-- PAGE_13 -->\n###### 또는 중합물\n\n<!-- PAGE_13 -->\n###### [\n\n<!-- PAGE_13 -->\n###### :\n\n<!-- PAGE_13 -->\n###### (fragment)\n\n<!-- PAGE_13 -->\n###### (trimer\n\n<!-- PAGE_13 -->\n###### 이상의\n\n<!-- PAGE_13 -->\n###### 역가\n\n<!-- PAGE_13 -->\n###### 등 안정성에 대하여 설정기간 동안 일정한 간격으로 시험\n\n<!-- PAGE_13 -->\n###### polymer)],\n\n<!-- PAGE_13 -->\n###### , pH\n\n<!-- PAGE_13 -->\n###### 하도록 적절히 고안되어야 한다.\n\n <!-- PAGE_13 -->\n###### 품목허가를 위해서는 유통에 사용할 용기와 밀봉 형태로 충진된 완제의약품에 대하\n\n<!-- PAGE_13 -->\n###### 여 유효기간을 입증할 수 있는 안정성시험을 수행하여야 한다\n\n<!-- PAGE_13 -->\n###### 원료의약품 및 중간산\n\n<!-- PAGE_13 -->\n###### .\n\n <!-- PAGE_13 -->\n###### 물을 보관할 경우 이에 대한 저장 및 유효기간도 안정성시험에 의해 입증하여야 한다.\n\n <!-- PAGE_13 -->\n###### 가속시험은 어떠한 시험항목이 안정성의 지표가 되는지를 확인하고 확립하는데 도\n\n<!-- PAGE_13 -->\n###### 움을 줄 수 있으며\n\n<!-- PAGE_13 -->\n###### , 장기보존시험 자료를 보완할 수는 있지만 대체하지는 못한다\n\n<!-- PAGE_13 -->\n###### .\n\n <!-- PAGE_13 -->\n###### .  비임상시험\n\n<!-- PAGE_13 -->\n###### Ⅳ\n\n<!-- PAGE_13 -->\n###### 일반적 고려사항\n\n<!-- PAGE_13 -->\n###### 1.\n\n",
        "original_sentence": "<!-- PAGE_13 -->\n###### 물을 보관할 경우 이에 대한 저장 및 유효기간도 안정성시험에 의해 입증하여야 한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_107",
      "text": "<!-- PAGE_13 -->\n###### 가속시험은 어떠한 시험항목이 안정성의 지표가 되는지를 확인하고 확립하는데 도\n\n<!-- PAGE_13 -->\n###### 움을 줄 수 있으며\n\n<!-- PAGE_13 -->\n###### , 장기보존시험 자료를 보완할 수는 있지만 대체하지는 못한다\n\n<!-- PAGE_13 -->\n###### .\n\n",
      "metadata": {
        "source": "(가이드라인-005)_정맥주사용+B형간염+사람면역글로불린제제의+안전성유효성+평가+가이드라인.pdf",
        "chunk_index": 106,
        "window_size": 3,
        "char_count": 190,
        "word_count": 38,
        "page_number": 13,
        "window_text": "안정성시험\n\n<!-- PAGE_13 -->\n###### Ⅲ\n\n<!-- PAGE_13 -->\n###### 안정성시험은 제제의 물리화학적 상태 예\n\n<!-- PAGE_13 -->\n###### 분해물\n\n<!-- PAGE_13 -->\n###### 또는 중합물\n\n<!-- PAGE_13 -->\n###### [\n\n<!-- PAGE_13 -->\n###### :\n\n<!-- PAGE_13 -->\n###### (fragment)\n\n<!-- PAGE_13 -->\n###### (trimer\n\n<!-- PAGE_13 -->\n###### 이상의\n\n<!-- PAGE_13 -->\n###### 역가\n\n<!-- PAGE_13 -->\n###### 등 안정성에 대하여 설정기간 동안 일정한 간격으로 시험\n\n<!-- PAGE_13 -->\n###### polymer)],\n\n<!-- PAGE_13 -->\n###### , pH\n\n<!-- PAGE_13 -->\n###### 하도록 적절히 고안되어야 한다.\n\n <!-- PAGE_13 -->\n###### 품목허가를 위해서는 유통에 사용할 용기와 밀봉 형태로 충진된 완제의약품에 대하\n\n<!-- PAGE_13 -->\n###### 여 유효기간을 입증할 수 있는 안정성시험을 수행하여야 한다\n\n<!-- PAGE_13 -->\n###### 원료의약품 및 중간산\n\n<!-- PAGE_13 -->\n###### .\n\n <!-- PAGE_13 -->\n###### 물을 보관할 경우 이에 대한 저장 및 유효기간도 안정성시험에 의해 입증하여야 한다.\n\n <!-- PAGE_13 -->\n###### 가속시험은 어떠한 시험항목이 안정성의 지표가 되는지를 확인하고 확립하는데 도\n\n<!-- PAGE_13 -->\n###### 움을 줄 수 있으며\n\n<!-- PAGE_13 -->\n###### , 장기보존시험 자료를 보완할 수는 있지만 대체하지는 못한다\n\n<!-- PAGE_13 -->\n###### .\n\n <!-- PAGE_13 -->\n###### .  비임상시험\n\n<!-- PAGE_13 -->\n###### Ⅳ\n\n<!-- PAGE_13 -->\n###### 일반적 고려사항\n\n<!-- PAGE_13 -->\n###### 1.\n\n <!-- PAGE_13 -->\n###### 비임상시험의 목적은 사람에 있어서의 잠재적 부작용 및 독성을 확인하고 가능하\n\n<!-- PAGE_13 -->\n###### 다면 임상시험에서의 안전한 초회 투여 용량 등을 결정하기 위함이다\n\n<!-- PAGE_13 -->\n###### 임상시험 실\n\n<!-- PAGE_13 -->\n###### .\n\n",
        "original_sentence": "<!-- PAGE_13 -->\n###### 가속시험은 어떠한 시험항목이 안정성의 지표가 되는지를 확인하고 확립하는데 도\n\n<!-- PAGE_13 -->\n###### 움을 줄 수 있으며\n\n<!-- PAGE_13 -->\n###### , 장기보존시험 자료를 보완할 수는 있지만 대체하지는 못한다\n\n<!-- PAGE_13 -->\n###### .\n\n"
      }
    },
    {
      "chunk_id": "chunk_108",
      "text": "<!-- PAGE_13 -->\n###### . ",
      "metadata": {
        "source": "(가이드라인-005)_정맥주사용+B형간염+사람면역글로불린제제의+안전성유효성+평가+가이드라인.pdf",
        "chunk_index": 107,
        "window_size": 3,
        "char_count": 26,
        "word_count": 5,
        "page_number": 13,
        "window_text": "<!-- PAGE_13 -->\n###### 품목허가를 위해서는 유통에 사용할 용기와 밀봉 형태로 충진된 완제의약품에 대하\n\n<!-- PAGE_13 -->\n###### 여 유효기간을 입증할 수 있는 안정성시험을 수행하여야 한다\n\n<!-- PAGE_13 -->\n###### 원료의약품 및 중간산\n\n<!-- PAGE_13 -->\n###### .\n\n <!-- PAGE_13 -->\n###### 물을 보관할 경우 이에 대한 저장 및 유효기간도 안정성시험에 의해 입증하여야 한다.\n\n <!-- PAGE_13 -->\n###### 가속시험은 어떠한 시험항목이 안정성의 지표가 되는지를 확인하고 확립하는데 도\n\n<!-- PAGE_13 -->\n###### 움을 줄 수 있으며\n\n<!-- PAGE_13 -->\n###### , 장기보존시험 자료를 보완할 수는 있지만 대체하지는 못한다\n\n<!-- PAGE_13 -->\n###### .\n\n <!-- PAGE_13 -->\n###### .  비임상시험\n\n<!-- PAGE_13 -->\n###### Ⅳ\n\n<!-- PAGE_13 -->\n###### 일반적 고려사항\n\n<!-- PAGE_13 -->\n###### 1.\n\n <!-- PAGE_13 -->\n###### 비임상시험의 목적은 사람에 있어서의 잠재적 부작용 및 독성을 확인하고 가능하\n\n<!-- PAGE_13 -->\n###### 다면 임상시험에서의 안전한 초회 투여 용량 등을 결정하기 위함이다\n\n<!-- PAGE_13 -->\n###### 임상시험 실\n\n<!-- PAGE_13 -->\n###### .\n\n <!-- PAGE_13 -->\n###### 시 이전뿐만 아니라 임상시험 전 단계를 통해서 약리 및 독성학적 특성을 파악할\n\n<!-- PAGE_13 -->\n###### 수 있다.\n\n",
        "original_sentence": "<!-- PAGE_13 -->\n###### . "
      }
    },
    {
      "chunk_id": "chunk_109",
      "text": "비임상시험\n\n<!-- PAGE_13 -->\n###### Ⅳ\n\n<!-- PAGE_13 -->\n###### 일반적 고려사항\n\n<!-- PAGE_13 -->\n###### 1.\n\n",
      "metadata": {
        "source": "(가이드라인-005)_정맥주사용+B형간염+사람면역글로불린제제의+안전성유효성+평가+가이드라인.pdf",
        "chunk_index": 108,
        "window_size": 3,
        "char_count": 96,
        "word_count": 17,
        "page_number": 13,
        "window_text": "<!-- PAGE_13 -->\n###### 물을 보관할 경우 이에 대한 저장 및 유효기간도 안정성시험에 의해 입증하여야 한다.\n\n <!-- PAGE_13 -->\n###### 가속시험은 어떠한 시험항목이 안정성의 지표가 되는지를 확인하고 확립하는데 도\n\n<!-- PAGE_13 -->\n###### 움을 줄 수 있으며\n\n<!-- PAGE_13 -->\n###### , 장기보존시험 자료를 보완할 수는 있지만 대체하지는 못한다\n\n<!-- PAGE_13 -->\n###### .\n\n <!-- PAGE_13 -->\n###### .  비임상시험\n\n<!-- PAGE_13 -->\n###### Ⅳ\n\n<!-- PAGE_13 -->\n###### 일반적 고려사항\n\n<!-- PAGE_13 -->\n###### 1.\n\n <!-- PAGE_13 -->\n###### 비임상시험의 목적은 사람에 있어서의 잠재적 부작용 및 독성을 확인하고 가능하\n\n<!-- PAGE_13 -->\n###### 다면 임상시험에서의 안전한 초회 투여 용량 등을 결정하기 위함이다\n\n<!-- PAGE_13 -->\n###### 임상시험 실\n\n<!-- PAGE_13 -->\n###### .\n\n <!-- PAGE_13 -->\n###### 시 이전뿐만 아니라 임상시험 전 단계를 통해서 약리 및 독성학적 특성을 파악할\n\n<!-- PAGE_13 -->\n###### 수 있다.\n\n <!-- PAGE_13 -->\n###### 면역글로불린제제는 사람의 혈장을 원료로 하여 혈장 내 면역글로불린이 변질되\n\n<!-- PAGE_13 -->\n###### 지 않도록 에탄올로 분획\n\n<!-- PAGE_13 -->\n###### 정제하여 제조한 사람 유래 단백질제제이다\n\n<!-- PAGE_13 -->\n###### 따라서 독성\n\n<!-- PAGE_13 -->\n###### ,\n\n<!-- PAGE_13 -->\n###### .\n\n",
        "original_sentence": "비임상시험\n\n<!-- PAGE_13 -->\n###### Ⅳ\n\n<!-- PAGE_13 -->\n###### 일반적 고려사항\n\n<!-- PAGE_13 -->\n###### 1.\n\n"
      }
    },
    {
      "chunk_id": "chunk_110",
      "text": "<!-- PAGE_13 -->\n###### 비임상시험의 목적은 사람에 있어서의 잠재적 부작용 및 독성을 확인하고 가능하\n\n<!-- PAGE_13 -->\n###### 다면 임상시험에서의 안전한 초회 투여 용량 등을 결정하기 위함이다\n\n<!-- PAGE_13 -->\n###### 임상시험 실\n\n<!-- PAGE_13 -->\n###### .\n\n",
      "metadata": {
        "source": "(가이드라인-005)_정맥주사용+B형간염+사람면역글로불린제제의+안전성유효성+평가+가이드라인.pdf",
        "chunk_index": 109,
        "window_size": 3,
        "char_count": 189,
        "word_count": 38,
        "page_number": 13,
        "window_text": "<!-- PAGE_13 -->\n###### 가속시험은 어떠한 시험항목이 안정성의 지표가 되는지를 확인하고 확립하는데 도\n\n<!-- PAGE_13 -->\n###### 움을 줄 수 있으며\n\n<!-- PAGE_13 -->\n###### , 장기보존시험 자료를 보완할 수는 있지만 대체하지는 못한다\n\n<!-- PAGE_13 -->\n###### .\n\n <!-- PAGE_13 -->\n###### .  비임상시험\n\n<!-- PAGE_13 -->\n###### Ⅳ\n\n<!-- PAGE_13 -->\n###### 일반적 고려사항\n\n<!-- PAGE_13 -->\n###### 1.\n\n <!-- PAGE_13 -->\n###### 비임상시험의 목적은 사람에 있어서의 잠재적 부작용 및 독성을 확인하고 가능하\n\n<!-- PAGE_13 -->\n###### 다면 임상시험에서의 안전한 초회 투여 용량 등을 결정하기 위함이다\n\n<!-- PAGE_13 -->\n###### 임상시험 실\n\n<!-- PAGE_13 -->\n###### .\n\n <!-- PAGE_13 -->\n###### 시 이전뿐만 아니라 임상시험 전 단계를 통해서 약리 및 독성학적 특성을 파악할\n\n<!-- PAGE_13 -->\n###### 수 있다.\n\n <!-- PAGE_13 -->\n###### 면역글로불린제제는 사람의 혈장을 원료로 하여 혈장 내 면역글로불린이 변질되\n\n<!-- PAGE_13 -->\n###### 지 않도록 에탄올로 분획\n\n<!-- PAGE_13 -->\n###### 정제하여 제조한 사람 유래 단백질제제이다\n\n<!-- PAGE_13 -->\n###### 따라서 독성\n\n<!-- PAGE_13 -->\n###### ,\n\n<!-- PAGE_13 -->\n###### .\n\n <!-- PAGE_13 -->\n###### 시험이 간소화 될 수 있으며\n\n<!-- PAGE_13 -->\n###### 동물에 투여했을 때 면역원성을 일으킬 수 있으므로\n\n<!-- PAGE_13 -->\n###### ,\n\n<!-- PAGE_13 -->\n###### 이를 고려하여야 한다.\n\n",
        "original_sentence": "<!-- PAGE_13 -->\n###### 비임상시험의 목적은 사람에 있어서의 잠재적 부작용 및 독성을 확인하고 가능하\n\n<!-- PAGE_13 -->\n###### 다면 임상시험에서의 안전한 초회 투여 용량 등을 결정하기 위함이다\n\n<!-- PAGE_13 -->\n###### 임상시험 실\n\n<!-- PAGE_13 -->\n###### .\n\n"
      }
    },
    {
      "chunk_id": "chunk_111",
      "text": "<!-- PAGE_13 -->\n###### 시 이전뿐만 아니라 임상시험 전 단계를 통해서 약리 및 독성학적 특성을 파악할\n\n<!-- PAGE_13 -->\n###### 수 있다.\n\n",
      "metadata": {
        "source": "(가이드라인-005)_정맥주사용+B형간염+사람면역글로불린제제의+안전성유효성+평가+가이드라인.pdf",
        "chunk_index": 110,
        "window_size": 3,
        "char_count": 100,
        "word_count": 22,
        "page_number": 13,
        "window_text": "<!-- PAGE_13 -->\n###### .  비임상시험\n\n<!-- PAGE_13 -->\n###### Ⅳ\n\n<!-- PAGE_13 -->\n###### 일반적 고려사항\n\n<!-- PAGE_13 -->\n###### 1.\n\n <!-- PAGE_13 -->\n###### 비임상시험의 목적은 사람에 있어서의 잠재적 부작용 및 독성을 확인하고 가능하\n\n<!-- PAGE_13 -->\n###### 다면 임상시험에서의 안전한 초회 투여 용량 등을 결정하기 위함이다\n\n<!-- PAGE_13 -->\n###### 임상시험 실\n\n<!-- PAGE_13 -->\n###### .\n\n <!-- PAGE_13 -->\n###### 시 이전뿐만 아니라 임상시험 전 단계를 통해서 약리 및 독성학적 특성을 파악할\n\n<!-- PAGE_13 -->\n###### 수 있다.\n\n <!-- PAGE_13 -->\n###### 면역글로불린제제는 사람의 혈장을 원료로 하여 혈장 내 면역글로불린이 변질되\n\n<!-- PAGE_13 -->\n###### 지 않도록 에탄올로 분획\n\n<!-- PAGE_13 -->\n###### 정제하여 제조한 사람 유래 단백질제제이다\n\n<!-- PAGE_13 -->\n###### 따라서 독성\n\n<!-- PAGE_13 -->\n###### ,\n\n<!-- PAGE_13 -->\n###### .\n\n <!-- PAGE_13 -->\n###### 시험이 간소화 될 수 있으며\n\n<!-- PAGE_13 -->\n###### 동물에 투여했을 때 면역원성을 일으킬 수 있으므로\n\n<!-- PAGE_13 -->\n###### ,\n\n<!-- PAGE_13 -->\n###### 이를 고려하여야 한다.\n\n <!-- PAGE_13 -->\n###### 독성시험 및 안전성약리시험은\n\n<!-- PAGE_13 -->\n###### “비임상시험관리기준\n\n<!-- PAGE_13 -->\n###### (Good Laboratory Practice,\n\n<!-- PAGE_13 -->\n###### 식품의약품안전청 고시\n\n<!-- PAGE_13 -->\n###### 에 적합하게 실시되어야 한다\n\n<!-- PAGE_13 -->\n###### 그러나\n\n<!-- PAGE_13 -->\n###### 에 준하여\n\n<!-- PAGE_13 -->\n###### GLP)(\n\n<!-- PAGE_13 -->\n###### )”\n\n<!-- PAGE_13 -->\n###### .\n\n",
        "original_sentence": "<!-- PAGE_13 -->\n###### 시 이전뿐만 아니라 임상시험 전 단계를 통해서 약리 및 독성학적 특성을 파악할\n\n<!-- PAGE_13 -->\n###### 수 있다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_112",
      "text": "<!-- PAGE_13 -->\n###### 면역글로불린제제는 사람의 혈장을 원료로 하여 혈장 내 면역글로불린이 변질되\n\n<!-- PAGE_13 -->\n###### 지 않도록 에탄올로 분획\n\n<!-- PAGE_13 -->\n###### 정제하여 제조한 사람 유래 단백질제제이다\n\n<!-- PAGE_13 -->\n###### 따라서 독성\n\n<!-- PAGE_13 -->\n###### ,\n\n<!-- PAGE_13 -->\n###### .\n\n",
      "metadata": {
        "source": "(가이드라인-005)_정맥주사용+B형간염+사람면역글로불린제제의+안전성유효성+평가+가이드라인.pdf",
        "chunk_index": 111,
        "window_size": 3,
        "char_count": 240,
        "word_count": 46,
        "page_number": 13,
        "window_text": "비임상시험\n\n<!-- PAGE_13 -->\n###### Ⅳ\n\n<!-- PAGE_13 -->\n###### 일반적 고려사항\n\n<!-- PAGE_13 -->\n###### 1.\n\n <!-- PAGE_13 -->\n###### 비임상시험의 목적은 사람에 있어서의 잠재적 부작용 및 독성을 확인하고 가능하\n\n<!-- PAGE_13 -->\n###### 다면 임상시험에서의 안전한 초회 투여 용량 등을 결정하기 위함이다\n\n<!-- PAGE_13 -->\n###### 임상시험 실\n\n<!-- PAGE_13 -->\n###### .\n\n <!-- PAGE_13 -->\n###### 시 이전뿐만 아니라 임상시험 전 단계를 통해서 약리 및 독성학적 특성을 파악할\n\n<!-- PAGE_13 -->\n###### 수 있다.\n\n <!-- PAGE_13 -->\n###### 면역글로불린제제는 사람의 혈장을 원료로 하여 혈장 내 면역글로불린이 변질되\n\n<!-- PAGE_13 -->\n###### 지 않도록 에탄올로 분획\n\n<!-- PAGE_13 -->\n###### 정제하여 제조한 사람 유래 단백질제제이다\n\n<!-- PAGE_13 -->\n###### 따라서 독성\n\n<!-- PAGE_13 -->\n###### ,\n\n<!-- PAGE_13 -->\n###### .\n\n <!-- PAGE_13 -->\n###### 시험이 간소화 될 수 있으며\n\n<!-- PAGE_13 -->\n###### 동물에 투여했을 때 면역원성을 일으킬 수 있으므로\n\n<!-- PAGE_13 -->\n###### ,\n\n<!-- PAGE_13 -->\n###### 이를 고려하여야 한다.\n\n <!-- PAGE_13 -->\n###### 독성시험 및 안전성약리시험은\n\n<!-- PAGE_13 -->\n###### “비임상시험관리기준\n\n<!-- PAGE_13 -->\n###### (Good Laboratory Practice,\n\n<!-- PAGE_13 -->\n###### 식품의약품안전청 고시\n\n<!-- PAGE_13 -->\n###### 에 적합하게 실시되어야 한다\n\n<!-- PAGE_13 -->\n###### 그러나\n\n<!-- PAGE_13 -->\n###### 에 준하여\n\n<!-- PAGE_13 -->\n###### GLP)(\n\n<!-- PAGE_13 -->\n###### )”\n\n<!-- PAGE_13 -->\n###### .\n\n <!-- PAGE_13 -->\n###### GLP\n\n<!-- PAGE_13 -->\n###### 수행하지 않은 시험인 경우에는 시험방법 및 평가 기준 등이 과학적 합리적으로 타\n\n<!-- PAGE_13 -->\n###### ․\n\n- - 6 -\n<!-- PAGE_14 -->\n###### 당성이 인정되어야 하며\n\n<!-- PAGE_14 -->\n###### 에 적합하지 않은 부분을 명확히 하고 안전성평가 전\n\n<!-- PAGE_14 -->\n###### , GLP\n\n<!-- PAGE_14 -->\n###### 체에 대한 중요성에 대하여 평가해야 한다.\n\n",
        "original_sentence": "<!-- PAGE_13 -->\n###### 면역글로불린제제는 사람의 혈장을 원료로 하여 혈장 내 면역글로불린이 변질되\n\n<!-- PAGE_13 -->\n###### 지 않도록 에탄올로 분획\n\n<!-- PAGE_13 -->\n###### 정제하여 제조한 사람 유래 단백질제제이다\n\n<!-- PAGE_13 -->\n###### 따라서 독성\n\n<!-- PAGE_13 -->\n###### ,\n\n<!-- PAGE_13 -->\n###### .\n\n"
      }
    },
    {
      "chunk_id": "chunk_113",
      "text": "<!-- PAGE_13 -->\n###### 시험이 간소화 될 수 있으며\n\n<!-- PAGE_13 -->\n###### 동물에 투여했을 때 면역원성을 일으킬 수 있으므로\n\n<!-- PAGE_13 -->\n###### ,\n\n<!-- PAGE_13 -->\n###### 이를 고려하여야 한다.\n\n",
      "metadata": {
        "source": "(가이드라인-005)_정맥주사용+B형간염+사람면역글로불린제제의+안전성유효성+평가+가이드라인.pdf",
        "chunk_index": 112,
        "window_size": 3,
        "char_count": 159,
        "word_count": 32,
        "page_number": 13,
        "window_text": "<!-- PAGE_13 -->\n###### 비임상시험의 목적은 사람에 있어서의 잠재적 부작용 및 독성을 확인하고 가능하\n\n<!-- PAGE_13 -->\n###### 다면 임상시험에서의 안전한 초회 투여 용량 등을 결정하기 위함이다\n\n<!-- PAGE_13 -->\n###### 임상시험 실\n\n<!-- PAGE_13 -->\n###### .\n\n <!-- PAGE_13 -->\n###### 시 이전뿐만 아니라 임상시험 전 단계를 통해서 약리 및 독성학적 특성을 파악할\n\n<!-- PAGE_13 -->\n###### 수 있다.\n\n <!-- PAGE_13 -->\n###### 면역글로불린제제는 사람의 혈장을 원료로 하여 혈장 내 면역글로불린이 변질되\n\n<!-- PAGE_13 -->\n###### 지 않도록 에탄올로 분획\n\n<!-- PAGE_13 -->\n###### 정제하여 제조한 사람 유래 단백질제제이다\n\n<!-- PAGE_13 -->\n###### 따라서 독성\n\n<!-- PAGE_13 -->\n###### ,\n\n<!-- PAGE_13 -->\n###### .\n\n <!-- PAGE_13 -->\n###### 시험이 간소화 될 수 있으며\n\n<!-- PAGE_13 -->\n###### 동물에 투여했을 때 면역원성을 일으킬 수 있으므로\n\n<!-- PAGE_13 -->\n###### ,\n\n<!-- PAGE_13 -->\n###### 이를 고려하여야 한다.\n\n <!-- PAGE_13 -->\n###### 독성시험 및 안전성약리시험은\n\n<!-- PAGE_13 -->\n###### “비임상시험관리기준\n\n<!-- PAGE_13 -->\n###### (Good Laboratory Practice,\n\n<!-- PAGE_13 -->\n###### 식품의약품안전청 고시\n\n<!-- PAGE_13 -->\n###### 에 적합하게 실시되어야 한다\n\n<!-- PAGE_13 -->\n###### 그러나\n\n<!-- PAGE_13 -->\n###### 에 준하여\n\n<!-- PAGE_13 -->\n###### GLP)(\n\n<!-- PAGE_13 -->\n###### )”\n\n<!-- PAGE_13 -->\n###### .\n\n <!-- PAGE_13 -->\n###### GLP\n\n<!-- PAGE_13 -->\n###### 수행하지 않은 시험인 경우에는 시험방법 및 평가 기준 등이 과학적 합리적으로 타\n\n<!-- PAGE_13 -->\n###### ․\n\n- - 6 -\n<!-- PAGE_14 -->\n###### 당성이 인정되어야 하며\n\n<!-- PAGE_14 -->\n###### 에 적합하지 않은 부분을 명확히 하고 안전성평가 전\n\n<!-- PAGE_14 -->\n###### , GLP\n\n<!-- PAGE_14 -->\n###### 체에 대한 중요성에 대하여 평가해야 한다.\n\n <!-- PAGE_14 -->\n###### 독성시험\n\n<!-- PAGE_14 -->\n###### 2.\n\n",
        "original_sentence": "<!-- PAGE_13 -->\n###### 시험이 간소화 될 수 있으며\n\n<!-- PAGE_13 -->\n###### 동물에 투여했을 때 면역원성을 일으킬 수 있으므로\n\n<!-- PAGE_13 -->\n###### ,\n\n<!-- PAGE_13 -->\n###### 이를 고려하여야 한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_114",
      "text": "<!-- PAGE_13 -->\n###### 독성시험 및 안전성약리시험은\n\n<!-- PAGE_13 -->\n###### “비임상시험관리기준\n\n<!-- PAGE_13 -->\n###### (Good Laboratory Practice,\n\n<!-- PAGE_13 -->\n###### 식품의약품안전청 고시\n\n<!-- PAGE_13 -->\n###### 에 적합하게 실시되어야 한다\n\n<!-- PAGE_13 -->\n###### 그러나\n\n<!-- PAGE_13 -->\n###### 에 준하여\n\n<!-- PAGE_13 -->\n###### GLP)(\n\n<!-- PAGE_13 -->\n###### )”\n\n<!-- PAGE_13 -->\n###### .\n\n",
      "metadata": {
        "source": "(가이드라인-005)_정맥주사용+B형간염+사람면역글로불린제제의+안전성유효성+평가+가이드라인.pdf",
        "chunk_index": 113,
        "window_size": 3,
        "char_count": 353,
        "word_count": 59,
        "page_number": 13,
        "window_text": "<!-- PAGE_13 -->\n###### 시 이전뿐만 아니라 임상시험 전 단계를 통해서 약리 및 독성학적 특성을 파악할\n\n<!-- PAGE_13 -->\n###### 수 있다.\n\n <!-- PAGE_13 -->\n###### 면역글로불린제제는 사람의 혈장을 원료로 하여 혈장 내 면역글로불린이 변질되\n\n<!-- PAGE_13 -->\n###### 지 않도록 에탄올로 분획\n\n<!-- PAGE_13 -->\n###### 정제하여 제조한 사람 유래 단백질제제이다\n\n<!-- PAGE_13 -->\n###### 따라서 독성\n\n<!-- PAGE_13 -->\n###### ,\n\n<!-- PAGE_13 -->\n###### .\n\n <!-- PAGE_13 -->\n###### 시험이 간소화 될 수 있으며\n\n<!-- PAGE_13 -->\n###### 동물에 투여했을 때 면역원성을 일으킬 수 있으므로\n\n<!-- PAGE_13 -->\n###### ,\n\n<!-- PAGE_13 -->\n###### 이를 고려하여야 한다.\n\n <!-- PAGE_13 -->\n###### 독성시험 및 안전성약리시험은\n\n<!-- PAGE_13 -->\n###### “비임상시험관리기준\n\n<!-- PAGE_13 -->\n###### (Good Laboratory Practice,\n\n<!-- PAGE_13 -->\n###### 식품의약품안전청 고시\n\n<!-- PAGE_13 -->\n###### 에 적합하게 실시되어야 한다\n\n<!-- PAGE_13 -->\n###### 그러나\n\n<!-- PAGE_13 -->\n###### 에 준하여\n\n<!-- PAGE_13 -->\n###### GLP)(\n\n<!-- PAGE_13 -->\n###### )”\n\n<!-- PAGE_13 -->\n###### .\n\n <!-- PAGE_13 -->\n###### GLP\n\n<!-- PAGE_13 -->\n###### 수행하지 않은 시험인 경우에는 시험방법 및 평가 기준 등이 과학적 합리적으로 타\n\n<!-- PAGE_13 -->\n###### ․\n\n- - 6 -\n<!-- PAGE_14 -->\n###### 당성이 인정되어야 하며\n\n<!-- PAGE_14 -->\n###### 에 적합하지 않은 부분을 명확히 하고 안전성평가 전\n\n<!-- PAGE_14 -->\n###### , GLP\n\n<!-- PAGE_14 -->\n###### 체에 대한 중요성에 대하여 평가해야 한다.\n\n <!-- PAGE_14 -->\n###### 독성시험\n\n<!-- PAGE_14 -->\n###### 2.\n\n <!-- PAGE_14 -->\n###### 근육주사용\n\n<!-- PAGE_14 -->\n###### 는 이미 사용 경험이 풍부한 제제이다\n\n<!-- PAGE_14 -->\n###### 정맥주사용\n\n<!-- PAGE_14 -->\n###### 는 근\n\n<!-- PAGE_14 -->\n###### HBIG\n\n<!-- PAGE_14 -->\n###### .\n\n",
        "original_sentence": "<!-- PAGE_13 -->\n###### 독성시험 및 안전성약리시험은\n\n<!-- PAGE_13 -->\n###### “비임상시험관리기준\n\n<!-- PAGE_13 -->\n###### (Good Laboratory Practice,\n\n<!-- PAGE_13 -->\n###### 식품의약품안전청 고시\n\n<!-- PAGE_13 -->\n###### 에 적합하게 실시되어야 한다\n\n<!-- PAGE_13 -->\n###### 그러나\n\n<!-- PAGE_13 -->\n###### 에 준하여\n\n<!-- PAGE_13 -->\n###### GLP)(\n\n<!-- PAGE_13 -->\n###### )”\n\n<!-- PAGE_13 -->\n###### .\n\n"
      }
    },
    {
      "chunk_id": "chunk_115",
      "text": "<!-- PAGE_13 -->\n###### GLP\n\n<!-- PAGE_13 -->\n###### 수행하지 않은 시험인 경우에는 시험방법 및 평가 기준 등이 과학적 합리적으로 타\n\n<!-- PAGE_13 -->\n###### ․\n\n- - 6 -\n<!-- PAGE_14 -->\n###### 당성이 인정되어야 하며\n\n<!-- PAGE_14 -->\n###### 에 적합하지 않은 부분을 명확히 하고 안전성평가 전\n\n<!-- PAGE_14 -->\n###### , GLP\n\n<!-- PAGE_14 -->\n###### 체에 대한 중요성에 대하여 평가해야 한다.\n\n",
      "metadata": {
        "source": "(가이드라인-005)_정맥주사용+B형간염+사람면역글로불린제제의+안전성유효성+평가+가이드라인.pdf",
        "chunk_index": 114,
        "window_size": 3,
        "char_count": 306,
        "word_count": 65,
        "page_number": 13,
        "window_text": "<!-- PAGE_13 -->\n###### 면역글로불린제제는 사람의 혈장을 원료로 하여 혈장 내 면역글로불린이 변질되\n\n<!-- PAGE_13 -->\n###### 지 않도록 에탄올로 분획\n\n<!-- PAGE_13 -->\n###### 정제하여 제조한 사람 유래 단백질제제이다\n\n<!-- PAGE_13 -->\n###### 따라서 독성\n\n<!-- PAGE_13 -->\n###### ,\n\n<!-- PAGE_13 -->\n###### .\n\n <!-- PAGE_13 -->\n###### 시험이 간소화 될 수 있으며\n\n<!-- PAGE_13 -->\n###### 동물에 투여했을 때 면역원성을 일으킬 수 있으므로\n\n<!-- PAGE_13 -->\n###### ,\n\n<!-- PAGE_13 -->\n###### 이를 고려하여야 한다.\n\n <!-- PAGE_13 -->\n###### 독성시험 및 안전성약리시험은\n\n<!-- PAGE_13 -->\n###### “비임상시험관리기준\n\n<!-- PAGE_13 -->\n###### (Good Laboratory Practice,\n\n<!-- PAGE_13 -->\n###### 식품의약품안전청 고시\n\n<!-- PAGE_13 -->\n###### 에 적합하게 실시되어야 한다\n\n<!-- PAGE_13 -->\n###### 그러나\n\n<!-- PAGE_13 -->\n###### 에 준하여\n\n<!-- PAGE_13 -->\n###### GLP)(\n\n<!-- PAGE_13 -->\n###### )”\n\n<!-- PAGE_13 -->\n###### .\n\n <!-- PAGE_13 -->\n###### GLP\n\n<!-- PAGE_13 -->\n###### 수행하지 않은 시험인 경우에는 시험방법 및 평가 기준 등이 과학적 합리적으로 타\n\n<!-- PAGE_13 -->\n###### ․\n\n- - 6 -\n<!-- PAGE_14 -->\n###### 당성이 인정되어야 하며\n\n<!-- PAGE_14 -->\n###### 에 적합하지 않은 부분을 명확히 하고 안전성평가 전\n\n<!-- PAGE_14 -->\n###### , GLP\n\n<!-- PAGE_14 -->\n###### 체에 대한 중요성에 대하여 평가해야 한다.\n\n <!-- PAGE_14 -->\n###### 독성시험\n\n<!-- PAGE_14 -->\n###### 2.\n\n <!-- PAGE_14 -->\n###### 근육주사용\n\n<!-- PAGE_14 -->\n###### 는 이미 사용 경험이 풍부한 제제이다\n\n<!-- PAGE_14 -->\n###### 정맥주사용\n\n<!-- PAGE_14 -->\n###### 는 근\n\n<!-- PAGE_14 -->\n###### HBIG\n\n<!-- PAGE_14 -->\n###### .\n\n <!-- PAGE_14 -->\n###### HBIG\n\n<!-- PAGE_14 -->\n###### 육주사용\n\n<!-- PAGE_14 -->\n###### 와 주성분은 동일하나 정맥주사용으로 사용하기 위하여 주성분의 물\n\n<!-- PAGE_14 -->\n###### HBIG\n\n<!-- PAGE_14 -->\n###### 리화학적 성질에는 거의 영향을 미치지 않으면서 순도를 향상시키기 위하여 정제공\n\n<!-- PAGE_14 -->\n###### 이에 따라 새로운 투여 경로 및 용법 용량에 대한 추가적인 독성시험이 요구된다.\n\n",
        "original_sentence": "<!-- PAGE_13 -->\n###### GLP\n\n<!-- PAGE_13 -->\n###### 수행하지 않은 시험인 경우에는 시험방법 및 평가 기준 등이 과학적 합리적으로 타\n\n<!-- PAGE_13 -->\n###### ․\n\n- - 6 -\n<!-- PAGE_14 -->\n###### 당성이 인정되어야 하며\n\n<!-- PAGE_14 -->\n###### 에 적합하지 않은 부분을 명확히 하고 안전성평가 전\n\n<!-- PAGE_14 -->\n###### , GLP\n\n<!-- PAGE_14 -->\n###### 체에 대한 중요성에 대하여 평가해야 한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_116",
      "text": "<!-- PAGE_14 -->\n###### 독성시험\n\n<!-- PAGE_14 -->\n###### 2.\n\n",
      "metadata": {
        "source": "(가이드라인-005)_정맥주사용+B형간염+사람면역글로불린제제의+안전성유효성+평가+가이드라인.pdf",
        "chunk_index": 115,
        "window_size": 3,
        "char_count": 58,
        "word_count": 10,
        "page_number": 14,
        "window_text": "<!-- PAGE_13 -->\n###### 시험이 간소화 될 수 있으며\n\n<!-- PAGE_13 -->\n###### 동물에 투여했을 때 면역원성을 일으킬 수 있으므로\n\n<!-- PAGE_13 -->\n###### ,\n\n<!-- PAGE_13 -->\n###### 이를 고려하여야 한다.\n\n <!-- PAGE_13 -->\n###### 독성시험 및 안전성약리시험은\n\n<!-- PAGE_13 -->\n###### “비임상시험관리기준\n\n<!-- PAGE_13 -->\n###### (Good Laboratory Practice,\n\n<!-- PAGE_13 -->\n###### 식품의약품안전청 고시\n\n<!-- PAGE_13 -->\n###### 에 적합하게 실시되어야 한다\n\n<!-- PAGE_13 -->\n###### 그러나\n\n<!-- PAGE_13 -->\n###### 에 준하여\n\n<!-- PAGE_13 -->\n###### GLP)(\n\n<!-- PAGE_13 -->\n###### )”\n\n<!-- PAGE_13 -->\n###### .\n\n <!-- PAGE_13 -->\n###### GLP\n\n<!-- PAGE_13 -->\n###### 수행하지 않은 시험인 경우에는 시험방법 및 평가 기준 등이 과학적 합리적으로 타\n\n<!-- PAGE_13 -->\n###### ․\n\n- - 6 -\n<!-- PAGE_14 -->\n###### 당성이 인정되어야 하며\n\n<!-- PAGE_14 -->\n###### 에 적합하지 않은 부분을 명확히 하고 안전성평가 전\n\n<!-- PAGE_14 -->\n###### , GLP\n\n<!-- PAGE_14 -->\n###### 체에 대한 중요성에 대하여 평가해야 한다.\n\n <!-- PAGE_14 -->\n###### 독성시험\n\n<!-- PAGE_14 -->\n###### 2.\n\n <!-- PAGE_14 -->\n###### 근육주사용\n\n<!-- PAGE_14 -->\n###### 는 이미 사용 경험이 풍부한 제제이다\n\n<!-- PAGE_14 -->\n###### 정맥주사용\n\n<!-- PAGE_14 -->\n###### 는 근\n\n<!-- PAGE_14 -->\n###### HBIG\n\n<!-- PAGE_14 -->\n###### .\n\n <!-- PAGE_14 -->\n###### HBIG\n\n<!-- PAGE_14 -->\n###### 육주사용\n\n<!-- PAGE_14 -->\n###### 와 주성분은 동일하나 정맥주사용으로 사용하기 위하여 주성분의 물\n\n<!-- PAGE_14 -->\n###### HBIG\n\n<!-- PAGE_14 -->\n###### 리화학적 성질에는 거의 영향을 미치지 않으면서 순도를 향상시키기 위하여 정제공\n\n<!-- PAGE_14 -->\n###### 이에 따라 새로운 투여 경로 및 용법 용량에 대한 추가적인 독성시험이 요구된다.\n\n <!-- PAGE_14 -->\n###### ․\n\n<!-- PAGE_14 -->\n###### 또한 제조공정 중에 새로이 사용한 물질 예\n\n<!-- PAGE_14 -->\n###### 유기용매\n\n<!-- PAGE_14 -->\n###### 계면활성제 등 이 있는 경\n\n<!-- PAGE_14 -->\n###### (\n\n<!-- PAGE_14 -->\n###### :\n\n<!-- PAGE_14 -->\n###### ,\n\n<!-- PAGE_14 -->\n###### )\n\n<!-- PAGE_14 -->\n###### 우에는 그 물질에 대해 최대 잔류량에서 나타날 수 있는 독성시험 자료가 추가로\n\n<!-- PAGE_14 -->\n###### 요구된다\n\n<!-- PAGE_14 -->\n###### 만약 사용한 물질이나 첨가제가 제품 사용량에서 독성이 없는 것으로 알\n\n<!-- PAGE_14 -->\n###### .\n\n",
        "original_sentence": "<!-- PAGE_14 -->\n###### 독성시험\n\n<!-- PAGE_14 -->\n###### 2.\n\n"
      }
    },
    {
      "chunk_id": "chunk_117",
      "text": "<!-- PAGE_14 -->\n###### 근육주사용\n\n<!-- PAGE_14 -->\n###### 는 이미 사용 경험이 풍부한 제제이다\n\n<!-- PAGE_14 -->\n###### 정맥주사용\n\n<!-- PAGE_14 -->\n###### 는 근\n\n<!-- PAGE_14 -->\n###### HBIG\n\n<!-- PAGE_14 -->\n###### .\n\n",
      "metadata": {
        "source": "(가이드라인-005)_정맥주사용+B형간염+사람면역글로불린제제의+안전성유효성+평가+가이드라인.pdf",
        "chunk_index": 116,
        "window_size": 3,
        "char_count": 194,
        "word_count": 36,
        "page_number": 14,
        "window_text": "<!-- PAGE_13 -->\n###### 독성시험 및 안전성약리시험은\n\n<!-- PAGE_13 -->\n###### “비임상시험관리기준\n\n<!-- PAGE_13 -->\n###### (Good Laboratory Practice,\n\n<!-- PAGE_13 -->\n###### 식품의약품안전청 고시\n\n<!-- PAGE_13 -->\n###### 에 적합하게 실시되어야 한다\n\n<!-- PAGE_13 -->\n###### 그러나\n\n<!-- PAGE_13 -->\n###### 에 준하여\n\n<!-- PAGE_13 -->\n###### GLP)(\n\n<!-- PAGE_13 -->\n###### )”\n\n<!-- PAGE_13 -->\n###### .\n\n <!-- PAGE_13 -->\n###### GLP\n\n<!-- PAGE_13 -->\n###### 수행하지 않은 시험인 경우에는 시험방법 및 평가 기준 등이 과학적 합리적으로 타\n\n<!-- PAGE_13 -->\n###### ․\n\n- - 6 -\n<!-- PAGE_14 -->\n###### 당성이 인정되어야 하며\n\n<!-- PAGE_14 -->\n###### 에 적합하지 않은 부분을 명확히 하고 안전성평가 전\n\n<!-- PAGE_14 -->\n###### , GLP\n\n<!-- PAGE_14 -->\n###### 체에 대한 중요성에 대하여 평가해야 한다.\n\n <!-- PAGE_14 -->\n###### 독성시험\n\n<!-- PAGE_14 -->\n###### 2.\n\n <!-- PAGE_14 -->\n###### 근육주사용\n\n<!-- PAGE_14 -->\n###### 는 이미 사용 경험이 풍부한 제제이다\n\n<!-- PAGE_14 -->\n###### 정맥주사용\n\n<!-- PAGE_14 -->\n###### 는 근\n\n<!-- PAGE_14 -->\n###### HBIG\n\n<!-- PAGE_14 -->\n###### .\n\n <!-- PAGE_14 -->\n###### HBIG\n\n<!-- PAGE_14 -->\n###### 육주사용\n\n<!-- PAGE_14 -->\n###### 와 주성분은 동일하나 정맥주사용으로 사용하기 위하여 주성분의 물\n\n<!-- PAGE_14 -->\n###### HBIG\n\n<!-- PAGE_14 -->\n###### 리화학적 성질에는 거의 영향을 미치지 않으면서 순도를 향상시키기 위하여 정제공\n\n<!-- PAGE_14 -->\n###### 이에 따라 새로운 투여 경로 및 용법 용량에 대한 추가적인 독성시험이 요구된다.\n\n <!-- PAGE_14 -->\n###### ․\n\n<!-- PAGE_14 -->\n###### 또한 제조공정 중에 새로이 사용한 물질 예\n\n<!-- PAGE_14 -->\n###### 유기용매\n\n<!-- PAGE_14 -->\n###### 계면활성제 등 이 있는 경\n\n<!-- PAGE_14 -->\n###### (\n\n<!-- PAGE_14 -->\n###### :\n\n<!-- PAGE_14 -->\n###### ,\n\n<!-- PAGE_14 -->\n###### )\n\n<!-- PAGE_14 -->\n###### 우에는 그 물질에 대해 최대 잔류량에서 나타날 수 있는 독성시험 자료가 추가로\n\n<!-- PAGE_14 -->\n###### 요구된다\n\n<!-- PAGE_14 -->\n###### 만약 사용한 물질이나 첨가제가 제품 사용량에서 독성이 없는 것으로 알\n\n<!-- PAGE_14 -->\n###### .\n\n <!-- PAGE_14 -->\n###### 만약 정맥주사용\n\n<!-- PAGE_14 -->\n###### 를 처음 개발하는 경우에는 그에 따른 독성시험 자료를 제\n\n<!-- PAGE_14 -->\n###### HBIG\n\n<!-- PAGE_14 -->\n###### 약리시험\n\n<!-- PAGE_14 -->\n###### 3.\n\n",
        "original_sentence": "<!-- PAGE_14 -->\n###### 근육주사용\n\n<!-- PAGE_14 -->\n###### 는 이미 사용 경험이 풍부한 제제이다\n\n<!-- PAGE_14 -->\n###### 정맥주사용\n\n<!-- PAGE_14 -->\n###### 는 근\n\n<!-- PAGE_14 -->\n###### HBIG\n\n<!-- PAGE_14 -->\n###### .\n\n"
      }
    },
    {
      "chunk_id": "chunk_118",
      "text": "<!-- PAGE_14 -->\n###### HBIG\n\n<!-- PAGE_14 -->\n###### 육주사용\n\n<!-- PAGE_14 -->\n###### 와 주성분은 동일하나 정맥주사용으로 사용하기 위하여 주성분의 물\n\n<!-- PAGE_14 -->\n###### HBIG\n\n<!-- PAGE_14 -->\n###### 리화학적 성질에는 거의 영향을 미치지 않으면서 순도를 향상시키기 위하여 정제공\n\n<!-- PAGE_14 -->\n###### 이에 따라 새로운 투여 경로 및 용법 용량에 대한 추가적인 독성시험이 요구된다.\n\n",
      "metadata": {
        "source": "(가이드라인-005)_정맥주사용+B형간염+사람면역글로불린제제의+안전성유효성+평가+가이드라인.pdf",
        "chunk_index": 117,
        "window_size": 3,
        "char_count": 290,
        "word_count": 57,
        "page_number": 14,
        "window_text": "<!-- PAGE_13 -->\n###### GLP\n\n<!-- PAGE_13 -->\n###### 수행하지 않은 시험인 경우에는 시험방법 및 평가 기준 등이 과학적 합리적으로 타\n\n<!-- PAGE_13 -->\n###### ․\n\n- - 6 -\n<!-- PAGE_14 -->\n###### 당성이 인정되어야 하며\n\n<!-- PAGE_14 -->\n###### 에 적합하지 않은 부분을 명확히 하고 안전성평가 전\n\n<!-- PAGE_14 -->\n###### , GLP\n\n<!-- PAGE_14 -->\n###### 체에 대한 중요성에 대하여 평가해야 한다.\n\n <!-- PAGE_14 -->\n###### 독성시험\n\n<!-- PAGE_14 -->\n###### 2.\n\n <!-- PAGE_14 -->\n###### 근육주사용\n\n<!-- PAGE_14 -->\n###### 는 이미 사용 경험이 풍부한 제제이다\n\n<!-- PAGE_14 -->\n###### 정맥주사용\n\n<!-- PAGE_14 -->\n###### 는 근\n\n<!-- PAGE_14 -->\n###### HBIG\n\n<!-- PAGE_14 -->\n###### .\n\n <!-- PAGE_14 -->\n###### HBIG\n\n<!-- PAGE_14 -->\n###### 육주사용\n\n<!-- PAGE_14 -->\n###### 와 주성분은 동일하나 정맥주사용으로 사용하기 위하여 주성분의 물\n\n<!-- PAGE_14 -->\n###### HBIG\n\n<!-- PAGE_14 -->\n###### 리화학적 성질에는 거의 영향을 미치지 않으면서 순도를 향상시키기 위하여 정제공\n\n<!-- PAGE_14 -->\n###### 이에 따라 새로운 투여 경로 및 용법 용량에 대한 추가적인 독성시험이 요구된다.\n\n <!-- PAGE_14 -->\n###### ․\n\n<!-- PAGE_14 -->\n###### 또한 제조공정 중에 새로이 사용한 물질 예\n\n<!-- PAGE_14 -->\n###### 유기용매\n\n<!-- PAGE_14 -->\n###### 계면활성제 등 이 있는 경\n\n<!-- PAGE_14 -->\n###### (\n\n<!-- PAGE_14 -->\n###### :\n\n<!-- PAGE_14 -->\n###### ,\n\n<!-- PAGE_14 -->\n###### )\n\n<!-- PAGE_14 -->\n###### 우에는 그 물질에 대해 최대 잔류량에서 나타날 수 있는 독성시험 자료가 추가로\n\n<!-- PAGE_14 -->\n###### 요구된다\n\n<!-- PAGE_14 -->\n###### 만약 사용한 물질이나 첨가제가 제품 사용량에서 독성이 없는 것으로 알\n\n<!-- PAGE_14 -->\n###### .\n\n <!-- PAGE_14 -->\n###### 만약 정맥주사용\n\n<!-- PAGE_14 -->\n###### 를 처음 개발하는 경우에는 그에 따른 독성시험 자료를 제\n\n<!-- PAGE_14 -->\n###### HBIG\n\n<!-- PAGE_14 -->\n###### 약리시험\n\n<!-- PAGE_14 -->\n###### 3.\n\n <!-- PAGE_14 -->\n###### 정맥주사용\n\n<!-- PAGE_14 -->\n###### 는 사람의 혈장을 에탄올로 분획\n\n<!-- PAGE_14 -->\n###### 정제하여 제조한 사람면역글\n\n<!-- PAGE_14 -->\n###### HBIG\n\n<!-- PAGE_14 -->\n###### ,\n\n<!-- PAGE_14 -->\n###### 로불린으로 이러한 제조공정이 면역글로불린 분자의 물리화학적 성질에는 거의 영\n\n<!-- PAGE_14 -->\n###### 향을 미치지 않아 천연의 면역글로불린과 유사한 대사적 반감기를 나타낼 것으로\n\n<!-- PAGE_14 -->\n###### 판단된다.\n\n",
        "original_sentence": "<!-- PAGE_14 -->\n###### HBIG\n\n<!-- PAGE_14 -->\n###### 육주사용\n\n<!-- PAGE_14 -->\n###### 와 주성분은 동일하나 정맥주사용으로 사용하기 위하여 주성분의 물\n\n<!-- PAGE_14 -->\n###### HBIG\n\n<!-- PAGE_14 -->\n###### 리화학적 성질에는 거의 영향을 미치지 않으면서 순도를 향상시키기 위하여 정제공\n\n<!-- PAGE_14 -->\n###### 이에 따라 새로운 투여 경로 및 용법 용량에 대한 추가적인 독성시험이 요구된다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_119",
      "text": "<!-- PAGE_14 -->\n###### ․\n\n<!-- PAGE_14 -->\n###### 또한 제조공정 중에 새로이 사용한 물질 예\n\n<!-- PAGE_14 -->\n###### 유기용매\n\n<!-- PAGE_14 -->\n###### 계면활성제 등 이 있는 경\n\n<!-- PAGE_14 -->\n###### (\n\n<!-- PAGE_14 -->\n###### :\n\n<!-- PAGE_14 -->\n###### ,\n\n<!-- PAGE_14 -->\n###### )\n\n<!-- PAGE_14 -->\n###### 우에는 그 물질에 대해 최대 잔류량에서 나타날 수 있는 독성시험 자료가 추가로\n\n<!-- PAGE_14 -->\n###### 요구된다\n\n<!-- PAGE_14 -->\n###### 만약 사용한 물질이나 첨가제가 제품 사용량에서 독성이 없는 것으로 알\n\n<!-- PAGE_14 -->\n###### .\n\n",
      "metadata": {
        "source": "(가이드라인-005)_정맥주사용+B형간염+사람면역글로불린제제의+안전성유효성+평가+가이드라인.pdf",
        "chunk_index": 118,
        "window_size": 3,
        "char_count": 444,
        "word_count": 90,
        "page_number": 14,
        "window_text": "<!-- PAGE_14 -->\n###### 독성시험\n\n<!-- PAGE_14 -->\n###### 2.\n\n <!-- PAGE_14 -->\n###### 근육주사용\n\n<!-- PAGE_14 -->\n###### 는 이미 사용 경험이 풍부한 제제이다\n\n<!-- PAGE_14 -->\n###### 정맥주사용\n\n<!-- PAGE_14 -->\n###### 는 근\n\n<!-- PAGE_14 -->\n###### HBIG\n\n<!-- PAGE_14 -->\n###### .\n\n <!-- PAGE_14 -->\n###### HBIG\n\n<!-- PAGE_14 -->\n###### 육주사용\n\n<!-- PAGE_14 -->\n###### 와 주성분은 동일하나 정맥주사용으로 사용하기 위하여 주성분의 물\n\n<!-- PAGE_14 -->\n###### HBIG\n\n<!-- PAGE_14 -->\n###### 리화학적 성질에는 거의 영향을 미치지 않으면서 순도를 향상시키기 위하여 정제공\n\n<!-- PAGE_14 -->\n###### 이에 따라 새로운 투여 경로 및 용법 용량에 대한 추가적인 독성시험이 요구된다.\n\n <!-- PAGE_14 -->\n###### ․\n\n<!-- PAGE_14 -->\n###### 또한 제조공정 중에 새로이 사용한 물질 예\n\n<!-- PAGE_14 -->\n###### 유기용매\n\n<!-- PAGE_14 -->\n###### 계면활성제 등 이 있는 경\n\n<!-- PAGE_14 -->\n###### (\n\n<!-- PAGE_14 -->\n###### :\n\n<!-- PAGE_14 -->\n###### ,\n\n<!-- PAGE_14 -->\n###### )\n\n<!-- PAGE_14 -->\n###### 우에는 그 물질에 대해 최대 잔류량에서 나타날 수 있는 독성시험 자료가 추가로\n\n<!-- PAGE_14 -->\n###### 요구된다\n\n<!-- PAGE_14 -->\n###### 만약 사용한 물질이나 첨가제가 제품 사용량에서 독성이 없는 것으로 알\n\n<!-- PAGE_14 -->\n###### .\n\n <!-- PAGE_14 -->\n###### 만약 정맥주사용\n\n<!-- PAGE_14 -->\n###### 를 처음 개발하는 경우에는 그에 따른 독성시험 자료를 제\n\n<!-- PAGE_14 -->\n###### HBIG\n\n<!-- PAGE_14 -->\n###### 약리시험\n\n<!-- PAGE_14 -->\n###### 3.\n\n <!-- PAGE_14 -->\n###### 정맥주사용\n\n<!-- PAGE_14 -->\n###### 는 사람의 혈장을 에탄올로 분획\n\n<!-- PAGE_14 -->\n###### 정제하여 제조한 사람면역글\n\n<!-- PAGE_14 -->\n###### HBIG\n\n<!-- PAGE_14 -->\n###### ,\n\n<!-- PAGE_14 -->\n###### 로불린으로 이러한 제조공정이 면역글로불린 분자의 물리화학적 성질에는 거의 영\n\n<!-- PAGE_14 -->\n###### 향을 미치지 않아 천연의 면역글로불린과 유사한 대사적 반감기를 나타낼 것으로\n\n<!-- PAGE_14 -->\n###### 판단된다.\n\n <!-- PAGE_14 -->\n###### 이미 허가되어 사용 경험이 풍부한 근육주사용\n\n<!-- PAGE_14 -->\n###### 의 제조방법을 변경하여 정\n\n<!-- PAGE_14 -->\n###### HBIG\n\n<!-- PAGE_14 -->\n###### 맥주사용\n\n<!-- PAGE_14 -->\n###### 를 제조하는 경우에는 주성분이 동일하여 추가적인 효력이나 약리시\n\n<!-- PAGE_14 -->\n###### HBIG\n\n<!-- PAGE_14 -->\n###### 험은 필요하지 않을 수 있으며 제품의 역가는 임상시험이나 역가시험으로 확인할\n\n<!-- PAGE_14 -->\n###### 수 있으나\n\n<!-- PAGE_14 -->\n###### , 새로운 효능 효과에 대해서는 효력시험자료가 요구될 수 있다\n\n<!-- PAGE_14 -->\n###### .\n\n",
        "original_sentence": "<!-- PAGE_14 -->\n###### ․\n\n<!-- PAGE_14 -->\n###### 또한 제조공정 중에 새로이 사용한 물질 예\n\n<!-- PAGE_14 -->\n###### 유기용매\n\n<!-- PAGE_14 -->\n###### 계면활성제 등 이 있는 경\n\n<!-- PAGE_14 -->\n###### (\n\n<!-- PAGE_14 -->\n###### :\n\n<!-- PAGE_14 -->\n###### ,\n\n<!-- PAGE_14 -->\n###### )\n\n<!-- PAGE_14 -->\n###### 우에는 그 물질에 대해 최대 잔류량에서 나타날 수 있는 독성시험 자료가 추가로\n\n<!-- PAGE_14 -->\n###### 요구된다\n\n<!-- PAGE_14 -->\n###### 만약 사용한 물질이나 첨가제가 제품 사용량에서 독성이 없는 것으로 알\n\n<!-- PAGE_14 -->\n###### .\n\n"
      }
    },
    {
      "chunk_id": "chunk_120",
      "text": "<!-- PAGE_14 -->\n###### 만약 정맥주사용\n\n<!-- PAGE_14 -->\n###### 를 처음 개발하는 경우에는 그에 따른 독성시험 자료를 제\n\n<!-- PAGE_14 -->\n###### HBIG\n\n<!-- PAGE_14 -->\n###### 약리시험\n\n<!-- PAGE_14 -->\n###### 3.\n\n",
      "metadata": {
        "source": "(가이드라인-005)_정맥주사용+B형간염+사람면역글로불린제제의+안전성유효성+평가+가이드라인.pdf",
        "chunk_index": 119,
        "window_size": 3,
        "char_count": 179,
        "word_count": 34,
        "page_number": 14,
        "window_text": "<!-- PAGE_14 -->\n###### 근육주사용\n\n<!-- PAGE_14 -->\n###### 는 이미 사용 경험이 풍부한 제제이다\n\n<!-- PAGE_14 -->\n###### 정맥주사용\n\n<!-- PAGE_14 -->\n###### 는 근\n\n<!-- PAGE_14 -->\n###### HBIG\n\n<!-- PAGE_14 -->\n###### .\n\n <!-- PAGE_14 -->\n###### HBIG\n\n<!-- PAGE_14 -->\n###### 육주사용\n\n<!-- PAGE_14 -->\n###### 와 주성분은 동일하나 정맥주사용으로 사용하기 위하여 주성분의 물\n\n<!-- PAGE_14 -->\n###### HBIG\n\n<!-- PAGE_14 -->\n###### 리화학적 성질에는 거의 영향을 미치지 않으면서 순도를 향상시키기 위하여 정제공\n\n<!-- PAGE_14 -->\n###### 이에 따라 새로운 투여 경로 및 용법 용량에 대한 추가적인 독성시험이 요구된다.\n\n <!-- PAGE_14 -->\n###### ․\n\n<!-- PAGE_14 -->\n###### 또한 제조공정 중에 새로이 사용한 물질 예\n\n<!-- PAGE_14 -->\n###### 유기용매\n\n<!-- PAGE_14 -->\n###### 계면활성제 등 이 있는 경\n\n<!-- PAGE_14 -->\n###### (\n\n<!-- PAGE_14 -->\n###### :\n\n<!-- PAGE_14 -->\n###### ,\n\n<!-- PAGE_14 -->\n###### )\n\n<!-- PAGE_14 -->\n###### 우에는 그 물질에 대해 최대 잔류량에서 나타날 수 있는 독성시험 자료가 추가로\n\n<!-- PAGE_14 -->\n###### 요구된다\n\n<!-- PAGE_14 -->\n###### 만약 사용한 물질이나 첨가제가 제품 사용량에서 독성이 없는 것으로 알\n\n<!-- PAGE_14 -->\n###### .\n\n <!-- PAGE_14 -->\n###### 만약 정맥주사용\n\n<!-- PAGE_14 -->\n###### 를 처음 개발하는 경우에는 그에 따른 독성시험 자료를 제\n\n<!-- PAGE_14 -->\n###### HBIG\n\n<!-- PAGE_14 -->\n###### 약리시험\n\n<!-- PAGE_14 -->\n###### 3.\n\n <!-- PAGE_14 -->\n###### 정맥주사용\n\n<!-- PAGE_14 -->\n###### 는 사람의 혈장을 에탄올로 분획\n\n<!-- PAGE_14 -->\n###### 정제하여 제조한 사람면역글\n\n<!-- PAGE_14 -->\n###### HBIG\n\n<!-- PAGE_14 -->\n###### ,\n\n<!-- PAGE_14 -->\n###### 로불린으로 이러한 제조공정이 면역글로불린 분자의 물리화학적 성질에는 거의 영\n\n<!-- PAGE_14 -->\n###### 향을 미치지 않아 천연의 면역글로불린과 유사한 대사적 반감기를 나타낼 것으로\n\n<!-- PAGE_14 -->\n###### 판단된다.\n\n <!-- PAGE_14 -->\n###### 이미 허가되어 사용 경험이 풍부한 근육주사용\n\n<!-- PAGE_14 -->\n###### 의 제조방법을 변경하여 정\n\n<!-- PAGE_14 -->\n###### HBIG\n\n<!-- PAGE_14 -->\n###### 맥주사용\n\n<!-- PAGE_14 -->\n###### 를 제조하는 경우에는 주성분이 동일하여 추가적인 효력이나 약리시\n\n<!-- PAGE_14 -->\n###### HBIG\n\n<!-- PAGE_14 -->\n###### 험은 필요하지 않을 수 있으며 제품의 역가는 임상시험이나 역가시험으로 확인할\n\n<!-- PAGE_14 -->\n###### 수 있으나\n\n<!-- PAGE_14 -->\n###### , 새로운 효능 효과에 대해서는 효력시험자료가 요구될 수 있다\n\n<!-- PAGE_14 -->\n###### .\n\n <!-- PAGE_14 -->\n###### ․\n\n- - 7 -\n<!-- PAGE_15 -->\n###### . ",
        "original_sentence": "<!-- PAGE_14 -->\n###### 만약 정맥주사용\n\n<!-- PAGE_14 -->\n###### 를 처음 개발하는 경우에는 그에 따른 독성시험 자료를 제\n\n<!-- PAGE_14 -->\n###### HBIG\n\n<!-- PAGE_14 -->\n###### 약리시험\n\n<!-- PAGE_14 -->\n###### 3.\n\n"
      }
    },
    {
      "chunk_id": "chunk_121",
      "text": "<!-- PAGE_14 -->\n###### 정맥주사용\n\n<!-- PAGE_14 -->\n###### 는 사람의 혈장을 에탄올로 분획\n\n<!-- PAGE_14 -->\n###### 정제하여 제조한 사람면역글\n\n<!-- PAGE_14 -->\n###### HBIG\n\n<!-- PAGE_14 -->\n###### ,\n\n<!-- PAGE_14 -->\n###### 로불린으로 이러한 제조공정이 면역글로불린 분자의 물리화학적 성질에는 거의 영\n\n<!-- PAGE_14 -->\n###### 향을 미치지 않아 천연의 면역글로불린과 유사한 대사적 반감기를 나타낼 것으로\n\n<!-- PAGE_14 -->\n###### 판단된다.\n\n",
      "metadata": {
        "source": "(가이드라인-005)_정맥주사용+B형간염+사람면역글로불린제제의+안전성유효성+평가+가이드라인.pdf",
        "chunk_index": 120,
        "window_size": 3,
        "char_count": 338,
        "word_count": 63,
        "page_number": 14,
        "window_text": "<!-- PAGE_14 -->\n###### HBIG\n\n<!-- PAGE_14 -->\n###### 육주사용\n\n<!-- PAGE_14 -->\n###### 와 주성분은 동일하나 정맥주사용으로 사용하기 위하여 주성분의 물\n\n<!-- PAGE_14 -->\n###### HBIG\n\n<!-- PAGE_14 -->\n###### 리화학적 성질에는 거의 영향을 미치지 않으면서 순도를 향상시키기 위하여 정제공\n\n<!-- PAGE_14 -->\n###### 이에 따라 새로운 투여 경로 및 용법 용량에 대한 추가적인 독성시험이 요구된다.\n\n <!-- PAGE_14 -->\n###### ․\n\n<!-- PAGE_14 -->\n###### 또한 제조공정 중에 새로이 사용한 물질 예\n\n<!-- PAGE_14 -->\n###### 유기용매\n\n<!-- PAGE_14 -->\n###### 계면활성제 등 이 있는 경\n\n<!-- PAGE_14 -->\n###### (\n\n<!-- PAGE_14 -->\n###### :\n\n<!-- PAGE_14 -->\n###### ,\n\n<!-- PAGE_14 -->\n###### )\n\n<!-- PAGE_14 -->\n###### 우에는 그 물질에 대해 최대 잔류량에서 나타날 수 있는 독성시험 자료가 추가로\n\n<!-- PAGE_14 -->\n###### 요구된다\n\n<!-- PAGE_14 -->\n###### 만약 사용한 물질이나 첨가제가 제품 사용량에서 독성이 없는 것으로 알\n\n<!-- PAGE_14 -->\n###### .\n\n <!-- PAGE_14 -->\n###### 만약 정맥주사용\n\n<!-- PAGE_14 -->\n###### 를 처음 개발하는 경우에는 그에 따른 독성시험 자료를 제\n\n<!-- PAGE_14 -->\n###### HBIG\n\n<!-- PAGE_14 -->\n###### 약리시험\n\n<!-- PAGE_14 -->\n###### 3.\n\n <!-- PAGE_14 -->\n###### 정맥주사용\n\n<!-- PAGE_14 -->\n###### 는 사람의 혈장을 에탄올로 분획\n\n<!-- PAGE_14 -->\n###### 정제하여 제조한 사람면역글\n\n<!-- PAGE_14 -->\n###### HBIG\n\n<!-- PAGE_14 -->\n###### ,\n\n<!-- PAGE_14 -->\n###### 로불린으로 이러한 제조공정이 면역글로불린 분자의 물리화학적 성질에는 거의 영\n\n<!-- PAGE_14 -->\n###### 향을 미치지 않아 천연의 면역글로불린과 유사한 대사적 반감기를 나타낼 것으로\n\n<!-- PAGE_14 -->\n###### 판단된다.\n\n <!-- PAGE_14 -->\n###### 이미 허가되어 사용 경험이 풍부한 근육주사용\n\n<!-- PAGE_14 -->\n###### 의 제조방법을 변경하여 정\n\n<!-- PAGE_14 -->\n###### HBIG\n\n<!-- PAGE_14 -->\n###### 맥주사용\n\n<!-- PAGE_14 -->\n###### 를 제조하는 경우에는 주성분이 동일하여 추가적인 효력이나 약리시\n\n<!-- PAGE_14 -->\n###### HBIG\n\n<!-- PAGE_14 -->\n###### 험은 필요하지 않을 수 있으며 제품의 역가는 임상시험이나 역가시험으로 확인할\n\n<!-- PAGE_14 -->\n###### 수 있으나\n\n<!-- PAGE_14 -->\n###### , 새로운 효능 효과에 대해서는 효력시험자료가 요구될 수 있다\n\n<!-- PAGE_14 -->\n###### .\n\n <!-- PAGE_14 -->\n###### ․\n\n- - 7 -\n<!-- PAGE_15 -->\n###### .  임상시험\n\n<!-- PAGE_15 -->\n###### Ⅴ\n\n<!-- PAGE_15 -->\n###### 일반적 고려사항\n\n<!-- PAGE_15 -->\n###### 1.\n\n",
        "original_sentence": "<!-- PAGE_14 -->\n###### 정맥주사용\n\n<!-- PAGE_14 -->\n###### 는 사람의 혈장을 에탄올로 분획\n\n<!-- PAGE_14 -->\n###### 정제하여 제조한 사람면역글\n\n<!-- PAGE_14 -->\n###### HBIG\n\n<!-- PAGE_14 -->\n###### ,\n\n<!-- PAGE_14 -->\n###### 로불린으로 이러한 제조공정이 면역글로불린 분자의 물리화학적 성질에는 거의 영\n\n<!-- PAGE_14 -->\n###### 향을 미치지 않아 천연의 면역글로불린과 유사한 대사적 반감기를 나타낼 것으로\n\n<!-- PAGE_14 -->\n###### 판단된다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_122",
      "text": "<!-- PAGE_14 -->\n###### 이미 허가되어 사용 경험이 풍부한 근육주사용\n\n<!-- PAGE_14 -->\n###### 의 제조방법을 변경하여 정\n\n<!-- PAGE_14 -->\n###### HBIG\n\n<!-- PAGE_14 -->\n###### 맥주사용\n\n<!-- PAGE_14 -->\n###### 를 제조하는 경우에는 주성분이 동일하여 추가적인 효력이나 약리시\n\n<!-- PAGE_14 -->\n###### HBIG\n\n<!-- PAGE_14 -->\n###### 험은 필요하지 않을 수 있으며 제품의 역가는 임상시험이나 역가시험으로 확인할\n\n<!-- PAGE_14 -->\n###### 수 있으나\n\n<!-- PAGE_14 -->\n###### , 새로운 효능 효과에 대해서는 효력시험자료가 요구될 수 있다\n\n<!-- PAGE_14 -->\n###### .\n\n",
      "metadata": {
        "source": "(가이드라인-005)_정맥주사용+B형간염+사람면역글로불린제제의+안전성유효성+평가+가이드라인.pdf",
        "chunk_index": 121,
        "window_size": 3,
        "char_count": 427,
        "word_count": 83,
        "page_number": 14,
        "window_text": "<!-- PAGE_14 -->\n###### ․\n\n<!-- PAGE_14 -->\n###### 또한 제조공정 중에 새로이 사용한 물질 예\n\n<!-- PAGE_14 -->\n###### 유기용매\n\n<!-- PAGE_14 -->\n###### 계면활성제 등 이 있는 경\n\n<!-- PAGE_14 -->\n###### (\n\n<!-- PAGE_14 -->\n###### :\n\n<!-- PAGE_14 -->\n###### ,\n\n<!-- PAGE_14 -->\n###### )\n\n<!-- PAGE_14 -->\n###### 우에는 그 물질에 대해 최대 잔류량에서 나타날 수 있는 독성시험 자료가 추가로\n\n<!-- PAGE_14 -->\n###### 요구된다\n\n<!-- PAGE_14 -->\n###### 만약 사용한 물질이나 첨가제가 제품 사용량에서 독성이 없는 것으로 알\n\n<!-- PAGE_14 -->\n###### .\n\n <!-- PAGE_14 -->\n###### 만약 정맥주사용\n\n<!-- PAGE_14 -->\n###### 를 처음 개발하는 경우에는 그에 따른 독성시험 자료를 제\n\n<!-- PAGE_14 -->\n###### HBIG\n\n<!-- PAGE_14 -->\n###### 약리시험\n\n<!-- PAGE_14 -->\n###### 3.\n\n <!-- PAGE_14 -->\n###### 정맥주사용\n\n<!-- PAGE_14 -->\n###### 는 사람의 혈장을 에탄올로 분획\n\n<!-- PAGE_14 -->\n###### 정제하여 제조한 사람면역글\n\n<!-- PAGE_14 -->\n###### HBIG\n\n<!-- PAGE_14 -->\n###### ,\n\n<!-- PAGE_14 -->\n###### 로불린으로 이러한 제조공정이 면역글로불린 분자의 물리화학적 성질에는 거의 영\n\n<!-- PAGE_14 -->\n###### 향을 미치지 않아 천연의 면역글로불린과 유사한 대사적 반감기를 나타낼 것으로\n\n<!-- PAGE_14 -->\n###### 판단된다.\n\n <!-- PAGE_14 -->\n###### 이미 허가되어 사용 경험이 풍부한 근육주사용\n\n<!-- PAGE_14 -->\n###### 의 제조방법을 변경하여 정\n\n<!-- PAGE_14 -->\n###### HBIG\n\n<!-- PAGE_14 -->\n###### 맥주사용\n\n<!-- PAGE_14 -->\n###### 를 제조하는 경우에는 주성분이 동일하여 추가적인 효력이나 약리시\n\n<!-- PAGE_14 -->\n###### HBIG\n\n<!-- PAGE_14 -->\n###### 험은 필요하지 않을 수 있으며 제품의 역가는 임상시험이나 역가시험으로 확인할\n\n<!-- PAGE_14 -->\n###### 수 있으나\n\n<!-- PAGE_14 -->\n###### , 새로운 효능 효과에 대해서는 효력시험자료가 요구될 수 있다\n\n<!-- PAGE_14 -->\n###### .\n\n <!-- PAGE_14 -->\n###### ․\n\n- - 7 -\n<!-- PAGE_15 -->\n###### .  임상시험\n\n<!-- PAGE_15 -->\n###### Ⅴ\n\n<!-- PAGE_15 -->\n###### 일반적 고려사항\n\n<!-- PAGE_15 -->\n###### 1.\n\n <!-- PAGE_15 -->\n###### 간 이식 후\n\n<!-- PAGE_15 -->\n###### 형 간염의 재발을 막기 위해서는\n\n<!-- PAGE_15 -->\n###### 를 단독 투여하거나 항바이러\n\n<!-- PAGE_15 -->\n###### B\n\n<!-- PAGE_15 -->\n###### HBIG\n\n<!-- PAGE_15 -->\n###### 본 가이드라인에서는 간 이식 환자의\n\n<!-- PAGE_15 -->\n###### 형 간염 재발의 예방 목적으로 사용되는\n\n<!-- PAGE_15 -->\n###### B\n\n<!-- PAGE_15 -->\n###### 정맥주사용\n\n<!-- PAGE_15 -->\n###### 단독 투여에 의한 임상시험을 위주로 언급하고자 한다\n\n<!-- PAGE_15 -->\n###### 만약\n\n<!-- PAGE_15 -->\n###### HBIG\n\n<!-- PAGE_15 -->\n###### .\n\n",
        "original_sentence": "<!-- PAGE_14 -->\n###### 이미 허가되어 사용 경험이 풍부한 근육주사용\n\n<!-- PAGE_14 -->\n###### 의 제조방법을 변경하여 정\n\n<!-- PAGE_14 -->\n###### HBIG\n\n<!-- PAGE_14 -->\n###### 맥주사용\n\n<!-- PAGE_14 -->\n###### 를 제조하는 경우에는 주성분이 동일하여 추가적인 효력이나 약리시\n\n<!-- PAGE_14 -->\n###### HBIG\n\n<!-- PAGE_14 -->\n###### 험은 필요하지 않을 수 있으며 제품의 역가는 임상시험이나 역가시험으로 확인할\n\n<!-- PAGE_14 -->\n###### 수 있으나\n\n<!-- PAGE_14 -->\n###### , 새로운 효능 효과에 대해서는 효력시험자료가 요구될 수 있다\n\n<!-- PAGE_14 -->\n###### .\n\n"
      }
    },
    {
      "chunk_id": "chunk_123",
      "text": "<!-- PAGE_14 -->\n###### ․\n\n- - 7 -\n<!-- PAGE_15 -->\n###### . ",
      "metadata": {
        "source": "(가이드라인-005)_정맥주사용+B형간염+사람면역글로불린제제의+안전성유효성+평가+가이드라인.pdf",
        "chunk_index": 122,
        "window_size": 3,
        "char_count": 61,
        "word_count": 14,
        "page_number": 14,
        "window_text": "<!-- PAGE_14 -->\n###### 만약 정맥주사용\n\n<!-- PAGE_14 -->\n###### 를 처음 개발하는 경우에는 그에 따른 독성시험 자료를 제\n\n<!-- PAGE_14 -->\n###### HBIG\n\n<!-- PAGE_14 -->\n###### 약리시험\n\n<!-- PAGE_14 -->\n###### 3.\n\n <!-- PAGE_14 -->\n###### 정맥주사용\n\n<!-- PAGE_14 -->\n###### 는 사람의 혈장을 에탄올로 분획\n\n<!-- PAGE_14 -->\n###### 정제하여 제조한 사람면역글\n\n<!-- PAGE_14 -->\n###### HBIG\n\n<!-- PAGE_14 -->\n###### ,\n\n<!-- PAGE_14 -->\n###### 로불린으로 이러한 제조공정이 면역글로불린 분자의 물리화학적 성질에는 거의 영\n\n<!-- PAGE_14 -->\n###### 향을 미치지 않아 천연의 면역글로불린과 유사한 대사적 반감기를 나타낼 것으로\n\n<!-- PAGE_14 -->\n###### 판단된다.\n\n <!-- PAGE_14 -->\n###### 이미 허가되어 사용 경험이 풍부한 근육주사용\n\n<!-- PAGE_14 -->\n###### 의 제조방법을 변경하여 정\n\n<!-- PAGE_14 -->\n###### HBIG\n\n<!-- PAGE_14 -->\n###### 맥주사용\n\n<!-- PAGE_14 -->\n###### 를 제조하는 경우에는 주성분이 동일하여 추가적인 효력이나 약리시\n\n<!-- PAGE_14 -->\n###### HBIG\n\n<!-- PAGE_14 -->\n###### 험은 필요하지 않을 수 있으며 제품의 역가는 임상시험이나 역가시험으로 확인할\n\n<!-- PAGE_14 -->\n###### 수 있으나\n\n<!-- PAGE_14 -->\n###### , 새로운 효능 효과에 대해서는 효력시험자료가 요구될 수 있다\n\n<!-- PAGE_14 -->\n###### .\n\n <!-- PAGE_14 -->\n###### ․\n\n- - 7 -\n<!-- PAGE_15 -->\n###### .  임상시험\n\n<!-- PAGE_15 -->\n###### Ⅴ\n\n<!-- PAGE_15 -->\n###### 일반적 고려사항\n\n<!-- PAGE_15 -->\n###### 1.\n\n <!-- PAGE_15 -->\n###### 간 이식 후\n\n<!-- PAGE_15 -->\n###### 형 간염의 재발을 막기 위해서는\n\n<!-- PAGE_15 -->\n###### 를 단독 투여하거나 항바이러\n\n<!-- PAGE_15 -->\n###### B\n\n<!-- PAGE_15 -->\n###### HBIG\n\n<!-- PAGE_15 -->\n###### 본 가이드라인에서는 간 이식 환자의\n\n<!-- PAGE_15 -->\n###### 형 간염 재발의 예방 목적으로 사용되는\n\n<!-- PAGE_15 -->\n###### B\n\n<!-- PAGE_15 -->\n###### 정맥주사용\n\n<!-- PAGE_15 -->\n###### 단독 투여에 의한 임상시험을 위주로 언급하고자 한다\n\n<!-- PAGE_15 -->\n###### 만약\n\n<!-- PAGE_15 -->\n###### HBIG\n\n<!-- PAGE_15 -->\n###### .\n\n <!-- PAGE_15 -->\n###### HBV\n\n<!-- PAGE_15 -->\n###### 에 노출된 후\n\n<!-- PAGE_15 -->\n###### 형 간염 발증의 예방 목적으로 사용하고자 하는 경우에는 해당 적응\n\n<!-- PAGE_15 -->\n###### B\n\n<!-- PAGE_15 -->\n###### 임상약리시험\n\n<!-- PAGE_15 -->\n###### 2.\n\n",
        "original_sentence": "<!-- PAGE_14 -->\n###### ․\n\n- - 7 -\n<!-- PAGE_15 -->\n###### . "
      }
    },
    {
      "chunk_id": "chunk_124",
      "text": "임상시험\n\n<!-- PAGE_15 -->\n###### Ⅴ\n\n<!-- PAGE_15 -->\n###### 일반적 고려사항\n\n<!-- PAGE_15 -->\n###### 1.\n\n",
      "metadata": {
        "source": "(가이드라인-005)_정맥주사용+B형간염+사람면역글로불린제제의+안전성유효성+평가+가이드라인.pdf",
        "chunk_index": 123,
        "window_size": 3,
        "char_count": 95,
        "word_count": 17,
        "page_number": 15,
        "window_text": "<!-- PAGE_14 -->\n###### 정맥주사용\n\n<!-- PAGE_14 -->\n###### 는 사람의 혈장을 에탄올로 분획\n\n<!-- PAGE_14 -->\n###### 정제하여 제조한 사람면역글\n\n<!-- PAGE_14 -->\n###### HBIG\n\n<!-- PAGE_14 -->\n###### ,\n\n<!-- PAGE_14 -->\n###### 로불린으로 이러한 제조공정이 면역글로불린 분자의 물리화학적 성질에는 거의 영\n\n<!-- PAGE_14 -->\n###### 향을 미치지 않아 천연의 면역글로불린과 유사한 대사적 반감기를 나타낼 것으로\n\n<!-- PAGE_14 -->\n###### 판단된다.\n\n <!-- PAGE_14 -->\n###### 이미 허가되어 사용 경험이 풍부한 근육주사용\n\n<!-- PAGE_14 -->\n###### 의 제조방법을 변경하여 정\n\n<!-- PAGE_14 -->\n###### HBIG\n\n<!-- PAGE_14 -->\n###### 맥주사용\n\n<!-- PAGE_14 -->\n###### 를 제조하는 경우에는 주성분이 동일하여 추가적인 효력이나 약리시\n\n<!-- PAGE_14 -->\n###### HBIG\n\n<!-- PAGE_14 -->\n###### 험은 필요하지 않을 수 있으며 제품의 역가는 임상시험이나 역가시험으로 확인할\n\n<!-- PAGE_14 -->\n###### 수 있으나\n\n<!-- PAGE_14 -->\n###### , 새로운 효능 효과에 대해서는 효력시험자료가 요구될 수 있다\n\n<!-- PAGE_14 -->\n###### .\n\n <!-- PAGE_14 -->\n###### ․\n\n- - 7 -\n<!-- PAGE_15 -->\n###### .  임상시험\n\n<!-- PAGE_15 -->\n###### Ⅴ\n\n<!-- PAGE_15 -->\n###### 일반적 고려사항\n\n<!-- PAGE_15 -->\n###### 1.\n\n <!-- PAGE_15 -->\n###### 간 이식 후\n\n<!-- PAGE_15 -->\n###### 형 간염의 재발을 막기 위해서는\n\n<!-- PAGE_15 -->\n###### 를 단독 투여하거나 항바이러\n\n<!-- PAGE_15 -->\n###### B\n\n<!-- PAGE_15 -->\n###### HBIG\n\n<!-- PAGE_15 -->\n###### 본 가이드라인에서는 간 이식 환자의\n\n<!-- PAGE_15 -->\n###### 형 간염 재발의 예방 목적으로 사용되는\n\n<!-- PAGE_15 -->\n###### B\n\n<!-- PAGE_15 -->\n###### 정맥주사용\n\n<!-- PAGE_15 -->\n###### 단독 투여에 의한 임상시험을 위주로 언급하고자 한다\n\n<!-- PAGE_15 -->\n###### 만약\n\n<!-- PAGE_15 -->\n###### HBIG\n\n<!-- PAGE_15 -->\n###### .\n\n <!-- PAGE_15 -->\n###### HBV\n\n<!-- PAGE_15 -->\n###### 에 노출된 후\n\n<!-- PAGE_15 -->\n###### 형 간염 발증의 예방 목적으로 사용하고자 하는 경우에는 해당 적응\n\n<!-- PAGE_15 -->\n###### B\n\n<!-- PAGE_15 -->\n###### 임상약리시험\n\n<!-- PAGE_15 -->\n###### 2.\n\n <!-- PAGE_15 -->\n###### 사람에서 실시되는 첫 임상시험으로서 주된 목적은 안전성을 평가하는 것이다.\n\n",
        "original_sentence": "임상시험\n\n<!-- PAGE_15 -->\n###### Ⅴ\n\n<!-- PAGE_15 -->\n###### 일반적 고려사항\n\n<!-- PAGE_15 -->\n###### 1.\n\n"
      }
    },
    {
      "chunk_id": "chunk_125",
      "text": "<!-- PAGE_15 -->\n###### 간 이식 후\n\n<!-- PAGE_15 -->\n###### 형 간염의 재발을 막기 위해서는\n\n<!-- PAGE_15 -->\n###### 를 단독 투여하거나 항바이러\n\n<!-- PAGE_15 -->\n###### B\n\n<!-- PAGE_15 -->\n###### HBIG\n\n<!-- PAGE_15 -->\n###### 본 가이드라인에서는 간 이식 환자의\n\n<!-- PAGE_15 -->\n###### 형 간염 재발의 예방 목적으로 사용되는\n\n<!-- PAGE_15 -->\n###### B\n\n<!-- PAGE_15 -->\n###### 정맥주사용\n\n<!-- PAGE_15 -->\n###### 단독 투여에 의한 임상시험을 위주로 언급하고자 한다\n\n<!-- PAGE_15 -->\n###### 만약\n\n<!-- PAGE_15 -->\n###### HBIG\n\n<!-- PAGE_15 -->\n###### .\n\n",
      "metadata": {
        "source": "(가이드라인-005)_정맥주사용+B형간염+사람면역글로불린제제의+안전성유효성+평가+가이드라인.pdf",
        "chunk_index": 124,
        "window_size": 3,
        "char_count": 462,
        "word_count": 89,
        "page_number": 15,
        "window_text": "<!-- PAGE_14 -->\n###### 이미 허가되어 사용 경험이 풍부한 근육주사용\n\n<!-- PAGE_14 -->\n###### 의 제조방법을 변경하여 정\n\n<!-- PAGE_14 -->\n###### HBIG\n\n<!-- PAGE_14 -->\n###### 맥주사용\n\n<!-- PAGE_14 -->\n###### 를 제조하는 경우에는 주성분이 동일하여 추가적인 효력이나 약리시\n\n<!-- PAGE_14 -->\n###### HBIG\n\n<!-- PAGE_14 -->\n###### 험은 필요하지 않을 수 있으며 제품의 역가는 임상시험이나 역가시험으로 확인할\n\n<!-- PAGE_14 -->\n###### 수 있으나\n\n<!-- PAGE_14 -->\n###### , 새로운 효능 효과에 대해서는 효력시험자료가 요구될 수 있다\n\n<!-- PAGE_14 -->\n###### .\n\n <!-- PAGE_14 -->\n###### ․\n\n- - 7 -\n<!-- PAGE_15 -->\n###### .  임상시험\n\n<!-- PAGE_15 -->\n###### Ⅴ\n\n<!-- PAGE_15 -->\n###### 일반적 고려사항\n\n<!-- PAGE_15 -->\n###### 1.\n\n <!-- PAGE_15 -->\n###### 간 이식 후\n\n<!-- PAGE_15 -->\n###### 형 간염의 재발을 막기 위해서는\n\n<!-- PAGE_15 -->\n###### 를 단독 투여하거나 항바이러\n\n<!-- PAGE_15 -->\n###### B\n\n<!-- PAGE_15 -->\n###### HBIG\n\n<!-- PAGE_15 -->\n###### 본 가이드라인에서는 간 이식 환자의\n\n<!-- PAGE_15 -->\n###### 형 간염 재발의 예방 목적으로 사용되는\n\n<!-- PAGE_15 -->\n###### B\n\n<!-- PAGE_15 -->\n###### 정맥주사용\n\n<!-- PAGE_15 -->\n###### 단독 투여에 의한 임상시험을 위주로 언급하고자 한다\n\n<!-- PAGE_15 -->\n###### 만약\n\n<!-- PAGE_15 -->\n###### HBIG\n\n<!-- PAGE_15 -->\n###### .\n\n <!-- PAGE_15 -->\n###### HBV\n\n<!-- PAGE_15 -->\n###### 에 노출된 후\n\n<!-- PAGE_15 -->\n###### 형 간염 발증의 예방 목적으로 사용하고자 하는 경우에는 해당 적응\n\n<!-- PAGE_15 -->\n###### B\n\n<!-- PAGE_15 -->\n###### 임상약리시험\n\n<!-- PAGE_15 -->\n###### 2.\n\n <!-- PAGE_15 -->\n###### 사람에서 실시되는 첫 임상시험으로서 주된 목적은 안전성을 평가하는 것이다.\n\n <!-- PAGE_15 -->\n###### 일반적으로 치료를 목적으로 하지 않으며 건강한 지원자를 대상으로 실시한다 본\n\n<!-- PAGE_15 -->\n###### (\n\n<!-- PAGE_15 -->\n###### 제제는 항암제 등과 같이 세포독성 등의 심각한 잠재적 독성을 갖고 있지 않으므로\n\n<!-- PAGE_15 -->\n###### 환자를 대상으로 하지 아니한다\n\n<!-- PAGE_15 -->\n###### 단기간의 안전성 및 내약성 평가\n\n<!-- PAGE_15 -->\n###### 약동학 및 약력\n\n<!-- PAGE_15 -->\n###### ).\n\n",
        "original_sentence": "<!-- PAGE_15 -->\n###### 간 이식 후\n\n<!-- PAGE_15 -->\n###### 형 간염의 재발을 막기 위해서는\n\n<!-- PAGE_15 -->\n###### 를 단독 투여하거나 항바이러\n\n<!-- PAGE_15 -->\n###### B\n\n<!-- PAGE_15 -->\n###### HBIG\n\n<!-- PAGE_15 -->\n###### 본 가이드라인에서는 간 이식 환자의\n\n<!-- PAGE_15 -->\n###### 형 간염 재발의 예방 목적으로 사용되는\n\n<!-- PAGE_15 -->\n###### B\n\n<!-- PAGE_15 -->\n###### 정맥주사용\n\n<!-- PAGE_15 -->\n###### 단독 투여에 의한 임상시험을 위주로 언급하고자 한다\n\n<!-- PAGE_15 -->\n###### 만약\n\n<!-- PAGE_15 -->\n###### HBIG\n\n<!-- PAGE_15 -->\n###### .\n\n"
      }
    },
    {
      "chunk_id": "chunk_126",
      "text": "<!-- PAGE_15 -->\n###### HBV\n\n<!-- PAGE_15 -->\n###### 에 노출된 후\n\n<!-- PAGE_15 -->\n###### 형 간염 발증의 예방 목적으로 사용하고자 하는 경우에는 해당 적응\n\n<!-- PAGE_15 -->\n###### B\n\n<!-- PAGE_15 -->\n###### 임상약리시험\n\n<!-- PAGE_15 -->\n###### 2.\n\n",
      "metadata": {
        "source": "(가이드라인-005)_정맥주사용+B형간염+사람면역글로불린제제의+안전성유효성+평가+가이드라인.pdf",
        "chunk_index": 125,
        "window_size": 3,
        "char_count": 211,
        "word_count": 41,
        "page_number": 15,
        "window_text": "<!-- PAGE_14 -->\n###### ․\n\n- - 7 -\n<!-- PAGE_15 -->\n###### .  임상시험\n\n<!-- PAGE_15 -->\n###### Ⅴ\n\n<!-- PAGE_15 -->\n###### 일반적 고려사항\n\n<!-- PAGE_15 -->\n###### 1.\n\n <!-- PAGE_15 -->\n###### 간 이식 후\n\n<!-- PAGE_15 -->\n###### 형 간염의 재발을 막기 위해서는\n\n<!-- PAGE_15 -->\n###### 를 단독 투여하거나 항바이러\n\n<!-- PAGE_15 -->\n###### B\n\n<!-- PAGE_15 -->\n###### HBIG\n\n<!-- PAGE_15 -->\n###### 본 가이드라인에서는 간 이식 환자의\n\n<!-- PAGE_15 -->\n###### 형 간염 재발의 예방 목적으로 사용되는\n\n<!-- PAGE_15 -->\n###### B\n\n<!-- PAGE_15 -->\n###### 정맥주사용\n\n<!-- PAGE_15 -->\n###### 단독 투여에 의한 임상시험을 위주로 언급하고자 한다\n\n<!-- PAGE_15 -->\n###### 만약\n\n<!-- PAGE_15 -->\n###### HBIG\n\n<!-- PAGE_15 -->\n###### .\n\n <!-- PAGE_15 -->\n###### HBV\n\n<!-- PAGE_15 -->\n###### 에 노출된 후\n\n<!-- PAGE_15 -->\n###### 형 간염 발증의 예방 목적으로 사용하고자 하는 경우에는 해당 적응\n\n<!-- PAGE_15 -->\n###### B\n\n<!-- PAGE_15 -->\n###### 임상약리시험\n\n<!-- PAGE_15 -->\n###### 2.\n\n <!-- PAGE_15 -->\n###### 사람에서 실시되는 첫 임상시험으로서 주된 목적은 안전성을 평가하는 것이다.\n\n <!-- PAGE_15 -->\n###### 일반적으로 치료를 목적으로 하지 않으며 건강한 지원자를 대상으로 실시한다 본\n\n<!-- PAGE_15 -->\n###### (\n\n<!-- PAGE_15 -->\n###### 제제는 항암제 등과 같이 세포독성 등의 심각한 잠재적 독성을 갖고 있지 않으므로\n\n<!-- PAGE_15 -->\n###### 환자를 대상으로 하지 아니한다\n\n<!-- PAGE_15 -->\n###### 단기간의 안전성 및 내약성 평가\n\n<!-- PAGE_15 -->\n###### 약동학 및 약력\n\n<!-- PAGE_15 -->\n###### ).\n\n <!-- PAGE_15 -->\n###### ,\n\n<!-- PAGE_15 -->\n###### 학적 정보를 제공하여 치료적 탐색 임상시험의 적절한 용량 범위와 투여 일정을 정\n\n<!-- PAGE_15 -->\n###### 약물의 흡수\n\n<!-- PAGE_15 -->\n###### 분포\n\n<!-- PAGE_15 -->\n###### 대사 및 배설에 대한 특성 규명을 위한 독립된 연구 또는 안\n\n<!-- PAGE_15 -->\n###### ,\n\n<!-- PAGE_15 -->\n###### ,\n\n<!-- PAGE_15 -->\n###### 전성 유효성 및 내약성 연구의 한 부분으로 약동학적 임상시험을 수행하여야 한다.\n\n",
        "original_sentence": "<!-- PAGE_15 -->\n###### HBV\n\n<!-- PAGE_15 -->\n###### 에 노출된 후\n\n<!-- PAGE_15 -->\n###### 형 간염 발증의 예방 목적으로 사용하고자 하는 경우에는 해당 적응\n\n<!-- PAGE_15 -->\n###### B\n\n<!-- PAGE_15 -->\n###### 임상약리시험\n\n<!-- PAGE_15 -->\n###### 2.\n\n"
      }
    },
    {
      "chunk_id": "chunk_127",
      "text": "<!-- PAGE_15 -->\n###### 사람에서 실시되는 첫 임상시험으로서 주된 목적은 안전성을 평가하는 것이다.\n\n",
      "metadata": {
        "source": "(가이드라인-005)_정맥주사용+B형간염+사람면역글로불린제제의+안전성유효성+평가+가이드라인.pdf",
        "chunk_index": 126,
        "window_size": 3,
        "char_count": 67,
        "word_count": 13,
        "page_number": 15,
        "window_text": "임상시험\n\n<!-- PAGE_15 -->\n###### Ⅴ\n\n<!-- PAGE_15 -->\n###### 일반적 고려사항\n\n<!-- PAGE_15 -->\n###### 1.\n\n <!-- PAGE_15 -->\n###### 간 이식 후\n\n<!-- PAGE_15 -->\n###### 형 간염의 재발을 막기 위해서는\n\n<!-- PAGE_15 -->\n###### 를 단독 투여하거나 항바이러\n\n<!-- PAGE_15 -->\n###### B\n\n<!-- PAGE_15 -->\n###### HBIG\n\n<!-- PAGE_15 -->\n###### 본 가이드라인에서는 간 이식 환자의\n\n<!-- PAGE_15 -->\n###### 형 간염 재발의 예방 목적으로 사용되는\n\n<!-- PAGE_15 -->\n###### B\n\n<!-- PAGE_15 -->\n###### 정맥주사용\n\n<!-- PAGE_15 -->\n###### 단독 투여에 의한 임상시험을 위주로 언급하고자 한다\n\n<!-- PAGE_15 -->\n###### 만약\n\n<!-- PAGE_15 -->\n###### HBIG\n\n<!-- PAGE_15 -->\n###### .\n\n <!-- PAGE_15 -->\n###### HBV\n\n<!-- PAGE_15 -->\n###### 에 노출된 후\n\n<!-- PAGE_15 -->\n###### 형 간염 발증의 예방 목적으로 사용하고자 하는 경우에는 해당 적응\n\n<!-- PAGE_15 -->\n###### B\n\n<!-- PAGE_15 -->\n###### 임상약리시험\n\n<!-- PAGE_15 -->\n###### 2.\n\n <!-- PAGE_15 -->\n###### 사람에서 실시되는 첫 임상시험으로서 주된 목적은 안전성을 평가하는 것이다.\n\n <!-- PAGE_15 -->\n###### 일반적으로 치료를 목적으로 하지 않으며 건강한 지원자를 대상으로 실시한다 본\n\n<!-- PAGE_15 -->\n###### (\n\n<!-- PAGE_15 -->\n###### 제제는 항암제 등과 같이 세포독성 등의 심각한 잠재적 독성을 갖고 있지 않으므로\n\n<!-- PAGE_15 -->\n###### 환자를 대상으로 하지 아니한다\n\n<!-- PAGE_15 -->\n###### 단기간의 안전성 및 내약성 평가\n\n<!-- PAGE_15 -->\n###### 약동학 및 약력\n\n<!-- PAGE_15 -->\n###### ).\n\n <!-- PAGE_15 -->\n###### ,\n\n<!-- PAGE_15 -->\n###### 학적 정보를 제공하여 치료적 탐색 임상시험의 적절한 용량 범위와 투여 일정을 정\n\n<!-- PAGE_15 -->\n###### 약물의 흡수\n\n<!-- PAGE_15 -->\n###### 분포\n\n<!-- PAGE_15 -->\n###### 대사 및 배설에 대한 특성 규명을 위한 독립된 연구 또는 안\n\n<!-- PAGE_15 -->\n###### ,\n\n<!-- PAGE_15 -->\n###### ,\n\n<!-- PAGE_15 -->\n###### 전성 유효성 및 내약성 연구의 한 부분으로 약동학적 임상시험을 수행하여야 한다.\n\n <!-- PAGE_15 -->\n###### ․\n\n<!-- PAGE_15 -->\n###### 일반적인 약동학적 평가에서 고려되어야 하는 고령자\n\n<!-- PAGE_15 -->\n###### 여성 등과 같은 특수 집단에\n\n<!-- PAGE_15 -->\n###### ,\n\n<!-- PAGE_15 -->\n###### 서의 약동학적 정보를 제공하여야 한다.\n\n",
        "original_sentence": "<!-- PAGE_15 -->\n###### 사람에서 실시되는 첫 임상시험으로서 주된 목적은 안전성을 평가하는 것이다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_128",
      "text": "<!-- PAGE_15 -->\n###### 일반적으로 치료를 목적으로 하지 않으며 건강한 지원자를 대상으로 실시한다 본\n\n<!-- PAGE_15 -->\n###### (\n\n<!-- PAGE_15 -->\n###### 제제는 항암제 등과 같이 세포독성 등의 심각한 잠재적 독성을 갖고 있지 않으므로\n\n<!-- PAGE_15 -->\n###### 환자를 대상으로 하지 아니한다\n\n<!-- PAGE_15 -->\n###### 단기간의 안전성 및 내약성 평가\n\n<!-- PAGE_15 -->\n###### 약동학 및 약력\n\n<!-- PAGE_15 -->\n###### ).\n\n",
      "metadata": {
        "source": "(가이드라인-005)_정맥주사용+B형간염+사람면역글로불린제제의+안전성유효성+평가+가이드라인.pdf",
        "chunk_index": 127,
        "window_size": 3,
        "char_count": 312,
        "word_count": 64,
        "page_number": 15,
        "window_text": "<!-- PAGE_15 -->\n###### 간 이식 후\n\n<!-- PAGE_15 -->\n###### 형 간염의 재발을 막기 위해서는\n\n<!-- PAGE_15 -->\n###### 를 단독 투여하거나 항바이러\n\n<!-- PAGE_15 -->\n###### B\n\n<!-- PAGE_15 -->\n###### HBIG\n\n<!-- PAGE_15 -->\n###### 본 가이드라인에서는 간 이식 환자의\n\n<!-- PAGE_15 -->\n###### 형 간염 재발의 예방 목적으로 사용되는\n\n<!-- PAGE_15 -->\n###### B\n\n<!-- PAGE_15 -->\n###### 정맥주사용\n\n<!-- PAGE_15 -->\n###### 단독 투여에 의한 임상시험을 위주로 언급하고자 한다\n\n<!-- PAGE_15 -->\n###### 만약\n\n<!-- PAGE_15 -->\n###### HBIG\n\n<!-- PAGE_15 -->\n###### .\n\n <!-- PAGE_15 -->\n###### HBV\n\n<!-- PAGE_15 -->\n###### 에 노출된 후\n\n<!-- PAGE_15 -->\n###### 형 간염 발증의 예방 목적으로 사용하고자 하는 경우에는 해당 적응\n\n<!-- PAGE_15 -->\n###### B\n\n<!-- PAGE_15 -->\n###### 임상약리시험\n\n<!-- PAGE_15 -->\n###### 2.\n\n <!-- PAGE_15 -->\n###### 사람에서 실시되는 첫 임상시험으로서 주된 목적은 안전성을 평가하는 것이다.\n\n <!-- PAGE_15 -->\n###### 일반적으로 치료를 목적으로 하지 않으며 건강한 지원자를 대상으로 실시한다 본\n\n<!-- PAGE_15 -->\n###### (\n\n<!-- PAGE_15 -->\n###### 제제는 항암제 등과 같이 세포독성 등의 심각한 잠재적 독성을 갖고 있지 않으므로\n\n<!-- PAGE_15 -->\n###### 환자를 대상으로 하지 아니한다\n\n<!-- PAGE_15 -->\n###### 단기간의 안전성 및 내약성 평가\n\n<!-- PAGE_15 -->\n###### 약동학 및 약력\n\n<!-- PAGE_15 -->\n###### ).\n\n <!-- PAGE_15 -->\n###### ,\n\n<!-- PAGE_15 -->\n###### 학적 정보를 제공하여 치료적 탐색 임상시험의 적절한 용량 범위와 투여 일정을 정\n\n<!-- PAGE_15 -->\n###### 약물의 흡수\n\n<!-- PAGE_15 -->\n###### 분포\n\n<!-- PAGE_15 -->\n###### 대사 및 배설에 대한 특성 규명을 위한 독립된 연구 또는 안\n\n<!-- PAGE_15 -->\n###### ,\n\n<!-- PAGE_15 -->\n###### ,\n\n<!-- PAGE_15 -->\n###### 전성 유효성 및 내약성 연구의 한 부분으로 약동학적 임상시험을 수행하여야 한다.\n\n <!-- PAGE_15 -->\n###### ․\n\n<!-- PAGE_15 -->\n###### 일반적인 약동학적 평가에서 고려되어야 하는 고령자\n\n<!-- PAGE_15 -->\n###### 여성 등과 같은 특수 집단에\n\n<!-- PAGE_15 -->\n###### ,\n\n<!-- PAGE_15 -->\n###### 서의 약동학적 정보를 제공하여야 한다.\n\n <!-- PAGE_15 -->\n###### 정맥주사용\n\n<!-- PAGE_15 -->\n###### 는 분자량이 큰 면역글로불린제제이므로 간이나 신장 등에서 여\n\n<!-- PAGE_15 -->\n###### HBIG\n\n<!-- PAGE_15 -->\n###### 과되거나 해독되지 않고 혈중을 다니다가 세망내피계(reticuloendothelial system,\n\n<!-- PAGE_15 -->\n###### 에서 탐식 당해 비장\n\n<!-- PAGE_15 -->\n###### 림프절\n\n<!-- PAGE_15 -->\n###### 골수 등에서 제거되므로 신장애 환자에 대한 약\n\n<!-- PAGE_15 -->\n###### RES)\n\n<!-- PAGE_15 -->\n###### ,\n\n<!-- PAGE_15 -->\n###### ,\n\n<!-- PAGE_15 -->\n###### 동학 정보의 확보는 필수사항은 아니다.\n\n",
        "original_sentence": "<!-- PAGE_15 -->\n###### 일반적으로 치료를 목적으로 하지 않으며 건강한 지원자를 대상으로 실시한다 본\n\n<!-- PAGE_15 -->\n###### (\n\n<!-- PAGE_15 -->\n###### 제제는 항암제 등과 같이 세포독성 등의 심각한 잠재적 독성을 갖고 있지 않으므로\n\n<!-- PAGE_15 -->\n###### 환자를 대상으로 하지 아니한다\n\n<!-- PAGE_15 -->\n###### 단기간의 안전성 및 내약성 평가\n\n<!-- PAGE_15 -->\n###### 약동학 및 약력\n\n<!-- PAGE_15 -->\n###### ).\n\n"
      }
    },
    {
      "chunk_id": "chunk_129",
      "text": "<!-- PAGE_15 -->\n###### ,\n\n<!-- PAGE_15 -->\n###### 학적 정보를 제공하여 치료적 탐색 임상시험의 적절한 용량 범위와 투여 일정을 정\n\n<!-- PAGE_15 -->\n###### 약물의 흡수\n\n<!-- PAGE_15 -->\n###### 분포\n\n<!-- PAGE_15 -->\n###### 대사 및 배설에 대한 특성 규명을 위한 독립된 연구 또는 안\n\n<!-- PAGE_15 -->\n###### ,\n\n<!-- PAGE_15 -->\n###### ,\n\n<!-- PAGE_15 -->\n###### 전성 유효성 및 내약성 연구의 한 부분으로 약동학적 임상시험을 수행하여야 한다.\n\n",
      "metadata": {
        "source": "(가이드라인-005)_정맥주사용+B형간염+사람면역글로불린제제의+안전성유효성+평가+가이드라인.pdf",
        "chunk_index": 128,
        "window_size": 3,
        "char_count": 340,
        "word_count": 72,
        "page_number": 15,
        "window_text": "<!-- PAGE_15 -->\n###### HBV\n\n<!-- PAGE_15 -->\n###### 에 노출된 후\n\n<!-- PAGE_15 -->\n###### 형 간염 발증의 예방 목적으로 사용하고자 하는 경우에는 해당 적응\n\n<!-- PAGE_15 -->\n###### B\n\n<!-- PAGE_15 -->\n###### 임상약리시험\n\n<!-- PAGE_15 -->\n###### 2.\n\n <!-- PAGE_15 -->\n###### 사람에서 실시되는 첫 임상시험으로서 주된 목적은 안전성을 평가하는 것이다.\n\n <!-- PAGE_15 -->\n###### 일반적으로 치료를 목적으로 하지 않으며 건강한 지원자를 대상으로 실시한다 본\n\n<!-- PAGE_15 -->\n###### (\n\n<!-- PAGE_15 -->\n###### 제제는 항암제 등과 같이 세포독성 등의 심각한 잠재적 독성을 갖고 있지 않으므로\n\n<!-- PAGE_15 -->\n###### 환자를 대상으로 하지 아니한다\n\n<!-- PAGE_15 -->\n###### 단기간의 안전성 및 내약성 평가\n\n<!-- PAGE_15 -->\n###### 약동학 및 약력\n\n<!-- PAGE_15 -->\n###### ).\n\n <!-- PAGE_15 -->\n###### ,\n\n<!-- PAGE_15 -->\n###### 학적 정보를 제공하여 치료적 탐색 임상시험의 적절한 용량 범위와 투여 일정을 정\n\n<!-- PAGE_15 -->\n###### 약물의 흡수\n\n<!-- PAGE_15 -->\n###### 분포\n\n<!-- PAGE_15 -->\n###### 대사 및 배설에 대한 특성 규명을 위한 독립된 연구 또는 안\n\n<!-- PAGE_15 -->\n###### ,\n\n<!-- PAGE_15 -->\n###### ,\n\n<!-- PAGE_15 -->\n###### 전성 유효성 및 내약성 연구의 한 부분으로 약동학적 임상시험을 수행하여야 한다.\n\n <!-- PAGE_15 -->\n###### ․\n\n<!-- PAGE_15 -->\n###### 일반적인 약동학적 평가에서 고려되어야 하는 고령자\n\n<!-- PAGE_15 -->\n###### 여성 등과 같은 특수 집단에\n\n<!-- PAGE_15 -->\n###### ,\n\n<!-- PAGE_15 -->\n###### 서의 약동학적 정보를 제공하여야 한다.\n\n <!-- PAGE_15 -->\n###### 정맥주사용\n\n<!-- PAGE_15 -->\n###### 는 분자량이 큰 면역글로불린제제이므로 간이나 신장 등에서 여\n\n<!-- PAGE_15 -->\n###### HBIG\n\n<!-- PAGE_15 -->\n###### 과되거나 해독되지 않고 혈중을 다니다가 세망내피계(reticuloendothelial system,\n\n<!-- PAGE_15 -->\n###### 에서 탐식 당해 비장\n\n<!-- PAGE_15 -->\n###### 림프절\n\n<!-- PAGE_15 -->\n###### 골수 등에서 제거되므로 신장애 환자에 대한 약\n\n<!-- PAGE_15 -->\n###### RES)\n\n<!-- PAGE_15 -->\n###### ,\n\n<!-- PAGE_15 -->\n###### ,\n\n<!-- PAGE_15 -->\n###### 동학 정보의 확보는 필수사항은 아니다.\n\n - - 8 -\n<!-- PAGE_16 -->\n###### 치료적 탐색 임상시험\n\n<!-- PAGE_16 -->\n###### 3.\n\n",
        "original_sentence": "<!-- PAGE_15 -->\n###### ,\n\n<!-- PAGE_15 -->\n###### 학적 정보를 제공하여 치료적 탐색 임상시험의 적절한 용량 범위와 투여 일정을 정\n\n<!-- PAGE_15 -->\n###### 약물의 흡수\n\n<!-- PAGE_15 -->\n###### 분포\n\n<!-- PAGE_15 -->\n###### 대사 및 배설에 대한 특성 규명을 위한 독립된 연구 또는 안\n\n<!-- PAGE_15 -->\n###### ,\n\n<!-- PAGE_15 -->\n###### ,\n\n<!-- PAGE_15 -->\n###### 전성 유효성 및 내약성 연구의 한 부분으로 약동학적 임상시험을 수행하여야 한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_130",
      "text": "<!-- PAGE_15 -->\n###### ․\n\n<!-- PAGE_15 -->\n###### 일반적인 약동학적 평가에서 고려되어야 하는 고령자\n\n<!-- PAGE_15 -->\n###### 여성 등과 같은 특수 집단에\n\n<!-- PAGE_15 -->\n###### ,\n\n<!-- PAGE_15 -->\n###### 서의 약동학적 정보를 제공하여야 한다.\n\n",
      "metadata": {
        "source": "(가이드라인-005)_정맥주사용+B형간염+사람면역글로불린제제의+안전성유효성+평가+가이드라인.pdf",
        "chunk_index": 129,
        "window_size": 3,
        "char_count": 195,
        "word_count": 38,
        "page_number": 15,
        "window_text": "<!-- PAGE_15 -->\n###### 사람에서 실시되는 첫 임상시험으로서 주된 목적은 안전성을 평가하는 것이다.\n\n <!-- PAGE_15 -->\n###### 일반적으로 치료를 목적으로 하지 않으며 건강한 지원자를 대상으로 실시한다 본\n\n<!-- PAGE_15 -->\n###### (\n\n<!-- PAGE_15 -->\n###### 제제는 항암제 등과 같이 세포독성 등의 심각한 잠재적 독성을 갖고 있지 않으므로\n\n<!-- PAGE_15 -->\n###### 환자를 대상으로 하지 아니한다\n\n<!-- PAGE_15 -->\n###### 단기간의 안전성 및 내약성 평가\n\n<!-- PAGE_15 -->\n###### 약동학 및 약력\n\n<!-- PAGE_15 -->\n###### ).\n\n <!-- PAGE_15 -->\n###### ,\n\n<!-- PAGE_15 -->\n###### 학적 정보를 제공하여 치료적 탐색 임상시험의 적절한 용량 범위와 투여 일정을 정\n\n<!-- PAGE_15 -->\n###### 약물의 흡수\n\n<!-- PAGE_15 -->\n###### 분포\n\n<!-- PAGE_15 -->\n###### 대사 및 배설에 대한 특성 규명을 위한 독립된 연구 또는 안\n\n<!-- PAGE_15 -->\n###### ,\n\n<!-- PAGE_15 -->\n###### ,\n\n<!-- PAGE_15 -->\n###### 전성 유효성 및 내약성 연구의 한 부분으로 약동학적 임상시험을 수행하여야 한다.\n\n <!-- PAGE_15 -->\n###### ․\n\n<!-- PAGE_15 -->\n###### 일반적인 약동학적 평가에서 고려되어야 하는 고령자\n\n<!-- PAGE_15 -->\n###### 여성 등과 같은 특수 집단에\n\n<!-- PAGE_15 -->\n###### ,\n\n<!-- PAGE_15 -->\n###### 서의 약동학적 정보를 제공하여야 한다.\n\n <!-- PAGE_15 -->\n###### 정맥주사용\n\n<!-- PAGE_15 -->\n###### 는 분자량이 큰 면역글로불린제제이므로 간이나 신장 등에서 여\n\n<!-- PAGE_15 -->\n###### HBIG\n\n<!-- PAGE_15 -->\n###### 과되거나 해독되지 않고 혈중을 다니다가 세망내피계(reticuloendothelial system,\n\n<!-- PAGE_15 -->\n###### 에서 탐식 당해 비장\n\n<!-- PAGE_15 -->\n###### 림프절\n\n<!-- PAGE_15 -->\n###### 골수 등에서 제거되므로 신장애 환자에 대한 약\n\n<!-- PAGE_15 -->\n###### RES)\n\n<!-- PAGE_15 -->\n###### ,\n\n<!-- PAGE_15 -->\n###### ,\n\n<!-- PAGE_15 -->\n###### 동학 정보의 확보는 필수사항은 아니다.\n\n - - 8 -\n<!-- PAGE_16 -->\n###### 치료적 탐색 임상시험\n\n<!-- PAGE_16 -->\n###### 3.\n\n <!-- PAGE_16 -->\n###### 치료적 유효성을 탐색하여 가능한 용량과 투여 기간 설정 등 다양한 정보 수집을\n\n<!-- PAGE_16 -->\n###### 목적으로 하며\n\n<!-- PAGE_16 -->\n###### 비교적 철저한 선정기준에 의해 모집된 환자군을 대상으로 수행하\n\n<!-- PAGE_16 -->\n###### ,\n\n<!-- PAGE_16 -->\n###### 여야 한다.\n\n",
        "original_sentence": "<!-- PAGE_15 -->\n###### ․\n\n<!-- PAGE_15 -->\n###### 일반적인 약동학적 평가에서 고려되어야 하는 고령자\n\n<!-- PAGE_15 -->\n###### 여성 등과 같은 특수 집단에\n\n<!-- PAGE_15 -->\n###### ,\n\n<!-- PAGE_15 -->\n###### 서의 약동학적 정보를 제공하여야 한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_131",
      "text": "<!-- PAGE_15 -->\n###### 정맥주사용\n\n<!-- PAGE_15 -->\n###### 는 분자량이 큰 면역글로불린제제이므로 간이나 신장 등에서 여\n\n<!-- PAGE_15 -->\n###### HBIG\n\n<!-- PAGE_15 -->\n###### 과되거나 해독되지 않고 혈중을 다니다가 세망내피계(reticuloendothelial system,\n\n<!-- PAGE_15 -->\n###### 에서 탐식 당해 비장\n\n<!-- PAGE_15 -->\n###### 림프절\n\n<!-- PAGE_15 -->\n###### 골수 등에서 제거되므로 신장애 환자에 대한 약\n\n<!-- PAGE_15 -->\n###### RES)\n\n<!-- PAGE_15 -->\n###### ,\n\n<!-- PAGE_15 -->\n###### ,\n\n<!-- PAGE_15 -->\n###### 동학 정보의 확보는 필수사항은 아니다.\n\n",
      "metadata": {
        "source": "(가이드라인-005)_정맥주사용+B형간염+사람면역글로불린제제의+안전성유효성+평가+가이드라인.pdf",
        "chunk_index": 130,
        "window_size": 3,
        "char_count": 449,
        "word_count": 81,
        "page_number": 15,
        "window_text": "<!-- PAGE_15 -->\n###### 일반적으로 치료를 목적으로 하지 않으며 건강한 지원자를 대상으로 실시한다 본\n\n<!-- PAGE_15 -->\n###### (\n\n<!-- PAGE_15 -->\n###### 제제는 항암제 등과 같이 세포독성 등의 심각한 잠재적 독성을 갖고 있지 않으므로\n\n<!-- PAGE_15 -->\n###### 환자를 대상으로 하지 아니한다\n\n<!-- PAGE_15 -->\n###### 단기간의 안전성 및 내약성 평가\n\n<!-- PAGE_15 -->\n###### 약동학 및 약력\n\n<!-- PAGE_15 -->\n###### ).\n\n <!-- PAGE_15 -->\n###### ,\n\n<!-- PAGE_15 -->\n###### 학적 정보를 제공하여 치료적 탐색 임상시험의 적절한 용량 범위와 투여 일정을 정\n\n<!-- PAGE_15 -->\n###### 약물의 흡수\n\n<!-- PAGE_15 -->\n###### 분포\n\n<!-- PAGE_15 -->\n###### 대사 및 배설에 대한 특성 규명을 위한 독립된 연구 또는 안\n\n<!-- PAGE_15 -->\n###### ,\n\n<!-- PAGE_15 -->\n###### ,\n\n<!-- PAGE_15 -->\n###### 전성 유효성 및 내약성 연구의 한 부분으로 약동학적 임상시험을 수행하여야 한다.\n\n <!-- PAGE_15 -->\n###### ․\n\n<!-- PAGE_15 -->\n###### 일반적인 약동학적 평가에서 고려되어야 하는 고령자\n\n<!-- PAGE_15 -->\n###### 여성 등과 같은 특수 집단에\n\n<!-- PAGE_15 -->\n###### ,\n\n<!-- PAGE_15 -->\n###### 서의 약동학적 정보를 제공하여야 한다.\n\n <!-- PAGE_15 -->\n###### 정맥주사용\n\n<!-- PAGE_15 -->\n###### 는 분자량이 큰 면역글로불린제제이므로 간이나 신장 등에서 여\n\n<!-- PAGE_15 -->\n###### HBIG\n\n<!-- PAGE_15 -->\n###### 과되거나 해독되지 않고 혈중을 다니다가 세망내피계(reticuloendothelial system,\n\n<!-- PAGE_15 -->\n###### 에서 탐식 당해 비장\n\n<!-- PAGE_15 -->\n###### 림프절\n\n<!-- PAGE_15 -->\n###### 골수 등에서 제거되므로 신장애 환자에 대한 약\n\n<!-- PAGE_15 -->\n###### RES)\n\n<!-- PAGE_15 -->\n###### ,\n\n<!-- PAGE_15 -->\n###### ,\n\n<!-- PAGE_15 -->\n###### 동학 정보의 확보는 필수사항은 아니다.\n\n - - 8 -\n<!-- PAGE_16 -->\n###### 치료적 탐색 임상시험\n\n<!-- PAGE_16 -->\n###### 3.\n\n <!-- PAGE_16 -->\n###### 치료적 유효성을 탐색하여 가능한 용량과 투여 기간 설정 등 다양한 정보 수집을\n\n<!-- PAGE_16 -->\n###### 목적으로 하며\n\n<!-- PAGE_16 -->\n###### 비교적 철저한 선정기준에 의해 모집된 환자군을 대상으로 수행하\n\n<!-- PAGE_16 -->\n###### ,\n\n<!-- PAGE_16 -->\n###### 여야 한다.\n\n <!-- PAGE_16 -->\n###### 치료적 확증 임상시험의 용량 및 용법을 결정하기 위하여 용량의 단계적 증량 디\n\n<!-- PAGE_16 -->\n###### 치료적 확증 임상시험\n\n<!-- PAGE_16 -->\n###### 4.\n\n",
        "original_sentence": "<!-- PAGE_15 -->\n###### 정맥주사용\n\n<!-- PAGE_15 -->\n###### 는 분자량이 큰 면역글로불린제제이므로 간이나 신장 등에서 여\n\n<!-- PAGE_15 -->\n###### HBIG\n\n<!-- PAGE_15 -->\n###### 과되거나 해독되지 않고 혈중을 다니다가 세망내피계(reticuloendothelial system,\n\n<!-- PAGE_15 -->\n###### 에서 탐식 당해 비장\n\n<!-- PAGE_15 -->\n###### 림프절\n\n<!-- PAGE_15 -->\n###### 골수 등에서 제거되므로 신장애 환자에 대한 약\n\n<!-- PAGE_15 -->\n###### RES)\n\n<!-- PAGE_15 -->\n###### ,\n\n<!-- PAGE_15 -->\n###### ,\n\n<!-- PAGE_15 -->\n###### 동학 정보의 확보는 필수사항은 아니다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_132",
      "text": "- - 8 -\n<!-- PAGE_16 -->\n###### 치료적 탐색 임상시험\n\n<!-- PAGE_16 -->\n###### 3.\n\n",
      "metadata": {
        "source": "(가이드라인-005)_정맥주사용+B형간염+사람면역글로불린제제의+안전성유효성+평가+가이드라인.pdf",
        "chunk_index": 131,
        "window_size": 3,
        "char_count": 73,
        "word_count": 16,
        "page_number": 16,
        "window_text": "<!-- PAGE_15 -->\n###### ,\n\n<!-- PAGE_15 -->\n###### 학적 정보를 제공하여 치료적 탐색 임상시험의 적절한 용량 범위와 투여 일정을 정\n\n<!-- PAGE_15 -->\n###### 약물의 흡수\n\n<!-- PAGE_15 -->\n###### 분포\n\n<!-- PAGE_15 -->\n###### 대사 및 배설에 대한 특성 규명을 위한 독립된 연구 또는 안\n\n<!-- PAGE_15 -->\n###### ,\n\n<!-- PAGE_15 -->\n###### ,\n\n<!-- PAGE_15 -->\n###### 전성 유효성 및 내약성 연구의 한 부분으로 약동학적 임상시험을 수행하여야 한다.\n\n <!-- PAGE_15 -->\n###### ․\n\n<!-- PAGE_15 -->\n###### 일반적인 약동학적 평가에서 고려되어야 하는 고령자\n\n<!-- PAGE_15 -->\n###### 여성 등과 같은 특수 집단에\n\n<!-- PAGE_15 -->\n###### ,\n\n<!-- PAGE_15 -->\n###### 서의 약동학적 정보를 제공하여야 한다.\n\n <!-- PAGE_15 -->\n###### 정맥주사용\n\n<!-- PAGE_15 -->\n###### 는 분자량이 큰 면역글로불린제제이므로 간이나 신장 등에서 여\n\n<!-- PAGE_15 -->\n###### HBIG\n\n<!-- PAGE_15 -->\n###### 과되거나 해독되지 않고 혈중을 다니다가 세망내피계(reticuloendothelial system,\n\n<!-- PAGE_15 -->\n###### 에서 탐식 당해 비장\n\n<!-- PAGE_15 -->\n###### 림프절\n\n<!-- PAGE_15 -->\n###### 골수 등에서 제거되므로 신장애 환자에 대한 약\n\n<!-- PAGE_15 -->\n###### RES)\n\n<!-- PAGE_15 -->\n###### ,\n\n<!-- PAGE_15 -->\n###### ,\n\n<!-- PAGE_15 -->\n###### 동학 정보의 확보는 필수사항은 아니다.\n\n - - 8 -\n<!-- PAGE_16 -->\n###### 치료적 탐색 임상시험\n\n<!-- PAGE_16 -->\n###### 3.\n\n <!-- PAGE_16 -->\n###### 치료적 유효성을 탐색하여 가능한 용량과 투여 기간 설정 등 다양한 정보 수집을\n\n<!-- PAGE_16 -->\n###### 목적으로 하며\n\n<!-- PAGE_16 -->\n###### 비교적 철저한 선정기준에 의해 모집된 환자군을 대상으로 수행하\n\n<!-- PAGE_16 -->\n###### ,\n\n<!-- PAGE_16 -->\n###### 여야 한다.\n\n <!-- PAGE_16 -->\n###### 치료적 확증 임상시험의 용량 및 용법을 결정하기 위하여 용량의 단계적 증량 디\n\n<!-- PAGE_16 -->\n###### 치료적 확증 임상시험\n\n<!-- PAGE_16 -->\n###### 4.\n\n <!-- PAGE_16 -->\n###### 감염에 의한 간경변증\n\n<!-- PAGE_16 -->\n###### 간암\n\n<!-- PAGE_16 -->\n###### 전격성 간부전 등 말기 간질환으로 간 이\n\n<!-- PAGE_16 -->\n###### HBV\n\n<!-- PAGE_16 -->\n###### ,\n\n<!-- PAGE_16 -->\n###### ,\n\n<!-- PAGE_16 -->\n###### 면역글로불린제제는 단백질의\n\n<!-- PAGE_16 -->\n###### 90% 이상이 면역글로불린\n\n<!-- PAGE_16 -->\n###### G(immunoglobulin\n\n<!-- PAGE_16 -->\n###### 이며 소량의\n\n<!-- PAGE_16 -->\n###### 및\n\n<!-- PAGE_16 -->\n###### 이 함유되어 있다\n\n<!-- PAGE_16 -->\n###### 최근 정제공정의 변경 또는 추\n\n<!-- PAGE_16 -->\n###### G, IgG)\n\n<!-- PAGE_16 -->\n###### IgA\n\n<!-- PAGE_16 -->\n###### IgM\n\n<!-- PAGE_16 -->\n###### .\n\n",
        "original_sentence": "- - 8 -\n<!-- PAGE_16 -->\n###### 치료적 탐색 임상시험\n\n<!-- PAGE_16 -->\n###### 3.\n\n"
      }
    },
    {
      "chunk_id": "chunk_133",
      "text": "<!-- PAGE_16 -->\n###### 치료적 유효성을 탐색하여 가능한 용량과 투여 기간 설정 등 다양한 정보 수집을\n\n<!-- PAGE_16 -->\n###### 목적으로 하며\n\n<!-- PAGE_16 -->\n###### 비교적 철저한 선정기준에 의해 모집된 환자군을 대상으로 수행하\n\n<!-- PAGE_16 -->\n###### ,\n\n<!-- PAGE_16 -->\n###### 여야 한다.\n\n",
      "metadata": {
        "source": "(가이드라인-005)_정맥주사용+B형간염+사람면역글로불린제제의+안전성유효성+평가+가이드라인.pdf",
        "chunk_index": 132,
        "window_size": 3,
        "char_count": 221,
        "word_count": 45,
        "page_number": 16,
        "window_text": "<!-- PAGE_15 -->\n###### ․\n\n<!-- PAGE_15 -->\n###### 일반적인 약동학적 평가에서 고려되어야 하는 고령자\n\n<!-- PAGE_15 -->\n###### 여성 등과 같은 특수 집단에\n\n<!-- PAGE_15 -->\n###### ,\n\n<!-- PAGE_15 -->\n###### 서의 약동학적 정보를 제공하여야 한다.\n\n <!-- PAGE_15 -->\n###### 정맥주사용\n\n<!-- PAGE_15 -->\n###### 는 분자량이 큰 면역글로불린제제이므로 간이나 신장 등에서 여\n\n<!-- PAGE_15 -->\n###### HBIG\n\n<!-- PAGE_15 -->\n###### 과되거나 해독되지 않고 혈중을 다니다가 세망내피계(reticuloendothelial system,\n\n<!-- PAGE_15 -->\n###### 에서 탐식 당해 비장\n\n<!-- PAGE_15 -->\n###### 림프절\n\n<!-- PAGE_15 -->\n###### 골수 등에서 제거되므로 신장애 환자에 대한 약\n\n<!-- PAGE_15 -->\n###### RES)\n\n<!-- PAGE_15 -->\n###### ,\n\n<!-- PAGE_15 -->\n###### ,\n\n<!-- PAGE_15 -->\n###### 동학 정보의 확보는 필수사항은 아니다.\n\n - - 8 -\n<!-- PAGE_16 -->\n###### 치료적 탐색 임상시험\n\n<!-- PAGE_16 -->\n###### 3.\n\n <!-- PAGE_16 -->\n###### 치료적 유효성을 탐색하여 가능한 용량과 투여 기간 설정 등 다양한 정보 수집을\n\n<!-- PAGE_16 -->\n###### 목적으로 하며\n\n<!-- PAGE_16 -->\n###### 비교적 철저한 선정기준에 의해 모집된 환자군을 대상으로 수행하\n\n<!-- PAGE_16 -->\n###### ,\n\n<!-- PAGE_16 -->\n###### 여야 한다.\n\n <!-- PAGE_16 -->\n###### 치료적 확증 임상시험의 용량 및 용법을 결정하기 위하여 용량의 단계적 증량 디\n\n<!-- PAGE_16 -->\n###### 치료적 확증 임상시험\n\n<!-- PAGE_16 -->\n###### 4.\n\n <!-- PAGE_16 -->\n###### 감염에 의한 간경변증\n\n<!-- PAGE_16 -->\n###### 간암\n\n<!-- PAGE_16 -->\n###### 전격성 간부전 등 말기 간질환으로 간 이\n\n<!-- PAGE_16 -->\n###### HBV\n\n<!-- PAGE_16 -->\n###### ,\n\n<!-- PAGE_16 -->\n###### ,\n\n<!-- PAGE_16 -->\n###### 면역글로불린제제는 단백질의\n\n<!-- PAGE_16 -->\n###### 90% 이상이 면역글로불린\n\n<!-- PAGE_16 -->\n###### G(immunoglobulin\n\n<!-- PAGE_16 -->\n###### 이며 소량의\n\n<!-- PAGE_16 -->\n###### 및\n\n<!-- PAGE_16 -->\n###### 이 함유되어 있다\n\n<!-- PAGE_16 -->\n###### 최근 정제공정의 변경 또는 추\n\n<!-- PAGE_16 -->\n###### G, IgG)\n\n<!-- PAGE_16 -->\n###### IgA\n\n<!-- PAGE_16 -->\n###### IgM\n\n<!-- PAGE_16 -->\n###### .\n\n <!-- PAGE_16 -->\n###### 가로\n\n<!-- PAGE_16 -->\n###### 함량이 총 단백질의\n\n<!-- PAGE_16 -->\n###### 이상으로 순도가 개선되어\n\n<!-- PAGE_16 -->\n###### 정맥주사용\n\n<!-- PAGE_16 -->\n###### IgG\n\n<!-- PAGE_16 -->\n###### 98%\n\n<!-- PAGE_16 -->\n###### ,\n\n<!-- PAGE_16 -->\n###### HBIG\n\n<!-- PAGE_16 -->\n###### 의\n\n<!-- PAGE_16 -->\n###### 함량은\n\n<!-- PAGE_16 -->\n###### 함량 대비\n\n<!-- PAGE_16 -->\n###### 미만이고 이는 근육주사용\n\n<!-- PAGE_16 -->\n###### 에 비해서 매\n\n<!-- PAGE_16 -->\n###### IgA\n\n<!-- PAGE_16 -->\n###### IgG\n\n<!-- PAGE_16 -->\n###### 0.1%\n\n<!-- PAGE_16 -->\n###### HBIG\n\n<!-- PAGE_16 -->\n###### 우 낮은 수준이다\n\n<!-- PAGE_16 -->\n###### 그러나\n\n<!-- PAGE_16 -->\n###### 에 대한 항체를 갖고 있는\n\n<!-- PAGE_16 -->\n###### 결핍증 환자는 면역\n\n<!-- PAGE_16 -->\n###### .\n\n",
        "original_sentence": "<!-- PAGE_16 -->\n###### 치료적 유효성을 탐색하여 가능한 용량과 투여 기간 설정 등 다양한 정보 수집을\n\n<!-- PAGE_16 -->\n###### 목적으로 하며\n\n<!-- PAGE_16 -->\n###### 비교적 철저한 선정기준에 의해 모집된 환자군을 대상으로 수행하\n\n<!-- PAGE_16 -->\n###### ,\n\n<!-- PAGE_16 -->\n###### 여야 한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_134",
      "text": "<!-- PAGE_16 -->\n###### 치료적 확증 임상시험의 용량 및 용법을 결정하기 위하여 용량의 단계적 증량 디\n\n<!-- PAGE_16 -->\n###### 치료적 확증 임상시험\n\n<!-- PAGE_16 -->\n###### 4.\n\n",
      "metadata": {
        "source": "(가이드라인-005)_정맥주사용+B형간염+사람면역글로불린제제의+안전성유효성+평가+가이드라인.pdf",
        "chunk_index": 133,
        "window_size": 3,
        "char_count": 134,
        "word_count": 28,
        "page_number": 16,
        "window_text": "<!-- PAGE_15 -->\n###### 정맥주사용\n\n<!-- PAGE_15 -->\n###### 는 분자량이 큰 면역글로불린제제이므로 간이나 신장 등에서 여\n\n<!-- PAGE_15 -->\n###### HBIG\n\n<!-- PAGE_15 -->\n###### 과되거나 해독되지 않고 혈중을 다니다가 세망내피계(reticuloendothelial system,\n\n<!-- PAGE_15 -->\n###### 에서 탐식 당해 비장\n\n<!-- PAGE_15 -->\n###### 림프절\n\n<!-- PAGE_15 -->\n###### 골수 등에서 제거되므로 신장애 환자에 대한 약\n\n<!-- PAGE_15 -->\n###### RES)\n\n<!-- PAGE_15 -->\n###### ,\n\n<!-- PAGE_15 -->\n###### ,\n\n<!-- PAGE_15 -->\n###### 동학 정보의 확보는 필수사항은 아니다.\n\n - - 8 -\n<!-- PAGE_16 -->\n###### 치료적 탐색 임상시험\n\n<!-- PAGE_16 -->\n###### 3.\n\n <!-- PAGE_16 -->\n###### 치료적 유효성을 탐색하여 가능한 용량과 투여 기간 설정 등 다양한 정보 수집을\n\n<!-- PAGE_16 -->\n###### 목적으로 하며\n\n<!-- PAGE_16 -->\n###### 비교적 철저한 선정기준에 의해 모집된 환자군을 대상으로 수행하\n\n<!-- PAGE_16 -->\n###### ,\n\n<!-- PAGE_16 -->\n###### 여야 한다.\n\n <!-- PAGE_16 -->\n###### 치료적 확증 임상시험의 용량 및 용법을 결정하기 위하여 용량의 단계적 증량 디\n\n<!-- PAGE_16 -->\n###### 치료적 확증 임상시험\n\n<!-- PAGE_16 -->\n###### 4.\n\n <!-- PAGE_16 -->\n###### 감염에 의한 간경변증\n\n<!-- PAGE_16 -->\n###### 간암\n\n<!-- PAGE_16 -->\n###### 전격성 간부전 등 말기 간질환으로 간 이\n\n<!-- PAGE_16 -->\n###### HBV\n\n<!-- PAGE_16 -->\n###### ,\n\n<!-- PAGE_16 -->\n###### ,\n\n<!-- PAGE_16 -->\n###### 면역글로불린제제는 단백질의\n\n<!-- PAGE_16 -->\n###### 90% 이상이 면역글로불린\n\n<!-- PAGE_16 -->\n###### G(immunoglobulin\n\n<!-- PAGE_16 -->\n###### 이며 소량의\n\n<!-- PAGE_16 -->\n###### 및\n\n<!-- PAGE_16 -->\n###### 이 함유되어 있다\n\n<!-- PAGE_16 -->\n###### 최근 정제공정의 변경 또는 추\n\n<!-- PAGE_16 -->\n###### G, IgG)\n\n<!-- PAGE_16 -->\n###### IgA\n\n<!-- PAGE_16 -->\n###### IgM\n\n<!-- PAGE_16 -->\n###### .\n\n <!-- PAGE_16 -->\n###### 가로\n\n<!-- PAGE_16 -->\n###### 함량이 총 단백질의\n\n<!-- PAGE_16 -->\n###### 이상으로 순도가 개선되어\n\n<!-- PAGE_16 -->\n###### 정맥주사용\n\n<!-- PAGE_16 -->\n###### IgG\n\n<!-- PAGE_16 -->\n###### 98%\n\n<!-- PAGE_16 -->\n###### ,\n\n<!-- PAGE_16 -->\n###### HBIG\n\n<!-- PAGE_16 -->\n###### 의\n\n<!-- PAGE_16 -->\n###### 함량은\n\n<!-- PAGE_16 -->\n###### 함량 대비\n\n<!-- PAGE_16 -->\n###### 미만이고 이는 근육주사용\n\n<!-- PAGE_16 -->\n###### 에 비해서 매\n\n<!-- PAGE_16 -->\n###### IgA\n\n<!-- PAGE_16 -->\n###### IgG\n\n<!-- PAGE_16 -->\n###### 0.1%\n\n<!-- PAGE_16 -->\n###### HBIG\n\n<!-- PAGE_16 -->\n###### 우 낮은 수준이다\n\n<!-- PAGE_16 -->\n###### 그러나\n\n<!-- PAGE_16 -->\n###### 에 대한 항체를 갖고 있는\n\n<!-- PAGE_16 -->\n###### 결핍증 환자는 면역\n\n<!-- PAGE_16 -->\n###### .\n\n <!-- PAGE_16 -->\n###### IgA\n\n<!-- PAGE_16 -->\n###### IgA\n\n<!-- PAGE_16 -->\n###### 글로불린제제 투여로 제품에 함유되어 있는\n\n<!-- PAGE_16 -->\n###### IgA로 인한 항원 항체 반응 때문에 과\n\n<!-- PAGE_16 -->\n###### -\n\n<!-- PAGE_16 -->\n###### 민반응이 생길 수 있으므로 투여해서는 안 된다.\n\n",
        "original_sentence": "<!-- PAGE_16 -->\n###### 치료적 확증 임상시험의 용량 및 용법을 결정하기 위하여 용량의 단계적 증량 디\n\n<!-- PAGE_16 -->\n###### 치료적 확증 임상시험\n\n<!-- PAGE_16 -->\n###### 4.\n\n"
      }
    },
    {
      "chunk_id": "chunk_135",
      "text": "<!-- PAGE_16 -->\n###### 감염에 의한 간경변증\n\n<!-- PAGE_16 -->\n###### 간암\n\n<!-- PAGE_16 -->\n###### 전격성 간부전 등 말기 간질환으로 간 이\n\n<!-- PAGE_16 -->\n###### HBV\n\n<!-- PAGE_16 -->\n###### ,\n\n<!-- PAGE_16 -->\n###### ,\n\n<!-- PAGE_16 -->\n###### 면역글로불린제제는 단백질의\n\n<!-- PAGE_16 -->\n###### 90% 이상이 면역글로불린\n\n<!-- PAGE_16 -->\n###### G(immunoglobulin\n\n<!-- PAGE_16 -->\n###### 이며 소량의\n\n<!-- PAGE_16 -->\n###### 및\n\n<!-- PAGE_16 -->\n###### 이 함유되어 있다\n\n<!-- PAGE_16 -->\n###### 최근 정제공정의 변경 또는 추\n\n<!-- PAGE_16 -->\n###### G, IgG)\n\n<!-- PAGE_16 -->\n###### IgA\n\n<!-- PAGE_16 -->\n###### IgM\n\n<!-- PAGE_16 -->\n###### .\n\n",
      "metadata": {
        "source": "(가이드라인-005)_정맥주사용+B형간염+사람면역글로불린제제의+안전성유효성+평가+가이드라인.pdf",
        "chunk_index": 134,
        "window_size": 3,
        "char_count": 572,
        "word_count": 104,
        "page_number": 16,
        "window_text": "- - 8 -\n<!-- PAGE_16 -->\n###### 치료적 탐색 임상시험\n\n<!-- PAGE_16 -->\n###### 3.\n\n <!-- PAGE_16 -->\n###### 치료적 유효성을 탐색하여 가능한 용량과 투여 기간 설정 등 다양한 정보 수집을\n\n<!-- PAGE_16 -->\n###### 목적으로 하며\n\n<!-- PAGE_16 -->\n###### 비교적 철저한 선정기준에 의해 모집된 환자군을 대상으로 수행하\n\n<!-- PAGE_16 -->\n###### ,\n\n<!-- PAGE_16 -->\n###### 여야 한다.\n\n <!-- PAGE_16 -->\n###### 치료적 확증 임상시험의 용량 및 용법을 결정하기 위하여 용량의 단계적 증량 디\n\n<!-- PAGE_16 -->\n###### 치료적 확증 임상시험\n\n<!-- PAGE_16 -->\n###### 4.\n\n <!-- PAGE_16 -->\n###### 감염에 의한 간경변증\n\n<!-- PAGE_16 -->\n###### 간암\n\n<!-- PAGE_16 -->\n###### 전격성 간부전 등 말기 간질환으로 간 이\n\n<!-- PAGE_16 -->\n###### HBV\n\n<!-- PAGE_16 -->\n###### ,\n\n<!-- PAGE_16 -->\n###### ,\n\n<!-- PAGE_16 -->\n###### 면역글로불린제제는 단백질의\n\n<!-- PAGE_16 -->\n###### 90% 이상이 면역글로불린\n\n<!-- PAGE_16 -->\n###### G(immunoglobulin\n\n<!-- PAGE_16 -->\n###### 이며 소량의\n\n<!-- PAGE_16 -->\n###### 및\n\n<!-- PAGE_16 -->\n###### 이 함유되어 있다\n\n<!-- PAGE_16 -->\n###### 최근 정제공정의 변경 또는 추\n\n<!-- PAGE_16 -->\n###### G, IgG)\n\n<!-- PAGE_16 -->\n###### IgA\n\n<!-- PAGE_16 -->\n###### IgM\n\n<!-- PAGE_16 -->\n###### .\n\n <!-- PAGE_16 -->\n###### 가로\n\n<!-- PAGE_16 -->\n###### 함량이 총 단백질의\n\n<!-- PAGE_16 -->\n###### 이상으로 순도가 개선되어\n\n<!-- PAGE_16 -->\n###### 정맥주사용\n\n<!-- PAGE_16 -->\n###### IgG\n\n<!-- PAGE_16 -->\n###### 98%\n\n<!-- PAGE_16 -->\n###### ,\n\n<!-- PAGE_16 -->\n###### HBIG\n\n<!-- PAGE_16 -->\n###### 의\n\n<!-- PAGE_16 -->\n###### 함량은\n\n<!-- PAGE_16 -->\n###### 함량 대비\n\n<!-- PAGE_16 -->\n###### 미만이고 이는 근육주사용\n\n<!-- PAGE_16 -->\n###### 에 비해서 매\n\n<!-- PAGE_16 -->\n###### IgA\n\n<!-- PAGE_16 -->\n###### IgG\n\n<!-- PAGE_16 -->\n###### 0.1%\n\n<!-- PAGE_16 -->\n###### HBIG\n\n<!-- PAGE_16 -->\n###### 우 낮은 수준이다\n\n<!-- PAGE_16 -->\n###### 그러나\n\n<!-- PAGE_16 -->\n###### 에 대한 항체를 갖고 있는\n\n<!-- PAGE_16 -->\n###### 결핍증 환자는 면역\n\n<!-- PAGE_16 -->\n###### .\n\n <!-- PAGE_16 -->\n###### IgA\n\n<!-- PAGE_16 -->\n###### IgA\n\n<!-- PAGE_16 -->\n###### 글로불린제제 투여로 제품에 함유되어 있는\n\n<!-- PAGE_16 -->\n###### IgA로 인한 항원 항체 반응 때문에 과\n\n<!-- PAGE_16 -->\n###### -\n\n<!-- PAGE_16 -->\n###### 민반응이 생길 수 있으므로 투여해서는 안 된다.\n\n <!-- PAGE_16 -->\n###### 투여 용량\n\n<!-- PAGE_16 -->\n###### 4.2.\n\n",
        "original_sentence": "<!-- PAGE_16 -->\n###### 감염에 의한 간경변증\n\n<!-- PAGE_16 -->\n###### 간암\n\n<!-- PAGE_16 -->\n###### 전격성 간부전 등 말기 간질환으로 간 이\n\n<!-- PAGE_16 -->\n###### HBV\n\n<!-- PAGE_16 -->\n###### ,\n\n<!-- PAGE_16 -->\n###### ,\n\n<!-- PAGE_16 -->\n###### 면역글로불린제제는 단백질의\n\n<!-- PAGE_16 -->\n###### 90% 이상이 면역글로불린\n\n<!-- PAGE_16 -->\n###### G(immunoglobulin\n\n<!-- PAGE_16 -->\n###### 이며 소량의\n\n<!-- PAGE_16 -->\n###### 및\n\n<!-- PAGE_16 -->\n###### 이 함유되어 있다\n\n<!-- PAGE_16 -->\n###### 최근 정제공정의 변경 또는 추\n\n<!-- PAGE_16 -->\n###### G, IgG)\n\n<!-- PAGE_16 -->\n###### IgA\n\n<!-- PAGE_16 -->\n###### IgM\n\n<!-- PAGE_16 -->\n###### .\n\n"
      }
    },
    {
      "chunk_id": "chunk_136",
      "text": "<!-- PAGE_16 -->\n###### 가로\n\n<!-- PAGE_16 -->\n###### 함량이 총 단백질의\n\n<!-- PAGE_16 -->\n###### 이상으로 순도가 개선되어\n\n<!-- PAGE_16 -->\n###### 정맥주사용\n\n<!-- PAGE_16 -->\n###### IgG\n\n<!-- PAGE_16 -->\n###### 98%\n\n<!-- PAGE_16 -->\n###### ,\n\n<!-- PAGE_16 -->\n###### HBIG\n\n<!-- PAGE_16 -->\n###### 의\n\n<!-- PAGE_16 -->\n###### 함량은\n\n<!-- PAGE_16 -->\n###### 함량 대비\n\n<!-- PAGE_16 -->\n###### 미만이고 이는 근육주사용\n\n<!-- PAGE_16 -->\n###### 에 비해서 매\n\n<!-- PAGE_16 -->\n###### IgA\n\n<!-- PAGE_16 -->\n###### IgG\n\n<!-- PAGE_16 -->\n###### 0.1%\n\n<!-- PAGE_16 -->\n###### HBIG\n\n<!-- PAGE_16 -->\n###### 우 낮은 수준이다\n\n<!-- PAGE_16 -->\n###### 그러나\n\n<!-- PAGE_16 -->\n###### 에 대한 항체를 갖고 있는\n\n<!-- PAGE_16 -->\n###### 결핍증 환자는 면역\n\n<!-- PAGE_16 -->\n###### .\n\n",
      "metadata": {
        "source": "(가이드라인-005)_정맥주사용+B형간염+사람면역글로불린제제의+안전성유효성+평가+가이드라인.pdf",
        "chunk_index": 135,
        "window_size": 3,
        "char_count": 693,
        "word_count": 127,
        "page_number": 16,
        "window_text": "<!-- PAGE_16 -->\n###### 치료적 유효성을 탐색하여 가능한 용량과 투여 기간 설정 등 다양한 정보 수집을\n\n<!-- PAGE_16 -->\n###### 목적으로 하며\n\n<!-- PAGE_16 -->\n###### 비교적 철저한 선정기준에 의해 모집된 환자군을 대상으로 수행하\n\n<!-- PAGE_16 -->\n###### ,\n\n<!-- PAGE_16 -->\n###### 여야 한다.\n\n <!-- PAGE_16 -->\n###### 치료적 확증 임상시험의 용량 및 용법을 결정하기 위하여 용량의 단계적 증량 디\n\n<!-- PAGE_16 -->\n###### 치료적 확증 임상시험\n\n<!-- PAGE_16 -->\n###### 4.\n\n <!-- PAGE_16 -->\n###### 감염에 의한 간경변증\n\n<!-- PAGE_16 -->\n###### 간암\n\n<!-- PAGE_16 -->\n###### 전격성 간부전 등 말기 간질환으로 간 이\n\n<!-- PAGE_16 -->\n###### HBV\n\n<!-- PAGE_16 -->\n###### ,\n\n<!-- PAGE_16 -->\n###### ,\n\n<!-- PAGE_16 -->\n###### 면역글로불린제제는 단백질의\n\n<!-- PAGE_16 -->\n###### 90% 이상이 면역글로불린\n\n<!-- PAGE_16 -->\n###### G(immunoglobulin\n\n<!-- PAGE_16 -->\n###### 이며 소량의\n\n<!-- PAGE_16 -->\n###### 및\n\n<!-- PAGE_16 -->\n###### 이 함유되어 있다\n\n<!-- PAGE_16 -->\n###### 최근 정제공정의 변경 또는 추\n\n<!-- PAGE_16 -->\n###### G, IgG)\n\n<!-- PAGE_16 -->\n###### IgA\n\n<!-- PAGE_16 -->\n###### IgM\n\n<!-- PAGE_16 -->\n###### .\n\n <!-- PAGE_16 -->\n###### 가로\n\n<!-- PAGE_16 -->\n###### 함량이 총 단백질의\n\n<!-- PAGE_16 -->\n###### 이상으로 순도가 개선되어\n\n<!-- PAGE_16 -->\n###### 정맥주사용\n\n<!-- PAGE_16 -->\n###### IgG\n\n<!-- PAGE_16 -->\n###### 98%\n\n<!-- PAGE_16 -->\n###### ,\n\n<!-- PAGE_16 -->\n###### HBIG\n\n<!-- PAGE_16 -->\n###### 의\n\n<!-- PAGE_16 -->\n###### 함량은\n\n<!-- PAGE_16 -->\n###### 함량 대비\n\n<!-- PAGE_16 -->\n###### 미만이고 이는 근육주사용\n\n<!-- PAGE_16 -->\n###### 에 비해서 매\n\n<!-- PAGE_16 -->\n###### IgA\n\n<!-- PAGE_16 -->\n###### IgG\n\n<!-- PAGE_16 -->\n###### 0.1%\n\n<!-- PAGE_16 -->\n###### HBIG\n\n<!-- PAGE_16 -->\n###### 우 낮은 수준이다\n\n<!-- PAGE_16 -->\n###### 그러나\n\n<!-- PAGE_16 -->\n###### 에 대한 항체를 갖고 있는\n\n<!-- PAGE_16 -->\n###### 결핍증 환자는 면역\n\n<!-- PAGE_16 -->\n###### .\n\n <!-- PAGE_16 -->\n###### IgA\n\n<!-- PAGE_16 -->\n###### IgA\n\n<!-- PAGE_16 -->\n###### 글로불린제제 투여로 제품에 함유되어 있는\n\n<!-- PAGE_16 -->\n###### IgA로 인한 항원 항체 반응 때문에 과\n\n<!-- PAGE_16 -->\n###### -\n\n<!-- PAGE_16 -->\n###### 민반응이 생길 수 있으므로 투여해서는 안 된다.\n\n <!-- PAGE_16 -->\n###### 투여 용량\n\n<!-- PAGE_16 -->\n###### 4.2.\n\n <!-- PAGE_16 -->\n###### 일반적으로 간 이식 후\n\n<!-- PAGE_16 -->\n###### 형 간염 재발 예방을 위한 투여 용량은 간 이식 전\n\n<!-- PAGE_16 -->\n###### B\n\n<!-- PAGE_16 -->\n###### 바이러스의 상태에 영향을 받는다\n\n<!-- PAGE_16 -->\n###### 대개의 경우 간 이식 전에\n\n<!-- PAGE_16 -->\n###### 가 양성인\n\n<!-- PAGE_16 -->\n###### .\n\n",
        "original_sentence": "<!-- PAGE_16 -->\n###### 가로\n\n<!-- PAGE_16 -->\n###### 함량이 총 단백질의\n\n<!-- PAGE_16 -->\n###### 이상으로 순도가 개선되어\n\n<!-- PAGE_16 -->\n###### 정맥주사용\n\n<!-- PAGE_16 -->\n###### IgG\n\n<!-- PAGE_16 -->\n###### 98%\n\n<!-- PAGE_16 -->\n###### ,\n\n<!-- PAGE_16 -->\n###### HBIG\n\n<!-- PAGE_16 -->\n###### 의\n\n<!-- PAGE_16 -->\n###### 함량은\n\n<!-- PAGE_16 -->\n###### 함량 대비\n\n<!-- PAGE_16 -->\n###### 미만이고 이는 근육주사용\n\n<!-- PAGE_16 -->\n###### 에 비해서 매\n\n<!-- PAGE_16 -->\n###### IgA\n\n<!-- PAGE_16 -->\n###### IgG\n\n<!-- PAGE_16 -->\n###### 0.1%\n\n<!-- PAGE_16 -->\n###### HBIG\n\n<!-- PAGE_16 -->\n###### 우 낮은 수준이다\n\n<!-- PAGE_16 -->\n###### 그러나\n\n<!-- PAGE_16 -->\n###### 에 대한 항체를 갖고 있는\n\n<!-- PAGE_16 -->\n###### 결핍증 환자는 면역\n\n<!-- PAGE_16 -->\n###### .\n\n"
      }
    },
    {
      "chunk_id": "chunk_137",
      "text": "<!-- PAGE_16 -->\n###### IgA\n\n<!-- PAGE_16 -->\n###### IgA\n\n<!-- PAGE_16 -->\n###### 글로불린제제 투여로 제품에 함유되어 있는\n\n<!-- PAGE_16 -->\n###### IgA로 인한 항원 항체 반응 때문에 과\n\n<!-- PAGE_16 -->\n###### -\n\n<!-- PAGE_16 -->\n###### 민반응이 생길 수 있으므로 투여해서는 안 된다.\n\n",
      "metadata": {
        "source": "(가이드라인-005)_정맥주사용+B형간염+사람면역글로불린제제의+안전성유효성+평가+가이드라인.pdf",
        "chunk_index": 136,
        "window_size": 3,
        "char_count": 233,
        "word_count": 46,
        "page_number": 16,
        "window_text": "<!-- PAGE_16 -->\n###### 치료적 확증 임상시험의 용량 및 용법을 결정하기 위하여 용량의 단계적 증량 디\n\n<!-- PAGE_16 -->\n###### 치료적 확증 임상시험\n\n<!-- PAGE_16 -->\n###### 4.\n\n <!-- PAGE_16 -->\n###### 감염에 의한 간경변증\n\n<!-- PAGE_16 -->\n###### 간암\n\n<!-- PAGE_16 -->\n###### 전격성 간부전 등 말기 간질환으로 간 이\n\n<!-- PAGE_16 -->\n###### HBV\n\n<!-- PAGE_16 -->\n###### ,\n\n<!-- PAGE_16 -->\n###### ,\n\n<!-- PAGE_16 -->\n###### 면역글로불린제제는 단백질의\n\n<!-- PAGE_16 -->\n###### 90% 이상이 면역글로불린\n\n<!-- PAGE_16 -->\n###### G(immunoglobulin\n\n<!-- PAGE_16 -->\n###### 이며 소량의\n\n<!-- PAGE_16 -->\n###### 및\n\n<!-- PAGE_16 -->\n###### 이 함유되어 있다\n\n<!-- PAGE_16 -->\n###### 최근 정제공정의 변경 또는 추\n\n<!-- PAGE_16 -->\n###### G, IgG)\n\n<!-- PAGE_16 -->\n###### IgA\n\n<!-- PAGE_16 -->\n###### IgM\n\n<!-- PAGE_16 -->\n###### .\n\n <!-- PAGE_16 -->\n###### 가로\n\n<!-- PAGE_16 -->\n###### 함량이 총 단백질의\n\n<!-- PAGE_16 -->\n###### 이상으로 순도가 개선되어\n\n<!-- PAGE_16 -->\n###### 정맥주사용\n\n<!-- PAGE_16 -->\n###### IgG\n\n<!-- PAGE_16 -->\n###### 98%\n\n<!-- PAGE_16 -->\n###### ,\n\n<!-- PAGE_16 -->\n###### HBIG\n\n<!-- PAGE_16 -->\n###### 의\n\n<!-- PAGE_16 -->\n###### 함량은\n\n<!-- PAGE_16 -->\n###### 함량 대비\n\n<!-- PAGE_16 -->\n###### 미만이고 이는 근육주사용\n\n<!-- PAGE_16 -->\n###### 에 비해서 매\n\n<!-- PAGE_16 -->\n###### IgA\n\n<!-- PAGE_16 -->\n###### IgG\n\n<!-- PAGE_16 -->\n###### 0.1%\n\n<!-- PAGE_16 -->\n###### HBIG\n\n<!-- PAGE_16 -->\n###### 우 낮은 수준이다\n\n<!-- PAGE_16 -->\n###### 그러나\n\n<!-- PAGE_16 -->\n###### 에 대한 항체를 갖고 있는\n\n<!-- PAGE_16 -->\n###### 결핍증 환자는 면역\n\n<!-- PAGE_16 -->\n###### .\n\n <!-- PAGE_16 -->\n###### IgA\n\n<!-- PAGE_16 -->\n###### IgA\n\n<!-- PAGE_16 -->\n###### 글로불린제제 투여로 제품에 함유되어 있는\n\n<!-- PAGE_16 -->\n###### IgA로 인한 항원 항체 반응 때문에 과\n\n<!-- PAGE_16 -->\n###### -\n\n<!-- PAGE_16 -->\n###### 민반응이 생길 수 있으므로 투여해서는 안 된다.\n\n <!-- PAGE_16 -->\n###### 투여 용량\n\n<!-- PAGE_16 -->\n###### 4.2.\n\n <!-- PAGE_16 -->\n###### 일반적으로 간 이식 후\n\n<!-- PAGE_16 -->\n###### 형 간염 재발 예방을 위한 투여 용량은 간 이식 전\n\n<!-- PAGE_16 -->\n###### B\n\n<!-- PAGE_16 -->\n###### 바이러스의 상태에 영향을 받는다\n\n<!-- PAGE_16 -->\n###### 대개의 경우 간 이식 전에\n\n<!-- PAGE_16 -->\n###### 가 양성인\n\n<!-- PAGE_16 -->\n###### .\n\n <!-- PAGE_16 -->\n###### HBV DNA\n\n<!-- PAGE_16 -->\n###### 경우에는\n\n<!-- PAGE_16 -->\n###### B형 간염 표면항체\n\n<!-- PAGE_16 -->\n###### (antibody to hepatitis B surface antigen, anti-HBs)\n\n<!-- PAGE_16 -->\n###### 농도를\n\n<!-- PAGE_16 -->\n###### 이상으로 유지하고\n\n<!-- PAGE_16 -->\n###### 가 음성인 경우에는 이보다 적은\n\n<!-- PAGE_16 -->\n###### 500 IU/L\n\n<!-- PAGE_16 -->\n###### , HBV DNA\n\n<!-- PAGE_16 -->\n###### 농도로 유지할 수 있다\n\n<!-- PAGE_16 -->\n###### 외에\n\n<!-- PAGE_16 -->\n###### 형 간염\n\n<!-- PAGE_16 -->\n###### 항원\n\n<!-- PAGE_16 -->\n###### . ",
        "original_sentence": "<!-- PAGE_16 -->\n###### IgA\n\n<!-- PAGE_16 -->\n###### IgA\n\n<!-- PAGE_16 -->\n###### 글로불린제제 투여로 제품에 함유되어 있는\n\n<!-- PAGE_16 -->\n###### IgA로 인한 항원 항체 반응 때문에 과\n\n<!-- PAGE_16 -->\n###### -\n\n<!-- PAGE_16 -->\n###### 민반응이 생길 수 있으므로 투여해서는 안 된다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_138",
      "text": "<!-- PAGE_16 -->\n###### 투여 용량\n\n<!-- PAGE_16 -->\n###### 4.2.\n\n",
      "metadata": {
        "source": "(가이드라인-005)_정맥주사용+B형간염+사람면역글로불린제제의+안전성유효성+평가+가이드라인.pdf",
        "chunk_index": 137,
        "window_size": 3,
        "char_count": 61,
        "word_count": 11,
        "page_number": 16,
        "window_text": "<!-- PAGE_16 -->\n###### 감염에 의한 간경변증\n\n<!-- PAGE_16 -->\n###### 간암\n\n<!-- PAGE_16 -->\n###### 전격성 간부전 등 말기 간질환으로 간 이\n\n<!-- PAGE_16 -->\n###### HBV\n\n<!-- PAGE_16 -->\n###### ,\n\n<!-- PAGE_16 -->\n###### ,\n\n<!-- PAGE_16 -->\n###### 면역글로불린제제는 단백질의\n\n<!-- PAGE_16 -->\n###### 90% 이상이 면역글로불린\n\n<!-- PAGE_16 -->\n###### G(immunoglobulin\n\n<!-- PAGE_16 -->\n###### 이며 소량의\n\n<!-- PAGE_16 -->\n###### 및\n\n<!-- PAGE_16 -->\n###### 이 함유되어 있다\n\n<!-- PAGE_16 -->\n###### 최근 정제공정의 변경 또는 추\n\n<!-- PAGE_16 -->\n###### G, IgG)\n\n<!-- PAGE_16 -->\n###### IgA\n\n<!-- PAGE_16 -->\n###### IgM\n\n<!-- PAGE_16 -->\n###### .\n\n <!-- PAGE_16 -->\n###### 가로\n\n<!-- PAGE_16 -->\n###### 함량이 총 단백질의\n\n<!-- PAGE_16 -->\n###### 이상으로 순도가 개선되어\n\n<!-- PAGE_16 -->\n###### 정맥주사용\n\n<!-- PAGE_16 -->\n###### IgG\n\n<!-- PAGE_16 -->\n###### 98%\n\n<!-- PAGE_16 -->\n###### ,\n\n<!-- PAGE_16 -->\n###### HBIG\n\n<!-- PAGE_16 -->\n###### 의\n\n<!-- PAGE_16 -->\n###### 함량은\n\n<!-- PAGE_16 -->\n###### 함량 대비\n\n<!-- PAGE_16 -->\n###### 미만이고 이는 근육주사용\n\n<!-- PAGE_16 -->\n###### 에 비해서 매\n\n<!-- PAGE_16 -->\n###### IgA\n\n<!-- PAGE_16 -->\n###### IgG\n\n<!-- PAGE_16 -->\n###### 0.1%\n\n<!-- PAGE_16 -->\n###### HBIG\n\n<!-- PAGE_16 -->\n###### 우 낮은 수준이다\n\n<!-- PAGE_16 -->\n###### 그러나\n\n<!-- PAGE_16 -->\n###### 에 대한 항체를 갖고 있는\n\n<!-- PAGE_16 -->\n###### 결핍증 환자는 면역\n\n<!-- PAGE_16 -->\n###### .\n\n <!-- PAGE_16 -->\n###### IgA\n\n<!-- PAGE_16 -->\n###### IgA\n\n<!-- PAGE_16 -->\n###### 글로불린제제 투여로 제품에 함유되어 있는\n\n<!-- PAGE_16 -->\n###### IgA로 인한 항원 항체 반응 때문에 과\n\n<!-- PAGE_16 -->\n###### -\n\n<!-- PAGE_16 -->\n###### 민반응이 생길 수 있으므로 투여해서는 안 된다.\n\n <!-- PAGE_16 -->\n###### 투여 용량\n\n<!-- PAGE_16 -->\n###### 4.2.\n\n <!-- PAGE_16 -->\n###### 일반적으로 간 이식 후\n\n<!-- PAGE_16 -->\n###### 형 간염 재발 예방을 위한 투여 용량은 간 이식 전\n\n<!-- PAGE_16 -->\n###### B\n\n<!-- PAGE_16 -->\n###### 바이러스의 상태에 영향을 받는다\n\n<!-- PAGE_16 -->\n###### 대개의 경우 간 이식 전에\n\n<!-- PAGE_16 -->\n###### 가 양성인\n\n<!-- PAGE_16 -->\n###### .\n\n <!-- PAGE_16 -->\n###### HBV DNA\n\n<!-- PAGE_16 -->\n###### 경우에는\n\n<!-- PAGE_16 -->\n###### B형 간염 표면항체\n\n<!-- PAGE_16 -->\n###### (antibody to hepatitis B surface antigen, anti-HBs)\n\n<!-- PAGE_16 -->\n###### 농도를\n\n<!-- PAGE_16 -->\n###### 이상으로 유지하고\n\n<!-- PAGE_16 -->\n###### 가 음성인 경우에는 이보다 적은\n\n<!-- PAGE_16 -->\n###### 500 IU/L\n\n<!-- PAGE_16 -->\n###### , HBV DNA\n\n<!-- PAGE_16 -->\n###### 농도로 유지할 수 있다\n\n<!-- PAGE_16 -->\n###### 외에\n\n<!-- PAGE_16 -->\n###### 형 간염\n\n<!-- PAGE_16 -->\n###### 항원\n\n<!-- PAGE_16 -->\n###### .  HBV DNA\n\n<!-- PAGE_16 -->\n###### B\n\n<!-- PAGE_16 -->\n###### e\n\n<!-- PAGE_16 -->\n###### (hepatitis B e antigen,\n\n<!-- PAGE_16 -->\n###### HBeAg)의 유 무도 고려하여 투여 용량을 결정하여야 한다\n\n<!-- PAGE_16 -->\n###### .\n\n",
        "original_sentence": "<!-- PAGE_16 -->\n###### 투여 용량\n\n<!-- PAGE_16 -->\n###### 4.2.\n\n"
      }
    },
    {
      "chunk_id": "chunk_139",
      "text": "<!-- PAGE_16 -->\n###### 일반적으로 간 이식 후\n\n<!-- PAGE_16 -->\n###### 형 간염 재발 예방을 위한 투여 용량은 간 이식 전\n\n<!-- PAGE_16 -->\n###### B\n\n<!-- PAGE_16 -->\n###### 바이러스의 상태에 영향을 받는다\n\n<!-- PAGE_16 -->\n###### 대개의 경우 간 이식 전에\n\n<!-- PAGE_16 -->\n###### 가 양성인\n\n<!-- PAGE_16 -->\n###### .\n\n",
      "metadata": {
        "source": "(가이드라인-005)_정맥주사용+B형간염+사람면역글로불린제제의+안전성유효성+평가+가이드라인.pdf",
        "chunk_index": 138,
        "window_size": 3,
        "char_count": 260,
        "word_count": 55,
        "page_number": 16,
        "window_text": "<!-- PAGE_16 -->\n###### 가로\n\n<!-- PAGE_16 -->\n###### 함량이 총 단백질의\n\n<!-- PAGE_16 -->\n###### 이상으로 순도가 개선되어\n\n<!-- PAGE_16 -->\n###### 정맥주사용\n\n<!-- PAGE_16 -->\n###### IgG\n\n<!-- PAGE_16 -->\n###### 98%\n\n<!-- PAGE_16 -->\n###### ,\n\n<!-- PAGE_16 -->\n###### HBIG\n\n<!-- PAGE_16 -->\n###### 의\n\n<!-- PAGE_16 -->\n###### 함량은\n\n<!-- PAGE_16 -->\n###### 함량 대비\n\n<!-- PAGE_16 -->\n###### 미만이고 이는 근육주사용\n\n<!-- PAGE_16 -->\n###### 에 비해서 매\n\n<!-- PAGE_16 -->\n###### IgA\n\n<!-- PAGE_16 -->\n###### IgG\n\n<!-- PAGE_16 -->\n###### 0.1%\n\n<!-- PAGE_16 -->\n###### HBIG\n\n<!-- PAGE_16 -->\n###### 우 낮은 수준이다\n\n<!-- PAGE_16 -->\n###### 그러나\n\n<!-- PAGE_16 -->\n###### 에 대한 항체를 갖고 있는\n\n<!-- PAGE_16 -->\n###### 결핍증 환자는 면역\n\n<!-- PAGE_16 -->\n###### .\n\n <!-- PAGE_16 -->\n###### IgA\n\n<!-- PAGE_16 -->\n###### IgA\n\n<!-- PAGE_16 -->\n###### 글로불린제제 투여로 제품에 함유되어 있는\n\n<!-- PAGE_16 -->\n###### IgA로 인한 항원 항체 반응 때문에 과\n\n<!-- PAGE_16 -->\n###### -\n\n<!-- PAGE_16 -->\n###### 민반응이 생길 수 있으므로 투여해서는 안 된다.\n\n <!-- PAGE_16 -->\n###### 투여 용량\n\n<!-- PAGE_16 -->\n###### 4.2.\n\n <!-- PAGE_16 -->\n###### 일반적으로 간 이식 후\n\n<!-- PAGE_16 -->\n###### 형 간염 재발 예방을 위한 투여 용량은 간 이식 전\n\n<!-- PAGE_16 -->\n###### B\n\n<!-- PAGE_16 -->\n###### 바이러스의 상태에 영향을 받는다\n\n<!-- PAGE_16 -->\n###### 대개의 경우 간 이식 전에\n\n<!-- PAGE_16 -->\n###### 가 양성인\n\n<!-- PAGE_16 -->\n###### .\n\n <!-- PAGE_16 -->\n###### HBV DNA\n\n<!-- PAGE_16 -->\n###### 경우에는\n\n<!-- PAGE_16 -->\n###### B형 간염 표면항체\n\n<!-- PAGE_16 -->\n###### (antibody to hepatitis B surface antigen, anti-HBs)\n\n<!-- PAGE_16 -->\n###### 농도를\n\n<!-- PAGE_16 -->\n###### 이상으로 유지하고\n\n<!-- PAGE_16 -->\n###### 가 음성인 경우에는 이보다 적은\n\n<!-- PAGE_16 -->\n###### 500 IU/L\n\n<!-- PAGE_16 -->\n###### , HBV DNA\n\n<!-- PAGE_16 -->\n###### 농도로 유지할 수 있다\n\n<!-- PAGE_16 -->\n###### 외에\n\n<!-- PAGE_16 -->\n###### 형 간염\n\n<!-- PAGE_16 -->\n###### 항원\n\n<!-- PAGE_16 -->\n###### .  HBV DNA\n\n<!-- PAGE_16 -->\n###### B\n\n<!-- PAGE_16 -->\n###### e\n\n<!-- PAGE_16 -->\n###### (hepatitis B e antigen,\n\n<!-- PAGE_16 -->\n###### HBeAg)의 유 무도 고려하여 투여 용량을 결정하여야 한다\n\n<!-- PAGE_16 -->\n###### .\n\n <!-- PAGE_16 -->\n###### ․\n\n- - 9 -\n<!-- PAGE_17 -->\n###### 환자마다 다양한 반감기를 보일 수 있으므로 간 이식 전 바이러스의 상태를\n\n<!-- PAGE_17 -->\n###### 고려하여 순환하는\n\n<!-- PAGE_17 -->\n###### 를 중화할 수 있는 안전한 농도를 투여하여야 하며\n\n<!-- PAGE_17 -->\n###### 정기\n\n<!-- PAGE_17 -->\n###### HBV\n\n<!-- PAGE_17 -->\n###### ,\n\n<!-- PAGE_17 -->\n###### 적으로 혈중\n\n<!-- PAGE_17 -->\n###### anti-HBs 농도를 모니터링 하여야 한다\n\n<!-- PAGE_17 -->\n###### .\n\n",
        "original_sentence": "<!-- PAGE_16 -->\n###### 일반적으로 간 이식 후\n\n<!-- PAGE_16 -->\n###### 형 간염 재발 예방을 위한 투여 용량은 간 이식 전\n\n<!-- PAGE_16 -->\n###### B\n\n<!-- PAGE_16 -->\n###### 바이러스의 상태에 영향을 받는다\n\n<!-- PAGE_16 -->\n###### 대개의 경우 간 이식 전에\n\n<!-- PAGE_16 -->\n###### 가 양성인\n\n<!-- PAGE_16 -->\n###### .\n\n"
      }
    },
    {
      "chunk_id": "chunk_140",
      "text": "<!-- PAGE_16 -->\n###### HBV DNA\n\n<!-- PAGE_16 -->\n###### 경우에는\n\n<!-- PAGE_16 -->\n###### B형 간염 표면항체\n\n<!-- PAGE_16 -->\n###### (antibody to hepatitis B surface antigen, anti-HBs)\n\n<!-- PAGE_16 -->\n###### 농도를\n\n<!-- PAGE_16 -->\n###### 이상으로 유지하고\n\n<!-- PAGE_16 -->\n###### 가 음성인 경우에는 이보다 적은\n\n<!-- PAGE_16 -->\n###### 500 IU/L\n\n<!-- PAGE_16 -->\n###### , HBV DNA\n\n<!-- PAGE_16 -->\n###### 농도로 유지할 수 있다\n\n<!-- PAGE_16 -->\n###### 외에\n\n<!-- PAGE_16 -->\n###### 형 간염\n\n<!-- PAGE_16 -->\n###### 항원\n\n<!-- PAGE_16 -->\n###### . ",
      "metadata": {
        "source": "(가이드라인-005)_정맥주사용+B형간염+사람면역글로불린제제의+안전성유효성+평가+가이드라인.pdf",
        "chunk_index": 139,
        "window_size": 3,
        "char_count": 502,
        "word_count": 91,
        "page_number": 16,
        "window_text": "<!-- PAGE_16 -->\n###### IgA\n\n<!-- PAGE_16 -->\n###### IgA\n\n<!-- PAGE_16 -->\n###### 글로불린제제 투여로 제품에 함유되어 있는\n\n<!-- PAGE_16 -->\n###### IgA로 인한 항원 항체 반응 때문에 과\n\n<!-- PAGE_16 -->\n###### -\n\n<!-- PAGE_16 -->\n###### 민반응이 생길 수 있으므로 투여해서는 안 된다.\n\n <!-- PAGE_16 -->\n###### 투여 용량\n\n<!-- PAGE_16 -->\n###### 4.2.\n\n <!-- PAGE_16 -->\n###### 일반적으로 간 이식 후\n\n<!-- PAGE_16 -->\n###### 형 간염 재발 예방을 위한 투여 용량은 간 이식 전\n\n<!-- PAGE_16 -->\n###### B\n\n<!-- PAGE_16 -->\n###### 바이러스의 상태에 영향을 받는다\n\n<!-- PAGE_16 -->\n###### 대개의 경우 간 이식 전에\n\n<!-- PAGE_16 -->\n###### 가 양성인\n\n<!-- PAGE_16 -->\n###### .\n\n <!-- PAGE_16 -->\n###### HBV DNA\n\n<!-- PAGE_16 -->\n###### 경우에는\n\n<!-- PAGE_16 -->\n###### B형 간염 표면항체\n\n<!-- PAGE_16 -->\n###### (antibody to hepatitis B surface antigen, anti-HBs)\n\n<!-- PAGE_16 -->\n###### 농도를\n\n<!-- PAGE_16 -->\n###### 이상으로 유지하고\n\n<!-- PAGE_16 -->\n###### 가 음성인 경우에는 이보다 적은\n\n<!-- PAGE_16 -->\n###### 500 IU/L\n\n<!-- PAGE_16 -->\n###### , HBV DNA\n\n<!-- PAGE_16 -->\n###### 농도로 유지할 수 있다\n\n<!-- PAGE_16 -->\n###### 외에\n\n<!-- PAGE_16 -->\n###### 형 간염\n\n<!-- PAGE_16 -->\n###### 항원\n\n<!-- PAGE_16 -->\n###### .  HBV DNA\n\n<!-- PAGE_16 -->\n###### B\n\n<!-- PAGE_16 -->\n###### e\n\n<!-- PAGE_16 -->\n###### (hepatitis B e antigen,\n\n<!-- PAGE_16 -->\n###### HBeAg)의 유 무도 고려하여 투여 용량을 결정하여야 한다\n\n<!-- PAGE_16 -->\n###### .\n\n <!-- PAGE_16 -->\n###### ․\n\n- - 9 -\n<!-- PAGE_17 -->\n###### 환자마다 다양한 반감기를 보일 수 있으므로 간 이식 전 바이러스의 상태를\n\n<!-- PAGE_17 -->\n###### 고려하여 순환하는\n\n<!-- PAGE_17 -->\n###### 를 중화할 수 있는 안전한 농도를 투여하여야 하며\n\n<!-- PAGE_17 -->\n###### 정기\n\n<!-- PAGE_17 -->\n###### HBV\n\n<!-- PAGE_17 -->\n###### ,\n\n<!-- PAGE_17 -->\n###### 적으로 혈중\n\n<!-- PAGE_17 -->\n###### anti-HBs 농도를 모니터링 하여야 한다\n\n<!-- PAGE_17 -->\n###### .\n\n <!-- PAGE_17 -->\n###### 상기 사항들을 고려하여 수술 중 무간기\n\n<!-- PAGE_17 -->\n###### 의 초회 투여 용량\n\n<!-- PAGE_17 -->\n###### (anheptic phase)\n\n<!-- PAGE_17 -->\n###### 간 이식 환자의\n\n<!-- PAGE_17 -->\n###### 형 간염 재발을 예방하기 위한 본 제제의 투여 기간은 현\n\n<!-- PAGE_17 -->\n###### B\n\n<!-- PAGE_17 -->\n###### 재까지 정해진 바 없으나\n\n<!-- PAGE_17 -->\n###### 의사의 판단과 환자의 여건에 따라 간 이식 수술 후 짧\n\n<!-- PAGE_17 -->\n###### ,\n\n<!-- PAGE_17 -->\n###### 게는\n\n<!-- PAGE_17 -->\n###### 년에서 길게는 평생 투여되고 있다\n\n<!-- PAGE_17 -->\n###### 따라서 치료적 확증 임상시험 시\n\n<!-- PAGE_17 -->\n###### 년\n\n<!-- PAGE_17 -->\n###### 1\n\n<!-- PAGE_17 -->\n###### .\n\n",
        "original_sentence": "<!-- PAGE_16 -->\n###### HBV DNA\n\n<!-- PAGE_16 -->\n###### 경우에는\n\n<!-- PAGE_16 -->\n###### B형 간염 표면항체\n\n<!-- PAGE_16 -->\n###### (antibody to hepatitis B surface antigen, anti-HBs)\n\n<!-- PAGE_16 -->\n###### 농도를\n\n<!-- PAGE_16 -->\n###### 이상으로 유지하고\n\n<!-- PAGE_16 -->\n###### 가 음성인 경우에는 이보다 적은\n\n<!-- PAGE_16 -->\n###### 500 IU/L\n\n<!-- PAGE_16 -->\n###### , HBV DNA\n\n<!-- PAGE_16 -->\n###### 농도로 유지할 수 있다\n\n<!-- PAGE_16 -->\n###### 외에\n\n<!-- PAGE_16 -->\n###### 형 간염\n\n<!-- PAGE_16 -->\n###### 항원\n\n<!-- PAGE_16 -->\n###### . "
      }
    },
    {
      "chunk_id": "chunk_141",
      "text": "HBV DNA\n\n<!-- PAGE_16 -->\n###### B\n\n<!-- PAGE_16 -->\n###### e\n\n<!-- PAGE_16 -->\n###### (hepatitis B e antigen,\n\n<!-- PAGE_16 -->\n###### HBeAg)의 유 무도 고려하여 투여 용량을 결정하여야 한다\n\n<!-- PAGE_16 -->\n###### .\n\n",
      "metadata": {
        "source": "(가이드라인-005)_정맥주사용+B형간염+사람면역글로불린제제의+안전성유효성+평가+가이드라인.pdf",
        "chunk_index": 140,
        "window_size": 3,
        "char_count": 198,
        "word_count": 37,
        "page_number": 16,
        "window_text": "<!-- PAGE_16 -->\n###### 투여 용량\n\n<!-- PAGE_16 -->\n###### 4.2.\n\n <!-- PAGE_16 -->\n###### 일반적으로 간 이식 후\n\n<!-- PAGE_16 -->\n###### 형 간염 재발 예방을 위한 투여 용량은 간 이식 전\n\n<!-- PAGE_16 -->\n###### B\n\n<!-- PAGE_16 -->\n###### 바이러스의 상태에 영향을 받는다\n\n<!-- PAGE_16 -->\n###### 대개의 경우 간 이식 전에\n\n<!-- PAGE_16 -->\n###### 가 양성인\n\n<!-- PAGE_16 -->\n###### .\n\n <!-- PAGE_16 -->\n###### HBV DNA\n\n<!-- PAGE_16 -->\n###### 경우에는\n\n<!-- PAGE_16 -->\n###### B형 간염 표면항체\n\n<!-- PAGE_16 -->\n###### (antibody to hepatitis B surface antigen, anti-HBs)\n\n<!-- PAGE_16 -->\n###### 농도를\n\n<!-- PAGE_16 -->\n###### 이상으로 유지하고\n\n<!-- PAGE_16 -->\n###### 가 음성인 경우에는 이보다 적은\n\n<!-- PAGE_16 -->\n###### 500 IU/L\n\n<!-- PAGE_16 -->\n###### , HBV DNA\n\n<!-- PAGE_16 -->\n###### 농도로 유지할 수 있다\n\n<!-- PAGE_16 -->\n###### 외에\n\n<!-- PAGE_16 -->\n###### 형 간염\n\n<!-- PAGE_16 -->\n###### 항원\n\n<!-- PAGE_16 -->\n###### .  HBV DNA\n\n<!-- PAGE_16 -->\n###### B\n\n<!-- PAGE_16 -->\n###### e\n\n<!-- PAGE_16 -->\n###### (hepatitis B e antigen,\n\n<!-- PAGE_16 -->\n###### HBeAg)의 유 무도 고려하여 투여 용량을 결정하여야 한다\n\n<!-- PAGE_16 -->\n###### .\n\n <!-- PAGE_16 -->\n###### ․\n\n- - 9 -\n<!-- PAGE_17 -->\n###### 환자마다 다양한 반감기를 보일 수 있으므로 간 이식 전 바이러스의 상태를\n\n<!-- PAGE_17 -->\n###### 고려하여 순환하는\n\n<!-- PAGE_17 -->\n###### 를 중화할 수 있는 안전한 농도를 투여하여야 하며\n\n<!-- PAGE_17 -->\n###### 정기\n\n<!-- PAGE_17 -->\n###### HBV\n\n<!-- PAGE_17 -->\n###### ,\n\n<!-- PAGE_17 -->\n###### 적으로 혈중\n\n<!-- PAGE_17 -->\n###### anti-HBs 농도를 모니터링 하여야 한다\n\n<!-- PAGE_17 -->\n###### .\n\n <!-- PAGE_17 -->\n###### 상기 사항들을 고려하여 수술 중 무간기\n\n<!-- PAGE_17 -->\n###### 의 초회 투여 용량\n\n<!-- PAGE_17 -->\n###### (anheptic phase)\n\n<!-- PAGE_17 -->\n###### 간 이식 환자의\n\n<!-- PAGE_17 -->\n###### 형 간염 재발을 예방하기 위한 본 제제의 투여 기간은 현\n\n<!-- PAGE_17 -->\n###### B\n\n<!-- PAGE_17 -->\n###### 재까지 정해진 바 없으나\n\n<!-- PAGE_17 -->\n###### 의사의 판단과 환자의 여건에 따라 간 이식 수술 후 짧\n\n<!-- PAGE_17 -->\n###### ,\n\n<!-- PAGE_17 -->\n###### 게는\n\n<!-- PAGE_17 -->\n###### 년에서 길게는 평생 투여되고 있다\n\n<!-- PAGE_17 -->\n###### 따라서 치료적 확증 임상시험 시\n\n<!-- PAGE_17 -->\n###### 년\n\n<!-- PAGE_17 -->\n###### 1\n\n<!-- PAGE_17 -->\n###### .\n\n <!-- PAGE_17 -->\n###### 1\n\n<!-- PAGE_17 -->\n###### 이상 장기간 투여가 요구되며\n\n<!-- PAGE_17 -->\n###### 이에 따라 전 연령층에 대하여 의약품의 품목허가\n\n<!-- PAGE_17 -->\n###### ,\n\n<!-- PAGE_17 -->\n###### 에 필요한 정보 예\n\n<!-- PAGE_17 -->\n###### 병용약물 요법\n\n<!-- PAGE_17 -->\n###### 약물 상호작용 등 가 충분히 확보되어야 한\n\n<!-- PAGE_17 -->\n###### (\n\n<!-- PAGE_17 -->\n###### :\n\n<!-- PAGE_17 -->\n###### ,\n\n<!-- PAGE_17 -->\n###### )\n\n<!-- PAGE_17 -->\n###### 다\n\n<!-- PAGE_17 -->\n###### 간 이식 수술 후\n\n<!-- PAGE_17 -->\n###### 년 내에\n\n<!-- PAGE_17 -->\n###### 형 간염의 재발이 빈번히 나타나므로\n\n<!-- PAGE_17 -->\n###### 최근 외\n\n<!-- PAGE_17 -->\n###### .\n\n",
        "original_sentence": "HBV DNA\n\n<!-- PAGE_16 -->\n###### B\n\n<!-- PAGE_16 -->\n###### e\n\n<!-- PAGE_16 -->\n###### (hepatitis B e antigen,\n\n<!-- PAGE_16 -->\n###### HBeAg)의 유 무도 고려하여 투여 용량을 결정하여야 한다\n\n<!-- PAGE_16 -->\n###### .\n\n"
      }
    },
    {
      "chunk_id": "chunk_142",
      "text": "<!-- PAGE_16 -->\n###### ․\n\n- - 9 -\n<!-- PAGE_17 -->\n###### 환자마다 다양한 반감기를 보일 수 있으므로 간 이식 전 바이러스의 상태를\n\n<!-- PAGE_17 -->\n###### 고려하여 순환하는\n\n<!-- PAGE_17 -->\n###### 를 중화할 수 있는 안전한 농도를 투여하여야 하며\n\n<!-- PAGE_17 -->\n###### 정기\n\n<!-- PAGE_17 -->\n###### HBV\n\n<!-- PAGE_17 -->\n###### ,\n\n<!-- PAGE_17 -->\n###### 적으로 혈중\n\n<!-- PAGE_17 -->\n###### anti-HBs 농도를 모니터링 하여야 한다\n\n<!-- PAGE_17 -->\n###### .\n\n",
      "metadata": {
        "source": "(가이드라인-005)_정맥주사용+B형간염+사람면역글로불린제제의+안전성유효성+평가+가이드라인.pdf",
        "chunk_index": 141,
        "window_size": 3,
        "char_count": 382,
        "word_count": 77,
        "page_number": 16,
        "window_text": "<!-- PAGE_16 -->\n###### 일반적으로 간 이식 후\n\n<!-- PAGE_16 -->\n###### 형 간염 재발 예방을 위한 투여 용량은 간 이식 전\n\n<!-- PAGE_16 -->\n###### B\n\n<!-- PAGE_16 -->\n###### 바이러스의 상태에 영향을 받는다\n\n<!-- PAGE_16 -->\n###### 대개의 경우 간 이식 전에\n\n<!-- PAGE_16 -->\n###### 가 양성인\n\n<!-- PAGE_16 -->\n###### .\n\n <!-- PAGE_16 -->\n###### HBV DNA\n\n<!-- PAGE_16 -->\n###### 경우에는\n\n<!-- PAGE_16 -->\n###### B형 간염 표면항체\n\n<!-- PAGE_16 -->\n###### (antibody to hepatitis B surface antigen, anti-HBs)\n\n<!-- PAGE_16 -->\n###### 농도를\n\n<!-- PAGE_16 -->\n###### 이상으로 유지하고\n\n<!-- PAGE_16 -->\n###### 가 음성인 경우에는 이보다 적은\n\n<!-- PAGE_16 -->\n###### 500 IU/L\n\n<!-- PAGE_16 -->\n###### , HBV DNA\n\n<!-- PAGE_16 -->\n###### 농도로 유지할 수 있다\n\n<!-- PAGE_16 -->\n###### 외에\n\n<!-- PAGE_16 -->\n###### 형 간염\n\n<!-- PAGE_16 -->\n###### 항원\n\n<!-- PAGE_16 -->\n###### .  HBV DNA\n\n<!-- PAGE_16 -->\n###### B\n\n<!-- PAGE_16 -->\n###### e\n\n<!-- PAGE_16 -->\n###### (hepatitis B e antigen,\n\n<!-- PAGE_16 -->\n###### HBeAg)의 유 무도 고려하여 투여 용량을 결정하여야 한다\n\n<!-- PAGE_16 -->\n###### .\n\n <!-- PAGE_16 -->\n###### ․\n\n- - 9 -\n<!-- PAGE_17 -->\n###### 환자마다 다양한 반감기를 보일 수 있으므로 간 이식 전 바이러스의 상태를\n\n<!-- PAGE_17 -->\n###### 고려하여 순환하는\n\n<!-- PAGE_17 -->\n###### 를 중화할 수 있는 안전한 농도를 투여하여야 하며\n\n<!-- PAGE_17 -->\n###### 정기\n\n<!-- PAGE_17 -->\n###### HBV\n\n<!-- PAGE_17 -->\n###### ,\n\n<!-- PAGE_17 -->\n###### 적으로 혈중\n\n<!-- PAGE_17 -->\n###### anti-HBs 농도를 모니터링 하여야 한다\n\n<!-- PAGE_17 -->\n###### .\n\n <!-- PAGE_17 -->\n###### 상기 사항들을 고려하여 수술 중 무간기\n\n<!-- PAGE_17 -->\n###### 의 초회 투여 용량\n\n<!-- PAGE_17 -->\n###### (anheptic phase)\n\n<!-- PAGE_17 -->\n###### 간 이식 환자의\n\n<!-- PAGE_17 -->\n###### 형 간염 재발을 예방하기 위한 본 제제의 투여 기간은 현\n\n<!-- PAGE_17 -->\n###### B\n\n<!-- PAGE_17 -->\n###### 재까지 정해진 바 없으나\n\n<!-- PAGE_17 -->\n###### 의사의 판단과 환자의 여건에 따라 간 이식 수술 후 짧\n\n<!-- PAGE_17 -->\n###### ,\n\n<!-- PAGE_17 -->\n###### 게는\n\n<!-- PAGE_17 -->\n###### 년에서 길게는 평생 투여되고 있다\n\n<!-- PAGE_17 -->\n###### 따라서 치료적 확증 임상시험 시\n\n<!-- PAGE_17 -->\n###### 년\n\n<!-- PAGE_17 -->\n###### 1\n\n<!-- PAGE_17 -->\n###### .\n\n <!-- PAGE_17 -->\n###### 1\n\n<!-- PAGE_17 -->\n###### 이상 장기간 투여가 요구되며\n\n<!-- PAGE_17 -->\n###### 이에 따라 전 연령층에 대하여 의약품의 품목허가\n\n<!-- PAGE_17 -->\n###### ,\n\n<!-- PAGE_17 -->\n###### 에 필요한 정보 예\n\n<!-- PAGE_17 -->\n###### 병용약물 요법\n\n<!-- PAGE_17 -->\n###### 약물 상호작용 등 가 충분히 확보되어야 한\n\n<!-- PAGE_17 -->\n###### (\n\n<!-- PAGE_17 -->\n###### :\n\n<!-- PAGE_17 -->\n###### ,\n\n<!-- PAGE_17 -->\n###### )\n\n<!-- PAGE_17 -->\n###### 다\n\n<!-- PAGE_17 -->\n###### 간 이식 수술 후\n\n<!-- PAGE_17 -->\n###### 년 내에\n\n<!-- PAGE_17 -->\n###### 형 간염의 재발이 빈번히 나타나므로\n\n<!-- PAGE_17 -->\n###### 최근 외\n\n<!-- PAGE_17 -->\n###### .\n\n <!-- PAGE_17 -->\n###### 2~3\n\n<!-- PAGE_17 -->\n###### B\n\n<!-- PAGE_17 -->\n###### ,\n\n<!-- PAGE_17 -->\n###### 간 이식 수술 중 및 수술 후 관리를 위한 목적의 투여 기간에 대한 정확한\n\n<!-- PAGE_17 -->\n###### 가이드가 확립되어 있지 않으므로\n\n<!-- PAGE_17 -->\n###### 간 이식 전후로 투여되는 다른 약물과의 상호\n\n<!-- PAGE_17 -->\n###### ,\n\n<!-- PAGE_17 -->\n###### 작용뿐만 아니라 간 이식 후에도 지속적인 모니터링을 통해 약물의 단독 및 잠재\n\n<!-- PAGE_17 -->\n###### 적 약물 약물 상호작용을 확인하여야 한다\n\n<!-- PAGE_17 -->\n###### -\n\n<!-- PAGE_17 -->\n###### .\n\n",
        "original_sentence": "<!-- PAGE_16 -->\n###### ․\n\n- - 9 -\n<!-- PAGE_17 -->\n###### 환자마다 다양한 반감기를 보일 수 있으므로 간 이식 전 바이러스의 상태를\n\n<!-- PAGE_17 -->\n###### 고려하여 순환하는\n\n<!-- PAGE_17 -->\n###### 를 중화할 수 있는 안전한 농도를 투여하여야 하며\n\n<!-- PAGE_17 -->\n###### 정기\n\n<!-- PAGE_17 -->\n###### HBV\n\n<!-- PAGE_17 -->\n###### ,\n\n<!-- PAGE_17 -->\n###### 적으로 혈중\n\n<!-- PAGE_17 -->\n###### anti-HBs 농도를 모니터링 하여야 한다\n\n<!-- PAGE_17 -->\n###### .\n\n"
      }
    },
    {
      "chunk_id": "chunk_143",
      "text": "<!-- PAGE_17 -->\n###### 상기 사항들을 고려하여 수술 중 무간기\n\n<!-- PAGE_17 -->\n###### 의 초회 투여 용량\n\n<!-- PAGE_17 -->\n###### (anheptic phase)\n\n<!-- PAGE_17 -->\n###### 간 이식 환자의\n\n<!-- PAGE_17 -->\n###### 형 간염 재발을 예방하기 위한 본 제제의 투여 기간은 현\n\n<!-- PAGE_17 -->\n###### B\n\n<!-- PAGE_17 -->\n###### 재까지 정해진 바 없으나\n\n<!-- PAGE_17 -->\n###### 의사의 판단과 환자의 여건에 따라 간 이식 수술 후 짧\n\n<!-- PAGE_17 -->\n###### ,\n\n<!-- PAGE_17 -->\n###### 게는\n\n<!-- PAGE_17 -->\n###### 년에서 길게는 평생 투여되고 있다\n\n<!-- PAGE_17 -->\n###### 따라서 치료적 확증 임상시험 시\n\n<!-- PAGE_17 -->\n###### 년\n\n<!-- PAGE_17 -->\n###### 1\n\n<!-- PAGE_17 -->\n###### .\n\n",
      "metadata": {
        "source": "(가이드라인-005)_정맥주사용+B형간염+사람면역글로불린제제의+안전성유효성+평가+가이드라인.pdf",
        "chunk_index": 142,
        "window_size": 3,
        "char_count": 561,
        "word_count": 115,
        "page_number": 17,
        "window_text": "<!-- PAGE_16 -->\n###### HBV DNA\n\n<!-- PAGE_16 -->\n###### 경우에는\n\n<!-- PAGE_16 -->\n###### B형 간염 표면항체\n\n<!-- PAGE_16 -->\n###### (antibody to hepatitis B surface antigen, anti-HBs)\n\n<!-- PAGE_16 -->\n###### 농도를\n\n<!-- PAGE_16 -->\n###### 이상으로 유지하고\n\n<!-- PAGE_16 -->\n###### 가 음성인 경우에는 이보다 적은\n\n<!-- PAGE_16 -->\n###### 500 IU/L\n\n<!-- PAGE_16 -->\n###### , HBV DNA\n\n<!-- PAGE_16 -->\n###### 농도로 유지할 수 있다\n\n<!-- PAGE_16 -->\n###### 외에\n\n<!-- PAGE_16 -->\n###### 형 간염\n\n<!-- PAGE_16 -->\n###### 항원\n\n<!-- PAGE_16 -->\n###### .  HBV DNA\n\n<!-- PAGE_16 -->\n###### B\n\n<!-- PAGE_16 -->\n###### e\n\n<!-- PAGE_16 -->\n###### (hepatitis B e antigen,\n\n<!-- PAGE_16 -->\n###### HBeAg)의 유 무도 고려하여 투여 용량을 결정하여야 한다\n\n<!-- PAGE_16 -->\n###### .\n\n <!-- PAGE_16 -->\n###### ․\n\n- - 9 -\n<!-- PAGE_17 -->\n###### 환자마다 다양한 반감기를 보일 수 있으므로 간 이식 전 바이러스의 상태를\n\n<!-- PAGE_17 -->\n###### 고려하여 순환하는\n\n<!-- PAGE_17 -->\n###### 를 중화할 수 있는 안전한 농도를 투여하여야 하며\n\n<!-- PAGE_17 -->\n###### 정기\n\n<!-- PAGE_17 -->\n###### HBV\n\n<!-- PAGE_17 -->\n###### ,\n\n<!-- PAGE_17 -->\n###### 적으로 혈중\n\n<!-- PAGE_17 -->\n###### anti-HBs 농도를 모니터링 하여야 한다\n\n<!-- PAGE_17 -->\n###### .\n\n <!-- PAGE_17 -->\n###### 상기 사항들을 고려하여 수술 중 무간기\n\n<!-- PAGE_17 -->\n###### 의 초회 투여 용량\n\n<!-- PAGE_17 -->\n###### (anheptic phase)\n\n<!-- PAGE_17 -->\n###### 간 이식 환자의\n\n<!-- PAGE_17 -->\n###### 형 간염 재발을 예방하기 위한 본 제제의 투여 기간은 현\n\n<!-- PAGE_17 -->\n###### B\n\n<!-- PAGE_17 -->\n###### 재까지 정해진 바 없으나\n\n<!-- PAGE_17 -->\n###### 의사의 판단과 환자의 여건에 따라 간 이식 수술 후 짧\n\n<!-- PAGE_17 -->\n###### ,\n\n<!-- PAGE_17 -->\n###### 게는\n\n<!-- PAGE_17 -->\n###### 년에서 길게는 평생 투여되고 있다\n\n<!-- PAGE_17 -->\n###### 따라서 치료적 확증 임상시험 시\n\n<!-- PAGE_17 -->\n###### 년\n\n<!-- PAGE_17 -->\n###### 1\n\n<!-- PAGE_17 -->\n###### .\n\n <!-- PAGE_17 -->\n###### 1\n\n<!-- PAGE_17 -->\n###### 이상 장기간 투여가 요구되며\n\n<!-- PAGE_17 -->\n###### 이에 따라 전 연령층에 대하여 의약품의 품목허가\n\n<!-- PAGE_17 -->\n###### ,\n\n<!-- PAGE_17 -->\n###### 에 필요한 정보 예\n\n<!-- PAGE_17 -->\n###### 병용약물 요법\n\n<!-- PAGE_17 -->\n###### 약물 상호작용 등 가 충분히 확보되어야 한\n\n<!-- PAGE_17 -->\n###### (\n\n<!-- PAGE_17 -->\n###### :\n\n<!-- PAGE_17 -->\n###### ,\n\n<!-- PAGE_17 -->\n###### )\n\n<!-- PAGE_17 -->\n###### 다\n\n<!-- PAGE_17 -->\n###### 간 이식 수술 후\n\n<!-- PAGE_17 -->\n###### 년 내에\n\n<!-- PAGE_17 -->\n###### 형 간염의 재발이 빈번히 나타나므로\n\n<!-- PAGE_17 -->\n###### 최근 외\n\n<!-- PAGE_17 -->\n###### .\n\n <!-- PAGE_17 -->\n###### 2~3\n\n<!-- PAGE_17 -->\n###### B\n\n<!-- PAGE_17 -->\n###### ,\n\n<!-- PAGE_17 -->\n###### 간 이식 수술 중 및 수술 후 관리를 위한 목적의 투여 기간에 대한 정확한\n\n<!-- PAGE_17 -->\n###### 가이드가 확립되어 있지 않으므로\n\n<!-- PAGE_17 -->\n###### 간 이식 전후로 투여되는 다른 약물과의 상호\n\n<!-- PAGE_17 -->\n###### ,\n\n<!-- PAGE_17 -->\n###### 작용뿐만 아니라 간 이식 후에도 지속적인 모니터링을 통해 약물의 단독 및 잠재\n\n<!-- PAGE_17 -->\n###### 적 약물 약물 상호작용을 확인하여야 한다\n\n<!-- PAGE_17 -->\n###### -\n\n<!-- PAGE_17 -->\n###### .\n\n <!-- PAGE_17 -->\n###### 효과 평가기준\n\n<!-- PAGE_17 -->\n###### 4.4.\n\n",
        "original_sentence": "<!-- PAGE_17 -->\n###### 상기 사항들을 고려하여 수술 중 무간기\n\n<!-- PAGE_17 -->\n###### 의 초회 투여 용량\n\n<!-- PAGE_17 -->\n###### (anheptic phase)\n\n<!-- PAGE_17 -->\n###### 간 이식 환자의\n\n<!-- PAGE_17 -->\n###### 형 간염 재발을 예방하기 위한 본 제제의 투여 기간은 현\n\n<!-- PAGE_17 -->\n###### B\n\n<!-- PAGE_17 -->\n###### 재까지 정해진 바 없으나\n\n<!-- PAGE_17 -->\n###### 의사의 판단과 환자의 여건에 따라 간 이식 수술 후 짧\n\n<!-- PAGE_17 -->\n###### ,\n\n<!-- PAGE_17 -->\n###### 게는\n\n<!-- PAGE_17 -->\n###### 년에서 길게는 평생 투여되고 있다\n\n<!-- PAGE_17 -->\n###### 따라서 치료적 확증 임상시험 시\n\n<!-- PAGE_17 -->\n###### 년\n\n<!-- PAGE_17 -->\n###### 1\n\n<!-- PAGE_17 -->\n###### .\n\n"
      }
    },
    {
      "chunk_id": "chunk_144",
      "text": "<!-- PAGE_17 -->\n###### 1\n\n<!-- PAGE_17 -->\n###### 이상 장기간 투여가 요구되며\n\n<!-- PAGE_17 -->\n###### 이에 따라 전 연령층에 대하여 의약품의 품목허가\n\n<!-- PAGE_17 -->\n###### ,\n\n<!-- PAGE_17 -->\n###### 에 필요한 정보 예\n\n<!-- PAGE_17 -->\n###### 병용약물 요법\n\n<!-- PAGE_17 -->\n###### 약물 상호작용 등 가 충분히 확보되어야 한\n\n<!-- PAGE_17 -->\n###### (\n\n<!-- PAGE_17 -->\n###### :\n\n<!-- PAGE_17 -->\n###### ,\n\n<!-- PAGE_17 -->\n###### )\n\n<!-- PAGE_17 -->\n###### 다\n\n<!-- PAGE_17 -->\n###### 간 이식 수술 후\n\n<!-- PAGE_17 -->\n###### 년 내에\n\n<!-- PAGE_17 -->\n###### 형 간염의 재발이 빈번히 나타나므로\n\n<!-- PAGE_17 -->\n###### 최근 외\n\n<!-- PAGE_17 -->\n###### .\n\n",
      "metadata": {
        "source": "(가이드라인-005)_정맥주사용+B형간염+사람면역글로불린제제의+안전성유효성+평가+가이드라인.pdf",
        "chunk_index": 143,
        "window_size": 3,
        "char_count": 567,
        "word_count": 113,
        "page_number": 17,
        "window_text": "HBV DNA\n\n<!-- PAGE_16 -->\n###### B\n\n<!-- PAGE_16 -->\n###### e\n\n<!-- PAGE_16 -->\n###### (hepatitis B e antigen,\n\n<!-- PAGE_16 -->\n###### HBeAg)의 유 무도 고려하여 투여 용량을 결정하여야 한다\n\n<!-- PAGE_16 -->\n###### .\n\n <!-- PAGE_16 -->\n###### ․\n\n- - 9 -\n<!-- PAGE_17 -->\n###### 환자마다 다양한 반감기를 보일 수 있으므로 간 이식 전 바이러스의 상태를\n\n<!-- PAGE_17 -->\n###### 고려하여 순환하는\n\n<!-- PAGE_17 -->\n###### 를 중화할 수 있는 안전한 농도를 투여하여야 하며\n\n<!-- PAGE_17 -->\n###### 정기\n\n<!-- PAGE_17 -->\n###### HBV\n\n<!-- PAGE_17 -->\n###### ,\n\n<!-- PAGE_17 -->\n###### 적으로 혈중\n\n<!-- PAGE_17 -->\n###### anti-HBs 농도를 모니터링 하여야 한다\n\n<!-- PAGE_17 -->\n###### .\n\n <!-- PAGE_17 -->\n###### 상기 사항들을 고려하여 수술 중 무간기\n\n<!-- PAGE_17 -->\n###### 의 초회 투여 용량\n\n<!-- PAGE_17 -->\n###### (anheptic phase)\n\n<!-- PAGE_17 -->\n###### 간 이식 환자의\n\n<!-- PAGE_17 -->\n###### 형 간염 재발을 예방하기 위한 본 제제의 투여 기간은 현\n\n<!-- PAGE_17 -->\n###### B\n\n<!-- PAGE_17 -->\n###### 재까지 정해진 바 없으나\n\n<!-- PAGE_17 -->\n###### 의사의 판단과 환자의 여건에 따라 간 이식 수술 후 짧\n\n<!-- PAGE_17 -->\n###### ,\n\n<!-- PAGE_17 -->\n###### 게는\n\n<!-- PAGE_17 -->\n###### 년에서 길게는 평생 투여되고 있다\n\n<!-- PAGE_17 -->\n###### 따라서 치료적 확증 임상시험 시\n\n<!-- PAGE_17 -->\n###### 년\n\n<!-- PAGE_17 -->\n###### 1\n\n<!-- PAGE_17 -->\n###### .\n\n <!-- PAGE_17 -->\n###### 1\n\n<!-- PAGE_17 -->\n###### 이상 장기간 투여가 요구되며\n\n<!-- PAGE_17 -->\n###### 이에 따라 전 연령층에 대하여 의약품의 품목허가\n\n<!-- PAGE_17 -->\n###### ,\n\n<!-- PAGE_17 -->\n###### 에 필요한 정보 예\n\n<!-- PAGE_17 -->\n###### 병용약물 요법\n\n<!-- PAGE_17 -->\n###### 약물 상호작용 등 가 충분히 확보되어야 한\n\n<!-- PAGE_17 -->\n###### (\n\n<!-- PAGE_17 -->\n###### :\n\n<!-- PAGE_17 -->\n###### ,\n\n<!-- PAGE_17 -->\n###### )\n\n<!-- PAGE_17 -->\n###### 다\n\n<!-- PAGE_17 -->\n###### 간 이식 수술 후\n\n<!-- PAGE_17 -->\n###### 년 내에\n\n<!-- PAGE_17 -->\n###### 형 간염의 재발이 빈번히 나타나므로\n\n<!-- PAGE_17 -->\n###### 최근 외\n\n<!-- PAGE_17 -->\n###### .\n\n <!-- PAGE_17 -->\n###### 2~3\n\n<!-- PAGE_17 -->\n###### B\n\n<!-- PAGE_17 -->\n###### ,\n\n<!-- PAGE_17 -->\n###### 간 이식 수술 중 및 수술 후 관리를 위한 목적의 투여 기간에 대한 정확한\n\n<!-- PAGE_17 -->\n###### 가이드가 확립되어 있지 않으므로\n\n<!-- PAGE_17 -->\n###### 간 이식 전후로 투여되는 다른 약물과의 상호\n\n<!-- PAGE_17 -->\n###### ,\n\n<!-- PAGE_17 -->\n###### 작용뿐만 아니라 간 이식 후에도 지속적인 모니터링을 통해 약물의 단독 및 잠재\n\n<!-- PAGE_17 -->\n###### 적 약물 약물 상호작용을 확인하여야 한다\n\n<!-- PAGE_17 -->\n###### -\n\n<!-- PAGE_17 -->\n###### .\n\n <!-- PAGE_17 -->\n###### 효과 평가기준\n\n<!-- PAGE_17 -->\n###### 4.4.\n\n <!-- PAGE_17 -->\n###### 정맥주사용\n\n<!-- PAGE_17 -->\n###### 의 유효성 평가는 간 이식 수술 후 혈청\n\n<!-- PAGE_17 -->\n###### 의 재발율\n\n<!-- PAGE_17 -->\n###### HBIG\n\n<!-- PAGE_17 -->\n###### HBsAg\n\n<!-- PAGE_17 -->\n###### ,\n\n<!-- PAGE_17 -->\n###### 즉\n\n<!-- PAGE_17 -->\n###### 간 이식 후\n\n<!-- PAGE_17 -->\n###### 가 음성에서 양성으로 재발한 피험자의 백분율로 설정하고\n\n<!-- PAGE_17 -->\n###### ,\n\n<!-- PAGE_17 -->\n###### HBsAg\n\n<!-- PAGE_17 -->\n###### 95% 신뢰구간을 제시하여야 한다\n\n<!-- PAGE_17 -->\n###### .\n\n",
        "original_sentence": "<!-- PAGE_17 -->\n###### 1\n\n<!-- PAGE_17 -->\n###### 이상 장기간 투여가 요구되며\n\n<!-- PAGE_17 -->\n###### 이에 따라 전 연령층에 대하여 의약품의 품목허가\n\n<!-- PAGE_17 -->\n###### ,\n\n<!-- PAGE_17 -->\n###### 에 필요한 정보 예\n\n<!-- PAGE_17 -->\n###### 병용약물 요법\n\n<!-- PAGE_17 -->\n###### 약물 상호작용 등 가 충분히 확보되어야 한\n\n<!-- PAGE_17 -->\n###### (\n\n<!-- PAGE_17 -->\n###### :\n\n<!-- PAGE_17 -->\n###### ,\n\n<!-- PAGE_17 -->\n###### )\n\n<!-- PAGE_17 -->\n###### 다\n\n<!-- PAGE_17 -->\n###### 간 이식 수술 후\n\n<!-- PAGE_17 -->\n###### 년 내에\n\n<!-- PAGE_17 -->\n###### 형 간염의 재발이 빈번히 나타나므로\n\n<!-- PAGE_17 -->\n###### 최근 외\n\n<!-- PAGE_17 -->\n###### .\n\n"
      }
    },
    {
      "chunk_id": "chunk_145",
      "text": "<!-- PAGE_17 -->\n###### 2~3\n\n<!-- PAGE_17 -->\n###### B\n\n<!-- PAGE_17 -->\n###### ,\n\n<!-- PAGE_17 -->\n###### 간 이식 수술 중 및 수술 후 관리를 위한 목적의 투여 기간에 대한 정확한\n\n<!-- PAGE_17 -->\n###### 가이드가 확립되어 있지 않으므로\n\n<!-- PAGE_17 -->\n###### 간 이식 전후로 투여되는 다른 약물과의 상호\n\n<!-- PAGE_17 -->\n###### ,\n\n<!-- PAGE_17 -->\n###### 작용뿐만 아니라 간 이식 후에도 지속적인 모니터링을 통해 약물의 단독 및 잠재\n\n<!-- PAGE_17 -->\n###### 적 약물 약물 상호작용을 확인하여야 한다\n\n<!-- PAGE_17 -->\n###### -\n\n<!-- PAGE_17 -->\n###### .\n\n",
      "metadata": {
        "source": "(가이드라인-005)_정맥주사용+B형간염+사람면역글로불린제제의+안전성유효성+평가+가이드라인.pdf",
        "chunk_index": 144,
        "window_size": 3,
        "char_count": 441,
        "word_count": 93,
        "page_number": 17,
        "window_text": "<!-- PAGE_16 -->\n###### ․\n\n- - 9 -\n<!-- PAGE_17 -->\n###### 환자마다 다양한 반감기를 보일 수 있으므로 간 이식 전 바이러스의 상태를\n\n<!-- PAGE_17 -->\n###### 고려하여 순환하는\n\n<!-- PAGE_17 -->\n###### 를 중화할 수 있는 안전한 농도를 투여하여야 하며\n\n<!-- PAGE_17 -->\n###### 정기\n\n<!-- PAGE_17 -->\n###### HBV\n\n<!-- PAGE_17 -->\n###### ,\n\n<!-- PAGE_17 -->\n###### 적으로 혈중\n\n<!-- PAGE_17 -->\n###### anti-HBs 농도를 모니터링 하여야 한다\n\n<!-- PAGE_17 -->\n###### .\n\n <!-- PAGE_17 -->\n###### 상기 사항들을 고려하여 수술 중 무간기\n\n<!-- PAGE_17 -->\n###### 의 초회 투여 용량\n\n<!-- PAGE_17 -->\n###### (anheptic phase)\n\n<!-- PAGE_17 -->\n###### 간 이식 환자의\n\n<!-- PAGE_17 -->\n###### 형 간염 재발을 예방하기 위한 본 제제의 투여 기간은 현\n\n<!-- PAGE_17 -->\n###### B\n\n<!-- PAGE_17 -->\n###### 재까지 정해진 바 없으나\n\n<!-- PAGE_17 -->\n###### 의사의 판단과 환자의 여건에 따라 간 이식 수술 후 짧\n\n<!-- PAGE_17 -->\n###### ,\n\n<!-- PAGE_17 -->\n###### 게는\n\n<!-- PAGE_17 -->\n###### 년에서 길게는 평생 투여되고 있다\n\n<!-- PAGE_17 -->\n###### 따라서 치료적 확증 임상시험 시\n\n<!-- PAGE_17 -->\n###### 년\n\n<!-- PAGE_17 -->\n###### 1\n\n<!-- PAGE_17 -->\n###### .\n\n <!-- PAGE_17 -->\n###### 1\n\n<!-- PAGE_17 -->\n###### 이상 장기간 투여가 요구되며\n\n<!-- PAGE_17 -->\n###### 이에 따라 전 연령층에 대하여 의약품의 품목허가\n\n<!-- PAGE_17 -->\n###### ,\n\n<!-- PAGE_17 -->\n###### 에 필요한 정보 예\n\n<!-- PAGE_17 -->\n###### 병용약물 요법\n\n<!-- PAGE_17 -->\n###### 약물 상호작용 등 가 충분히 확보되어야 한\n\n<!-- PAGE_17 -->\n###### (\n\n<!-- PAGE_17 -->\n###### :\n\n<!-- PAGE_17 -->\n###### ,\n\n<!-- PAGE_17 -->\n###### )\n\n<!-- PAGE_17 -->\n###### 다\n\n<!-- PAGE_17 -->\n###### 간 이식 수술 후\n\n<!-- PAGE_17 -->\n###### 년 내에\n\n<!-- PAGE_17 -->\n###### 형 간염의 재발이 빈번히 나타나므로\n\n<!-- PAGE_17 -->\n###### 최근 외\n\n<!-- PAGE_17 -->\n###### .\n\n <!-- PAGE_17 -->\n###### 2~3\n\n<!-- PAGE_17 -->\n###### B\n\n<!-- PAGE_17 -->\n###### ,\n\n<!-- PAGE_17 -->\n###### 간 이식 수술 중 및 수술 후 관리를 위한 목적의 투여 기간에 대한 정확한\n\n<!-- PAGE_17 -->\n###### 가이드가 확립되어 있지 않으므로\n\n<!-- PAGE_17 -->\n###### 간 이식 전후로 투여되는 다른 약물과의 상호\n\n<!-- PAGE_17 -->\n###### ,\n\n<!-- PAGE_17 -->\n###### 작용뿐만 아니라 간 이식 후에도 지속적인 모니터링을 통해 약물의 단독 및 잠재\n\n<!-- PAGE_17 -->\n###### 적 약물 약물 상호작용을 확인하여야 한다\n\n<!-- PAGE_17 -->\n###### -\n\n<!-- PAGE_17 -->\n###### .\n\n <!-- PAGE_17 -->\n###### 효과 평가기준\n\n<!-- PAGE_17 -->\n###### 4.4.\n\n <!-- PAGE_17 -->\n###### 정맥주사용\n\n<!-- PAGE_17 -->\n###### 의 유효성 평가는 간 이식 수술 후 혈청\n\n<!-- PAGE_17 -->\n###### 의 재발율\n\n<!-- PAGE_17 -->\n###### HBIG\n\n<!-- PAGE_17 -->\n###### HBsAg\n\n<!-- PAGE_17 -->\n###### ,\n\n<!-- PAGE_17 -->\n###### 즉\n\n<!-- PAGE_17 -->\n###### 간 이식 후\n\n<!-- PAGE_17 -->\n###### 가 음성에서 양성으로 재발한 피험자의 백분율로 설정하고\n\n<!-- PAGE_17 -->\n###### ,\n\n<!-- PAGE_17 -->\n###### HBsAg\n\n<!-- PAGE_17 -->\n###### 95% 신뢰구간을 제시하여야 한다\n\n<!-- PAGE_17 -->\n###### .\n\n <!-- PAGE_17 -->\n###### 그러나\n\n<!-- PAGE_17 -->\n###### 투여로 인해\n\n<!-- PAGE_17 -->\n###### 존재가 마스킹 될 우려가 있고\n\n<!-- PAGE_17 -->\n###### 가\n\n<!-- PAGE_17 -->\n###### HBIG\n\n<!-- PAGE_17 -->\n###### HBsAg\n\n<!-- PAGE_17 -->\n###### HBsAg\n\n<!-- PAGE_17 -->\n###### 양성이라 함은 혈중에 바이러스가 존재만 하고 염증을 일으키지 않는 상태부터 급\n\n<!-- PAGE_17 -->\n###### 성 및 만성 간염을 일으켜 심각한 문제를 야기하는 상태까지 다양하므로, HBsAg\n\n<!-- PAGE_17 -->\n###### 만으로는\n\n<!-- PAGE_17 -->\n###### 형 간염의 재발에 대하여 정확한 평가가 어려울 수 있어\n\n<!-- PAGE_17 -->\n###### 형 간염과\n\n<!-- PAGE_17 -->\n###### B\n\n<!-- PAGE_17 -->\n###### B\n\n- - 10 -\n<!-- PAGE_18 -->\n###### 관련된 혈청학적 지표 예\n\n<!-- PAGE_18 -->\n###### 형 간염\n\n<!-- PAGE_18 -->\n###### 항원 항체\n\n<!-- PAGE_18 -->\n###### [\n\n<!-- PAGE_18 -->\n###### : HBV DNA, HBeAg, B\n\n<!-- PAGE_18 -->\n###### e\n\n<!-- PAGE_18 -->\n###### (antibody\n\n<!-- PAGE_18 -->\n###### to hepatitis B e antigen, anti-HBe)] 등을 고려하여야 한다.\n\n",
        "original_sentence": "<!-- PAGE_17 -->\n###### 2~3\n\n<!-- PAGE_17 -->\n###### B\n\n<!-- PAGE_17 -->\n###### ,\n\n<!-- PAGE_17 -->\n###### 간 이식 수술 중 및 수술 후 관리를 위한 목적의 투여 기간에 대한 정확한\n\n<!-- PAGE_17 -->\n###### 가이드가 확립되어 있지 않으므로\n\n<!-- PAGE_17 -->\n###### 간 이식 전후로 투여되는 다른 약물과의 상호\n\n<!-- PAGE_17 -->\n###### ,\n\n<!-- PAGE_17 -->\n###### 작용뿐만 아니라 간 이식 후에도 지속적인 모니터링을 통해 약물의 단독 및 잠재\n\n<!-- PAGE_17 -->\n###### 적 약물 약물 상호작용을 확인하여야 한다\n\n<!-- PAGE_17 -->\n###### -\n\n<!-- PAGE_17 -->\n###### .\n\n"
      }
    },
    {
      "chunk_id": "chunk_146",
      "text": "<!-- PAGE_17 -->\n###### 효과 평가기준\n\n<!-- PAGE_17 -->\n###### 4.4.\n\n",
      "metadata": {
        "source": "(가이드라인-005)_정맥주사용+B형간염+사람면역글로불린제제의+안전성유효성+평가+가이드라인.pdf",
        "chunk_index": 145,
        "window_size": 3,
        "char_count": 63,
        "word_count": 11,
        "page_number": 17,
        "window_text": "<!-- PAGE_17 -->\n###### 상기 사항들을 고려하여 수술 중 무간기\n\n<!-- PAGE_17 -->\n###### 의 초회 투여 용량\n\n<!-- PAGE_17 -->\n###### (anheptic phase)\n\n<!-- PAGE_17 -->\n###### 간 이식 환자의\n\n<!-- PAGE_17 -->\n###### 형 간염 재발을 예방하기 위한 본 제제의 투여 기간은 현\n\n<!-- PAGE_17 -->\n###### B\n\n<!-- PAGE_17 -->\n###### 재까지 정해진 바 없으나\n\n<!-- PAGE_17 -->\n###### 의사의 판단과 환자의 여건에 따라 간 이식 수술 후 짧\n\n<!-- PAGE_17 -->\n###### ,\n\n<!-- PAGE_17 -->\n###### 게는\n\n<!-- PAGE_17 -->\n###### 년에서 길게는 평생 투여되고 있다\n\n<!-- PAGE_17 -->\n###### 따라서 치료적 확증 임상시험 시\n\n<!-- PAGE_17 -->\n###### 년\n\n<!-- PAGE_17 -->\n###### 1\n\n<!-- PAGE_17 -->\n###### .\n\n <!-- PAGE_17 -->\n###### 1\n\n<!-- PAGE_17 -->\n###### 이상 장기간 투여가 요구되며\n\n<!-- PAGE_17 -->\n###### 이에 따라 전 연령층에 대하여 의약품의 품목허가\n\n<!-- PAGE_17 -->\n###### ,\n\n<!-- PAGE_17 -->\n###### 에 필요한 정보 예\n\n<!-- PAGE_17 -->\n###### 병용약물 요법\n\n<!-- PAGE_17 -->\n###### 약물 상호작용 등 가 충분히 확보되어야 한\n\n<!-- PAGE_17 -->\n###### (\n\n<!-- PAGE_17 -->\n###### :\n\n<!-- PAGE_17 -->\n###### ,\n\n<!-- PAGE_17 -->\n###### )\n\n<!-- PAGE_17 -->\n###### 다\n\n<!-- PAGE_17 -->\n###### 간 이식 수술 후\n\n<!-- PAGE_17 -->\n###### 년 내에\n\n<!-- PAGE_17 -->\n###### 형 간염의 재발이 빈번히 나타나므로\n\n<!-- PAGE_17 -->\n###### 최근 외\n\n<!-- PAGE_17 -->\n###### .\n\n <!-- PAGE_17 -->\n###### 2~3\n\n<!-- PAGE_17 -->\n###### B\n\n<!-- PAGE_17 -->\n###### ,\n\n<!-- PAGE_17 -->\n###### 간 이식 수술 중 및 수술 후 관리를 위한 목적의 투여 기간에 대한 정확한\n\n<!-- PAGE_17 -->\n###### 가이드가 확립되어 있지 않으므로\n\n<!-- PAGE_17 -->\n###### 간 이식 전후로 투여되는 다른 약물과의 상호\n\n<!-- PAGE_17 -->\n###### ,\n\n<!-- PAGE_17 -->\n###### 작용뿐만 아니라 간 이식 후에도 지속적인 모니터링을 통해 약물의 단독 및 잠재\n\n<!-- PAGE_17 -->\n###### 적 약물 약물 상호작용을 확인하여야 한다\n\n<!-- PAGE_17 -->\n###### -\n\n<!-- PAGE_17 -->\n###### .\n\n <!-- PAGE_17 -->\n###### 효과 평가기준\n\n<!-- PAGE_17 -->\n###### 4.4.\n\n <!-- PAGE_17 -->\n###### 정맥주사용\n\n<!-- PAGE_17 -->\n###### 의 유효성 평가는 간 이식 수술 후 혈청\n\n<!-- PAGE_17 -->\n###### 의 재발율\n\n<!-- PAGE_17 -->\n###### HBIG\n\n<!-- PAGE_17 -->\n###### HBsAg\n\n<!-- PAGE_17 -->\n###### ,\n\n<!-- PAGE_17 -->\n###### 즉\n\n<!-- PAGE_17 -->\n###### 간 이식 후\n\n<!-- PAGE_17 -->\n###### 가 음성에서 양성으로 재발한 피험자의 백분율로 설정하고\n\n<!-- PAGE_17 -->\n###### ,\n\n<!-- PAGE_17 -->\n###### HBsAg\n\n<!-- PAGE_17 -->\n###### 95% 신뢰구간을 제시하여야 한다\n\n<!-- PAGE_17 -->\n###### .\n\n <!-- PAGE_17 -->\n###### 그러나\n\n<!-- PAGE_17 -->\n###### 투여로 인해\n\n<!-- PAGE_17 -->\n###### 존재가 마스킹 될 우려가 있고\n\n<!-- PAGE_17 -->\n###### 가\n\n<!-- PAGE_17 -->\n###### HBIG\n\n<!-- PAGE_17 -->\n###### HBsAg\n\n<!-- PAGE_17 -->\n###### HBsAg\n\n<!-- PAGE_17 -->\n###### 양성이라 함은 혈중에 바이러스가 존재만 하고 염증을 일으키지 않는 상태부터 급\n\n<!-- PAGE_17 -->\n###### 성 및 만성 간염을 일으켜 심각한 문제를 야기하는 상태까지 다양하므로, HBsAg\n\n<!-- PAGE_17 -->\n###### 만으로는\n\n<!-- PAGE_17 -->\n###### 형 간염의 재발에 대하여 정확한 평가가 어려울 수 있어\n\n<!-- PAGE_17 -->\n###### 형 간염과\n\n<!-- PAGE_17 -->\n###### B\n\n<!-- PAGE_17 -->\n###### B\n\n- - 10 -\n<!-- PAGE_18 -->\n###### 관련된 혈청학적 지표 예\n\n<!-- PAGE_18 -->\n###### 형 간염\n\n<!-- PAGE_18 -->\n###### 항원 항체\n\n<!-- PAGE_18 -->\n###### [\n\n<!-- PAGE_18 -->\n###### : HBV DNA, HBeAg, B\n\n<!-- PAGE_18 -->\n###### e\n\n<!-- PAGE_18 -->\n###### (antibody\n\n<!-- PAGE_18 -->\n###### to hepatitis B e antigen, anti-HBe)] 등을 고려하여야 한다.\n\n <!-- PAGE_18 -->\n###### 기타\n\n<!-- PAGE_18 -->\n###### 재발까지의 기간\n\n<!-- PAGE_18 -->\n###### 피험자의 생존율\n\n<!-- PAGE_18 -->\n###### 생존기간 등을 추가로 제시\n\n<!-- PAGE_18 -->\n###### HBsAg\n\n<!-- PAGE_18 -->\n###### ,\n\n<!-- PAGE_18 -->\n###### ,\n\n<!-- PAGE_18 -->\n###### 할 수 있다.\n\n",
        "original_sentence": "<!-- PAGE_17 -->\n###### 효과 평가기준\n\n<!-- PAGE_17 -->\n###### 4.4.\n\n"
      }
    },
    {
      "chunk_id": "chunk_147",
      "text": "<!-- PAGE_17 -->\n###### 정맥주사용\n\n<!-- PAGE_17 -->\n###### 의 유효성 평가는 간 이식 수술 후 혈청\n\n<!-- PAGE_17 -->\n###### 의 재발율\n\n<!-- PAGE_17 -->\n###### HBIG\n\n<!-- PAGE_17 -->\n###### HBsAg\n\n<!-- PAGE_17 -->\n###### ,\n\n<!-- PAGE_17 -->\n###### 즉\n\n<!-- PAGE_17 -->\n###### 간 이식 후\n\n<!-- PAGE_17 -->\n###### 가 음성에서 양성으로 재발한 피험자의 백분율로 설정하고\n\n<!-- PAGE_17 -->\n###### ,\n\n<!-- PAGE_17 -->\n###### HBsAg\n\n<!-- PAGE_17 -->\n###### 95% 신뢰구간을 제시하여야 한다\n\n<!-- PAGE_17 -->\n###### .\n\n",
      "metadata": {
        "source": "(가이드라인-005)_정맥주사용+B형간염+사람면역글로불린제제의+안전성유효성+평가+가이드라인.pdf",
        "chunk_index": 146,
        "window_size": 3,
        "char_count": 442,
        "word_count": 84,
        "page_number": 17,
        "window_text": "<!-- PAGE_17 -->\n###### 1\n\n<!-- PAGE_17 -->\n###### 이상 장기간 투여가 요구되며\n\n<!-- PAGE_17 -->\n###### 이에 따라 전 연령층에 대하여 의약품의 품목허가\n\n<!-- PAGE_17 -->\n###### ,\n\n<!-- PAGE_17 -->\n###### 에 필요한 정보 예\n\n<!-- PAGE_17 -->\n###### 병용약물 요법\n\n<!-- PAGE_17 -->\n###### 약물 상호작용 등 가 충분히 확보되어야 한\n\n<!-- PAGE_17 -->\n###### (\n\n<!-- PAGE_17 -->\n###### :\n\n<!-- PAGE_17 -->\n###### ,\n\n<!-- PAGE_17 -->\n###### )\n\n<!-- PAGE_17 -->\n###### 다\n\n<!-- PAGE_17 -->\n###### 간 이식 수술 후\n\n<!-- PAGE_17 -->\n###### 년 내에\n\n<!-- PAGE_17 -->\n###### 형 간염의 재발이 빈번히 나타나므로\n\n<!-- PAGE_17 -->\n###### 최근 외\n\n<!-- PAGE_17 -->\n###### .\n\n <!-- PAGE_17 -->\n###### 2~3\n\n<!-- PAGE_17 -->\n###### B\n\n<!-- PAGE_17 -->\n###### ,\n\n<!-- PAGE_17 -->\n###### 간 이식 수술 중 및 수술 후 관리를 위한 목적의 투여 기간에 대한 정확한\n\n<!-- PAGE_17 -->\n###### 가이드가 확립되어 있지 않으므로\n\n<!-- PAGE_17 -->\n###### 간 이식 전후로 투여되는 다른 약물과의 상호\n\n<!-- PAGE_17 -->\n###### ,\n\n<!-- PAGE_17 -->\n###### 작용뿐만 아니라 간 이식 후에도 지속적인 모니터링을 통해 약물의 단독 및 잠재\n\n<!-- PAGE_17 -->\n###### 적 약물 약물 상호작용을 확인하여야 한다\n\n<!-- PAGE_17 -->\n###### -\n\n<!-- PAGE_17 -->\n###### .\n\n <!-- PAGE_17 -->\n###### 효과 평가기준\n\n<!-- PAGE_17 -->\n###### 4.4.\n\n <!-- PAGE_17 -->\n###### 정맥주사용\n\n<!-- PAGE_17 -->\n###### 의 유효성 평가는 간 이식 수술 후 혈청\n\n<!-- PAGE_17 -->\n###### 의 재발율\n\n<!-- PAGE_17 -->\n###### HBIG\n\n<!-- PAGE_17 -->\n###### HBsAg\n\n<!-- PAGE_17 -->\n###### ,\n\n<!-- PAGE_17 -->\n###### 즉\n\n<!-- PAGE_17 -->\n###### 간 이식 후\n\n<!-- PAGE_17 -->\n###### 가 음성에서 양성으로 재발한 피험자의 백분율로 설정하고\n\n<!-- PAGE_17 -->\n###### ,\n\n<!-- PAGE_17 -->\n###### HBsAg\n\n<!-- PAGE_17 -->\n###### 95% 신뢰구간을 제시하여야 한다\n\n<!-- PAGE_17 -->\n###### .\n\n <!-- PAGE_17 -->\n###### 그러나\n\n<!-- PAGE_17 -->\n###### 투여로 인해\n\n<!-- PAGE_17 -->\n###### 존재가 마스킹 될 우려가 있고\n\n<!-- PAGE_17 -->\n###### 가\n\n<!-- PAGE_17 -->\n###### HBIG\n\n<!-- PAGE_17 -->\n###### HBsAg\n\n<!-- PAGE_17 -->\n###### HBsAg\n\n<!-- PAGE_17 -->\n###### 양성이라 함은 혈중에 바이러스가 존재만 하고 염증을 일으키지 않는 상태부터 급\n\n<!-- PAGE_17 -->\n###### 성 및 만성 간염을 일으켜 심각한 문제를 야기하는 상태까지 다양하므로, HBsAg\n\n<!-- PAGE_17 -->\n###### 만으로는\n\n<!-- PAGE_17 -->\n###### 형 간염의 재발에 대하여 정확한 평가가 어려울 수 있어\n\n<!-- PAGE_17 -->\n###### 형 간염과\n\n<!-- PAGE_17 -->\n###### B\n\n<!-- PAGE_17 -->\n###### B\n\n- - 10 -\n<!-- PAGE_18 -->\n###### 관련된 혈청학적 지표 예\n\n<!-- PAGE_18 -->\n###### 형 간염\n\n<!-- PAGE_18 -->\n###### 항원 항체\n\n<!-- PAGE_18 -->\n###### [\n\n<!-- PAGE_18 -->\n###### : HBV DNA, HBeAg, B\n\n<!-- PAGE_18 -->\n###### e\n\n<!-- PAGE_18 -->\n###### (antibody\n\n<!-- PAGE_18 -->\n###### to hepatitis B e antigen, anti-HBe)] 등을 고려하여야 한다.\n\n <!-- PAGE_18 -->\n###### 기타\n\n<!-- PAGE_18 -->\n###### 재발까지의 기간\n\n<!-- PAGE_18 -->\n###### 피험자의 생존율\n\n<!-- PAGE_18 -->\n###### 생존기간 등을 추가로 제시\n\n<!-- PAGE_18 -->\n###### HBsAg\n\n<!-- PAGE_18 -->\n###### ,\n\n<!-- PAGE_18 -->\n###### ,\n\n<!-- PAGE_18 -->\n###### 할 수 있다.\n\n - - 11 -\n<!-- PAGE_19 -->\n###### . ",
        "original_sentence": "<!-- PAGE_17 -->\n###### 정맥주사용\n\n<!-- PAGE_17 -->\n###### 의 유효성 평가는 간 이식 수술 후 혈청\n\n<!-- PAGE_17 -->\n###### 의 재발율\n\n<!-- PAGE_17 -->\n###### HBIG\n\n<!-- PAGE_17 -->\n###### HBsAg\n\n<!-- PAGE_17 -->\n###### ,\n\n<!-- PAGE_17 -->\n###### 즉\n\n<!-- PAGE_17 -->\n###### 간 이식 후\n\n<!-- PAGE_17 -->\n###### 가 음성에서 양성으로 재발한 피험자의 백분율로 설정하고\n\n<!-- PAGE_17 -->\n###### ,\n\n<!-- PAGE_17 -->\n###### HBsAg\n\n<!-- PAGE_17 -->\n###### 95% 신뢰구간을 제시하여야 한다\n\n<!-- PAGE_17 -->\n###### .\n\n"
      }
    },
    {
      "chunk_id": "chunk_148",
      "text": "<!-- PAGE_17 -->\n###### 그러나\n\n<!-- PAGE_17 -->\n###### 투여로 인해\n\n<!-- PAGE_17 -->\n###### 존재가 마스킹 될 우려가 있고\n\n<!-- PAGE_17 -->\n###### 가\n\n<!-- PAGE_17 -->\n###### HBIG\n\n<!-- PAGE_17 -->\n###### HBsAg\n\n<!-- PAGE_17 -->\n###### HBsAg\n\n<!-- PAGE_17 -->\n###### 양성이라 함은 혈중에 바이러스가 존재만 하고 염증을 일으키지 않는 상태부터 급\n\n<!-- PAGE_17 -->\n###### 성 및 만성 간염을 일으켜 심각한 문제를 야기하는 상태까지 다양하므로, HBsAg\n\n<!-- PAGE_17 -->\n###### 만으로는\n\n<!-- PAGE_17 -->\n###### 형 간염의 재발에 대하여 정확한 평가가 어려울 수 있어\n\n<!-- PAGE_17 -->\n###### 형 간염과\n\n<!-- PAGE_17 -->\n###### B\n\n<!-- PAGE_17 -->\n###### B\n\n- - 10 -\n<!-- PAGE_18 -->\n###### 관련된 혈청학적 지표 예\n\n<!-- PAGE_18 -->\n###### 형 간염\n\n<!-- PAGE_18 -->\n###### 항원 항체\n\n<!-- PAGE_18 -->\n###### [\n\n<!-- PAGE_18 -->\n###### : HBV DNA, HBeAg, B\n\n<!-- PAGE_18 -->\n###### e\n\n<!-- PAGE_18 -->\n###### (antibody\n\n<!-- PAGE_18 -->\n###### to hepatitis B e antigen, anti-HBe)] 등을 고려하여야 한다.\n\n",
      "metadata": {
        "source": "(가이드라인-005)_정맥주사용+B형간염+사람면역글로불린제제의+안전성유효성+평가+가이드라인.pdf",
        "chunk_index": 147,
        "window_size": 3,
        "char_count": 851,
        "word_count": 165,
        "page_number": 17,
        "window_text": "<!-- PAGE_17 -->\n###### 2~3\n\n<!-- PAGE_17 -->\n###### B\n\n<!-- PAGE_17 -->\n###### ,\n\n<!-- PAGE_17 -->\n###### 간 이식 수술 중 및 수술 후 관리를 위한 목적의 투여 기간에 대한 정확한\n\n<!-- PAGE_17 -->\n###### 가이드가 확립되어 있지 않으므로\n\n<!-- PAGE_17 -->\n###### 간 이식 전후로 투여되는 다른 약물과의 상호\n\n<!-- PAGE_17 -->\n###### ,\n\n<!-- PAGE_17 -->\n###### 작용뿐만 아니라 간 이식 후에도 지속적인 모니터링을 통해 약물의 단독 및 잠재\n\n<!-- PAGE_17 -->\n###### 적 약물 약물 상호작용을 확인하여야 한다\n\n<!-- PAGE_17 -->\n###### -\n\n<!-- PAGE_17 -->\n###### .\n\n <!-- PAGE_17 -->\n###### 효과 평가기준\n\n<!-- PAGE_17 -->\n###### 4.4.\n\n <!-- PAGE_17 -->\n###### 정맥주사용\n\n<!-- PAGE_17 -->\n###### 의 유효성 평가는 간 이식 수술 후 혈청\n\n<!-- PAGE_17 -->\n###### 의 재발율\n\n<!-- PAGE_17 -->\n###### HBIG\n\n<!-- PAGE_17 -->\n###### HBsAg\n\n<!-- PAGE_17 -->\n###### ,\n\n<!-- PAGE_17 -->\n###### 즉\n\n<!-- PAGE_17 -->\n###### 간 이식 후\n\n<!-- PAGE_17 -->\n###### 가 음성에서 양성으로 재발한 피험자의 백분율로 설정하고\n\n<!-- PAGE_17 -->\n###### ,\n\n<!-- PAGE_17 -->\n###### HBsAg\n\n<!-- PAGE_17 -->\n###### 95% 신뢰구간을 제시하여야 한다\n\n<!-- PAGE_17 -->\n###### .\n\n <!-- PAGE_17 -->\n###### 그러나\n\n<!-- PAGE_17 -->\n###### 투여로 인해\n\n<!-- PAGE_17 -->\n###### 존재가 마스킹 될 우려가 있고\n\n<!-- PAGE_17 -->\n###### 가\n\n<!-- PAGE_17 -->\n###### HBIG\n\n<!-- PAGE_17 -->\n###### HBsAg\n\n<!-- PAGE_17 -->\n###### HBsAg\n\n<!-- PAGE_17 -->\n###### 양성이라 함은 혈중에 바이러스가 존재만 하고 염증을 일으키지 않는 상태부터 급\n\n<!-- PAGE_17 -->\n###### 성 및 만성 간염을 일으켜 심각한 문제를 야기하는 상태까지 다양하므로, HBsAg\n\n<!-- PAGE_17 -->\n###### 만으로는\n\n<!-- PAGE_17 -->\n###### 형 간염의 재발에 대하여 정확한 평가가 어려울 수 있어\n\n<!-- PAGE_17 -->\n###### 형 간염과\n\n<!-- PAGE_17 -->\n###### B\n\n<!-- PAGE_17 -->\n###### B\n\n- - 10 -\n<!-- PAGE_18 -->\n###### 관련된 혈청학적 지표 예\n\n<!-- PAGE_18 -->\n###### 형 간염\n\n<!-- PAGE_18 -->\n###### 항원 항체\n\n<!-- PAGE_18 -->\n###### [\n\n<!-- PAGE_18 -->\n###### : HBV DNA, HBeAg, B\n\n<!-- PAGE_18 -->\n###### e\n\n<!-- PAGE_18 -->\n###### (antibody\n\n<!-- PAGE_18 -->\n###### to hepatitis B e antigen, anti-HBe)] 등을 고려하여야 한다.\n\n <!-- PAGE_18 -->\n###### 기타\n\n<!-- PAGE_18 -->\n###### 재발까지의 기간\n\n<!-- PAGE_18 -->\n###### 피험자의 생존율\n\n<!-- PAGE_18 -->\n###### 생존기간 등을 추가로 제시\n\n<!-- PAGE_18 -->\n###### HBsAg\n\n<!-- PAGE_18 -->\n###### ,\n\n<!-- PAGE_18 -->\n###### ,\n\n<!-- PAGE_18 -->\n###### 할 수 있다.\n\n - - 11 -\n<!-- PAGE_19 -->\n###### .  참고문헌\n\n<!-- PAGE_19 -->\n###### Ⅵ\n\n<!-- PAGE_19 -->\n###### 1. ",
        "original_sentence": "<!-- PAGE_17 -->\n###### 그러나\n\n<!-- PAGE_17 -->\n###### 투여로 인해\n\n<!-- PAGE_17 -->\n###### 존재가 마스킹 될 우려가 있고\n\n<!-- PAGE_17 -->\n###### 가\n\n<!-- PAGE_17 -->\n###### HBIG\n\n<!-- PAGE_17 -->\n###### HBsAg\n\n<!-- PAGE_17 -->\n###### HBsAg\n\n<!-- PAGE_17 -->\n###### 양성이라 함은 혈중에 바이러스가 존재만 하고 염증을 일으키지 않는 상태부터 급\n\n<!-- PAGE_17 -->\n###### 성 및 만성 간염을 일으켜 심각한 문제를 야기하는 상태까지 다양하므로, HBsAg\n\n<!-- PAGE_17 -->\n###### 만으로는\n\n<!-- PAGE_17 -->\n###### 형 간염의 재발에 대하여 정확한 평가가 어려울 수 있어\n\n<!-- PAGE_17 -->\n###### 형 간염과\n\n<!-- PAGE_17 -->\n###### B\n\n<!-- PAGE_17 -->\n###### B\n\n- - 10 -\n<!-- PAGE_18 -->\n###### 관련된 혈청학적 지표 예\n\n<!-- PAGE_18 -->\n###### 형 간염\n\n<!-- PAGE_18 -->\n###### 항원 항체\n\n<!-- PAGE_18 -->\n###### [\n\n<!-- PAGE_18 -->\n###### : HBV DNA, HBeAg, B\n\n<!-- PAGE_18 -->\n###### e\n\n<!-- PAGE_18 -->\n###### (antibody\n\n<!-- PAGE_18 -->\n###### to hepatitis B e antigen, anti-HBe)] 등을 고려하여야 한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_149",
      "text": "<!-- PAGE_18 -->\n###### 기타\n\n<!-- PAGE_18 -->\n###### 재발까지의 기간\n\n<!-- PAGE_18 -->\n###### 피험자의 생존율\n\n<!-- PAGE_18 -->\n###### 생존기간 등을 추가로 제시\n\n<!-- PAGE_18 -->\n###### HBsAg\n\n<!-- PAGE_18 -->\n###### ,\n\n<!-- PAGE_18 -->\n###### ,\n\n<!-- PAGE_18 -->\n###### 할 수 있다.\n\n",
      "metadata": {
        "source": "(가이드라인-005)_정맥주사용+B형간염+사람면역글로불린제제의+안전성유효성+평가+가이드라인.pdf",
        "chunk_index": 148,
        "window_size": 3,
        "char_count": 254,
        "word_count": 47,
        "page_number": 18,
        "window_text": "<!-- PAGE_17 -->\n###### 효과 평가기준\n\n<!-- PAGE_17 -->\n###### 4.4.\n\n <!-- PAGE_17 -->\n###### 정맥주사용\n\n<!-- PAGE_17 -->\n###### 의 유효성 평가는 간 이식 수술 후 혈청\n\n<!-- PAGE_17 -->\n###### 의 재발율\n\n<!-- PAGE_17 -->\n###### HBIG\n\n<!-- PAGE_17 -->\n###### HBsAg\n\n<!-- PAGE_17 -->\n###### ,\n\n<!-- PAGE_17 -->\n###### 즉\n\n<!-- PAGE_17 -->\n###### 간 이식 후\n\n<!-- PAGE_17 -->\n###### 가 음성에서 양성으로 재발한 피험자의 백분율로 설정하고\n\n<!-- PAGE_17 -->\n###### ,\n\n<!-- PAGE_17 -->\n###### HBsAg\n\n<!-- PAGE_17 -->\n###### 95% 신뢰구간을 제시하여야 한다\n\n<!-- PAGE_17 -->\n###### .\n\n <!-- PAGE_17 -->\n###### 그러나\n\n<!-- PAGE_17 -->\n###### 투여로 인해\n\n<!-- PAGE_17 -->\n###### 존재가 마스킹 될 우려가 있고\n\n<!-- PAGE_17 -->\n###### 가\n\n<!-- PAGE_17 -->\n###### HBIG\n\n<!-- PAGE_17 -->\n###### HBsAg\n\n<!-- PAGE_17 -->\n###### HBsAg\n\n<!-- PAGE_17 -->\n###### 양성이라 함은 혈중에 바이러스가 존재만 하고 염증을 일으키지 않는 상태부터 급\n\n<!-- PAGE_17 -->\n###### 성 및 만성 간염을 일으켜 심각한 문제를 야기하는 상태까지 다양하므로, HBsAg\n\n<!-- PAGE_17 -->\n###### 만으로는\n\n<!-- PAGE_17 -->\n###### 형 간염의 재발에 대하여 정확한 평가가 어려울 수 있어\n\n<!-- PAGE_17 -->\n###### 형 간염과\n\n<!-- PAGE_17 -->\n###### B\n\n<!-- PAGE_17 -->\n###### B\n\n- - 10 -\n<!-- PAGE_18 -->\n###### 관련된 혈청학적 지표 예\n\n<!-- PAGE_18 -->\n###### 형 간염\n\n<!-- PAGE_18 -->\n###### 항원 항체\n\n<!-- PAGE_18 -->\n###### [\n\n<!-- PAGE_18 -->\n###### : HBV DNA, HBeAg, B\n\n<!-- PAGE_18 -->\n###### e\n\n<!-- PAGE_18 -->\n###### (antibody\n\n<!-- PAGE_18 -->\n###### to hepatitis B e antigen, anti-HBe)] 등을 고려하여야 한다.\n\n <!-- PAGE_18 -->\n###### 기타\n\n<!-- PAGE_18 -->\n###### 재발까지의 기간\n\n<!-- PAGE_18 -->\n###### 피험자의 생존율\n\n<!-- PAGE_18 -->\n###### 생존기간 등을 추가로 제시\n\n<!-- PAGE_18 -->\n###### HBsAg\n\n<!-- PAGE_18 -->\n###### ,\n\n<!-- PAGE_18 -->\n###### ,\n\n<!-- PAGE_18 -->\n###### 할 수 있다.\n\n - - 11 -\n<!-- PAGE_19 -->\n###### .  참고문헌\n\n<!-- PAGE_19 -->\n###### Ⅵ\n\n<!-- PAGE_19 -->\n###### 1.  혈장분획제제\n\n<!-- PAGE_19 -->\n###### 품질평가\n\n<!-- PAGE_19 -->\n###### 가이드 식품의약품안전청\n\n<!-- PAGE_19 -->\n###### 행정간행물\n\n<!-- PAGE_19 -->\n###### (\n\n<!-- PAGE_19 -->\n###### 11-1470000-\n\n<!-- PAGE_19 -->\n###### 000154-01, 생물의약품평가가이드\n\n<!-- PAGE_19 -->\n###### 4), 2002\n\n<!-- PAGE_19 -->\n###### 2. ",
        "original_sentence": "<!-- PAGE_18 -->\n###### 기타\n\n<!-- PAGE_18 -->\n###### 재발까지의 기간\n\n<!-- PAGE_18 -->\n###### 피험자의 생존율\n\n<!-- PAGE_18 -->\n###### 생존기간 등을 추가로 제시\n\n<!-- PAGE_18 -->\n###### HBsAg\n\n<!-- PAGE_18 -->\n###### ,\n\n<!-- PAGE_18 -->\n###### ,\n\n<!-- PAGE_18 -->\n###### 할 수 있다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_150",
      "text": "- - 11 -\n<!-- PAGE_19 -->\n###### . ",
      "metadata": {
        "source": "(가이드라인-005)_정맥주사용+B형간염+사람면역글로불린제제의+안전성유효성+평가+가이드라인.pdf",
        "chunk_index": 149,
        "window_size": 3,
        "char_count": 35,
        "word_count": 9,
        "page_number": 19,
        "window_text": "<!-- PAGE_17 -->\n###### 정맥주사용\n\n<!-- PAGE_17 -->\n###### 의 유효성 평가는 간 이식 수술 후 혈청\n\n<!-- PAGE_17 -->\n###### 의 재발율\n\n<!-- PAGE_17 -->\n###### HBIG\n\n<!-- PAGE_17 -->\n###### HBsAg\n\n<!-- PAGE_17 -->\n###### ,\n\n<!-- PAGE_17 -->\n###### 즉\n\n<!-- PAGE_17 -->\n###### 간 이식 후\n\n<!-- PAGE_17 -->\n###### 가 음성에서 양성으로 재발한 피험자의 백분율로 설정하고\n\n<!-- PAGE_17 -->\n###### ,\n\n<!-- PAGE_17 -->\n###### HBsAg\n\n<!-- PAGE_17 -->\n###### 95% 신뢰구간을 제시하여야 한다\n\n<!-- PAGE_17 -->\n###### .\n\n <!-- PAGE_17 -->\n###### 그러나\n\n<!-- PAGE_17 -->\n###### 투여로 인해\n\n<!-- PAGE_17 -->\n###### 존재가 마스킹 될 우려가 있고\n\n<!-- PAGE_17 -->\n###### 가\n\n<!-- PAGE_17 -->\n###### HBIG\n\n<!-- PAGE_17 -->\n###### HBsAg\n\n<!-- PAGE_17 -->\n###### HBsAg\n\n<!-- PAGE_17 -->\n###### 양성이라 함은 혈중에 바이러스가 존재만 하고 염증을 일으키지 않는 상태부터 급\n\n<!-- PAGE_17 -->\n###### 성 및 만성 간염을 일으켜 심각한 문제를 야기하는 상태까지 다양하므로, HBsAg\n\n<!-- PAGE_17 -->\n###### 만으로는\n\n<!-- PAGE_17 -->\n###### 형 간염의 재발에 대하여 정확한 평가가 어려울 수 있어\n\n<!-- PAGE_17 -->\n###### 형 간염과\n\n<!-- PAGE_17 -->\n###### B\n\n<!-- PAGE_17 -->\n###### B\n\n- - 10 -\n<!-- PAGE_18 -->\n###### 관련된 혈청학적 지표 예\n\n<!-- PAGE_18 -->\n###### 형 간염\n\n<!-- PAGE_18 -->\n###### 항원 항체\n\n<!-- PAGE_18 -->\n###### [\n\n<!-- PAGE_18 -->\n###### : HBV DNA, HBeAg, B\n\n<!-- PAGE_18 -->\n###### e\n\n<!-- PAGE_18 -->\n###### (antibody\n\n<!-- PAGE_18 -->\n###### to hepatitis B e antigen, anti-HBe)] 등을 고려하여야 한다.\n\n <!-- PAGE_18 -->\n###### 기타\n\n<!-- PAGE_18 -->\n###### 재발까지의 기간\n\n<!-- PAGE_18 -->\n###### 피험자의 생존율\n\n<!-- PAGE_18 -->\n###### 생존기간 등을 추가로 제시\n\n<!-- PAGE_18 -->\n###### HBsAg\n\n<!-- PAGE_18 -->\n###### ,\n\n<!-- PAGE_18 -->\n###### ,\n\n<!-- PAGE_18 -->\n###### 할 수 있다.\n\n - - 11 -\n<!-- PAGE_19 -->\n###### .  참고문헌\n\n<!-- PAGE_19 -->\n###### Ⅵ\n\n<!-- PAGE_19 -->\n###### 1.  혈장분획제제\n\n<!-- PAGE_19 -->\n###### 품질평가\n\n<!-- PAGE_19 -->\n###### 가이드 식품의약품안전청\n\n<!-- PAGE_19 -->\n###### 행정간행물\n\n<!-- PAGE_19 -->\n###### (\n\n<!-- PAGE_19 -->\n###### 11-1470000-\n\n<!-- PAGE_19 -->\n###### 000154-01, 생물의약품평가가이드\n\n<!-- PAGE_19 -->\n###### 4), 2002\n\n<!-- PAGE_19 -->\n###### 2.  Note\n\n<!-- PAGE_19 -->\n###### for\n\n<!-- PAGE_19 -->\n###### Guidance\n\n<!-- PAGE_19 -->\n###### on\n\n<!-- PAGE_19 -->\n###### Plasma-Derived\n\n<!-- PAGE_19 -->\n###### Medicinal\n\n<!-- PAGE_19 -->\n###### Products(CPMP/BWP/\n\n<!-- PAGE_19 -->\n###### 3. ",
        "original_sentence": "- - 11 -\n<!-- PAGE_19 -->\n###### . "
      }
    },
    {
      "chunk_id": "chunk_151",
      "text": "참고문헌\n\n<!-- PAGE_19 -->\n###### Ⅵ\n\n<!-- PAGE_19 -->\n###### 1. ",
      "metadata": {
        "source": "(가이드라인-005)_정맥주사용+B형간염+사람면역글로불린제제의+안전성유효성+평가+가이드라인.pdf",
        "chunk_index": 150,
        "window_size": 3,
        "char_count": 60,
        "word_count": 11,
        "page_number": 19,
        "window_text": "<!-- PAGE_17 -->\n###### 그러나\n\n<!-- PAGE_17 -->\n###### 투여로 인해\n\n<!-- PAGE_17 -->\n###### 존재가 마스킹 될 우려가 있고\n\n<!-- PAGE_17 -->\n###### 가\n\n<!-- PAGE_17 -->\n###### HBIG\n\n<!-- PAGE_17 -->\n###### HBsAg\n\n<!-- PAGE_17 -->\n###### HBsAg\n\n<!-- PAGE_17 -->\n###### 양성이라 함은 혈중에 바이러스가 존재만 하고 염증을 일으키지 않는 상태부터 급\n\n<!-- PAGE_17 -->\n###### 성 및 만성 간염을 일으켜 심각한 문제를 야기하는 상태까지 다양하므로, HBsAg\n\n<!-- PAGE_17 -->\n###### 만으로는\n\n<!-- PAGE_17 -->\n###### 형 간염의 재발에 대하여 정확한 평가가 어려울 수 있어\n\n<!-- PAGE_17 -->\n###### 형 간염과\n\n<!-- PAGE_17 -->\n###### B\n\n<!-- PAGE_17 -->\n###### B\n\n- - 10 -\n<!-- PAGE_18 -->\n###### 관련된 혈청학적 지표 예\n\n<!-- PAGE_18 -->\n###### 형 간염\n\n<!-- PAGE_18 -->\n###### 항원 항체\n\n<!-- PAGE_18 -->\n###### [\n\n<!-- PAGE_18 -->\n###### : HBV DNA, HBeAg, B\n\n<!-- PAGE_18 -->\n###### e\n\n<!-- PAGE_18 -->\n###### (antibody\n\n<!-- PAGE_18 -->\n###### to hepatitis B e antigen, anti-HBe)] 등을 고려하여야 한다.\n\n <!-- PAGE_18 -->\n###### 기타\n\n<!-- PAGE_18 -->\n###### 재발까지의 기간\n\n<!-- PAGE_18 -->\n###### 피험자의 생존율\n\n<!-- PAGE_18 -->\n###### 생존기간 등을 추가로 제시\n\n<!-- PAGE_18 -->\n###### HBsAg\n\n<!-- PAGE_18 -->\n###### ,\n\n<!-- PAGE_18 -->\n###### ,\n\n<!-- PAGE_18 -->\n###### 할 수 있다.\n\n - - 11 -\n<!-- PAGE_19 -->\n###### .  참고문헌\n\n<!-- PAGE_19 -->\n###### Ⅵ\n\n<!-- PAGE_19 -->\n###### 1.  혈장분획제제\n\n<!-- PAGE_19 -->\n###### 품질평가\n\n<!-- PAGE_19 -->\n###### 가이드 식품의약품안전청\n\n<!-- PAGE_19 -->\n###### 행정간행물\n\n<!-- PAGE_19 -->\n###### (\n\n<!-- PAGE_19 -->\n###### 11-1470000-\n\n<!-- PAGE_19 -->\n###### 000154-01, 생물의약품평가가이드\n\n<!-- PAGE_19 -->\n###### 4), 2002\n\n<!-- PAGE_19 -->\n###### 2.  Note\n\n<!-- PAGE_19 -->\n###### for\n\n<!-- PAGE_19 -->\n###### Guidance\n\n<!-- PAGE_19 -->\n###### on\n\n<!-- PAGE_19 -->\n###### Plasma-Derived\n\n<!-- PAGE_19 -->\n###### Medicinal\n\n<!-- PAGE_19 -->\n###### Products(CPMP/BWP/\n\n<!-- PAGE_19 -->\n###### 3.  분획용 혈장 마스터 파일 가이드라인 식품의약품안전청 행정간행물\n\n<!-- PAGE_19 -->\n###### (\n\n<!-- PAGE_19 -->\n###### 11-1470000\n\n<!-- PAGE_19 -->\n###### 4. ",
        "original_sentence": "참고문헌\n\n<!-- PAGE_19 -->\n###### Ⅵ\n\n<!-- PAGE_19 -->\n###### 1. "
      }
    },
    {
      "chunk_id": "chunk_152",
      "text": "혈장분획제제\n\n<!-- PAGE_19 -->\n###### 품질평가\n\n<!-- PAGE_19 -->\n###### 가이드 식품의약품안전청\n\n<!-- PAGE_19 -->\n###### 행정간행물\n\n<!-- PAGE_19 -->\n###### (\n\n<!-- PAGE_19 -->\n###### 11-1470000-\n\n<!-- PAGE_19 -->\n###### 000154-01, 생물의약품평가가이드\n\n<!-- PAGE_19 -->\n###### 4), 2002\n\n<!-- PAGE_19 -->\n###### 2. ",
      "metadata": {
        "source": "(가이드라인-005)_정맥주사용+B형간염+사람면역글로불린제제의+안전성유효성+평가+가이드라인.pdf",
        "chunk_index": 151,
        "window_size": 3,
        "char_count": 279,
        "word_count": 44,
        "page_number": 19,
        "window_text": "<!-- PAGE_18 -->\n###### 기타\n\n<!-- PAGE_18 -->\n###### 재발까지의 기간\n\n<!-- PAGE_18 -->\n###### 피험자의 생존율\n\n<!-- PAGE_18 -->\n###### 생존기간 등을 추가로 제시\n\n<!-- PAGE_18 -->\n###### HBsAg\n\n<!-- PAGE_18 -->\n###### ,\n\n<!-- PAGE_18 -->\n###### ,\n\n<!-- PAGE_18 -->\n###### 할 수 있다.\n\n - - 11 -\n<!-- PAGE_19 -->\n###### .  참고문헌\n\n<!-- PAGE_19 -->\n###### Ⅵ\n\n<!-- PAGE_19 -->\n###### 1.  혈장분획제제\n\n<!-- PAGE_19 -->\n###### 품질평가\n\n<!-- PAGE_19 -->\n###### 가이드 식품의약품안전청\n\n<!-- PAGE_19 -->\n###### 행정간행물\n\n<!-- PAGE_19 -->\n###### (\n\n<!-- PAGE_19 -->\n###### 11-1470000-\n\n<!-- PAGE_19 -->\n###### 000154-01, 생물의약품평가가이드\n\n<!-- PAGE_19 -->\n###### 4), 2002\n\n<!-- PAGE_19 -->\n###### 2.  Note\n\n<!-- PAGE_19 -->\n###### for\n\n<!-- PAGE_19 -->\n###### Guidance\n\n<!-- PAGE_19 -->\n###### on\n\n<!-- PAGE_19 -->\n###### Plasma-Derived\n\n<!-- PAGE_19 -->\n###### Medicinal\n\n<!-- PAGE_19 -->\n###### Products(CPMP/BWP/\n\n<!-- PAGE_19 -->\n###### 3.  분획용 혈장 마스터 파일 가이드라인 식품의약품안전청 행정간행물\n\n<!-- PAGE_19 -->\n###### (\n\n<!-- PAGE_19 -->\n###### 11-1470000\n\n<!-- PAGE_19 -->\n###### 4.  혈장분획제제\n\n<!-- PAGE_19 -->\n###### 등\n\n<!-- PAGE_19 -->\n###### 바이러스\n\n<!-- PAGE_19 -->\n###### 검증\n\n<!-- PAGE_19 -->\n###### 평가가이드 식품의약품안전청\n\n<!-- PAGE_19 -->\n###### 행정간행물\n\n<!-- PAGE_19 -->\n###### (\n\n<!-- PAGE_19 -->\n###### 11-\n\n<!-- PAGE_19 -->\n###### 5. ",
        "original_sentence": "혈장분획제제\n\n<!-- PAGE_19 -->\n###### 품질평가\n\n<!-- PAGE_19 -->\n###### 가이드 식품의약품안전청\n\n<!-- PAGE_19 -->\n###### 행정간행물\n\n<!-- PAGE_19 -->\n###### (\n\n<!-- PAGE_19 -->\n###### 11-1470000-\n\n<!-- PAGE_19 -->\n###### 000154-01, 생물의약품평가가이드\n\n<!-- PAGE_19 -->\n###### 4), 2002\n\n<!-- PAGE_19 -->\n###### 2. "
      }
    },
    {
      "chunk_id": "chunk_153",
      "text": "Note\n\n<!-- PAGE_19 -->\n###### for\n\n<!-- PAGE_19 -->\n###### Guidance\n\n<!-- PAGE_19 -->\n###### on\n\n<!-- PAGE_19 -->\n###### Plasma-Derived\n\n<!-- PAGE_19 -->\n###### Medicinal\n\n<!-- PAGE_19 -->\n###### Products(CPMP/BWP/\n\n<!-- PAGE_19 -->\n###### 3. ",
      "metadata": {
        "source": "(가이드라인-005)_정맥주사용+B형간염+사람면역글로불린제제의+안전성유효성+평가+가이드라인.pdf",
        "chunk_index": 152,
        "window_size": 3,
        "char_count": 243,
        "word_count": 36,
        "page_number": 19,
        "window_text": "- - 11 -\n<!-- PAGE_19 -->\n###### .  참고문헌\n\n<!-- PAGE_19 -->\n###### Ⅵ\n\n<!-- PAGE_19 -->\n###### 1.  혈장분획제제\n\n<!-- PAGE_19 -->\n###### 품질평가\n\n<!-- PAGE_19 -->\n###### 가이드 식품의약품안전청\n\n<!-- PAGE_19 -->\n###### 행정간행물\n\n<!-- PAGE_19 -->\n###### (\n\n<!-- PAGE_19 -->\n###### 11-1470000-\n\n<!-- PAGE_19 -->\n###### 000154-01, 생물의약품평가가이드\n\n<!-- PAGE_19 -->\n###### 4), 2002\n\n<!-- PAGE_19 -->\n###### 2.  Note\n\n<!-- PAGE_19 -->\n###### for\n\n<!-- PAGE_19 -->\n###### Guidance\n\n<!-- PAGE_19 -->\n###### on\n\n<!-- PAGE_19 -->\n###### Plasma-Derived\n\n<!-- PAGE_19 -->\n###### Medicinal\n\n<!-- PAGE_19 -->\n###### Products(CPMP/BWP/\n\n<!-- PAGE_19 -->\n###### 3.  분획용 혈장 마스터 파일 가이드라인 식품의약품안전청 행정간행물\n\n<!-- PAGE_19 -->\n###### (\n\n<!-- PAGE_19 -->\n###### 11-1470000\n\n<!-- PAGE_19 -->\n###### 4.  혈장분획제제\n\n<!-- PAGE_19 -->\n###### 등\n\n<!-- PAGE_19 -->\n###### 바이러스\n\n<!-- PAGE_19 -->\n###### 검증\n\n<!-- PAGE_19 -->\n###### 평가가이드 식품의약품안전청\n\n<!-- PAGE_19 -->\n###### 행정간행물\n\n<!-- PAGE_19 -->\n###### (\n\n<!-- PAGE_19 -->\n###### 11-\n\n<!-- PAGE_19 -->\n###### 5.  Note for Guidance on Virus Validation Studies: The Design, Contribution and\n\n<!-- PAGE_19 -->\n###### Interpretation of Studies Validating the Inactivation and Removal of Viruses\n\n<!-- PAGE_19 -->\n###### 6. ",
        "original_sentence": "Note\n\n<!-- PAGE_19 -->\n###### for\n\n<!-- PAGE_19 -->\n###### Guidance\n\n<!-- PAGE_19 -->\n###### on\n\n<!-- PAGE_19 -->\n###### Plasma-Derived\n\n<!-- PAGE_19 -->\n###### Medicinal\n\n<!-- PAGE_19 -->\n###### Products(CPMP/BWP/\n\n<!-- PAGE_19 -->\n###### 3. "
      }
    },
    {
      "chunk_id": "chunk_154",
      "text": "분획용 혈장 마스터 파일 가이드라인 식품의약품안전청 행정간행물\n\n<!-- PAGE_19 -->\n###### (\n\n<!-- PAGE_19 -->\n###### 11-1470000\n\n<!-- PAGE_19 -->\n###### 4. ",
      "metadata": {
        "source": "(가이드라인-005)_정맥주사용+B형간염+사람면역글로불린제제의+안전성유효성+평가+가이드라인.pdf",
        "chunk_index": 153,
        "window_size": 3,
        "char_count": 126,
        "word_count": 22,
        "page_number": 19,
        "window_text": "참고문헌\n\n<!-- PAGE_19 -->\n###### Ⅵ\n\n<!-- PAGE_19 -->\n###### 1.  혈장분획제제\n\n<!-- PAGE_19 -->\n###### 품질평가\n\n<!-- PAGE_19 -->\n###### 가이드 식품의약품안전청\n\n<!-- PAGE_19 -->\n###### 행정간행물\n\n<!-- PAGE_19 -->\n###### (\n\n<!-- PAGE_19 -->\n###### 11-1470000-\n\n<!-- PAGE_19 -->\n###### 000154-01, 생물의약품평가가이드\n\n<!-- PAGE_19 -->\n###### 4), 2002\n\n<!-- PAGE_19 -->\n###### 2.  Note\n\n<!-- PAGE_19 -->\n###### for\n\n<!-- PAGE_19 -->\n###### Guidance\n\n<!-- PAGE_19 -->\n###### on\n\n<!-- PAGE_19 -->\n###### Plasma-Derived\n\n<!-- PAGE_19 -->\n###### Medicinal\n\n<!-- PAGE_19 -->\n###### Products(CPMP/BWP/\n\n<!-- PAGE_19 -->\n###### 3.  분획용 혈장 마스터 파일 가이드라인 식품의약품안전청 행정간행물\n\n<!-- PAGE_19 -->\n###### (\n\n<!-- PAGE_19 -->\n###### 11-1470000\n\n<!-- PAGE_19 -->\n###### 4.  혈장분획제제\n\n<!-- PAGE_19 -->\n###### 등\n\n<!-- PAGE_19 -->\n###### 바이러스\n\n<!-- PAGE_19 -->\n###### 검증\n\n<!-- PAGE_19 -->\n###### 평가가이드 식품의약품안전청\n\n<!-- PAGE_19 -->\n###### 행정간행물\n\n<!-- PAGE_19 -->\n###### (\n\n<!-- PAGE_19 -->\n###### 11-\n\n<!-- PAGE_19 -->\n###### 5.  Note for Guidance on Virus Validation Studies: The Design, Contribution and\n\n<!-- PAGE_19 -->\n###### Interpretation of Studies Validating the Inactivation and Removal of Viruses\n\n<!-- PAGE_19 -->\n###### 6.  Guideline\n\n<!-- PAGE_19 -->\n###### on\n\n<!-- PAGE_19 -->\n###### the\n\n<!-- PAGE_19 -->\n###### Clinical\n\n<!-- PAGE_19 -->\n###### Evaluation\n\n<!-- PAGE_19 -->\n###### of\n\n<!-- PAGE_19 -->\n###### Medicinal\n\n<!-- PAGE_19 -->\n###### Products\n\n<!-- PAGE_19 -->\n###### Intended\n\n<!-- PAGE_19 -->\n###### for\n\n<!-- PAGE_19 -->\n###### 7. ",
        "original_sentence": "분획용 혈장 마스터 파일 가이드라인 식품의약품안전청 행정간행물\n\n<!-- PAGE_19 -->\n###### (\n\n<!-- PAGE_19 -->\n###### 11-1470000\n\n<!-- PAGE_19 -->\n###### 4. "
      }
    },
    {
      "chunk_id": "chunk_155",
      "text": "혈장분획제제\n\n<!-- PAGE_19 -->\n###### 등\n\n<!-- PAGE_19 -->\n###### 바이러스\n\n<!-- PAGE_19 -->\n###### 검증\n\n<!-- PAGE_19 -->\n###### 평가가이드 식품의약품안전청\n\n<!-- PAGE_19 -->\n###### 행정간행물\n\n<!-- PAGE_19 -->\n###### (\n\n<!-- PAGE_19 -->\n###### 11-\n\n<!-- PAGE_19 -->\n###### 5. ",
      "metadata": {
        "source": "(가이드라인-005)_정맥주사용+B형간염+사람면역글로불린제제의+안전성유효성+평가+가이드라인.pdf",
        "chunk_index": 154,
        "window_size": 3,
        "char_count": 247,
        "word_count": 42,
        "page_number": 19,
        "window_text": "혈장분획제제\n\n<!-- PAGE_19 -->\n###### 품질평가\n\n<!-- PAGE_19 -->\n###### 가이드 식품의약품안전청\n\n<!-- PAGE_19 -->\n###### 행정간행물\n\n<!-- PAGE_19 -->\n###### (\n\n<!-- PAGE_19 -->\n###### 11-1470000-\n\n<!-- PAGE_19 -->\n###### 000154-01, 생물의약품평가가이드\n\n<!-- PAGE_19 -->\n###### 4), 2002\n\n<!-- PAGE_19 -->\n###### 2.  Note\n\n<!-- PAGE_19 -->\n###### for\n\n<!-- PAGE_19 -->\n###### Guidance\n\n<!-- PAGE_19 -->\n###### on\n\n<!-- PAGE_19 -->\n###### Plasma-Derived\n\n<!-- PAGE_19 -->\n###### Medicinal\n\n<!-- PAGE_19 -->\n###### Products(CPMP/BWP/\n\n<!-- PAGE_19 -->\n###### 3.  분획용 혈장 마스터 파일 가이드라인 식품의약품안전청 행정간행물\n\n<!-- PAGE_19 -->\n###### (\n\n<!-- PAGE_19 -->\n###### 11-1470000\n\n<!-- PAGE_19 -->\n###### 4.  혈장분획제제\n\n<!-- PAGE_19 -->\n###### 등\n\n<!-- PAGE_19 -->\n###### 바이러스\n\n<!-- PAGE_19 -->\n###### 검증\n\n<!-- PAGE_19 -->\n###### 평가가이드 식품의약품안전청\n\n<!-- PAGE_19 -->\n###### 행정간행물\n\n<!-- PAGE_19 -->\n###### (\n\n<!-- PAGE_19 -->\n###### 11-\n\n<!-- PAGE_19 -->\n###### 5.  Note for Guidance on Virus Validation Studies: The Design, Contribution and\n\n<!-- PAGE_19 -->\n###### Interpretation of Studies Validating the Inactivation and Removal of Viruses\n\n<!-- PAGE_19 -->\n###### 6.  Guideline\n\n<!-- PAGE_19 -->\n###### on\n\n<!-- PAGE_19 -->\n###### the\n\n<!-- PAGE_19 -->\n###### Clinical\n\n<!-- PAGE_19 -->\n###### Evaluation\n\n<!-- PAGE_19 -->\n###### of\n\n<!-- PAGE_19 -->\n###### Medicinal\n\n<!-- PAGE_19 -->\n###### Products\n\n<!-- PAGE_19 -->\n###### Intended\n\n<!-- PAGE_19 -->\n###### for\n\n<!-- PAGE_19 -->\n###### 7.  Note\n\n<!-- PAGE_19 -->\n###### For\n\n<!-- PAGE_19 -->\n###### Guidance\n\n<!-- PAGE_19 -->\n###### on\n\n<!-- PAGE_19 -->\n###### the\n\n<!-- PAGE_19 -->\n###### Clinical\n\n<!-- PAGE_19 -->\n###### Investigation\n\n<!-- PAGE_19 -->\n###### of\n\n<!-- PAGE_19 -->\n###### Human\n\n<!-- PAGE_19 -->\n###### Normal\n\n<!-- PAGE_19 -->\n###### Immunoglobulin for Intravenous Administration(IVIg)(CPMP/BPWG/388/95 rev.\n\n",
        "original_sentence": "혈장분획제제\n\n<!-- PAGE_19 -->\n###### 등\n\n<!-- PAGE_19 -->\n###### 바이러스\n\n<!-- PAGE_19 -->\n###### 검증\n\n<!-- PAGE_19 -->\n###### 평가가이드 식품의약품안전청\n\n<!-- PAGE_19 -->\n###### 행정간행물\n\n<!-- PAGE_19 -->\n###### (\n\n<!-- PAGE_19 -->\n###### 11-\n\n<!-- PAGE_19 -->\n###### 5. "
      }
    },
    {
      "chunk_id": "chunk_156",
      "text": "Note for Guidance on Virus Validation Studies: The Design, Contribution and\n\n<!-- PAGE_19 -->\n###### Interpretation of Studies Validating the Inactivation and Removal of Viruses\n\n<!-- PAGE_19 -->\n###### 6. ",
      "metadata": {
        "source": "(가이드라인-005)_정맥주사용+B형간염+사람면역글로불린제제의+안전성유효성+평가+가이드라인.pdf",
        "chunk_index": 155,
        "window_size": 3,
        "char_count": 206,
        "word_count": 30,
        "page_number": 19,
        "window_text": "Note\n\n<!-- PAGE_19 -->\n###### for\n\n<!-- PAGE_19 -->\n###### Guidance\n\n<!-- PAGE_19 -->\n###### on\n\n<!-- PAGE_19 -->\n###### Plasma-Derived\n\n<!-- PAGE_19 -->\n###### Medicinal\n\n<!-- PAGE_19 -->\n###### Products(CPMP/BWP/\n\n<!-- PAGE_19 -->\n###### 3.  분획용 혈장 마스터 파일 가이드라인 식품의약품안전청 행정간행물\n\n<!-- PAGE_19 -->\n###### (\n\n<!-- PAGE_19 -->\n###### 11-1470000\n\n<!-- PAGE_19 -->\n###### 4.  혈장분획제제\n\n<!-- PAGE_19 -->\n###### 등\n\n<!-- PAGE_19 -->\n###### 바이러스\n\n<!-- PAGE_19 -->\n###### 검증\n\n<!-- PAGE_19 -->\n###### 평가가이드 식품의약품안전청\n\n<!-- PAGE_19 -->\n###### 행정간행물\n\n<!-- PAGE_19 -->\n###### (\n\n<!-- PAGE_19 -->\n###### 11-\n\n<!-- PAGE_19 -->\n###### 5.  Note for Guidance on Virus Validation Studies: The Design, Contribution and\n\n<!-- PAGE_19 -->\n###### Interpretation of Studies Validating the Inactivation and Removal of Viruses\n\n<!-- PAGE_19 -->\n###### 6.  Guideline\n\n<!-- PAGE_19 -->\n###### on\n\n<!-- PAGE_19 -->\n###### the\n\n<!-- PAGE_19 -->\n###### Clinical\n\n<!-- PAGE_19 -->\n###### Evaluation\n\n<!-- PAGE_19 -->\n###### of\n\n<!-- PAGE_19 -->\n###### Medicinal\n\n<!-- PAGE_19 -->\n###### Products\n\n<!-- PAGE_19 -->\n###### Intended\n\n<!-- PAGE_19 -->\n###### for\n\n<!-- PAGE_19 -->\n###### 7.  Note\n\n<!-- PAGE_19 -->\n###### For\n\n<!-- PAGE_19 -->\n###### Guidance\n\n<!-- PAGE_19 -->\n###### on\n\n<!-- PAGE_19 -->\n###### the\n\n<!-- PAGE_19 -->\n###### Clinical\n\n<!-- PAGE_19 -->\n###### Investigation\n\n<!-- PAGE_19 -->\n###### of\n\n<!-- PAGE_19 -->\n###### Human\n\n<!-- PAGE_19 -->\n###### Normal\n\n<!-- PAGE_19 -->\n###### Immunoglobulin for Intravenous Administration(IVIg)(CPMP/BPWG/388/95 rev.\n\n <!-- PAGE_19 -->\n###### 8. ",
        "original_sentence": "Note for Guidance on Virus Validation Studies: The Design, Contribution and\n\n<!-- PAGE_19 -->\n###### Interpretation of Studies Validating the Inactivation and Removal of Viruses\n\n<!-- PAGE_19 -->\n###### 6. "
      }
    },
    {
      "chunk_id": "chunk_157",
      "text": "Guideline\n\n<!-- PAGE_19 -->\n###### on\n\n<!-- PAGE_19 -->\n###### the\n\n<!-- PAGE_19 -->\n###### Clinical\n\n<!-- PAGE_19 -->\n###### Evaluation\n\n<!-- PAGE_19 -->\n###### of\n\n<!-- PAGE_19 -->\n###### Medicinal\n\n<!-- PAGE_19 -->\n###### Products\n\n<!-- PAGE_19 -->\n###### Intended\n\n<!-- PAGE_19 -->\n###### for\n\n<!-- PAGE_19 -->\n###### 7. ",
      "metadata": {
        "source": "(가이드라인-005)_정맥주사용+B형간염+사람면역글로불린제제의+안전성유효성+평가+가이드라인.pdf",
        "chunk_index": 156,
        "window_size": 3,
        "char_count": 325,
        "word_count": 51,
        "page_number": 19,
        "window_text": "분획용 혈장 마스터 파일 가이드라인 식품의약품안전청 행정간행물\n\n<!-- PAGE_19 -->\n###### (\n\n<!-- PAGE_19 -->\n###### 11-1470000\n\n<!-- PAGE_19 -->\n###### 4.  혈장분획제제\n\n<!-- PAGE_19 -->\n###### 등\n\n<!-- PAGE_19 -->\n###### 바이러스\n\n<!-- PAGE_19 -->\n###### 검증\n\n<!-- PAGE_19 -->\n###### 평가가이드 식품의약품안전청\n\n<!-- PAGE_19 -->\n###### 행정간행물\n\n<!-- PAGE_19 -->\n###### (\n\n<!-- PAGE_19 -->\n###### 11-\n\n<!-- PAGE_19 -->\n###### 5.  Note for Guidance on Virus Validation Studies: The Design, Contribution and\n\n<!-- PAGE_19 -->\n###### Interpretation of Studies Validating the Inactivation and Removal of Viruses\n\n<!-- PAGE_19 -->\n###### 6.  Guideline\n\n<!-- PAGE_19 -->\n###### on\n\n<!-- PAGE_19 -->\n###### the\n\n<!-- PAGE_19 -->\n###### Clinical\n\n<!-- PAGE_19 -->\n###### Evaluation\n\n<!-- PAGE_19 -->\n###### of\n\n<!-- PAGE_19 -->\n###### Medicinal\n\n<!-- PAGE_19 -->\n###### Products\n\n<!-- PAGE_19 -->\n###### Intended\n\n<!-- PAGE_19 -->\n###### for\n\n<!-- PAGE_19 -->\n###### 7.  Note\n\n<!-- PAGE_19 -->\n###### For\n\n<!-- PAGE_19 -->\n###### Guidance\n\n<!-- PAGE_19 -->\n###### on\n\n<!-- PAGE_19 -->\n###### the\n\n<!-- PAGE_19 -->\n###### Clinical\n\n<!-- PAGE_19 -->\n###### Investigation\n\n<!-- PAGE_19 -->\n###### of\n\n<!-- PAGE_19 -->\n###### Human\n\n<!-- PAGE_19 -->\n###### Normal\n\n<!-- PAGE_19 -->\n###### Immunoglobulin for Intravenous Administration(IVIg)(CPMP/BPWG/388/95 rev.\n\n <!-- PAGE_19 -->\n###### 8.  Note\n\n<!-- PAGE_19 -->\n###### For\n\n<!-- PAGE_19 -->\n###### Guidance\n\n<!-- PAGE_19 -->\n###### on\n\n<!-- PAGE_19 -->\n###### the\n\n<!-- PAGE_19 -->\n###### Clinical\n\n<!-- PAGE_19 -->\n###### Investigation\n\n<!-- PAGE_19 -->\n###### of\n\n<!-- PAGE_19 -->\n###### Human\n\n<!-- PAGE_19 -->\n###### Normal\n\n<!-- PAGE_19 -->\n###### Immunoglobulin for Subcutaneous and Intramuscular Use(CPMP/BPWG/283/\n\n<!-- PAGE_19 -->\n###### 00), EMEA, 2003\n\n<!-- PAGE_19 -->\n###### 9. ",
        "original_sentence": "Guideline\n\n<!-- PAGE_19 -->\n###### on\n\n<!-- PAGE_19 -->\n###### the\n\n<!-- PAGE_19 -->\n###### Clinical\n\n<!-- PAGE_19 -->\n###### Evaluation\n\n<!-- PAGE_19 -->\n###### of\n\n<!-- PAGE_19 -->\n###### Medicinal\n\n<!-- PAGE_19 -->\n###### Products\n\n<!-- PAGE_19 -->\n###### Intended\n\n<!-- PAGE_19 -->\n###### for\n\n<!-- PAGE_19 -->\n###### 7. "
      }
    },
    {
      "chunk_id": "chunk_158",
      "text": "Note\n\n<!-- PAGE_19 -->\n###### For\n\n<!-- PAGE_19 -->\n###### Guidance\n\n<!-- PAGE_19 -->\n###### on\n\n<!-- PAGE_19 -->\n###### the\n\n<!-- PAGE_19 -->\n###### Clinical\n\n<!-- PAGE_19 -->\n###### Investigation\n\n<!-- PAGE_19 -->\n###### of\n\n<!-- PAGE_19 -->\n###### Human\n\n<!-- PAGE_19 -->\n###### Normal\n\n<!-- PAGE_19 -->\n###### Immunoglobulin for Intravenous Administration(IVIg)(CPMP/BPWG/388/95 rev.\n\n",
      "metadata": {
        "source": "(가이드라인-005)_정맥주사용+B형간염+사람면역글로불린제제의+안전성유효성+평가+가이드라인.pdf",
        "chunk_index": 157,
        "window_size": 3,
        "char_count": 389,
        "word_count": 55,
        "page_number": 19,
        "window_text": "혈장분획제제\n\n<!-- PAGE_19 -->\n###### 등\n\n<!-- PAGE_19 -->\n###### 바이러스\n\n<!-- PAGE_19 -->\n###### 검증\n\n<!-- PAGE_19 -->\n###### 평가가이드 식품의약품안전청\n\n<!-- PAGE_19 -->\n###### 행정간행물\n\n<!-- PAGE_19 -->\n###### (\n\n<!-- PAGE_19 -->\n###### 11-\n\n<!-- PAGE_19 -->\n###### 5.  Note for Guidance on Virus Validation Studies: The Design, Contribution and\n\n<!-- PAGE_19 -->\n###### Interpretation of Studies Validating the Inactivation and Removal of Viruses\n\n<!-- PAGE_19 -->\n###### 6.  Guideline\n\n<!-- PAGE_19 -->\n###### on\n\n<!-- PAGE_19 -->\n###### the\n\n<!-- PAGE_19 -->\n###### Clinical\n\n<!-- PAGE_19 -->\n###### Evaluation\n\n<!-- PAGE_19 -->\n###### of\n\n<!-- PAGE_19 -->\n###### Medicinal\n\n<!-- PAGE_19 -->\n###### Products\n\n<!-- PAGE_19 -->\n###### Intended\n\n<!-- PAGE_19 -->\n###### for\n\n<!-- PAGE_19 -->\n###### 7.  Note\n\n<!-- PAGE_19 -->\n###### For\n\n<!-- PAGE_19 -->\n###### Guidance\n\n<!-- PAGE_19 -->\n###### on\n\n<!-- PAGE_19 -->\n###### the\n\n<!-- PAGE_19 -->\n###### Clinical\n\n<!-- PAGE_19 -->\n###### Investigation\n\n<!-- PAGE_19 -->\n###### of\n\n<!-- PAGE_19 -->\n###### Human\n\n<!-- PAGE_19 -->\n###### Normal\n\n<!-- PAGE_19 -->\n###### Immunoglobulin for Intravenous Administration(IVIg)(CPMP/BPWG/388/95 rev.\n\n <!-- PAGE_19 -->\n###### 8.  Note\n\n<!-- PAGE_19 -->\n###### For\n\n<!-- PAGE_19 -->\n###### Guidance\n\n<!-- PAGE_19 -->\n###### on\n\n<!-- PAGE_19 -->\n###### the\n\n<!-- PAGE_19 -->\n###### Clinical\n\n<!-- PAGE_19 -->\n###### Investigation\n\n<!-- PAGE_19 -->\n###### of\n\n<!-- PAGE_19 -->\n###### Human\n\n<!-- PAGE_19 -->\n###### Normal\n\n<!-- PAGE_19 -->\n###### Immunoglobulin for Subcutaneous and Intramuscular Use(CPMP/BPWG/283/\n\n<!-- PAGE_19 -->\n###### 00), EMEA, 2003\n\n<!-- PAGE_19 -->\n###### 9.  Safety,\n\n<!-- PAGE_19 -->\n###### Efficacy,\n\n<!-- PAGE_19 -->\n###### and\n\n<!-- PAGE_19 -->\n###### Pharmacokinetic\n\n<!-- PAGE_19 -->\n###### Studies\n\n<!-- PAGE_19 -->\n###### to\n\n<!-- PAGE_19 -->\n###### Support\n\n<!-- PAGE_19 -->\n###### Marketing\n\n<!-- PAGE_19 -->\n###### of\n\n<!-- PAGE_19 -->\n###### Immune Globulin Intravenous(Human)\n\n<!-- PAGE_19 -->\n###### as Replacement Therapy\n\n<!-- PAGE_19 -->\n###### for Primary\n\n<!-- PAGE_19 -->\n###### Humoral Immunodeficiency, CBER, FDA, 2008\n\n<!-- PAGE_19 -->\n###### 10. ",
        "original_sentence": "Note\n\n<!-- PAGE_19 -->\n###### For\n\n<!-- PAGE_19 -->\n###### Guidance\n\n<!-- PAGE_19 -->\n###### on\n\n<!-- PAGE_19 -->\n###### the\n\n<!-- PAGE_19 -->\n###### Clinical\n\n<!-- PAGE_19 -->\n###### Investigation\n\n<!-- PAGE_19 -->\n###### of\n\n<!-- PAGE_19 -->\n###### Human\n\n<!-- PAGE_19 -->\n###### Normal\n\n<!-- PAGE_19 -->\n###### Immunoglobulin for Intravenous Administration(IVIg)(CPMP/BPWG/388/95 rev.\n\n"
      }
    },
    {
      "chunk_id": "chunk_159",
      "text": "<!-- PAGE_19 -->\n###### 8. ",
      "metadata": {
        "source": "(가이드라인-005)_정맥주사용+B형간염+사람면역글로불린제제의+안전성유효성+평가+가이드라인.pdf",
        "chunk_index": 158,
        "window_size": 3,
        "char_count": 27,
        "word_count": 5,
        "page_number": 19,
        "window_text": "Note for Guidance on Virus Validation Studies: The Design, Contribution and\n\n<!-- PAGE_19 -->\n###### Interpretation of Studies Validating the Inactivation and Removal of Viruses\n\n<!-- PAGE_19 -->\n###### 6.  Guideline\n\n<!-- PAGE_19 -->\n###### on\n\n<!-- PAGE_19 -->\n###### the\n\n<!-- PAGE_19 -->\n###### Clinical\n\n<!-- PAGE_19 -->\n###### Evaluation\n\n<!-- PAGE_19 -->\n###### of\n\n<!-- PAGE_19 -->\n###### Medicinal\n\n<!-- PAGE_19 -->\n###### Products\n\n<!-- PAGE_19 -->\n###### Intended\n\n<!-- PAGE_19 -->\n###### for\n\n<!-- PAGE_19 -->\n###### 7.  Note\n\n<!-- PAGE_19 -->\n###### For\n\n<!-- PAGE_19 -->\n###### Guidance\n\n<!-- PAGE_19 -->\n###### on\n\n<!-- PAGE_19 -->\n###### the\n\n<!-- PAGE_19 -->\n###### Clinical\n\n<!-- PAGE_19 -->\n###### Investigation\n\n<!-- PAGE_19 -->\n###### of\n\n<!-- PAGE_19 -->\n###### Human\n\n<!-- PAGE_19 -->\n###### Normal\n\n<!-- PAGE_19 -->\n###### Immunoglobulin for Intravenous Administration(IVIg)(CPMP/BPWG/388/95 rev.\n\n <!-- PAGE_19 -->\n###### 8.  Note\n\n<!-- PAGE_19 -->\n###### For\n\n<!-- PAGE_19 -->\n###### Guidance\n\n<!-- PAGE_19 -->\n###### on\n\n<!-- PAGE_19 -->\n###### the\n\n<!-- PAGE_19 -->\n###### Clinical\n\n<!-- PAGE_19 -->\n###### Investigation\n\n<!-- PAGE_19 -->\n###### of\n\n<!-- PAGE_19 -->\n###### Human\n\n<!-- PAGE_19 -->\n###### Normal\n\n<!-- PAGE_19 -->\n###### Immunoglobulin for Subcutaneous and Intramuscular Use(CPMP/BPWG/283/\n\n<!-- PAGE_19 -->\n###### 00), EMEA, 2003\n\n<!-- PAGE_19 -->\n###### 9.  Safety,\n\n<!-- PAGE_19 -->\n###### Efficacy,\n\n<!-- PAGE_19 -->\n###### and\n\n<!-- PAGE_19 -->\n###### Pharmacokinetic\n\n<!-- PAGE_19 -->\n###### Studies\n\n<!-- PAGE_19 -->\n###### to\n\n<!-- PAGE_19 -->\n###### Support\n\n<!-- PAGE_19 -->\n###### Marketing\n\n<!-- PAGE_19 -->\n###### of\n\n<!-- PAGE_19 -->\n###### Immune Globulin Intravenous(Human)\n\n<!-- PAGE_19 -->\n###### as Replacement Therapy\n\n<!-- PAGE_19 -->\n###### for Primary\n\n<!-- PAGE_19 -->\n###### Humoral Immunodeficiency, CBER, FDA, 2008\n\n<!-- PAGE_19 -->\n###### 10.  Guidance\n\n<!-- PAGE_19 -->\n###### for Industry\n\n<!-- PAGE_19 -->\n###### Pharmacokinetics\n\n<!-- PAGE_19 -->\n###### in Patients\n\n<!-- PAGE_19 -->\n###### with Impaired\n\n<!-- PAGE_19 -->\n###### Hepatic\n\n<!-- PAGE_19 -->\n###### Function: Study Design, Data Analysis, and Impact on Dosing and Labeling,\n\n<!-- PAGE_19 -->\n###### CDER, FDA, 2003\n\n- - 12 -\n<!-- PAGE_20 -->\n###### 생물의약품국에서 발간한 행정간행물 목록\n\n<!-- PAGE_20 -->\n###### 생물의약품 국가표준품 카다로그 시리즈\n\n<!-- PAGE_20 -->\n###### 1.\n\n",
        "original_sentence": "<!-- PAGE_19 -->\n###### 8. "
      }
    },
    {
      "chunk_id": "chunk_160",
      "text": "Note\n\n<!-- PAGE_19 -->\n###### For\n\n<!-- PAGE_19 -->\n###### Guidance\n\n<!-- PAGE_19 -->\n###### on\n\n<!-- PAGE_19 -->\n###### the\n\n<!-- PAGE_19 -->\n###### Clinical\n\n<!-- PAGE_19 -->\n###### Investigation\n\n<!-- PAGE_19 -->\n###### of\n\n<!-- PAGE_19 -->\n###### Human\n\n<!-- PAGE_19 -->\n###### Normal\n\n<!-- PAGE_19 -->\n###### Immunoglobulin for Subcutaneous and Intramuscular Use(CPMP/BPWG/283/\n\n<!-- PAGE_19 -->\n###### 00), EMEA, 2003\n\n<!-- PAGE_19 -->\n###### 9. ",
      "metadata": {
        "source": "(가이드라인-005)_정맥주사용+B형간염+사람면역글로불린제제의+안전성유효성+평가+가이드라인.pdf",
        "chunk_index": 159,
        "window_size": 3,
        "char_count": 452,
        "word_count": 68,
        "page_number": 19,
        "window_text": "Guideline\n\n<!-- PAGE_19 -->\n###### on\n\n<!-- PAGE_19 -->\n###### the\n\n<!-- PAGE_19 -->\n###### Clinical\n\n<!-- PAGE_19 -->\n###### Evaluation\n\n<!-- PAGE_19 -->\n###### of\n\n<!-- PAGE_19 -->\n###### Medicinal\n\n<!-- PAGE_19 -->\n###### Products\n\n<!-- PAGE_19 -->\n###### Intended\n\n<!-- PAGE_19 -->\n###### for\n\n<!-- PAGE_19 -->\n###### 7.  Note\n\n<!-- PAGE_19 -->\n###### For\n\n<!-- PAGE_19 -->\n###### Guidance\n\n<!-- PAGE_19 -->\n###### on\n\n<!-- PAGE_19 -->\n###### the\n\n<!-- PAGE_19 -->\n###### Clinical\n\n<!-- PAGE_19 -->\n###### Investigation\n\n<!-- PAGE_19 -->\n###### of\n\n<!-- PAGE_19 -->\n###### Human\n\n<!-- PAGE_19 -->\n###### Normal\n\n<!-- PAGE_19 -->\n###### Immunoglobulin for Intravenous Administration(IVIg)(CPMP/BPWG/388/95 rev.\n\n <!-- PAGE_19 -->\n###### 8.  Note\n\n<!-- PAGE_19 -->\n###### For\n\n<!-- PAGE_19 -->\n###### Guidance\n\n<!-- PAGE_19 -->\n###### on\n\n<!-- PAGE_19 -->\n###### the\n\n<!-- PAGE_19 -->\n###### Clinical\n\n<!-- PAGE_19 -->\n###### Investigation\n\n<!-- PAGE_19 -->\n###### of\n\n<!-- PAGE_19 -->\n###### Human\n\n<!-- PAGE_19 -->\n###### Normal\n\n<!-- PAGE_19 -->\n###### Immunoglobulin for Subcutaneous and Intramuscular Use(CPMP/BPWG/283/\n\n<!-- PAGE_19 -->\n###### 00), EMEA, 2003\n\n<!-- PAGE_19 -->\n###### 9.  Safety,\n\n<!-- PAGE_19 -->\n###### Efficacy,\n\n<!-- PAGE_19 -->\n###### and\n\n<!-- PAGE_19 -->\n###### Pharmacokinetic\n\n<!-- PAGE_19 -->\n###### Studies\n\n<!-- PAGE_19 -->\n###### to\n\n<!-- PAGE_19 -->\n###### Support\n\n<!-- PAGE_19 -->\n###### Marketing\n\n<!-- PAGE_19 -->\n###### of\n\n<!-- PAGE_19 -->\n###### Immune Globulin Intravenous(Human)\n\n<!-- PAGE_19 -->\n###### as Replacement Therapy\n\n<!-- PAGE_19 -->\n###### for Primary\n\n<!-- PAGE_19 -->\n###### Humoral Immunodeficiency, CBER, FDA, 2008\n\n<!-- PAGE_19 -->\n###### 10.  Guidance\n\n<!-- PAGE_19 -->\n###### for Industry\n\n<!-- PAGE_19 -->\n###### Pharmacokinetics\n\n<!-- PAGE_19 -->\n###### in Patients\n\n<!-- PAGE_19 -->\n###### with Impaired\n\n<!-- PAGE_19 -->\n###### Hepatic\n\n<!-- PAGE_19 -->\n###### Function: Study Design, Data Analysis, and Impact on Dosing and Labeling,\n\n<!-- PAGE_19 -->\n###### CDER, FDA, 2003\n\n- - 12 -\n<!-- PAGE_20 -->\n###### 생물의약품국에서 발간한 행정간행물 목록\n\n<!-- PAGE_20 -->\n###### 생물의약품 국가표준품 카다로그 시리즈\n\n<!-- PAGE_20 -->\n###### 1.\n\n <!-- PAGE_20 -->\n###### 생물의약품평가가이드 시리즈\n\n<!-- PAGE_20 -->\n###### 2.\n\n",
        "original_sentence": "Note\n\n<!-- PAGE_19 -->\n###### For\n\n<!-- PAGE_19 -->\n###### Guidance\n\n<!-- PAGE_19 -->\n###### on\n\n<!-- PAGE_19 -->\n###### the\n\n<!-- PAGE_19 -->\n###### Clinical\n\n<!-- PAGE_19 -->\n###### Investigation\n\n<!-- PAGE_19 -->\n###### of\n\n<!-- PAGE_19 -->\n###### Human\n\n<!-- PAGE_19 -->\n###### Normal\n\n<!-- PAGE_19 -->\n###### Immunoglobulin for Subcutaneous and Intramuscular Use(CPMP/BPWG/283/\n\n<!-- PAGE_19 -->\n###### 00), EMEA, 2003\n\n<!-- PAGE_19 -->\n###### 9. "
      }
    },
    {
      "chunk_id": "chunk_161",
      "text": "Safety,\n\n<!-- PAGE_19 -->\n###### Efficacy,\n\n<!-- PAGE_19 -->\n###### and\n\n<!-- PAGE_19 -->\n###### Pharmacokinetic\n\n<!-- PAGE_19 -->\n###### Studies\n\n<!-- PAGE_19 -->\n###### to\n\n<!-- PAGE_19 -->\n###### Support\n\n<!-- PAGE_19 -->\n###### Marketing\n\n<!-- PAGE_19 -->\n###### of\n\n<!-- PAGE_19 -->\n###### Immune Globulin Intravenous(Human)\n\n<!-- PAGE_19 -->\n###### as Replacement Therapy\n\n<!-- PAGE_19 -->\n###### for Primary\n\n<!-- PAGE_19 -->\n###### Humoral Immunodeficiency, CBER, FDA, 2008\n\n<!-- PAGE_19 -->\n###### 10. ",
      "metadata": {
        "source": "(가이드라인-005)_정맥주사용+B형간염+사람면역글로불린제제의+안전성유효성+평가+가이드라인.pdf",
        "chunk_index": 160,
        "window_size": 3,
        "char_count": 511,
        "word_count": 75,
        "page_number": 19,
        "window_text": "Note\n\n<!-- PAGE_19 -->\n###### For\n\n<!-- PAGE_19 -->\n###### Guidance\n\n<!-- PAGE_19 -->\n###### on\n\n<!-- PAGE_19 -->\n###### the\n\n<!-- PAGE_19 -->\n###### Clinical\n\n<!-- PAGE_19 -->\n###### Investigation\n\n<!-- PAGE_19 -->\n###### of\n\n<!-- PAGE_19 -->\n###### Human\n\n<!-- PAGE_19 -->\n###### Normal\n\n<!-- PAGE_19 -->\n###### Immunoglobulin for Intravenous Administration(IVIg)(CPMP/BPWG/388/95 rev.\n\n <!-- PAGE_19 -->\n###### 8.  Note\n\n<!-- PAGE_19 -->\n###### For\n\n<!-- PAGE_19 -->\n###### Guidance\n\n<!-- PAGE_19 -->\n###### on\n\n<!-- PAGE_19 -->\n###### the\n\n<!-- PAGE_19 -->\n###### Clinical\n\n<!-- PAGE_19 -->\n###### Investigation\n\n<!-- PAGE_19 -->\n###### of\n\n<!-- PAGE_19 -->\n###### Human\n\n<!-- PAGE_19 -->\n###### Normal\n\n<!-- PAGE_19 -->\n###### Immunoglobulin for Subcutaneous and Intramuscular Use(CPMP/BPWG/283/\n\n<!-- PAGE_19 -->\n###### 00), EMEA, 2003\n\n<!-- PAGE_19 -->\n###### 9.  Safety,\n\n<!-- PAGE_19 -->\n###### Efficacy,\n\n<!-- PAGE_19 -->\n###### and\n\n<!-- PAGE_19 -->\n###### Pharmacokinetic\n\n<!-- PAGE_19 -->\n###### Studies\n\n<!-- PAGE_19 -->\n###### to\n\n<!-- PAGE_19 -->\n###### Support\n\n<!-- PAGE_19 -->\n###### Marketing\n\n<!-- PAGE_19 -->\n###### of\n\n<!-- PAGE_19 -->\n###### Immune Globulin Intravenous(Human)\n\n<!-- PAGE_19 -->\n###### as Replacement Therapy\n\n<!-- PAGE_19 -->\n###### for Primary\n\n<!-- PAGE_19 -->\n###### Humoral Immunodeficiency, CBER, FDA, 2008\n\n<!-- PAGE_19 -->\n###### 10.  Guidance\n\n<!-- PAGE_19 -->\n###### for Industry\n\n<!-- PAGE_19 -->\n###### Pharmacokinetics\n\n<!-- PAGE_19 -->\n###### in Patients\n\n<!-- PAGE_19 -->\n###### with Impaired\n\n<!-- PAGE_19 -->\n###### Hepatic\n\n<!-- PAGE_19 -->\n###### Function: Study Design, Data Analysis, and Impact on Dosing and Labeling,\n\n<!-- PAGE_19 -->\n###### CDER, FDA, 2003\n\n- - 12 -\n<!-- PAGE_20 -->\n###### 생물의약품국에서 발간한 행정간행물 목록\n\n<!-- PAGE_20 -->\n###### 생물의약품 국가표준품 카다로그 시리즈\n\n<!-- PAGE_20 -->\n###### 1.\n\n <!-- PAGE_20 -->\n###### 생물의약품평가가이드 시리즈\n\n<!-- PAGE_20 -->\n###### 2.\n\n 행정간행물 제목\n\n발행\n\n연도\n\n행정간행물 번호\n\n발행과\n\n홈페이지\n\n게재 상태\n\n생물의약품 국가표준품\n\n카다로그 (2008)\n\n2008\n\n11-1470000-000547-10\n\n생물진단의약품과\n\n자료실 간행물\n\n/\n\n,\n\n지침/\n\n생물의약품 국가표준품\n\n카다로그 (2006)\n\n2006\n\n11-1470000-000547-10\n\n생물진단제제팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/159\n\n생물의약품 국가표준품\n\n카다로그 (2004)\n\n2004\n\n11-1470000-000547-10\n\n생물의약품규격과\n\n자료실 간행물\n\n/\n\n,\n\n지침/56\n\n생물의약품 국가표준품\n\n카다로그 (2003)\n\n2003\n\n11-1470000-000547-10\n\n생물의약품규격과\n\n자료실 간행물\n\n/\n\n,\n\n지침/43\n\n생물의약품 국가표준품\n\n카다로그 (2002)\n\n2002\n\n11-1470000-000547-10\n\n백신과\n\n바이러스제제과\n\n(\n\n)\n\n舊\n\n자료실 간행물\n\n/\n\n,\n\n지침/22, 23\n\n행정간행물 제목\n\n발행\n\n연도\n\n행정간행물 번호\n\n발행과\n\n홈페이지\n\n게재 상태\n\n생물의약품\n\n국제공통기술문서 작성\n\n가이드라인 해설\n\n- -III. ",
        "original_sentence": "Safety,\n\n<!-- PAGE_19 -->\n###### Efficacy,\n\n<!-- PAGE_19 -->\n###### and\n\n<!-- PAGE_19 -->\n###### Pharmacokinetic\n\n<!-- PAGE_19 -->\n###### Studies\n\n<!-- PAGE_19 -->\n###### to\n\n<!-- PAGE_19 -->\n###### Support\n\n<!-- PAGE_19 -->\n###### Marketing\n\n<!-- PAGE_19 -->\n###### of\n\n<!-- PAGE_19 -->\n###### Immune Globulin Intravenous(Human)\n\n<!-- PAGE_19 -->\n###### as Replacement Therapy\n\n<!-- PAGE_19 -->\n###### for Primary\n\n<!-- PAGE_19 -->\n###### Humoral Immunodeficiency, CBER, FDA, 2008\n\n<!-- PAGE_19 -->\n###### 10. "
      }
    },
    {
      "chunk_id": "chunk_162",
      "text": "Guidance\n\n<!-- PAGE_19 -->\n###### for Industry\n\n<!-- PAGE_19 -->\n###### Pharmacokinetics\n\n<!-- PAGE_19 -->\n###### in Patients\n\n<!-- PAGE_19 -->\n###### with Impaired\n\n<!-- PAGE_19 -->\n###### Hepatic\n\n<!-- PAGE_19 -->\n###### Function: Study Design, Data Analysis, and Impact on Dosing and Labeling,\n\n<!-- PAGE_19 -->\n###### CDER, FDA, 2003\n\n- - 12 -\n<!-- PAGE_20 -->\n###### 생물의약품국에서 발간한 행정간행물 목록\n\n<!-- PAGE_20 -->\n###### 생물의약품 국가표준품 카다로그 시리즈\n\n<!-- PAGE_20 -->\n###### 1.\n\n",
      "metadata": {
        "source": "(가이드라인-005)_정맥주사용+B형간염+사람면역글로불린제제의+안전성유효성+평가+가이드라인.pdf",
        "chunk_index": 161,
        "window_size": 3,
        "char_count": 469,
        "word_count": 76,
        "page_number": 19,
        "window_text": "<!-- PAGE_19 -->\n###### 8.  Note\n\n<!-- PAGE_19 -->\n###### For\n\n<!-- PAGE_19 -->\n###### Guidance\n\n<!-- PAGE_19 -->\n###### on\n\n<!-- PAGE_19 -->\n###### the\n\n<!-- PAGE_19 -->\n###### Clinical\n\n<!-- PAGE_19 -->\n###### Investigation\n\n<!-- PAGE_19 -->\n###### of\n\n<!-- PAGE_19 -->\n###### Human\n\n<!-- PAGE_19 -->\n###### Normal\n\n<!-- PAGE_19 -->\n###### Immunoglobulin for Subcutaneous and Intramuscular Use(CPMP/BPWG/283/\n\n<!-- PAGE_19 -->\n###### 00), EMEA, 2003\n\n<!-- PAGE_19 -->\n###### 9.  Safety,\n\n<!-- PAGE_19 -->\n###### Efficacy,\n\n<!-- PAGE_19 -->\n###### and\n\n<!-- PAGE_19 -->\n###### Pharmacokinetic\n\n<!-- PAGE_19 -->\n###### Studies\n\n<!-- PAGE_19 -->\n###### to\n\n<!-- PAGE_19 -->\n###### Support\n\n<!-- PAGE_19 -->\n###### Marketing\n\n<!-- PAGE_19 -->\n###### of\n\n<!-- PAGE_19 -->\n###### Immune Globulin Intravenous(Human)\n\n<!-- PAGE_19 -->\n###### as Replacement Therapy\n\n<!-- PAGE_19 -->\n###### for Primary\n\n<!-- PAGE_19 -->\n###### Humoral Immunodeficiency, CBER, FDA, 2008\n\n<!-- PAGE_19 -->\n###### 10.  Guidance\n\n<!-- PAGE_19 -->\n###### for Industry\n\n<!-- PAGE_19 -->\n###### Pharmacokinetics\n\n<!-- PAGE_19 -->\n###### in Patients\n\n<!-- PAGE_19 -->\n###### with Impaired\n\n<!-- PAGE_19 -->\n###### Hepatic\n\n<!-- PAGE_19 -->\n###### Function: Study Design, Data Analysis, and Impact on Dosing and Labeling,\n\n<!-- PAGE_19 -->\n###### CDER, FDA, 2003\n\n- - 12 -\n<!-- PAGE_20 -->\n###### 생물의약품국에서 발간한 행정간행물 목록\n\n<!-- PAGE_20 -->\n###### 생물의약품 국가표준품 카다로그 시리즈\n\n<!-- PAGE_20 -->\n###### 1.\n\n <!-- PAGE_20 -->\n###### 생물의약품평가가이드 시리즈\n\n<!-- PAGE_20 -->\n###### 2.\n\n 행정간행물 제목\n\n발행\n\n연도\n\n행정간행물 번호\n\n발행과\n\n홈페이지\n\n게재 상태\n\n생물의약품 국가표준품\n\n카다로그 (2008)\n\n2008\n\n11-1470000-000547-10\n\n생물진단의약품과\n\n자료실 간행물\n\n/\n\n,\n\n지침/\n\n생물의약품 국가표준품\n\n카다로그 (2006)\n\n2006\n\n11-1470000-000547-10\n\n생물진단제제팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/159\n\n생물의약품 국가표준품\n\n카다로그 (2004)\n\n2004\n\n11-1470000-000547-10\n\n생물의약품규격과\n\n자료실 간행물\n\n/\n\n,\n\n지침/56\n\n생물의약품 국가표준품\n\n카다로그 (2003)\n\n2003\n\n11-1470000-000547-10\n\n생물의약품규격과\n\n자료실 간행물\n\n/\n\n,\n\n지침/43\n\n생물의약품 국가표준품\n\n카다로그 (2002)\n\n2002\n\n11-1470000-000547-10\n\n백신과\n\n바이러스제제과\n\n(\n\n)\n\n舊\n\n자료실 간행물\n\n/\n\n,\n\n지침/22, 23\n\n행정간행물 제목\n\n발행\n\n연도\n\n행정간행물 번호\n\n발행과\n\n홈페이지\n\n게재 상태\n\n생물의약품\n\n국제공통기술문서 작성\n\n가이드라인 해설\n\n- -III.  품질\n2007\n\n11-1470000-001625-14\n\n(생물의약품평가가이드\n\n34)\n\n재조합의약품과\n\n바이러스백신과\n\n혈액제제과\n\n유전자치료제과\n\n세포조직공학제제과\n\n자료실 간행물\n\n/\n\n,\n\n지침/315\n\nHBsAg 진단제제의 기준\n\n및 시험방법 작성 지침\n\n2008\n\n11-1470000-000143-01\n\n(생물의약품평가가이드\n\n33)\n\n생물진단의약품과\n\n자료실 간행물\n\n/\n\n,\n\n지침/289\n\n혈장수출업소 실태조사\n\n지침\n\n2007\n\n11-1470000-001627-01\n\n(생물의약품평가가이드\n\n32)\n\n생물의약품관리팀\n\n혈액제제팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/234\n\nHIV, HBV, HCV, HTLV\n\n관련 체외진단용의약품\n\n안전성 유효성 심사평가\n\n․\n\n지침서\n\n2007\n\n11-1470000-001622-01\n\n(생물의약품평가가이드\n\n31)\n\n생물진단제제팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/252\n\n대유행 인플루엔자 백신의\n\n임상시험 평가 가이드 안\n\n(\n\n)\n\n2007\n\n11-1470000-001621-01\n\n(생물의약품평가가이드\n\n30)\n\n바이러스백신팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/228\n\n바이러스백신\n\n자가품질관리요약서(\n\nⅠ)\n\n2007\n\n11-1470000-001620-01\n\n(생물의약품평가가이드\n\n29)\n\n바이러스백신팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/227\n\n- - 13 -\n행정간행물 제목\n\n발행\n\n연도\n\n행정간행물 번호\n\n발행과\n\n홈페이지\n\n게재 상태\n\n불활화 인플루엔자백신\n\n평가 지침\n\n2007\n\n11-1470000-001587-01\n\n(생물의약품평가가이드\n\n28)\n\n바이러스백신팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/226\n\n당단백질의약품의 당구조\n\n분석 시험법 길라잡이\n\n2007\n\n11-1470000-001589-01\n\n(생물의약품평가가이드\n\n27)\n\n재조합의약품팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/280\n\n류마티스관절염 치료제\n\n임상평가지침\n\n2007\n\n11-1470000-001432-01\n\n(생물의약품평가가이드\n\n26)\n\n재조합의약품팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/190\n\n분획용 혈장 마스터 파일\n\n가이드라인\n\n2007\n\n11-1470000-001560-01\n\n(생물의약품평가가이드\n\n25)\n\n생물의약품관리팀\n\n혈액제제팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/210\n\n인플루엔자백신의 자가\n\n기준 및 시험방법 작성\n\n지침 개정판\n\n(\n\n)\n\n2007\n\n11-1470000-001468-01\n\n(생물의약품평가가이드\n\n24)\n\n바이러스백신팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/197\n\nHIV 항체 진단제제의\n\n기준 및 시험방법\n\n작성\n\n‘\n\n’\n\n지침\n\n2007\n\n11-1470000-001462-01\n\n(생물의약품평가가이드\n\n23)\n\n생물진단제제팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/196\n\n세균백신 자가 기준 및\n\n시험방법 작성 지침서\n\n2007\n\n11-1470000-001428-01\n\n(생물의약품평가가이드\n\n22)\n\n세균백신팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/177\n\n바이오 칩 평가 가이드\n\n- -HPV DNA칩 기준 및\n시험방법 작성 지침-\n\n2006\n\n11-1470000-001165-01\n\n(생물의약품평가가이드\n\n21)\n\n생물진단제제팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/154\n\n혈장분획제제 등 바이러스\n\n검증 평가 가이드\n\n2006\n\n11-1470000-001176-01\n\n(생물의약품평가가이드\n\n20)\n\n혈액제제팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/170\n\n유전자재조합의약품\n\n생산용 세포의 발현구조체\n\n분석 및 안정성\n\n평가가이드\n\n2006\n\n11-1470000-001116-01\n\n(생물의약품평가가이드\n\n19)\n\n재조합의약품팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/229\n\n유전재재조합의약품 및\n\n단클론항체의약품의 제조\n\n및 품질관리 자료에 관한\n\n평가가이드\n\n2006\n\n11-1470000-000902-01\n\n(생물의약품평가가이드\n\n18)\n\n재조합의약품팀\n\n생물의약품관리팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/139\n\n이종이식제제의 전임상 및\n\n임상시험에 대한 가이드\n\n2006\n\n11-1470000-001088-01\n\n(생물의약품평가가이드\n\n17)\n\n세포조직공학제제팀\n\n재조합의약품팀\n\n생물의약품안전팀\n\n생물의약품관리팀\n\n국립독성연구원\n\n생명공학지원팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/130\n\n- - 14 -\n행정간행물 제목\n\n발행\n\n연도\n\n행정간행물 번호\n\n발행과\n\n홈페이지\n\n게재 상태\n\n이종이식제제의 품질관리\n\n및 이식 후 감염관리에\n\n대한 가이드\n\n2006\n\n11-1470000-001086-01\n\n(생물의약품평가가이드\n\n16)\n\n세포조직공학제제팀\n\n재조합의약품팀\n\n생물의약품안전팀\n\n생물의약품관리팀\n\n국립독성연구원\n\n생명공학지원팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/130\n\n자료실 간행물\n\n/\n\n,\n\n지침/130\n\n자료실 간행물\n\n/\n\n,\n\n지침/116\n\n자료실 간행물\n\n/\n\n,\n\n지침/110\n\n자료실 간행물\n\n/\n\n,\n\n지침/118\n\n임상시험용\n\n유전자치료제의 특성분석,\n\n제조 및 품질관리\n\n평가가이드\n\n2005\n\n11-1470000-000876-01\n\n(생물의약품평가가이드\n\n11)\n\n생명공학의약품과\n\n자료실 간행물\n\n/\n\n,\n\n지침/107\n\n두창백신의 안전성 유효성\n\n․\n\n평가시 고려사항\n\n2005\n\n11-1470000-000872-01\n\n(생물의약품평가가이드\n\n10)\n\n생물의약품평가과\n\n자료실 간행물\n\n/\n\n,\n\n지침/105\n\n**[표 시작]**\n\n| 2004 | 11-1470000-000684-01 | (생물의약품평가자료집 | 15) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/84 |\n| --- | --- | --- | --- | --- | --- | --- | --- | --- |\n| 생명공학의약품 허가를 | 위한 Q&A | 2006 | 11-1470000-000895-01 | (생물의약품평가자료집 | 28) | 재조합의약품팀 | 생명공학의약품과 | ( | ) | 舊 | 자료실 간행물 | / | , | 지침127 |\n| 유전자치료제의 | 안전성평가 2006 | 2006 | 11-1470000-001140-01 | (생물의약품평가자료집 | 38) | 유전자치료제팀 | 자료실 간행물 | / | , | 지침/169 |\n| 행정간행물 제목 | 발행 | 연도 | 행정간행물 번호 | 발행과 | 홈페이지 | 게재 상태 |\n| 세포치료제의 | 안전성 유효성 및 품질 | ․ | 평가 2006 | 2006 | 11-1470000-001146-01 | (생물의약품평가자료집 | 37) | 세포조직공학제제팀 자료실 간행물 | / | , | 지침/148 | KFDA Bio Handbook | 2005 | 11-1470000-000873-01 | (생물의약품평가자료집 | 26) | 생명공학의약품과 | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/91 |\n| 세포치료제의 임상시험 | 사례분석 | 2007 | 11-1470000-001586-14 | (생물의약품평가자료집 | 50) | 세포조직공학제제팀 자료실 간행물 | / | , | 지침/259 |\n| 생명공학의약품의 | 안전성 유효성 평가 - | ․ | 비교동등성 평가시 | 고려사항 |\n| 정맥주사용 | B형 간염 사람면역글로불린제제의 | 안전성․유효성 평가 가이드라인 |\n| 임상시험의 전반적인 | 고려사항 | 2004 | 11-1470000-000681-01 | (생물의약품평가자료집 | 12) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/79 | 2005 | 11-1470000-000871-01 | (생물의약품평가자료집 | 25) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/103 |\n| 생명공학의약품 | 생산세포주 관리를 위한 | 시험방법 | 2007 | 11-1470000-000903-01 | (생물의약품평가자료집 | 48) | 재조합의약품팀 | 자료실 간행물 | / | , | 지침/236 | 생물의약품의 독성평가 | 사례분석 | 2004 | 11-1470000-000680-01 | (생물의약품평가자료집 | 11) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/77 |\n**════════════════════════════════════════════**\n| 유전자치료제의 | 안전성평가 2005 | 2005 | 11-1470000-000677-14 | (생물의약품평가자료집 | 24) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/104 |\n| 발 | 행 | 일 | 년 | 월 | : | 2008 | 12 |\n| 2006 | 11-1470000-001144-01 | (생물의약품평가자료집 | 35) | 자료실 간행물 | / | , | 지침/146 |\n| 발 | 행 | 기 | 관 | 식품의약품안전청 | : |\n| 백신의 안전성 유효성 | ․ | 평가 2005 | 2005 | 11-1470000-000870-01 | (생물의약품평가자료집 | 23) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/102 | 단클론항체의약품의 | 평가가이드 | 2005 | 11-1470000-000851-01 | (생물의약품평가가이드 | 9) | 자료실 간행물 | / | , | 지침/74 |\n\n**[표 끝]**\n\n생명공학의약품과\n\n생물의약품평가과\n\n국립독성연구원\n\n생화학약리과\n\nTNF 길항제 사용시\n\n잠복결핵 치료지침\n\n2005\n\n11-1470000-000686-01\n\n(생물의약품평가가이드\n\n8)\n\n생물의약품평가과\n\n자료실 간행물\n\n/\n\n,\n\n지침/65\n\nDNA 백신의 평가지침서\n\n2004\n\n11-1470000-000669-01\n\n(생물의약품평가가이드\n\n7)\n\n생명공학의약품과\n\n생물의약품평가과\n\n자료실 간행물\n\n/\n\n,\n\n지침/60\n\n생명공학의약품/\n\n생물학적제제의\n\n규격설정에 관한 가이드\n\n2004\n\n11-1470000-000538-01\n\n(생물의약품평가가이드\n\n6)\n\n생명공학의약품과\n\n자료실 간행물\n\n/\n\n,\n\n지침/59\n\n- - 15 -\n<!-- PAGE_23 -->\n###### 생물의약품평가자료집 시리즈\n\n<!-- PAGE_23 -->\n###### 3.\n\n",
        "original_sentence": "Guidance\n\n<!-- PAGE_19 -->\n###### for Industry\n\n<!-- PAGE_19 -->\n###### Pharmacokinetics\n\n<!-- PAGE_19 -->\n###### in Patients\n\n<!-- PAGE_19 -->\n###### with Impaired\n\n<!-- PAGE_19 -->\n###### Hepatic\n\n<!-- PAGE_19 -->\n###### Function: Study Design, Data Analysis, and Impact on Dosing and Labeling,\n\n<!-- PAGE_19 -->\n###### CDER, FDA, 2003\n\n- - 12 -\n<!-- PAGE_20 -->\n###### 생물의약품국에서 발간한 행정간행물 목록\n\n<!-- PAGE_20 -->\n###### 생물의약품 국가표준품 카다로그 시리즈\n\n<!-- PAGE_20 -->\n###### 1.\n\n"
      }
    },
    {
      "chunk_id": "chunk_163",
      "text": "<!-- PAGE_20 -->\n###### 생물의약품평가가이드 시리즈\n\n<!-- PAGE_20 -->\n###### 2.\n\n",
      "metadata": {
        "source": "(가이드라인-005)_정맥주사용+B형간염+사람면역글로불린제제의+안전성유효성+평가+가이드라인.pdf",
        "chunk_index": 162,
        "window_size": 3,
        "char_count": 68,
        "word_count": 11,
        "page_number": 20,
        "window_text": "Note\n\n<!-- PAGE_19 -->\n###### For\n\n<!-- PAGE_19 -->\n###### Guidance\n\n<!-- PAGE_19 -->\n###### on\n\n<!-- PAGE_19 -->\n###### the\n\n<!-- PAGE_19 -->\n###### Clinical\n\n<!-- PAGE_19 -->\n###### Investigation\n\n<!-- PAGE_19 -->\n###### of\n\n<!-- PAGE_19 -->\n###### Human\n\n<!-- PAGE_19 -->\n###### Normal\n\n<!-- PAGE_19 -->\n###### Immunoglobulin for Subcutaneous and Intramuscular Use(CPMP/BPWG/283/\n\n<!-- PAGE_19 -->\n###### 00), EMEA, 2003\n\n<!-- PAGE_19 -->\n###### 9.  Safety,\n\n<!-- PAGE_19 -->\n###### Efficacy,\n\n<!-- PAGE_19 -->\n###### and\n\n<!-- PAGE_19 -->\n###### Pharmacokinetic\n\n<!-- PAGE_19 -->\n###### Studies\n\n<!-- PAGE_19 -->\n###### to\n\n<!-- PAGE_19 -->\n###### Support\n\n<!-- PAGE_19 -->\n###### Marketing\n\n<!-- PAGE_19 -->\n###### of\n\n<!-- PAGE_19 -->\n###### Immune Globulin Intravenous(Human)\n\n<!-- PAGE_19 -->\n###### as Replacement Therapy\n\n<!-- PAGE_19 -->\n###### for Primary\n\n<!-- PAGE_19 -->\n###### Humoral Immunodeficiency, CBER, FDA, 2008\n\n<!-- PAGE_19 -->\n###### 10.  Guidance\n\n<!-- PAGE_19 -->\n###### for Industry\n\n<!-- PAGE_19 -->\n###### Pharmacokinetics\n\n<!-- PAGE_19 -->\n###### in Patients\n\n<!-- PAGE_19 -->\n###### with Impaired\n\n<!-- PAGE_19 -->\n###### Hepatic\n\n<!-- PAGE_19 -->\n###### Function: Study Design, Data Analysis, and Impact on Dosing and Labeling,\n\n<!-- PAGE_19 -->\n###### CDER, FDA, 2003\n\n- - 12 -\n<!-- PAGE_20 -->\n###### 생물의약품국에서 발간한 행정간행물 목록\n\n<!-- PAGE_20 -->\n###### 생물의약품 국가표준품 카다로그 시리즈\n\n<!-- PAGE_20 -->\n###### 1.\n\n <!-- PAGE_20 -->\n###### 생물의약품평가가이드 시리즈\n\n<!-- PAGE_20 -->\n###### 2.\n\n 행정간행물 제목\n\n발행\n\n연도\n\n행정간행물 번호\n\n발행과\n\n홈페이지\n\n게재 상태\n\n생물의약품 국가표준품\n\n카다로그 (2008)\n\n2008\n\n11-1470000-000547-10\n\n생물진단의약품과\n\n자료실 간행물\n\n/\n\n,\n\n지침/\n\n생물의약품 국가표준품\n\n카다로그 (2006)\n\n2006\n\n11-1470000-000547-10\n\n생물진단제제팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/159\n\n생물의약품 국가표준품\n\n카다로그 (2004)\n\n2004\n\n11-1470000-000547-10\n\n생물의약품규격과\n\n자료실 간행물\n\n/\n\n,\n\n지침/56\n\n생물의약품 국가표준품\n\n카다로그 (2003)\n\n2003\n\n11-1470000-000547-10\n\n생물의약품규격과\n\n자료실 간행물\n\n/\n\n,\n\n지침/43\n\n생물의약품 국가표준품\n\n카다로그 (2002)\n\n2002\n\n11-1470000-000547-10\n\n백신과\n\n바이러스제제과\n\n(\n\n)\n\n舊\n\n자료실 간행물\n\n/\n\n,\n\n지침/22, 23\n\n행정간행물 제목\n\n발행\n\n연도\n\n행정간행물 번호\n\n발행과\n\n홈페이지\n\n게재 상태\n\n생물의약품\n\n국제공통기술문서 작성\n\n가이드라인 해설\n\n- -III.  품질\n2007\n\n11-1470000-001625-14\n\n(생물의약품평가가이드\n\n34)\n\n재조합의약품과\n\n바이러스백신과\n\n혈액제제과\n\n유전자치료제과\n\n세포조직공학제제과\n\n자료실 간행물\n\n/\n\n,\n\n지침/315\n\nHBsAg 진단제제의 기준\n\n및 시험방법 작성 지침\n\n2008\n\n11-1470000-000143-01\n\n(생물의약품평가가이드\n\n33)\n\n생물진단의약품과\n\n자료실 간행물\n\n/\n\n,\n\n지침/289\n\n혈장수출업소 실태조사\n\n지침\n\n2007\n\n11-1470000-001627-01\n\n(생물의약품평가가이드\n\n32)\n\n생물의약품관리팀\n\n혈액제제팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/234\n\nHIV, HBV, HCV, HTLV\n\n관련 체외진단용의약품\n\n안전성 유효성 심사평가\n\n․\n\n지침서\n\n2007\n\n11-1470000-001622-01\n\n(생물의약품평가가이드\n\n31)\n\n생물진단제제팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/252\n\n대유행 인플루엔자 백신의\n\n임상시험 평가 가이드 안\n\n(\n\n)\n\n2007\n\n11-1470000-001621-01\n\n(생물의약품평가가이드\n\n30)\n\n바이러스백신팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/228\n\n바이러스백신\n\n자가품질관리요약서(\n\nⅠ)\n\n2007\n\n11-1470000-001620-01\n\n(생물의약품평가가이드\n\n29)\n\n바이러스백신팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/227\n\n- - 13 -\n행정간행물 제목\n\n발행\n\n연도\n\n행정간행물 번호\n\n발행과\n\n홈페이지\n\n게재 상태\n\n불활화 인플루엔자백신\n\n평가 지침\n\n2007\n\n11-1470000-001587-01\n\n(생물의약품평가가이드\n\n28)\n\n바이러스백신팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/226\n\n당단백질의약품의 당구조\n\n분석 시험법 길라잡이\n\n2007\n\n11-1470000-001589-01\n\n(생물의약품평가가이드\n\n27)\n\n재조합의약품팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/280\n\n류마티스관절염 치료제\n\n임상평가지침\n\n2007\n\n11-1470000-001432-01\n\n(생물의약품평가가이드\n\n26)\n\n재조합의약품팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/190\n\n분획용 혈장 마스터 파일\n\n가이드라인\n\n2007\n\n11-1470000-001560-01\n\n(생물의약품평가가이드\n\n25)\n\n생물의약품관리팀\n\n혈액제제팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/210\n\n인플루엔자백신의 자가\n\n기준 및 시험방법 작성\n\n지침 개정판\n\n(\n\n)\n\n2007\n\n11-1470000-001468-01\n\n(생물의약품평가가이드\n\n24)\n\n바이러스백신팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/197\n\nHIV 항체 진단제제의\n\n기준 및 시험방법\n\n작성\n\n‘\n\n’\n\n지침\n\n2007\n\n11-1470000-001462-01\n\n(생물의약품평가가이드\n\n23)\n\n생물진단제제팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/196\n\n세균백신 자가 기준 및\n\n시험방법 작성 지침서\n\n2007\n\n11-1470000-001428-01\n\n(생물의약품평가가이드\n\n22)\n\n세균백신팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/177\n\n바이오 칩 평가 가이드\n\n- -HPV DNA칩 기준 및\n시험방법 작성 지침-\n\n2006\n\n11-1470000-001165-01\n\n(생물의약품평가가이드\n\n21)\n\n생물진단제제팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/154\n\n혈장분획제제 등 바이러스\n\n검증 평가 가이드\n\n2006\n\n11-1470000-001176-01\n\n(생물의약품평가가이드\n\n20)\n\n혈액제제팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/170\n\n유전자재조합의약품\n\n생산용 세포의 발현구조체\n\n분석 및 안정성\n\n평가가이드\n\n2006\n\n11-1470000-001116-01\n\n(생물의약품평가가이드\n\n19)\n\n재조합의약품팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/229\n\n유전재재조합의약품 및\n\n단클론항체의약품의 제조\n\n및 품질관리 자료에 관한\n\n평가가이드\n\n2006\n\n11-1470000-000902-01\n\n(생물의약품평가가이드\n\n18)\n\n재조합의약품팀\n\n생물의약품관리팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/139\n\n이종이식제제의 전임상 및\n\n임상시험에 대한 가이드\n\n2006\n\n11-1470000-001088-01\n\n(생물의약품평가가이드\n\n17)\n\n세포조직공학제제팀\n\n재조합의약품팀\n\n생물의약품안전팀\n\n생물의약품관리팀\n\n국립독성연구원\n\n생명공학지원팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/130\n\n- - 14 -\n행정간행물 제목\n\n발행\n\n연도\n\n행정간행물 번호\n\n발행과\n\n홈페이지\n\n게재 상태\n\n이종이식제제의 품질관리\n\n및 이식 후 감염관리에\n\n대한 가이드\n\n2006\n\n11-1470000-001086-01\n\n(생물의약품평가가이드\n\n16)\n\n세포조직공학제제팀\n\n재조합의약품팀\n\n생물의약품안전팀\n\n생물의약품관리팀\n\n국립독성연구원\n\n생명공학지원팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/130\n\n자료실 간행물\n\n/\n\n,\n\n지침/130\n\n자료실 간행물\n\n/\n\n,\n\n지침/116\n\n자료실 간행물\n\n/\n\n,\n\n지침/110\n\n자료실 간행물\n\n/\n\n,\n\n지침/118\n\n임상시험용\n\n유전자치료제의 특성분석,\n\n제조 및 품질관리\n\n평가가이드\n\n2005\n\n11-1470000-000876-01\n\n(생물의약품평가가이드\n\n11)\n\n생명공학의약품과\n\n자료실 간행물\n\n/\n\n,\n\n지침/107\n\n두창백신의 안전성 유효성\n\n․\n\n평가시 고려사항\n\n2005\n\n11-1470000-000872-01\n\n(생물의약품평가가이드\n\n10)\n\n생물의약품평가과\n\n자료실 간행물\n\n/\n\n,\n\n지침/105\n\n**[표 시작]**\n\n| 2004 | 11-1470000-000684-01 | (생물의약품평가자료집 | 15) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/84 |\n| --- | --- | --- | --- | --- | --- | --- | --- | --- |\n| 생명공학의약품 허가를 | 위한 Q&A | 2006 | 11-1470000-000895-01 | (생물의약품평가자료집 | 28) | 재조합의약품팀 | 생명공학의약품과 | ( | ) | 舊 | 자료실 간행물 | / | , | 지침127 |\n| 유전자치료제의 | 안전성평가 2006 | 2006 | 11-1470000-001140-01 | (생물의약품평가자료집 | 38) | 유전자치료제팀 | 자료실 간행물 | / | , | 지침/169 |\n| 행정간행물 제목 | 발행 | 연도 | 행정간행물 번호 | 발행과 | 홈페이지 | 게재 상태 |\n| 세포치료제의 | 안전성 유효성 및 품질 | ․ | 평가 2006 | 2006 | 11-1470000-001146-01 | (생물의약품평가자료집 | 37) | 세포조직공학제제팀 자료실 간행물 | / | , | 지침/148 | KFDA Bio Handbook | 2005 | 11-1470000-000873-01 | (생물의약품평가자료집 | 26) | 생명공학의약품과 | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/91 |\n| 세포치료제의 임상시험 | 사례분석 | 2007 | 11-1470000-001586-14 | (생물의약품평가자료집 | 50) | 세포조직공학제제팀 자료실 간행물 | / | , | 지침/259 |\n| 생명공학의약품의 | 안전성 유효성 평가 - | ․ | 비교동등성 평가시 | 고려사항 |\n| 정맥주사용 | B형 간염 사람면역글로불린제제의 | 안전성․유효성 평가 가이드라인 |\n| 임상시험의 전반적인 | 고려사항 | 2004 | 11-1470000-000681-01 | (생물의약품평가자료집 | 12) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/79 | 2005 | 11-1470000-000871-01 | (생물의약품평가자료집 | 25) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/103 |\n| 생명공학의약품 | 생산세포주 관리를 위한 | 시험방법 | 2007 | 11-1470000-000903-01 | (생물의약품평가자료집 | 48) | 재조합의약품팀 | 자료실 간행물 | / | , | 지침/236 | 생물의약품의 독성평가 | 사례분석 | 2004 | 11-1470000-000680-01 | (생물의약품평가자료집 | 11) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/77 |\n**════════════════════════════════════════════**\n| 유전자치료제의 | 안전성평가 2005 | 2005 | 11-1470000-000677-14 | (생물의약품평가자료집 | 24) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/104 |\n| 발 | 행 | 일 | 년 | 월 | : | 2008 | 12 |\n| 2006 | 11-1470000-001144-01 | (생물의약품평가자료집 | 35) | 자료실 간행물 | / | , | 지침/146 |\n| 발 | 행 | 기 | 관 | 식품의약품안전청 | : |\n| 백신의 안전성 유효성 | ․ | 평가 2005 | 2005 | 11-1470000-000870-01 | (생물의약품평가자료집 | 23) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/102 | 단클론항체의약품의 | 평가가이드 | 2005 | 11-1470000-000851-01 | (생물의약품평가가이드 | 9) | 자료실 간행물 | / | , | 지침/74 |\n\n**[표 끝]**\n\n생명공학의약품과\n\n생물의약품평가과\n\n국립독성연구원\n\n생화학약리과\n\nTNF 길항제 사용시\n\n잠복결핵 치료지침\n\n2005\n\n11-1470000-000686-01\n\n(생물의약품평가가이드\n\n8)\n\n생물의약품평가과\n\n자료실 간행물\n\n/\n\n,\n\n지침/65\n\nDNA 백신의 평가지침서\n\n2004\n\n11-1470000-000669-01\n\n(생물의약품평가가이드\n\n7)\n\n생명공학의약품과\n\n생물의약품평가과\n\n자료실 간행물\n\n/\n\n,\n\n지침/60\n\n생명공학의약품/\n\n생물학적제제의\n\n규격설정에 관한 가이드\n\n2004\n\n11-1470000-000538-01\n\n(생물의약품평가가이드\n\n6)\n\n생명공학의약품과\n\n자료실 간행물\n\n/\n\n,\n\n지침/59\n\n- - 15 -\n<!-- PAGE_23 -->\n###### 생물의약품평가자료집 시리즈\n\n<!-- PAGE_23 -->\n###### 3.\n\n 행정간행물 제목\n\n발행\n\n연도\n\n행정간행물 번호\n\n발행과\n\n홈페이지\n\n게재 상태\n\n핵산증폭검사법 검증\n\n가이드라인\n\n2003\n\n11-1470000-000277-01\n\n(생물의약품평가가이드\n\n5)\n\n혈액제제과\n\n자료실 간행물\n\n/\n\n,\n\n지침/44\n\n혈장분획제제\n\n품질평가 가이드\n\n2002\n\n11-1470000-000154-01\n\n(생물의약품평가가이드\n\n4)\n\n혈액제제과\n\n자료실 간행물\n\n/\n\n,\n\n지침/27\n\n2002\n\n11-1470000-000144-01\n\n(생물의약품평가가이드\n\n3)\n\n백신과\n\n바이러스제제과\n\n(\n\n)\n\n舊\n\n자료실 간행물\n\n/\n\n,\n\n지침/19\n\n생물의약품의 생산에\n\n사용되는 세포기질관리\n\n가이드\n\n2002\n\n11-1470000-000140-14\n\n(생물의약품평가가이드\n\n2)\n\n생명공학의약품과\n\n생물공학과\n\n(\n\n)\n\n舊\n\n자료실 간행물\n\n/\n\n,\n\n지침/17\n\n유전자치료제의\n\n품질평가 가이드\n\n2001\n\n11-1470000-000074-14\n\n(생물의약품평가가이드\n\n1)\n\n생명공학의약품과\n\n생물공학과\n\n(\n\n)\n\n舊\n\n자료실 간행물\n\n/\n\n,\n\n지침/54\n\n세포치료제의 비임상시험\n\n사례분석\n\n2007\n\n11-1470000-001585-14\n\n(생물의약품평가자료집\n\n49)\n\n세포조직공학제제팀 자료실 간행물\n\n/\n\n,\n\n지침/259\n\n혈액제제의 자가 기준 및\n\n시험방법 작성 지침\n\n2007\n\n11-1470000-001457-01\n\n(생물의약품평가자료집\n\n47)\n\n혈액제제팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/195\n\n혈관질환 등의\n\n유전자치료제\n\n비임상 임상시험 사례분석\n\n∙\n\n2007\n\n11-1470000-001441-10\n\n(생물의약품평가자료집\n\n46)\n\n유전자치료제팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/233\n\n항암 유전자치료제\n\n비임상 임상시험 사례분석\n\n∙\n\n2007\n\n11-1470000-001440-10\n\n(생물의약품평가자료집\n\n45)\n\n유전자치료제팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/209\n\n백신 임상 평가 시\n\n고려사항 2007\n\n2007\n\n11-1470000-001446-10\n\n(생물의약품평가자료집\n\n44)\n\n세균백신팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/192\n\n- - 16 -\n행정간행물 제목\n\n발행\n\n연도\n\n행정간행물 번호\n\n발행과\n\n홈페이지\n\n게재 상태\n\n생바이러스 백신의\n\n자가 기준 및 시험방법\n\n작성 지침\n\n2007\n\n11-1470000-001345-01\n\n(생물의약품평가자료집\n\n43)\n\n바이러스백신팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/172\n\n불활화 바이러스 백신의\n\n자가 기준 및 시험방법\n\n작성 지침\n\n2007\n\n11-1470000-001346-01\n\n(생물의약품평가자료집\n\n42)\n\n바이러스백신팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/173\n\n백신의 임상 평가 시\n\n고려사항\n\n2006\n\n11-1470000-001163-01\n\n(생물의약품평가자료집\n\n41)\n\n바이러스백신팀\n\n세균백신팀\n\n자료실 간행물\n\n/\n\n,\n\n지침 150\n\nDNA 백신의 평가\n\n:\n\nWHO 및 미국\n\nFDA\n\n가이드라인\n\n2006\n\n11-1470000-001142-01\n\n(생물의약품평가자료집\n\n40)\n\n유전자치료제팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/168\n\n유전자치료 임상시험-\n\n지연성 이상반응에 대비한\n\n환자 관찰\n\n2006\n\n11-1470000-001141-01\n\n(생물의약품평가자료집\n\n39)\n\n유전자치료제팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/157\n\n세포치료제 안전성 유효성\n\n․\n\n및 품질 평가시 고려사항\n\n2006\n\n2006\n\n11-1470000-001145-01\n\n(생물의약품평가자료집\n\n36)\n\n세포조직공학제제팀 자료실 간행물\n\n/\n\n,\n\n지침/147\n\n세포조직공학제제\n\n(세포치료제\n\n,\n\n조직공학제제,\n\n이종이식제제\n\n가이드라인\n\n)\n\n세포조직공학제제팀\n\n세균백신팀\n\n바이러스백신팀\n\n혈액제제팀\n\n재조합의약품팀\n\n유전자치료제팀\n\n생물 생명공학의약품의\n\n․\n\n독성평가 사례분석 2006\n\n2006\n\n11-1470000-001143-01\n\n(생물의약품평가자료집\n\n34)\n\n세포조직공학제제팀 자료실 간행물\n\n/\n\n,\n\n지침/145\n\n만성 피부 궤양 및 화상\n\n치료제 개발을 위한\n\n전임상 및\n\n임상 관련\n\n고려사항\n\n2006\n\n11-1470000-001228-01\n\n(생물의약품평가자료집\n\n33)\n\n세포조직공학제제팀 자료실 간행물\n\n/\n\n,\n\n지침/144\n\n- - 17 -\n행정간행물 제목\n\n발행\n\n연도\n\n행정간행물 번호\n\n발행과\n\n홈페이지\n\n게재 상태\n\n미국 약전 세포치료제,\n\n유전자치료제 및\n\n조직공학제제의 보조물질\n\n(ancillary product)\n\n평가자료집\n\n2006\n\n11-1470000-001109-01\n\n(생물의약품평가자료집\n\n32)\n\n세포조직공학제제팀\n\n유전자치료제팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/143\n\n미국 약전 세포치료제 및\n\n유전자치료제\n\n2006\n\n11-1470000-001108-01\n\n(생물의약품평가자료집\n\n31)\n\n세포조직공학제제팀\n\n유전자치료제팀\n\n자료실 간행물\n\n/\n\n,\n\n지침 142\n\n백신의 안전성 유효성\n\n․\n\n평가 2006\n\n2006\n\n11-1470000-001125-01\n\n(생물의약품평가자료집\n\n30)\n\n세균백신팀\n\n바이러스백신팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/141\n\n인플루엔자 백신\n\n자가 기준 및 시험방법\n\n작성 지침\n\n2006\n\n11-1470000-001114-01\n\n(생물의약품평가자료집\n\n29)\n\n바이러스백신팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/138\n\n생명공학의약품 길라잡이\n\n2005\n\n11-1470000-000893-01\n\n(생물의약품평가자료집\n\n27)\n\n재조합의약품팀\n\n생명공학의약품과\n\n(\n\n)\n\n舊\n\n자료실 간행물\n\n/\n\n,\n\n지침/109\n\n탄저백신의 안전성 유효성\n\n․\n\n평가 2005\n\n2005\n\n11-1470000-000867-01\n\n(생물의약품평가자료집\n\n22)\n\n생물의약품평가과\n\n자료실 간행물\n\n/\n\n,\n\n지침/99\n\n인플루엔자백신의\n\n안전성 유효성 평가 2005\n\n․\n\n2005\n\n11-1470000-000866-01\n\n(생물의약품평가자료집\n\n21)\n\n생물의약품평가과\n\n자료실 간행물\n\n/\n\n,\n\n지침/98\n\n항암 생물의약품의\n\n안전성 유효성 평가\n\n․\n\n2005\n\n11-1470000-000865-01\n\n(생물의약품평가자료집\n\n20)\n\n생물의약품평가과\n\n자료실 간행물\n\n/\n\n,\n\n지침/101\n\n- - 18 -\n행정간행물 제목\n\n발행\n\n연도\n\n행정간행물 번호\n\n발행과\n\n홈페이지\n\n게재 상태\n\n우수심사기준\n\n2005\n\n11-1470000-000684-01\n\n(생물의약품평가자료집\n\n19)\n\n생물의약품평가과\n\n자료실 간행물\n\n/\n\n,\n\n지침/100\n\n사람 세포\n\n조직\n\n세포 및\n\n,\n\n,\n\n조직유래제품\n\n: 미\n\nFDA\n\n시설등록 및 등재 규정\n\n2005\n\n11-1470000-000860-01\n\n(생물의약품평가자료집\n\n18)\n\n생명공학의약품과\n\n인체조직정보\n\n방 자료게시판\n\n/\n\n/\n\n4\n\n사람 세포\n\n조직\n\n세포 및\n\n,\n\n,\n\n조직유래제품 제조시설의\n\n미\n\nFDA 우수조직관리기준\n\n2005\n\n11-1470000-000859-01\n\n(생물의약품평가자료집\n\n17)\n\n생명공학의약품과\n\n인체조직정보\n\n방 자료게시판\n\n/\n\n/\n\n5\n\n세포치료제 및\n\n유전자치료제 자료집\n\n2004\n\n11-1470000-000685-01\n\n(생물의약품평가자료집\n\n16)\n\n생물의약품평가과\n\n자료실 간행물\n\n/\n\n,\n\n지침/78\n\n생명공학의약품등의\n\n1상\n\n임상시험계획 승인 신청시\n\n고려사항\n\n2004\n\n11-1470000-000683-01\n\n(생물의약품평가자료집\n\n14)\n\n생물의약품평가과\n\n자료실 간행물\n\n/\n\n,\n\n지침/83\n\n생물의약품등의\n\n효능입증을 위한 고려사항 2004\n\n11-1470000-000682-01\n\n(생물의약품평가자료집\n\n13)\n\n생물의약품평가과\n\n자료실 간행물\n\n/\n\n,\n\n지침/82\n\n혈액제제의 안전성 유효성\n\n․\n\n평가 2004\n\n2004\n\n11-1470000-000679-14\n\n(생물의약품평가자료집\n\n10)\n\n생물의약품평가과\n\n자료실 간행물\n\n/\n\n,\n\n지침/76\n\n세포치료제의\n\n안전성 유효성 평가시\n\n․\n\n고려사항 2004\n\n2004\n\n11-1470000-000678-14\n\n(생물의약품평가자료집\n\n9)\n\n생물의약품평가과\n\n자료실 간행물\n\n/\n\n,\n\n지침/75\n\n유전자치료제의\n\n안전성평가 2004\n\n2004\n\n11-1470000-000677-14\n\n(생물의약품평가자료집\n\n8)\n\n생물의약품평가과\n\n자료실 간행물\n\n/\n\n,\n\n지침/72\n\n생명공학의약품의\n\n안전성평가(4)\n\n2004\n\n11-1470000-000676-14\n\n(생물의약품평가자료집\n\n7)\n\n생물의약품평가과\n\n자료실 간행물\n\n/\n\n,\n\n지침/71\n\n- - 19 -\n행정간행물 제목\n\n발행\n\n연도\n\n행정간행물 번호\n\n발행과\n\n홈페이지\n\n게재 상태\n\n생명공학의약품의\n\n안전성평가(3)\n\n2004\n\n11-1470000-000676-14\n\n(생물의약품평가자료집\n\n6)\n\n생물의약품평가과\n\n자료실 간행물\n\n/\n\n,\n\n지침/70\n\n생명공학의약품의\n\n안전성평가(2)\n\n2004\n\n11-1470000-000676-14\n\n(생물의약품평가자료집\n\n5)\n\n생물의약품평가과\n\n자료실 간행물\n\n/\n\n,\n\n지침/69\n\n생명공학의약품의\n\n안전성평가(1)\n\n2004\n\n11-1470000-000676-14\n\n(생물의약품평가자료집\n\n4)\n\n생물의약품평가과\n\n자료실 간행물\n\n/\n\n,\n\n지침/68\n\n백신의 안전성평가 2004\n\n2004\n\n11-1470000-000675-14\n\n(생물의약품평가자료집\n\n3)\n\n생물의약품평가과\n\n자료실 간행물\n\n/\n\n,\n\n지침/67\n\n진단제제의\n\n기준\n\nHBsAg\n\n‘\n\n및 시험방법\n\n’ 작성 지침\n\n2004\n\n11-1470000-000143-01\n\n(생물의약품평가자료집\n\n2)\n\n백신과\n\n자료실 간행물\n\n/\n\n,\n\n지침/48\n\n<!-- PAGE_28 -->\n###### 발\n\n<!-- PAGE_28 -->\n###### 행\n\n<!-- PAGE_28 -->\n###### 부\n\n<!-- PAGE_28 -->\n###### 서\n\n<!-- PAGE_28 -->\n###### 생물의약품국 혈액제제과\n\n<!-- PAGE_28 -->\n###### :\n\n════════════════════════════════════════════\n\n<!-- PAGE_28 -->\n###### 연\n\n<!-- PAGE_28 -->\n###### 락\n\n<!-- PAGE_28 -->\n###### 처\n\n<!-- PAGE_28 -->\n###### 식품의약품안전청 혈액제제과\n\n<!-- PAGE_28 -->\n###### :\n\n<!-- PAGE_28 -->\n###### 전\n\n<!-- PAGE_28 -->\n###### 화\n\n<!-- PAGE_28 -->\n###### 번\n\n<!-- PAGE_28 -->\n###### 호 :\n\n<!-- PAGE_28 -->\n###### 02) 380-1715, 1765\n\n<!-- PAGE_28 -->\n###### 팩\n\n<!-- PAGE_28 -->\n###### 스\n\n<!-- PAGE_28 -->\n###### 번\n\n<!-- PAGE_28 -->\n###### 호 :\n\n<!-- PAGE_28 -->\n###### 02) 386-6584\n",
        "original_sentence": "<!-- PAGE_20 -->\n###### 생물의약품평가가이드 시리즈\n\n<!-- PAGE_20 -->\n###### 2.\n\n"
      }
    },
    {
      "chunk_id": "chunk_164",
      "text": "행정간행물 제목\n\n발행\n\n연도\n\n행정간행물 번호\n\n발행과\n\n홈페이지\n\n게재 상태\n\n생물의약품 국가표준품\n\n카다로그 (2008)\n\n2008\n\n11-1470000-000547-10\n\n생물진단의약품과\n\n자료실 간행물\n\n/\n\n,\n\n지침/\n\n생물의약품 국가표준품\n\n카다로그 (2006)\n\n2006\n\n11-1470000-000547-10\n\n생물진단제제팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/159\n\n생물의약품 국가표준품\n\n카다로그 (2004)\n\n2004\n\n11-1470000-000547-10\n\n생물의약품규격과\n\n자료실 간행물\n\n/\n\n,\n\n지침/56\n\n생물의약품 국가표준품\n\n카다로그 (2003)\n\n2003\n\n11-1470000-000547-10\n\n생물의약품규격과\n\n자료실 간행물\n\n/\n\n,\n\n지침/43\n\n생물의약품 국가표준품\n\n카다로그 (2002)\n\n2002\n\n11-1470000-000547-10\n\n백신과\n\n바이러스제제과\n\n(\n\n)\n\n舊\n\n자료실 간행물\n\n/\n\n,\n\n지침/22, 23\n\n행정간행물 제목\n\n발행\n\n연도\n\n행정간행물 번호\n\n발행과\n\n홈페이지\n\n게재 상태\n\n생물의약품\n\n국제공통기술문서 작성\n\n가이드라인 해설\n\n- -III. ",
      "metadata": {
        "source": "(가이드라인-005)_정맥주사용+B형간염+사람면역글로불린제제의+안전성유효성+평가+가이드라인.pdf",
        "chunk_index": 163,
        "window_size": 3,
        "char_count": 575,
        "word_count": 92,
        "page_number": 8,
        "window_text": "Safety,\n\n<!-- PAGE_19 -->\n###### Efficacy,\n\n<!-- PAGE_19 -->\n###### and\n\n<!-- PAGE_19 -->\n###### Pharmacokinetic\n\n<!-- PAGE_19 -->\n###### Studies\n\n<!-- PAGE_19 -->\n###### to\n\n<!-- PAGE_19 -->\n###### Support\n\n<!-- PAGE_19 -->\n###### Marketing\n\n<!-- PAGE_19 -->\n###### of\n\n<!-- PAGE_19 -->\n###### Immune Globulin Intravenous(Human)\n\n<!-- PAGE_19 -->\n###### as Replacement Therapy\n\n<!-- PAGE_19 -->\n###### for Primary\n\n<!-- PAGE_19 -->\n###### Humoral Immunodeficiency, CBER, FDA, 2008\n\n<!-- PAGE_19 -->\n###### 10.  Guidance\n\n<!-- PAGE_19 -->\n###### for Industry\n\n<!-- PAGE_19 -->\n###### Pharmacokinetics\n\n<!-- PAGE_19 -->\n###### in Patients\n\n<!-- PAGE_19 -->\n###### with Impaired\n\n<!-- PAGE_19 -->\n###### Hepatic\n\n<!-- PAGE_19 -->\n###### Function: Study Design, Data Analysis, and Impact on Dosing and Labeling,\n\n<!-- PAGE_19 -->\n###### CDER, FDA, 2003\n\n- - 12 -\n<!-- PAGE_20 -->\n###### 생물의약품국에서 발간한 행정간행물 목록\n\n<!-- PAGE_20 -->\n###### 생물의약품 국가표준품 카다로그 시리즈\n\n<!-- PAGE_20 -->\n###### 1.\n\n <!-- PAGE_20 -->\n###### 생물의약품평가가이드 시리즈\n\n<!-- PAGE_20 -->\n###### 2.\n\n 행정간행물 제목\n\n발행\n\n연도\n\n행정간행물 번호\n\n발행과\n\n홈페이지\n\n게재 상태\n\n생물의약품 국가표준품\n\n카다로그 (2008)\n\n2008\n\n11-1470000-000547-10\n\n생물진단의약품과\n\n자료실 간행물\n\n/\n\n,\n\n지침/\n\n생물의약품 국가표준품\n\n카다로그 (2006)\n\n2006\n\n11-1470000-000547-10\n\n생물진단제제팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/159\n\n생물의약품 국가표준품\n\n카다로그 (2004)\n\n2004\n\n11-1470000-000547-10\n\n생물의약품규격과\n\n자료실 간행물\n\n/\n\n,\n\n지침/56\n\n생물의약품 국가표준품\n\n카다로그 (2003)\n\n2003\n\n11-1470000-000547-10\n\n생물의약품규격과\n\n자료실 간행물\n\n/\n\n,\n\n지침/43\n\n생물의약품 국가표준품\n\n카다로그 (2002)\n\n2002\n\n11-1470000-000547-10\n\n백신과\n\n바이러스제제과\n\n(\n\n)\n\n舊\n\n자료실 간행물\n\n/\n\n,\n\n지침/22, 23\n\n행정간행물 제목\n\n발행\n\n연도\n\n행정간행물 번호\n\n발행과\n\n홈페이지\n\n게재 상태\n\n생물의약품\n\n국제공통기술문서 작성\n\n가이드라인 해설\n\n- -III.  품질\n2007\n\n11-1470000-001625-14\n\n(생물의약품평가가이드\n\n34)\n\n재조합의약품과\n\n바이러스백신과\n\n혈액제제과\n\n유전자치료제과\n\n세포조직공학제제과\n\n자료실 간행물\n\n/\n\n,\n\n지침/315\n\nHBsAg 진단제제의 기준\n\n및 시험방법 작성 지침\n\n2008\n\n11-1470000-000143-01\n\n(생물의약품평가가이드\n\n33)\n\n생물진단의약품과\n\n자료실 간행물\n\n/\n\n,\n\n지침/289\n\n혈장수출업소 실태조사\n\n지침\n\n2007\n\n11-1470000-001627-01\n\n(생물의약품평가가이드\n\n32)\n\n생물의약품관리팀\n\n혈액제제팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/234\n\nHIV, HBV, HCV, HTLV\n\n관련 체외진단용의약품\n\n안전성 유효성 심사평가\n\n․\n\n지침서\n\n2007\n\n11-1470000-001622-01\n\n(생물의약품평가가이드\n\n31)\n\n생물진단제제팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/252\n\n대유행 인플루엔자 백신의\n\n임상시험 평가 가이드 안\n\n(\n\n)\n\n2007\n\n11-1470000-001621-01\n\n(생물의약품평가가이드\n\n30)\n\n바이러스백신팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/228\n\n바이러스백신\n\n자가품질관리요약서(\n\nⅠ)\n\n2007\n\n11-1470000-001620-01\n\n(생물의약품평가가이드\n\n29)\n\n바이러스백신팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/227\n\n- - 13 -\n행정간행물 제목\n\n발행\n\n연도\n\n행정간행물 번호\n\n발행과\n\n홈페이지\n\n게재 상태\n\n불활화 인플루엔자백신\n\n평가 지침\n\n2007\n\n11-1470000-001587-01\n\n(생물의약품평가가이드\n\n28)\n\n바이러스백신팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/226\n\n당단백질의약품의 당구조\n\n분석 시험법 길라잡이\n\n2007\n\n11-1470000-001589-01\n\n(생물의약품평가가이드\n\n27)\n\n재조합의약품팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/280\n\n류마티스관절염 치료제\n\n임상평가지침\n\n2007\n\n11-1470000-001432-01\n\n(생물의약품평가가이드\n\n26)\n\n재조합의약품팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/190\n\n분획용 혈장 마스터 파일\n\n가이드라인\n\n2007\n\n11-1470000-001560-01\n\n(생물의약품평가가이드\n\n25)\n\n생물의약품관리팀\n\n혈액제제팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/210\n\n인플루엔자백신의 자가\n\n기준 및 시험방법 작성\n\n지침 개정판\n\n(\n\n)\n\n2007\n\n11-1470000-001468-01\n\n(생물의약품평가가이드\n\n24)\n\n바이러스백신팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/197\n\nHIV 항체 진단제제의\n\n기준 및 시험방법\n\n작성\n\n‘\n\n’\n\n지침\n\n2007\n\n11-1470000-001462-01\n\n(생물의약품평가가이드\n\n23)\n\n생물진단제제팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/196\n\n세균백신 자가 기준 및\n\n시험방법 작성 지침서\n\n2007\n\n11-1470000-001428-01\n\n(생물의약품평가가이드\n\n22)\n\n세균백신팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/177\n\n바이오 칩 평가 가이드\n\n- -HPV DNA칩 기준 및\n시험방법 작성 지침-\n\n2006\n\n11-1470000-001165-01\n\n(생물의약품평가가이드\n\n21)\n\n생물진단제제팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/154\n\n혈장분획제제 등 바이러스\n\n검증 평가 가이드\n\n2006\n\n11-1470000-001176-01\n\n(생물의약품평가가이드\n\n20)\n\n혈액제제팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/170\n\n유전자재조합의약품\n\n생산용 세포의 발현구조체\n\n분석 및 안정성\n\n평가가이드\n\n2006\n\n11-1470000-001116-01\n\n(생물의약품평가가이드\n\n19)\n\n재조합의약품팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/229\n\n유전재재조합의약품 및\n\n단클론항체의약품의 제조\n\n및 품질관리 자료에 관한\n\n평가가이드\n\n2006\n\n11-1470000-000902-01\n\n(생물의약품평가가이드\n\n18)\n\n재조합의약품팀\n\n생물의약품관리팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/139\n\n이종이식제제의 전임상 및\n\n임상시험에 대한 가이드\n\n2006\n\n11-1470000-001088-01\n\n(생물의약품평가가이드\n\n17)\n\n세포조직공학제제팀\n\n재조합의약품팀\n\n생물의약품안전팀\n\n생물의약품관리팀\n\n국립독성연구원\n\n생명공학지원팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/130\n\n- - 14 -\n행정간행물 제목\n\n발행\n\n연도\n\n행정간행물 번호\n\n발행과\n\n홈페이지\n\n게재 상태\n\n이종이식제제의 품질관리\n\n및 이식 후 감염관리에\n\n대한 가이드\n\n2006\n\n11-1470000-001086-01\n\n(생물의약품평가가이드\n\n16)\n\n세포조직공학제제팀\n\n재조합의약품팀\n\n생물의약품안전팀\n\n생물의약품관리팀\n\n국립독성연구원\n\n생명공학지원팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/130\n\n자료실 간행물\n\n/\n\n,\n\n지침/130\n\n자료실 간행물\n\n/\n\n,\n\n지침/116\n\n자료실 간행물\n\n/\n\n,\n\n지침/110\n\n자료실 간행물\n\n/\n\n,\n\n지침/118\n\n임상시험용\n\n유전자치료제의 특성분석,\n\n제조 및 품질관리\n\n평가가이드\n\n2005\n\n11-1470000-000876-01\n\n(생물의약품평가가이드\n\n11)\n\n생명공학의약품과\n\n자료실 간행물\n\n/\n\n,\n\n지침/107\n\n두창백신의 안전성 유효성\n\n․\n\n평가시 고려사항\n\n2005\n\n11-1470000-000872-01\n\n(생물의약품평가가이드\n\n10)\n\n생물의약품평가과\n\n자료실 간행물\n\n/\n\n,\n\n지침/105\n\n**[표 시작]**\n\n| 2004 | 11-1470000-000684-01 | (생물의약품평가자료집 | 15) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/84 |\n| --- | --- | --- | --- | --- | --- | --- | --- | --- |\n| 생명공학의약품 허가를 | 위한 Q&A | 2006 | 11-1470000-000895-01 | (생물의약품평가자료집 | 28) | 재조합의약품팀 | 생명공학의약품과 | ( | ) | 舊 | 자료실 간행물 | / | , | 지침127 |\n| 유전자치료제의 | 안전성평가 2006 | 2006 | 11-1470000-001140-01 | (생물의약품평가자료집 | 38) | 유전자치료제팀 | 자료실 간행물 | / | , | 지침/169 |\n| 행정간행물 제목 | 발행 | 연도 | 행정간행물 번호 | 발행과 | 홈페이지 | 게재 상태 |\n| 세포치료제의 | 안전성 유효성 및 품질 | ․ | 평가 2006 | 2006 | 11-1470000-001146-01 | (생물의약품평가자료집 | 37) | 세포조직공학제제팀 자료실 간행물 | / | , | 지침/148 | KFDA Bio Handbook | 2005 | 11-1470000-000873-01 | (생물의약품평가자료집 | 26) | 생명공학의약품과 | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/91 |\n| 세포치료제의 임상시험 | 사례분석 | 2007 | 11-1470000-001586-14 | (생물의약품평가자료집 | 50) | 세포조직공학제제팀 자료실 간행물 | / | , | 지침/259 |\n| 생명공학의약품의 | 안전성 유효성 평가 - | ․ | 비교동등성 평가시 | 고려사항 |\n| 정맥주사용 | B형 간염 사람면역글로불린제제의 | 안전성․유효성 평가 가이드라인 |\n| 임상시험의 전반적인 | 고려사항 | 2004 | 11-1470000-000681-01 | (생물의약품평가자료집 | 12) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/79 | 2005 | 11-1470000-000871-01 | (생물의약품평가자료집 | 25) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/103 |\n| 생명공학의약품 | 생산세포주 관리를 위한 | 시험방법 | 2007 | 11-1470000-000903-01 | (생물의약품평가자료집 | 48) | 재조합의약품팀 | 자료실 간행물 | / | , | 지침/236 | 생물의약품의 독성평가 | 사례분석 | 2004 | 11-1470000-000680-01 | (생물의약품평가자료집 | 11) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/77 |\n**════════════════════════════════════════════**\n| 유전자치료제의 | 안전성평가 2005 | 2005 | 11-1470000-000677-14 | (생물의약품평가자료집 | 24) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/104 |\n| 발 | 행 | 일 | 년 | 월 | : | 2008 | 12 |\n| 2006 | 11-1470000-001144-01 | (생물의약품평가자료집 | 35) | 자료실 간행물 | / | , | 지침/146 |\n| 발 | 행 | 기 | 관 | 식품의약품안전청 | : |\n| 백신의 안전성 유효성 | ․ | 평가 2005 | 2005 | 11-1470000-000870-01 | (생물의약품평가자료집 | 23) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/102 | 단클론항체의약품의 | 평가가이드 | 2005 | 11-1470000-000851-01 | (생물의약품평가가이드 | 9) | 자료실 간행물 | / | , | 지침/74 |\n\n**[표 끝]**\n\n생명공학의약품과\n\n생물의약품평가과\n\n국립독성연구원\n\n생화학약리과\n\nTNF 길항제 사용시\n\n잠복결핵 치료지침\n\n2005\n\n11-1470000-000686-01\n\n(생물의약품평가가이드\n\n8)\n\n생물의약품평가과\n\n자료실 간행물\n\n/\n\n,\n\n지침/65\n\nDNA 백신의 평가지침서\n\n2004\n\n11-1470000-000669-01\n\n(생물의약품평가가이드\n\n7)\n\n생명공학의약품과\n\n생물의약품평가과\n\n자료실 간행물\n\n/\n\n,\n\n지침/60\n\n생명공학의약품/\n\n생물학적제제의\n\n규격설정에 관한 가이드\n\n2004\n\n11-1470000-000538-01\n\n(생물의약품평가가이드\n\n6)\n\n생명공학의약품과\n\n자료실 간행물\n\n/\n\n,\n\n지침/59\n\n- - 15 -\n<!-- PAGE_23 -->\n###### 생물의약품평가자료집 시리즈\n\n<!-- PAGE_23 -->\n###### 3.\n\n 행정간행물 제목\n\n발행\n\n연도\n\n행정간행물 번호\n\n발행과\n\n홈페이지\n\n게재 상태\n\n핵산증폭검사법 검증\n\n가이드라인\n\n2003\n\n11-1470000-000277-01\n\n(생물의약품평가가이드\n\n5)\n\n혈액제제과\n\n자료실 간행물\n\n/\n\n,\n\n지침/44\n\n혈장분획제제\n\n품질평가 가이드\n\n2002\n\n11-1470000-000154-01\n\n(생물의약품평가가이드\n\n4)\n\n혈액제제과\n\n자료실 간행물\n\n/\n\n,\n\n지침/27\n\n2002\n\n11-1470000-000144-01\n\n(생물의약품평가가이드\n\n3)\n\n백신과\n\n바이러스제제과\n\n(\n\n)\n\n舊\n\n자료실 간행물\n\n/\n\n,\n\n지침/19\n\n생물의약품의 생산에\n\n사용되는 세포기질관리\n\n가이드\n\n2002\n\n11-1470000-000140-14\n\n(생물의약품평가가이드\n\n2)\n\n생명공학의약품과\n\n생물공학과\n\n(\n\n)\n\n舊\n\n자료실 간행물\n\n/\n\n,\n\n지침/17\n\n유전자치료제의\n\n품질평가 가이드\n\n2001\n\n11-1470000-000074-14\n\n(생물의약품평가가이드\n\n1)\n\n생명공학의약품과\n\n생물공학과\n\n(\n\n)\n\n舊\n\n자료실 간행물\n\n/\n\n,\n\n지침/54\n\n세포치료제의 비임상시험\n\n사례분석\n\n2007\n\n11-1470000-001585-14\n\n(생물의약품평가자료집\n\n49)\n\n세포조직공학제제팀 자료실 간행물\n\n/\n\n,\n\n지침/259\n\n혈액제제의 자가 기준 및\n\n시험방법 작성 지침\n\n2007\n\n11-1470000-001457-01\n\n(생물의약품평가자료집\n\n47)\n\n혈액제제팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/195\n\n혈관질환 등의\n\n유전자치료제\n\n비임상 임상시험 사례분석\n\n∙\n\n2007\n\n11-1470000-001441-10\n\n(생물의약품평가자료집\n\n46)\n\n유전자치료제팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/233\n\n항암 유전자치료제\n\n비임상 임상시험 사례분석\n\n∙\n\n2007\n\n11-1470000-001440-10\n\n(생물의약품평가자료집\n\n45)\n\n유전자치료제팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/209\n\n백신 임상 평가 시\n\n고려사항 2007\n\n2007\n\n11-1470000-001446-10\n\n(생물의약품평가자료집\n\n44)\n\n세균백신팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/192\n\n- - 16 -\n행정간행물 제목\n\n발행\n\n연도\n\n행정간행물 번호\n\n발행과\n\n홈페이지\n\n게재 상태\n\n생바이러스 백신의\n\n자가 기준 및 시험방법\n\n작성 지침\n\n2007\n\n11-1470000-001345-01\n\n(생물의약품평가자료집\n\n43)\n\n바이러스백신팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/172\n\n불활화 바이러스 백신의\n\n자가 기준 및 시험방법\n\n작성 지침\n\n2007\n\n11-1470000-001346-01\n\n(생물의약품평가자료집\n\n42)\n\n바이러스백신팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/173\n\n백신의 임상 평가 시\n\n고려사항\n\n2006\n\n11-1470000-001163-01\n\n(생물의약품평가자료집\n\n41)\n\n바이러스백신팀\n\n세균백신팀\n\n자료실 간행물\n\n/\n\n,\n\n지침 150\n\nDNA 백신의 평가\n\n:\n\nWHO 및 미국\n\nFDA\n\n가이드라인\n\n2006\n\n11-1470000-001142-01\n\n(생물의약품평가자료집\n\n40)\n\n유전자치료제팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/168\n\n유전자치료 임상시험-\n\n지연성 이상반응에 대비한\n\n환자 관찰\n\n2006\n\n11-1470000-001141-01\n\n(생물의약품평가자료집\n\n39)\n\n유전자치료제팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/157\n\n세포치료제 안전성 유효성\n\n․\n\n및 품질 평가시 고려사항\n\n2006\n\n2006\n\n11-1470000-001145-01\n\n(생물의약품평가자료집\n\n36)\n\n세포조직공학제제팀 자료실 간행물\n\n/\n\n,\n\n지침/147\n\n세포조직공학제제\n\n(세포치료제\n\n,\n\n조직공학제제,\n\n이종이식제제\n\n가이드라인\n\n)\n\n세포조직공학제제팀\n\n세균백신팀\n\n바이러스백신팀\n\n혈액제제팀\n\n재조합의약품팀\n\n유전자치료제팀\n\n생물 생명공학의약품의\n\n․\n\n독성평가 사례분석 2006\n\n2006\n\n11-1470000-001143-01\n\n(생물의약품평가자료집\n\n34)\n\n세포조직공학제제팀 자료실 간행물\n\n/\n\n,\n\n지침/145\n\n만성 피부 궤양 및 화상\n\n치료제 개발을 위한\n\n전임상 및\n\n임상 관련\n\n고려사항\n\n2006\n\n11-1470000-001228-01\n\n(생물의약품평가자료집\n\n33)\n\n세포조직공학제제팀 자료실 간행물\n\n/\n\n,\n\n지침/144\n\n- - 17 -\n행정간행물 제목\n\n발행\n\n연도\n\n행정간행물 번호\n\n발행과\n\n홈페이지\n\n게재 상태\n\n미국 약전 세포치료제,\n\n유전자치료제 및\n\n조직공학제제의 보조물질\n\n(ancillary product)\n\n평가자료집\n\n2006\n\n11-1470000-001109-01\n\n(생물의약품평가자료집\n\n32)\n\n세포조직공학제제팀\n\n유전자치료제팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/143\n\n미국 약전 세포치료제 및\n\n유전자치료제\n\n2006\n\n11-1470000-001108-01\n\n(생물의약품평가자료집\n\n31)\n\n세포조직공학제제팀\n\n유전자치료제팀\n\n자료실 간행물\n\n/\n\n,\n\n지침 142\n\n백신의 안전성 유효성\n\n․\n\n평가 2006\n\n2006\n\n11-1470000-001125-01\n\n(생물의약품평가자료집\n\n30)\n\n세균백신팀\n\n바이러스백신팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/141\n\n인플루엔자 백신\n\n자가 기준 및 시험방법\n\n작성 지침\n\n2006\n\n11-1470000-001114-01\n\n(생물의약품평가자료집\n\n29)\n\n바이러스백신팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/138\n\n생명공학의약품 길라잡이\n\n2005\n\n11-1470000-000893-01\n\n(생물의약품평가자료집\n\n27)\n\n재조합의약품팀\n\n생명공학의약품과\n\n(\n\n)\n\n舊\n\n자료실 간행물\n\n/\n\n,\n\n지침/109\n\n탄저백신의 안전성 유효성\n\n․\n\n평가 2005\n\n2005\n\n11-1470000-000867-01\n\n(생물의약품평가자료집\n\n22)\n\n생물의약품평가과\n\n자료실 간행물\n\n/\n\n,\n\n지침/99\n\n인플루엔자백신의\n\n안전성 유효성 평가 2005\n\n․\n\n2005\n\n11-1470000-000866-01\n\n(생물의약품평가자료집\n\n21)\n\n생물의약품평가과\n\n자료실 간행물\n\n/\n\n,\n\n지침/98\n\n항암 생물의약품의\n\n안전성 유효성 평가\n\n․\n\n2005\n\n11-1470000-000865-01\n\n(생물의약품평가자료집\n\n20)\n\n생물의약품평가과\n\n자료실 간행물\n\n/\n\n,\n\n지침/101\n\n- - 18 -\n행정간행물 제목\n\n발행\n\n연도\n\n행정간행물 번호\n\n발행과\n\n홈페이지\n\n게재 상태\n\n우수심사기준\n\n2005\n\n11-1470000-000684-01\n\n(생물의약품평가자료집\n\n19)\n\n생물의약품평가과\n\n자료실 간행물\n\n/\n\n,\n\n지침/100\n\n사람 세포\n\n조직\n\n세포 및\n\n,\n\n,\n\n조직유래제품\n\n: 미\n\nFDA\n\n시설등록 및 등재 규정\n\n2005\n\n11-1470000-000860-01\n\n(생물의약품평가자료집\n\n18)\n\n생명공학의약품과\n\n인체조직정보\n\n방 자료게시판\n\n/\n\n/\n\n4\n\n사람 세포\n\n조직\n\n세포 및\n\n,\n\n,\n\n조직유래제품 제조시설의\n\n미\n\nFDA 우수조직관리기준\n\n2005\n\n11-1470000-000859-01\n\n(생물의약품평가자료집\n\n17)\n\n생명공학의약품과\n\n인체조직정보\n\n방 자료게시판\n\n/\n\n/\n\n5\n\n세포치료제 및\n\n유전자치료제 자료집\n\n2004\n\n11-1470000-000685-01\n\n(생물의약품평가자료집\n\n16)\n\n생물의약품평가과\n\n자료실 간행물\n\n/\n\n,\n\n지침/78\n\n생명공학의약품등의\n\n1상\n\n임상시험계획 승인 신청시\n\n고려사항\n\n2004\n\n11-1470000-000683-01\n\n(생물의약품평가자료집\n\n14)\n\n생물의약품평가과\n\n자료실 간행물\n\n/\n\n,\n\n지침/83\n\n생물의약품등의\n\n효능입증을 위한 고려사항 2004\n\n11-1470000-000682-01\n\n(생물의약품평가자료집\n\n13)\n\n생물의약품평가과\n\n자료실 간행물\n\n/\n\n,\n\n지침/82\n\n혈액제제의 안전성 유효성\n\n․\n\n평가 2004\n\n2004\n\n11-1470000-000679-14\n\n(생물의약품평가자료집\n\n10)\n\n생물의약품평가과\n\n자료실 간행물\n\n/\n\n,\n\n지침/76\n\n세포치료제의\n\n안전성 유효성 평가시\n\n․\n\n고려사항 2004\n\n2004\n\n11-1470000-000678-14\n\n(생물의약품평가자료집\n\n9)\n\n생물의약품평가과\n\n자료실 간행물\n\n/\n\n,\n\n지침/75\n\n유전자치료제의\n\n안전성평가 2004\n\n2004\n\n11-1470000-000677-14\n\n(생물의약품평가자료집\n\n8)\n\n생물의약품평가과\n\n자료실 간행물\n\n/\n\n,\n\n지침/72\n\n생명공학의약품의\n\n안전성평가(4)\n\n2004\n\n11-1470000-000676-14\n\n(생물의약품평가자료집\n\n7)\n\n생물의약품평가과\n\n자료실 간행물\n\n/\n\n,\n\n지침/71\n\n- - 19 -\n행정간행물 제목\n\n발행\n\n연도\n\n행정간행물 번호\n\n발행과\n\n홈페이지\n\n게재 상태\n\n생명공학의약품의\n\n안전성평가(3)\n\n2004\n\n11-1470000-000676-14\n\n(생물의약품평가자료집\n\n6)\n\n생물의약품평가과\n\n자료실 간행물\n\n/\n\n,\n\n지침/70\n\n생명공학의약품의\n\n안전성평가(2)\n\n2004\n\n11-1470000-000676-14\n\n(생물의약품평가자료집\n\n5)\n\n생물의약품평가과\n\n자료실 간행물\n\n/\n\n,\n\n지침/69\n\n생명공학의약품의\n\n안전성평가(1)\n\n2004\n\n11-1470000-000676-14\n\n(생물의약품평가자료집\n\n4)\n\n생물의약품평가과\n\n자료실 간행물\n\n/\n\n,\n\n지침/68\n\n백신의 안전성평가 2004\n\n2004\n\n11-1470000-000675-14\n\n(생물의약품평가자료집\n\n3)\n\n생물의약품평가과\n\n자료실 간행물\n\n/\n\n,\n\n지침/67\n\n진단제제의\n\n기준\n\nHBsAg\n\n‘\n\n및 시험방법\n\n’ 작성 지침\n\n2004\n\n11-1470000-000143-01\n\n(생물의약품평가자료집\n\n2)\n\n백신과\n\n자료실 간행물\n\n/\n\n,\n\n지침/48\n\n<!-- PAGE_28 -->\n###### 발\n\n<!-- PAGE_28 -->\n###### 행\n\n<!-- PAGE_28 -->\n###### 부\n\n<!-- PAGE_28 -->\n###### 서\n\n<!-- PAGE_28 -->\n###### 생물의약품국 혈액제제과\n\n<!-- PAGE_28 -->\n###### :\n\n════════════════════════════════════════════\n\n<!-- PAGE_28 -->\n###### 연\n\n<!-- PAGE_28 -->\n###### 락\n\n<!-- PAGE_28 -->\n###### 처\n\n<!-- PAGE_28 -->\n###### 식품의약품안전청 혈액제제과\n\n<!-- PAGE_28 -->\n###### :\n\n<!-- PAGE_28 -->\n###### 전\n\n<!-- PAGE_28 -->\n###### 화\n\n<!-- PAGE_28 -->\n###### 번\n\n<!-- PAGE_28 -->\n###### 호 :\n\n<!-- PAGE_28 -->\n###### 02) 380-1715, 1765\n\n<!-- PAGE_28 -->\n###### 팩\n\n<!-- PAGE_28 -->\n###### 스\n\n<!-- PAGE_28 -->\n###### 번\n\n<!-- PAGE_28 -->\n###### 호 :\n\n<!-- PAGE_28 -->\n###### 02) 386-6584\n",
        "original_sentence": "행정간행물 제목\n\n발행\n\n연도\n\n행정간행물 번호\n\n발행과\n\n홈페이지\n\n게재 상태\n\n생물의약품 국가표준품\n\n카다로그 (2008)\n\n2008\n\n11-1470000-000547-10\n\n생물진단의약품과\n\n자료실 간행물\n\n/\n\n,\n\n지침/\n\n생물의약품 국가표준품\n\n카다로그 (2006)\n\n2006\n\n11-1470000-000547-10\n\n생물진단제제팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/159\n\n생물의약품 국가표준품\n\n카다로그 (2004)\n\n2004\n\n11-1470000-000547-10\n\n생물의약품규격과\n\n자료실 간행물\n\n/\n\n,\n\n지침/56\n\n생물의약품 국가표준품\n\n카다로그 (2003)\n\n2003\n\n11-1470000-000547-10\n\n생물의약품규격과\n\n자료실 간행물\n\n/\n\n,\n\n지침/43\n\n생물의약품 국가표준품\n\n카다로그 (2002)\n\n2002\n\n11-1470000-000547-10\n\n백신과\n\n바이러스제제과\n\n(\n\n)\n\n舊\n\n자료실 간행물\n\n/\n\n,\n\n지침/22, 23\n\n행정간행물 제목\n\n발행\n\n연도\n\n행정간행물 번호\n\n발행과\n\n홈페이지\n\n게재 상태\n\n생물의약품\n\n국제공통기술문서 작성\n\n가이드라인 해설\n\n- -III. "
      }
    },
    {
      "chunk_id": "chunk_165",
      "text": "품질\n2007\n\n11-1470000-001625-14\n\n(생물의약품평가가이드\n\n34)\n\n재조합의약품과\n\n바이러스백신과\n\n혈액제제과\n\n유전자치료제과\n\n세포조직공학제제과\n\n자료실 간행물\n\n/\n\n,\n\n지침/315\n\nHBsAg 진단제제의 기준\n\n및 시험방법 작성 지침\n\n2008\n\n11-1470000-000143-01\n\n(생물의약품평가가이드\n\n33)\n\n생물진단의약품과\n\n자료실 간행물\n\n/\n\n,\n\n지침/289\n\n혈장수출업소 실태조사\n\n지침\n\n2007\n\n11-1470000-001627-01\n\n(생물의약품평가가이드\n\n32)\n\n생물의약품관리팀\n\n혈액제제팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/234\n\nHIV, HBV, HCV, HTLV\n\n관련 체외진단용의약품\n\n안전성 유효성 심사평가\n\n․\n\n지침서\n\n2007\n\n11-1470000-001622-01\n\n(생물의약품평가가이드\n\n31)\n\n생물진단제제팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/252\n\n대유행 인플루엔자 백신의\n\n임상시험 평가 가이드 안\n\n(\n\n)\n\n2007\n\n11-1470000-001621-01\n\n(생물의약품평가가이드\n\n30)\n\n바이러스백신팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/228\n\n바이러스백신\n\n자가품질관리요약서(\n\nⅠ)\n\n2007\n\n11-1470000-001620-01\n\n(생물의약품평가가이드\n\n29)\n\n바이러스백신팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/227\n\n- - 13 -\n행정간행물 제목\n\n발행\n\n연도\n\n행정간행물 번호\n\n발행과\n\n홈페이지\n\n게재 상태\n\n불활화 인플루엔자백신\n\n평가 지침\n\n2007\n\n11-1470000-001587-01\n\n(생물의약품평가가이드\n\n28)\n\n바이러스백신팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/226\n\n당단백질의약품의 당구조\n\n분석 시험법 길라잡이\n\n2007\n\n11-1470000-001589-01\n\n(생물의약품평가가이드\n\n27)\n\n재조합의약품팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/280\n\n류마티스관절염 치료제\n\n임상평가지침\n\n2007\n\n11-1470000-001432-01\n\n(생물의약품평가가이드\n\n26)\n\n재조합의약품팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/190\n\n분획용 혈장 마스터 파일\n\n가이드라인\n\n2007\n\n11-1470000-001560-01\n\n(생물의약품평가가이드\n\n25)\n\n생물의약품관리팀\n\n혈액제제팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/210\n\n인플루엔자백신의 자가\n\n기준 및 시험방법 작성\n\n지침 개정판\n\n(\n\n)\n\n2007\n\n11-1470000-001468-01\n\n(생물의약품평가가이드\n\n24)\n\n바이러스백신팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/197\n\nHIV 항체 진단제제의\n\n기준 및 시험방법\n\n작성\n\n‘\n\n’\n\n지침\n\n2007\n\n11-1470000-001462-01\n\n(생물의약품평가가이드\n\n23)\n\n생물진단제제팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/196\n\n세균백신 자가 기준 및\n\n시험방법 작성 지침서\n\n2007\n\n11-1470000-001428-01\n\n(생물의약품평가가이드\n\n22)\n\n세균백신팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/177\n\n바이오 칩 평가 가이드\n\n- -HPV DNA칩 기준 및\n시험방법 작성 지침-\n\n2006\n\n11-1470000-001165-01\n\n(생물의약품평가가이드\n\n21)\n\n생물진단제제팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/154\n\n혈장분획제제 등 바이러스\n\n검증 평가 가이드\n\n2006\n\n11-1470000-001176-01\n\n(생물의약품평가가이드\n\n20)\n\n혈액제제팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/170\n\n유전자재조합의약품\n\n생산용 세포의 발현구조체\n\n분석 및 안정성\n\n평가가이드\n\n2006\n\n11-1470000-001116-01\n\n(생물의약품평가가이드\n\n19)\n\n재조합의약품팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/229\n\n유전재재조합의약품 및\n\n단클론항체의약품의 제조\n\n및 품질관리 자료에 관한\n\n평가가이드\n\n2006\n\n11-1470000-000902-01\n\n(생물의약품평가가이드\n\n18)\n\n재조합의약품팀\n\n생물의약품관리팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/139\n\n이종이식제제의 전임상 및\n\n임상시험에 대한 가이드\n\n2006\n\n11-1470000-001088-01\n\n(생물의약품평가가이드\n\n17)\n\n세포조직공학제제팀\n\n재조합의약품팀\n\n생물의약품안전팀\n\n생물의약품관리팀\n\n국립독성연구원\n\n생명공학지원팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/130\n\n- - 14 -\n행정간행물 제목\n\n발행\n\n연도\n\n행정간행물 번호\n\n발행과\n\n홈페이지\n\n게재 상태\n\n이종이식제제의 품질관리\n\n및 이식 후 감염관리에\n\n대한 가이드\n\n2006\n\n11-1470000-001086-01\n\n(생물의약품평가가이드\n\n16)\n\n세포조직공학제제팀\n\n재조합의약품팀\n\n생물의약품안전팀\n\n생물의약품관리팀\n\n국립독성연구원\n\n생명공학지원팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/130\n\n자료실 간행물\n\n/\n\n,\n\n지침/130\n\n자료실 간행물\n\n/\n\n,\n\n지침/116\n\n자료실 간행물\n\n/\n\n,\n\n지침/110\n\n자료실 간행물\n\n/\n\n,\n\n지침/118\n\n임상시험용\n\n유전자치료제의 특성분석,\n\n제조 및 품질관리\n\n평가가이드\n\n2005\n\n11-1470000-000876-01\n\n(생물의약품평가가이드\n\n11)\n\n생명공학의약품과\n\n자료실 간행물\n\n/\n\n,\n\n지침/107\n\n두창백신의 안전성 유효성\n\n․\n\n평가시 고려사항\n\n2005\n\n11-1470000-000872-01\n\n(생물의약품평가가이드\n\n10)\n\n생물의약품평가과\n\n자료실 간행물\n\n/\n\n,\n\n지침/105\n\n**[표 시작]**\n\n| 2004 | 11-1470000-000684-01 | (생물의약품평가자료집 | 15) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/84 |\n| --- | --- | --- | --- | --- | --- | --- | --- | --- |\n| 생명공학의약품 허가를 | 위한 Q&A | 2006 | 11-1470000-000895-01 | (생물의약품평가자료집 | 28) | 재조합의약품팀 | 생명공학의약품과 | ( | ) | 舊 | 자료실 간행물 | / | , | 지침127 |\n| 유전자치료제의 | 안전성평가 2006 | 2006 | 11-1470000-001140-01 | (생물의약품평가자료집 | 38) | 유전자치료제팀 | 자료실 간행물 | / | , | 지침/169 |\n| 행정간행물 제목 | 발행 | 연도 | 행정간행물 번호 | 발행과 | 홈페이지 | 게재 상태 |\n| 세포치료제의 | 안전성 유효성 및 품질 | ․ | 평가 2006 | 2006 | 11-1470000-001146-01 | (생물의약품평가자료집 | 37) | 세포조직공학제제팀 자료실 간행물 | / | , | 지침/148 | KFDA Bio Handbook | 2005 | 11-1470000-000873-01 | (생물의약품평가자료집 | 26) | 생명공학의약품과 | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/91 |\n| 세포치료제의 임상시험 | 사례분석 | 2007 | 11-1470000-001586-14 | (생물의약품평가자료집 | 50) | 세포조직공학제제팀 자료실 간행물 | / | , | 지침/259 |\n| 생명공학의약품의 | 안전성 유효성 평가 - | ․ | 비교동등성 평가시 | 고려사항 |\n| 정맥주사용 | B형 간염 사람면역글로불린제제의 | 안전성․유효성 평가 가이드라인 |\n| 임상시험의 전반적인 | 고려사항 | 2004 | 11-1470000-000681-01 | (생물의약품평가자료집 | 12) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/79 | 2005 | 11-1470000-000871-01 | (생물의약품평가자료집 | 25) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/103 |\n| 생명공학의약품 | 생산세포주 관리를 위한 | 시험방법 | 2007 | 11-1470000-000903-01 | (생물의약품평가자료집 | 48) | 재조합의약품팀 | 자료실 간행물 | / | , | 지침/236 | 생물의약품의 독성평가 | 사례분석 | 2004 | 11-1470000-000680-01 | (생물의약품평가자료집 | 11) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/77 |\n**════════════════════════════════════════════**\n| 유전자치료제의 | 안전성평가 2005 | 2005 | 11-1470000-000677-14 | (생물의약품평가자료집 | 24) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/104 |\n| 발 | 행 | 일 | 년 | 월 | : | 2008 | 12 |\n| 2006 | 11-1470000-001144-01 | (생물의약품평가자료집 | 35) | 자료실 간행물 | / | , | 지침/146 |\n| 발 | 행 | 기 | 관 | 식품의약품안전청 | : |\n| 백신의 안전성 유효성 | ․ | 평가 2005 | 2005 | 11-1470000-000870-01 | (생물의약품평가자료집 | 23) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/102 | 단클론항체의약품의 | 평가가이드 | 2005 | 11-1470000-000851-01 | (생물의약품평가가이드 | 9) | 자료실 간행물 | / | , | 지침/74 |\n\n**[표 끝]**\n\n생명공학의약품과\n\n생물의약품평가과\n\n국립독성연구원\n\n생화학약리과\n\nTNF 길항제 사용시\n\n잠복결핵 치료지침\n\n2005\n\n11-1470000-000686-01\n\n(생물의약품평가가이드\n\n8)\n\n생물의약품평가과\n\n자료실 간행물\n\n/\n\n,\n\n지침/65\n\nDNA 백신의 평가지침서\n\n2004\n\n11-1470000-000669-01\n\n(생물의약품평가가이드\n\n7)\n\n생명공학의약품과\n\n생물의약품평가과\n\n자료실 간행물\n\n/\n\n,\n\n지침/60\n\n생명공학의약품/\n\n생물학적제제의\n\n규격설정에 관한 가이드\n\n2004\n\n11-1470000-000538-01\n\n(생물의약품평가가이드\n\n6)\n\n생명공학의약품과\n\n자료실 간행물\n\n/\n\n,\n\n지침/59\n\n- - 15 -\n<!-- PAGE_23 -->\n###### 생물의약품평가자료집 시리즈\n\n<!-- PAGE_23 -->\n###### 3.\n\n",
      "metadata": {
        "source": "(가이드라인-005)_정맥주사용+B형간염+사람면역글로불린제제의+안전성유효성+평가+가이드라인.pdf",
        "chunk_index": 164,
        "window_size": 3,
        "char_count": 4960,
        "word_count": 924,
        "page_number": 23,
        "window_text": "Guidance\n\n<!-- PAGE_19 -->\n###### for Industry\n\n<!-- PAGE_19 -->\n###### Pharmacokinetics\n\n<!-- PAGE_19 -->\n###### in Patients\n\n<!-- PAGE_19 -->\n###### with Impaired\n\n<!-- PAGE_19 -->\n###### Hepatic\n\n<!-- PAGE_19 -->\n###### Function: Study Design, Data Analysis, and Impact on Dosing and Labeling,\n\n<!-- PAGE_19 -->\n###### CDER, FDA, 2003\n\n- - 12 -\n<!-- PAGE_20 -->\n###### 생물의약품국에서 발간한 행정간행물 목록\n\n<!-- PAGE_20 -->\n###### 생물의약품 국가표준품 카다로그 시리즈\n\n<!-- PAGE_20 -->\n###### 1.\n\n <!-- PAGE_20 -->\n###### 생물의약품평가가이드 시리즈\n\n<!-- PAGE_20 -->\n###### 2.\n\n 행정간행물 제목\n\n발행\n\n연도\n\n행정간행물 번호\n\n발행과\n\n홈페이지\n\n게재 상태\n\n생물의약품 국가표준품\n\n카다로그 (2008)\n\n2008\n\n11-1470000-000547-10\n\n생물진단의약품과\n\n자료실 간행물\n\n/\n\n,\n\n지침/\n\n생물의약품 국가표준품\n\n카다로그 (2006)\n\n2006\n\n11-1470000-000547-10\n\n생물진단제제팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/159\n\n생물의약품 국가표준품\n\n카다로그 (2004)\n\n2004\n\n11-1470000-000547-10\n\n생물의약품규격과\n\n자료실 간행물\n\n/\n\n,\n\n지침/56\n\n생물의약품 국가표준품\n\n카다로그 (2003)\n\n2003\n\n11-1470000-000547-10\n\n생물의약품규격과\n\n자료실 간행물\n\n/\n\n,\n\n지침/43\n\n생물의약품 국가표준품\n\n카다로그 (2002)\n\n2002\n\n11-1470000-000547-10\n\n백신과\n\n바이러스제제과\n\n(\n\n)\n\n舊\n\n자료실 간행물\n\n/\n\n,\n\n지침/22, 23\n\n행정간행물 제목\n\n발행\n\n연도\n\n행정간행물 번호\n\n발행과\n\n홈페이지\n\n게재 상태\n\n생물의약품\n\n국제공통기술문서 작성\n\n가이드라인 해설\n\n- -III.  품질\n2007\n\n11-1470000-001625-14\n\n(생물의약품평가가이드\n\n34)\n\n재조합의약품과\n\n바이러스백신과\n\n혈액제제과\n\n유전자치료제과\n\n세포조직공학제제과\n\n자료실 간행물\n\n/\n\n,\n\n지침/315\n\nHBsAg 진단제제의 기준\n\n및 시험방법 작성 지침\n\n2008\n\n11-1470000-000143-01\n\n(생물의약품평가가이드\n\n33)\n\n생물진단의약품과\n\n자료실 간행물\n\n/\n\n,\n\n지침/289\n\n혈장수출업소 실태조사\n\n지침\n\n2007\n\n11-1470000-001627-01\n\n(생물의약품평가가이드\n\n32)\n\n생물의약품관리팀\n\n혈액제제팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/234\n\nHIV, HBV, HCV, HTLV\n\n관련 체외진단용의약품\n\n안전성 유효성 심사평가\n\n․\n\n지침서\n\n2007\n\n11-1470000-001622-01\n\n(생물의약품평가가이드\n\n31)\n\n생물진단제제팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/252\n\n대유행 인플루엔자 백신의\n\n임상시험 평가 가이드 안\n\n(\n\n)\n\n2007\n\n11-1470000-001621-01\n\n(생물의약품평가가이드\n\n30)\n\n바이러스백신팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/228\n\n바이러스백신\n\n자가품질관리요약서(\n\nⅠ)\n\n2007\n\n11-1470000-001620-01\n\n(생물의약품평가가이드\n\n29)\n\n바이러스백신팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/227\n\n- - 13 -\n행정간행물 제목\n\n발행\n\n연도\n\n행정간행물 번호\n\n발행과\n\n홈페이지\n\n게재 상태\n\n불활화 인플루엔자백신\n\n평가 지침\n\n2007\n\n11-1470000-001587-01\n\n(생물의약품평가가이드\n\n28)\n\n바이러스백신팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/226\n\n당단백질의약품의 당구조\n\n분석 시험법 길라잡이\n\n2007\n\n11-1470000-001589-01\n\n(생물의약품평가가이드\n\n27)\n\n재조합의약품팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/280\n\n류마티스관절염 치료제\n\n임상평가지침\n\n2007\n\n11-1470000-001432-01\n\n(생물의약품평가가이드\n\n26)\n\n재조합의약품팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/190\n\n분획용 혈장 마스터 파일\n\n가이드라인\n\n2007\n\n11-1470000-001560-01\n\n(생물의약품평가가이드\n\n25)\n\n생물의약품관리팀\n\n혈액제제팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/210\n\n인플루엔자백신의 자가\n\n기준 및 시험방법 작성\n\n지침 개정판\n\n(\n\n)\n\n2007\n\n11-1470000-001468-01\n\n(생물의약품평가가이드\n\n24)\n\n바이러스백신팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/197\n\nHIV 항체 진단제제의\n\n기준 및 시험방법\n\n작성\n\n‘\n\n’\n\n지침\n\n2007\n\n11-1470000-001462-01\n\n(생물의약품평가가이드\n\n23)\n\n생물진단제제팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/196\n\n세균백신 자가 기준 및\n\n시험방법 작성 지침서\n\n2007\n\n11-1470000-001428-01\n\n(생물의약품평가가이드\n\n22)\n\n세균백신팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/177\n\n바이오 칩 평가 가이드\n\n- -HPV DNA칩 기준 및\n시험방법 작성 지침-\n\n2006\n\n11-1470000-001165-01\n\n(생물의약품평가가이드\n\n21)\n\n생물진단제제팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/154\n\n혈장분획제제 등 바이러스\n\n검증 평가 가이드\n\n2006\n\n11-1470000-001176-01\n\n(생물의약품평가가이드\n\n20)\n\n혈액제제팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/170\n\n유전자재조합의약품\n\n생산용 세포의 발현구조체\n\n분석 및 안정성\n\n평가가이드\n\n2006\n\n11-1470000-001116-01\n\n(생물의약품평가가이드\n\n19)\n\n재조합의약품팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/229\n\n유전재재조합의약품 및\n\n단클론항체의약품의 제조\n\n및 품질관리 자료에 관한\n\n평가가이드\n\n2006\n\n11-1470000-000902-01\n\n(생물의약품평가가이드\n\n18)\n\n재조합의약품팀\n\n생물의약품관리팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/139\n\n이종이식제제의 전임상 및\n\n임상시험에 대한 가이드\n\n2006\n\n11-1470000-001088-01\n\n(생물의약품평가가이드\n\n17)\n\n세포조직공학제제팀\n\n재조합의약품팀\n\n생물의약품안전팀\n\n생물의약품관리팀\n\n국립독성연구원\n\n생명공학지원팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/130\n\n- - 14 -\n행정간행물 제목\n\n발행\n\n연도\n\n행정간행물 번호\n\n발행과\n\n홈페이지\n\n게재 상태\n\n이종이식제제의 품질관리\n\n및 이식 후 감염관리에\n\n대한 가이드\n\n2006\n\n11-1470000-001086-01\n\n(생물의약품평가가이드\n\n16)\n\n세포조직공학제제팀\n\n재조합의약품팀\n\n생물의약품안전팀\n\n생물의약품관리팀\n\n국립독성연구원\n\n생명공학지원팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/130\n\n자료실 간행물\n\n/\n\n,\n\n지침/130\n\n자료실 간행물\n\n/\n\n,\n\n지침/116\n\n자료실 간행물\n\n/\n\n,\n\n지침/110\n\n자료실 간행물\n\n/\n\n,\n\n지침/118\n\n임상시험용\n\n유전자치료제의 특성분석,\n\n제조 및 품질관리\n\n평가가이드\n\n2005\n\n11-1470000-000876-01\n\n(생물의약품평가가이드\n\n11)\n\n생명공학의약품과\n\n자료실 간행물\n\n/\n\n,\n\n지침/107\n\n두창백신의 안전성 유효성\n\n․\n\n평가시 고려사항\n\n2005\n\n11-1470000-000872-01\n\n(생물의약품평가가이드\n\n10)\n\n생물의약품평가과\n\n자료실 간행물\n\n/\n\n,\n\n지침/105\n\n**[표 시작]**\n\n| 2004 | 11-1470000-000684-01 | (생물의약품평가자료집 | 15) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/84 |\n| --- | --- | --- | --- | --- | --- | --- | --- | --- |\n| 생명공학의약품 허가를 | 위한 Q&A | 2006 | 11-1470000-000895-01 | (생물의약품평가자료집 | 28) | 재조합의약품팀 | 생명공학의약품과 | ( | ) | 舊 | 자료실 간행물 | / | , | 지침127 |\n| 유전자치료제의 | 안전성평가 2006 | 2006 | 11-1470000-001140-01 | (생물의약품평가자료집 | 38) | 유전자치료제팀 | 자료실 간행물 | / | , | 지침/169 |\n| 행정간행물 제목 | 발행 | 연도 | 행정간행물 번호 | 발행과 | 홈페이지 | 게재 상태 |\n| 세포치료제의 | 안전성 유효성 및 품질 | ․ | 평가 2006 | 2006 | 11-1470000-001146-01 | (생물의약품평가자료집 | 37) | 세포조직공학제제팀 자료실 간행물 | / | , | 지침/148 | KFDA Bio Handbook | 2005 | 11-1470000-000873-01 | (생물의약품평가자료집 | 26) | 생명공학의약품과 | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/91 |\n| 세포치료제의 임상시험 | 사례분석 | 2007 | 11-1470000-001586-14 | (생물의약품평가자료집 | 50) | 세포조직공학제제팀 자료실 간행물 | / | , | 지침/259 |\n| 생명공학의약품의 | 안전성 유효성 평가 - | ․ | 비교동등성 평가시 | 고려사항 |\n| 정맥주사용 | B형 간염 사람면역글로불린제제의 | 안전성․유효성 평가 가이드라인 |\n| 임상시험의 전반적인 | 고려사항 | 2004 | 11-1470000-000681-01 | (생물의약품평가자료집 | 12) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/79 | 2005 | 11-1470000-000871-01 | (생물의약품평가자료집 | 25) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/103 |\n| 생명공학의약품 | 생산세포주 관리를 위한 | 시험방법 | 2007 | 11-1470000-000903-01 | (생물의약품평가자료집 | 48) | 재조합의약품팀 | 자료실 간행물 | / | , | 지침/236 | 생물의약품의 독성평가 | 사례분석 | 2004 | 11-1470000-000680-01 | (생물의약품평가자료집 | 11) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/77 |\n**════════════════════════════════════════════**\n| 유전자치료제의 | 안전성평가 2005 | 2005 | 11-1470000-000677-14 | (생물의약품평가자료집 | 24) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/104 |\n| 발 | 행 | 일 | 년 | 월 | : | 2008 | 12 |\n| 2006 | 11-1470000-001144-01 | (생물의약품평가자료집 | 35) | 자료실 간행물 | / | , | 지침/146 |\n| 발 | 행 | 기 | 관 | 식품의약품안전청 | : |\n| 백신의 안전성 유효성 | ․ | 평가 2005 | 2005 | 11-1470000-000870-01 | (생물의약품평가자료집 | 23) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/102 | 단클론항체의약품의 | 평가가이드 | 2005 | 11-1470000-000851-01 | (생물의약품평가가이드 | 9) | 자료실 간행물 | / | , | 지침/74 |\n\n**[표 끝]**\n\n생명공학의약품과\n\n생물의약품평가과\n\n국립독성연구원\n\n생화학약리과\n\nTNF 길항제 사용시\n\n잠복결핵 치료지침\n\n2005\n\n11-1470000-000686-01\n\n(생물의약품평가가이드\n\n8)\n\n생물의약품평가과\n\n자료실 간행물\n\n/\n\n,\n\n지침/65\n\nDNA 백신의 평가지침서\n\n2004\n\n11-1470000-000669-01\n\n(생물의약품평가가이드\n\n7)\n\n생명공학의약품과\n\n생물의약품평가과\n\n자료실 간행물\n\n/\n\n,\n\n지침/60\n\n생명공학의약품/\n\n생물학적제제의\n\n규격설정에 관한 가이드\n\n2004\n\n11-1470000-000538-01\n\n(생물의약품평가가이드\n\n6)\n\n생명공학의약품과\n\n자료실 간행물\n\n/\n\n,\n\n지침/59\n\n- - 15 -\n<!-- PAGE_23 -->\n###### 생물의약품평가자료집 시리즈\n\n<!-- PAGE_23 -->\n###### 3.\n\n 행정간행물 제목\n\n발행\n\n연도\n\n행정간행물 번호\n\n발행과\n\n홈페이지\n\n게재 상태\n\n핵산증폭검사법 검증\n\n가이드라인\n\n2003\n\n11-1470000-000277-01\n\n(생물의약품평가가이드\n\n5)\n\n혈액제제과\n\n자료실 간행물\n\n/\n\n,\n\n지침/44\n\n혈장분획제제\n\n품질평가 가이드\n\n2002\n\n11-1470000-000154-01\n\n(생물의약품평가가이드\n\n4)\n\n혈액제제과\n\n자료실 간행물\n\n/\n\n,\n\n지침/27\n\n2002\n\n11-1470000-000144-01\n\n(생물의약품평가가이드\n\n3)\n\n백신과\n\n바이러스제제과\n\n(\n\n)\n\n舊\n\n자료실 간행물\n\n/\n\n,\n\n지침/19\n\n생물의약품의 생산에\n\n사용되는 세포기질관리\n\n가이드\n\n2002\n\n11-1470000-000140-14\n\n(생물의약품평가가이드\n\n2)\n\n생명공학의약품과\n\n생물공학과\n\n(\n\n)\n\n舊\n\n자료실 간행물\n\n/\n\n,\n\n지침/17\n\n유전자치료제의\n\n품질평가 가이드\n\n2001\n\n11-1470000-000074-14\n\n(생물의약품평가가이드\n\n1)\n\n생명공학의약품과\n\n생물공학과\n\n(\n\n)\n\n舊\n\n자료실 간행물\n\n/\n\n,\n\n지침/54\n\n세포치료제의 비임상시험\n\n사례분석\n\n2007\n\n11-1470000-001585-14\n\n(생물의약품평가자료집\n\n49)\n\n세포조직공학제제팀 자료실 간행물\n\n/\n\n,\n\n지침/259\n\n혈액제제의 자가 기준 및\n\n시험방법 작성 지침\n\n2007\n\n11-1470000-001457-01\n\n(생물의약품평가자료집\n\n47)\n\n혈액제제팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/195\n\n혈관질환 등의\n\n유전자치료제\n\n비임상 임상시험 사례분석\n\n∙\n\n2007\n\n11-1470000-001441-10\n\n(생물의약품평가자료집\n\n46)\n\n유전자치료제팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/233\n\n항암 유전자치료제\n\n비임상 임상시험 사례분석\n\n∙\n\n2007\n\n11-1470000-001440-10\n\n(생물의약품평가자료집\n\n45)\n\n유전자치료제팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/209\n\n백신 임상 평가 시\n\n고려사항 2007\n\n2007\n\n11-1470000-001446-10\n\n(생물의약품평가자료집\n\n44)\n\n세균백신팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/192\n\n- - 16 -\n행정간행물 제목\n\n발행\n\n연도\n\n행정간행물 번호\n\n발행과\n\n홈페이지\n\n게재 상태\n\n생바이러스 백신의\n\n자가 기준 및 시험방법\n\n작성 지침\n\n2007\n\n11-1470000-001345-01\n\n(생물의약품평가자료집\n\n43)\n\n바이러스백신팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/172\n\n불활화 바이러스 백신의\n\n자가 기준 및 시험방법\n\n작성 지침\n\n2007\n\n11-1470000-001346-01\n\n(생물의약품평가자료집\n\n42)\n\n바이러스백신팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/173\n\n백신의 임상 평가 시\n\n고려사항\n\n2006\n\n11-1470000-001163-01\n\n(생물의약품평가자료집\n\n41)\n\n바이러스백신팀\n\n세균백신팀\n\n자료실 간행물\n\n/\n\n,\n\n지침 150\n\nDNA 백신의 평가\n\n:\n\nWHO 및 미국\n\nFDA\n\n가이드라인\n\n2006\n\n11-1470000-001142-01\n\n(생물의약품평가자료집\n\n40)\n\n유전자치료제팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/168\n\n유전자치료 임상시험-\n\n지연성 이상반응에 대비한\n\n환자 관찰\n\n2006\n\n11-1470000-001141-01\n\n(생물의약품평가자료집\n\n39)\n\n유전자치료제팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/157\n\n세포치료제 안전성 유효성\n\n․\n\n및 품질 평가시 고려사항\n\n2006\n\n2006\n\n11-1470000-001145-01\n\n(생물의약품평가자료집\n\n36)\n\n세포조직공학제제팀 자료실 간행물\n\n/\n\n,\n\n지침/147\n\n세포조직공학제제\n\n(세포치료제\n\n,\n\n조직공학제제,\n\n이종이식제제\n\n가이드라인\n\n)\n\n세포조직공학제제팀\n\n세균백신팀\n\n바이러스백신팀\n\n혈액제제팀\n\n재조합의약품팀\n\n유전자치료제팀\n\n생물 생명공학의약품의\n\n․\n\n독성평가 사례분석 2006\n\n2006\n\n11-1470000-001143-01\n\n(생물의약품평가자료집\n\n34)\n\n세포조직공학제제팀 자료실 간행물\n\n/\n\n,\n\n지침/145\n\n만성 피부 궤양 및 화상\n\n치료제 개발을 위한\n\n전임상 및\n\n임상 관련\n\n고려사항\n\n2006\n\n11-1470000-001228-01\n\n(생물의약품평가자료집\n\n33)\n\n세포조직공학제제팀 자료실 간행물\n\n/\n\n,\n\n지침/144\n\n- - 17 -\n행정간행물 제목\n\n발행\n\n연도\n\n행정간행물 번호\n\n발행과\n\n홈페이지\n\n게재 상태\n\n미국 약전 세포치료제,\n\n유전자치료제 및\n\n조직공학제제의 보조물질\n\n(ancillary product)\n\n평가자료집\n\n2006\n\n11-1470000-001109-01\n\n(생물의약품평가자료집\n\n32)\n\n세포조직공학제제팀\n\n유전자치료제팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/143\n\n미국 약전 세포치료제 및\n\n유전자치료제\n\n2006\n\n11-1470000-001108-01\n\n(생물의약품평가자료집\n\n31)\n\n세포조직공학제제팀\n\n유전자치료제팀\n\n자료실 간행물\n\n/\n\n,\n\n지침 142\n\n백신의 안전성 유효성\n\n․\n\n평가 2006\n\n2006\n\n11-1470000-001125-01\n\n(생물의약품평가자료집\n\n30)\n\n세균백신팀\n\n바이러스백신팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/141\n\n인플루엔자 백신\n\n자가 기준 및 시험방법\n\n작성 지침\n\n2006\n\n11-1470000-001114-01\n\n(생물의약품평가자료집\n\n29)\n\n바이러스백신팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/138\n\n생명공학의약품 길라잡이\n\n2005\n\n11-1470000-000893-01\n\n(생물의약품평가자료집\n\n27)\n\n재조합의약품팀\n\n생명공학의약품과\n\n(\n\n)\n\n舊\n\n자료실 간행물\n\n/\n\n,\n\n지침/109\n\n탄저백신의 안전성 유효성\n\n․\n\n평가 2005\n\n2005\n\n11-1470000-000867-01\n\n(생물의약품평가자료집\n\n22)\n\n생물의약품평가과\n\n자료실 간행물\n\n/\n\n,\n\n지침/99\n\n인플루엔자백신의\n\n안전성 유효성 평가 2005\n\n․\n\n2005\n\n11-1470000-000866-01\n\n(생물의약품평가자료집\n\n21)\n\n생물의약품평가과\n\n자료실 간행물\n\n/\n\n,\n\n지침/98\n\n항암 생물의약품의\n\n안전성 유효성 평가\n\n․\n\n2005\n\n11-1470000-000865-01\n\n(생물의약품평가자료집\n\n20)\n\n생물의약품평가과\n\n자료실 간행물\n\n/\n\n,\n\n지침/101\n\n- - 18 -\n행정간행물 제목\n\n발행\n\n연도\n\n행정간행물 번호\n\n발행과\n\n홈페이지\n\n게재 상태\n\n우수심사기준\n\n2005\n\n11-1470000-000684-01\n\n(생물의약품평가자료집\n\n19)\n\n생물의약품평가과\n\n자료실 간행물\n\n/\n\n,\n\n지침/100\n\n사람 세포\n\n조직\n\n세포 및\n\n,\n\n,\n\n조직유래제품\n\n: 미\n\nFDA\n\n시설등록 및 등재 규정\n\n2005\n\n11-1470000-000860-01\n\n(생물의약품평가자료집\n\n18)\n\n생명공학의약품과\n\n인체조직정보\n\n방 자료게시판\n\n/\n\n/\n\n4\n\n사람 세포\n\n조직\n\n세포 및\n\n,\n\n,\n\n조직유래제품 제조시설의\n\n미\n\nFDA 우수조직관리기준\n\n2005\n\n11-1470000-000859-01\n\n(생물의약품평가자료집\n\n17)\n\n생명공학의약품과\n\n인체조직정보\n\n방 자료게시판\n\n/\n\n/\n\n5\n\n세포치료제 및\n\n유전자치료제 자료집\n\n2004\n\n11-1470000-000685-01\n\n(생물의약품평가자료집\n\n16)\n\n생물의약품평가과\n\n자료실 간행물\n\n/\n\n,\n\n지침/78\n\n생명공학의약품등의\n\n1상\n\n임상시험계획 승인 신청시\n\n고려사항\n\n2004\n\n11-1470000-000683-01\n\n(생물의약품평가자료집\n\n14)\n\n생물의약품평가과\n\n자료실 간행물\n\n/\n\n,\n\n지침/83\n\n생물의약품등의\n\n효능입증을 위한 고려사항 2004\n\n11-1470000-000682-01\n\n(생물의약품평가자료집\n\n13)\n\n생물의약품평가과\n\n자료실 간행물\n\n/\n\n,\n\n지침/82\n\n혈액제제의 안전성 유효성\n\n․\n\n평가 2004\n\n2004\n\n11-1470000-000679-14\n\n(생물의약품평가자료집\n\n10)\n\n생물의약품평가과\n\n자료실 간행물\n\n/\n\n,\n\n지침/76\n\n세포치료제의\n\n안전성 유효성 평가시\n\n․\n\n고려사항 2004\n\n2004\n\n11-1470000-000678-14\n\n(생물의약품평가자료집\n\n9)\n\n생물의약품평가과\n\n자료실 간행물\n\n/\n\n,\n\n지침/75\n\n유전자치료제의\n\n안전성평가 2004\n\n2004\n\n11-1470000-000677-14\n\n(생물의약품평가자료집\n\n8)\n\n생물의약품평가과\n\n자료실 간행물\n\n/\n\n,\n\n지침/72\n\n생명공학의약품의\n\n안전성평가(4)\n\n2004\n\n11-1470000-000676-14\n\n(생물의약품평가자료집\n\n7)\n\n생물의약품평가과\n\n자료실 간행물\n\n/\n\n,\n\n지침/71\n\n- - 19 -\n행정간행물 제목\n\n발행\n\n연도\n\n행정간행물 번호\n\n발행과\n\n홈페이지\n\n게재 상태\n\n생명공학의약품의\n\n안전성평가(3)\n\n2004\n\n11-1470000-000676-14\n\n(생물의약품평가자료집\n\n6)\n\n생물의약품평가과\n\n자료실 간행물\n\n/\n\n,\n\n지침/70\n\n생명공학의약품의\n\n안전성평가(2)\n\n2004\n\n11-1470000-000676-14\n\n(생물의약품평가자료집\n\n5)\n\n생물의약품평가과\n\n자료실 간행물\n\n/\n\n,\n\n지침/69\n\n생명공학의약품의\n\n안전성평가(1)\n\n2004\n\n11-1470000-000676-14\n\n(생물의약품평가자료집\n\n4)\n\n생물의약품평가과\n\n자료실 간행물\n\n/\n\n,\n\n지침/68\n\n백신의 안전성평가 2004\n\n2004\n\n11-1470000-000675-14\n\n(생물의약품평가자료집\n\n3)\n\n생물의약품평가과\n\n자료실 간행물\n\n/\n\n,\n\n지침/67\n\n진단제제의\n\n기준\n\nHBsAg\n\n‘\n\n및 시험방법\n\n’ 작성 지침\n\n2004\n\n11-1470000-000143-01\n\n(생물의약품평가자료집\n\n2)\n\n백신과\n\n자료실 간행물\n\n/\n\n,\n\n지침/48\n\n<!-- PAGE_28 -->\n###### 발\n\n<!-- PAGE_28 -->\n###### 행\n\n<!-- PAGE_28 -->\n###### 부\n\n<!-- PAGE_28 -->\n###### 서\n\n<!-- PAGE_28 -->\n###### 생물의약품국 혈액제제과\n\n<!-- PAGE_28 -->\n###### :\n\n════════════════════════════════════════════\n\n<!-- PAGE_28 -->\n###### 연\n\n<!-- PAGE_28 -->\n###### 락\n\n<!-- PAGE_28 -->\n###### 처\n\n<!-- PAGE_28 -->\n###### 식품의약품안전청 혈액제제과\n\n<!-- PAGE_28 -->\n###### :\n\n<!-- PAGE_28 -->\n###### 전\n\n<!-- PAGE_28 -->\n###### 화\n\n<!-- PAGE_28 -->\n###### 번\n\n<!-- PAGE_28 -->\n###### 호 :\n\n<!-- PAGE_28 -->\n###### 02) 380-1715, 1765\n\n<!-- PAGE_28 -->\n###### 팩\n\n<!-- PAGE_28 -->\n###### 스\n\n<!-- PAGE_28 -->\n###### 번\n\n<!-- PAGE_28 -->\n###### 호 :\n\n<!-- PAGE_28 -->\n###### 02) 386-6584\n",
        "original_sentence": "품질\n2007\n\n11-1470000-001625-14\n\n(생물의약품평가가이드\n\n34)\n\n재조합의약품과\n\n바이러스백신과\n\n혈액제제과\n\n유전자치료제과\n\n세포조직공학제제과\n\n자료실 간행물\n\n/\n\n,\n\n지침/315\n\nHBsAg 진단제제의 기준\n\n및 시험방법 작성 지침\n\n2008\n\n11-1470000-000143-01\n\n(생물의약품평가가이드\n\n33)\n\n생물진단의약품과\n\n자료실 간행물\n\n/\n\n,\n\n지침/289\n\n혈장수출업소 실태조사\n\n지침\n\n2007\n\n11-1470000-001627-01\n\n(생물의약품평가가이드\n\n32)\n\n생물의약품관리팀\n\n혈액제제팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/234\n\nHIV, HBV, HCV, HTLV\n\n관련 체외진단용의약품\n\n안전성 유효성 심사평가\n\n․\n\n지침서\n\n2007\n\n11-1470000-001622-01\n\n(생물의약품평가가이드\n\n31)\n\n생물진단제제팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/252\n\n대유행 인플루엔자 백신의\n\n임상시험 평가 가이드 안\n\n(\n\n)\n\n2007\n\n11-1470000-001621-01\n\n(생물의약품평가가이드\n\n30)\n\n바이러스백신팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/228\n\n바이러스백신\n\n자가품질관리요약서(\n\nⅠ)\n\n2007\n\n11-1470000-001620-01\n\n(생물의약품평가가이드\n\n29)\n\n바이러스백신팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/227\n\n- - 13 -\n행정간행물 제목\n\n발행\n\n연도\n\n행정간행물 번호\n\n발행과\n\n홈페이지\n\n게재 상태\n\n불활화 인플루엔자백신\n\n평가 지침\n\n2007\n\n11-1470000-001587-01\n\n(생물의약품평가가이드\n\n28)\n\n바이러스백신팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/226\n\n당단백질의약품의 당구조\n\n분석 시험법 길라잡이\n\n2007\n\n11-1470000-001589-01\n\n(생물의약품평가가이드\n\n27)\n\n재조합의약품팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/280\n\n류마티스관절염 치료제\n\n임상평가지침\n\n2007\n\n11-1470000-001432-01\n\n(생물의약품평가가이드\n\n26)\n\n재조합의약품팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/190\n\n분획용 혈장 마스터 파일\n\n가이드라인\n\n2007\n\n11-1470000-001560-01\n\n(생물의약품평가가이드\n\n25)\n\n생물의약품관리팀\n\n혈액제제팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/210\n\n인플루엔자백신의 자가\n\n기준 및 시험방법 작성\n\n지침 개정판\n\n(\n\n)\n\n2007\n\n11-1470000-001468-01\n\n(생물의약품평가가이드\n\n24)\n\n바이러스백신팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/197\n\nHIV 항체 진단제제의\n\n기준 및 시험방법\n\n작성\n\n‘\n\n’\n\n지침\n\n2007\n\n11-1470000-001462-01\n\n(생물의약품평가가이드\n\n23)\n\n생물진단제제팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/196\n\n세균백신 자가 기준 및\n\n시험방법 작성 지침서\n\n2007\n\n11-1470000-001428-01\n\n(생물의약품평가가이드\n\n22)\n\n세균백신팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/177\n\n바이오 칩 평가 가이드\n\n- -HPV DNA칩 기준 및\n시험방법 작성 지침-\n\n2006\n\n11-1470000-001165-01\n\n(생물의약품평가가이드\n\n21)\n\n생물진단제제팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/154\n\n혈장분획제제 등 바이러스\n\n검증 평가 가이드\n\n2006\n\n11-1470000-001176-01\n\n(생물의약품평가가이드\n\n20)\n\n혈액제제팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/170\n\n유전자재조합의약품\n\n생산용 세포의 발현구조체\n\n분석 및 안정성\n\n평가가이드\n\n2006\n\n11-1470000-001116-01\n\n(생물의약품평가가이드\n\n19)\n\n재조합의약품팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/229\n\n유전재재조합의약품 및\n\n단클론항체의약품의 제조\n\n및 품질관리 자료에 관한\n\n평가가이드\n\n2006\n\n11-1470000-000902-01\n\n(생물의약품평가가이드\n\n18)\n\n재조합의약품팀\n\n생물의약품관리팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/139\n\n이종이식제제의 전임상 및\n\n임상시험에 대한 가이드\n\n2006\n\n11-1470000-001088-01\n\n(생물의약품평가가이드\n\n17)\n\n세포조직공학제제팀\n\n재조합의약품팀\n\n생물의약품안전팀\n\n생물의약품관리팀\n\n국립독성연구원\n\n생명공학지원팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/130\n\n- - 14 -\n행정간행물 제목\n\n발행\n\n연도\n\n행정간행물 번호\n\n발행과\n\n홈페이지\n\n게재 상태\n\n이종이식제제의 품질관리\n\n및 이식 후 감염관리에\n\n대한 가이드\n\n2006\n\n11-1470000-001086-01\n\n(생물의약품평가가이드\n\n16)\n\n세포조직공학제제팀\n\n재조합의약품팀\n\n생물의약품안전팀\n\n생물의약품관리팀\n\n국립독성연구원\n\n생명공학지원팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/130\n\n자료실 간행물\n\n/\n\n,\n\n지침/130\n\n자료실 간행물\n\n/\n\n,\n\n지침/116\n\n자료실 간행물\n\n/\n\n,\n\n지침/110\n\n자료실 간행물\n\n/\n\n,\n\n지침/118\n\n임상시험용\n\n유전자치료제의 특성분석,\n\n제조 및 품질관리\n\n평가가이드\n\n2005\n\n11-1470000-000876-01\n\n(생물의약품평가가이드\n\n11)\n\n생명공학의약품과\n\n자료실 간행물\n\n/\n\n,\n\n지침/107\n\n두창백신의 안전성 유효성\n\n․\n\n평가시 고려사항\n\n2005\n\n11-1470000-000872-01\n\n(생물의약품평가가이드\n\n10)\n\n생물의약품평가과\n\n자료실 간행물\n\n/\n\n,\n\n지침/105\n\n**[표 시작]**\n\n| 2004 | 11-1470000-000684-01 | (생물의약품평가자료집 | 15) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/84 |\n| --- | --- | --- | --- | --- | --- | --- | --- | --- |\n| 생명공학의약품 허가를 | 위한 Q&A | 2006 | 11-1470000-000895-01 | (생물의약품평가자료집 | 28) | 재조합의약품팀 | 생명공학의약품과 | ( | ) | 舊 | 자료실 간행물 | / | , | 지침127 |\n| 유전자치료제의 | 안전성평가 2006 | 2006 | 11-1470000-001140-01 | (생물의약품평가자료집 | 38) | 유전자치료제팀 | 자료실 간행물 | / | , | 지침/169 |\n| 행정간행물 제목 | 발행 | 연도 | 행정간행물 번호 | 발행과 | 홈페이지 | 게재 상태 |\n| 세포치료제의 | 안전성 유효성 및 품질 | ․ | 평가 2006 | 2006 | 11-1470000-001146-01 | (생물의약품평가자료집 | 37) | 세포조직공학제제팀 자료실 간행물 | / | , | 지침/148 | KFDA Bio Handbook | 2005 | 11-1470000-000873-01 | (생물의약품평가자료집 | 26) | 생명공학의약품과 | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/91 |\n| 세포치료제의 임상시험 | 사례분석 | 2007 | 11-1470000-001586-14 | (생물의약품평가자료집 | 50) | 세포조직공학제제팀 자료실 간행물 | / | , | 지침/259 |\n| 생명공학의약품의 | 안전성 유효성 평가 - | ․ | 비교동등성 평가시 | 고려사항 |\n| 정맥주사용 | B형 간염 사람면역글로불린제제의 | 안전성․유효성 평가 가이드라인 |\n| 임상시험의 전반적인 | 고려사항 | 2004 | 11-1470000-000681-01 | (생물의약품평가자료집 | 12) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/79 | 2005 | 11-1470000-000871-01 | (생물의약품평가자료집 | 25) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/103 |\n| 생명공학의약품 | 생산세포주 관리를 위한 | 시험방법 | 2007 | 11-1470000-000903-01 | (생물의약품평가자료집 | 48) | 재조합의약품팀 | 자료실 간행물 | / | , | 지침/236 | 생물의약품의 독성평가 | 사례분석 | 2004 | 11-1470000-000680-01 | (생물의약품평가자료집 | 11) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/77 |\n**════════════════════════════════════════════**\n| 유전자치료제의 | 안전성평가 2005 | 2005 | 11-1470000-000677-14 | (생물의약품평가자료집 | 24) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/104 |\n| 발 | 행 | 일 | 년 | 월 | : | 2008 | 12 |\n| 2006 | 11-1470000-001144-01 | (생물의약품평가자료집 | 35) | 자료실 간행물 | / | , | 지침/146 |\n| 발 | 행 | 기 | 관 | 식품의약품안전청 | : |\n| 백신의 안전성 유효성 | ․ | 평가 2005 | 2005 | 11-1470000-000870-01 | (생물의약품평가자료집 | 23) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/102 | 단클론항체의약품의 | 평가가이드 | 2005 | 11-1470000-000851-01 | (생물의약품평가가이드 | 9) | 자료실 간행물 | / | , | 지침/74 |\n\n**[표 끝]**\n\n생명공학의약품과\n\n생물의약품평가과\n\n국립독성연구원\n\n생화학약리과\n\nTNF 길항제 사용시\n\n잠복결핵 치료지침\n\n2005\n\n11-1470000-000686-01\n\n(생물의약품평가가이드\n\n8)\n\n생물의약품평가과\n\n자료실 간행물\n\n/\n\n,\n\n지침/65\n\nDNA 백신의 평가지침서\n\n2004\n\n11-1470000-000669-01\n\n(생물의약품평가가이드\n\n7)\n\n생명공학의약품과\n\n생물의약품평가과\n\n자료실 간행물\n\n/\n\n,\n\n지침/60\n\n생명공학의약품/\n\n생물학적제제의\n\n규격설정에 관한 가이드\n\n2004\n\n11-1470000-000538-01\n\n(생물의약품평가가이드\n\n6)\n\n생명공학의약품과\n\n자료실 간행물\n\n/\n\n,\n\n지침/59\n\n- - 15 -\n<!-- PAGE_23 -->\n###### 생물의약품평가자료집 시리즈\n\n<!-- PAGE_23 -->\n###### 3.\n\n"
      }
    },
    {
      "chunk_id": "chunk_166",
      "text": "행정간행물 제목\n\n발행\n\n연도\n\n행정간행물 번호\n\n발행과\n\n홈페이지\n\n게재 상태\n\n핵산증폭검사법 검증\n\n가이드라인\n\n2003\n\n11-1470000-000277-01\n\n(생물의약품평가가이드\n\n5)\n\n혈액제제과\n\n자료실 간행물\n\n/\n\n,\n\n지침/44\n\n혈장분획제제\n\n품질평가 가이드\n\n2002\n\n11-1470000-000154-01\n\n(생물의약품평가가이드\n\n4)\n\n혈액제제과\n\n자료실 간행물\n\n/\n\n,\n\n지침/27\n\n2002\n\n11-1470000-000144-01\n\n(생물의약품평가가이드\n\n3)\n\n백신과\n\n바이러스제제과\n\n(\n\n)\n\n舊\n\n자료실 간행물\n\n/\n\n,\n\n지침/19\n\n생물의약품의 생산에\n\n사용되는 세포기질관리\n\n가이드\n\n2002\n\n11-1470000-000140-14\n\n(생물의약품평가가이드\n\n2)\n\n생명공학의약품과\n\n생물공학과\n\n(\n\n)\n\n舊\n\n자료실 간행물\n\n/\n\n,\n\n지침/17\n\n유전자치료제의\n\n품질평가 가이드\n\n2001\n\n11-1470000-000074-14\n\n(생물의약품평가가이드\n\n1)\n\n생명공학의약품과\n\n생물공학과\n\n(\n\n)\n\n舊\n\n자료실 간행물\n\n/\n\n,\n\n지침/54\n\n세포치료제의 비임상시험\n\n사례분석\n\n2007\n\n11-1470000-001585-14\n\n(생물의약품평가자료집\n\n49)\n\n세포조직공학제제팀 자료실 간행물\n\n/\n\n,\n\n지침/259\n\n혈액제제의 자가 기준 및\n\n시험방법 작성 지침\n\n2007\n\n11-1470000-001457-01\n\n(생물의약품평가자료집\n\n47)\n\n혈액제제팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/195\n\n혈관질환 등의\n\n유전자치료제\n\n비임상 임상시험 사례분석\n\n∙\n\n2007\n\n11-1470000-001441-10\n\n(생물의약품평가자료집\n\n46)\n\n유전자치료제팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/233\n\n항암 유전자치료제\n\n비임상 임상시험 사례분석\n\n∙\n\n2007\n\n11-1470000-001440-10\n\n(생물의약품평가자료집\n\n45)\n\n유전자치료제팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/209\n\n백신 임상 평가 시\n\n고려사항 2007\n\n2007\n\n11-1470000-001446-10\n\n(생물의약품평가자료집\n\n44)\n\n세균백신팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/192\n\n- - 16 -\n행정간행물 제목\n\n발행\n\n연도\n\n행정간행물 번호\n\n발행과\n\n홈페이지\n\n게재 상태\n\n생바이러스 백신의\n\n자가 기준 및 시험방법\n\n작성 지침\n\n2007\n\n11-1470000-001345-01\n\n(생물의약품평가자료집\n\n43)\n\n바이러스백신팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/172\n\n불활화 바이러스 백신의\n\n자가 기준 및 시험방법\n\n작성 지침\n\n2007\n\n11-1470000-001346-01\n\n(생물의약품평가자료집\n\n42)\n\n바이러스백신팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/173\n\n백신의 임상 평가 시\n\n고려사항\n\n2006\n\n11-1470000-001163-01\n\n(생물의약품평가자료집\n\n41)\n\n바이러스백신팀\n\n세균백신팀\n\n자료실 간행물\n\n/\n\n,\n\n지침 150\n\nDNA 백신의 평가\n\n:\n\nWHO 및 미국\n\nFDA\n\n가이드라인\n\n2006\n\n11-1470000-001142-01\n\n(생물의약품평가자료집\n\n40)\n\n유전자치료제팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/168\n\n유전자치료 임상시험-\n\n지연성 이상반응에 대비한\n\n환자 관찰\n\n2006\n\n11-1470000-001141-01\n\n(생물의약품평가자료집\n\n39)\n\n유전자치료제팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/157\n\n세포치료제 안전성 유효성\n\n․\n\n및 품질 평가시 고려사항\n\n2006\n\n2006\n\n11-1470000-001145-01\n\n(생물의약품평가자료집\n\n36)\n\n세포조직공학제제팀 자료실 간행물\n\n/\n\n,\n\n지침/147\n\n세포조직공학제제\n\n(세포치료제\n\n,\n\n조직공학제제,\n\n이종이식제제\n\n가이드라인\n\n)\n\n세포조직공학제제팀\n\n세균백신팀\n\n바이러스백신팀\n\n혈액제제팀\n\n재조합의약품팀\n\n유전자치료제팀\n\n생물 생명공학의약품의\n\n․\n\n독성평가 사례분석 2006\n\n2006\n\n11-1470000-001143-01\n\n(생물의약품평가자료집\n\n34)\n\n세포조직공학제제팀 자료실 간행물\n\n/\n\n,\n\n지침/145\n\n만성 피부 궤양 및 화상\n\n치료제 개발을 위한\n\n전임상 및\n\n임상 관련\n\n고려사항\n\n2006\n\n11-1470000-001228-01\n\n(생물의약품평가자료집\n\n33)\n\n세포조직공학제제팀 자료실 간행물\n\n/\n\n,\n\n지침/144\n\n- - 17 -\n행정간행물 제목\n\n발행\n\n연도\n\n행정간행물 번호\n\n발행과\n\n홈페이지\n\n게재 상태\n\n미국 약전 세포치료제,\n\n유전자치료제 및\n\n조직공학제제의 보조물질\n\n(ancillary product)\n\n평가자료집\n\n2006\n\n11-1470000-001109-01\n\n(생물의약품평가자료집\n\n32)\n\n세포조직공학제제팀\n\n유전자치료제팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/143\n\n미국 약전 세포치료제 및\n\n유전자치료제\n\n2006\n\n11-1470000-001108-01\n\n(생물의약품평가자료집\n\n31)\n\n세포조직공학제제팀\n\n유전자치료제팀\n\n자료실 간행물\n\n/\n\n,\n\n지침 142\n\n백신의 안전성 유효성\n\n․\n\n평가 2006\n\n2006\n\n11-1470000-001125-01\n\n(생물의약품평가자료집\n\n30)\n\n세균백신팀\n\n바이러스백신팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/141\n\n인플루엔자 백신\n\n자가 기준 및 시험방법\n\n작성 지침\n\n2006\n\n11-1470000-001114-01\n\n(생물의약품평가자료집\n\n29)\n\n바이러스백신팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/138\n\n생명공학의약품 길라잡이\n\n2005\n\n11-1470000-000893-01\n\n(생물의약품평가자료집\n\n27)\n\n재조합의약품팀\n\n생명공학의약품과\n\n(\n\n)\n\n舊\n\n자료실 간행물\n\n/\n\n,\n\n지침/109\n\n탄저백신의 안전성 유효성\n\n․\n\n평가 2005\n\n2005\n\n11-1470000-000867-01\n\n(생물의약품평가자료집\n\n22)\n\n생물의약품평가과\n\n자료실 간행물\n\n/\n\n,\n\n지침/99\n\n인플루엔자백신의\n\n안전성 유효성 평가 2005\n\n․\n\n2005\n\n11-1470000-000866-01\n\n(생물의약품평가자료집\n\n21)\n\n생물의약품평가과\n\n자료실 간행물\n\n/\n\n,\n\n지침/98\n\n항암 생물의약품의\n\n안전성 유효성 평가\n\n․\n\n2005\n\n11-1470000-000865-01\n\n(생물의약품평가자료집\n\n20)\n\n생물의약품평가과\n\n자료실 간행물\n\n/\n\n,\n\n지침/101\n\n- - 18 -\n행정간행물 제목\n\n발행\n\n연도\n\n행정간행물 번호\n\n발행과\n\n홈페이지\n\n게재 상태\n\n우수심사기준\n\n2005\n\n11-1470000-000684-01\n\n(생물의약품평가자료집\n\n19)\n\n생물의약품평가과\n\n자료실 간행물\n\n/\n\n,\n\n지침/100\n\n사람 세포\n\n조직\n\n세포 및\n\n,\n\n,\n\n조직유래제품\n\n: 미\n\nFDA\n\n시설등록 및 등재 규정\n\n2005\n\n11-1470000-000860-01\n\n(생물의약품평가자료집\n\n18)\n\n생명공학의약품과\n\n인체조직정보\n\n방 자료게시판\n\n/\n\n/\n\n4\n\n사람 세포\n\n조직\n\n세포 및\n\n,\n\n,\n\n조직유래제품 제조시설의\n\n미\n\nFDA 우수조직관리기준\n\n2005\n\n11-1470000-000859-01\n\n(생물의약품평가자료집\n\n17)\n\n생명공학의약품과\n\n인체조직정보\n\n방 자료게시판\n\n/\n\n/\n\n5\n\n세포치료제 및\n\n유전자치료제 자료집\n\n2004\n\n11-1470000-000685-01\n\n(생물의약품평가자료집\n\n16)\n\n생물의약품평가과\n\n자료실 간행물\n\n/\n\n,\n\n지침/78\n\n생명공학의약품등의\n\n1상\n\n임상시험계획 승인 신청시\n\n고려사항\n\n2004\n\n11-1470000-000683-01\n\n(생물의약품평가자료집\n\n14)\n\n생물의약품평가과\n\n자료실 간행물\n\n/\n\n,\n\n지침/83\n\n생물의약품등의\n\n효능입증을 위한 고려사항 2004\n\n11-1470000-000682-01\n\n(생물의약품평가자료집\n\n13)\n\n생물의약품평가과\n\n자료실 간행물\n\n/\n\n,\n\n지침/82\n\n혈액제제의 안전성 유효성\n\n․\n\n평가 2004\n\n2004\n\n11-1470000-000679-14\n\n(생물의약품평가자료집\n\n10)\n\n생물의약품평가과\n\n자료실 간행물\n\n/\n\n,\n\n지침/76\n\n세포치료제의\n\n안전성 유효성 평가시\n\n․\n\n고려사항 2004\n\n2004\n\n11-1470000-000678-14\n\n(생물의약품평가자료집\n\n9)\n\n생물의약품평가과\n\n자료실 간행물\n\n/\n\n,\n\n지침/75\n\n유전자치료제의\n\n안전성평가 2004\n\n2004\n\n11-1470000-000677-14\n\n(생물의약품평가자료집\n\n8)\n\n생물의약품평가과\n\n자료실 간행물\n\n/\n\n,\n\n지침/72\n\n생명공학의약품의\n\n안전성평가(4)\n\n2004\n\n11-1470000-000676-14\n\n(생물의약품평가자료집\n\n7)\n\n생물의약품평가과\n\n자료실 간행물\n\n/\n\n,\n\n지침/71\n\n- - 19 -\n행정간행물 제목\n\n발행\n\n연도\n\n행정간행물 번호\n\n발행과\n\n홈페이지\n\n게재 상태\n\n생명공학의약품의\n\n안전성평가(3)\n\n2004\n\n11-1470000-000676-14\n\n(생물의약품평가자료집\n\n6)\n\n생물의약품평가과\n\n자료실 간행물\n\n/\n\n,\n\n지침/70\n\n생명공학의약품의\n\n안전성평가(2)\n\n2004\n\n11-1470000-000676-14\n\n(생물의약품평가자료집\n\n5)\n\n생물의약품평가과\n\n자료실 간행물\n\n/\n\n,\n\n지침/69\n\n생명공학의약품의\n\n안전성평가(1)\n\n2004\n\n11-1470000-000676-14\n\n(생물의약품평가자료집\n\n4)\n\n생물의약품평가과\n\n자료실 간행물\n\n/\n\n,\n\n지침/68\n\n백신의 안전성평가 2004\n\n2004\n\n11-1470000-000675-14\n\n(생물의약품평가자료집\n\n3)\n\n생물의약품평가과\n\n자료실 간행물\n\n/\n\n,\n\n지침/67\n\n진단제제의\n\n기준\n\nHBsAg\n\n‘\n\n및 시험방법\n\n’ 작성 지침\n\n2004\n\n11-1470000-000143-01\n\n(생물의약품평가자료집\n\n2)\n\n백신과\n\n자료실 간행물\n\n/\n\n,\n\n지침/48\n\n<!-- PAGE_28 -->\n###### 발\n\n<!-- PAGE_28 -->\n###### 행\n\n<!-- PAGE_28 -->\n###### 부\n\n<!-- PAGE_28 -->\n###### 서\n\n<!-- PAGE_28 -->\n###### 생물의약품국 혈액제제과\n\n<!-- PAGE_28 -->\n###### :\n\n════════════════════════════════════════════\n\n<!-- PAGE_28 -->\n###### 연\n\n<!-- PAGE_28 -->\n###### 락\n\n<!-- PAGE_28 -->\n###### 처\n\n<!-- PAGE_28 -->\n###### 식품의약품안전청 혈액제제과\n\n<!-- PAGE_28 -->\n###### :\n\n<!-- PAGE_28 -->\n###### 전\n\n<!-- PAGE_28 -->\n###### 화\n\n<!-- PAGE_28 -->\n###### 번\n\n<!-- PAGE_28 -->\n###### 호 :\n\n<!-- PAGE_28 -->\n###### 02) 380-1715, 1765\n\n<!-- PAGE_28 -->\n###### 팩\n\n<!-- PAGE_28 -->\n###### 스\n\n<!-- PAGE_28 -->\n###### 번\n\n<!-- PAGE_28 -->\n###### 호 :\n\n<!-- PAGE_28 -->\n###### 02) 386-6584\n",
      "metadata": {
        "source": "(가이드라인-005)_정맥주사용+B형간염+사람면역글로불린제제의+안전성유효성+평가+가이드라인.pdf",
        "chunk_index": 165,
        "window_size": 3,
        "char_count": 5470,
        "word_count": 862,
        "page_number": 28,
        "window_text": "<!-- PAGE_20 -->\n###### 생물의약품평가가이드 시리즈\n\n<!-- PAGE_20 -->\n###### 2.\n\n 행정간행물 제목\n\n발행\n\n연도\n\n행정간행물 번호\n\n발행과\n\n홈페이지\n\n게재 상태\n\n생물의약품 국가표준품\n\n카다로그 (2008)\n\n2008\n\n11-1470000-000547-10\n\n생물진단의약품과\n\n자료실 간행물\n\n/\n\n,\n\n지침/\n\n생물의약품 국가표준품\n\n카다로그 (2006)\n\n2006\n\n11-1470000-000547-10\n\n생물진단제제팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/159\n\n생물의약품 국가표준품\n\n카다로그 (2004)\n\n2004\n\n11-1470000-000547-10\n\n생물의약품규격과\n\n자료실 간행물\n\n/\n\n,\n\n지침/56\n\n생물의약품 국가표준품\n\n카다로그 (2003)\n\n2003\n\n11-1470000-000547-10\n\n생물의약품규격과\n\n자료실 간행물\n\n/\n\n,\n\n지침/43\n\n생물의약품 국가표준품\n\n카다로그 (2002)\n\n2002\n\n11-1470000-000547-10\n\n백신과\n\n바이러스제제과\n\n(\n\n)\n\n舊\n\n자료실 간행물\n\n/\n\n,\n\n지침/22, 23\n\n행정간행물 제목\n\n발행\n\n연도\n\n행정간행물 번호\n\n발행과\n\n홈페이지\n\n게재 상태\n\n생물의약품\n\n국제공통기술문서 작성\n\n가이드라인 해설\n\n- -III.  품질\n2007\n\n11-1470000-001625-14\n\n(생물의약품평가가이드\n\n34)\n\n재조합의약품과\n\n바이러스백신과\n\n혈액제제과\n\n유전자치료제과\n\n세포조직공학제제과\n\n자료실 간행물\n\n/\n\n,\n\n지침/315\n\nHBsAg 진단제제의 기준\n\n및 시험방법 작성 지침\n\n2008\n\n11-1470000-000143-01\n\n(생물의약품평가가이드\n\n33)\n\n생물진단의약품과\n\n자료실 간행물\n\n/\n\n,\n\n지침/289\n\n혈장수출업소 실태조사\n\n지침\n\n2007\n\n11-1470000-001627-01\n\n(생물의약품평가가이드\n\n32)\n\n생물의약품관리팀\n\n혈액제제팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/234\n\nHIV, HBV, HCV, HTLV\n\n관련 체외진단용의약품\n\n안전성 유효성 심사평가\n\n․\n\n지침서\n\n2007\n\n11-1470000-001622-01\n\n(생물의약품평가가이드\n\n31)\n\n생물진단제제팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/252\n\n대유행 인플루엔자 백신의\n\n임상시험 평가 가이드 안\n\n(\n\n)\n\n2007\n\n11-1470000-001621-01\n\n(생물의약품평가가이드\n\n30)\n\n바이러스백신팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/228\n\n바이러스백신\n\n자가품질관리요약서(\n\nⅠ)\n\n2007\n\n11-1470000-001620-01\n\n(생물의약품평가가이드\n\n29)\n\n바이러스백신팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/227\n\n- - 13 -\n행정간행물 제목\n\n발행\n\n연도\n\n행정간행물 번호\n\n발행과\n\n홈페이지\n\n게재 상태\n\n불활화 인플루엔자백신\n\n평가 지침\n\n2007\n\n11-1470000-001587-01\n\n(생물의약품평가가이드\n\n28)\n\n바이러스백신팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/226\n\n당단백질의약품의 당구조\n\n분석 시험법 길라잡이\n\n2007\n\n11-1470000-001589-01\n\n(생물의약품평가가이드\n\n27)\n\n재조합의약품팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/280\n\n류마티스관절염 치료제\n\n임상평가지침\n\n2007\n\n11-1470000-001432-01\n\n(생물의약품평가가이드\n\n26)\n\n재조합의약품팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/190\n\n분획용 혈장 마스터 파일\n\n가이드라인\n\n2007\n\n11-1470000-001560-01\n\n(생물의약품평가가이드\n\n25)\n\n생물의약품관리팀\n\n혈액제제팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/210\n\n인플루엔자백신의 자가\n\n기준 및 시험방법 작성\n\n지침 개정판\n\n(\n\n)\n\n2007\n\n11-1470000-001468-01\n\n(생물의약품평가가이드\n\n24)\n\n바이러스백신팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/197\n\nHIV 항체 진단제제의\n\n기준 및 시험방법\n\n작성\n\n‘\n\n’\n\n지침\n\n2007\n\n11-1470000-001462-01\n\n(생물의약품평가가이드\n\n23)\n\n생물진단제제팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/196\n\n세균백신 자가 기준 및\n\n시험방법 작성 지침서\n\n2007\n\n11-1470000-001428-01\n\n(생물의약품평가가이드\n\n22)\n\n세균백신팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/177\n\n바이오 칩 평가 가이드\n\n- -HPV DNA칩 기준 및\n시험방법 작성 지침-\n\n2006\n\n11-1470000-001165-01\n\n(생물의약품평가가이드\n\n21)\n\n생물진단제제팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/154\n\n혈장분획제제 등 바이러스\n\n검증 평가 가이드\n\n2006\n\n11-1470000-001176-01\n\n(생물의약품평가가이드\n\n20)\n\n혈액제제팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/170\n\n유전자재조합의약품\n\n생산용 세포의 발현구조체\n\n분석 및 안정성\n\n평가가이드\n\n2006\n\n11-1470000-001116-01\n\n(생물의약품평가가이드\n\n19)\n\n재조합의약품팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/229\n\n유전재재조합의약품 및\n\n단클론항체의약품의 제조\n\n및 품질관리 자료에 관한\n\n평가가이드\n\n2006\n\n11-1470000-000902-01\n\n(생물의약품평가가이드\n\n18)\n\n재조합의약품팀\n\n생물의약품관리팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/139\n\n이종이식제제의 전임상 및\n\n임상시험에 대한 가이드\n\n2006\n\n11-1470000-001088-01\n\n(생물의약품평가가이드\n\n17)\n\n세포조직공학제제팀\n\n재조합의약품팀\n\n생물의약품안전팀\n\n생물의약품관리팀\n\n국립독성연구원\n\n생명공학지원팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/130\n\n- - 14 -\n행정간행물 제목\n\n발행\n\n연도\n\n행정간행물 번호\n\n발행과\n\n홈페이지\n\n게재 상태\n\n이종이식제제의 품질관리\n\n및 이식 후 감염관리에\n\n대한 가이드\n\n2006\n\n11-1470000-001086-01\n\n(생물의약품평가가이드\n\n16)\n\n세포조직공학제제팀\n\n재조합의약품팀\n\n생물의약품안전팀\n\n생물의약품관리팀\n\n국립독성연구원\n\n생명공학지원팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/130\n\n자료실 간행물\n\n/\n\n,\n\n지침/130\n\n자료실 간행물\n\n/\n\n,\n\n지침/116\n\n자료실 간행물\n\n/\n\n,\n\n지침/110\n\n자료실 간행물\n\n/\n\n,\n\n지침/118\n\n임상시험용\n\n유전자치료제의 특성분석,\n\n제조 및 품질관리\n\n평가가이드\n\n2005\n\n11-1470000-000876-01\n\n(생물의약품평가가이드\n\n11)\n\n생명공학의약품과\n\n자료실 간행물\n\n/\n\n,\n\n지침/107\n\n두창백신의 안전성 유효성\n\n․\n\n평가시 고려사항\n\n2005\n\n11-1470000-000872-01\n\n(생물의약품평가가이드\n\n10)\n\n생물의약품평가과\n\n자료실 간행물\n\n/\n\n,\n\n지침/105\n\n**[표 시작]**\n\n| 2004 | 11-1470000-000684-01 | (생물의약품평가자료집 | 15) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/84 |\n| --- | --- | --- | --- | --- | --- | --- | --- | --- |\n| 생명공학의약품 허가를 | 위한 Q&A | 2006 | 11-1470000-000895-01 | (생물의약품평가자료집 | 28) | 재조합의약품팀 | 생명공학의약품과 | ( | ) | 舊 | 자료실 간행물 | / | , | 지침127 |\n| 유전자치료제의 | 안전성평가 2006 | 2006 | 11-1470000-001140-01 | (생물의약품평가자료집 | 38) | 유전자치료제팀 | 자료실 간행물 | / | , | 지침/169 |\n| 행정간행물 제목 | 발행 | 연도 | 행정간행물 번호 | 발행과 | 홈페이지 | 게재 상태 |\n| 세포치료제의 | 안전성 유효성 및 품질 | ․ | 평가 2006 | 2006 | 11-1470000-001146-01 | (생물의약품평가자료집 | 37) | 세포조직공학제제팀 자료실 간행물 | / | , | 지침/148 | KFDA Bio Handbook | 2005 | 11-1470000-000873-01 | (생물의약품평가자료집 | 26) | 생명공학의약품과 | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/91 |\n| 세포치료제의 임상시험 | 사례분석 | 2007 | 11-1470000-001586-14 | (생물의약품평가자료집 | 50) | 세포조직공학제제팀 자료실 간행물 | / | , | 지침/259 |\n| 생명공학의약품의 | 안전성 유효성 평가 - | ․ | 비교동등성 평가시 | 고려사항 |\n| 정맥주사용 | B형 간염 사람면역글로불린제제의 | 안전성․유효성 평가 가이드라인 |\n| 임상시험의 전반적인 | 고려사항 | 2004 | 11-1470000-000681-01 | (생물의약품평가자료집 | 12) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/79 | 2005 | 11-1470000-000871-01 | (생물의약품평가자료집 | 25) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/103 |\n| 생명공학의약품 | 생산세포주 관리를 위한 | 시험방법 | 2007 | 11-1470000-000903-01 | (생물의약품평가자료집 | 48) | 재조합의약품팀 | 자료실 간행물 | / | , | 지침/236 | 생물의약품의 독성평가 | 사례분석 | 2004 | 11-1470000-000680-01 | (생물의약품평가자료집 | 11) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/77 |\n**════════════════════════════════════════════**\n| 유전자치료제의 | 안전성평가 2005 | 2005 | 11-1470000-000677-14 | (생물의약품평가자료집 | 24) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/104 |\n| 발 | 행 | 일 | 년 | 월 | : | 2008 | 12 |\n| 2006 | 11-1470000-001144-01 | (생물의약품평가자료집 | 35) | 자료실 간행물 | / | , | 지침/146 |\n| 발 | 행 | 기 | 관 | 식품의약품안전청 | : |\n| 백신의 안전성 유효성 | ․ | 평가 2005 | 2005 | 11-1470000-000870-01 | (생물의약품평가자료집 | 23) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/102 | 단클론항체의약품의 | 평가가이드 | 2005 | 11-1470000-000851-01 | (생물의약품평가가이드 | 9) | 자료실 간행물 | / | , | 지침/74 |\n\n**[표 끝]**\n\n생명공학의약품과\n\n생물의약품평가과\n\n국립독성연구원\n\n생화학약리과\n\nTNF 길항제 사용시\n\n잠복결핵 치료지침\n\n2005\n\n11-1470000-000686-01\n\n(생물의약품평가가이드\n\n8)\n\n생물의약품평가과\n\n자료실 간행물\n\n/\n\n,\n\n지침/65\n\nDNA 백신의 평가지침서\n\n2004\n\n11-1470000-000669-01\n\n(생물의약품평가가이드\n\n7)\n\n생명공학의약품과\n\n생물의약품평가과\n\n자료실 간행물\n\n/\n\n,\n\n지침/60\n\n생명공학의약품/\n\n생물학적제제의\n\n규격설정에 관한 가이드\n\n2004\n\n11-1470000-000538-01\n\n(생물의약품평가가이드\n\n6)\n\n생명공학의약품과\n\n자료실 간행물\n\n/\n\n,\n\n지침/59\n\n- - 15 -\n<!-- PAGE_23 -->\n###### 생물의약품평가자료집 시리즈\n\n<!-- PAGE_23 -->\n###### 3.\n\n 행정간행물 제목\n\n발행\n\n연도\n\n행정간행물 번호\n\n발행과\n\n홈페이지\n\n게재 상태\n\n핵산증폭검사법 검증\n\n가이드라인\n\n2003\n\n11-1470000-000277-01\n\n(생물의약품평가가이드\n\n5)\n\n혈액제제과\n\n자료실 간행물\n\n/\n\n,\n\n지침/44\n\n혈장분획제제\n\n품질평가 가이드\n\n2002\n\n11-1470000-000154-01\n\n(생물의약품평가가이드\n\n4)\n\n혈액제제과\n\n자료실 간행물\n\n/\n\n,\n\n지침/27\n\n2002\n\n11-1470000-000144-01\n\n(생물의약품평가가이드\n\n3)\n\n백신과\n\n바이러스제제과\n\n(\n\n)\n\n舊\n\n자료실 간행물\n\n/\n\n,\n\n지침/19\n\n생물의약품의 생산에\n\n사용되는 세포기질관리\n\n가이드\n\n2002\n\n11-1470000-000140-14\n\n(생물의약품평가가이드\n\n2)\n\n생명공학의약품과\n\n생물공학과\n\n(\n\n)\n\n舊\n\n자료실 간행물\n\n/\n\n,\n\n지침/17\n\n유전자치료제의\n\n품질평가 가이드\n\n2001\n\n11-1470000-000074-14\n\n(생물의약품평가가이드\n\n1)\n\n생명공학의약품과\n\n생물공학과\n\n(\n\n)\n\n舊\n\n자료실 간행물\n\n/\n\n,\n\n지침/54\n\n세포치료제의 비임상시험\n\n사례분석\n\n2007\n\n11-1470000-001585-14\n\n(생물의약품평가자료집\n\n49)\n\n세포조직공학제제팀 자료실 간행물\n\n/\n\n,\n\n지침/259\n\n혈액제제의 자가 기준 및\n\n시험방법 작성 지침\n\n2007\n\n11-1470000-001457-01\n\n(생물의약품평가자료집\n\n47)\n\n혈액제제팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/195\n\n혈관질환 등의\n\n유전자치료제\n\n비임상 임상시험 사례분석\n\n∙\n\n2007\n\n11-1470000-001441-10\n\n(생물의약품평가자료집\n\n46)\n\n유전자치료제팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/233\n\n항암 유전자치료제\n\n비임상 임상시험 사례분석\n\n∙\n\n2007\n\n11-1470000-001440-10\n\n(생물의약품평가자료집\n\n45)\n\n유전자치료제팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/209\n\n백신 임상 평가 시\n\n고려사항 2007\n\n2007\n\n11-1470000-001446-10\n\n(생물의약품평가자료집\n\n44)\n\n세균백신팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/192\n\n- - 16 -\n행정간행물 제목\n\n발행\n\n연도\n\n행정간행물 번호\n\n발행과\n\n홈페이지\n\n게재 상태\n\n생바이러스 백신의\n\n자가 기준 및 시험방법\n\n작성 지침\n\n2007\n\n11-1470000-001345-01\n\n(생물의약품평가자료집\n\n43)\n\n바이러스백신팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/172\n\n불활화 바이러스 백신의\n\n자가 기준 및 시험방법\n\n작성 지침\n\n2007\n\n11-1470000-001346-01\n\n(생물의약품평가자료집\n\n42)\n\n바이러스백신팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/173\n\n백신의 임상 평가 시\n\n고려사항\n\n2006\n\n11-1470000-001163-01\n\n(생물의약품평가자료집\n\n41)\n\n바이러스백신팀\n\n세균백신팀\n\n자료실 간행물\n\n/\n\n,\n\n지침 150\n\nDNA 백신의 평가\n\n:\n\nWHO 및 미국\n\nFDA\n\n가이드라인\n\n2006\n\n11-1470000-001142-01\n\n(생물의약품평가자료집\n\n40)\n\n유전자치료제팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/168\n\n유전자치료 임상시험-\n\n지연성 이상반응에 대비한\n\n환자 관찰\n\n2006\n\n11-1470000-001141-01\n\n(생물의약품평가자료집\n\n39)\n\n유전자치료제팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/157\n\n세포치료제 안전성 유효성\n\n․\n\n및 품질 평가시 고려사항\n\n2006\n\n2006\n\n11-1470000-001145-01\n\n(생물의약품평가자료집\n\n36)\n\n세포조직공학제제팀 자료실 간행물\n\n/\n\n,\n\n지침/147\n\n세포조직공학제제\n\n(세포치료제\n\n,\n\n조직공학제제,\n\n이종이식제제\n\n가이드라인\n\n)\n\n세포조직공학제제팀\n\n세균백신팀\n\n바이러스백신팀\n\n혈액제제팀\n\n재조합의약품팀\n\n유전자치료제팀\n\n생물 생명공학의약품의\n\n․\n\n독성평가 사례분석 2006\n\n2006\n\n11-1470000-001143-01\n\n(생물의약품평가자료집\n\n34)\n\n세포조직공학제제팀 자료실 간행물\n\n/\n\n,\n\n지침/145\n\n만성 피부 궤양 및 화상\n\n치료제 개발을 위한\n\n전임상 및\n\n임상 관련\n\n고려사항\n\n2006\n\n11-1470000-001228-01\n\n(생물의약품평가자료집\n\n33)\n\n세포조직공학제제팀 자료실 간행물\n\n/\n\n,\n\n지침/144\n\n- - 17 -\n행정간행물 제목\n\n발행\n\n연도\n\n행정간행물 번호\n\n발행과\n\n홈페이지\n\n게재 상태\n\n미국 약전 세포치료제,\n\n유전자치료제 및\n\n조직공학제제의 보조물질\n\n(ancillary product)\n\n평가자료집\n\n2006\n\n11-1470000-001109-01\n\n(생물의약품평가자료집\n\n32)\n\n세포조직공학제제팀\n\n유전자치료제팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/143\n\n미국 약전 세포치료제 및\n\n유전자치료제\n\n2006\n\n11-1470000-001108-01\n\n(생물의약품평가자료집\n\n31)\n\n세포조직공학제제팀\n\n유전자치료제팀\n\n자료실 간행물\n\n/\n\n,\n\n지침 142\n\n백신의 안전성 유효성\n\n․\n\n평가 2006\n\n2006\n\n11-1470000-001125-01\n\n(생물의약품평가자료집\n\n30)\n\n세균백신팀\n\n바이러스백신팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/141\n\n인플루엔자 백신\n\n자가 기준 및 시험방법\n\n작성 지침\n\n2006\n\n11-1470000-001114-01\n\n(생물의약품평가자료집\n\n29)\n\n바이러스백신팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/138\n\n생명공학의약품 길라잡이\n\n2005\n\n11-1470000-000893-01\n\n(생물의약품평가자료집\n\n27)\n\n재조합의약품팀\n\n생명공학의약품과\n\n(\n\n)\n\n舊\n\n자료실 간행물\n\n/\n\n,\n\n지침/109\n\n탄저백신의 안전성 유효성\n\n․\n\n평가 2005\n\n2005\n\n11-1470000-000867-01\n\n(생물의약품평가자료집\n\n22)\n\n생물의약품평가과\n\n자료실 간행물\n\n/\n\n,\n\n지침/99\n\n인플루엔자백신의\n\n안전성 유효성 평가 2005\n\n․\n\n2005\n\n11-1470000-000866-01\n\n(생물의약품평가자료집\n\n21)\n\n생물의약품평가과\n\n자료실 간행물\n\n/\n\n,\n\n지침/98\n\n항암 생물의약품의\n\n안전성 유효성 평가\n\n․\n\n2005\n\n11-1470000-000865-01\n\n(생물의약품평가자료집\n\n20)\n\n생물의약품평가과\n\n자료실 간행물\n\n/\n\n,\n\n지침/101\n\n- - 18 -\n행정간행물 제목\n\n발행\n\n연도\n\n행정간행물 번호\n\n발행과\n\n홈페이지\n\n게재 상태\n\n우수심사기준\n\n2005\n\n11-1470000-000684-01\n\n(생물의약품평가자료집\n\n19)\n\n생물의약품평가과\n\n자료실 간행물\n\n/\n\n,\n\n지침/100\n\n사람 세포\n\n조직\n\n세포 및\n\n,\n\n,\n\n조직유래제품\n\n: 미\n\nFDA\n\n시설등록 및 등재 규정\n\n2005\n\n11-1470000-000860-01\n\n(생물의약품평가자료집\n\n18)\n\n생명공학의약품과\n\n인체조직정보\n\n방 자료게시판\n\n/\n\n/\n\n4\n\n사람 세포\n\n조직\n\n세포 및\n\n,\n\n,\n\n조직유래제품 제조시설의\n\n미\n\nFDA 우수조직관리기준\n\n2005\n\n11-1470000-000859-01\n\n(생물의약품평가자료집\n\n17)\n\n생명공학의약품과\n\n인체조직정보\n\n방 자료게시판\n\n/\n\n/\n\n5\n\n세포치료제 및\n\n유전자치료제 자료집\n\n2004\n\n11-1470000-000685-01\n\n(생물의약품평가자료집\n\n16)\n\n생물의약품평가과\n\n자료실 간행물\n\n/\n\n,\n\n지침/78\n\n생명공학의약품등의\n\n1상\n\n임상시험계획 승인 신청시\n\n고려사항\n\n2004\n\n11-1470000-000683-01\n\n(생물의약품평가자료집\n\n14)\n\n생물의약품평가과\n\n자료실 간행물\n\n/\n\n,\n\n지침/83\n\n생물의약품등의\n\n효능입증을 위한 고려사항 2004\n\n11-1470000-000682-01\n\n(생물의약품평가자료집\n\n13)\n\n생물의약품평가과\n\n자료실 간행물\n\n/\n\n,\n\n지침/82\n\n혈액제제의 안전성 유효성\n\n․\n\n평가 2004\n\n2004\n\n11-1470000-000679-14\n\n(생물의약품평가자료집\n\n10)\n\n생물의약품평가과\n\n자료실 간행물\n\n/\n\n,\n\n지침/76\n\n세포치료제의\n\n안전성 유효성 평가시\n\n․\n\n고려사항 2004\n\n2004\n\n11-1470000-000678-14\n\n(생물의약품평가자료집\n\n9)\n\n생물의약품평가과\n\n자료실 간행물\n\n/\n\n,\n\n지침/75\n\n유전자치료제의\n\n안전성평가 2004\n\n2004\n\n11-1470000-000677-14\n\n(생물의약품평가자료집\n\n8)\n\n생물의약품평가과\n\n자료실 간행물\n\n/\n\n,\n\n지침/72\n\n생명공학의약품의\n\n안전성평가(4)\n\n2004\n\n11-1470000-000676-14\n\n(생물의약품평가자료집\n\n7)\n\n생물의약품평가과\n\n자료실 간행물\n\n/\n\n,\n\n지침/71\n\n- - 19 -\n행정간행물 제목\n\n발행\n\n연도\n\n행정간행물 번호\n\n발행과\n\n홈페이지\n\n게재 상태\n\n생명공학의약품의\n\n안전성평가(3)\n\n2004\n\n11-1470000-000676-14\n\n(생물의약품평가자료집\n\n6)\n\n생물의약품평가과\n\n자료실 간행물\n\n/\n\n,\n\n지침/70\n\n생명공학의약품의\n\n안전성평가(2)\n\n2004\n\n11-1470000-000676-14\n\n(생물의약품평가자료집\n\n5)\n\n생물의약품평가과\n\n자료실 간행물\n\n/\n\n,\n\n지침/69\n\n생명공학의약품의\n\n안전성평가(1)\n\n2004\n\n11-1470000-000676-14\n\n(생물의약품평가자료집\n\n4)\n\n생물의약품평가과\n\n자료실 간행물\n\n/\n\n,\n\n지침/68\n\n백신의 안전성평가 2004\n\n2004\n\n11-1470000-000675-14\n\n(생물의약품평가자료집\n\n3)\n\n생물의약품평가과\n\n자료실 간행물\n\n/\n\n,\n\n지침/67\n\n진단제제의\n\n기준\n\nHBsAg\n\n‘\n\n및 시험방법\n\n’ 작성 지침\n\n2004\n\n11-1470000-000143-01\n\n(생물의약품평가자료집\n\n2)\n\n백신과\n\n자료실 간행물\n\n/\n\n,\n\n지침/48\n\n<!-- PAGE_28 -->\n###### 발\n\n<!-- PAGE_28 -->\n###### 행\n\n<!-- PAGE_28 -->\n###### 부\n\n<!-- PAGE_28 -->\n###### 서\n\n<!-- PAGE_28 -->\n###### 생물의약품국 혈액제제과\n\n<!-- PAGE_28 -->\n###### :\n\n════════════════════════════════════════════\n\n<!-- PAGE_28 -->\n###### 연\n\n<!-- PAGE_28 -->\n###### 락\n\n<!-- PAGE_28 -->\n###### 처\n\n<!-- PAGE_28 -->\n###### 식품의약품안전청 혈액제제과\n\n<!-- PAGE_28 -->\n###### :\n\n<!-- PAGE_28 -->\n###### 전\n\n<!-- PAGE_28 -->\n###### 화\n\n<!-- PAGE_28 -->\n###### 번\n\n<!-- PAGE_28 -->\n###### 호 :\n\n<!-- PAGE_28 -->\n###### 02) 380-1715, 1765\n\n<!-- PAGE_28 -->\n###### 팩\n\n<!-- PAGE_28 -->\n###### 스\n\n<!-- PAGE_28 -->\n###### 번\n\n<!-- PAGE_28 -->\n###### 호 :\n\n<!-- PAGE_28 -->\n###### 02) 386-6584\n",
        "original_sentence": "행정간행물 제목\n\n발행\n\n연도\n\n행정간행물 번호\n\n발행과\n\n홈페이지\n\n게재 상태\n\n핵산증폭검사법 검증\n\n가이드라인\n\n2003\n\n11-1470000-000277-01\n\n(생물의약품평가가이드\n\n5)\n\n혈액제제과\n\n자료실 간행물\n\n/\n\n,\n\n지침/44\n\n혈장분획제제\n\n품질평가 가이드\n\n2002\n\n11-1470000-000154-01\n\n(생물의약품평가가이드\n\n4)\n\n혈액제제과\n\n자료실 간행물\n\n/\n\n,\n\n지침/27\n\n2002\n\n11-1470000-000144-01\n\n(생물의약품평가가이드\n\n3)\n\n백신과\n\n바이러스제제과\n\n(\n\n)\n\n舊\n\n자료실 간행물\n\n/\n\n,\n\n지침/19\n\n생물의약품의 생산에\n\n사용되는 세포기질관리\n\n가이드\n\n2002\n\n11-1470000-000140-14\n\n(생물의약품평가가이드\n\n2)\n\n생명공학의약품과\n\n생물공학과\n\n(\n\n)\n\n舊\n\n자료실 간행물\n\n/\n\n,\n\n지침/17\n\n유전자치료제의\n\n품질평가 가이드\n\n2001\n\n11-1470000-000074-14\n\n(생물의약품평가가이드\n\n1)\n\n생명공학의약품과\n\n생물공학과\n\n(\n\n)\n\n舊\n\n자료실 간행물\n\n/\n\n,\n\n지침/54\n\n세포치료제의 비임상시험\n\n사례분석\n\n2007\n\n11-1470000-001585-14\n\n(생물의약품평가자료집\n\n49)\n\n세포조직공학제제팀 자료실 간행물\n\n/\n\n,\n\n지침/259\n\n혈액제제의 자가 기준 및\n\n시험방법 작성 지침\n\n2007\n\n11-1470000-001457-01\n\n(생물의약품평가자료집\n\n47)\n\n혈액제제팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/195\n\n혈관질환 등의\n\n유전자치료제\n\n비임상 임상시험 사례분석\n\n∙\n\n2007\n\n11-1470000-001441-10\n\n(생물의약품평가자료집\n\n46)\n\n유전자치료제팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/233\n\n항암 유전자치료제\n\n비임상 임상시험 사례분석\n\n∙\n\n2007\n\n11-1470000-001440-10\n\n(생물의약품평가자료집\n\n45)\n\n유전자치료제팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/209\n\n백신 임상 평가 시\n\n고려사항 2007\n\n2007\n\n11-1470000-001446-10\n\n(생물의약품평가자료집\n\n44)\n\n세균백신팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/192\n\n- - 16 -\n행정간행물 제목\n\n발행\n\n연도\n\n행정간행물 번호\n\n발행과\n\n홈페이지\n\n게재 상태\n\n생바이러스 백신의\n\n자가 기준 및 시험방법\n\n작성 지침\n\n2007\n\n11-1470000-001345-01\n\n(생물의약품평가자료집\n\n43)\n\n바이러스백신팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/172\n\n불활화 바이러스 백신의\n\n자가 기준 및 시험방법\n\n작성 지침\n\n2007\n\n11-1470000-001346-01\n\n(생물의약품평가자료집\n\n42)\n\n바이러스백신팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/173\n\n백신의 임상 평가 시\n\n고려사항\n\n2006\n\n11-1470000-001163-01\n\n(생물의약품평가자료집\n\n41)\n\n바이러스백신팀\n\n세균백신팀\n\n자료실 간행물\n\n/\n\n,\n\n지침 150\n\nDNA 백신의 평가\n\n:\n\nWHO 및 미국\n\nFDA\n\n가이드라인\n\n2006\n\n11-1470000-001142-01\n\n(생물의약품평가자료집\n\n40)\n\n유전자치료제팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/168\n\n유전자치료 임상시험-\n\n지연성 이상반응에 대비한\n\n환자 관찰\n\n2006\n\n11-1470000-001141-01\n\n(생물의약품평가자료집\n\n39)\n\n유전자치료제팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/157\n\n세포치료제 안전성 유효성\n\n․\n\n및 품질 평가시 고려사항\n\n2006\n\n2006\n\n11-1470000-001145-01\n\n(생물의약품평가자료집\n\n36)\n\n세포조직공학제제팀 자료실 간행물\n\n/\n\n,\n\n지침/147\n\n세포조직공학제제\n\n(세포치료제\n\n,\n\n조직공학제제,\n\n이종이식제제\n\n가이드라인\n\n)\n\n세포조직공학제제팀\n\n세균백신팀\n\n바이러스백신팀\n\n혈액제제팀\n\n재조합의약품팀\n\n유전자치료제팀\n\n생물 생명공학의약품의\n\n․\n\n독성평가 사례분석 2006\n\n2006\n\n11-1470000-001143-01\n\n(생물의약품평가자료집\n\n34)\n\n세포조직공학제제팀 자료실 간행물\n\n/\n\n,\n\n지침/145\n\n만성 피부 궤양 및 화상\n\n치료제 개발을 위한\n\n전임상 및\n\n임상 관련\n\n고려사항\n\n2006\n\n11-1470000-001228-01\n\n(생물의약품평가자료집\n\n33)\n\n세포조직공학제제팀 자료실 간행물\n\n/\n\n,\n\n지침/144\n\n- - 17 -\n행정간행물 제목\n\n발행\n\n연도\n\n행정간행물 번호\n\n발행과\n\n홈페이지\n\n게재 상태\n\n미국 약전 세포치료제,\n\n유전자치료제 및\n\n조직공학제제의 보조물질\n\n(ancillary product)\n\n평가자료집\n\n2006\n\n11-1470000-001109-01\n\n(생물의약품평가자료집\n\n32)\n\n세포조직공학제제팀\n\n유전자치료제팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/143\n\n미국 약전 세포치료제 및\n\n유전자치료제\n\n2006\n\n11-1470000-001108-01\n\n(생물의약품평가자료집\n\n31)\n\n세포조직공학제제팀\n\n유전자치료제팀\n\n자료실 간행물\n\n/\n\n,\n\n지침 142\n\n백신의 안전성 유효성\n\n․\n\n평가 2006\n\n2006\n\n11-1470000-001125-01\n\n(생물의약품평가자료집\n\n30)\n\n세균백신팀\n\n바이러스백신팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/141\n\n인플루엔자 백신\n\n자가 기준 및 시험방법\n\n작성 지침\n\n2006\n\n11-1470000-001114-01\n\n(생물의약품평가자료집\n\n29)\n\n바이러스백신팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/138\n\n생명공학의약품 길라잡이\n\n2005\n\n11-1470000-000893-01\n\n(생물의약품평가자료집\n\n27)\n\n재조합의약품팀\n\n생명공학의약품과\n\n(\n\n)\n\n舊\n\n자료실 간행물\n\n/\n\n,\n\n지침/109\n\n탄저백신의 안전성 유효성\n\n․\n\n평가 2005\n\n2005\n\n11-1470000-000867-01\n\n(생물의약품평가자료집\n\n22)\n\n생물의약품평가과\n\n자료실 간행물\n\n/\n\n,\n\n지침/99\n\n인플루엔자백신의\n\n안전성 유효성 평가 2005\n\n․\n\n2005\n\n11-1470000-000866-01\n\n(생물의약품평가자료집\n\n21)\n\n생물의약품평가과\n\n자료실 간행물\n\n/\n\n,\n\n지침/98\n\n항암 생물의약품의\n\n안전성 유효성 평가\n\n․\n\n2005\n\n11-1470000-000865-01\n\n(생물의약품평가자료집\n\n20)\n\n생물의약품평가과\n\n자료실 간행물\n\n/\n\n,\n\n지침/101\n\n- - 18 -\n행정간행물 제목\n\n발행\n\n연도\n\n행정간행물 번호\n\n발행과\n\n홈페이지\n\n게재 상태\n\n우수심사기준\n\n2005\n\n11-1470000-000684-01\n\n(생물의약품평가자료집\n\n19)\n\n생물의약품평가과\n\n자료실 간행물\n\n/\n\n,\n\n지침/100\n\n사람 세포\n\n조직\n\n세포 및\n\n,\n\n,\n\n조직유래제품\n\n: 미\n\nFDA\n\n시설등록 및 등재 규정\n\n2005\n\n11-1470000-000860-01\n\n(생물의약품평가자료집\n\n18)\n\n생명공학의약품과\n\n인체조직정보\n\n방 자료게시판\n\n/\n\n/\n\n4\n\n사람 세포\n\n조직\n\n세포 및\n\n,\n\n,\n\n조직유래제품 제조시설의\n\n미\n\nFDA 우수조직관리기준\n\n2005\n\n11-1470000-000859-01\n\n(생물의약품평가자료집\n\n17)\n\n생명공학의약품과\n\n인체조직정보\n\n방 자료게시판\n\n/\n\n/\n\n5\n\n세포치료제 및\n\n유전자치료제 자료집\n\n2004\n\n11-1470000-000685-01\n\n(생물의약품평가자료집\n\n16)\n\n생물의약품평가과\n\n자료실 간행물\n\n/\n\n,\n\n지침/78\n\n생명공학의약품등의\n\n1상\n\n임상시험계획 승인 신청시\n\n고려사항\n\n2004\n\n11-1470000-000683-01\n\n(생물의약품평가자료집\n\n14)\n\n생물의약품평가과\n\n자료실 간행물\n\n/\n\n,\n\n지침/83\n\n생물의약품등의\n\n효능입증을 위한 고려사항 2004\n\n11-1470000-000682-01\n\n(생물의약품평가자료집\n\n13)\n\n생물의약품평가과\n\n자료실 간행물\n\n/\n\n,\n\n지침/82\n\n혈액제제의 안전성 유효성\n\n․\n\n평가 2004\n\n2004\n\n11-1470000-000679-14\n\n(생물의약품평가자료집\n\n10)\n\n생물의약품평가과\n\n자료실 간행물\n\n/\n\n,\n\n지침/76\n\n세포치료제의\n\n안전성 유효성 평가시\n\n․\n\n고려사항 2004\n\n2004\n\n11-1470000-000678-14\n\n(생물의약품평가자료집\n\n9)\n\n생물의약품평가과\n\n자료실 간행물\n\n/\n\n,\n\n지침/75\n\n유전자치료제의\n\n안전성평가 2004\n\n2004\n\n11-1470000-000677-14\n\n(생물의약품평가자료집\n\n8)\n\n생물의약품평가과\n\n자료실 간행물\n\n/\n\n,\n\n지침/72\n\n생명공학의약품의\n\n안전성평가(4)\n\n2004\n\n11-1470000-000676-14\n\n(생물의약품평가자료집\n\n7)\n\n생물의약품평가과\n\n자료실 간행물\n\n/\n\n,\n\n지침/71\n\n- - 19 -\n행정간행물 제목\n\n발행\n\n연도\n\n행정간행물 번호\n\n발행과\n\n홈페이지\n\n게재 상태\n\n생명공학의약품의\n\n안전성평가(3)\n\n2004\n\n11-1470000-000676-14\n\n(생물의약품평가자료집\n\n6)\n\n생물의약품평가과\n\n자료실 간행물\n\n/\n\n,\n\n지침/70\n\n생명공학의약품의\n\n안전성평가(2)\n\n2004\n\n11-1470000-000676-14\n\n(생물의약품평가자료집\n\n5)\n\n생물의약품평가과\n\n자료실 간행물\n\n/\n\n,\n\n지침/69\n\n생명공학의약품의\n\n안전성평가(1)\n\n2004\n\n11-1470000-000676-14\n\n(생물의약품평가자료집\n\n4)\n\n생물의약품평가과\n\n자료실 간행물\n\n/\n\n,\n\n지침/68\n\n백신의 안전성평가 2004\n\n2004\n\n11-1470000-000675-14\n\n(생물의약품평가자료집\n\n3)\n\n생물의약품평가과\n\n자료실 간행물\n\n/\n\n,\n\n지침/67\n\n진단제제의\n\n기준\n\nHBsAg\n\n‘\n\n및 시험방법\n\n’ 작성 지침\n\n2004\n\n11-1470000-000143-01\n\n(생물의약품평가자료집\n\n2)\n\n백신과\n\n자료실 간행물\n\n/\n\n,\n\n지침/48\n\n<!-- PAGE_28 -->\n###### 발\n\n<!-- PAGE_28 -->\n###### 행\n\n<!-- PAGE_28 -->\n###### 부\n\n<!-- PAGE_28 -->\n###### 서\n\n<!-- PAGE_28 -->\n###### 생물의약품국 혈액제제과\n\n<!-- PAGE_28 -->\n###### :\n\n════════════════════════════════════════════\n\n<!-- PAGE_28 -->\n###### 연\n\n<!-- PAGE_28 -->\n###### 락\n\n<!-- PAGE_28 -->\n###### 처\n\n<!-- PAGE_28 -->\n###### 식품의약품안전청 혈액제제과\n\n<!-- PAGE_28 -->\n###### :\n\n<!-- PAGE_28 -->\n###### 전\n\n<!-- PAGE_28 -->\n###### 화\n\n<!-- PAGE_28 -->\n###### 번\n\n<!-- PAGE_28 -->\n###### 호 :\n\n<!-- PAGE_28 -->\n###### 02) 380-1715, 1765\n\n<!-- PAGE_28 -->\n###### 팩\n\n<!-- PAGE_28 -->\n###### 스\n\n<!-- PAGE_28 -->\n###### 번\n\n<!-- PAGE_28 -->\n###### 호 :\n\n<!-- PAGE_28 -->\n###### 02) 386-6584\n"
      }
    }
  ],
  "chunking_analysis": {
    "total_chunks": 166,
    "avg_chunk_length": 295.0240963855422,
    "min_chunk_length": 13,
    "max_chunk_length": 5470,
    "total_characters": 48974,
    "total_words": 8904,
    "window_size": 3
  },
  "statistics": {
    "total_text_blocks": 2273,
    "heading_count": 912,
    "paragraph_count": 964,
    "list_item_count": 22,
    "table_cell_count": 375,
    "tables_detected": 2,
    "chunks_generated": 166
  }
}